NAME,TID,TARGET_TYPE,PREF_NAME_target,TAX_ID,ORGANISM,CHEMBL_ID_target,SPECIAS_GROUP_FLAG,SPECIES_GROUP_FLAG,MEC_ID,RECORD_ID,MOLREGNO,MECHANISM_OF_ACTION,SITE_ID,ACTION_TYPE,DIRECT_INTERACTION,MOLECULAR_MECHANISM,DISEASE_EFFICACY,MECHANISM_COMMENT,SELECTIVITY_COMMENT,BINDING_SITE_COMMENT,VARIANT_ID,PREF_NAME_drug,CHEMBL_ID_drug,MAX_PHASE,THERAPEUTIC_FLAG,DOSED_INGREDIENT,STRUCTURE_TYPE,CHEBI_PAR_ID,MOLECULE_TYPE,FIRST_APPROVAL,ORAL,PARENTERAL,TOPICAL,BLACK_BOX_WARNING,NATURAL_PRODUCT,FIRST_IN_CLASS,CHIRALITY,PRODRUG,INORGANIC_FLAG,USAN_YEAR,AVAILABILITY_TYPE,USAN_STEM,POLYMER_FLAG,USAN_SUBSTEM,USAN_STEM_DEFINITION,INDICATION_CLASS,WITHDRAWN_FLAG,CHEMICAL_PROBE,ORPHAN,STANDARD_INCHI,STANDARD_INCHI_KEY,SMILES,QED,Lipinski Rules Followed,MolWt,logP,Hydrogen Bond Acceptors,Hydrogen Bond Donors,Stereo Centers,tPSA,Aqueous Solubility Score,Bioavailability,Caco-2 Permeability,HIA,Hydration Free Energy,PAMPA Permeability,P-glycoprotein Inhibition,BBB,PPBR,Volume of Distribution at Steady State,CYP1A2 Inhibition,CYP2C19 Inhibition,CYP2C9 Inhibition,CYP2D6 Inhibition,CYP3A4 Inhibition,Half Life,Hepatocyte Clearance,Microsome Clearance,Acute Toxicity,AMES,Carcinogens,Clinical Toxicity,DILI,hERG,Androgen Receptor Binding (Full Length),Androgen Receptor Binding (Ligand Binding Domain),Estrogen Receptor Binding (Full Length),Estrogen Receptor Binding (Ligand Binding Domain),Aryl Hydrocarbon Receptor Binding,Aromatase Binding,PPAR-Gamma Binding,ATAD5 Binding,Heat Shock Factor Binding,Mitochondrial Membrane Potential,TP53 Binding,Skin Reaction,PAINS
PSEN1,104717,PROTEIN COMPLEX,Gamma-secretase,9606,Homo sapiens,CHEMBL2094135,,0.0,5705.0,1705122.0,317540.0,Gamma-secretase modulator,,MODULATOR,1.0,1.0,1.0,,,,,TARENFLURBIL,CHEMBL190083,3.0,0.0,0.0,MOL,38666.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2005.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m1/s1",SYTBZMRGLBWNTM-SNVBAGLBSA-N,C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,0.8937504426107861,4.0,244.265,3.6808000000000023,1,1,1,37.3,-3.847657521287482,0.9866367936134338,-4.228324050485776,0.9996099710464478,-7.847181345773916,0.6989413142204285,0.010129122715443372,0.7189110398292542,98.6026505467158,-0.11571901163546983,0.11663759499788284,0.11818069517612458,0.19415098577737808,0.0027701074490323664,0.005209306860342622,-8.052190549470689,13.741870732253199,19.603980854100474,2.9647751454794085,0.04722917638719082,0.614677369594574,0.04065560139715672,0.9641344428062439,0.018772313185036183,0.055930642411112785,0.003952287824358791,0.2708830952644348,0.03543384037911892,0.056834762915968895,0.02178905960172415,0.3840158641338348,0.07072436846792698,0.002893247362226248,0.015595658961683512,0.009722225554287433,0.18976258635520935,False
PSEN1,104717,PROTEIN COMPLEX,Gamma-secretase,9606,Homo sapiens,CHEMBL2094135,,0.0,5712.0,1705227.0,447948.0,Gamma-secretase inhibitor,,INHIBITOR,1.0,1.0,1.0,Decreases dose-dependently AÃŸ production in the human central nervous system,,,,SEMAGACESTAT,CHEMBL520733,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2007.0,,-stat,0.0,-stat (-gacestat),enzyme inhibitors: gamma secretase inhibitors,,0.0,0.0,0.0,"InChI=1S/C19H27N3O4/c1-11(2)16(23)18(25)20-12(3)17(24)21-15-14-8-6-5-7-13(14)9-10-22(4)19(15)26/h5-8,11-12,15-16,23H,9-10H2,1-4H3,(H,20,25)(H,21,24)/t12-,15-,16-/m0/s1",PKXWXXPNHIWQHW-RCBQFDQVSA-N,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc21,0.7060433188817483,4.0,361.4420000000001,0.3800000000000008,4,3,3,98.74,-1.8346051696650065,0.7759839653968811,-5.467553553710086,0.9380156040191651,-14.683125182934427,0.5381125807762146,0.08466625958681107,0.20106601268053054,34.304533546735605,3.3720831981980033,0.0011485380004160107,0.010312408581376076,0.001751501887338236,0.008089203154668212,0.05343738235533237,14.07865655034237,16.53854034811391,27.692921003485775,3.0317109533216224,0.17888023853302001,0.17562867403030397,0.11455190032720566,0.2125379592180252,0.10900972187519073,0.133829203248024,0.017715460248291494,0.06555222794413566,0.007910447660833597,0.01626410856842995,0.0047991250641644,0.0014539791736751795,0.0012518003466539084,0.002457364823203534,0.0025334228994324803,0.0039567734813317655,0.14665687531232835,False
PSEN1,104717,PROTEIN COMPLEX,Gamma-secretase,9606,Homo sapiens,CHEMBL2094135,,0.0,5723.0,1705246.0,619010.0,Gamma-secretase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AVAGACESTAT,CHEMBL1090771,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2010.0,,-stat,0.0,-stat (-gacestat),enzyme inhibitors: gamma secretase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31,32)29(17(18(26)30)7-8-20(23,24)25)10-13-2-1-12(9-16(13)22)19-27-11-33-28-19/h1-6,9,11,17H,7-8,10H2,(H2,26,30)/t17-/m1/s1",XEAOPVUAMONVLA-QGZVFWFLSA-N,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,0.42709116497100486,3.0,520.8920000000002,3.916400000000003,6,1,1,119.39000000000001,-6.05192290402222,0.887372624874115,-4.995800395587987,0.9998879194259643,-7.7005015535156405,0.9442734479904175,0.6207166910171509,0.8622470378875733,98.8049073876364,1.273954180234873,0.5081593513488769,0.8586588501930237,0.8757872819900513,0.13756039664149283,0.9563115358352661,26.46114871482198,37.27102904760223,70.09151750749535,3.1515090432110773,0.2058702066540718,0.34412660598754885,0.29019480645656587,0.904629933834076,0.8037203073501586,0.03619575835764408,0.03950149789452553,0.08719153925776482,0.051148634403944016,0.06706486344337463,0.2634043037891388,0.20433336794376372,0.014246829599142075,0.047185177356004714,0.4672056376934052,0.10887965261936187,0.1261545144021511,False
PSEN1,104717,PROTEIN COMPLEX,Gamma-secretase,9606,Homo sapiens,CHEMBL2094135,,0.0,5728.0,1705782.0,515421.0,Gamma-secretase inhibitor,,INHIBITOR,1.0,1.0,1.0,Thiophene sulfonamide gamma-secretase inhibitor (GSI) that selectively inhibits cleavage of APP over Notch.,,,,BEGACESTAT,CHEMBL463981,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-stat,0.0,-stat (-gacestat),enzyme inhibitors: gamma secretase inhibitors,,0.0,0.0,0.0,"InChI=1S/C9H8ClF6NO3S2/c10-5-1-2-6(21-5)22(19,20)17-4(3-18)7(8(11,12)13)9(14,15)16/h1-2,4,7,17-18H,3H2/t4-/m1/s1",PSXOKXJMVRSARX-SCSAIBSYSA-N,O=S(=O)(N[C@H](CO)C(C(F)(F)F)C(F)(F)F)c1ccc(Cl)s1,0.7585200794847413,4.0,391.74199999999996,2.7815000000000003,4,2,1,66.4,-3.8058795151945843,0.6374918997287751,-5.172898090747468,0.9998496532440185,-7.202467022742806,0.9158018112182618,0.31389794647693636,0.8030217051506042,91.08244377251694,14.816457857795848,0.510208809375763,0.937430226802826,0.8071080088615418,0.39082651734352114,0.48658297061920164,-3.7631220527939595,44.87739637178129,11.460210849678012,2.947623609891501,0.01600558515638113,0.4519903749227524,0.015412587951868773,0.7506802022457123,0.477441743016243,0.022032232768833638,0.021302288956940175,0.11882955729961395,0.05077068507671356,0.02813242729753256,0.24246200621128083,0.062356763146817686,0.009795218706130981,0.09450091812759638,0.7870381891727447,0.18730624280869962,0.2791651666164398,False
PSEN1,104717,PROTEIN COMPLEX,Gamma-secretase,9606,Homo sapiens,CHEMBL2094135,,0.0,7917.0,3132990.0,2335393.0,Gamma-secretase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RG-4733,CHEMBL4297422,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H20F5N3O3/c1-20(2,18(32)28-11-21(23,24)22(25,26)27)19(33)30-16-14-9-4-3-7-12(14)13-8-5-6-10-15(13)29-17(16)31/h3-10,16H,11H2,1-2H3,(H,28,32)(H,29,31)(H,30,33)/t16-/m0/s1",OJPLJFIFUQPSJR-INIZCTEOSA-N,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2-c2ccccc21,0.45999835517130294,4.0,469.4100000000001,3.8030000000000017,3,3,1,87.30000000000001,-6.431632695581774,0.7945327877998352,-5.052130467502641,0.9928735613822937,-6.058972706582912,0.8000156283378601,0.5654791176319123,0.8069574952125549,96.78670175218824,4.417862329590191,0.12414911687374115,0.6132099390029907,0.4219784736633301,0.07892409712076187,0.6848107814788819,64.66675300743324,20.882955797332126,51.739750845240295,3.6403096401754027,0.14361560344696045,0.7944453597068787,0.19381343424320222,0.8375121355056763,0.9102665662765503,0.026076423563063146,0.008486488577909767,0.06638561561703682,0.018507457710802554,0.09483303055167198,0.11644732058048249,0.04739477261900902,0.014640896208584308,0.037658448703587054,0.6311155021190643,0.19196954369544983,0.27855909168720244,False
PSEN1,104717,PROTEIN COMPLEX,Gamma-secretase,9606,Homo sapiens,CHEMBL2094135,,0.0,9221.0,2583402.0,1143222.0,Gamma-secretase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NIROGACESTAT,CHEMBL1770916,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2015.0,,-stat,0.0,-stat (-gacestat),enzyme inhibitors: gamma secretase inhibitors,,0.0,0.0,0.0,"InChI=1S/C27H41F2N5O/c1-7-8-23(32-20-10-9-18-11-19(28)12-22(29)21(18)13-20)25(35)33-24-14-34(17-31-24)27(5,6)16-30-15-26(2,3)4/h11-12,14,17,20,23,30,32H,7-10,13,15-16H2,1-6H3,(H,33,35)/t20-,23-/m0/s1",VFCRKLWBYMDAED-REWPJTCUSA-N,CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1,0.44898767005799106,4.0,489.65500000000026,4.786400000000004,5,3,2,70.98,-3.4123876125642854,0.8287977457046509,-5.4146721170560355,0.9997262477874755,-8.32451466237064,0.925905966758728,0.9447451233863831,0.9202485799789428,79.16139379854886,17.847635533321238,0.045345238782465457,0.5838950634002685,0.45388506054878236,0.8866322278976441,0.9652608156204223,112.74969805523922,14.831553129598205,62.549548042087906,3.4898520288234787,0.38755338191986083,0.3348492681980133,0.5641325682401657,0.26063492298126223,0.9697686553001403,0.007317891158163547,0.006445773225277662,0.029236841294914485,0.01333495331928134,0.1708104893565178,0.2673451483249664,0.0033233303343877195,0.01452854685485363,0.06443811506032944,0.450584352016449,0.023444892652332783,0.32420684546232226,False
CDK5,109746,PROTEIN FAMILY,Cyclin-dependent kinase,9606,Homo sapiens,CHEMBL3559691,,0.0,4138.0,2473486.0,452952.0,Cyclin-dependent kinase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9  (CDK1 CDK2 and CDK9)",,,,AZD-5438,CHEMBL488436,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H21N5O2S/c1-12(2)23-13(3)20-11-17(23)16-9-10-19-18(22-16)21-14-5-7-15(8-6-14)26(4,24)25/h5-12H,1-4H3,(H,19,21,22)",WJRRGYBTGDJBFX-UHFFFAOYSA-N,Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,0.7394031145969058,4.0,371.4660000000001,3.376520000000002,7,1,0,89.77000000000001,-3.8259353015427267,0.936194920539856,-4.992731886775413,0.9961562871932983,-9.80161442206132,0.9262018799781799,0.29999861121177673,0.7993293523788452,88.81646780176018,0.28624088389408764,0.3716246038675308,0.16335145086050035,0.039602108858525754,0.25058273375034334,0.6738168120384216,35.7900646545218,19.395764556988222,30.07667957920895,2.1674861076676684,0.21668092161417007,0.42350847125053404,0.2850823372602463,0.9042480707168579,0.6144204139709473,0.039671565964818,0.019188570231199263,0.06312475018203259,0.017045263573527335,0.14076616764068603,0.10702681541442871,0.003731121716555208,0.019303478440269826,0.019608671125024558,0.0891251727938652,0.032950650248676536,0.09963859468698502,False
CDK5,109746,PROTEIN FAMILY,Cyclin-dependent kinase,9606,Homo sapiens,CHEMBL3559691,,0.0,4319.0,2473435.0,692957.0,Cyclin-dependent kinase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PHA-793887,CHEMBL1230607,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25)",HUXYBQXJVXOMKX-UHFFFAOYSA-N,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,0.8622393374431375,4.0,361.4900000000002,2.3134000000000006,4,2,0,81.33,-2.601225777381436,0.5291106343269348,-4.955549470893788,0.984660017490387,-11.265600925529409,0.6554547429084778,0.047112089581787586,0.9438090920448303,45.96301985970092,2.0267241742268807,0.0003835372495814227,0.016601781966164707,0.008257343829609454,0.02835235372185707,0.011614769231528044,-7.918046031307182,-6.670783911283843,0.6751887364530426,3.10520403738515,0.023605453968048095,0.06021154504269362,0.19332341104745865,0.10371274501085281,0.5196710526943207,0.020971085131168365,0.004353459738194942,0.05113642290234566,0.004175232257694006,0.011349881207570434,0.0042897028848528865,0.00016972567682387306,0.0009660326759330928,0.002552551496773958,0.0029584496514871716,0.004845833359286189,0.22078779935836793,False
CDK5,109746,PROTEIN FAMILY,Cyclin-dependent kinase,9606,Homo sapiens,CHEMBL3559691,,0.0,4632.0,2473459.0,511261.0,Cyclin-dependent kinase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AT-7519,CHEMBL445813,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)",OVPNQJVDAFNBDN-UHFFFAOYSA-N,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,0.6529263890140131,4.0,382.2510000000001,2.4505999999999997,4,4,0,98.91,-3.8170945866532238,0.8440669417381287,-5.608866550571716,0.9925374627113343,-14.488615717420373,0.47695760130882264,0.10322268269956111,0.8194682359695434,75.34445842084502,12.857758381935138,0.10006370153278113,0.26872417479753496,0.15624603852629662,0.06417344808578491,0.07866467535495758,53.85274138158089,7.005184443513171,-42.42520215572929,1.7167032460462621,0.3710760921239853,0.35279099345207215,0.459891802072525,0.8100114464759827,0.48259211182594297,0.012112716119736433,0.0153366569429636,0.118842214345932,0.014511233195662498,0.1688200607895851,0.07127958163619041,0.005786790640559048,0.07611600309610367,0.033065597712993625,0.14769472181797028,0.11901986375451087,0.5918694496154785,False
CDK5,109746,PROTEIN FAMILY,Cyclin-dependent kinase,9606,Homo sapiens,CHEMBL3559691,,0.0,4654.0,2472730.0,2349629.0,Cyclin-dependent kinase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RONICICLIB,CHEMBL4442620,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-ciclib,0.0,-ciclib,cyclin dependent kinase inhibitors (formerly-cidib),,0.0,0.0,0.0,"InChI=1S/C18H21F3N4O3S/c1-10(26)11(2)28-16-15(18(19,20)21)9-23-17(25-16)24-12-3-5-13(6-4-12)29(22,27)14-7-8-14/h3-6,9-11,14,22,26H,7-8H2,1-2H3,(H,23,24,25)/t10-,11-,29?/m1/s1",UELYDGOOJPRWGF-MFOHZAOFSA-N,C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F,0.6137860935627716,4.0,430.45200000000017,3.9551700000000025,7,3,3,108.19000000000001,-4.021949557613591,0.9165665030479431,-4.969857569916141,0.9982077598571777,-10.064594778572213,0.7996548414230347,0.1441633753478527,0.6907728910446167,89.45326381993706,2.9103921752755264,0.21973453760147094,0.145887902751565,0.12798441126942633,0.11218543723225594,0.22756081074476242,42.877193185043836,5.5412807685508145,21.20568243632006,2.8925788589297525,0.17460684552788736,0.4254230082035065,0.3913533926010132,0.8851259112358093,0.5847482919692993,0.07088267132639885,0.051074922829866407,0.09506217688322068,0.013232020288705825,0.0977532785385847,0.20324382781982422,0.026853849366307258,0.056244440749287604,0.027598718646913767,0.6415924727916718,0.28640965819358827,0.04493914907798171,False
CDK5,12947,SINGLE PROTEIN,Cyclin-dependent kinase 5,9606,Homo sapiens,CHEMBL4036,,0.0,4356.0,2472994.0,1926932.0,Cyclin-dependent kinase 5 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RGB-286638,CHEMBL3545083,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)",XLSYZSRXVVCHLS-UHFFFAOYSA-N,COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1,0.3093922698692974,3.0,545.6440000000002,2.4208000000000007,8,3,0,115.06,-3.977226652977783,0.7356414556503296,-4.966899876611842,0.9662410974502563,-12.74461543007933,0.5387359380722045,0.5525554865598679,0.7141098439693451,78.87388528875381,4.44269852049379,0.17158030159771442,0.36861380338668825,0.46234909296035764,0.10196100845932961,0.7257068872451782,83.62565385689359,-10.016842353523902,24.42964166894216,2.3116514572060756,0.5917740345001221,0.41398111581802366,0.893314003944397,0.9407618761062622,0.958165442943573,0.018195353634655475,0.019325701147317888,0.03421095609664917,0.019293115846812724,0.544627207517624,0.06346161924302578,0.011746207205578684,0.0925035946071148,0.024775895988568664,0.48783276081085203,0.4734838008880615,0.3812730014324188,False
CDK5,12947,SINGLE PROTEIN,Cyclin-dependent kinase 5,9606,Homo sapiens,CHEMBL4036,,0.0,4703.0,1706014.0,14221.0,Cyclin-dependent kinase 5 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SELICICLIB,CHEMBL14762,2.0,0.0,0.0,MOL,45307.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,,-ciclib,0.0,-ciclib,cyclin dependent kinase inhibitors (formerly-cidib),,0.0,0.0,0.0,"InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1",BTIHMVBBUGXLCJ-OAHLLOKOSA-N,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,0.5756719627819336,4.0,354.4580000000001,3.2021000000000015,7,3,1,87.89,-4.091832189248061,0.7419442653656005,-5.321713429622073,0.9997287869453431,-10.778178400888411,0.9209054589271546,0.6144997358322144,0.7493266344070435,92.91378192033497,22.132027058550307,0.768160080909729,0.5837295174598693,0.5627023696899414,0.6569525063037872,0.7393021941184997,66.00495270112079,49.000024296317875,75.79997922960145,1.988839151503753,0.28813415467739106,0.18750777393579482,0.20704183727502823,0.7652227997779846,0.8983279466629028,0.024534379318356513,0.024149572104215623,0.08716072142124176,0.015648019127547742,0.7972334027290344,0.48850340843200685,0.01452145241200924,0.10515408590435982,0.10760750472545624,0.6965287208557129,0.1908707559108734,0.37188711762428284,False
CDK5,12947,SINGLE PROTEIN,Cyclin-dependent kinase 5,9606,Homo sapiens,CHEMBL4036,,0.0,5305.0,1699827.0,1376110.0,Cyclin-dependent kinase 5 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DINACICLIB,CHEMBL2103840,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,,-ciclib,0.0,-ciclib,cyclin dependent kinase inhibitors (formerly-cidib),,0.0,0.0,0.0,"InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1",PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,0.47016975266866856,4.0,396.4950000000003,2.2785000000000006,7,2,1,92.63,-2.3414777942276914,0.5719939887523651,-5.664015292290552,0.9832141995429993,-10.93455771291009,0.7277009725570679,0.3525309920310974,0.5584617912769317,86.64817510754557,14.916512181856598,0.016729332553222776,0.03570824721828103,0.030253210803493857,0.193418700248003,0.050413443520665166,29.403601799983175,64.47955585300022,75.74036207430125,2.6266804889740247,0.12992473393678666,0.11195156574249268,0.1896250620484352,0.5212397336959839,0.7219894051551818,0.07271746918559074,0.05185171365737915,0.17383716702461244,0.009968416765332222,0.08057809062302113,0.07130613923072815,0.0028457220352720468,0.008273870218545198,0.015800084080547096,0.1039687905460596,0.053135350719094275,0.18726023733615876,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,760.0,1344798.0,27229.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PREDNISONE,CHEMBL635,4.0,1.0,1.0,MOL,8382.0,Small molecule,1955.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,,1.0,pred-,0.0,pred-,prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",XOFYZVNMUHMLCC-ZPOLXVRWSA-N,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,0.7848332802556961,4.0,358.43400000000014,1.7658,5,2,6,91.67,-3.236908176900502,0.7905087471008301,-4.821661442799483,0.999811851978302,-10.57868323877311,0.9193441152572632,0.08150202743709087,0.7981615185737609,64.38567826246069,-1.5478563138182706,0.0012321757356403395,0.030198422633111476,0.01159324956825003,0.0021820706548169254,0.03731858804821968,3.811743869839271,78.13602842668028,7.279237348108779,3.759143145686127,0.09434065446257592,0.011775628378381952,0.09293252304196357,0.15052126049995423,0.05809885859489441,0.9710988759994507,0.919708001613617,0.49529117345809937,0.04954334199428558,0.004748758400091901,0.17928577959537506,0.001992790086660534,0.006578394444659352,0.0032206238247454166,0.022823205776512624,0.010333037399686874,0.1778041258454323,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,761.0,1344066.0,674796.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HALCINONIDE,CHEMBL1200845,4.0,1.0,1.0,MOL,,Small molecule,1974.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1973.0,1.0,-onide,0.0,-onide,topical steroids (acetal derivatives),Anti-Inflammatory (topical),0.0,0.0,0.0,"InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1",MUQNGPZZQDCDFT-JNQJZLCISA-N,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1,0.6406683863701529,4.0,454.96600000000024,3.889300000000003,5,1,8,72.83,-4.9800622225967235,0.904745590686798,-5.0358032623187325,0.9999857187271118,-7.392073506648582,0.9707090139389039,0.20274305641651152,0.9891263008117676,85.82573066925636,4.408271916898111,0.0014201105812389869,0.06575781740248203,0.038931760797277094,0.0029432126320898533,0.5227982044219971,18.192187294259156,73.11668941360203,29.74738110874274,3.6660237339805386,0.3087036103010178,0.02382436825428158,0.028418360836803915,0.1670621156692505,0.20985806435346605,0.9779857635498047,0.4709464550018311,0.37571459710597993,0.03268332425504923,0.030791119486093522,0.5446736931800842,0.005343963415361941,0.02710540909320116,0.005541336769238114,0.2930655971169472,0.03406348004937172,0.11014018468558788,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,762.0,1344648.0,675124.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,MEDRYSONE,CHEMBL1201173,4.0,1.0,1.0,MOL,34829.0,Small molecule,1969.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1965.0,0.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C22H32O3/c1-12-9-15-17-6-5-16(13(2)23)22(17,4)11-19(25)20(15)21(3)8-7-14(24)10-18(12)21/h10,12,15-17,19-20,25H,5-9,11H2,1-4H3/t12-,15-,16+,17-,19-,20+,21-,22+/m0/s1",GZENKSODFLBBHQ-ILSZZQPISA-N,CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,0.7837023582235211,4.0,344.49500000000006,3.9403000000000032,3,1,8,54.370000000000005,-4.219929275497051,0.8255613207817077,-4.544633581115365,0.9998915433883667,-6.808767351524014,0.9880903005599976,0.4825977563858032,0.940451979637146,85.77345521693168,-3.0143523891438404,0.0049662314006127415,0.11064791530370713,0.03689586892724037,0.010907962429337203,0.04031002596020698,-9.921564116414718,91.06351359857159,7.786237141879594,2.5198325223040547,0.02929053260013461,0.01735791066312231,0.05209911670535803,0.095918720215559,0.21592288613319396,0.862542736530304,0.48112912774086,0.40840354561805725,0.04829661324620247,0.007572350732516497,0.055628753080964086,0.0019115806848276407,0.0017253408790566028,0.00921081572305411,0.04119925596751273,0.005369789432734251,0.17586616836488247,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,763.0,1344517.0,675700.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DIFLUPREDNATE,CHEMBL1201749,4.0,1.0,1.0,MOL,31485.0,Small molecule,2008.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,1970.0,1.0,-pred-,0.0,-pred-,prednisone and prednisolone derivatives,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C27H34F2O7/c1-5-6-23(34)36-26(22(33)14-35-15(2)30)10-8-17-18-12-20(28)19-11-16(31)7-9-24(19,3)27(18,29)21(32)13-25(17,26)4/h7,9,11,17-18,20-21,32H,5-6,8,10,12-14H2,1-4H3/t17-,18-,20-,21-,24-,25-,26-,27-/m0/s1",WYQPLTPSGFELIB-JTQPXKBDSA-N,CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.5473104243510836,3.0,508.5580000000002,3.5195000000000025,7,1,8,106.97000000000001,-5.158786768404188,0.7733508944511414,-4.714554777415762,0.9999332308769227,-6.255950254299707,0.9631240129470825,0.3812825262546539,0.994215989112854,90.18863318173905,3.297716192489401,0.0016376627510908293,0.01660589352250099,0.028768252674490215,0.027965857274830343,0.3973870098590851,-24.72983158946102,116.54311846571845,87.55928994001843,2.914484628792235,0.17468896508216858,0.016992512438446284,0.04755976162850857,0.17543551400303842,0.26427034437656405,0.9884992599487304,0.8989797353744506,0.19461439847946166,0.012384318932890891,0.010134708450641483,0.33560213148593904,0.0011156511201988906,0.011433993000537157,0.002328974544070661,0.3329249739646912,0.020266137085855007,0.05588203755905852,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,764.0,1343565.0,27152.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BETAMETHASONE,CHEMBL632,4.0,1.0,1.0,MOL,3077.0,Small molecule,1961.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1962.0,0.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1",UREBDLICKHMUKA-DVTGEIKXSA-N,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,0.667213496992105,4.0,392.4670000000002,1.8957000000000002,5,3,8,94.83,-4.207072788753516,0.9101053595542907,-5.134882436402617,0.9999621868133545,-8.92159545936459,0.9281339049339294,0.09847009479999543,0.9824888706207275,74.3885278631621,0.5189544958271881,0.0010201202740063309,0.024640429439023136,0.010539380891714245,0.004160045203752816,0.15596201717853547,-11.351695504338116,66.3719852770618,13.53502759849457,3.2309923561906784,0.1631464973092079,0.01978734596632421,0.05861943811178207,0.14009025394916536,0.1309180110692978,0.9871644496917724,0.8205852270126343,0.250665956735611,0.01234074728563428,0.014318971161264927,0.31421972513198854,0.0007767009505187161,0.005509626143611968,0.0011999563779681922,0.05314077362418175,0.004447590559720993,0.06907524550333619,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,765.0,1343850.0,374052.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTISONE,CHEMBL389621,4.0,1.0,1.0,MOL,17650.0,Small molecule,1952.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-cort-,0.0,-cort-,cortisone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",JYGXADMDTFJGBT-VWUMJDOOSA-N,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,0.6960164410604959,4.0,362.4660000000002,1.7815999999999996,5,3,7,94.83,-3.214002040339987,0.7755302548408508,-4.8875845449403315,0.9996827840805054,-9.814226587603448,0.9226837277412414,0.08360916785895825,0.5305968642234802,68.4571627263755,-0.09845219679916895,0.0015535940503468737,0.029733201395720242,0.011407319211866707,0.002370627666823566,0.022466443106532098,-9.541854765909994,72.76118725292878,-8.7981459038346,3.218168106558553,0.037334378249943255,0.007536340953447507,0.05729813389480114,0.07966042906045914,0.06703575737774373,0.975431501865387,0.9266667246818543,0.7204445838928223,0.10691688731312751,0.003691441304545151,0.11121735870838165,0.0014416980557143688,0.003750067693181336,0.002406424278160557,0.011236665351316334,0.007484319317154586,0.13413719981908798,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,766.0,1343594.0,419622.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TRIAMCINOLONE ACETONIDE,CHEMBL1504,4.0,1.0,1.0,MOL,71418.0,Small molecule,1960.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,2.0,-olone; -onide,0.0,-olone; -onide,steroids (not prednisolone derivatives); topical steroids (acetal derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1",YNDXUCZADRHECN-JNQJZLCISA-N,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,0.6935078414535659,4.0,434.50400000000025,2.4188000000000005,6,2,8,93.06,-4.107907268556763,0.8830278754234314,-5.279025169926626,0.9999756574630737,-8.997850126032304,0.9528711557388305,0.16311966478824616,0.9895267128944397,78.52835221557089,0.60234394143339,0.00046235463305492884,0.02684011831879616,0.01240377922076732,0.0030152085702866314,0.33527705669403074,-8.024582382641986,65.8015891418783,30.428784302988287,3.8675417590182457,0.35830508470535277,0.012115062889643013,0.061618803068995476,0.16869830042123796,0.15650203675031663,0.9745745539665223,0.3852678030729294,0.24969868510961532,0.016910576820373537,0.01687778059858829,0.4860048294067383,0.0019133555935695768,0.01189546613022685,0.0027034377213567494,0.11884284541010856,0.010422310046851634,0.10322282565757632,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,767.0,1344409.0,439720.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTISONE CYPIONATE,CHEMBL1549,4.0,1.0,1.0,MOL,5783.0,Small molecule,1955.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,0.0,-cort-,0.0,-cort-,cortisone derivatives,,0.0,0.0,0.0,"InChI=1S/C29H42O6/c1-27-13-11-20(30)15-19(27)8-9-21-22-12-14-29(34,28(22,2)16-23(31)26(21)27)24(32)17-35-25(33)10-7-18-5-3-4-6-18/h15,18,21-23,26,31,34H,3-14,16-17H2,1-2H3/t21-,22-,23-,26+,27-,28-,29-/m0/s1",DLVOSEUFIRPIRM-KAQKJVHQSA-N,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC1CCCC1,0.5429922145181357,4.0,486.6490000000005,4.302900000000004,6,2,7,100.9,-5.738054181055494,0.6293500483036041,-4.8798736785174555,0.9997451424598693,-5.903925930981069,0.9555775403976441,0.8467541694641113,0.8109087347984314,100.03063489664764,-1.0352466845876318,0.006797241134336218,0.05187719371169806,0.06424545999616385,0.026721923798322677,0.25800020396709444,-12.937420069365075,125.98349626227287,92.31686283235202,3.0648764563759956,0.03389668222516775,0.018625294044613838,0.04998757038265467,0.11762893348932266,0.3450911521911621,0.9581293821334839,0.9373857378959656,0.5903316915035248,0.11677596867084503,0.00438237875350751,0.1536085069179535,0.008426346909254789,0.014182764664292335,0.013163822330534458,0.19072581827640533,0.054546747356653214,0.11269096378237009,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,768.0,1344368.0,641189.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,CLOBETASOL PROPIONATE,CHEMBL1159650,4.0,1.0,1.0,MOL,31414.0,Small molecule,1985.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1983.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C25H32ClFO5/c1-5-21(31)32-25(20(30)13-26)14(2)10-18-17-7-6-15-11-16(28)8-9-22(15,3)24(17,27)19(29)12-23(18,25)4/h8-9,11,14,17-19,29H,5-7,10,12-13H2,1-4H3/t14-,17-,18-,19-,22-,23-,24-,25-/m0/s1",CBGUOGMQLZIXBE-XGQKBEPLSA-N,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.49795893985199036,4.0,466.97700000000026,4.103100000000003,5,1,8,80.67,-5.351539831011658,0.775406789779663,-4.6112361579979595,0.999981689453125,-5.964767740876279,0.9600221633911132,0.4114375948905945,0.9904909729957581,94.6083888882126,1.1666701276074238,0.004561153577378718,0.09210388027131558,0.08375343345105649,0.019489099271595478,0.7449230909347534,-27.214592144791794,99.15242262677502,71.53630002379934,2.694443825468208,0.09953436255455017,0.03676443644799292,0.021649547293782233,0.13752287700772287,0.2136036142706871,0.9865758180618286,0.8836985945701599,0.3028546690940857,0.02267068363726139,0.027735883463174106,0.3588636636734009,0.0035557466093450786,0.021588550694286824,0.00860427157022059,0.5803659558296204,0.04055165573954582,0.09897231413051485,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,769.0,1344612.0,674446.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTISONE SODIUM SUCCINATE,CHEMBL1200495,4.0,1.0,1.0,MOL,5782.0,Small molecule,1955.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,,1.0,-cort-,0.0,-cort-,cortisone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C25H34O8.Na/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30;/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30);/q;+1/p-1/t16-,17-,18-,22+,23-,24-,25-;/m0./s1",HHZQLQREDATOBM-CODXZCKSSA-M,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+],0.32172279553438154,4.0,484.5210000000004,-2.1333999999999937,8,2,7,141.03,-2.0559985913633287,0.6011872351169586,-5.76478883867073,0.9783711552619934,-10.257021760792142,0.4854878544807434,0.055793676525354385,0.6149118185043335,62.33626902480428,1.3768440262224804,0.0003902406723682361,0.003731235282612033,0.0026821898238267748,0.005325972312130034,0.008214183803647756,-16.756390457931364,41.93051798393763,14.08766398991195,3.110316310669135,0.009440167713910342,0.007165966762113385,0.024396128533408046,0.27426069155335425,0.019590919092297553,0.9278459787368775,0.8582504868507386,0.2727500110864639,0.011977221677079796,0.0012867777637438848,0.03962619472295046,0.00827786133158952,0.002722254884429276,0.0019789160520303994,0.008440642536152154,0.010367319500073791,0.05844376711174846,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,770.0,1343503.0,674551.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUOROMETHOLONE,CHEMBL1200600,4.0,1.0,1.0,MOL,31625.0,Small molecule,1972.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-olone,0.0,-olone,steroids (not prednisolone derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C22H29FO4/c1-12-9-17-15-6-8-21(27,13(2)24)20(15,4)11-18(26)22(17,23)19(3)7-5-14(25)10-16(12)19/h5,7,10,12,15,17-18,26-27H,6,8-9,11H2,1-4H3/t12-,15-,17-,18-,19-,20-,21-,22-/m0/s1",FAOZLTXFLGPHNG-KNAQIMQKSA-N,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.7379088954419751,4.0,376.46800000000013,2.923300000000001,4,2,8,74.6,-4.447117121687275,0.9060429215431214,-4.850020853102477,0.9999902248382568,-8.32880478371971,0.9664627909660339,0.12556443363428116,0.9885656476020813,77.93165990889545,-0.8065130364076258,0.0020666464377427475,0.03853787649422884,0.017851685534697025,0.003333897260017693,0.2314565435051918,-18.361973282559042,69.97786937493797,15.056042450545391,3.1312806371646844,0.12897827178239823,0.01892315954901278,0.03982612639665604,0.1324247967451811,0.14970359653234483,0.9920196890830993,0.8925285696983337,0.36260769665241244,0.027844248898327352,0.02572534701321274,0.41455765068531036,0.0009909329266520217,0.005331999436020851,0.0023607370792888107,0.1020273145288229,0.006127983471378684,0.11180594582110644,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,771.0,1344481.0,674586.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTAMATE HYDROCHLORIDE,CHEMBL1200635,4.0,1.0,1.0,MOL,50854.0,Small molecule,1956.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,,0.0,-cort-,0.0,-cort-,cortisone derivatives,,0.0,0.0,0.0,"InChI=1S/C27H41NO6.ClH/c1-5-28(6-2)15-23(32)34-16-22(31)27(33)12-10-20-19-8-7-17-13-18(29)9-11-25(17,3)24(19)21(30)14-26(20,27)4;/h13,19-21,24,30,33H,5-12,14-16H2,1-4H3;1H/t19-,20-,21-,24+,25-,26-,27-;/m0./s1",AKQNAIYKSALPKV-OYHXESGYSA-N,CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C.Cl,0.5059276007180583,3.0,512.0870000000004,3.096100000000001,7,2,7,104.14,-3.157682534275231,0.7366092324256897,-4.8524085368052665,0.9961469411849976,-7.3547127176831495,0.8988203406333923,0.5030936777591706,0.8898569703102112,72.27385985836483,7.085758058850613,0.005902562174014747,0.04611266441643238,0.023382634017616512,0.158437080681324,0.2476128250360489,35.94655132996827,117.96417936976043,68.15149160461705,3.0227923445768416,0.13822811767458915,0.029087436432018877,0.1479649543762207,0.09508657716214657,0.3384166657924652,0.8464501857757568,0.8127210378646851,0.21373749077320098,0.02362938467413187,0.007043404976138845,0.031712775491178034,0.0038726833881810308,0.017333596758544446,0.0064806171460077165,0.08874545246362686,0.03001303393393755,0.16194588113576175,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,772.0,1344294.0,674713.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BETAMETHASONE SODIUM PHOSPHATE,CHEMBL1200762,4.0,1.0,1.0,MOL,3078.0,Small molecule,1965.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,,1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15-,16-,17-,19-,20-,21-,22-;;/m0../s1",PLCQGRYPOISRTQ-LWCNAHDDSA-L,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+],0.278514355874111,3.0,516.4100000000003,-5.243299999999994,8,2,8,147.02,-1.2445819442810497,0.8099586963653564,-5.602544222045451,0.9975324392318725,-10.077669863271202,0.698505288362503,0.06834256388247013,0.9568453431129456,71.22168420001444,0.3004780761612763,0.00012257720132566874,0.0026660974719561635,0.0014207090978743508,0.006423426233232022,0.016961103584617377,-20.06068294972292,47.260420022176575,11.465122508306564,3.8185866070121213,0.028225461742840706,0.011344142828602344,0.014330777898430824,0.0882391576655209,0.05842759422957897,0.985483992099762,0.790493905544281,0.41830010116100313,0.009905743203125894,0.0016475343916681595,0.08852028343826532,0.0002856059903933783,0.0015457091038115322,0.0002483803531504236,0.030515619553625584,0.002261585323140025,0.024851249461062253,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,773.0,1343629.0,674816.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,LOTEPREDNOL ETABONATE,CHEMBL1200865,4.0,1.0,1.0,MOL,31784.0,Small molecule,1998.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1990.0,1.0,-pred-,0.0,-pred-,prednisone and prednisolone derivatives,Anti-Inflammatory (topical),0.0,0.0,0.0,"InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1",DMKSVUSAATWOCU-HROMYWEYSA-N,CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.49480398580664986,4.0,466.95800000000025,3.9165000000000028,7,1,7,99.13000000000001,-4.976885018932522,0.5816699147224427,-4.551149457110872,0.9998745918273926,-6.758320530857712,0.9437648057937622,0.4498111367225647,0.9770898938179016,94.61179043525918,8.782749338687472,0.02139663086272776,0.1565163291990757,0.1440797246992588,0.12372718006372452,0.5856576502323151,-2.5574029535093197,106.4763220511018,85.10276224162172,2.9176655605925275,0.16284037679433822,0.035037083411589266,0.0368462361395359,0.17823282033205032,0.3830749452114105,0.9452960371971131,0.8843361139297485,0.38402069807052613,0.05651414096355438,0.0181514834985137,0.3648263603448868,0.007556504150852561,0.033348510041832924,0.015767327416688202,0.5213037222623825,0.09355883523821831,0.18559764102101325,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,774.0,1343996.0,674860.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PREDNISOLONE TEBUTATE,CHEMBL1200909,4.0,1.0,1.0,MOL,8381.0,Small molecule,1956.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,0.0,-olone; pred-,0.0,-olone; pred-,steroids (not prednisolone derivatives); prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C27H38O6/c1-24(2,3)14-22(31)33-15-21(30)27(32)11-9-19-18-7-6-16-12-17(28)8-10-25(16,4)23(18)20(29)13-26(19,27)5/h8,10,12,18-20,23,29,32H,6-7,9,11,13-15H2,1-5H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1",HUMXXHTVHHLNRO-KAJVQRHHSA-N,CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.6251252881597862,4.0,458.5950000000002,3.5447000000000024,6,2,7,100.90000000000002,-5.108271380585029,0.7132442772388459,-4.722162958574067,0.9997478008270264,-6.788214546614881,0.971462345123291,0.6189624786376953,0.9360504031181336,93.24689999708285,-1.2369462494991164,0.002698488495661877,0.11836476325988769,0.08369659259915352,0.020901919808238745,0.2846774995326996,-15.521571977819576,134.67306089946504,85.98800437420189,3.4402635815461076,0.07537722587585449,0.023722401401028038,0.04920666180551052,0.14852766767144204,0.2677876740694046,0.8858679056167602,0.7844042181968689,0.25437808930873873,0.03369479551911354,0.009045682445866987,0.13007893934845924,0.006829103222116828,0.009927339851856232,0.010855575976893305,0.23518494069576262,0.027160427160561086,0.16644113389775156,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,775.0,1344057.0,27370.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PREDNISOLONE,CHEMBL131,4.0,1.0,1.0,MOL,8378.0,Small molecule,1955.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-olone; pred-,0.0,-olone; pred-,steroids (not prednisolone derivatives); prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",OIGNJSKKLXVSLS-VWUMJDOOSA-N,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,0.6946116752943168,4.0,360.4500000000002,1.5575999999999999,5,3,7,94.83,-3.009973568362236,0.7499280214309693,-4.9819304676537115,0.9996296286582946,-10.707597932745514,0.8951095581054688,0.06606182754039765,0.6181284546852112,66.96352177057186,0.5340582571551682,0.001946060245973058,0.03532065358012915,0.011679612344596534,0.004320978675968945,0.029408120922744273,2.6238814367617858,81.30106273848233,-7.762622051214109,3.613375663154141,0.05468137860298157,0.008794263524760027,0.07712721601128578,0.10214036218822002,0.0652460653334856,0.9755813717842102,0.9470700263977051,0.6667727112770081,0.0843407690525055,0.005159955618000822,0.15979809761047364,0.0022052314365282656,0.007068543322384357,0.0034245631890371443,0.02338196192868054,0.011883581592701375,0.17189748883247374,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,776.0,1343379.0,421058.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUNISOLIDE,CHEMBL1512,4.0,1.0,1.0,MOL,5106.0,Small molecule,1981.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1974.0,1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C24H31FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h5-7,13-14,16-17,19-20,26,28H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1",XSFJVAJPIHIPKU-XWCQMRHXSA-N,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,0.6927713808384576,4.0,434.50400000000025,2.2747000000000006,6,2,9,93.06,-4.131499119896066,0.8808050870895385,-5.364442873627564,0.9999630451202393,-9.130812749007765,0.9527495384216309,0.16098983585834503,0.989035713672638,78.04825720997128,2.77450936061361,0.00036715102978632783,0.01804299782961607,0.006234441872220486,0.0027431938564404846,0.22026432305574417,-9.47948649948233,75.03131496239212,18.23019729662809,3.977716527244472,0.37877069115638734,0.010772787244059145,0.07336981892585755,0.15662230961024762,0.15942977964878083,0.9671683669090271,0.363347253203392,0.16977538615465165,0.00884093316271901,0.013395167497219519,0.4177005529403687,0.0011042044032365083,0.006007395824417472,0.0019401536439545453,0.07054415736347437,0.0061051733791828156,0.11670763911679387,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,777.0,1343447.0,674293.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PARAMETHASONE ACETATE,CHEMBL1200342,4.0,1.0,1.0,MOL,31963.0,Small molecule,1982.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1962.0,0.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C24H31FO6/c1-12-7-16-15-9-18(25)17-8-14(27)5-6-22(17,3)21(15)19(28)10-23(16,4)24(12,30)20(29)11-31-13(2)26/h5-6,8,12,15-16,18-19,21,28,30H,7,9-11H2,1-4H3/t12-,15+,16+,18+,19+,21-,22+,23+,24+/m1/s1",HYRKAAMZBDSJFJ-LFDBJOOHSA-N,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.661485150928691,4.0,434.50400000000025,2.3224,6,2,9,100.90000000000002,-4.546925722640815,0.8522413372993469,-5.0058150551643905,0.999941599369049,-7.98857314447299,0.9577041149139405,0.18671579360961915,0.9912854909896851,84.5575894756817,2.454851436346469,0.0015400946283079975,0.016134528932161628,0.009157280379440635,0.011784734018146992,0.11661907136440278,-46.20445153267248,111.26646126357537,53.96610623503657,3.145545485781316,0.12411776930093765,0.00925463360035792,0.04963759183883667,0.1424348745495081,0.15913985222578048,0.9916256546974183,0.9095940113067627,0.19839686155319214,0.009487790567800403,0.010716088413028046,0.20785588398575783,0.0005496751247846988,0.0049443204887211325,0.0009942663629772142,0.08024672158062458,0.006737286597490311,0.059531185438390824,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,778.0,1343300.0,674335.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BETAMETHASONE DIPROPIONATE,CHEMBL1200384,4.0,1.0,1.0,MOL,31276.0,Small molecule,1975.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1974.0,1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1",CIWBQSYVNNPZIQ-XYWKZLDCSA-N,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.5482119854331166,3.0,504.5950000000003,3.8175000000000026,7,1,8,106.97000000000001,-5.347607877294961,0.7845675468444824,-4.60192451879755,0.9999414086341858,-5.595483413633308,0.969103479385376,0.5125598073005676,0.9941984295845032,92.64323479445822,-0.28936580621467894,0.002014340171990625,0.03495320547372103,0.039944364689290524,0.017614697013050316,0.628440797328949,-32.728957574888966,114.48072612320075,98.58574391009422,2.7432080319209797,0.1174063216894865,0.026674930984154344,0.02982337474822998,0.2307070955634117,0.2641910821199417,0.9823322176933289,0.8189458727836609,0.14945423007011413,0.01079158103093505,0.019663120992481707,0.27637261152267456,0.0017337447497993708,0.01362256621941924,0.003063492150977254,0.49442420303821566,0.022623270750045776,0.06360950665548444,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,779.0,1344293.0,674489.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BETAMETHASONE ACETATE,CHEMBL1200538,4.0,1.0,1.0,MOL,31275.0,Small molecule,1965.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,,1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17-,18-,19-,21-,22-,23-,24-/m0/s1",AKUJBENLRBOFTD-QZIXMDIESA-N,CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.6621165611785135,4.0,434.5040000000002,2.466500000000001,6,2,8,100.90000000000002,-4.712074804316302,0.8754240036010742,-4.888635348332752,0.999951183795929,-7.3974502890972245,0.9600943446159362,0.22099606692790985,0.9925464034080506,83.99828763769838,1.164679789874492,0.0018067724733555224,0.025935469008982182,0.0191147078294307,0.01198046738281846,0.16201254725456238,-43.61715429753125,102.1283255127946,67.19024176784154,2.9606311501557663,0.11991903968155385,0.012804926582612097,0.043194401636719705,0.17891379520297052,0.1647467792034149,0.9908479571342468,0.8863115906715393,0.22401293367147446,0.01224653092212975,0.012171394552569836,0.25934312418103217,0.0009586131345713511,0.009293840173631907,0.0012305725482292472,0.1485510528087616,0.011408076994121075,0.04709200190845877,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,780.0,1344178.0,1337005.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DEXAMETHASONE SODIUM PHOSPHATE,CHEMBL2021430,4.0,1.0,1.0,MOL,4462.0,Small molecule,1959.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15+,16+,17+,19+,20+,21+,22+;;/m1../s1",PLCQGRYPOISRTQ-FCJDYXGNSA-L,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+],0.278514355874111,3.0,516.4100000000003,-5.243299999999994,8,2,8,147.02,-1.2515033304999714,0.7957334995269776,-5.617366815476051,0.9976690292358399,-10.145126407708773,0.7010394334793091,0.06339935734868049,0.9544475674629211,71.34479404628827,0.20890301321481272,0.00012037245455474022,0.002711907250341028,0.0014459366466326173,0.006355497846379876,0.017003200389444827,-19.887584598407155,46.85739964995868,11.007361353614337,3.8278613836676136,0.0258887174539268,0.010591839713742956,0.013744647242128849,0.08378786472603679,0.056964675337076186,0.9874760270118713,0.8085511803627015,0.4316867679357529,0.010536850872449577,0.0015352001850260423,0.08727974817156792,0.00027632400542643154,0.0015258700936101378,0.00022853032569400967,0.0291125001385808,0.0023563968483358622,0.024508286936907098,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,781.0,1343289.0,675032.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,METHYLPREDNISOLONE SODIUM SUCCINATE,CHEMBL1201081,4.0,1.0,1.0,MOL,,Small molecule,1959.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,,1.0,-olone; -pred-,0.0,-olone; -pred-,steroids (not prednisolone derivatives); prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C26H34O8.Na/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24;/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31);/q;+1/p-1/t14-,16-,17-,19-,23+,24-,25-,26-;/m0./s1",FQISKWAFAHGMGT-SGJOWKDISA-M,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)[O-])[C@@]2(C)C=CC(=O)C=C12.[Na+],0.3144734731044849,4.0,496.5320000000003,-2.1113999999999935,8,2,8,141.03,-2.2861536607568045,0.6582184493541717,-5.785317849530588,0.9879584550857544,-10.070493054962103,0.49660282731056216,0.1035686455667019,0.7836180686950683,69.72202283250104,2.727547998401852,0.00057544939500076,0.007870017731329426,0.005337503284681589,0.013335378491319716,0.03572263391688466,-20.6669247087301,55.03970548561709,24.72189496186499,3.3331754444408808,0.01588723696768284,0.011785445746500044,0.042768394388258454,0.3231735847890377,0.01871020030230284,0.8629135727882385,0.7177526116371155,0.15701819062232972,0.007282084855251014,0.002980849992309231,0.03975447788834572,0.012541135819628835,0.003539547882974148,0.004492454323917627,0.01745705514913425,0.010297680064104498,0.077376629691571,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,782.0,1344145.0,675060.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DESONIDE,CHEMBL1201109,4.0,1.0,1.0,MOL,204734.0,Small molecule,1972.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1970.0,1.0,-onide,0.0,-onide,topical steroids (acetal derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C24H32O6/c1-21(2)29-19-10-16-15-6-5-13-9-14(26)7-8-22(13,3)20(15)17(27)11-23(16,4)24(19,30-21)18(28)12-25/h7-9,15-17,19-20,25,27H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,20+,22-,23-,24+/m0/s1",WBGKWQHBNHJJPZ-LECWWXJVSA-N,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,0.7177493123306525,4.0,416.51400000000024,2.326700000000001,6,2,8,93.06,-3.7316539361122807,0.7727990627288819,-5.106816497584468,0.9998456239700317,-9.662312470585123,0.9363377094268799,0.2790235638618469,0.9245515465736389,74.97091545110938,-0.9700003743128759,0.0006123721723270137,0.061013486981391904,0.01957317516207695,0.006498253019526601,0.24415747523307801,14.929331767551284,83.57694009027868,17.987222334451342,4.098899783093305,0.2174985647201538,0.011652873689308762,0.11555110216140747,0.17271852493286133,0.1238558828830719,0.8588562369346618,0.3054816544055939,0.2911680042743683,0.021377285942435265,0.009906408376991749,0.25959062576293945,0.003936937591060996,0.009809204097837209,0.00787503384053707,0.05555460937321186,0.014407232031226158,0.18102012518793345,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,783.0,1344502.0,674337.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PREDNICARBATE,CHEMBL1200386,4.0,1.0,1.0,MOL,,Small molecule,1991.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,1983.0,1.0,pred-,0.0,pred-,prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1",FNPXMHRZILFCKX-KAJVQRHHSA-N,CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.562816868972934,4.0,488.5770000000002,3.6993000000000027,8,1,7,116.2,-4.445152566417375,0.6125674962997436,-4.47608145297311,0.9997543096542358,-6.692444577088452,0.9596898317337036,0.5403876066207886,0.9775890588760376,90.2205415994087,5.437811315419337,0.005237049325660337,0.06326940171420574,0.10188066586852074,0.06434215046465397,0.48599037528038025,-26.079408755122614,129.19979451566292,104.47544782805457,3.139830889804677,0.06998634599149227,0.018547359947115184,0.05291951037943363,0.24833269119262696,0.3066285789012909,0.9472015023231506,0.8588571190834046,0.19470493048429488,0.018238429352641104,0.014371605101041495,0.16884490773081778,0.0038469535065814853,0.01698431195691228,0.005789091275073588,0.2836019530892372,0.05088148675858974,0.07706841244362295,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,784.0,1343414.0,674451.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BECLOMETHASONE DIPROPIONATE,CHEMBL1200500,4.0,1.0,1.0,MOL,3002.0,Small molecule,1976.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,1973.0,1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1",KUVIULQEHSCUHY-XYWKZLDCSA-N,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C,0.4149432383701715,3.0,521.0500000000003,4.086800000000004,7,1,8,106.97000000000001,-5.4633268966734505,0.7269801497459412,-4.642888776155751,0.9998106360435486,-5.699475239084393,0.9325950264930725,0.7598310470581054,0.9648302078247071,92.26228871724368,1.1027040368956729,0.004797762981615961,0.16146334111690522,0.11685837730765343,0.04738369919359684,0.8401295304298401,-8.857069492375178,111.95153802360653,90.28256458741491,2.779203354417698,0.0809327706694603,0.08119314592331647,0.0230840103700757,0.25492371022701266,0.20855372548103332,0.8791053175926209,0.7300986409187317,0.23082225024700165,0.024754878133535385,0.014906621538102627,0.15563762784004212,0.006118036573752761,0.016175854299217463,0.01735769221559167,0.5918610155582428,0.03976908139884472,0.13777192225679755,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,785.0,1343517.0,674496.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DIFLORASONE DIACETATE,CHEMBL1200545,4.0,1.0,1.0,MOL,31483.0,Small molecule,1977.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1973.0,1.0,,0.0,,,Anti-Inflammatory (topical),0.0,0.0,0.0,"InChI=1S/C26H32F2O7/c1-13-8-17-18-10-20(27)19-9-16(31)6-7-23(19,4)25(18,28)21(32)11-24(17,5)26(13,35-15(3)30)22(33)12-34-14(2)29/h6-7,9,13,17-18,20-21,32H,8,10-12H2,1-5H3/t13-,17-,18-,20-,21-,23-,24-,25-,26-/m0/s1",BOBLHFUVNSFZPJ-JOYXJVLSSA-N,CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.5990209425922626,4.0,494.53100000000023,2.9853000000000014,7,1,9,106.97000000000001,-4.746822019998066,0.8021342873573303,-4.746383466841442,0.9998497724533081,-6.85503818490646,0.9573963522911072,0.4106679022312164,0.9947323799133301,85.8451619752417,1.1677767617666044,0.0013256739344797096,0.014223956177011133,0.01832863399758935,0.024350487068295477,0.31990085244178773,-30.693353729433063,108.8265737282316,80.19197428417795,2.915164079268336,0.18003688603639603,0.019490056624636053,0.05008575916290283,0.22380271255970002,0.24028852880001067,0.976787781715393,0.8114813685417175,0.16056418120861055,0.010637568682432175,0.010551347211003304,0.2848247267305851,0.0008725724794203416,0.011740315798670053,0.002204823651118204,0.3426845416426659,0.01460737083107233,0.06081279271747917,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,786.0,1344383.0,674828.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUMETHASONE PIVALATE,CHEMBL1200877,4.0,1.0,1.0,MOL,31620.0,Small molecule,1982.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1963.0,0.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C27H36F2O6/c1-14-9-16-17-11-19(28)18-10-15(30)7-8-24(18,5)26(17,29)20(31)12-25(16,6)27(14,34)21(32)13-35-22(33)23(2,3)4/h7-8,10,14,16-17,19-20,31,34H,9,11-13H2,1-6H3/t14-,16+,17+,19+,20+,24+,25+,26+,27+/m1/s1",JWRMHDSINXPDHB-OJAGFMMFSA-N,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C,0.5832736199916968,4.0,494.5750000000004,3.4407000000000023,6,2,9,100.9,-5.59467441515059,0.835179328918457,-4.826963605927144,0.9999359011650085,-6.564571296365695,0.9657836794853211,0.31619622707366946,0.9867057919502258,95.59174089949424,3.6225517950776904,0.0008771306093876774,0.013683519954793156,0.01801005264278501,0.009191491734236478,0.26112284064292907,-32.45738659827316,117.85786512419448,84.08429460922115,2.961072037767258,0.14404288828372955,0.01950181587599218,0.037525727227330205,0.15356630496680737,0.2724520698189735,0.9753783702850342,0.7929637670516968,0.151454459130764,0.011900959070771933,0.009615546918939798,0.3736479088664055,0.0011673430155497045,0.007799822697415948,0.0017750923638232053,0.2524027079343796,0.009157967194914818,0.06067017603199929,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,787.0,1343706.0,674859.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HALOBETASOL PROPIONATE,CHEMBL1200908,4.0,1.0,1.0,MOL,,Small molecule,1990.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1990.0,1.0,,0.0,,,Anti-Inflammatory (topical),0.0,0.0,0.0,"InChI=1S/C25H31ClF2O5/c1-5-21(32)33-25(20(31)12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15-,16-,18-,19-,22-,23-,24-,25-/m0/s1",BDSYKGHYMJNPAB-LICBFIPMSA-N,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.4806760513310261,4.0,484.9670000000002,4.0511000000000035,5,1,9,80.67,-5.54662477889394,0.8115009188652038,-4.697156826031458,0.9999648094177246,-6.138801565918705,0.960940158367157,0.46171302199363706,0.9913400888442994,95.2596649522706,3.390249084044407,0.003073135063823429,0.052150638028979304,0.06667002402245999,0.02222180962562561,0.6699521243572235,-17.99974756472045,104.41179979171599,69.13720649887662,2.8004094174649774,0.10400326568633318,0.03686090097762644,0.028247395530343056,0.15511666014790534,0.24300719797611237,0.976280152797699,0.8313352942466736,0.21066410541534425,0.01379379043355584,0.021709442744031547,0.3766802832484245,0.0029364807531237604,0.016248312033712863,0.007019022945314646,0.5589740693569183,0.026395652815699576,0.08536777859553694,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,788.0,1343405.0,674919.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTISONE SODIUM PHOSPHATE,CHEMBL1200968,4.0,1.0,1.0,MOL,5781.0,Small molecule,1960.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,,0.0,-cort-,0.0,-cort-,cortisone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C21H31O8P.2Na/c1-19-7-5-13(22)9-12(19)3-4-14-15-6-8-21(25,17(24)11-29-30(26,27)28)20(15,2)10-16(23)18(14)19;;/h9,14-16,18,23,25H,3-8,10-11H2,1-2H3,(H2,26,27,28);;/q;2*+1/p-2/t14-,15-,16-,18+,19-,20-,21-;;/m0../s1",RYJIRNNXCHOUTQ-OJJGEMKLSA-L,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+],0.29589532902078175,4.0,486.4090000000003,-5.357399999999995,8,2,7,147.02,-0.5519106187456108,0.6104790568351746,-5.524153961809406,0.9656630873680114,-10.564970301449332,0.6459210693836213,0.05498173236846924,0.5032986342906952,63.94567223380345,2.8902162142275136,0.00019256848630107016,0.0038994160946458577,0.001803452955937246,0.004499756835866719,0.005365860956953838,19.816338133685914,52.45843745583845,1.4716564465972737,3.947730616373213,0.004534633690491318,0.00442375179627561,0.015103224664926529,0.05908181890845299,0.05796441547572613,0.9584017992019653,0.8752012014389038,0.6593969941139222,0.038584188465029,0.000746741313560051,0.035620728693902495,0.0006293815260505653,0.0013777571308310143,0.00037726517457485896,0.015021326605346986,0.005293360119685531,0.041650496516376735,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,789.0,1343771.0,675015.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUOROMETHOLONE ACETATE,CHEMBL1201064,4.0,1.0,1.0,MOL,78354.0,Small molecule,1986.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1984.0,1.0,-olone,0.0,-olone,steroids (not prednisolone derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C24H31FO5/c1-13-10-19-17-7-9-23(14(2)26,30-15(3)27)22(17,5)12-20(29)24(19,25)21(4)8-6-16(28)11-18(13)21/h6,8,11,13,17,19-20,29H,7,9-10,12H2,1-5H3/t13-,17-,19-,20-,21-,22-,23-,24-/m0/s1",YRFXGQHBPBMFHW-SBTZIJSASA-N,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.6945533405618345,4.0,418.50500000000017,3.494100000000002,5,1,8,80.67,-4.7837625912927235,0.8097038984298706,-4.515012381620195,0.999985146522522,-6.348585259257261,0.9759567856788636,0.25499937534332273,0.9934581041336059,88.05453804408198,-4.877991682602859,0.001950067096913699,0.044603359699249265,0.037637814925983545,0.008391239680349827,0.3526888400316238,-38.49883435816443,87.98851185199521,54.81216979275225,2.8154904595468526,0.09476166367530822,0.019346262025646866,0.029817158356308937,0.12728338800370692,0.17884153872728348,0.9921105146408081,0.8910489559173584,0.25578655004501344,0.01852361802011728,0.009213291457854211,0.35834784507751466,0.001554381602909416,0.008037867676466703,0.0034005432622507214,0.2708893373608589,0.015306886285543442,0.10274227308109403,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,790.0,1344148.0,27575.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,METHYLPREDNISOLONE,CHEMBL650,4.0,1.0,1.0,MOL,6888.0,Small molecule,1957.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-olone; -pred-,0.0,-olone; -pred-,steroids (not prednisolone derivatives); prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1",VHRSUDSXCMQTMA-PJHHCJLFSA-N,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12,0.685142538776804,4.0,374.4770000000001,1.8036,5,3,8,94.83000000000001,-3.3796784068533094,0.8008372187614441,-4.945904502008792,0.9997571587562561,-9.801793175391945,0.9138321995735168,0.14682018905878066,0.8138093829154969,74.23343115600048,0.16647968726661394,0.002361649918020703,0.05013622734695673,0.016299105470534415,0.008959245053119957,0.09135625138878822,3.129453127355299,91.56222849927804,2.2984838962451937,3.56258897171425,0.08575950860977173,0.01324773601954803,0.11964785009622574,0.13449138924479484,0.10118384286761284,0.9353688597679138,0.8408629894256592,0.4228416562080383,0.037478364631533624,0.013889216689858586,0.17288414239883423,0.00277513723121956,0.007082937425002456,0.006702178600244224,0.05841895220801234,0.012369672465138138,0.17126035764813424,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,791.0,1344367.0,381691.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TRIAMCINOLONE,CHEMBL1451,4.0,1.0,1.0,MOL,9667.0,Small molecule,1957.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,0.0,-olone,0.0,-olone,steroids (not prednisolone derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1",GFNANZIMVAIWHM-OBYCQNJPSA-N,C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F,0.545907213602937,4.0,394.4390000000002,0.6204999999999998,6,4,8,115.06,-3.4213306648579573,0.8688959121704102,-5.367465012130357,0.9997879862785339,-10.44902980451688,0.7724032044410706,0.03686182759702206,0.9487951397895813,66.65225108488825,-1.1432056942106932,0.0008458962462100317,0.011178278713487089,0.00477482692222111,0.003570096124894917,0.07998641729354858,-9.50734191061917,56.84072060996978,0.01014245628765167,3.367355572780684,0.17251615226268768,0.013840315124252812,0.06752263680100441,0.15316314436495304,0.09882390722632409,0.9861458778381348,0.8729056596755982,0.30632505714893343,0.015672948956489564,0.010626165324356406,0.2703479707241058,0.0007960178787470795,0.007139988802373409,0.0012667215021792799,0.036478026770055294,0.00604862836189568,0.07557328259572386,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,792.0,1344076.0,419542.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUOCINONIDE,CHEMBL1501,4.0,1.0,1.0,MOL,,Small molecule,1971.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1970.0,1.0,-onide,0.0,-onide,topical steroids (acetal derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1",WJOHZNCJWYWUJD-IUGZLZTKSA-N,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,0.6025729235661365,4.0,494.53100000000023,2.9376000000000015,7,1,9,99.13000000000001,-4.593383505977008,0.9028485894203186,-5.174873333705167,0.9999221682548523,-7.7157081121109625,0.9725554466247559,0.2731418043375015,0.9942733407020569,85.18608872703278,6.80928900441553,0.0005434292721474776,0.015696422941982747,0.011203068913891912,0.0077415590174496176,0.20439793467521666,-35.70400521952044,104.20442856025059,73.13360082021381,3.879513131836223,0.33817018419504163,0.012896997854113579,0.05624545142054558,0.3315776169300079,0.17722060680389404,0.9575171709060669,0.3093351095914841,0.10955122485756874,0.00636365688405931,0.011901077046059073,0.3070580378174782,0.002011576748918742,0.011335116345435381,0.0018956038111355156,0.28921147212386134,0.0101726152934134,0.0681104723829776,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,793.0,1344879.0,508532.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUTICASONE FUROATE,CHEMBL1676,4.0,1.0,1.0,MOL,74899.0,Small molecule,2007.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,2006.0,2.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H29F3O6S/c1-14-9-16-17-11-19(29)18-10-15(31)6-7-24(18,2)26(17,30)21(32)12-25(16,3)27(14,23(34)37-13-28)36-22(33)20-5-4-8-35-20/h4-8,10,14,16-17,19,21,32H,9,11-13H2,1-3H3/t14-,16+,17+,19+,21+,24+,25+,26+,27+/m1/s1",XTULMSXFIHGYFS-VLSRWLAYSA-N,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,0.5437695227604175,3.0,538.5840000000003,4.9268000000000045,7,1,9,93.81,-6.273319149332937,0.7982496738433837,-4.822678280440978,0.9999815464019776,-7.222346871311338,0.9626201868057251,0.5282026171684265,0.9850777745246887,102.1209742368773,7.76520382935018,0.013142688886728138,0.1294528692960739,0.21757658645510675,0.03319872952997684,0.6737746119499206,56.807876218941466,111.36515636688043,87.20701952806627,2.8030309245415364,0.05458331424742937,0.015523613244295121,0.011570288985967635,0.31190550327301025,0.3555115818977356,0.9741635918617249,0.7336138606071472,0.29402569234371184,0.024737745244055986,0.016995345894247293,0.49309265315532685,0.0061467956751585,0.016486416570842266,0.012208256032317876,0.7485870778560638,0.028390897996723653,0.09333700244314969,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,794.0,1344891.0,591037.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DESOXIMETASONE,CHEMBL1766,4.0,1.0,1.0,MOL,691037.0,Small molecule,1977.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1975.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C22H29FO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-21(13,3)22(15,23)18(27)10-20(16,2)19(12)17(26)11-24/h6-7,9,12,15-16,18-19,24,27H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,18+,19-,20+,21+,22+/m1/s1",VWVSBHGCDBMOOT-IIEHVVJPSA-N,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,0.7771649436279087,4.0,376.4680000000002,2.7808000000000015,4,2,8,74.6,-4.212590742269371,0.9051381349563599,-4.9085592977070895,0.9999816417694092,-8.490355079276535,0.9561945080757142,0.1719590410590172,0.9901770949363708,80.42840055842241,0.5595719324291029,0.002306570514338091,0.0387134363874793,0.016369658568874002,0.00613466901704669,0.18960400074720382,-13.795695431818476,80.99426891967643,16.68377013983761,3.060187205224835,0.15074125826358795,0.022103508724831043,0.059882257133722305,0.11289253458380699,0.13418707251548767,0.9870506167411804,0.8296297550201416,0.2739425152540207,0.01815369799733162,0.014830118312966078,0.23288122862577437,0.0008765324659179896,0.005093097733333707,0.0020183250890113413,0.07107932083308696,0.004647543746978044,0.0928681630641222,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,795.0,1344911.0,674327.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BETAMETHASONE BENZOATE,CHEMBL1200376,4.0,1.0,1.0,MOL,,Small molecule,1982.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1969.0,0.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C29H33FO6/c1-17-13-22-21-10-9-19-14-20(32)11-12-26(19,2)28(21,30)23(33)15-27(22,3)29(17,24(34)16-31)36-25(35)18-7-5-4-6-8-18/h4-8,11-12,14,17,21-23,31,33H,9-10,13,15-16H2,1-3H3/t17-,21-,22-,23-,26-,27-,28-,29-/m0/s1",SOQJPQZCPBDOMF-YCUXZELOSA-N,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccccc1)C(=O)CO,0.6159542688928459,4.0,496.57500000000033,3.760400000000003,6,2,8,100.9,-6.059951403954699,0.840279507637024,-4.80264088666298,0.9999423146247863,-6.723032955880083,0.9388019919395447,0.5806945323944092,0.9838794946670533,101.96705555161591,3.493785814668783,0.005718171155604068,0.06568640731275081,0.09355579987168312,0.024377907067537306,0.5132770597934723,-30.089834854225803,123.79810324822475,91.2049016937752,3.173909116989268,0.0955183744430542,0.03598995329812169,0.036204385384917256,0.33801608979701997,0.3473066329956055,0.9694514274597168,0.7759639263153076,0.2328576534986496,0.012762952223420143,0.04125233832746744,0.3150708205997944,0.00409125464502722,0.03690419178456068,0.0048884647898375985,0.7154676973819732,0.05208293441683054,0.06219105033669621,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,796.0,1344251.0,674400.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TRIAMCINOLONE DIACETATE,CHEMBL1200449,4.0,1.0,1.0,MOL,9669.0,Small molecule,1959.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,,0.0,-olone,0.0,-olone,steroids (not prednisolone derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C25H31FO8/c1-13(27)33-12-20(31)25(32)21(34-14(2)28)10-18-17-6-5-15-9-16(29)7-8-22(15,3)24(17,26)19(30)11-23(18,25)4/h7-9,17-19,21,30,32H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22-,23-,24-,25+/m0/s1",XGMPVBXKDAHORN-RBWIMXSLSA-N,CC(=O)OCC(=O)[C@@]1(O)[C@H](OC(C)=O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.5855060519155003,4.0,478.5130000000003,1.7620999999999991,8,2,8,127.2,-4.361919793031387,0.7732176661491394,-5.008990731536938,0.9996876001358033,-8.088706328213059,0.9051390767097474,0.19745067954063417,0.9870877623558044,79.16609303988943,0.573932580508348,0.0016400464588514295,0.011352679482661188,0.01076870267279446,0.024707103334367275,0.10376322343945503,-36.511269760743346,97.50410616348009,64.7802636895947,3.0553732755455294,0.19343308880925178,0.013390705012716353,0.06085175275802612,0.2071441426873207,0.16797138154506683,0.9880381464958191,0.9102631688117981,0.3121760219335556,0.02297659758478403,0.008214547688839956,0.25224636495113373,0.0010631586337694898,0.01549775330349803,0.001816097489790991,0.15857655182480812,0.02084150966256857,0.04800522951409221,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,797.0,1344677.0,674513.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTISONE VALERATE,CHEMBL1200562,4.0,1.0,1.0,MOL,50865.0,Small molecule,1978.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,1977.0,1.0,-cort-,0.0,-cort-,cortisone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C26H38O6/c1-4-5-6-22(31)32-26(21(30)15-27)12-10-19-18-8-7-16-13-17(28)9-11-24(16,2)23(18)20(29)14-25(19,26)3/h13,18-20,23,27,29H,4-12,14-15H2,1-3H3/t18-,19-,20-,23+,24-,25-,26-/m0/s1",FZCHYNWYXKICIO-FZNHGJLXSA-N,CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.6056137866355813,4.0,446.58400000000023,3.522700000000002,6,2,7,100.90000000000002,-4.6875287701845485,0.6546264231204987,-4.73525255424236,0.9998591542243958,-6.280907387416019,0.9582508325576782,0.5760040163993836,0.902973473072052,86.41355175503031,0.5571681093201765,0.0050945618626428765,0.06545182392001152,0.07570799328386783,0.021873768512159587,0.32524076104164124,-10.420279215621857,122.48515853025114,70.60540465315955,3.005364152561179,0.0654927745461464,0.017506489832885563,0.05217577181756496,0.13138306215405465,0.2144880011677742,0.9673293828964233,0.9323379278182984,0.41479986906051636,0.05452667027711868,0.0053234391321893785,0.1899037927389145,0.005367140402086079,0.013052114006131887,0.008514357823878526,0.15058962255716324,0.04703969396650791,0.11491044461727143,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,798.0,1343325.0,674683.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,AMCINONIDE,CHEMBL1200732,4.0,1.0,1.0,MOL,31199.0,Small molecule,1979.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1975.0,1.0,-onide,0.0,-onide,topical steroids (acetal derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1",ILKJAFIWWBXGDU-MOGDOJJUSA-N,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,0.5897471433786257,3.0,502.5790000000003,3.5238000000000023,7,1,8,99.13000000000001,-4.87314116241355,0.886525285243988,-5.107570494118909,0.999962854385376,-7.417543040759135,0.9702975988388062,0.3713913977146149,0.994832181930542,88.99296377667997,2.0862691234622246,0.0012355494043731596,0.030581273883581162,0.02640510299243033,0.007968777581118048,0.37157238125801084,-32.381992794425635,98.81396250007502,81.79352923535119,3.5470397132241525,0.26987995132803916,0.013343052472919226,0.0477560980245471,0.3358671605587006,0.1603248193860054,0.9816646575927734,0.4903359472751617,0.189633047580719,0.010536392591893673,0.016517025837674736,0.3284205585718155,0.0035935681546106933,0.020648927241563798,0.00395069569349289,0.4972536787390709,0.02792334072291851,0.0768700526561588,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,799.0,1343698.0,674940.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ALCLOMETASONE DIPROPIONATE,CHEMBL1200989,4.0,1.0,1.0,MOL,31184.0,Small molecule,1982.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1979.0,1.0,,0.0,,,Anti-Inflammatory (topical),0.0,0.0,0.0,"InChI=1S/C28H37ClO7/c1-6-22(33)35-14-21(32)28(36-23(34)7-2)15(3)10-18-24-19(29)12-16-11-17(30)8-9-26(16,4)25(24)20(31)13-27(18,28)5/h8-9,11,15,18-20,24-25,31H,6-7,10,12-14H2,1-5H3/t15-,18+,19-,20+,24-,25+,26+,27+,28+/m1/s1",DJHCCTTVDRAMEH-DUUJBDRPSA-N,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl,0.41719552308352964,3.0,521.0500000000003,3.942700000000003,7,1,9,106.97000000000003,-5.245090045637805,0.757602846622467,-4.709014061342083,0.9996510744094849,-5.873449703264534,0.9462888836860657,0.7141113758087159,0.970724093914032,90.4727810195546,0.4008146004457543,0.00428299096529372,0.12250521630048752,0.07391645759344101,0.06958966199308633,0.7867334842681885,1.99435776193695,120.39725188543169,80.48273420795968,2.9099921744675923,0.07671495303511619,0.07354956539347768,0.03248336259275675,0.2264014631509781,0.22592743188142778,0.8661099433898926,0.749439823627472,0.15811512470245362,0.014334513992071151,0.012708792591001838,0.10060288682579994,0.004201726743485778,0.009993586596101523,0.011872152285650372,0.40743989050388335,0.024927713535726072,0.12274964498355985,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,800.0,1343304.0,674965.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PREDNISOLONE SODIUM PHOSPHATE,CHEMBL1201014,4.0,1.0,1.0,MOL,,Small molecule,1973.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-olone; pred-,0.0,-olone; pred-,steroids (not prednisolone derivatives); prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C21H29O8P.2Na/c1-19-7-5-13(22)9-12(19)3-4-14-15-6-8-21(25,17(24)11-29-30(26,27)28)20(15,2)10-16(23)18(14)19;;/h5,7,9,14-16,18,23,25H,3-4,6,8,10-11H2,1-2H3,(H2,26,27,28);;/q;2*+1/p-2/t14-,15-,16-,18+,19-,20-,21-;;/m0../s1",VJZLQIPZNBPASX-OJJGEMKLSA-L,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+],0.2967556709135343,4.0,484.3930000000003,-5.581399999999994,8,2,7,147.02,-0.23502142470245121,0.5976182579994201,-5.5771656372031035,0.972659170627594,-11.164590719427787,0.6434625923633576,0.05984882153570652,0.5568111538887024,65.07465172501685,2.798343271628347,0.00019512469940536904,0.00506640097592026,0.0017437694652471692,0.006262131687253714,0.006713964079972356,2.751612884099422,56.81470328885607,2.945914768945772,4.217731006312858,0.005725694878492504,0.005693593904288719,0.01694266814738512,0.06613115947693586,0.04171944782137871,0.965694260597229,0.8983384370803833,0.6704647779464722,0.03725973991677165,0.0008901227549358737,0.0368481021374464,0.0006126217826022184,0.0014787660053116269,0.00046648932075186165,0.018132610563770867,0.00457531709689647,0.05009435634128749,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,801.0,1343865.0,150313.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTISONE ACETATE,CHEMBL1091,4.0,1.0,1.0,MOL,17609.0,Small molecule,1951.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-cort-,0.0,-cort-,cortisone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C23H32O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-18,20,26,28H,4-9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1",ALEXXDVDDISNDU-JZYPGELDSA-N,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.7005234282178955,4.0,404.5030000000002,2.3524000000000003,6,2,7,100.90000000000002,-4.045257991002659,0.7633855819702149,-4.756980906463175,0.9997639775276184,-8.00152227796519,0.9546664118766784,0.25803090780973437,0.8968402981758118,76.64767755946362,0.15618851288251667,0.003614399640355259,0.0434413880109787,0.025262844283133745,0.013294624211266638,0.050415811315178874,-30.027514847252938,110.2171375371177,48.613417941289754,2.94588660726994,0.04342822749167681,0.009207411961688195,0.05505735352635384,0.13303399160504342,0.12018845900893212,0.9771979808807373,0.9338128685951232,0.5259074211120606,0.06449311152100563,0.0053562703207717275,0.08890451826155185,0.002180317521560937,0.006304076476953924,0.0028155797510407863,0.041870797798037526,0.017546458821743726,0.0939055718947202,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,802.0,1344391.0,187696.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,MOMETASONE FUROATE,CHEMBL1161,4.0,1.0,1.0,MOL,47564.0,Small molecule,1987.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,1987.0,1.0,,0.0,,,Steroid (topical),0.0,0.0,0.0,"InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1",WOFMFGQZHJDGCX-ZULDAHANSA-N,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,0.44910184900220873,3.0,521.4370000000004,4.869200000000005,6,1,8,93.81,-5.464427432213615,0.6940423607826233,-4.757537186132341,0.9999758243560791,-7.117558814986649,0.9400083899497986,0.773053503036499,0.9527373433113098,104.67217276529198,4.271358047003443,0.03067138607148081,0.4117469280958176,0.4422403037548065,0.12964827567338943,0.8187708497047425,35.37840275800413,104.89637558172527,80.16258283849126,3.384457160545847,0.0549380362033844,0.054491208773106335,0.017463496793061493,0.2709843456745148,0.2903882533311844,0.901914370059967,0.7627730011940003,0.43779892921447755,0.05144087187945843,0.024460542481392622,0.3512136846780777,0.017076854314655065,0.03509340547025204,0.06880555599927902,0.8648566603660583,0.08339858874678611,0.17841754518449307,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,803.0,1344659.0,954312.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DEXAMETHASONE ACETATE,CHEMBL1530428,4.0,1.0,1.0,MOL,4463.0,Small molecule,1973.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1979.0,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17+,18+,19+,21+,22+,23+,24+/m1/s1",AKUJBENLRBOFTD-RPRRAYFGSA-N,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.6621165611785135,4.0,434.5040000000002,2.466500000000001,6,2,8,100.90000000000002,-4.708805349875387,0.8670000433921814,-4.905217244033549,0.9999577283859253,-7.47084284502144,0.9603926301002502,0.2017297625541687,0.9918614864349365,84.19488739538006,1.1090638390121086,0.001845504868470016,0.02629213808104396,0.019243938894942404,0.01228888463228941,0.1626999020576477,-43.636363216682916,101.55869967831788,66.44983670377819,2.9721911485617345,0.11379770785570145,0.01190254803514108,0.04075048007071018,0.1702808741480112,0.16403904110193251,0.9923416495323181,0.901223075389862,0.24459025412797927,0.013668391201645137,0.011680500663351268,0.270938403904438,0.000954535196069628,0.00948480386286974,0.0011999614827800543,0.14214474260807036,0.011984516214579344,0.04730265088146553,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,804.0,1343159.0,515027.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTISONE BUTYRATE,CHEMBL1683,4.0,1.0,1.0,MOL,31674.0,Small molecule,1982.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1980.0,1.0,-cort-,0.0,-cort-,cortisone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C25H36O6/c1-4-5-21(30)31-25(20(29)14-26)11-9-18-17-7-6-15-12-16(27)8-10-23(15,2)22(17)19(28)13-24(18,25)3/h12,17-19,22,26,28H,4-11,13-14H2,1-3H3/t17-,18-,19-,22+,23-,24-,25-/m0/s1",BMCQMVFGOVHVNG-TUFAYURCSA-N,CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.6475279981236738,4.0,432.5570000000002,3.132600000000002,6,2,7,100.90000000000002,-4.437943319198878,0.6973718643188477,-4.710462209982932,0.9998154759407043,-6.722047840861859,0.9607882499694824,0.35523307919502256,0.8960192561149597,81.53888133448098,-0.5475135160958124,0.0035124704474583266,0.05402244012802839,0.0502877906896174,0.016879679588600992,0.19824853986501695,-7.9255077451525064,121.4651270055163,62.10905520880813,3.0210426036873814,0.053160414844751355,0.014603739604353905,0.056613074615597725,0.11870927847921849,0.17958096116781236,0.9728991031646729,0.9353898882865905,0.38842234909534457,0.03648598752915859,0.00375703546742443,0.13441860862076283,0.003777503944002092,0.009746594913303852,0.004386294388677925,0.08954537883400918,0.031501979753375056,0.09349248185753822,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,805.0,1343056.0,674725.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUPREDNISOLONE,CHEMBL1200774,4.0,1.0,1.0,MOL,34474.0,Small molecule,1982.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1962.0,0.0,-olone; -pred-,0.0,-olone; -pred-,steroids (not prednisolone derivatives); prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C21H27FO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7,12-13,15-16,18,23,25,27H,4,6,8-10H2,1-2H3/t12-,13-,15-,16-,18+,19-,20-,21-/m0/s1",MYYIMZRZXIQBGI-HVIRSNARSA-N,C[C@]12C=CC(=O)C=C1[C@@H](F)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,0.6770422256433893,4.0,378.44000000000017,1.5056,5,3,8,94.83,-3.566092285208852,0.8896032214164734,-5.2409124569787675,0.9999571561813354,-9.988761279506596,0.9031404852867126,0.03529492300003767,0.9613865494728089,69.82194901298723,2.829293404267168,0.0011040346493246035,0.015780477318912745,0.004849416370416293,0.002601822098949924,0.07687511332333088,-12.999612720652284,72.56221306946577,-4.9071468827824445,3.3980030926122873,0.1630776196718216,0.008741146510874386,0.0549007523804903,0.11588366087526084,0.09230588972568513,0.9942226886749268,0.942815625667572,0.39368014633655546,0.023300044983625413,0.014801658492797288,0.3140797704458237,0.0004661676703108242,0.0038401484373025594,0.0010490014276001603,0.029944760911166667,0.0039905916899442674,0.10278501491993666,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,806.0,1343507.0,674829.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TRIAMCINOLONE HEXACETONIDE,CHEMBL1200878,4.0,1.0,1.0,MOL,9670.0,Small molecule,1969.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1964.0,1.0,-olone; -onide,0.0,-olone; -onide,steroids (not prednisolone derivatives); topical steroids (acetal derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C30H41FO7/c1-25(2,3)15-24(35)36-16-22(34)30-23(37-26(4,5)38-30)13-20-19-9-8-17-12-18(32)10-11-27(17,6)29(19,31)21(33)14-28(20,30)7/h10-12,19-21,23,33H,8-9,13-16H2,1-7H3/t19-,20-,21-,23+,27-,28-,29-,30+/m0/s1",TZIZWYVVGLXXFV-FLRHRWPCSA-N,CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,0.5358144370210589,3.0,532.6490000000002,4.405900000000004,7,1,8,99.13000000000001,-5.734685482154224,0.8825755000114441,-4.9676692108061316,0.9999677419662476,-6.337621570846042,0.9842840552330017,0.5121872901916504,0.9948999404907226,98.24973187183461,3.1686074965727684,0.0005388327121181646,0.06465537063777446,0.044919059798121455,0.005892685614526272,0.48303775787353515,-37.15920623823348,114.45933528242146,103.59334088449596,3.6122113477241142,0.3322588577866554,0.03410237189382315,0.036878361739218234,0.2933113366365433,0.24513649046421052,0.8972562193870545,0.14025643318891526,0.08989744782447814,0.007232579635456204,0.026561092399060727,0.315017095208168,0.003156688716262579,0.012473493302240967,0.005863084876909852,0.6269385844469071,0.015441457368433475,0.12140041855163872,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,807.0,1343980.0,674926.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,CLOCORTOLONE PIVALATE,CHEMBL1200975,4.0,1.0,1.0,MOL,59583.0,Small molecule,1977.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1972.0,1.0,-cort-; -olone,0.0,-cort-; -olone,cortisone derivatives; steroids (not prednisolone derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C27H36ClFO5/c1-14-9-16-17-11-19(29)18-10-15(30)7-8-26(18,6)27(17,28)21(32)12-25(16,5)22(14)20(31)13-34-23(33)24(2,3)4/h7-8,10,14,16-17,19,21-22,32H,9,11-13H2,1-6H3/t14-,16+,17+,19+,21+,22-,25+,26+,27+/m1/s1",SXYZQZLHAIHKKY-GSTUPEFVSA-N,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,0.4579880475870269,4.0,495.03100000000035,4.595100000000004,5,1,9,80.66999999999999,-6.104160463180948,0.8605187892913818,-4.767622965421737,0.9999389529228211,-5.765341869578339,0.9741713643074036,0.5548972368240357,0.9861784815788269,102.66660249581719,3.894937089081998,0.0016656676005368353,0.04118447247892618,0.03704066853970289,0.008604184910655021,0.4255090653896332,-15.979210285871366,118.90324969633866,81.08946486160319,2.6519461315089474,0.12754999324679375,0.05805366262793541,0.0218705452978611,0.12768407799303533,0.2279476821422577,0.961380684375763,0.7107360005378723,0.19802667647600175,0.014164835773408413,0.013538939272984862,0.27965079694986344,0.003213233209680766,0.009228709759190679,0.006371439667418599,0.42550877332687376,0.01069956673309207,0.09612189105246216,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,808.0,1343631.0,675099.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,MEPREDNISONE,CHEMBL1201148,4.0,1.0,1.0,MOL,,Small molecule,1982.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1965.0,0.0,-pred-,0.0,-pred-,prednisone and prednisolone derivatives,,0.0,0.0,0.0,"InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,12,15-16,19,23,27H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,19+,20-,21-,22-/m0/s1",PIDANAQULIKBQS-RNUIGHNZSA-N,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO,0.7736478932798779,4.0,372.4610000000002,2.0118000000000005,5,2,7,91.67,-3.5006729607859604,0.8071373343467713,-4.817480971620698,0.9997637748718262,-9.996930346825675,0.921024763584137,0.18854090869426726,0.9023942112922668,69.6371107537557,-1.4122623530317149,0.0008905840397346765,0.030301863607019187,0.01021950941067189,0.003990555927157402,0.05243405289947987,0.9077537480989057,86.64294629231524,14.769106728682761,3.701865480471554,0.0851818673312664,0.019413330755196512,0.11372418403625488,0.15035332590341569,0.06704988516867161,0.9224098920822144,0.7651382088661194,0.2745033323764801,0.020511186309158803,0.005234840835328214,0.08212111219763756,0.001597094372846186,0.003549476317130029,0.0034570991178043188,0.024656554800458252,0.005081590265035629,0.1538446344435215,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,809.0,1344946.0,1347273.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,CICLESONIDE,CHEMBL2040682,4.0,1.0,1.0,MOL,,Small molecule,2006.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,2004.0,1.0,-onide,0.0,-onide,topical steroids (acetal derivatives),,0.0,0.0,0.0,"InChI=1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1",LUKZNWIVRBCLON-GXOBDPJESA-N,CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,0.5046539264256359,3.0,540.6970000000002,4.703900000000005,7,1,9,99.13000000000001,-6.061736036804388,0.7001795172691345,-5.103414935162887,0.9997281789779663,-6.483837594302233,0.9323855757713317,0.8937978744506836,0.911887788772583,100.48800998484086,1.2477831537811557,0.001981446798890829,0.10282457321882248,0.08547366000711917,0.02624786370433867,0.6314534842967987,-6.759010572822751,135.69339897891103,105.71461016235335,3.4612701233585916,0.17492900602519512,0.02511053211055696,0.09827816411852837,0.41444119811058044,0.3120697021484375,0.7753741979598999,0.36304842233657836,0.19757405072450637,0.027096420899033545,0.014995552133768797,0.2652348861098289,0.017775931488722564,0.029614030197262765,0.028338952735066415,0.613611689209938,0.06424784138798714,0.19646629709750413,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,810.0,1343120.0,105252.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUOCINOLONE ACETONIDE,CHEMBL989,4.0,1.0,1.0,MOL,31623.0,Small molecule,1963.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1962.0,1.0,-olone; -onide,0.0,-olone; -onide,steroids (not prednisolone derivatives); topical steroids (acetal derivatives),Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C24H30F2O6/c1-20(2)31-19-9-13-14-8-16(25)15-7-12(28)5-6-21(15,3)23(14,26)17(29)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19,27,29H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1",FEBLZLNTKCEFIT-VSXGLTOVSA-N,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,0.6684104451867194,4.0,452.49400000000026,2.366800000000001,6,2,9,93.06,-4.143865325489073,0.8800386905670166,-5.328853149112983,0.9999517440795899,-8.878997532649525,0.9449440121650696,0.16445505023002624,0.9883177399635314,78.81902918313463,5.256864039127311,0.000351752621736523,0.01588373607955873,0.008943272440228611,0.0038194072432816027,0.2582392945885658,-7.489737471601143,74.01125809423215,26.897540624139502,4.19496522682481,0.3759070098400116,0.012136458046734333,0.07316086292266846,0.18907597064971923,0.19512450098991393,0.9588413715362549,0.32759282886981966,0.16101713478565216,0.009876609314233065,0.010518499207682908,0.47218239307403564,0.001578808232443407,0.0097962218336761,0.002316759154200554,0.10584457665681839,0.008075173757970334,0.0836154785938561,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,811.0,1343831.0,182546.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PREDNISOLONE ACETATE,CHEMBL1152,4.0,1.0,1.0,MOL,8380.0,Small molecule,1955.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-olone; pred-,0.0,-olone; pred-,steroids (not prednisolone derivatives); prednisone and prednisolone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1",LRJOMUJRLNCICJ-JZYPGELDSA-N,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.7016123362777874,4.0,402.48700000000014,2.1284,6,2,7,100.90000000000002,-3.964423552619676,0.7429353713989257,-4.8213477883161415,0.9997743129730224,-8.652513820141795,0.949139142036438,0.2714948087930679,0.9202605009078979,79.31408016168432,-0.5981892354532184,0.0037547606480075046,0.05750109478831291,0.027617677580565214,0.02247891929000616,0.07166923247277737,-33.62260122516094,112.09228801331253,51.305933708254734,3.154782254867775,0.05710897948592901,0.010675621303380466,0.07191075086593628,0.16522888019680976,0.1125078447163105,0.9757770895957947,0.9374716281890869,0.49697176814079286,0.05369905643165111,0.008300751147908158,0.11913170963525772,0.0025270008074585347,0.009147235890850425,0.00403320238692686,0.06573536172509194,0.020967737305909395,0.1170560483355075,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,812.0,1343876.0,313314.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BUDESONIDE,CHEMBL1370,4.0,1.0,1.0,MOL,3207.0,Small molecule,1994.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1979.0,2.0,-onide,0.0,-onide,topical steroids (acetal derivatives),Anti-Inflammatory,0.0,0.0,1.0,"InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1",VOVIALXJUBGFJZ-KWVAZRHASA-N,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,0.7124527920741569,4.0,430.5410000000002,2.7168000000000014,6,2,9,93.06,-4.3989140007274985,0.7159249305725097,-5.13840220237335,0.9998877882957459,-8.634225816409339,0.931131112575531,0.49122018814086915,0.902618145942688,85.50505553183596,-1.1513324964104616,0.0016752267212723382,0.09311305284500122,0.04346112832427025,0.011518052034080028,0.38627415895462036,26.41575782904966,96.30519181565948,30.537697485579105,4.004133171370939,0.20080108046531678,0.011588681128341705,0.13079966008663177,0.21707739382982255,0.21011358499526978,0.9080713987350464,0.5007865130901337,0.3550741821527481,0.028958693146705627,0.010391680104658008,0.3403013080358505,0.009229880012571811,0.02843337841331959,0.01597714554518461,0.1295828141272068,0.044583926908671856,0.1730459976941347,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,813.0,1344337.0,365281.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DEXAMETHASONE,CHEMBL384467,4.0,1.0,1.0,MOL,41879.0,Small molecule,1958.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",UREBDLICKHMUKA-CXSFZGCWSA-N,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,0.667213496992105,4.0,392.4670000000002,1.8957000000000002,5,3,8,94.83,-4.202952787531676,0.9034817457199097,-5.154886974632332,0.9999674797058106,-9.030585023064532,0.9274654507637023,0.0893045723438263,0.9809369206428528,74.58612768314134,0.38613808603927013,0.0010168755550694186,0.024793874844908713,0.010561542480718344,0.004178602038882673,0.1586127206683159,-11.240543325995034,65.60778516410588,12.454310328038936,3.2532596773281837,0.15538932755589485,0.018150983762461693,0.05506055653095245,0.13124963231384754,0.13075148910284043,0.9893248558044434,0.8433833599090577,0.2741942644119263,0.013664600439369678,0.01323096037376672,0.32748867124319075,0.0007521429230109789,0.005640311515890062,0.001124821079429239,0.04898548517376185,0.0045753795420750976,0.06972570335492492,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,814.0,1344538.0,419410.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BETAMETHASONE VALERATE,CHEMBL1497,4.0,1.0,1.0,MOL,31277.0,Small molecule,1967.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1969.0,1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C27H37FO6/c1-5-6-7-23(33)34-27(22(32)15-29)16(2)12-20-19-9-8-17-13-18(30)10-11-24(17,3)26(19,28)21(31)14-25(20,27)4/h10-11,13,16,19-21,29,31H,5-9,12,14-15H2,1-4H3/t16-,19-,20-,21-,24-,25-,26-,27-/m0/s1",SNHRLVCMMWUAJD-SUYDQAKGSA-N,CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.5679557810972998,4.0,476.58500000000026,3.6368000000000027,6,2,8,100.90000000000002,-5.184591783440743,0.7858420133590698,-4.812212845156802,0.9999797821044922,-6.121344912509906,0.9646116495132446,0.4871955633163452,0.9919708728790283,92.9585865272285,3.642431565153718,0.0028971145464311123,0.044840832613408564,0.055669222958385944,0.02236405685544014,0.6793117463588715,-24.737423622611203,116.24249124517871,86.43868207075911,3.0690829337698298,0.1452446848154068,0.0206937906332314,0.0406517282128334,0.14898867532610893,0.28034268617630004,0.9877658128738404,0.8813910365104676,0.21176616251468658,0.01365829324349761,0.01855328045785427,0.36603720486164093,0.0018272143322974443,0.015482120960950852,0.003535823489073664,0.4842084050178528,0.03204728178679943,0.07409219602122903,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,815.0,1344638.0,487711.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,CORTISONE ACETATE,CHEMBL1650,4.0,1.0,1.0,MOL,3897.0,Small molecule,1950.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-17,20,28H,4-9,11-12H2,1-3H3/t16-,17-,20+,21-,22-,23-/m0/s1",ITRJWOMZKQRYTA-RFZYENFJSA-N,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C,0.7288385619310164,4.0,402.48700000000025,2.560600000000001,6,1,6,97.74000000000001,-4.163411471637827,0.8485547423362731,-4.580702632148901,0.999854326248169,-6.781915314423732,0.9754063606262207,0.2831828385591507,0.9559311270713806,76.74776505669354,0.07582666085703851,0.003859772354189772,0.06976221203804016,0.03461016919463873,0.008537571597844362,0.06532723531126976,-30.755991233381025,116.08741847300419,63.81229971233417,3.1336793032705033,0.06851994805037975,0.016210157785099,0.06913816705346107,0.19474147260189056,0.11924945935606956,0.9538936138153076,0.8674863576889038,0.35275166630744936,0.05368214808404446,0.00510103470296599,0.07818545773625374,0.00263926568441093,0.007462063012644649,0.0033278312417678534,0.05578463161364198,0.024694616626948118,0.12248837109655142,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,816.0,1344010.0,674568.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,RIMEXOLONE,CHEMBL1200617,4.0,1.0,1.0,MOL,,Small molecule,1994.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1990.0,1.0,-olone,0.0,-olone,steroids (not prednisolone derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C24H34O3/c1-6-20(27)24(5)14(2)11-18-17-8-7-15-12-16(25)9-10-22(15,3)21(17)19(26)13-23(18,24)4/h9-10,12,14,17-19,21,26H,6-8,11,13H2,1-5H3/t14-,17+,18+,19+,21-,22+,23+,24-/m1/s1",QTTRZHGPGKRAFB-OOKHYKNYSA-N,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.7786891088285057,4.0,370.53300000000013,4.496500000000005,3,1,8,54.370000000000005,-5.232107612888079,0.766492772102356,-4.527102529410506,0.9999799013137818,-6.191690183613496,0.9904487133026123,0.7158620476722717,0.9536949157714844,92.98328794663449,-3.0899827417404397,0.004481074213981628,0.19544631540775298,0.0763300035148859,0.02697229031473398,0.3858244985342026,-5.788247317280686,100.97598427563875,35.35912108438101,2.9529403255798576,0.039311247691512105,0.03214721756521612,0.06520459279417992,0.12078883200883865,0.273912550508976,0.8487937569618225,0.5041087627410888,0.3265292376279831,0.03861616384238005,0.013160433806478977,0.18734869956970215,0.0027621402870863674,0.0034396004397422076,0.015209861192852258,0.10952576473355294,0.009040543343871832,0.219297331944108,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,817.0,1344438.0,788028.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,METHYLPREDNISOLONE ACETATE,CHEMBL1364144,4.0,1.0,1.0,MOL,6889.0,Small molecule,1959.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-olone; -pred-,0.0,-olone; -pred-,steroids (not prednisolone derivatives); prednisone and prednisolone derivatives,,0.0,0.0,0.0,"InChI=1S/C24H32O6/c1-13-9-16-17-6-8-24(29,20(28)12-30-14(2)25)23(17,4)11-19(27)21(16)22(3)7-5-15(26)10-18(13)22/h5,7,10,13,16-17,19,21,27,29H,6,8-9,11-12H2,1-4H3/t13-,16-,17-,19-,21+,22-,23-,24-/m0/s1",PLBHSZGDDKCEHR-LFYFAGGJSA-N,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.6853079587762,4.0,416.5140000000002,2.3744000000000005,6,2,8,100.90000000000002,-4.317273084681224,0.7493470549583435,-4.836884270832683,0.999838364124298,-8.168470996920195,0.9607969880104065,0.3669282555580139,0.9454277157783508,84.34557905677013,-0.8491693484112595,0.0032991479529300705,0.06212235428392887,0.03357526045292616,0.025251134671270846,0.12852266505360604,-33.576634405092,118.39990360199485,59.73669825629054,3.16016706218864,0.06262668166309596,0.01242753490805626,0.0767402894794941,0.17506355009973049,0.1453683316707611,0.9641385078430176,0.8977336645126343,0.32676432132720945,0.02846188973635435,0.011402991411159746,0.12017802372574807,0.002613410708727315,0.0079344843281433,0.004982215445488691,0.08663202486932278,0.019933925848454236,0.11887915823608637,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,818.0,1343676.0,674904.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROCORTISONE PROBUTATE,CHEMBL1200953,4.0,1.0,1.0,MOL,31675.0,Small molecule,1997.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,1997.0,1.0,-cort-,0.0,-cort-,cortisone derivatives,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C28H40O7/c1-5-7-24(33)35-28(22(31)16-34-23(32)6-2)13-11-20-19-9-8-17-14-18(29)10-12-26(17,3)25(19)21(30)15-27(20,28)4/h14,19-21,25,30H,5-13,15-16H2,1-4H3/t19-,20-,21-,25+,26-,27-,28-/m0/s1",FOGXJPFPZOHSQS-AYVLZSQQSA-N,CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.5378739644790023,4.0,488.6210000000003,4.093500000000003,7,1,7,106.97000000000001,-5.07033950132855,0.636846399307251,-4.524086418595369,0.9997599720954895,-5.431745745963026,0.9698880791664124,0.6116504907608032,0.9443308353424072,86.66348044777456,-3.511648493697929,0.003967131327954121,0.06746010836213827,0.08339127488434314,0.028897978086024522,0.4758813142776489,-2.95019680806591,128.62429925235344,93.25171993559357,2.8383128978735206,0.04816723018884659,0.022043177613522858,0.04056877978146076,0.17236481457948685,0.2709836572408676,0.957727587223053,0.9067938923835754,0.27428663372993467,0.03192855045199394,0.006057733489433304,0.12697360292077065,0.005244591156952083,0.012631995230913162,0.006831290246918797,0.19947805106639863,0.04709734879434109,0.09438314908184112,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,819.0,1343439.0,674963.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLURANDRENOLIDE,CHEMBL1201012,4.0,1.0,1.0,MOL,,Small molecule,1965.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1969.0,1.0,-andr-,0.0,-andr-,androgens,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C24H33FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h7,13-14,16-17,19-20,26,28H,5-6,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1",POPFMWWJOGLOIF-XWCQMRHXSA-N,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,0.6910281010512151,4.0,436.5200000000002,2.498700000000001,6,2,9,93.06,-4.16361800503644,0.8953651189804077,-5.296996472546466,0.9999643564224243,-8.815976570746983,0.9606534481048584,0.1273554101586342,0.989173424243927,75.79316113565483,1.6083043845883171,0.0002711588468628179,0.014242517435923219,0.0060911718930583445,0.0016366126365028322,0.1894915983080864,0.29309177431740674,69.87625767996323,13.36152948910969,3.8393745540388027,0.3426798164844513,0.009322597086429596,0.05477070212364197,0.11890891194343567,0.17730872184038163,0.9763885498046875,0.3590276390314102,0.179036645591259,0.008531131036579608,0.009399040043354035,0.38930381536483766,0.0010381037660408764,0.004618194000795483,0.0013022946659475565,0.04719556667841971,0.005351665150374174,0.08734615105204284,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,820.0,1344541.0,401141.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUTICASONE PROPIONATE,CHEMBL1473,4.0,1.0,1.0,MOL,31441.0,Small molecule,1990.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1985.0,2.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1",WMWTYOKRWGGJOA-CENSZEJFSA-N,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.5755860893833779,3.0,500.57900000000024,4.430000000000004,6,1,9,80.67,-6.163008613073707,0.7770822167396545,-4.7452694270148665,0.9999794960021973,-6.239606687439642,0.9711852431297302,0.3804842889308929,0.9909440755844117,91.39170114330852,4.818259740326237,0.003325531762675382,0.060639307275414465,0.07710138782858848,0.019719231687486172,0.6852645218372345,-2.2796139052221838,113.56857043940752,84.68890903981222,2.5197099025336924,0.08952373676002026,0.020550191402435303,0.01881482042372227,0.15485183894634247,0.3438546985387802,0.984298312664032,0.8207845211029052,0.23219643235206605,0.018968426249921323,0.014717793837189675,0.5026746958494186,0.0024879472912289202,0.009572395496070385,0.0046737139578908685,0.6080296874046326,0.02482945639640093,0.11856840448454023,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,821.0,1344451.0,712273.0,Glucocorticoid receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,Selective,,,MIFEPRISTONE,CHEMBL1276308,4.0,1.0,1.0,MOL,50692.0,Small molecule,2000.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1998.0,1.0,-pris-; -pristone,0.0,-pris-; -pristone,steriodal compounds acting on progesterone receptors (excluding-gest- compounds); progesterone receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1",VKHAHZOOUSRJNA-GCNJZUOMSA-N,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,0.6395257442251707,3.0,429.6040000000001,5.406500000000006,3,1,5,40.54,-5.6454022050311625,0.7288925051689148,-4.566883624062297,0.9997769713401794,-5.779590757914738,0.9319572210311889,0.8794900417327881,0.7092836916446685,102.31461350081614,7.022675520688148,0.1370862327516079,0.4912024199962616,0.3160757154226303,0.07854799292981625,0.7547720074653625,14.59734414324439,51.138728555727994,62.06474832622712,3.2114128213018276,0.08455024510622025,0.1953943747561425,0.05432013049721718,0.3715670704841614,0.553786712884903,0.5806249499320983,0.5908389687538147,0.6798143982887268,0.4497970432043076,0.08997541591525078,0.37000314295291903,0.04453393630683422,0.14231456220149993,0.313948979973793,0.7466596901416779,0.3757022500038147,0.3347782015800476,True
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,4072.0,2473754.0,436607.0,Glucocorticoid receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Company reports initiation of No Ph1 trial in 2010 but no ID found and no further trials planned. Discontinuedcompound?,,,,CORT 108297,CHEMBL271220,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H25F4N3O3S/c1-2-36-17-25-14-18-15-31-33(22-7-5-21(27)6-8-22)24(18)13-20(25)11-12-32(16-25)37(34,35)23-9-3-19(4-10-23)26(28,29)30/h3-10,13,15H,2,11-12,14,16-17H2,1H3/t25-/m1/s1",SLKURXRZHJOZOD-RUZDIDTESA-N,CCOC[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2,0.41295069051231537,2.0,535.5630000000002,5.0872000000000055,5,0,1,64.43,-6.320505332452259,0.8283923149108887,-4.889778913568925,0.9999685287475586,-5.274743521405357,0.9620730161666871,0.8653095960617065,0.9407832503318787,103.64597094086882,-0.2330877040963843,0.2243664175271988,0.40300793647766114,0.6097384929656983,0.1370611645281315,0.9289848327636718,-50.751221035897444,50.94797260546925,54.38570241655835,3.633130801659262,0.26257185637950897,0.2553970530629158,0.34912006855010985,0.6163006365299225,0.9532813549041748,0.09809518232941628,0.0406204491853714,0.12476732879877091,0.0654118537902832,0.069276013225317,0.3900678396224976,0.014550949074327945,0.02583122458308935,0.03345864526927471,0.6702831566333771,0.07808257043361663,0.19989573508501052,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,4073.0,2472766.0,2208522.0,Glucocorticoid receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Ph1 trial initiated in Septemebr 2014, no trial ID found.",,,,RELACORILANT,CHEMBL4068611,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,,-corilant,0.0,-corilant,glucocorticoid receptor antagonists (not glucocorticoids),,0.0,0.0,0.0,"InChI=1S/C27H22F4N6O3S/c1-35-15-22(14-33-35)41(39,40)36-9-7-18-11-24-17(13-34-37(24)21-4-2-20(28)3-5-21)12-26(18,16-36)25(38)23-10-19(6-8-32-23)27(29,30)31/h2-6,8,10-11,13-15H,7,9,12,16H2,1H3/t26-/m0/s1",WANIDIGFXJFFEL-SANMLTNESA-N,Cn1cc(S(=O)(=O)N2CCC3=Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)cn1,0.25826790792021065,3.0,586.571,4.062100000000003,8,0,1,102.98,-4.8230670394418285,0.8977482318878174,-5.158949714827682,0.999970555305481,-7.282016173791715,0.9845449209213257,0.9019992589950562,0.9617182731628418,93.70794417930858,-2.6942014539893493,0.08979924842715263,0.2887371346354485,0.5415786385536194,0.072562275826931,0.8863543510437012,-16.827405814329378,69.6683211870798,53.54004702473109,3.7252190833737786,0.13210639879107475,0.15126150473952293,0.35783207714557647,0.8763181209564209,0.8656994819641113,0.16997782438993453,0.0836230106651783,0.06753347292542458,0.011916024796664714,0.054631131887435916,0.33535856306552886,0.018874901346862316,0.06902468502521515,0.013479975704103708,0.618555623292923,0.06418070197105408,0.07361250780522824,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,4573.0,1976719.0,1626735.0,Glucocorticoid receptor modulator,,MODULATOR,1.0,1.0,1.0,Active metbolite of PF-04171327,,,,DAGROCORAT,CHEMBL3137304,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2013.0,-1.0,-corat,0.0,-corat,glucocorticoid receptor agonists ( not glucocorticoids),,0.0,0.0,0.0,"InChI=1S/C29H29F3N2O2/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(36,29(30,31)32)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23,36H,9,11,13-14,17-18H2,1H3,(H,34,35)/t23-,27+,28-/m1/s1",QJJBNCHSWFGXML-KEKPKEOLSA-N,Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](O)(C(F)(F)F)CC[C@@]21Cc1ccccc1,0.45654381025635765,3.0,494.55700000000024,6.162520000000007,3,2,3,62.22,-5.727056551491001,0.909231424331665,-4.7770041164749,0.999931001663208,-6.880309592883831,0.848908269405365,0.9091303825378418,0.9127224922180176,100.6389672349983,3.2884435148109064,0.0748476816341281,0.44321841299533843,0.42621062099933626,0.07173681519925594,0.7889144539833068,74.32253333474708,55.6395545944225,47.88369718400674,4.935940677247234,0.3263640463352203,0.49823963791131975,0.1826959103345871,0.3682059019804001,0.8862775087356567,0.2517033487558365,0.1589686803519726,0.4230224072933197,0.06426692903041839,0.0639839518815279,0.3315299481153488,0.04300344493240118,0.15169058963656426,0.07574954405426979,0.9707510232925415,0.41535707116127013,0.13841264620423316,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,4574.0,2473704.0,1927240.0,Glucocorticoid receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ORG-34517,CHEMBL3545391,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C28H30O4/c1-3-11-28(30)12-10-23-21-7-4-17-13-19(29)6-8-20(17)26(21)22(15-27(23,28)2)18-5-9-24-25(14-18)32-16-31-24/h5,9,13-14,21-23,30H,4,6-8,10,12,15-16H2,1-2H3/t21?,22-,23?,27+,28+/m1/s1",DFELGYQKEOCHOA-RBXNTRDFSA-N,CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc4c(c3)OCO4)C[C@@]21C,0.632312151737607,3.0,430.54400000000015,5.069200000000006,4,1,5,55.760000000000005,-6.100381555896661,0.6542733192443848,-4.746605186842167,0.9999535799026489,-5.307225826286174,0.9297998547554016,0.8558990001678467,0.6942876100540161,99.91139190983905,4.056436819936322,0.2773711383342743,0.7339255571365356,0.6918444156646728,0.46149076223373414,0.9610967993736267,-17.518496797430608,52.267221277616784,70.79232448968263,3.29004156109268,0.07622350230813027,0.09964096511248499,0.06772363483905793,0.3598414123058319,0.3364646196365356,0.5877573192119598,0.46147567629814146,0.7277333021163941,0.4462146580219269,0.10328814759850502,0.3109695553779602,0.05210689716041088,0.10957733690738677,0.4518588185310364,0.804183840751648,0.39290307760238646,0.3124472424387932,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,5177.0,1976737.0,1626747.0,Glucocorticoid receptor modulator,,MODULATOR,1.0,1.0,1.0,pro-drug of PF-00251802. Indication: Rheumatoid Arthritis,,,,FOSDAGROCORAT,CHEMBL3137316,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,2013.0,,-corat; fos-,0.0,-corat; fos-,glucocorticoid receptor agonists ( not glucocorticoids); phosphoro-derivatives,,0.0,0.0,0.0,"InChI=1S/C29H30F3N2O5P/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(29(30,31)32,39-40(36,37)38)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23H,9,11,13-14,17-18H2,1H3,(H,34,35)(H2,36,37,38)/t23-,27+,28-/m1/s1",BVXLAHSJXXSWFF-KEKPKEOLSA-N,Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](OP(=O)(O)O)(C(F)(F)F)CC[C@@]21Cc1ccccc1,0.29927986710791293,2.0,574.5360000000003,6.279520000000007,4,3,3,108.75,-3.865392735077176,0.8425901293754577,-5.198656256422934,0.9964514017105103,-7.006295576015566,0.6189400434494019,0.7010509550571442,0.8191752314567566,96.81032914100055,-2.577818382778942,0.025730108749121426,0.20512708574533461,0.2898252584040165,0.16473107635974885,0.39896388351917267,121.40001699788506,25.56089432558553,31.63391500721436,4.284101981149296,0.11876925081014633,0.40587097890675067,0.27037246376276014,0.3810347318649292,0.811121118068695,0.24323936998844148,0.12643681988120078,0.5299673557281495,0.14175196066498758,0.0459456916898489,0.2751554995775223,0.049159253295511005,0.06685279533267022,0.020089752273634076,0.8252044200897217,0.25007552206516265,0.09565580487251282,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,5222.0,1699886.0,1376146.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,MAPRACORAT,CHEMBL2103876,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2011.0,,-corat,0.0,-corat,glucocorticoid receptor agonists ( not glucocorticoids),,0.0,0.0,0.0,"InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m1/s1",VJGFOYBQOIPQFY-XMMPIXPASA-N,Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1,0.46234548509584394,3.0,462.4870000000002,5.690420000000004,4,2,1,54.379999999999995,-6.43041909851012,0.8605496048927307,-4.946876283549463,0.9999609231948853,-8.043195227985656,0.9589328169822693,0.9605546951293945,0.8516837954521179,98.7190815562632,15.683371844943093,0.42814153134822847,0.9604068636894226,0.7631122946739197,0.6017537832260131,0.9641940355300903,53.263673356916605,36.92929151594529,109.05458232495212,4.728246244389682,0.17365335971117019,0.4763998031616211,0.11097531691193581,0.49029298424720763,0.9738267660140991,0.016115212067961692,0.010390873532742262,0.10782082825899124,0.026932690851390363,0.43575559854507445,0.6566666245460511,0.04603665918111801,0.013313435390591622,0.09159113839268684,0.9748601198196412,0.22186485230922698,0.11514296159148216,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,6166.0,1702930.0,675842.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,"Prodrug - activity due to metabolite, 21-desDFZ",,,,DEFLAZACORT,CHEMBL1201891,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1986.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22+,23-,24-,25+/m0/s1",FBHSPRKOSMHSIF-GRMWVWQJSA-N,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,0.6756078663027947,4.0,441.5240000000002,2.5632,7,1,8,102.26,-4.247204764784094,0.7142828464508056,-5.020016099996215,0.99972984790802,-8.012425517279057,0.9471461534500122,0.5786576926708221,0.9419184684753418,85.1768626962019,-0.0055323691300602105,0.0018324997145100497,0.07718561477959156,0.027724292408674956,0.08875692486763001,0.1846674785017967,-43.08090408429699,115.87134716390855,79.03529355446126,3.159203971232141,0.11793503649532795,0.013208451122045517,0.12649059891700745,0.25897258818149566,0.11357072740793228,0.906056261062622,0.5568028748035431,0.2912384390830994,0.019504865258932115,0.010792727093212306,0.14226724058389664,0.002984975650906563,0.011831458192318678,0.005558646842837333,0.1311265379190445,0.019595575891435145,0.1363916269503534,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,6683.0,1703080.0,1378112.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,"Structurally, cortivazol possesses the unique feature of a bulky phenylpyrazole structure fused at carbon atoms 2 and 3 to the A ring of the steroid moiety. This pyrazoloid structure imparts a significant increase in potency to the molecule and results in unusual two-site binding kinetics with the glucocorticoid receptor. Cortivazol induces the nuclear translocation and transactivation function of the glucocorticoid receptor, but not of the mineralocorticoid receptor.",Cortivazol has high affinity for the glucocorticoid receptor (GR) (10â€“20 times greater affinity for the GR than dexamethasone),"Cortivazol binds to the glucocorticoid receptor in the cytosol from CEM C7 cells (a human acute lymphoblastic leukemia line) in a fashion consistent with interaction with at least two sites. In mutant leukemia cells derived from CEM C7, resistant to kill by 10-4 M dexamethasone and deficient in standard glucocorticoid binding sites, cortivazol still finds a binding site and kills the cells. In wild-type leukemia cells, the binding sites of cortivazol, those with both higher (Kd ~5 x 10-10 M) and lower (Kd ~1 X 10-8 M) affinity appear to be on forms of the glucocorticoid receptor itself, and not on two different classes of molecules. Cortivazol interacts with the distinct portion of the ligand binding domain (LBD) and differentially modulates the ligand-dependent interaction between transcription intermediary factor 2 and the LBD when compared with cortisol, dexamethasone and aldosterone.",,CORTIVAZOL,CHEMBL2105842,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1970.0,-1.0,,0.0,,,Glucocorticoid,0.0,0.0,0.0,"InChI=1S/C32H38N2O5/c1-18-11-23-25-12-19(2)32(38,28(37)17-39-20(3)35)31(25,5)15-27(36)29(23)30(4)14-21-16-33-34(26(21)13-24(18)30)22-9-7-6-8-10-22/h6-11,13,16,19,23,25,27,29,36,38H,12,14-15,17H2,1-5H3/t19-,23+,25+,27+,29-,30+,31+,32+/m1/s1",RKHQGWMMUURILY-UHRZLXHJSA-N,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.5718657623662142,3.0,530.6650000000002,4.300600000000004,7,2,8,101.65000000000002,-4.865144386020972,0.7508570551872253,-4.912506630373031,0.9999577283859253,-9.161273382735235,0.9434884428977967,0.9064492106437683,0.9335202693939209,102.16572459550105,-0.3994040523542748,0.02622072914382443,0.1756254393607378,0.2712187848985195,0.07933769673109055,0.7213343977928162,-5.685489014824878,112.16409022824197,109.09405511449738,3.8633558369132333,0.07312269657850265,0.041231597773730755,0.13844561725854873,0.49453463554382326,0.5766336441040039,0.6297112584114075,0.6047344982624054,0.1462494283914566,0.03118591960519552,0.07152019664645196,0.3844994157552719,0.02331607472151518,0.054498481750488284,0.03545528249815107,0.6400878131389618,0.1228395164012909,0.09778447058051824,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,6894.0,1702935.0,236019.0,Glucocorticoid receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Cyproterone acetate has been shown to compete with dihydrotestosterone for binding to the androgen receptor and to exhibit progestogenic activities. Cyproterone also suppresses the secretion of gonadotropins and thus interferes with testosterone production. Cyproterone acetate is a potent glucocorticoid receptor antagonist.,"Cyproterone acetate is known to possess the following pharmacological activity: Androgen receptor antagonist/very weak partial agonist (IC50 = 57 nM) Progesterone receptor agonist (Kd = 15 nM; IC50 = 79 nM) Glucocorticoid receptor antagonist (Kd = 45 nM; IC50 = 360 nM) Weak inhibitor of 3Î²-hydroxysteroid dehydrogenase, 17Î±-hydroxylase/17,20-lyase, and 21-hydroxylase",,,CYPROTERONE ACETATE,CHEMBL139835,4.0,1.0,1.0,MOL,50743.0,Small molecule,,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1965.0,-1.0,-terone,0.0,-terone,antiandrogens,Anti-Androgen,0.0,0.0,0.0,"InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1",UWFYSQMTEOIJJG-FDTZYFLXSA-N,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,0.6166116116190477,4.0,416.9450000000003,4.607600000000004,4,0,8,60.440000000000005,-4.905652542048905,0.7247574746608734,-4.573001495013505,0.9999485850334168,-4.654135324158086,0.9872769713401794,0.5507380306720734,0.9280148148536682,96.43206051907974,-3.988000836100986,0.019265034375712274,0.2955450087785721,0.20035067945718765,0.020071104541420935,0.3528459817171097,5.560474641558168,99.07639262944642,44.2649141349015,2.9004981831906087,0.03682330809533596,0.051829376356909054,0.023122360371053217,0.20125284045934677,0.19084231108427047,0.9411229491233826,0.884776484966278,0.5505578100681305,0.16939399093389512,0.003697748063132167,0.22785085141658784,0.016181672271341086,0.019290948659181593,0.036025453358888626,0.27868891060352324,0.08579027578234673,0.3229871541261673,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,6688.0,1702935.0,236019.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Cyproterone acetate has been shown to compete with dihydrotestosterone for binding to the androgen receptor and to exhibit progestogenic activities. Cyproterone also suppresses the secretion of gonadotropins and thus interferes with testosterone production. Cyproterone acetate is a potent glucocorticoid receptor antagonist.,"Cyproterone acetate is known to possess the following pharmacological activity: Androgen receptor antagonist/very weak partial agonist (IC50 = 57 nM) Progesterone receptor agonist (Kd = 15 nM; IC50 = 79 nM) Glucocorticoid receptor antagonist (Kd = 45 nM; IC50 = 360 nM) Weak inhibitor of 3Î²-hydroxysteroid dehydrogenase, 17Î±-hydroxylase/17,20-lyase, and 21-hydroxylase",,,CYPROTERONE ACETATE,CHEMBL139835,4.0,1.0,1.0,MOL,50743.0,Small molecule,,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1965.0,-1.0,-terone,0.0,-terone,antiandrogens,Anti-Androgen,0.0,0.0,0.0,"InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1",UWFYSQMTEOIJJG-FDTZYFLXSA-N,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,0.6166116116190477,4.0,416.9450000000003,4.607600000000004,4,0,8,60.440000000000005,-4.905652542048905,0.7247574746608734,-4.573001495013505,0.9999485850334168,-4.654135324158086,0.9872769713401794,0.5507380306720734,0.9280148148536682,96.43206051907974,-3.988000836100986,0.019265034375712274,0.2955450087785721,0.20035067945718765,0.020071104541420935,0.3528459817171097,5.560474641558168,99.07639262944642,44.2649141349015,2.9004981831906087,0.03682330809533596,0.051829376356909054,0.023122360371053217,0.20125284045934677,0.19084231108427047,0.9411229491233826,0.884776484966278,0.5505578100681305,0.16939399093389512,0.003697748063132167,0.22785085141658784,0.016181672271341086,0.019290948659181593,0.036025453358888626,0.27868891060352324,0.08579027578234673,0.3229871541261673,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,7903.0,3132464.0,2212667.0,Glucocorticoid receptor modulator,,MODULATOR,1.0,1.0,1.0,,,,,AZD-5423,CHEMBL4072756,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H21F4N3O3/c1-15(31-24(33)25(27,28)29)23(16-4-3-5-20(12-16)34-2)35-21-10-11-22-17(13-21)14-30-32(22)19-8-6-18(26)7-9-19/h3-15,23H,1-2H3,(H,31,33)/t15-,23-/m0/s1",FCNQMDSJHADDFT-WNSKOXEYSA-N,COc1cccc([C@@H](Oc2ccc3c(cnn3-c3ccc(F)cc3)c2)[C@H](C)NC(=O)C(F)(F)F)c1,0.35668054108631975,3.0,487.4530000000001,5.360300000000003,5,1,2,65.38,-6.585066800714914,0.919071364402771,-4.788648632072923,0.9995463132858277,-8.399238063492431,0.8589060425758361,0.8976046323776246,0.5127699136734009,100.13657431318791,3.2422191776871343,0.2197803571820259,0.9063773512840271,0.8812190532684326,0.09785879552364349,0.9503780364990234,17.672339112401385,12.684544979165278,66.72370093040702,3.9880568431304155,0.19445710778236389,0.446966278553009,0.1527843192219734,0.943812882900238,0.911572265625,0.012849977612495423,0.003970654238946736,0.09592417478561402,0.015251532103866339,0.3531180739402771,0.21687571406364442,0.0698294285684824,0.019977316819131376,0.05150392353534698,0.7241805076599122,0.11846099495887756,0.06278616972267628,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,9257.0,3461113.0,1999771.0,Glucocorticoid receptor modulator,,MODULATOR,1.0,1.0,1.0,,,,,VELSECORAT,CHEMBL3666807,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2020.0,,-corat,0.0,-corat,glucocorticoid receptor agonists ( not glucocorticoids),,0.0,0.0,0.0,"InChI=1S/C32H32F2N4O6/c1-19(36-31(40)32(2,33)34)29(20-6-9-27-28(16-20)43-13-12-42-27)44-25-7-8-26-22(15-25)17-35-38(26)24-5-3-4-21(14-24)30(39)37-23-10-11-41-18-23/h3-9,14-17,19,23,29H,10-13,18H2,1-2H3,(H,36,40)(H,37,39)/t19-,23+,29-/m0/s1",ZZWJKLGCDHYVMB-BWGXUDETSA-N,C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2,0.2865814910533015,3.0,606.6260000000002,4.595400000000003,8,2,3,112.94000000000001,-5.369880314152185,0.8649247169494629,-5.17132237346046,0.9993980169296265,-12.028285136096336,0.7463321685791016,0.8995461821556091,0.3897179901599884,96.95869487352422,0.6524491115993398,0.1475483939051628,0.8034086704254151,0.884492290019989,0.10595237687230111,0.9662100315093994,141.41922883949354,8.18176224423198,56.49618265793073,3.723340136847407,0.34698950946331025,0.2803490489721298,0.37279540598392485,0.9708898425102234,0.9035283088684082,0.01757035031914711,0.005100564903113991,0.0926178127527237,0.014246798027306795,0.15496359914541244,0.32663497924804685,0.1081413596868515,0.053971342369914056,0.07571681551635265,0.7870994448661804,0.2767459213733673,0.0994575023651123,False
NR3C1_GR,25,SINGLE PROTEIN,Glucocorticoid receptor,9606,Homo sapiens,CHEMBL2034,,0.0,9636.0,2583401.0,2039282.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,Mechanism is not fully elucidated,,,,VAMOROLONE,CHEMBL3707311,4.0,1.0,1.0,MOL,,Small molecule,2023.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2015.0,1.0,-olone,0.0,-olone,steroids (not prednisolone derivatives),,0.0,0.0,0.0,"InChI=1S/C23H30O3/c1-5-20(25)23(26)14(2)12-19-17-7-6-15-13-16(24)8-10-21(15,3)18(17)9-11-22(19,23)4/h8-10,13-14,17,19,26H,5-7,11-12H2,1-4H3/t14-,17-,19+,21+,22+,23+/m1/s1",AJAMXPWEAPICIM-XCAPYKEYSA-N,CCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@@]21C,0.7573211077991329,4.0,354.4900000000001,4.170600000000004,3,1,6,54.37,-4.782763659608039,0.8206270456314086,-4.513529544410661,0.9999876022338867,-6.442947585285616,0.9865062713623047,0.5666609287261963,0.9479443073272705,93.20857032625743,-2.2182774716782934,0.004873151273932308,0.27950306236743927,0.10306623429059983,0.026785431988537313,0.4887179911136627,-23.442729070827138,91.22304478521235,36.16062060961299,3.355791992211425,0.0695108212530613,0.040415299334563316,0.11784763410687446,0.14088092967867852,0.17396986186504365,0.8835531830787658,0.6426331579685212,0.49098416566848757,0.10794473476707936,0.013323229644447565,0.22551517188549042,0.004379778949078173,0.0074994400143623356,0.019876630418002604,0.10920826867222785,0.0151801198720932,0.26810028627514837,False
NR3C1_GR,117571,SINGLE PROTEIN,Glucocorticoid receptor,9615,Canis lupus familiaris,CHEMBL4105966,,0.0,9699.0,1703973.0,1378579.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,Approved veterinary,,,,HYDROCORTISONE ACEPONATE,CHEMBL2106309,2.0,0.0,0.0,MOL,,Small molecule,2018.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,,-cort-,0.0,-cort-,cortisone derivatives,,0.0,0.0,0.0,"InChI=1S/C26H36O7/c1-5-22(31)33-26(21(30)14-32-15(2)27)11-9-19-18-7-6-16-12-17(28)8-10-24(16,3)23(18)20(29)13-25(19,26)4/h12,18-20,23,29H,5-11,13-14H2,1-4H3/t18-,19-,20-,23+,24-,25-,26-/m0/s1",MFBMYAOAMQLLPK-FZNHGJLXSA-N,CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.6273259328568856,4.0,460.5670000000003,3.3133000000000017,7,1,7,106.97000000000001,-4.556943699632354,0.655757749080658,-4.570059159583201,0.9997625708580017,-6.254032595249889,0.965118944644928,0.49084641933441164,0.9430768251419067,81.90400187354001,-3.203572400409685,0.002821171441610204,0.05470640417188406,0.04928015293553471,0.023730542324483395,0.26769188046455383,-23.53236903248486,112.74696812252493,80.44995403446192,2.767688594525247,0.049334185943007466,0.016173060872824864,0.04521776773035526,0.1704811081290245,0.1852698802947998,0.9668547868728637,0.9066393375396729,0.32666216492652894,0.03552240170538425,0.0056053887296002355,0.12411174848675728,0.0029998742276802657,0.009197926335036754,0.004698247392661869,0.10973791405558586,0.03095136359333992,0.09259485336951911,False
NR3C1_GR,117571,SINGLE PROTEIN,Glucocorticoid receptor,9615,Canis lupus familiaris,CHEMBL4105966,,0.0,9700.0,1704906.0,1379456.0,Glucocorticoid receptor agonist,,AGONIST,1.0,1.0,1.0,Approved veterinary,,,,RESOCORTOL BUTYRATE,CHEMBL2107186,2.0,0.0,0.0,MOL,,Small molecule,2000.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1995.0,,-cort-,0.0,-cort-,cortisone derivatives,Anti-Inflammatory (topical),0.0,0.0,0.0,"InChI=1S/C26H38O5/c1-5-7-22(30)31-26(21(29)6-2)13-11-19-18-9-8-16-14-17(27)10-12-24(16,3)23(18)20(28)15-25(19,26)4/h14,18-20,23,28H,5-13,15H2,1-4H3/t18-,19-,20-,23+,24-,25-,26-/m0/s1",NYLJGSLNIOEAHY-FZNHGJLXSA-N,CCCC(=O)O[C@]1(C(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,0.6473225547964904,4.0,430.5850000000002,4.5503000000000045,5,1,7,80.67,-5.078816442126578,0.6519751965999603,-4.418953240441963,0.9999514222145081,-5.390450376882733,0.9833956718444824,0.732641625404358,0.9351869225502014,93.80231925510829,-7.814954267129768,0.004617342833080329,0.09144494272768497,0.11224326826632022,0.019032548554241656,0.37888835966587064,-7.80324988540869,110.27785070411326,64.69673243964507,2.805199358181752,0.03885677270591259,0.02076344662345946,0.03603901639580727,0.09630087912082672,0.2527270048856735,0.9618168950080872,0.8742719173431397,0.42821683287620543,0.056436467170715335,0.003593928093323484,0.12091780677437783,0.005045223399065435,0.006833384372293949,0.009766194270923734,0.11992504745721817,0.028751981258392335,0.1222424354404211,False
NR3C1_GR,102423,SINGLE PROTEIN,Bcl-2-related protein A1,9606,Homo sapiens,CHEMBL6044,,0.0,5833.0,1705098.0,1379628.0,Bcl-2-related protein A1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OBATOCLAX MESYLATE,CHEMBL2107358,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,-toclax,0.0,-toclax,bcl-2 (B-cell lymphoma 2) inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-;",ZFKXDVMHNXPEIY-PEZBNFGJSA-N,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,0.5643033374308488,4.0,413.4990000000002,3.990940000000002,4,3,0,107.54,-2.9740809178209,0.9037579774856568,-5.286825153864973,0.9978184103965759,-10.321457033121966,0.8706183910369873,0.84936683177948,0.7314963936805725,104.44653381002331,-5.485290965994812,0.8344173550605773,0.5599706053733826,0.5874875962734223,0.1651598997414112,0.3459006369113922,92.28261003955349,-1.9352840625605097,30.78878162458029,2.8482837908453225,0.5474939525127411,0.37399322986602784,0.5998749613761902,0.9423092126846313,0.7948444962501526,0.02253207452595234,0.012232433818280698,0.09366383031010628,0.07413987815380096,0.7227606534957886,0.22398655563592912,0.08609360083937645,0.2749191850423813,0.2867062360048294,0.6360623836517334,0.44327244758605955,0.3018384546041489,False
HMGCR,104844,PROTEIN COMPLEX GROUP,"AMP-activated protein kinase, AMPK",9606,Homo sapiens,CHEMBL2096907,,0.0,9153.0,1699578.0,975608.0,"AMP-activated protein kinase, AMPK activator",,ACTIVATOR,1.0,1.0,1.0,,,,,ACADESINE,CHEMBL1551724,3.0,0.0,0.0,MOL,28498.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1992.0,,,0.0,,,Platelet Aggregation Inhibitor,0.0,0.0,0.0,"InChI=1S/C9H14N4O5/c10-7-4(8(11)17)12-2-13(7)9-6(16)5(15)3(1-14)18-9/h2-3,5-6,9,14-16H,1,10H2,(H2,11,17)/t3-,5-,6-,9-/m1/s1",RTRQQBHATOEIAF-UUOKFMHZSA-N,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N,0.3908498923708794,4.0,258.23400000000004,-2.8242999999999996,8,5,4,156.85000000000002,-0.574848897291498,0.6763640284538269,-5.983908014406562,0.7876587867736816,-23.92541152800851,0.041885463520884514,0.005220639239996672,0.721450662612915,10.455931586776964,0.4675439014087958,0.0005855678722582524,0.0013007854227907955,0.0022391361184418202,0.0008540348200767767,3.2776435182313436e-05,13.335579097503492,21.999201487081883,-12.736158434779572,1.5652479757628572,0.6862032175064087,0.07450555898249149,0.19567307233810424,0.7368684530258178,0.08662565648555756,0.02957769390195608,0.014119944535195827,0.10197707116603852,0.019330987054854632,0.005497794621624053,0.017389780608937144,0.0003496637422358617,0.0020181477768346666,0.0036760243121534584,0.002345117635559291,0.1804769415408373,0.301751908659935,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,1052.0,1344871.0,9495.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LOVASTATIN,CHEMBL503,4.0,1.0,1.0,MOL,40303.0,Small molecule,1987.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1987.0,1.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),Inhibitor (HMG-CoA reductase); Antihyperlipidemic,0.0,0.0,0.0,"InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1",PCZOHLXUXFIOCF-BXMDZJJMSA-N,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,0.671999391844661,4.0,404.54700000000025,4.195500000000004,5,1,8,72.83,-5.48788331299752,0.6103337109088898,-5.004700028909354,0.9996058225631714,-5.670788267749133,0.938546645641327,0.8843124389648438,0.5769351661205292,95.57327925265353,-3.1696071674018604,0.0060767209506593645,0.12680515721440316,0.08435355685651302,0.05579081661999226,0.899496054649353,3.4867349621776746,93.3842513908623,42.95447207247167,2.8914010498562086,0.638254028558731,0.06623231247067451,0.39895087778568267,0.19773244261741638,0.49488617181777955,0.36708725094795225,0.0875154010951519,0.4160597205162048,0.11135999262332916,0.027643900411203504,0.6251920700073242,0.027038963697850703,0.019831114821135996,0.15388579219579696,0.5929170250892639,0.18399617075920105,0.647551766037941,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,1053.0,1343621.0,674514.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CERIVASTATIN SODIUM,CHEMBL1200563,4.0,1.0,1.0,MOL,3559.0,Small molecule,1997.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1996.0,-2.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),Inhibitor (HMG-CoA reductase); Antihyperlipidemic,1.0,0.0,0.0,"InChI=1S/C26H34FNO5.Na/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4;/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32);/q;+1/p-1/b11-10+;/t19-,20-;/m1./s1",GPUADMRJQVPIAS-QCVDVZFFSA-M,COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])c1-c1ccc(F)cc1.[Na+],0.4547580567514618,4.0,481.54000000000025,0.5500000000000004,6,2,2,102.71000000000001,-1.7857205200908104,0.7977200031280518,-5.390948139464179,0.971435272693634,-10.786593449911,0.652500057220459,0.4987389981746674,0.658533263206482,79.87591635382587,4.269257781815976,0.04704132229089737,0.06794451475143433,0.21247738301754,0.08421338722109795,0.2809580862522125,-5.672273691142687,-7.2783162001517425,15.588562681045255,3.038440368388153,0.21847857013344765,0.11368958353996277,0.13029368817806244,0.45186980366706847,0.42413080632686617,0.04034263826906681,0.024303382821381093,0.06058884561061859,0.019758216477930544,0.05711456201970577,0.2168506994843483,0.12955360859632492,0.007627165596932173,0.02671393137425184,0.05635858103632927,0.0258901109918952,0.104726742208004,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,1054.0,1343985.0,699412.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PITAVASTATIN CALCIUM,CHEMBL1237061,4.0,1.0,1.0,MOL,71258.0,Small molecule,2009.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),,0.0,0.0,0.0,"InChI=1S/2C25H24FNO4.Ca/c2*26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h2*1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;;+2/p-2/b2*12-11+;/t2*18-,19-;/m11./s1",RHGYHLPFVJEAOC-FFNUKLMVSA-L,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca+2],0.08426549815143221,2.0,880.9979999999999,5.986000000000008,10,4,4,186.95999999999998,-3.8052457779284885,0.8039975881576538,-5.617553129643696,0.9842381715774536,-12.841684675832576,0.36736794114112853,0.5670847594738007,0.5063408553600312,93.2679502527669,-5.1300745270394135,0.12070336490869522,0.10962893590331077,0.28219400644302367,0.058737019263207915,0.1261028230190277,30.517131794294095,-8.888607297680887,10.350060502220412,3.9898741228757957,0.11724345237016678,0.23689025193452834,0.20291293561458587,0.927765941619873,0.5301202833652496,0.02605909910053015,0.020317181013524532,0.08344244211912155,0.014439330156892537,0.20346422195434571,0.3485168069601059,0.32889089584350584,0.053669079579412936,0.10187706425786018,0.6305153489112854,0.1367798127233982,0.13156531155109405,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,1055.0,1344848.0,1449167.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FLUVASTATIN SODIUM,CHEMBL2218894,4.0,1.0,1.0,MOL,,Small molecule,1993.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1989.0,1.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),Antihyperlipidemic; Inhibitor (HMG-CoA reductase),0.0,0.0,0.0,"InChI=1S/C24H26FNO4.Na/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);/q;+1/p-1/b12-11+;",ZGGHKIMDNBDHJB-CALJPSDSSA-M,CC(C)n1c(/C=C/C(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21.[Na+],0.5006657654315045,4.0,433.45500000000004,0.2973999999999999,5,2,2,85.52,-1.3068493996224029,0.8299999833106995,-5.484934861069658,0.9874349951744079,-11.94289657117426,0.5002399742603302,0.351481220126152,0.7885957717895508,84.90727349579656,0.04853010807127678,0.26701694130897524,0.3067856341600418,0.5534708678722382,0.1410032518208027,0.20860480517148972,24.11683877054059,-13.392660161803226,-2.0144131440860074,3.3014029991013865,0.0653376504778862,0.16118924915790558,0.12801127433776854,0.7493102312088012,0.3469083845615387,0.03753558099269867,0.01969466246664524,0.05334918163716793,0.012633380107581615,0.17173146679997445,0.2547423914074898,0.3239089697599411,0.015481444634497165,0.053558215498924255,0.15740253329277037,0.03629726208746433,0.09792647808790207,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,1056.0,1343886.0,1123018.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ROSUVASTATIN CALCIUM,CHEMBL1744447,4.0,1.0,1.0,MOL,77249.0,Small molecule,2003.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2000.0,1.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),,0.0,0.0,0.0,"InChI=1S/2C22H28FN3O6S.Ca/c2*1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h2*5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;;+2/p-2/b2*10-9+;/t2*16-,17-;/m11./s1",LALFOYNTGMUKGG-BGRFNVSISA-L,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2],0.09178884090998568,2.0,1001.154,1.7532000000000014,16,4,4,287.49999999999994,-2.7952873318110667,0.5581968486309051,-5.675432996466606,0.8857628464698791,-12.445598982065098,0.36934194564819334,0.31881158947944643,0.2667325705289841,89.86859743603746,-4.080015860149427,0.1454152472317219,0.2686677575111389,0.4732031047344208,0.21538803726434708,0.4739154756069183,14.74687151776306,-18.985680116712526,35.93134564207351,2.866248783429306,0.052656518295407295,0.1542987957596779,0.07076225318014621,0.9530080676078796,0.6643005847930908,0.04875748846679926,0.023243840783834457,0.049435678869485855,0.009916740469634533,0.05267253704369068,0.20750938057899476,0.18498377576470376,0.01806065421551466,0.027838431857526304,0.20533220767974852,0.06369923427700996,0.09332588464021682,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,1057.0,1343150.0,30602.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PRAVASTATIN SODIUM,CHEMBL690,4.0,1.0,1.0,MOL,8361.0,Small molecule,1991.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1988.0,1.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),Antihyperlipidemic,0.0,0.0,0.0,"InChI=1S/C23H36O7.Na/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28;/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28);/q;+1/p-1/t13-,14-,16+,17+,18+,19-,20-,22-;/m0./s1",VWBQYTRBTXKKOG-IYNICTALSA-M,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+],0.2645140542313631,4.0,446.51600000000025,-1.8902999999999948,7,3,8,127.12,-1.1943012985643875,0.3463411271572113,-5.986252625225771,0.8971260070800782,-10.710711123146273,0.23050412833690642,0.13581746593117713,0.42659975290298463,59.879533252578405,-2.2670386639889415,0.004998678108677268,0.02697151154279709,0.021425055526196956,0.07657568082213402,0.21651555895805358,5.557812042993184,24.929581777146172,4.297331754473722,3.1361515287542354,0.1370612695813179,0.04216546807438135,0.0943554736673832,0.10701197199523449,0.1413479745388031,0.27110185027122496,0.12232501655817032,0.17485331892967224,0.028679050970822573,0.014209147915244103,0.09306256845593452,0.03552019763737917,0.008916749712079763,0.047742870450019834,0.03916000034660101,0.04223697707056999,0.3249657452106476,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,1058.0,1344888.0,407354.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ATORVASTATIN CALCIUM,CHEMBL393220,4.0,1.0,1.0,MOL,50686.0,Small molecule,1996.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1994.0,1.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),Inhibitor (HMG-CoA reductase),0.0,0.0,0.0,"InChI=1S/2C33H35FN2O5.Ca/c2*1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;/h2*3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;;+2/p-2/t2*26-,27-;/m11./s1",FQCKMBLVYCEXJB-MNSAWQCASA-L,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2],0.031394954448040996,0.0,1155.362,9.577000000000004,12,6,4,229.23999999999998,-3.961033959578752,0.6898898005485534,-5.549546157232671,0.9622007012367249,-13.351371440745812,0.3029816269874573,0.7032621383666993,0.12066280543804168,98.07162743507725,-4.630287400743802,0.11383172422647476,0.5011369526386261,0.6708969712257385,0.2239999905228615,0.35165270119905473,107.82415448713418,-1.4791077992451591,24.876875850272956,3.54818979973881,0.053156812116503714,0.3353597640991211,0.08459440656006337,0.939166271686554,0.7419425129890442,0.012932022660970688,0.006319415825419128,0.06331210993230343,0.007006650324910879,0.1293191894888878,0.3326132208108902,0.3061335891485214,0.007816633163020014,0.08532563522458077,0.7117593050003052,0.08449311032891274,0.12651384472846985,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,1059.0,1343830.0,138562.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SIMVASTATIN,CHEMBL1064,4.0,1.0,1.0,MOL,9150.0,Small molecule,1991.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1987.0,1.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),Antihyperlipidemic,0.0,0.0,0.0,"InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1",RYMZZMVNJRMUDD-HGQWONQESA-N,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,0.6390622750209786,4.0,418.57400000000024,4.585600000000005,5,1,7,72.83,-5.892024771749469,0.5930130541324615,-4.986558236203008,0.9996099233627319,-5.249267165094691,0.9515240550041199,0.8911025285720825,0.5380914121866226,97.12444975862797,-4.089618072889342,0.003409256337909028,0.10876193940639496,0.08586758002638817,0.039751610811799766,0.9167441844940185,9.492135735848677,94.32300519886624,49.95017227380549,2.8311641162985355,0.6173259675502777,0.07617619894444942,0.3300962567329407,0.18891218602657317,0.502490347623825,0.3107928052544594,0.06455326080322266,0.37553443014621735,0.12227988988161087,0.02187885087914765,0.6345844864845276,0.024755275063216686,0.014817917719483376,0.15283095985651016,0.6113668203353881,0.15869717299938202,0.6577776432037353,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,6914.0,2973279.0,2197794.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PITAVASTATIN MAGNESIUM,CHEMBL3989923,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),,0.0,0.0,0.0,"InChI=1S/2C25H24FNO4.Mg/c2*26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h2*1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;;+2/p-2/b2*12-11+;/t2*18-,19-;/m11./s1",MPAZKXHCZWDZDY-FFNUKLMVSA-L,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Mg+2],0.0843301241031928,2.0,865.2249999999999,5.986000000000008,10,4,4,186.95999999999998,-3.8250674401593856,0.7988545894622803,-5.615805395562797,0.9836642146110535,-12.847525031945036,0.3644951045513153,0.5704012036323547,0.4865253448486328,93.4596402048144,-5.022051016302617,0.12068722769618034,0.11325700953602791,0.28537642657756807,0.06036465680226684,0.1306329607963562,31.06248043325893,-8.810766776420028,10.417574903971238,3.9863745280826173,0.11732373461127281,0.23439837843179703,0.19617979675531388,0.9286398530006409,0.5297635912895202,0.0268815154209733,0.021041198074817656,0.08806315362453461,0.015320428926497699,0.20766030251979828,0.35803167819976806,0.338253116607666,0.055252638086676596,0.10408847592771053,0.64131880402565,0.13924016281962395,0.13210709095001222,False
HMGCR,24,SINGLE PROTEIN,HMG-CoA reductase,9606,Homo sapiens,CHEMBL402,,0.0,6915.0,2973276.0,2197791.0,HMG-CoA reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PITAVASTATIN SODIUM,CHEMBL3989920,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,0.0,-stat-,0.0,-stat- (-statin),enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors),,0.0,0.0,0.0,"InChI=1S/C25H24FNO4.Na/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;+1/p-1/b12-11+;/t18-,19-;/m1./s1",NBDQGOCGYHMDSJ-NRFPMOEYSA-M,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Na+],0.4850943980305593,4.0,443.4500000000001,0.18739999999999957,5,2,2,93.48,-1.7160164381261551,0.880099356174469,-5.403677931675205,0.9934716701507569,-12.714298282232633,0.47188990116119384,0.17856263145804405,0.8429003596305847,78.48955008914012,-1.0995206905512243,0.15202246829867364,0.060397139936685565,0.19943782091140747,0.05984981842339039,0.09156446605920791,-7.719673605951878,-12.188687016720051,-10.81201295930472,3.5037146788454456,0.13124077916145324,0.1569090113043785,0.2880788117647171,0.7531748652458191,0.23126752376556398,0.06072830408811569,0.03424241691827774,0.06887674033641815,0.012334110587835312,0.14675926715135573,0.19722873717546463,0.23549184203147888,0.03334424253553152,0.0348524771630764,0.17312950938940047,0.05339567251503467,0.09278158247470855,False
KEAP1,104593,SINGLE PROTEIN,Kelch-like ECH-associated protein 1,9606,Homo sapiens,CHEMBL2069156,,0.0,1298.0,1705068.0,1379603.0,Kelch-like ECH-associated protein 1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Alykylates Keap1 to prevent interaction with Nrf2 (PMID: 22732183, PMID: 23709213, PMID: 18618599)",,,,DIMETHYL FUMARATE,CHEMBL2107333,4.0,1.0,1.0,MOL,76004.0,Small molecule,2013.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,2005.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+",LDCRTTXIJACKKU-ONEGZZNKSA-N,COC(=O)/C=C/C(=O)OC,0.40047702269500696,4.0,144.12599999999998,-0.11140000000000017,4,0,0,52.60000000000001,-1.0953648884181184,0.6585056722164154,-4.0445642024673365,0.9965951442718506,-7.330878638610265,0.9174679756164551,0.04356287438422442,0.9858988642692565,66.81045873752588,-1.5237087691796227,0.21756851077079772,0.2833017408847809,0.04638262987136841,0.02840378964319825,0.0045602683210745456,-21.06008548615481,49.303630043714506,65.73836778253283,1.9027267578511513,0.08748623142018915,0.09975070664659143,0.04441405925899744,0.8521365642547607,0.04637027219869196,0.01763810752891004,0.047834683954715726,0.02461304347962141,0.016545037273317575,0.001991438277764246,0.000930637214332819,0.012011662311851978,0.04658239707350731,0.03910644315183163,0.002677745604887605,0.012103733606636524,0.9068626999855042,False
KEAP1,104593,SINGLE PROTEIN,Kelch-like ECH-associated protein 1,9606,Homo sapiens,CHEMBL2069156,,0.0,7642.0,2973302.0,2197815.0,Kelch-like ECH-associated protein 1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Not fully elucidated. Activates the Nrf2 pathway involved in cellular response to oxidative stress, potentially through S-alkylation of the Nrf2 inhibitor Keap1",MMF is also a nicotinic acid receptor agonist in vitro.,,,DIROXIMEL FUMARATE,CHEMBL3989944,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,2016.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+",YIMYDTCOUQIDMT-SNAWJCMRSA-N,COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O,0.3702501101980568,4.0,255.2259999999999,-0.592200000000001,6,0,0,89.98000000000002,-1.4744220669674903,0.706298577785492,-4.465865732872065,0.9949076890945434,-12.783728616281541,0.8613888025283813,0.00998960374854505,0.9941273093223572,61.814560751488344,7.223149323625063,0.14587389677762985,0.3262627929449081,0.0571932477876544,0.0024236632976680993,0.004646208835765719,-14.282942235739839,59.981528185928894,27.888893732892804,2.197076515581034,0.3558584153652191,0.04154208097606897,0.15379173755645753,0.7715619504451752,0.023198052146472036,0.0049784386996179816,0.03963730745017528,0.029131902381777763,0.010878985468298196,0.0011896449374035,0.003422502800822258,0.022221718169748782,0.04355960711836815,0.061241667717695236,0.0004447267652722076,0.03991054743528366,0.8825479388237,False
KEAP1,104593,SINGLE PROTEIN,Kelch-like ECH-associated protein 1,9606,Homo sapiens,CHEMBL2069156,,0.0,7643.0,3132752.0,598560.0,Kelch-like ECH-associated protein 1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Not fully elucidated. Activates the Nrf2 pathway involved in cellular response to oxidative stress, potentially through S-alkylation of the Nrf2 inhibitor Keap1",MMF is also a nicotinic acid receptor agonist in vitro.,,,MONOMETHYL FUMARATE,CHEMBL589586,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2018.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+",NKHAVTQWNUWKEO-NSCUHMNNSA-N,COC(=O)/C=C/C(=O)O,0.4149910533965467,4.0,130.099,-0.19980000000000003,3,1,0,63.60000000000001,-0.9218428609787225,0.6083151876926423,-4.821180127704947,0.977663791179657,-9.06944590794767,0.3308280974626541,0.013774994760751724,0.9640655279159546,77.2684468115796,1.5519818303975734,0.017008082277607174,0.11754843927919864,0.05155349709093571,0.020300988829694687,0.0007576709103886969,-15.551938664761906,-21.18481933549964,10.780911155745864,1.7180933589314544,0.02284095101058483,0.06972659986931831,0.0913915779441595,0.8063793778419495,0.007540085690561682,0.04162869094870984,0.011298876721411943,0.0406351197976619,0.02893490609712899,0.0004970015477738343,8.06771895440761e-05,0.004733494308311492,0.00839669038541615,0.011453321063891053,0.00041175451187882575,0.0024606894236057996,0.7881808280944824,False
KEAP1,107924,PROTEIN-PROTEIN INTERACTION,Keap1/Nrf2,9606,Homo sapiens,CHEMBL3038498,,0.0,5237.0,1702475.0,1139916.0,Keap1/Nrf2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Ph3 study terminated, safety and efficacy to be re-evaluated in new Ph2 study in 2014/2015. Activates KEAP1-Nrf2 pathway (http://en.wikipedia.org/wiki/Bardoxolone_methyl, http://www.kyowa-kirin.com/news_releases/2014/e20140702_01.html)",,,,BARDOXOLONE METHYL,CHEMBL1762621,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2008.0,,-olone,0.0,-olone,steroids (not prednisolone derivatives),,0.0,0.0,0.0,"InChI=1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1",WPTTVJLTNAWYAO-KPOXMGGZSA-N,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,0.38618059545364897,2.0,505.69900000000047,6.378980000000007,5,0,7,84.22999999999999,-6.844722429751295,0.6489666700363159,-4.405837328032727,0.9997955441474915,-3.162907568903526,0.9693501234054566,0.9039571523666382,0.8645406365394592,108.60400398982293,5.07486300709999,0.0032644001534208656,0.07875023037195206,0.17719440460205077,0.004061174637172371,0.6775667667388916,20.13412501568171,124.03736773610231,119.38314099179578,3.709465628988629,0.1051431130617857,0.0902322269976139,0.055829905346035956,0.33108713030815123,0.598765629529953,0.13288019970059395,0.16320082545280457,0.05384285412728786,0.1241118848323822,0.006854674685746432,0.35191594660282133,0.02777529861778021,0.0481337221339345,0.07016714178025722,0.7697338879108429,0.2362528681755066,0.3656993582844734,False
TYK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,1565.0,1698797.0,1376013.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TOFACITINIB CITRATE,CHEMBL2103743,4.0,1.0,1.0,MOL,71197.0,Small molecule,2012.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1",SYIKUFDOYJFGBQ-YLAFAASESA-N,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,0.32732088368122125,3.0,504.5000000000003,0.29628000000000065,9,5,2,221.03999999999996,-1.9664984486477715,0.4891192317008972,-6.437261596740534,0.43822804689407346,-15.600657293873104,0.057449690997600555,0.01794855040498078,0.46929141879081726,63.31457676434328,10.22544834703189,0.013066271739080548,0.013106588274240494,0.0188572249840945,0.05303051490336656,0.051221237238496545,12.567118817733313,-21.034286446382023,-13.318419639409388,3.160413049699813,0.07663432788103819,0.0796009797602892,0.7275431156158447,0.7273617029190064,0.29610386192798616,0.026530874893069267,0.018006755970418453,0.05155108198523521,0.017160114645957947,0.036200946755707265,0.010617315396666526,0.0027557652676478027,0.016555091738700865,0.0025495575449895115,0.0039949398371391,0.0587028406560421,0.07791302353143692,False
JAK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,1565.0,1698797.0,1376013.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TOFACITINIB CITRATE,CHEMBL2103743,4.0,1.0,1.0,MOL,71197.0,Small molecule,2012.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1",SYIKUFDOYJFGBQ-YLAFAASESA-N,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,0.32732088368122125,3.0,504.5000000000003,0.29628000000000065,9,5,2,221.03999999999996,-1.9664984486477715,0.4891192317008972,-6.437261596740534,0.43822804689407346,-15.600657293873104,0.057449690997600555,0.01794855040498078,0.46929141879081726,63.31457676434328,10.22544834703189,0.013066271739080548,0.013106588274240494,0.0188572249840945,0.05303051490336656,0.051221237238496545,12.567118817733313,-21.034286446382023,-13.318419639409388,3.160413049699813,0.07663432788103819,0.0796009797602892,0.7275431156158447,0.7273617029190064,0.29610386192798616,0.026530874893069267,0.018006755970418453,0.05155108198523521,0.017160114645957947,0.036200946755707265,0.010617315396666526,0.0027557652676478027,0.016555091738700865,0.0025495575449895115,0.0039949398371391,0.0587028406560421,0.07791302353143692,False
TYK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,4631.0,1976724.0,1626739.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEFICITINIB,CHEMBL3137308,4.0,1.0,0.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2013.0,-1.0,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)/t9?,10-,11+,14-,18-",DREIJXJRTLTGJC-ZLBJMMTISA-N,NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2,0.6923710324400739,4.0,326.40000000000015,2.0133,4,4,5,104.03000000000002,-3.3300782897103196,0.9440353035926818,-5.365070497798731,0.9995425343513489,-15.75070470173724,0.7011408090591431,0.01684866948053241,0.5959320306777954,75.39420767441621,10.802148267791534,0.17613208144903184,0.07624245062470436,0.0448197478428483,0.0144841686822474,0.1780846208333969,-6.954695662915677,2.248358019255683,-25.20660013096757,3.3076253535149505,0.41788039803504945,0.07171441707760096,0.3341771125793457,0.6311671197414398,0.4145288228988647,0.17478492856025696,0.1635009840130806,0.44561193585395814,0.09530944377183914,0.15771269723773002,0.07360478267073631,0.007212860463187099,0.08024736344814301,0.034974180534482,0.2740884363651276,0.29930837005376815,0.14717917740345002,False
JAK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,4631.0,1976724.0,1626739.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEFICITINIB,CHEMBL3137308,4.0,1.0,0.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2013.0,-1.0,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)/t9?,10-,11+,14-,18-",DREIJXJRTLTGJC-ZLBJMMTISA-N,NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2,0.6923710324400739,4.0,326.40000000000015,2.0133,4,4,5,104.03000000000002,-3.3300782897103196,0.9440353035926818,-5.365070497798731,0.9995425343513489,-15.75070470173724,0.7011408090591431,0.01684866948053241,0.5959320306777954,75.39420767441621,10.802148267791534,0.17613208144903184,0.07624245062470436,0.0448197478428483,0.0144841686822474,0.1780846208333969,-6.954695662915677,2.248358019255683,-25.20660013096757,3.3076253535149505,0.41788039803504945,0.07171441707760096,0.3341771125793457,0.6311671197414398,0.4145288228988647,0.17478492856025696,0.1635009840130806,0.44561193585395814,0.09530944377183914,0.15771269723773002,0.07360478267073631,0.007212860463187099,0.08024736344814301,0.034974180534482,0.2740884363651276,0.29930837005376815,0.14717917740345002,False
TYK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,7629.0,3133079.0,2335478.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for the JAK family over LCK members. Some activity against ROCK-II kinase at a concentration < 1 uM. Highest affinity for JAK1 and JAK2.,,,DELGOCITINIB,CHEMBL4297507,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H18N6O/c1-11-8-22(13(23)2-5-17)16(11)4-7-21(9-16)15-12-3-6-18-14(12)19-10-20-15/h3,6,10-11H,2,4,7-9H2,1H3,(H,18,19,20)/t11-,16-/m0/s1",LOWWYYZBZNSPDT-ZBEGNZNMSA-N,C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2,0.9028284909836287,4.0,310.36100000000005,1.2987799999999996,5,1,2,88.91,-3.1693610781489516,0.8573432803153992,-4.994098068205742,0.9997556328773498,-15.341035271933595,0.8325080037117004,0.007368644024245441,0.7831547975540161,70.45999992714009,3.750682295785059,0.20160360895097257,0.028612478007562458,0.019092349498532713,0.007294034585356712,0.1755907006561756,-4.160337864383463,35.71918424478944,22.307819223099465,3.035221485078003,0.28026835471391676,0.030742571223527193,0.3396197646856308,0.652904611825943,0.6714852809906006,0.018275278527289628,0.02894804198294878,0.08215972855687141,0.02145281545817852,0.16374564450234175,0.06627576574683189,0.0010663921537343412,0.03680196590721607,0.005098858405835927,0.006788694532588124,0.10004055052995682,0.24916959404945374,False
JAK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,7629.0,3133079.0,2335478.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for the JAK family over LCK members. Some activity against ROCK-II kinase at a concentration < 1 uM. Highest affinity for JAK1 and JAK2.,,,DELGOCITINIB,CHEMBL4297507,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H18N6O/c1-11-8-22(13(23)2-5-17)16(11)4-7-21(9-16)15-12-3-6-18-14(12)19-10-20-15/h3,6,10-11H,2,4,7-9H2,1H3,(H,18,19,20)/t11-,16-/m0/s1",LOWWYYZBZNSPDT-ZBEGNZNMSA-N,C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2,0.9028284909836287,4.0,310.36100000000005,1.2987799999999996,5,1,2,88.91,-3.1693610781489516,0.8573432803153992,-4.994098068205742,0.9997556328773498,-15.341035271933595,0.8325080037117004,0.007368644024245441,0.7831547975540161,70.45999992714009,3.750682295785059,0.20160360895097257,0.028612478007562458,0.019092349498532713,0.007294034585356712,0.1755907006561756,-4.160337864383463,35.71918424478944,22.307819223099465,3.035221485078003,0.28026835471391676,0.030742571223527193,0.3396197646856308,0.652904611825943,0.6714852809906006,0.018275278527289628,0.02894804198294878,0.08215972855687141,0.02145281545817852,0.16374564450234175,0.06627576574683189,0.0010663921537343412,0.03680196590721607,0.005098858405835927,0.006788694532588124,0.10004055052995682,0.24916959404945374,False
TYK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,8230.0,3460916.0,2464706.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GUSACITINIB,CHEMBL4594275,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H28N8O2/c25-10-5-16-6-11-32(12-7-16)24-28-20-15-26-30-23(34)21(20)22(29-24)27-17-1-3-18(4-2-17)31-13-8-19(33)9-14-31/h1-4,15-16,19,33H,5-9,11-14H2,(H,30,34)(H,27,28,29)",NLFLXLJXEIUQDL-UHFFFAOYSA-N,N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1,0.5249174747282044,4.0,460.5420000000003,2.54788,9,3,0,134.06,-4.227071250557569,0.7356660604476929,-5.656875917112253,0.9802249670028687,-13.65981754504071,0.7596872448921204,0.25585857033729553,0.2550005495548248,90.71339755125395,12.056288112917176,0.20902441516518594,0.21167894899845124,0.4701969623565674,0.02207194045186043,0.16610029339790344,58.46381938549739,12.006269464476429,38.89129919145122,3.2265993400464312,0.14398445636034013,0.2265195406973362,0.45198758840560915,0.9659201145172119,0.9397824525833129,0.027278347872197628,0.0448446024209261,0.06144346967339516,0.026258047111332415,0.38496493697166445,0.23522783815860748,0.025733921304345132,0.25827719271183014,0.061510277539491655,0.813415801525116,0.8053309917449951,0.18488546311855317,True
JAK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,8230.0,3460916.0,2464706.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GUSACITINIB,CHEMBL4594275,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H28N8O2/c25-10-5-16-6-11-32(12-7-16)24-28-20-15-26-30-23(34)21(20)22(29-24)27-17-1-3-18(4-2-17)31-13-8-19(33)9-14-31/h1-4,15-16,19,33H,5-9,11-14H2,(H,30,34)(H,27,28,29)",NLFLXLJXEIUQDL-UHFFFAOYSA-N,N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1,0.5249174747282044,4.0,460.5420000000003,2.54788,9,3,0,134.06,-4.227071250557569,0.7356660604476929,-5.656875917112253,0.9802249670028687,-13.65981754504071,0.7596872448921204,0.25585857033729553,0.2550005495548248,90.71339755125395,12.056288112917176,0.20902441516518594,0.21167894899845124,0.4701969623565674,0.02207194045186043,0.16610029339790344,58.46381938549739,12.006269464476429,38.89129919145122,3.2265993400464312,0.14398445636034013,0.2265195406973362,0.45198758840560915,0.9659201145172119,0.9397824525833129,0.027278347872197628,0.0448446024209261,0.06144346967339516,0.026258047111332415,0.38496493697166445,0.23522783815860748,0.025733921304345132,0.25827719271183014,0.061510277539491655,0.813415801525116,0.8053309917449951,0.18488546311855317,True
TYK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,8878.0,3490131.0,2486603.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IZENCITINIB,CHEMBL4650343,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H26N8/c1-14-10-21(29-28-14)26-20-13-19-18(4-2-8-24-19)22(27-20)25-15-11-16-5-6-17(12-15)30(16)9-3-7-23/h2,4,8,10,13,15-17H,3,5-6,9,11-12H2,1H3,(H3,25,26,27,28,29)/t15-,16-,17+",DADAEARVGOQWHV-OSYLJGHBSA-N,Cc1cc(Nc2cc3ncccc3c(N[C@@H]3C[C@H]4CC[C@@H](C3)N4CCC#N)n2)n[nH]1,0.5768000623357462,4.0,402.5060000000002,3.725900000000001,7,3,3,105.55000000000001,-3.1375211709139976,0.8499050498008728,-5.98053375925958,0.9922580003738404,-12.457293147371391,0.7833810091018677,0.3212532103061676,0.7567016005516052,86.39476139901087,20.40217768528882,0.18594006896018983,0.0470938278362155,0.0660795634612441,0.32009748816490174,0.32315037548542025,65.13076384144863,17.038218481704558,9.8473405603439,2.6234310077603507,0.4118596017360687,0.10416415333747864,0.7922513723373413,0.6987770915031433,0.9640706539154053,0.055957453325390816,0.059252992272377014,0.1500469461083412,0.06411866098642349,0.43098868131637574,0.17540270686149598,0.0030238843988627194,0.08495647311210633,0.023249536007642745,0.2898700416088104,0.4867758274078369,0.2485696479678154,False
JAK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,8878.0,3490131.0,2486603.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IZENCITINIB,CHEMBL4650343,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H26N8/c1-14-10-21(29-28-14)26-20-13-19-18(4-2-8-24-19)22(27-20)25-15-11-16-5-6-17(12-15)30(16)9-3-7-23/h2,4,8,10,13,15-17H,3,5-6,9,11-12H2,1H3,(H3,25,26,27,28,29)/t15-,16-,17+",DADAEARVGOQWHV-OSYLJGHBSA-N,Cc1cc(Nc2cc3ncccc3c(N[C@@H]3C[C@H]4CC[C@@H](C3)N4CCC#N)n2)n[nH]1,0.5768000623357462,4.0,402.5060000000002,3.725900000000001,7,3,3,105.55000000000001,-3.1375211709139976,0.8499050498008728,-5.98053375925958,0.9922580003738404,-12.457293147371391,0.7833810091018677,0.3212532103061676,0.7567016005516052,86.39476139901087,20.40217768528882,0.18594006896018983,0.0470938278362155,0.0660795634612441,0.32009748816490174,0.32315037548542025,65.13076384144863,17.038218481704558,9.8473405603439,2.6234310077603507,0.4118596017360687,0.10416415333747864,0.7922513723373413,0.6987770915031433,0.9640706539154053,0.055957453325390816,0.059252992272377014,0.1500469461083412,0.06411866098642349,0.43098868131637574,0.17540270686149598,0.0030238843988627194,0.08495647311210633,0.023249536007642745,0.2898700416088104,0.4867758274078369,0.2485696479678154,False
TYK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,9536.0,3589942.0,2537414.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NEZULCITINIB,CHEMBL4802163,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2021.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H37N7O2/c1-6-18-11-21(38)8-10-22(18)19-7-9-23-24(12-19)33-34-28(23)29-31-25-13-27(37(17(2)3)16-26(25)32-29)30(39)36-14-20(15-36)35(4)5/h7-12,17,20,27,38H,6,13-16H2,1-5H3,(H,31,32)(H,33,34)/t27-/m0/s1",VQIIUJSNIKEMCK-MHZLTWQESA-N,CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)C[C@@H](C(=O)N3CC(N(C)C)C3)N(C(C)C)C4)n[nH]c2c1,0.35248536048755874,3.0,527.6730000000003,3.7955000000000023,6,3,1,104.38,-3.7998407846032682,0.5977974772453308,-5.936300747220189,0.9852336525917054,-12.022783505847693,0.7151423573493958,0.8135584831237793,0.3580543100833893,83.18335357958532,8.084445399733708,0.19949362501502038,0.3208528131246567,0.2265686571598053,0.331243135035038,0.5564783573150635,27.79549406435968,23.00964808774245,75.51066845004051,2.9204300729660413,0.47299270033836366,0.14806938134133815,0.5885011792182923,0.6539737224578858,0.924019205570221,0.008268313994631172,0.014495956432074308,0.08998975083231926,0.04584593772888183,0.1994844689965248,0.07760526537895203,0.006575371604412794,0.07122159823775291,0.05228528082370758,0.20393054634332658,0.18850523829460145,0.2562825888395309,False
JAK2,105757,PROTEIN FAMILY,Janus Kinase (JAK),9606,Homo sapiens,CHEMBL2363062,,0.0,9536.0,3589942.0,2537414.0,Janus Kinase (JAK) inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NEZULCITINIB,CHEMBL4802163,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2021.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H37N7O2/c1-6-18-11-21(38)8-10-22(18)19-7-9-23-24(12-19)33-34-28(23)29-31-25-13-27(37(17(2)3)16-26(25)32-29)30(39)36-14-20(15-36)35(4)5/h7-12,17,20,27,38H,6,13-16H2,1-5H3,(H,31,32)(H,33,34)/t27-/m0/s1",VQIIUJSNIKEMCK-MHZLTWQESA-N,CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)C[C@@H](C(=O)N3CC(N(C)C)C3)N(C(C)C)C4)n[nH]c2c1,0.35248536048755874,3.0,527.6730000000003,3.7955000000000023,6,3,1,104.38,-3.7998407846032682,0.5977974772453308,-5.936300747220189,0.9852336525917054,-12.022783505847693,0.7151423573493958,0.8135584831237793,0.3580543100833893,83.18335357958532,8.084445399733708,0.19949362501502038,0.3208528131246567,0.2265686571598053,0.331243135035038,0.5564783573150635,27.79549406435968,23.00964808774245,75.51066845004051,2.9204300729660413,0.47299270033836366,0.14806938134133815,0.5885011792182923,0.6539737224578858,0.924019205570221,0.008268313994631172,0.014495956432074308,0.08998975083231926,0.04584593772888183,0.1994844689965248,0.07760526537895203,0.006575371604412794,0.07122159823775291,0.05228528082370758,0.20393054634332658,0.18850523829460145,0.2562825888395309,False
TYK2,12694,SINGLE PROTEIN,Tyrosine-protein kinase TYK2,9606,Homo sapiens,CHEMBL3553,,0.0,4090.0,2473465.0,2255359.0,Tyrosine-protein kinase TYK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor ,,,,CERDULATINIB,CHEMBL4116008,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25)",BGLPECHZZQDNCD-UHFFFAOYSA-N,CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1,0.55466520924993,4.0,445.5490000000003,1.3651000000000009,8,3,0,133.55,-4.2314949313746695,0.8260319352149963,-5.435345617338178,0.9976902723312377,-12.438629444297707,0.8997140288352966,0.09742597378790378,0.6988256812095642,82.89659779507092,5.445850814551198,0.2916873894631863,0.40392561852931974,0.5082022577524186,0.059311277326196434,0.4882168352603912,-27.40485885764872,28.42445532616149,50.23660235211459,2.9796346138781558,0.28796297311782837,0.12087728083133698,0.32272992134094236,0.9539158821105957,0.670199191570282,0.05604419559240341,0.04276549406349659,0.1847851186990738,0.07393521219491958,0.06730487719178199,0.14447724372148513,0.07149834781885148,0.193439219892025,0.10658375173807144,0.6502431511878968,0.5876042902469635,0.24641140252351762,True
TYK2,12694,SINGLE PROTEIN,Tyrosine-protein kinase TYK2,9606,Homo sapiens,CHEMBL3553,,0.0,7818.0,3133045.0,2335448.0,Tyrosine-protein kinase TYK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Lower activity against Jak2,,,BREPOCITINIB,CHEMBL4297477,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2019.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H21F2N7O/c1-25-8-11(7-22-25)23-17-21-5-4-15(24-17)26-9-12-2-3-13(10-26)27(12)16(28)14-6-18(14,19)20/h4-5,7-8,12-14H,2-3,6,9-10H2,1H3,(H,21,23,24)/t12-,13+,14-/m0/s1",BUWBRTXGQRBBHG-MJBXVCDLSA-N,Cn1cc(Nc2nccc(N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1,0.8590270054441072,4.0,389.41,1.7884999999999995,7,1,3,79.18,-3.780971741680837,0.9235970139503479,-4.959730776919986,0.9997593402862549,-11.492073517435148,0.882256031036377,0.04367016302421689,0.8900423526763916,78.6100015010053,2.62085363627937,0.07886958383023739,0.09425329542718827,0.0384741046698764,0.024290024302899837,0.4509298950433731,16.312912335816396,41.035907748664194,50.27519260091497,3.5792165190247447,0.6322842180728913,0.11901740431785583,0.4948290169239044,0.866757082939148,0.7576878428459167,0.05704359263181687,0.022464810125529765,0.1336372047662735,0.01715996488928795,0.05421644225716591,0.15243228673934936,0.0036414497066289187,0.06644902676343918,0.007206193020101637,0.08123053647577763,0.08407462909817695,0.17762144431471824,False
TYK2,12694,SINGLE PROTEIN,Tyrosine-protein kinase TYK2,9606,Homo sapiens,CHEMBL3553,,0.0,8226.0,3841187.0,2466823.0,Tyrosine-protein kinase TYK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CRAVACITINIB,CHEMBL4596392,4.0,1.0,0.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,2020.0,1.0,deu-; -tinib,0.0,deu-; -tinib (-citinib),deuterated compounds; tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)",BZZKEPGENYLQSC-UHFFFAOYSA-N,CNC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,0.5237289112980588,4.0,422.4490000000002,1.7323999999999995,9,3,0,135.95,-3.93722751849475,0.9526706337928772,-5.111124453822141,0.9965473294258118,-11.767618156421133,0.8635312438011169,0.232539102435112,0.6199126243591309,83.59930622237746,-1.35076222722008,0.12196043152362109,0.056342801358550784,0.11933137774467469,0.01587012249510735,0.3964575543999672,3.677923227552055,38.90341845297338,46.065170030875834,2.490211326932623,0.48529945611953734,0.19756527841091157,0.32428996860980985,0.9718837380409241,0.5124933421611786,0.008643232751637697,0.008317002048715948,0.03871212042868137,0.0071901225484907625,0.2126469910144806,0.027090460434556006,0.0184345749206841,0.1434056580066681,0.034299001563340425,0.15012685358524322,0.18085278570652008,0.20041163116693497,False
TYK2,12694,SINGLE PROTEIN,Tyrosine-protein kinase TYK2,9606,Homo sapiens,CHEMBL3553,,0.0,8661.0,3489979.0,2366594.0,Tyrosine-protein kinase TYK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ROPSACITINIB,CHEMBL4459585,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2021.0,,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3/t14-,20-",XPLZTJWZDBFWDE-OYOVHJISSA-N,Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1,0.5349503101515823,4.0,383.4190000000001,2.5358600000000004,9,0,0,113.41,-3.446981731719344,0.9094942092895508,-5.070696880386561,0.996518361568451,-9.999861903018928,0.8981626510620118,0.1731561005115509,0.7444204568862915,82.9019979918424,-4.4304481647497775,0.21517524141818284,0.03578924415633082,0.05485349744558334,0.02968755755573511,0.7364150285720825,-16.346043083852003,4.235907590599168,15.622426868972038,3.26354058005424,0.4316191852092743,0.1143056370317936,0.6510248124599457,0.7987854957580567,0.7193515539169312,0.04473641328513622,0.06314025148749351,0.05015651658177376,0.049093978479504585,0.09892065301537514,0.19798814952373506,0.017496765311807393,0.12020910307765006,0.028430088236927987,0.043502858839929104,0.17124064825475216,0.21228676289319992,False
TYK2,12694,SINGLE PROTEIN,Tyrosine-protein kinase TYK2,9606,Homo sapiens,CHEMBL3553,,0.0,8904.0,3460698.0,2342179.0,Tyrosine-protein kinase TYK2 negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,,,,,DEUCRAVACITINIB,CHEMBL4435170,4.0,1.0,1.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,2020.0,1.0,deu-; -tinib,0.0,deu-; -tinib (-citinib),deuterated compounds; tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3",BZZKEPGENYLQSC-FIBGUPNXSA-N,[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,0.49641291938995996,4.0,425.4673053340002,1.7324,9,3,0,135.95,-3.951376272165619,0.9409024596214295,-5.110793323034775,0.9991754174232483,-12.07140698623753,0.845158064365387,0.18053389564156533,0.7246172428131104,80.03601435894038,1.1101478215049947,0.13194232247769833,0.0822902264073491,0.1482868254184723,0.025488806422799826,0.43204493522644044,21.11040741100846,33.82687640949417,35.083707908794146,2.3473818381898046,0.5461540818214417,0.28622953295707704,0.39778528213500974,0.9362387657165527,0.4679999053478241,0.0073962670750916,0.008844722993671894,0.036161229200661185,0.007584200007840991,0.1302173063158989,0.024744913913309574,0.00988907110877335,0.05388428680598736,0.021754291979596017,0.09654657319188117,0.08754339963197708,0.16554166674613952,False
TYK2,12694,SINGLE PROTEIN,Tyrosine-protein kinase TYK2,9606,Homo sapiens,CHEMBL3553,,0.0,9796.0,2139018.0,1763569.0,Tyrosine-protein kinase TYK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,JAK1 preferential inhibitory activity,,,,FILGOTINIB,CHEMBL3301607,4.0,1.0,0.0,MOL,,Small molecule,2020.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,-1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)",RIJLVEAXPNLDTC-UHFFFAOYSA-N,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,0.6714427615145171,4.0,425.5140000000002,1.9751999999999998,7,1,0,96.67,-3.727445322689415,0.8124213933944702,-5.150047358349303,0.9866591572761536,-11.16850097715634,0.7197441577911377,0.2565056324005127,0.8469727277755738,83.94718000491727,-4.802850756612772,0.1662248842418194,0.12882839217782022,0.22775053977966309,0.07005550861358642,0.37525531053543093,1.33568921681374,19.73167540787157,27.284124801603724,2.699860350335789,0.3799066632986069,0.26749595403671267,0.6193182110786438,0.9221848011016845,0.6309301972389221,0.034669407084584235,0.04633984565734863,0.14026207476854324,0.053374186903238294,0.08026344366371632,0.06855418272316456,0.09968657046556473,0.24713660776615143,0.050591572374105456,0.27315452694892883,0.4690458536148071,0.23230402022600175,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,9795.0,2139018.0,1763569.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,JAK1 preferential inhibitory activity,,,,FILGOTINIB,CHEMBL3301607,4.0,1.0,0.0,MOL,,Small molecule,2020.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,-1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)",RIJLVEAXPNLDTC-UHFFFAOYSA-N,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,0.6714427615145171,4.0,425.5140000000002,1.9751999999999998,7,1,0,96.67,-3.727445322689415,0.8124213933944702,-5.150047358349303,0.9866591572761536,-11.16850097715634,0.7197441577911377,0.2565056324005127,0.8469727277755738,83.94718000491727,-4.802850756612772,0.1662248842418194,0.12882839217782022,0.22775053977966309,0.07005550861358642,0.37525531053543093,1.33568921681374,19.73167540787157,27.284124801603724,2.699860350335789,0.3799066632986069,0.26749595403671267,0.6193182110786438,0.9221848011016845,0.6309301972389221,0.034669407084584235,0.04633984565734863,0.14026207476854324,0.053374186903238294,0.08026344366371632,0.06855418272316456,0.09968657046556473,0.24713660776615143,0.050591572374105456,0.27315452694892883,0.4690458536148071,0.23230402022600175,False
TYK2,12694,SINGLE PROTEIN,Tyrosine-protein kinase TYK2,9606,Homo sapiens,CHEMBL3553,,0.0,9821.0,3133866.0,2336138.0,Tyrosine-protein kinase TYK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,JAK1 preferential inhibitory activity,,,,FILGOTINIB MALEATE,CHEMBL4298167,4.0,1.0,1.0,MOL,,Small molecule,2020.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,-1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H23N5O3S.C4H4O4/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25;5-3(6)1-2-4(7)8/h1-7,17H,8-14H2,(H,23,24,27);1-2H,(H,5,6)(H,7,8)/b;2-1-",BFENHEAPFWQJFL-BTJKTKAUSA-N,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1.O=C(O)/C=C\C(=O)O,0.37384943765654766,3.0,541.5860000000004,1.6869999999999998,9,3,0,171.26999999999998,-2.8836113453622945,0.682485020160675,-5.872274752270551,0.2936036974191666,-12.554642485672938,0.11822745054960251,0.050205836445093154,0.7208713531494141,72.98918576979281,-4.485288525012454,0.06531575173139573,0.09702223762869835,0.14041630774736405,0.12095153778791427,0.09673591554164887,15.217198842064471,-24.960301502666862,4.108943031865529,2.9659214235803675,0.2535951197147369,0.2162303864955902,0.7208115458488464,0.9376991391181946,0.2683800280094147,0.033083708584308626,0.028681303933262826,0.12314382791519166,0.047312884405255315,0.021269599813967942,0.02509360257536173,0.09417520202696324,0.18242240250110625,0.03569499664008617,0.07642873506993056,0.2828613966703415,0.243371319770813,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,9822.0,3133866.0,2336138.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,JAK1 preferential inhibitory activity,,,,FILGOTINIB MALEATE,CHEMBL4298167,4.0,1.0,1.0,MOL,,Small molecule,2020.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,-1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H23N5O3S.C4H4O4/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25;5-3(6)1-2-4(7)8/h1-7,17H,8-14H2,(H,23,24,27);1-2H,(H,5,6)(H,7,8)/b;2-1-",BFENHEAPFWQJFL-BTJKTKAUSA-N,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1.O=C(O)/C=C\C(=O)O,0.37384943765654766,3.0,541.5860000000004,1.6869999999999998,9,3,0,171.26999999999998,-2.8836113453622945,0.682485020160675,-5.872274752270551,0.2936036974191666,-12.554642485672938,0.11822745054960251,0.050205836445093154,0.7208713531494141,72.98918576979281,-4.485288525012454,0.06531575173139573,0.09702223762869835,0.14041630774736405,0.12095153778791427,0.09673591554164887,15.217198842064471,-24.960301502666862,4.108943031865529,2.9659214235803675,0.2535951197147369,0.2162303864955902,0.7208115458488464,0.9376991391181946,0.2683800280094147,0.033083708584308626,0.028681303933262826,0.12314382791519166,0.047312884405255315,0.021269599813967942,0.02509360257536173,0.09417520202696324,0.18242240250110625,0.03569499664008617,0.07642873506993056,0.2828613966703415,0.243371319770813,False
TYK2,12694,SINGLE PROTEIN,Tyrosine-protein kinase TYK2,9606,Homo sapiens,CHEMBL3553,,0.0,9834.0,3956785.0,2832770.0,Tyrosine-protein kinase TYK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,UPADACITINIB HEMIHYDRATE,CHEMBL5315119,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,,1.0,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/2C17H19F3N6O.H2O/c2*1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15;/h2*3-6,10-11,21H,2,7-9H2,1H3,(H,24,27);1H2/t2*10-,11+;/m11./s1",GJMQTRCDSIQEFK-SCDRJROZSA-N,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.O,0.17250955831844922,3.0,778.763,4.991100000000006,8,4,4,188.14,-5.053466770681673,0.6117628514766693,-5.5085459076357015,0.988003933429718,-12.126883002455177,0.5887482166290283,0.7595451235771179,0.4974829912185669,89.74262214252703,-6.170186881944102,0.16144626289606095,0.3557426244020462,0.5966509759426117,0.2034355491399765,0.8142133116722107,66.30165634195836,5.8505087550791055,50.841625185947365,3.904972212297835,0.3558409720659256,0.17330384701490403,0.48135976791381835,0.8542394161224365,0.9527922868728638,0.01842213310301304,0.014111722633242608,0.11908203363418579,0.02888444159179926,0.18421490639448165,0.1838560789823532,0.03288922943174839,0.29982206523418425,0.08418758567422628,0.6210210382938385,0.3650441437959671,0.17016908526420593,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,9836.0,3956785.0,2832770.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,UPADACITINIB HEMIHYDRATE,CHEMBL5315119,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,,1.0,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/2C17H19F3N6O.H2O/c2*1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15;/h2*3-6,10-11,21H,2,7-9H2,1H3,(H,24,27);1H2/t2*10-,11+;/m11./s1",GJMQTRCDSIQEFK-SCDRJROZSA-N,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.O,0.17250955831844922,3.0,778.763,4.991100000000006,8,4,4,188.14,-5.053466770681673,0.6117628514766693,-5.5085459076357015,0.988003933429718,-12.126883002455177,0.5887482166290283,0.7595451235771179,0.4974829912185669,89.74262214252703,-6.170186881944102,0.16144626289606095,0.3557426244020462,0.5966509759426117,0.2034355491399765,0.8142133116722107,66.30165634195836,5.8505087550791055,50.841625185947365,3.904972212297835,0.3558409720659256,0.17330384701490403,0.48135976791381835,0.8542394161224365,0.9527922868728638,0.01842213310301304,0.014111722633242608,0.11908203363418579,0.02888444159179926,0.18421490639448165,0.1838560789823532,0.03288922943174839,0.29982206523418425,0.08418758567422628,0.6210210382938385,0.3650441437959671,0.17016908526420593,False
DRD2,104754,SELECTIVITY GROUP,Dopamine receptors; D2 & D3,9606,Homo sapiens,CHEMBL2095169,,0.0,5603.0,1699813.0,1376102.0,Dopamine receptors; D2 & D3 partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,PARDOPRUNOX,CHEMBL2103832,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2008.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)",YVPUUUDAZYFFQT-UHFFFAOYSA-N,CN1CCN(c2cccc3[nH]c(=O)oc23)CC1,0.7938647558549867,4.0,233.27099999999993,0.8729,4,1,0,52.480000000000004,-1.9499353265298396,0.7075550436973572,-4.397050547781552,0.9953880190849305,-13.591105276390039,0.49381733536720274,0.017540124710649252,0.9692195534706116,50.688558835907884,11.761259994092423,0.0868267472833395,0.01134893363341689,0.002070578606799245,0.028938365820795297,0.003628654370550066,-19.910071745634404,23.20849085343058,-11.431304656052095,2.215872215152232,0.17222102135419845,0.042232824862003325,0.3505517214536667,0.733294403553009,0.5076855003833771,0.04705837592482567,0.016728297155350447,0.05480037238448858,0.002358778635971248,0.06617672964930535,0.0013269248767755926,0.0011809589166659861,0.004513186449185014,0.0028327837237156926,0.0037305215024389326,0.022385209426283838,0.6217742025852203,False
DRD3,104754,SELECTIVITY GROUP,Dopamine receptors; D2 & D3,9606,Homo sapiens,CHEMBL2095169,,0.0,5603.0,1699813.0,1376102.0,Dopamine receptors; D2 & D3 partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,PARDOPRUNOX,CHEMBL2103832,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2008.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)",YVPUUUDAZYFFQT-UHFFFAOYSA-N,CN1CCN(c2cccc3[nH]c(=O)oc23)CC1,0.7938647558549867,4.0,233.27099999999993,0.8729,4,1,0,52.480000000000004,-1.9499353265298396,0.7075550436973572,-4.397050547781552,0.9953880190849305,-13.591105276390039,0.49381733536720274,0.017540124710649252,0.9692195534706116,50.688558835907884,11.761259994092423,0.0868267472833395,0.01134893363341689,0.002070578606799245,0.028938365820795297,0.003628654370550066,-19.910071745634404,23.20849085343058,-11.431304656052095,2.215872215152232,0.17222102135419845,0.042232824862003325,0.3505517214536667,0.733294403553009,0.5076855003833771,0.04705837592482567,0.016728297155350447,0.05480037238448858,0.002358778635971248,0.06617672964930535,0.0013269248767755926,0.0011809589166659861,0.004513186449185014,0.0028327837237156926,0.0037305215024389326,0.022385209426283838,0.6217742025852203,False
DRD2,104754,SELECTIVITY GROUP,Dopamine receptors; D2 & D3,9606,Homo sapiens,CHEMBL2095169,,0.0,6889.0,1702809.0,389011.0,Dopamine receptors; D2 & D3 antagonist,,ANTAGONIST,1.0,1.0,1.0,"Amisulpride blocks pre- and post synaptic dopamine D2, D3 receptors as well as the 5-HT7a receptor.","The chemical structure of amisulpride contains a chiral center and, thus, is a mixture of two optical isomers: (S)-amisulpride and (R)-amisulpride. The enantiomers bind at dopamine D2/3 and Î±2- adrenoceptors in a stereoselective manner with marked differences in affinity: (S)-amisulpride displays high affinity binding at both D2 and D3 receptors. On the other hand, the isomers display reversed stereoselectivity (but weaker affinity) at Î±2-adrenoceptors.",,,AMISULPRIDE,CHEMBL243712,4.0,1.0,1.0,MOL,64045.0,Small molecule,1986.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,1.0,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)",NTJOBXMMWNYJFB-UHFFFAOYSA-N,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,0.7023165228263907,4.0,369.4870000000002,1.2851000000000006,6,2,1,101.73,-2.228700080099659,0.8517745733261108,-5.243469213743185,0.9962151169776916,-13.57585412519144,0.6300853013992309,0.032187952660024166,0.9546600818634033,38.041011036899704,-0.870640816578268,0.02276503648608923,0.03658617436885834,0.005032486794516444,0.32940198183059693,0.2819835186004639,10.314015754500684,9.22809328141857,-10.553635592292448,2.151504554432177,0.6285526931285859,0.26774856746196746,0.660745632648468,0.3142778486013412,0.7096391916275024,0.01228708615526557,0.005877817329019308,0.026865079812705518,0.0065642073284834625,0.014962902432307601,0.008397458819672465,0.0005096693261293694,0.0010392309224698693,0.0010820703231729568,0.003253689128905535,0.002335010748356581,0.30989629626274107,False
DRD3,104754,SELECTIVITY GROUP,Dopamine receptors; D2 & D3,9606,Homo sapiens,CHEMBL2095169,,0.0,6889.0,1702809.0,389011.0,Dopamine receptors; D2 & D3 antagonist,,ANTAGONIST,1.0,1.0,1.0,"Amisulpride blocks pre- and post synaptic dopamine D2, D3 receptors as well as the 5-HT7a receptor.","The chemical structure of amisulpride contains a chiral center and, thus, is a mixture of two optical isomers: (S)-amisulpride and (R)-amisulpride. The enantiomers bind at dopamine D2/3 and Î±2- adrenoceptors in a stereoselective manner with marked differences in affinity: (S)-amisulpride displays high affinity binding at both D2 and D3 receptors. On the other hand, the isomers display reversed stereoselectivity (but weaker affinity) at Î±2-adrenoceptors.",,,AMISULPRIDE,CHEMBL243712,4.0,1.0,1.0,MOL,64045.0,Small molecule,1986.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,1.0,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)",NTJOBXMMWNYJFB-UHFFFAOYSA-N,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,0.7023165228263907,4.0,369.4870000000002,1.2851000000000006,6,2,1,101.73,-2.228700080099659,0.8517745733261108,-5.243469213743185,0.9962151169776916,-13.57585412519144,0.6300853013992309,0.032187952660024166,0.9546600818634033,38.041011036899704,-0.870640816578268,0.02276503648608923,0.03658617436885834,0.005032486794516444,0.32940198183059693,0.2819835186004639,10.314015754500684,9.22809328141857,-10.553635592292448,2.151504554432177,0.6285526931285859,0.26774856746196746,0.660745632648468,0.3142778486013412,0.7096391916275024,0.01228708615526557,0.005877817329019308,0.026865079812705518,0.0065642073284834625,0.014962902432307601,0.008397458819672465,0.0005096693261293694,0.0010392309224698693,0.0010820703231729568,0.003253689128905535,0.002335010748356581,0.30989629626274107,False
HTR2A,104841,PROTEIN FAMILY,Serotonin (5-HT) receptor,9606,Homo sapiens,CHEMBL2096904,,0.0,6452.0,1702809.0,389011.0,Serotonin (5-HT) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Amisulpride blocks pre- and post synaptic dopamine D2, D3 receptors as well as the 5-HT7a receptor.","The chemical structure of amisulpride contains a chiral center and, thus, is a mixture of two optical isomers: (S)-amisulpride and (R)-amisulpride. The enantiomers bind at dopamine D2/3 and Î±2- adrenoceptors in a stereoselective manner with marked differences in affinity: (S)-amisulpride displays high affinity binding at both D2 and D3 receptors. On the other hand, the isomers display reversed stereoselectivity (but weaker affinity) at Î±2-adrenoceptors.",,,AMISULPRIDE,CHEMBL243712,4.0,1.0,1.0,MOL,64045.0,Small molecule,1986.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,1.0,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)",NTJOBXMMWNYJFB-UHFFFAOYSA-N,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,0.7023165228263907,4.0,369.4870000000002,1.2851000000000006,6,2,1,101.73,-2.228700080099659,0.8517745733261108,-5.243469213743185,0.9962151169776916,-13.57585412519144,0.6300853013992309,0.032187952660024166,0.9546600818634033,38.041011036899704,-0.870640816578268,0.02276503648608923,0.03658617436885834,0.005032486794516444,0.32940198183059693,0.2819835186004639,10.314015754500684,9.22809328141857,-10.553635592292448,2.151504554432177,0.6285526931285859,0.26774856746196746,0.660745632648468,0.3142778486013412,0.7096391916275024,0.01228708615526557,0.005877817329019308,0.026865079812705518,0.0065642073284834625,0.014962902432307601,0.008397458819672465,0.0005096693261293694,0.0010392309224698693,0.0010820703231729568,0.003253689128905535,0.002335010748356581,0.30989629626274107,False
DRD2,104842,PROTEIN FAMILY,Dopamine receptor,9606,Homo sapiens,CHEMBL2096905,,0.0,1151.0,1343650.0,249814.0,Dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PERGOLIDE MESYLATE,CHEMBL1275,4.0,1.0,1.0,MOL,8021.0,Small molecule,1988.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1979.0,-2.0,-erg-,0.0,-erg-,ergot alkaloid derivatives,Dopamine Agonist,1.0,0.0,0.0,"InChI=1S/C19H26N2S.CH4O3S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21;1-5(2,3)4/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3;1H3,(H,2,3,4)/t13-,16-,18-;/m1./s1",UWCVGPLTGZWHGS-ZORIOUSZSA-N,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O,0.750715872884489,4.0,410.6050000000002,3.775100000000002,4,2,3,73.4,-2.793330289039259,0.8305325269699096,-5.641989062585269,0.9979447364807129,-9.843482734113119,0.846572756767273,0.3193677216768265,0.9785383224487305,86.86948283946961,3.396370634792406,0.46295291781425474,0.15130224041640758,0.06256817020475865,0.8677145004272461,0.3409848600625992,61.45090292101573,21.595613729448125,4.06967278671242,2.6553712058069405,0.5198176026344299,0.19788212701678276,0.8415377736091614,0.6051545858383178,0.8974194288253784,0.016433499287813902,0.006488406239077449,0.09472682327032089,0.02065481822937727,0.4463090360164642,0.05860028751194477,0.002602713368833065,0.00800489797256887,0.03763751592487097,0.12490662783384324,0.0581215038895607,0.5051298499107361,False
DRD3,104842,PROTEIN FAMILY,Dopamine receptor,9606,Homo sapiens,CHEMBL2096905,,0.0,1151.0,1343650.0,249814.0,Dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PERGOLIDE MESYLATE,CHEMBL1275,4.0,1.0,1.0,MOL,8021.0,Small molecule,1988.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1979.0,-2.0,-erg-,0.0,-erg-,ergot alkaloid derivatives,Dopamine Agonist,1.0,0.0,0.0,"InChI=1S/C19H26N2S.CH4O3S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21;1-5(2,3)4/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3;1H3,(H,2,3,4)/t13-,16-,18-;/m1./s1",UWCVGPLTGZWHGS-ZORIOUSZSA-N,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O,0.750715872884489,4.0,410.6050000000002,3.775100000000002,4,2,3,73.4,-2.793330289039259,0.8305325269699096,-5.641989062585269,0.9979447364807129,-9.843482734113119,0.846572756767273,0.3193677216768265,0.9785383224487305,86.86948283946961,3.396370634792406,0.46295291781425474,0.15130224041640758,0.06256817020475865,0.8677145004272461,0.3409848600625992,61.45090292101573,21.595613729448125,4.06967278671242,2.6553712058069405,0.5198176026344299,0.19788212701678276,0.8415377736091614,0.6051545858383178,0.8974194288253784,0.016433499287813902,0.006488406239077449,0.09472682327032089,0.02065481822937727,0.4463090360164642,0.05860028751194477,0.002602713368833065,0.00800489797256887,0.03763751592487097,0.12490662783384324,0.0581215038895607,0.5051298499107361,False
DRD2,104842,PROTEIN FAMILY,Dopamine receptor,9606,Homo sapiens,CHEMBL2096905,,0.0,1152.0,1343950.0,155045.0,Dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,AMOXAPINE,CHEMBL1113,4.0,1.0,1.0,MOL,2675.0,Small molecule,1980.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1971.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antidepressant,0.0,0.0,0.0,"InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2",QWGDMFLQWFTERH-UHFFFAOYSA-N,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,0.8093498766353519,4.0,313.788,3.4292000000000025,4,1,0,36.86,-4.217227570111381,0.9332904934883117,-4.615886704494051,0.9999473452568054,-7.8964208761673,0.9624495267868042,0.7843209862709045,0.990663743019104,91.44033234107772,1.1107545970279253,0.9521677851676941,0.48493855595588686,0.14751966893672944,0.8768840670585633,0.4039670765399933,1.104709392934661,15.91614708554601,-8.678064000698077,2.986617458850417,0.21027689576148986,0.07379874587059021,0.2422166645526886,0.6941454887390137,0.9568403363227844,0.016618180088698864,0.004845630098134279,0.09952081590890885,0.008623816864565014,0.18418140858411788,0.1657789796590805,0.010600811429321766,0.009801589883863926,0.0144733855035156,0.09679636433720588,0.018529040180146693,0.5415803790092468,False
DRD3,104842,PROTEIN FAMILY,Dopamine receptor,9606,Homo sapiens,CHEMBL2096905,,0.0,1152.0,1343950.0,155045.0,Dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,AMOXAPINE,CHEMBL1113,4.0,1.0,1.0,MOL,2675.0,Small molecule,1980.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1971.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antidepressant,0.0,0.0,0.0,"InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2",QWGDMFLQWFTERH-UHFFFAOYSA-N,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,0.8093498766353519,4.0,313.788,3.4292000000000025,4,1,0,36.86,-4.217227570111381,0.9332904934883117,-4.615886704494051,0.9999473452568054,-7.8964208761673,0.9624495267868042,0.7843209862709045,0.990663743019104,91.44033234107772,1.1107545970279253,0.9521677851676941,0.48493855595588686,0.14751966893672944,0.8768840670585633,0.4039670765399933,1.104709392934661,15.91614708554601,-8.678064000698077,2.986617458850417,0.21027689576148986,0.07379874587059021,0.2422166645526886,0.6941454887390137,0.9568403363227844,0.016618180088698864,0.004845630098134279,0.09952081590890885,0.008623816864565014,0.18418140858411788,0.1657789796590805,0.010600811429321766,0.009801589883863926,0.0144733855035156,0.09679636433720588,0.018529040180146693,0.5415803790092468,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,899.0,1343950.0,155045.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AMOXAPINE,CHEMBL1113,4.0,1.0,1.0,MOL,2675.0,Small molecule,1980.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1971.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antidepressant,0.0,0.0,0.0,"InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2",QWGDMFLQWFTERH-UHFFFAOYSA-N,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,0.8093498766353519,4.0,313.788,3.4292000000000025,4,1,0,36.86,-4.217227570111381,0.9332904934883117,-4.615886704494051,0.9999473452568054,-7.8964208761673,0.9624495267868042,0.7843209862709045,0.990663743019104,91.44033234107772,1.1107545970279253,0.9521677851676941,0.48493855595588686,0.14751966893672944,0.8768840670585633,0.4039670765399933,1.104709392934661,15.91614708554601,-8.678064000698077,2.986617458850417,0.21027689576148986,0.07379874587059021,0.2422166645526886,0.6941454887390137,0.9568403363227844,0.016618180088698864,0.004845630098134279,0.09952081590890885,0.008623816864565014,0.18418140858411788,0.1657789796590805,0.010600811429321766,0.009801589883863926,0.0144733855035156,0.09679636433720588,0.018529040180146693,0.5415803790092468,False
DRD2,104842,PROTEIN FAMILY,Dopamine receptor,9606,Homo sapiens,CHEMBL2096905,,0.0,1153.0,1343983.0,364141.0,Dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PIMOZIDE,CHEMBL1423,4.0,1.0,1.0,MOL,8212.0,Small molecule,1984.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1967.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)",YVUQSNJEYSNKRX-UHFFFAOYSA-N,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,0.37471274722994996,3.0,461.5560000000001,5.8570000000000055,3,1,0,41.03,-5.0000217267856275,0.7298430442810059,-5.313198154498808,0.9985127210617065,-9.039179879378107,0.7995720624923706,0.9572834491729736,0.9088837385177613,96.72417486362967,3.298724558046591,0.13678017109632493,0.17676784172654153,0.27198921144008636,0.9515727758407593,0.626968389749527,-1.4597145207157023,30.53341368255989,-3.8837448464371733,3.131168634292691,0.07313801348209381,0.12606089636683465,0.6569998681545257,0.13834114968776703,0.993195378780365,0.005742006609216333,0.007855844730511308,0.03031810037791729,0.005760499695315957,0.047964829951524734,0.09638710841536521,0.003166201472049579,0.0013702001771889627,0.040397254005074504,0.1373729318380356,0.008107703039422631,0.49097009301185607,False
DRD3,104842,PROTEIN FAMILY,Dopamine receptor,9606,Homo sapiens,CHEMBL2096905,,0.0,1153.0,1343983.0,364141.0,Dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PIMOZIDE,CHEMBL1423,4.0,1.0,1.0,MOL,8212.0,Small molecule,1984.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1967.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)",YVUQSNJEYSNKRX-UHFFFAOYSA-N,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,0.37471274722994996,3.0,461.5560000000001,5.8570000000000055,3,1,0,41.03,-5.0000217267856275,0.7298430442810059,-5.313198154498808,0.9985127210617065,-9.039179879378107,0.7995720624923706,0.9572834491729736,0.9088837385177613,96.72417486362967,3.298724558046591,0.13678017109632493,0.17676784172654153,0.27198921144008636,0.9515727758407593,0.626968389749527,-1.4597145207157023,30.53341368255989,-3.8837448464371733,3.131168634292691,0.07313801348209381,0.12606089636683465,0.6569998681545257,0.13834114968776703,0.993195378780365,0.005742006609216333,0.007855844730511308,0.03031810037791729,0.005760499695315957,0.047964829951524734,0.09638710841536521,0.003166201472049579,0.0013702001771889627,0.040397254005074504,0.1373729318380356,0.008107703039422631,0.49097009301185607,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,600.0,1343983.0,364141.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PIMOZIDE,CHEMBL1423,4.0,1.0,1.0,MOL,8212.0,Small molecule,1984.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1967.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)",YVUQSNJEYSNKRX-UHFFFAOYSA-N,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,0.37471274722994996,3.0,461.5560000000001,5.8570000000000055,3,1,0,41.03,-5.0000217267856275,0.7298430442810059,-5.313198154498808,0.9985127210617065,-9.039179879378107,0.7995720624923706,0.9572834491729736,0.9088837385177613,96.72417486362967,3.298724558046591,0.13678017109632493,0.17676784172654153,0.27198921144008636,0.9515727758407593,0.626968389749527,-1.4597145207157023,30.53341368255989,-3.8837448464371733,3.131168634292691,0.07313801348209381,0.12606089636683465,0.6569998681545257,0.13834114968776703,0.993195378780365,0.005742006609216333,0.007855844730511308,0.03031810037791729,0.005760499695315957,0.047964829951524734,0.09638710841536521,0.003166201472049579,0.0013702001771889627,0.040397254005074504,0.1373729318380356,0.008107703039422631,0.49097009301185607,False
DRD2,105040,SELECTIVITY GROUP,Dopamine D1 and D2 receptor,9606,Homo sapiens,CHEMBL2111341,,0.0,6198.0,1699619.0,176014.0,Dopamine D1 and D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Amineptine is a selective inhibitor of dopamine reuptake and its effects are selectively exerted on the mesolimbocortical system, resulting in reactivation of this system.",,,,AMINEPTINE,CHEMBL418995,4.0,0.0,1.0,MOL,32499.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,-2.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/C22H27NO2/c24-21(25)13-3-1-2-8-16-23-22-19-11-6-4-9-17(19)14-15-18-10-5-7-12-20(18)22/h4-7,9-12,22-23H,1-3,8,13-16H2,(H,24,25)",ONNOFKFOZAJDHT-UHFFFAOYSA-N,O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21,0.6973898862604911,4.0,337.46300000000014,4.499300000000004,2,2,0,49.33,-3.626432419831302,0.8670647859573364,-5.2053375785818865,0.9942683577537537,-7.339530508728231,0.5010043025016785,0.3180110096931458,0.846994948387146,93.88059423999002,4.112073813036636,0.35453945845365525,0.263104709982872,0.11412319764494896,0.686660635471344,0.06982032731175422,37.042165182371065,59.93209063325666,-2.5620021921681824,2.5453020691165404,0.18712205886840821,0.2697980344295502,0.3031030461192131,0.30081715285778043,0.6950626909732819,0.012599556986242533,0.004428102425299585,0.21246907114982605,0.0728229396045208,0.15372347086668015,0.05555099137127399,0.22601271271705628,0.014386629965156317,0.08150618150830269,0.1938341364264488,0.02819875758141279,0.693381953239441,False
DRD2,105040,SELECTIVITY GROUP,Dopamine D1 and D2 receptor,9606,Homo sapiens,CHEMBL2111341,,0.0,6869.0,1703475.0,788435.0,Dopamine D1 and D2 receptor agonist,,AGONIST,1.0,1.0,1.0,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85ÂµM on homogenized rat striatum acetylcholinesterase.,,,MINAPRINE HYDROCHLORIDE,CHEMBL1364551,4.0,1.0,1.0,MOL,51040.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1986.0,-2.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H",GNUCGROXDZMCJI-UHFFFAOYSA-N,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl,0.8757185716512059,4.0,371.31200000000007,3.0397200000000018,5,1,0,50.28,-2.5310728167039223,0.9658366799354553,-4.6945769717976535,0.9972587466239929,-9.338853761250496,0.8384151458740234,0.3393876016139984,0.9634400606155396,86.10257997320193,5.809192332207666,0.43576743006706237,0.20801481530070304,0.043004581704735756,0.3337113559246063,0.12688853442668915,42.222489653980915,52.20117645203027,23.394016819375107,2.3090266054196213,0.8740067481994629,0.43126171827316284,0.8028242230415344,0.5331406146287918,0.8229300379753113,0.015811649896204472,0.031588003225624564,0.14120565056800843,0.02600974664092064,0.11056735217571259,0.0483593225479126,0.018382386304438114,0.09626054465770721,0.028812216594815254,0.012010873481631278,0.09978612586855888,0.7170204401016236,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,6868.0,1703475.0,788435.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85ÂµM on homogenized rat striatum acetylcholinesterase.,,,MINAPRINE HYDROCHLORIDE,CHEMBL1364551,4.0,1.0,1.0,MOL,51040.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1986.0,-2.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H",GNUCGROXDZMCJI-UHFFFAOYSA-N,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl,0.8757185716512059,4.0,371.31200000000007,3.0397200000000018,5,1,0,50.28,-2.5310728167039223,0.9658366799354553,-4.6945769717976535,0.9972587466239929,-9.338853761250496,0.8384151458740234,0.3393876016139984,0.9634400606155396,86.10257997320193,5.809192332207666,0.43576743006706237,0.20801481530070304,0.043004581704735756,0.3337113559246063,0.12688853442668915,42.222489653980915,52.20117645203027,23.394016819375107,2.3090266054196213,0.8740067481994629,0.43126171827316284,0.8028242230415344,0.5331406146287918,0.8229300379753113,0.015811649896204472,0.031588003225624564,0.14120565056800843,0.02600974664092064,0.11056735217571259,0.0483593225479126,0.018382386304438114,0.09626054465770721,0.028812216594815254,0.012010873481631278,0.09978612586855888,0.7170204401016236,False
HTR2A,104784,PROTEIN FAMILY,Serotonin 2 (5-HT2) receptor,9606,Homo sapiens,CHEMBL2095200,,0.0,8642.0,1703475.0,788435.0,Serotonin 2 (5-HT2) receptor,,ANTAGONIST,1.0,1.0,1.0,,,,,MINAPRINE HYDROCHLORIDE,CHEMBL1364551,4.0,1.0,1.0,MOL,51040.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1986.0,-2.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H",GNUCGROXDZMCJI-UHFFFAOYSA-N,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl,0.8757185716512059,4.0,371.31200000000007,3.0397200000000018,5,1,0,50.28,-2.5310728167039223,0.9658366799354553,-4.6945769717976535,0.9972587466239929,-9.338853761250496,0.8384151458740234,0.3393876016139984,0.9634400606155396,86.10257997320193,5.809192332207666,0.43576743006706237,0.20801481530070304,0.043004581704735756,0.3337113559246063,0.12688853442668915,42.222489653980915,52.20117645203027,23.394016819375107,2.3090266054196213,0.8740067481994629,0.43126171827316284,0.8028242230415344,0.5331406146287918,0.8229300379753113,0.015811649896204472,0.031588003225624564,0.14120565056800843,0.02600974664092064,0.11056735217571259,0.0483593225479126,0.018382386304438114,0.09626054465770721,0.028812216594815254,0.012010873481631278,0.09978612586855888,0.7170204401016236,False
DRD2,105040,SELECTIVITY GROUP,Dopamine D1 and D2 receptor,9606,Homo sapiens,CHEMBL2111341,,0.0,6873.0,1703570.0,33583.0,Dopamine D1 and D2 receptor agonist,,AGONIST,1.0,1.0,1.0,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85ÂµM on homogenized rat striatum acetylcholinesterase.,,,MINAPRINE,CHEMBL278819,4.0,1.0,0.0,MOL,51038.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1986.0,-2.0,,0.0,,,"Antidepressant,Psychotropic",1.0,0.0,0.0,"InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)",LDMWSLGGVTVJPG-UHFFFAOYSA-N,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,0.9168214991162381,4.0,298.39000000000004,2.1961199999999996,5,1,0,50.28,-2.3180247602475164,0.9706691145896912,-4.551359928410148,0.9995845198631287,-9.362376827619814,0.9195497274398804,0.13867846876382828,0.9750775098800659,72.6512756796602,3.513230737509681,0.6286392986774445,0.14870445281267167,0.01996356397867203,0.17792798280715943,0.16740065291523934,10.100006229249335,51.73195126166072,15.096263474453115,2.746529408644867,0.7122469007968902,0.1767575114965439,0.5978184640407562,0.5255201816558838,0.7138458371162415,0.030863822996616365,0.026022515073418618,0.15459538102149964,0.012052278034389019,0.15543701723217965,0.016267736814916132,0.005788548476994037,0.054841399937868116,0.01427522748708725,0.003348763007670641,0.03550750408321619,0.7100456118583679,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,6872.0,1703570.0,33583.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85ÂµM on homogenized rat striatum acetylcholinesterase.,,,MINAPRINE,CHEMBL278819,4.0,1.0,0.0,MOL,51038.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1986.0,-2.0,,0.0,,,"Antidepressant,Psychotropic",1.0,0.0,0.0,"InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)",LDMWSLGGVTVJPG-UHFFFAOYSA-N,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,0.9168214991162381,4.0,298.39000000000004,2.1961199999999996,5,1,0,50.28,-2.3180247602475164,0.9706691145896912,-4.551359928410148,0.9995845198631287,-9.362376827619814,0.9195497274398804,0.13867846876382828,0.9750775098800659,72.6512756796602,3.513230737509681,0.6286392986774445,0.14870445281267167,0.01996356397867203,0.17792798280715943,0.16740065291523934,10.100006229249335,51.73195126166072,15.096263474453115,2.746529408644867,0.7122469007968902,0.1767575114965439,0.5978184640407562,0.5255201816558838,0.7138458371162415,0.030863822996616365,0.026022515073418618,0.15459538102149964,0.012052278034389019,0.15543701723217965,0.016267736814916132,0.005788548476994037,0.054841399937868116,0.01427522748708725,0.003348763007670641,0.03550750408321619,0.7100456118583679,False
HTR2A,104784,PROTEIN FAMILY,Serotonin 2 (5-HT2) receptor,9606,Homo sapiens,CHEMBL2095200,,0.0,8641.0,1703570.0,33583.0,Serotonin 2 (5-HT2) receptor,,ANTAGONIST,1.0,1.0,1.0,,,,,MINAPRINE,CHEMBL278819,4.0,1.0,0.0,MOL,51038.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1986.0,-2.0,,0.0,,,"Antidepressant,Psychotropic",1.0,0.0,0.0,"InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)",LDMWSLGGVTVJPG-UHFFFAOYSA-N,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,0.9168214991162381,4.0,298.39000000000004,2.1961199999999996,5,1,0,50.28,-2.3180247602475164,0.9706691145896912,-4.551359928410148,0.9995845198631287,-9.362376827619814,0.9195497274398804,0.13867846876382828,0.9750775098800659,72.6512756796602,3.513230737509681,0.6286392986774445,0.14870445281267167,0.01996356397867203,0.17792798280715943,0.16740065291523934,10.100006229249335,51.73195126166072,15.096263474453115,2.746529408644867,0.7122469007968902,0.1767575114965439,0.5978184640407562,0.5255201816558838,0.7138458371162415,0.030863822996616365,0.026022515073418618,0.15459538102149964,0.012052278034389019,0.15543701723217965,0.016267736814916132,0.005788548476994037,0.054841399937868116,0.01427522748708725,0.003348763007670641,0.03550750408321619,0.7100456118583679,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,191.0,1344923.0,1536859.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIETHYLPERAZINE MALATE,CHEMBL2359670,4.0,1.0,1.0,MOL,,Small molecule,1961.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H29N3S2.2C4H6O5/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24;2*5-2(4(8)9)1-3(6)7/h4-5,7-10,17H,3,6,11-16H2,1-2H3;2*2,5H,1H2,(H,6,7)(H,8,9)",GTHHLZDYRHLACN-UHFFFAOYSA-N,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)CC(O)C(=O)O.O=C(O)CC(O)C(=O)O,0.18048075073176073,1.0,667.8030000000005,2.852,11,6,2,199.37999999999997,-1.204714820406431,0.29598928689956666,-6.273818945756494,0.22436397075653075,-11.540724929434422,0.10052059143781662,0.25656057298183443,0.5492998361587524,74.86244282951924,4.490702102526252,0.24942488968372345,0.18822465538978578,0.02455103974789381,0.8138695478439331,0.09596299529075622,23.910256905271574,-19.704498644877646,16.93189432886065,2.4335373560085607,0.10154030546545982,0.07762112691998482,0.4594338297843933,0.6410301268100739,0.5334770858287812,0.07579036429524422,0.008839957229793072,0.10745110809803009,0.03514961013570428,0.043719905987381937,0.017284978833049535,0.018173101544380187,0.006087500602006912,0.02179934671148658,0.02918744385242462,0.02880900464951992,0.3942447602748871,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,192.0,1344877.0,2197349.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIETHYLPERAZINE MALEATE,CHEMBL3989478,4.0,1.0,1.0,MOL,,Small molecule,1961.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H29N3S2.2C4H4O4/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24;2*5-3(6)1-2-4(7)8/h4-5,7-10,17H,3,6,11-16H2,1-2H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-",RVBRTNPNFYFDMZ-SPIKMXEPSA-N,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.21524811301479535,3.0,631.7730000000004,4.462400000000002,9,4,0,158.92000000000002,-2.9889322657339528,0.42554171085357667,-5.708344417348918,0.2549057759344578,-9.540833274949765,0.24032143354415894,0.26568808406591415,0.8452258944511414,84.94122966550816,-4.769967930907853,0.13355094343423843,0.45253312587738037,0.08284068554639816,0.7024381399154663,0.07211015596985818,-6.568327595213461,4.268316813342162,12.138987608038802,2.439191712956438,0.17542384341359138,0.13384166210889817,0.5251600623130799,0.8002844452857971,0.499140202999115,0.028828190825879573,0.008085346315056086,0.0944246619939804,0.04156525619328022,0.026194625347852708,0.018557940237224103,0.08412805274128914,0.029344837367534637,0.10095017403364182,0.03162937518209219,0.08264902979135513,0.6191902935504914,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,193.0,1343055.0,674902.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,FLUPHENAZINE ENANTHATE,CHEMBL1200951,4.0,1.0,1.0,MOL,5125.0,Small molecule,1967.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C29H38F3N3O2S/c1-2-3-4-5-11-28(36)37-21-20-34-18-16-33(17-19-34)14-8-15-35-24-9-6-7-10-26(24)38-27-13-12-23(22-25(27)35)29(30,31)32/h6-7,9-10,12-13,22H,2-5,8,11,14-21H2,1H3",LRWSFOSWNAQHHW-UHFFFAOYSA-N,CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,0.21340139673913963,2.0,549.7029999999999,6.829400000000008,6,0,0,36.02,-5.724354228021503,0.41268512010574343,-4.772250134627925,0.9988927721977234,-5.104373806574517,0.9183829307556153,0.9827614188194275,0.987533688545227,111.07967929313197,1.8002429583989081,0.19761908948421478,0.42423698902130125,0.093632323294878,0.861112368106842,0.8267769694328309,44.27101417267603,103.70209535656731,89.65956331432024,3.8361502264884835,0.13786962628364563,0.36151924431324006,0.4942415446043015,0.22038705199956893,0.9953734755516053,0.02352071609348059,0.02035617996007204,0.022158473543822766,0.010001679230481387,0.03337112776935101,0.0607010543346405,0.003932670800713823,0.0009430235426407307,0.02407249975949526,0.1621148869395256,0.03403730317950249,0.7394715189933777,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,194.0,1343294.0,16505.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PERPHENAZINE,CHEMBL567,4.0,1.0,1.0,MOL,8028.0,Small molecule,1957.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2",RGCVKNLCSQQDEP-UHFFFAOYSA-N,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,0.7886610933771963,4.0,403.9790000000002,3.942700000000003,5,1,0,29.950000000000003,-3.560353224455241,0.6425979733467102,-4.808053898468643,0.9984729170799256,-8.101002063533858,0.862398898601532,0.8773610830307007,0.9909245252609253,106.72300211819909,20.255905346920674,0.610042130947113,0.3583183825016022,0.05097880288958549,0.9685671329498291,0.09804925918579102,46.2116658934729,39.12968224487046,17.796501188366374,2.558542719407515,0.15456095188856125,0.13718378096818923,0.5570418298244476,0.3784280359745026,0.9903607130050659,0.011553867906332015,0.006552247609943151,0.02162145134061575,0.0044272303814068435,0.26274717450141905,0.06108975186944008,0.0019443961995420978,0.0006714575865771621,0.030416011810302734,0.07550446540117264,0.025626812130212784,0.8370185256004333,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,195.0,1344432.0,674658.0,Dopamine D2 receptor modulator,,MODULATOR,1.0,1.0,1.0,Antiemetic,,,,BENZQUINAMIDE HYDROCHLORIDE,CHEMBL1200707,4.0,1.0,1.0,MOL,,Small molecule,1974.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H32N2O5.ClH/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25;/h10-11,17-19H,6-9,12-13H2,1-5H3;1H",KZLNXGBVFTWMPS-UHFFFAOYSA-N,CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O.Cl,0.6334465559699739,4.0,440.96800000000013,2.8448000000000015,6,0,3,68.31,-1.8092907172730999,0.7479981422424317,-4.881780194499839,0.9847647428512574,-7.07780595686952,0.949147641658783,0.4439040839672089,0.8992731213569641,68.15486644748819,1.2528181818744226,0.00986444097943604,0.17658904790878296,0.04016883624717593,0.2671012908220291,0.33837677985429765,8.270495654406332,59.38930523783523,86.29830966739746,2.7060467880387904,0.4323731243610382,0.1038066640496254,0.32279216647148135,0.2045661687850952,0.7332217931747437,0.04181409440934658,0.019231733307242392,0.0897720217704773,0.02306952849030495,0.03286985978484154,0.014640561491250991,0.0015364368679001927,0.02470315475948155,0.006601966265588999,0.00700534803327173,0.024219917505979537,0.28251598626375196,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,196.0,1344288.0,37266.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROCHLORPERAZINE,CHEMBL728,4.0,1.0,1.0,MOL,8435.0,Small molecule,1956.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,"Anti-Emetic,Anti-Emetic; Antipsychotic,Antipsychotic; Anti-Emetic",0.0,0.0,0.0,"InChI=1S/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3",WIKYUJGCLQQFNW-UHFFFAOYSA-N,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,0.775124662295156,4.0,373.95300000000015,4.580200000000004,4,0,0,9.72,-4.519698573400387,0.7754490375518799,-4.394470042139581,0.9993220925331116,-6.135442701844677,0.9684903621673584,0.7652546882629394,0.999004065990448,107.29943621067127,11.158087497470465,0.5925438284873963,0.38077948689460756,0.012680093850940466,0.9745320200920105,0.20000230222940446,19.688089594656276,66.47988372138369,0.16708187246670292,2.5538697492630087,0.2208675280213356,0.10598937720060349,0.588671737909317,0.5706539452075958,0.9862306952476502,0.010845472570508718,0.0031239727861247955,0.016560390032827853,0.004064514441415668,0.12868403494358063,0.05550833381712437,0.002294884651200846,0.0005310716776875779,0.014703636337071658,0.041042706742882726,0.018225734867155553,0.8754860043525696,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,197.0,1343808.0,872071.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,FLUPHENAZINE HYDROCHLORIDE,CHEMBL1448187,4.0,1.0,1.0,MOL,,Small molecule,1959.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H",MBHNWCYEGXQEIT-UHFFFAOYSA-N,Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,0.5809812496557052,2.0,510.45300000000015,5.151700000000005,5,1,0,29.950000000000003,-4.158545681201656,0.5657324612140655,-4.828793455291443,0.9970069527626038,-7.56375039590616,0.8025233149528503,0.9434959650039673,0.9640771985054016,103.1378758268678,-1.013744286188316,0.421279239654541,0.31206820607185365,0.05814059935510159,0.9282723784446716,0.47691869735717773,21.429611757860638,17.252170146029687,30.566337948627837,3.633638034322966,0.19477746784687042,0.4922123849391937,0.7334282994270325,0.20130712687969207,0.9957558870315552,0.016602020896971225,0.014349871221929789,0.022583051398396493,0.0074348887894302605,0.08448473811149597,0.04759862031787634,0.0030340754834469407,0.0011688170954585076,0.020391681231558323,0.2712100952863693,0.0791137084364891,0.5267414331436158,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,198.0,1344159.0,675038.0,Dopamine D2 receptor agonist,,AGONIST,1.0,1.0,1.0,Long acting,,,,CABERGOLINE,CHEMBL1201087,4.0,1.0,1.0,MOL,3286.0,Small molecule,1996.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1996.0,1.0,-erg-,0.0,-erg-,ergot alkaloid derivatives,Dopamine Agonist; Antidyskinetic; Antihyperprolactinemic,0.0,0.0,0.0,"InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1",KORNTPPJEAJQIU-KJXAQDMKSA-N,C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,0.6049384423595515,4.0,451.61500000000024,3.193900000000001,4,2,3,71.68,-3.3702639567337003,0.4318058431148529,-5.351517701357868,0.9975533246994018,-10.482840797170141,0.8010239243507385,0.31804169714450836,0.9882031798362731,84.81020252645828,3.723493550122721,0.17736536413431167,0.07919079065322876,0.05046336278319359,0.7563128232955932,0.7082234799861908,1.8867302886831525,33.69301221293635,28.14056234434842,3.1595824848375407,0.1996337115764618,0.07566369641572238,0.8073349833488465,0.19855424463748933,0.9217872142791748,0.01171192042529583,0.007572384271770716,0.04229813888669014,0.009097742289304734,0.16284701079130173,0.022317569330334665,0.0004414774390170351,0.008491797465831041,0.012703180499374866,0.030374996736645697,0.03294752798974514,0.4531655639410019,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,199.0,1344535.0,738635.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROCHLORPERAZINE MALEATE,CHEMBL1314751,4.0,1.0,1.0,MOL,8436.0,Small molecule,1956.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H24ClN3S.2C4H4O4/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;2*5-3(6)1-2-4(7)8/h2-3,5-8,15H,4,9-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-",DSKIOWHQLUWFLG-SPIKMXEPSA-N,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.3208123281450717,3.0,606.0970000000004,4.003800000000001,8,4,0,158.92000000000002,-3.163506885380907,0.43230508267879486,-5.5578181636640664,0.4031135499477386,-8.793049629061857,0.3097797930240631,0.2830503165721893,0.9090302109718322,92.32882955571618,-6.259567382377213,0.14454022645950318,0.4611835300922394,0.06456356346607209,0.7726081132888794,0.03462855778634548,0.4639596434087306,-12.514346127820662,-16.54650454260628,2.768684413245724,0.1550869420170784,0.16533892899751662,0.5884097993373871,0.786732840538025,0.5192683875560761,0.02227423470467329,0.006256586126983166,0.07064629234373569,0.028539197519421577,0.024959524534642695,0.015292047522962093,0.042174043506383894,0.012180612655356526,0.0819912500679493,0.026642308011651038,0.04734668731689453,0.6385953962802887,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,200.0,1343543.0,674805.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,FLUPHENAZINE DECANOATE,CHEMBL1200854,4.0,1.0,1.0,MOL,,Small molecule,1972.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,1.0,0.0,,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3",VIQCGTZFEYDQMR-UHFFFAOYSA-N,CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,0.15432075680363713,2.0,591.7840000000001,7.99970000000001,6,0,0,36.02,-6.040958404507885,0.3872662290930748,-4.760986463407042,0.9989735007286071,-4.894767344613401,0.8996755957603455,0.9902287483215332,0.9862153172492981,113.61502671290597,2.7921964030144393,0.14911737143993378,0.400795990228653,0.08593697994947433,0.8178712129592896,0.7903800129890441,47.606203627107625,105.26913141006094,96.63485703399176,3.870323772189729,0.1093247726559639,0.3497981518507004,0.3994699686765671,0.20618569999933242,0.9952649116516114,0.021529377438127995,0.017156116617843508,0.021468281373381616,0.008689832570962609,0.027143828757107257,0.058455285429954526,0.004101632378296927,0.0007720866677118465,0.02739279828965664,0.16847023367881775,0.03440542463213205,0.7617186069488525,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,201.0,1344181.0,1537268.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ACETOPHENAZINE MALEATE,CHEMBL2360079,4.0,1.0,1.0,MOL,2402.0,Small molecule,1961.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1963.0,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C23H29N3O2S.2C4H4O4/c1-18(28)19-7-8-23-21(17-19)26(20-5-2-3-6-22(20)29-23)10-4-9-24-11-13-25(14-12-24)15-16-27;2*5-3(6)1-2-4(7)8/h2-3,5-8,17,27H,4,9-16H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-",NUKVZKPNSKJGBK-SPIKMXEPSA-N,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.17701113965134102,3.0,643.7150000000004,2.9154999999999998,10,5,0,196.22,-2.3962427262035604,0.2886481672525406,-5.817032756217019,0.27302186191082,-12.018664667679886,0.11708540096879005,0.4177573502063751,0.7300952434539795,86.00561267835675,-0.2726583886186525,0.0604677377268672,0.3645543247461319,0.1224422961473465,0.6355718195438385,0.018492974154651166,0.8078835889437752,-10.735501583398827,20.033874502456136,2.808576946134757,0.12306713461875915,0.11335863545536995,0.512680858373642,0.66118905544281,0.5009155690670013,0.04896276779472828,0.029971935972571372,0.08064918667078018,0.012780807726085187,0.044327101483941075,0.01362103745341301,0.022634887229651214,0.030067876540124418,0.05720206126570702,0.045696253329515456,0.06014527827501297,0.39768260419368745,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,202.0,1344886.0,80209.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROTHIXENE,CHEMBL908,4.0,1.0,1.0,MOL,50931.0,Small molecule,1967.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-",WSPOMRSOLSGNFJ-AUWJEWJLSA-N,CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21,0.6542213588943052,3.0,315.869,5.188000000000004,2,0,0,3.24,-5.7726692448073775,0.8807940244674682,-4.545294200544764,0.9994469285011292,-5.234609941866939,0.9660401582717896,0.7600566983222962,0.9966030597686768,97.66320832695855,17.68752404300706,0.8762162923812866,0.2583511769771576,0.021059267595410346,0.8643157720565796,0.08026813268661499,66.27450019560175,67.96139666774627,10.172332833470069,2.955210554388544,0.4961868584156036,0.24392204284667968,0.49317401349544526,0.5744966387748718,0.9329267740249634,0.018101230822503568,0.012488915026187897,0.050299408845603466,0.017829955741763114,0.1010202519595623,0.09195191785693169,0.009650650434195995,0.0024741046130657197,0.05095315370708704,0.13768569827079774,0.05644857063889504,0.8719791173934937,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,247.0,1344886.0,80209.0,Dopamine D3 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROTHIXENE,CHEMBL908,4.0,1.0,1.0,MOL,50931.0,Small molecule,1967.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-",WSPOMRSOLSGNFJ-AUWJEWJLSA-N,CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21,0.6542213588943052,3.0,315.869,5.188000000000004,2,0,0,3.24,-5.7726692448073775,0.8807940244674682,-4.545294200544764,0.9994469285011292,-5.234609941866939,0.9660401582717896,0.7600566983222962,0.9966030597686768,97.66320832695855,17.68752404300706,0.8762162923812866,0.2583511769771576,0.021059267595410346,0.8643157720565796,0.08026813268661499,66.27450019560175,67.96139666774627,10.172332833470069,2.955210554388544,0.4961868584156036,0.24392204284667968,0.49317401349544526,0.5744966387748718,0.9329267740249634,0.018101230822503568,0.012488915026187897,0.050299408845603466,0.017829955741763114,0.1010202519595623,0.09195191785693169,0.009650650434195995,0.0024741046130657197,0.05095315370708704,0.13768569827079774,0.05644857063889504,0.8719791173934937,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,577.0,1344886.0,80209.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROTHIXENE,CHEMBL908,4.0,1.0,1.0,MOL,50931.0,Small molecule,1967.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-",WSPOMRSOLSGNFJ-AUWJEWJLSA-N,CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21,0.6542213588943052,3.0,315.869,5.188000000000004,2,0,0,3.24,-5.7726692448073775,0.8807940244674682,-4.545294200544764,0.9994469285011292,-5.234609941866939,0.9660401582717896,0.7600566983222962,0.9966030597686768,97.66320832695855,17.68752404300706,0.8762162923812866,0.2583511769771576,0.021059267595410346,0.8643157720565796,0.08026813268661499,66.27450019560175,67.96139666774627,10.172332833470069,2.955210554388544,0.4961868584156036,0.24392204284667968,0.49317401349544526,0.5744966387748718,0.9329267740249634,0.018101230822503568,0.012488915026187897,0.050299408845603466,0.017829955741763114,0.1010202519595623,0.09195191785693169,0.009650650434195995,0.0024741046130657197,0.05095315370708704,0.13768569827079774,0.05644857063889504,0.8719791173934937,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,203.0,1343076.0,675053.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRIFLUPROMAZINE HYDROCHLORIDE,CHEMBL1201102,4.0,1.0,1.0,MOL,9712.0,Small molecule,1957.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C18H19F3N2S.ClH/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H",FTNWXGFYRHWUKG-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21.Cl,0.6647176030098713,3.0,388.886,5.681600000000005,3,0,0,6.48,-4.829648046317876,0.8676671504974365,-4.567043680346293,0.9984643459320068,-4.887482844813112,0.9238909244537353,0.8996458053588867,0.9946224331855774,99.8473153310031,-9.615100492374642,0.6205714523792267,0.2483976125717163,0.028867638483643532,0.8203749895095825,0.2266785442829132,9.583056522200565,46.852598501181625,27.419833396523735,3.1516510840195964,0.1827910214662552,0.6276659667491913,0.4963896542787552,0.2904806718230247,0.9876810789108277,0.017895835265517235,0.01704310216009617,0.04316069446504116,0.018427296355366708,0.06893991231918335,0.07811236679553986,0.009454153943806887,0.00253179301507771,0.02323292875662446,0.4511130154132843,0.10923626869916916,0.5466775536537171,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,204.0,1343144.0,1926823.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ASENAPINE MALEATE,CHEMBL3544974,4.0,1.0,1.0,MOL,,Small molecule,2009.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,2002.0,1.0,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C17H16ClNO.C4H4O4/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19;5-3(6)1-2-4(7)8/h2-8,14-15H,9-10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-",GMDCDXMAFMEDAG-BTJKTKAUSA-N,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1.O=C(O)/C=C\C(=O)O,0.740220328537148,4.0,401.8460000000002,3.9703000000000017,4,2,2,87.07000000000001,-3.236018672789055,0.8583148956298828,-5.2917762915275715,0.9400768756866456,-8.459198734626238,0.6132098436355591,0.293813419342041,0.9154370188713074,89.91484249402195,-8.348257388158569,0.09199574589729309,0.21655353307723998,0.029294865578413008,0.6783014297485351,0.010518181044608355,6.18932959479169,-22.904002700686988,-18.919998417792137,3.3221762225213993,0.11156806722283363,0.1319310650229454,0.6322550773620605,0.7443665623664856,0.304700568318367,0.032049883902072904,0.005658267042599618,0.0810241810977459,0.01437758868560195,0.028586219437420367,0.010860278736799955,0.06677423529326916,0.005470538092777133,0.05207988135516643,0.012888689711689948,0.010811642231419682,0.43963309526443484,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,586.0,1343144.0,1926823.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ASENAPINE MALEATE,CHEMBL3544974,4.0,1.0,1.0,MOL,,Small molecule,2009.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,2002.0,1.0,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C17H16ClNO.C4H4O4/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19;5-3(6)1-2-4(7)8/h2-8,14-15H,9-10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-",GMDCDXMAFMEDAG-BTJKTKAUSA-N,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1.O=C(O)/C=C\C(=O)O,0.740220328537148,4.0,401.8460000000002,3.9703000000000017,4,2,2,87.07000000000001,-3.236018672789055,0.8583148956298828,-5.2917762915275715,0.9400768756866456,-8.459198734626238,0.6132098436355591,0.293813419342041,0.9154370188713074,89.91484249402195,-8.348257388158569,0.09199574589729309,0.21655353307723998,0.029294865578413008,0.6783014297485351,0.010518181044608355,6.18932959479169,-22.904002700686988,-18.919998417792137,3.3221762225213993,0.11156806722283363,0.1319310650229454,0.6322550773620605,0.7443665623664856,0.304700568318367,0.032049883902072904,0.005658267042599618,0.0810241810977459,0.01437758868560195,0.028586219437420367,0.010860278736799955,0.06677423529326916,0.005470538092777133,0.05207988135516643,0.012888689711689948,0.010811642231419682,0.43963309526443484,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,205.0,1343887.0,155006.0,Dopamine D2 receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,ARIPIPRAZOLE,CHEMBL1112,4.0,1.0,1.0,MOL,31236.0,Small molecule,2002.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1997.0,1.0,-prazole,0.0,-prazole,antiulcer agents (benzimidazole derivatives),Antipsychotic; Antischizophrenic,0.0,0.0,0.0,"InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)",CEUORZQYGODEFX-UHFFFAOYSA-N,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,0.6149801508040519,4.0,448.39400000000006,4.859300000000005,4,1,0,44.81,-3.9746414871634115,0.6376510620117187,-4.885552442032133,0.9933654546737671,-8.466295051969501,0.8305561184883118,0.8988428711891174,0.9193574547767639,103.31836786022927,3.038649235342598,0.2348160356283188,0.5235517501831055,0.15213833451271058,0.7362050294876099,0.5588477611541748,46.99750896652931,50.1975941046309,52.04978941287315,3.1612357951878876,0.3480944693088531,0.36751413643360137,0.47295055389404295,0.5590373039245605,0.9464531779289246,0.04158366322517395,0.024241481348872183,0.12851718366146087,0.04314165711402893,0.21095881015062332,0.11649837046861648,0.024611782189458607,0.018878157995641232,0.12037036716938018,0.26638334393501284,0.3203095644712448,0.52926664352417,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,585.0,1343887.0,155006.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ARIPIPRAZOLE,CHEMBL1112,4.0,1.0,1.0,MOL,31236.0,Small molecule,2002.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1997.0,1.0,-prazole,0.0,-prazole,antiulcer agents (benzimidazole derivatives),Antipsychotic; Antischizophrenic,0.0,0.0,0.0,"InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)",CEUORZQYGODEFX-UHFFFAOYSA-N,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,0.6149801508040519,4.0,448.39400000000006,4.859300000000005,4,1,0,44.81,-3.9746414871634115,0.6376510620117187,-4.885552442032133,0.9933654546737671,-8.466295051969501,0.8305561184883118,0.8988428711891174,0.9193574547767639,103.31836786022927,3.038649235342598,0.2348160356283188,0.5235517501831055,0.15213833451271058,0.7362050294876099,0.5588477611541748,46.99750896652931,50.1975941046309,52.04978941287315,3.1612357951878876,0.3480944693088531,0.36751413643360137,0.47295055389404295,0.5590373039245605,0.9464531779289246,0.04158366322517395,0.024241481348872183,0.12851718366146087,0.04314165711402893,0.21095881015062332,0.11649837046861648,0.024611782189458607,0.018878157995641232,0.12037036716938018,0.26638334393501284,0.3203095644712448,0.52926664352417,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,206.0,1343540.0,1379630.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PALIPERIDONE PALMITATE,CHEMBL2107360,4.0,1.0,1.0,MOL,83808.0,Small molecule,2009.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2004.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C39H57FN4O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-36(45)47-34-17-16-24-44-38(34)41-29(2)32(39(44)46)23-27-43-25-21-30(22-26-43)37-33-20-19-31(40)28-35(33)48-42-37/h19-20,28,30,34H,3-18,21-27H2,1-2H3",VOMKSBFLAZZBOW-UHFFFAOYSA-N,CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O,0.09325911873265398,2.0,664.9070000000002,9.113520000000003,8,0,1,90.46000000000001,-4.964546747300299,0.6007967412471771,-5.1129147986295305,0.9994102597236634,-5.703460830697051,0.9688787698745728,0.997932243347168,0.983457088470459,101.88153736399526,0.474892047152453,0.039178121462464334,0.2668745517730713,0.33563614785671236,0.5801527023315429,0.7152178168296814,35.41867217037451,104.92537900848757,82.90550641141964,3.220711647219516,0.20200712680816652,0.06842858828604222,0.5705056011676788,0.38188600540161133,0.9786783337593079,0.038516318798065184,0.009741683769971133,0.0407452829182148,0.005010013282299042,0.014370267745107412,0.048328731954097745,0.0020523999235592784,0.0036092622904106975,0.019712035171687604,0.02281110640615225,0.004700366547331214,0.5105258703231812,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,597.0,1343540.0,1379630.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PALIPERIDONE PALMITATE,CHEMBL2107360,4.0,1.0,1.0,MOL,83808.0,Small molecule,2009.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2004.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C39H57FN4O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-36(45)47-34-17-16-24-44-38(34)41-29(2)32(39(44)46)23-27-43-25-21-30(22-26-43)37-33-20-19-31(40)28-35(33)48-42-37/h19-20,28,30,34H,3-18,21-27H2,1-2H3",VOMKSBFLAZZBOW-UHFFFAOYSA-N,CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O,0.09325911873265398,2.0,664.9070000000002,9.113520000000003,8,0,1,90.46000000000001,-4.964546747300299,0.6007967412471771,-5.1129147986295305,0.9994102597236634,-5.703460830697051,0.9688787698745728,0.997932243347168,0.983457088470459,101.88153736399526,0.474892047152453,0.039178121462464334,0.2668745517730713,0.33563614785671236,0.5801527023315429,0.7152178168296814,35.41867217037451,104.92537900848757,82.90550641141964,3.220711647219516,0.20200712680816652,0.06842858828604222,0.5705056011676788,0.38188600540161133,0.9786783337593079,0.038516318798065184,0.009741683769971133,0.0407452829182148,0.005010013282299042,0.014370267745107412,0.048328731954097745,0.0020523999235592784,0.0036092622904106975,0.019712035171687604,0.02281110640615225,0.004700366547331214,0.5105258703231812,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,207.0,1344016.0,13949.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ILOPERIDONE,CHEMBL14376,4.0,1.0,1.0,MOL,65173.0,Small molecule,2009.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1993.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3",XMXHEBAFVSFQEX-UHFFFAOYSA-N,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,0.3798624175213931,4.0,426.4880000000001,4.826600000000004,6,0,0,64.80000000000001,-3.2385233387997125,0.8857075572013855,-4.633600347943096,0.9998648047447205,-8.361495090050617,0.976584255695343,0.9831439971923828,0.9893176794052124,93.22668868573749,6.800149082982033,0.18670694828033446,0.19319258630275726,0.1624319151043892,0.8515242338180542,0.5560328006744385,-2.8610312353564438,65.9497100227031,47.776822308909274,2.993270631901049,0.329195237159729,0.06872705221176148,0.6628968119621277,0.37899650931358336,0.9686708569526672,0.02417548540979624,0.01268827160820365,0.058351854979991916,0.00516239651478827,0.41233469247817994,0.060733063519001006,0.0029789525782689453,0.01988427434116602,0.020061908289790154,0.03652009759098292,0.023945760168135165,0.1435129776597023,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,605.0,1344016.0,13949.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ILOPERIDONE,CHEMBL14376,4.0,1.0,1.0,MOL,65173.0,Small molecule,2009.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1993.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3",XMXHEBAFVSFQEX-UHFFFAOYSA-N,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,0.3798624175213931,4.0,426.4880000000001,4.826600000000004,6,0,0,64.80000000000001,-3.2385233387997125,0.8857075572013855,-4.633600347943096,0.9998648047447205,-8.361495090050617,0.976584255695343,0.9831439971923828,0.9893176794052124,93.22668868573749,6.800149082982033,0.18670694828033446,0.19319258630275726,0.1624319151043892,0.8515242338180542,0.5560328006744385,-2.8610312353564438,65.9497100227031,47.776822308909274,2.993270631901049,0.329195237159729,0.06872705221176148,0.6628968119621277,0.37899650931358336,0.9686708569526672,0.02417548540979624,0.01268827160820365,0.058351854979991916,0.00516239651478827,0.41233469247817994,0.060733063519001006,0.0029789525782689453,0.01988427434116602,0.020061908289790154,0.03652009759098292,0.023945760168135165,0.1435129776597023,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,208.0,1344981.0,675003.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,MESORIDAZINE BESYLATE,CHEMBL1201052,4.0,1.0,1.0,MOL,6781.0,Small molecule,1970.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C21H26N2OS2.C6H6O3S/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23;7-10(8,9)6-4-2-1-3-5-6/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1-5H,(H,7,8,9)",CRJHBCPQHRVYBS-UHFFFAOYSA-N,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21.O=S(=O)(O)c1ccccc1,0.3193433671913398,2.0,544.7640000000002,5.834400000000006,6,1,2,83.91,-2.065324910149458,0.6474788069725037,-5.637438713421049,0.9040721178054809,-8.79847226744639,0.7495253682136536,0.7731129765510559,0.9501543760299682,95.04198045085359,-4.028636804945201,0.11922704670578241,0.1319052457809448,0.03467932557687163,0.8695063114166259,0.0397989640943706,180.54699821695166,32.083197558354804,14.325063062561076,2.7969917971910303,0.0952643521130085,0.4426884323358536,0.46912296712398527,0.5725376009941101,0.9487015724182128,0.01538320742547512,0.006530788727104664,0.04685015380382538,0.0036001820117235184,0.03457416519522667,0.024067904427647592,0.002154320222325623,0.0009069652995094657,0.02098021823912859,0.11635390222072602,0.007890124805271626,0.47427425980567933,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,590.0,1344981.0,675003.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,MESORIDAZINE BESYLATE,CHEMBL1201052,4.0,1.0,1.0,MOL,6781.0,Small molecule,1970.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C21H26N2OS2.C6H6O3S/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23;7-10(8,9)6-4-2-1-3-5-6/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1-5H,(H,7,8,9)",CRJHBCPQHRVYBS-UHFFFAOYSA-N,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21.O=S(=O)(O)c1ccccc1,0.3193433671913398,2.0,544.7640000000002,5.834400000000006,6,1,2,83.91,-2.065324910149458,0.6474788069725037,-5.637438713421049,0.9040721178054809,-8.79847226744639,0.7495253682136536,0.7731129765510559,0.9501543760299682,95.04198045085359,-4.028636804945201,0.11922704670578241,0.1319052457809448,0.03467932557687163,0.8695063114166259,0.0397989640943706,180.54699821695166,32.083197558354804,14.325063062561076,2.7969917971910303,0.0952643521130085,0.4426884323358536,0.46912296712398527,0.5725376009941101,0.9487015724182128,0.01538320742547512,0.006530788727104664,0.04685015380382538,0.0036001820117235184,0.03457416519522667,0.024067904427647592,0.002154320222325623,0.0009069652995094657,0.02098021823912859,0.11635390222072602,0.007890124805271626,0.47427425980567933,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,209.0,1344810.0,674891.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,METOCLOPRAMIDE HYDROCHLORIDE,CHEMBL1200940,4.0,1.0,1.0,MOL,6899.0,Small molecule,1979.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1964.0,1.0,,0.0,,,Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C14H22ClN3O2.ClH.H2O/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3;;/h8-9H,4-7,16H2,1-3H3,(H,17,19);1H;1H2",KJBLQGHJOCAOJP-UHFFFAOYSA-N,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl.O,0.7267152509117338,4.0,354.27800000000013,1.5995000000000004,4,2,0,99.09,-2.3835834086976537,0.9707036852836609,-5.114589447081309,0.9927599787712097,-12.360014998500095,0.715532261133194,0.029026595782488583,0.9527934789657593,40.70182851820336,1.53849700565964,0.3976237207651138,0.07362801879644394,0.008337732660584152,0.7150474309921264,0.049963599815964696,7.9669499798983665,53.19035592420654,13.598244955543688,2.3640026920420043,0.9394560098648072,0.7386269330978393,0.7333782076835632,0.3319650232791901,0.8593449711799621,0.005776154203340411,0.004210721398703754,0.055445119738578796,0.010084239905700088,0.11113068759441376,0.014127093739807606,0.0012464325234759599,0.02542852032929659,0.004084845283068716,0.005898298532702029,0.01582467891275883,0.7183724224567414,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,210.0,1344796.0,674370.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,MOLINDONE HYDROCHLORIDE,CHEMBL1200419,4.0,1.0,1.0,MOL,,Small molecule,1974.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1967.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H",GQWNECFJGBQMBO-UHFFFAOYSA-N,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2.Cl,0.9318524593663999,4.0,312.84099999999995,2.3846200000000013,3,1,1,45.33,-1.2912506025484811,0.9357084274291992,-4.638176943694033,0.9999598264694214,-10.495285187197592,0.8477533340454102,0.5298581063747406,0.9808421015739441,58.13629260838604,10.849077189378944,0.35000498294830323,0.36485244929790495,0.038585055619478226,0.6809133052825928,0.5952764928340912,7.939707344820514,35.37718873784695,11.071582294355249,2.6233075804210126,0.5360133707523346,0.07177839204668998,0.4977313160896301,0.15807173252105713,0.7127720952033997,0.0066682224627584216,0.00973480634856969,0.06168651133775711,0.016445458680391312,0.24696048796176912,0.022065523266792297,0.002183581946883351,0.030391728132963182,0.02846044898033142,0.017067360877990722,0.03752210214734077,0.5135595023632049,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,592.0,1344796.0,674370.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,MOLINDONE HYDROCHLORIDE,CHEMBL1200419,4.0,1.0,1.0,MOL,,Small molecule,1974.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1967.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H",GQWNECFJGBQMBO-UHFFFAOYSA-N,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2.Cl,0.9318524593663999,4.0,312.84099999999995,2.3846200000000013,3,1,1,45.33,-1.2912506025484811,0.9357084274291992,-4.638176943694033,0.9999598264694214,-10.495285187197592,0.8477533340454102,0.5298581063747406,0.9808421015739441,58.13629260838604,10.849077189378944,0.35000498294830323,0.36485244929790495,0.038585055619478226,0.6809133052825928,0.5952764928340912,7.939707344820514,35.37718873784695,11.071582294355249,2.6233075804210126,0.5360133707523346,0.07177839204668998,0.4977313160896301,0.15807173252105713,0.7127720952033997,0.0066682224627584216,0.00973480634856969,0.06168651133775711,0.016445458680391312,0.24696048796176912,0.022065523266792297,0.002183581946883351,0.030391728132963182,0.02846044898033142,0.017067360877990722,0.03752210214734077,0.5135595023632049,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,211.0,1344495.0,468656.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PALIPERIDONE,CHEMBL1621,4.0,1.0,1.0,MOL,83804.0,Small molecule,2006.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2004.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3",PMXMIIMHBWHSKN-UHFFFAOYSA-N,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,0.6902887957170618,4.0,426.49200000000025,3.081320000000002,7,1,1,84.39,-2.0002748602636027,0.7753960013389587,-5.140145310725219,0.9993828535079956,-12.26546513708048,0.9514075756072998,0.8563679456710815,0.9728775262832642,73.26038664909228,-0.8093953547441686,0.01829788666218519,0.029674988240003586,0.023943878151476382,0.5208663880825043,0.09328086860477924,33.534781614247336,10.568448166812349,14.691423157221198,3.5487763577438587,0.3173765629529953,0.08708291500806808,0.7547449946403504,0.3237048745155334,0.9501174211502075,0.11946796923875809,0.015371564775705338,0.09939932003617287,0.00421910067088902,0.020732342824339868,0.024730140529572963,0.00045212259283289313,0.0019554946571588515,0.0024523776257410644,0.005256479803938419,0.0023788269551005214,0.19081899672746658,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,596.0,1344495.0,468656.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PALIPERIDONE,CHEMBL1621,4.0,1.0,1.0,MOL,83804.0,Small molecule,2006.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2004.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3",PMXMIIMHBWHSKN-UHFFFAOYSA-N,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,0.6902887957170618,4.0,426.49200000000025,3.081320000000002,7,1,1,84.39,-2.0002748602636027,0.7753960013389587,-5.140145310725219,0.9993828535079956,-12.26546513708048,0.9514075756072998,0.8563679456710815,0.9728775262832642,73.26038664909228,-0.8093953547441686,0.01829788666218519,0.029674988240003586,0.023943878151476382,0.5208663880825043,0.09328086860477924,33.534781614247336,10.568448166812349,14.691423157221198,3.5487763577438587,0.3173765629529953,0.08708291500806808,0.7547449946403504,0.3237048745155334,0.9501174211502075,0.11946796923875809,0.015371564775705338,0.09939932003617287,0.00421910067088902,0.020732342824339868,0.024730140529572963,0.00045212259283289313,0.0019554946571588515,0.0024523776257410644,0.005256479803938419,0.0023788269551005214,0.19081899672746658,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,212.0,1343298.0,209829.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIOTHIXENE,CHEMBL1201,4.0,1.0,1.0,MOL,,Small molecule,1967.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1965.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-",GFBKORZTTCHDGY-UWVJOHFNSA-N,CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,0.6041780809786208,4.0,443.63800000000026,3.4707000000000026,5,0,0,43.86000000000001,-4.533528113166588,0.648978841304779,-4.817505565872179,0.9941536545753479,-7.56120304900293,0.9716879487037658,0.5658714175224304,0.9781601548194885,89.05113817503299,-4.608461391671739,0.23126772046089172,0.22489446252584458,0.05547831114381552,0.7257833838462829,0.6464329957962036,-35.7968742131779,70.20617225648328,52.39589357160204,2.993727954484125,0.23125328719615937,0.2026272714138031,0.6152078151702881,0.7212063193321228,0.9519035696983338,0.02562105152755976,0.009992106352001429,0.020343568921089173,0.00939572611823678,0.037286254577338696,0.03316068463027477,0.004435516521334648,0.0008418897894443944,0.015863996045663954,0.03287940714508295,0.007417820720002055,0.6411027789115906,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,608.0,1343298.0,209829.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIOTHIXENE,CHEMBL1201,4.0,1.0,1.0,MOL,,Small molecule,1967.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1965.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-",GFBKORZTTCHDGY-UWVJOHFNSA-N,CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,0.6041780809786208,4.0,443.63800000000026,3.4707000000000026,5,0,0,43.86000000000001,-4.533528113166588,0.648978841304779,-4.817505565872179,0.9941536545753479,-7.56120304900293,0.9716879487037658,0.5658714175224304,0.9781601548194885,89.05113817503299,-4.608461391671739,0.23126772046089172,0.22489446252584458,0.05547831114381552,0.7257833838462829,0.6464329957962036,-35.7968742131779,70.20617225648328,52.39589357160204,2.993727954484125,0.23125328719615937,0.2026272714138031,0.6152078151702881,0.7212063193321228,0.9519035696983338,0.02562105152755976,0.009992106352001429,0.020343568921089173,0.00939572611823678,0.037286254577338696,0.03316068463027477,0.004435516521334648,0.0008418897894443944,0.015863996045663954,0.03287940714508295,0.007417820720002055,0.6411027789115906,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,213.0,1344890.0,2197695.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIOTHIXENE HYDROCHLORIDE,CHEMBL3989824,4.0,1.0,1.0,MOL,,Small molecule,1970.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1969.0,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H29N3O2S2.2ClH.2H2O/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26;;;;/h4-5,7-11,17H,6,12-16H2,1-3H3;2*1H;2*1H2/b19-8-;;;;",MEUAAEMCZUPORO-LRSHZYOCSA-N,CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1.Cl.Cl.O.O,0.4839634305664952,3.0,552.5900000000003,2.6649000000000043,5,0,0,106.86000000000001,-2.5141557131334973,0.6132451891899109,-5.185945799463255,0.9429393410682678,-8.655736652111612,0.8452057838439941,0.3870192885398865,0.8570350766181946,90.49466365110246,-2.4441237010785914,0.12965127825737,0.19082145094871522,0.03672935450449586,0.7725565671920777,0.2763304442167282,-9.441858230212706,33.64613986833589,32.38433738164304,2.835471045857922,0.3925226032733917,0.3560378193855286,0.6295919001102448,0.6423288881778717,0.923963189125061,0.017887423932552337,0.0066107410006225106,0.026533673889935015,0.011427762731909753,0.021682039741426705,0.016768436320126055,0.004167576003237627,0.0022647579316981137,0.01127226511016488,0.023731796257197856,0.007894463185220957,0.5570706486701965,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,609.0,1344890.0,2197695.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIOTHIXENE HYDROCHLORIDE,CHEMBL3989824,4.0,1.0,1.0,MOL,,Small molecule,1970.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1969.0,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H29N3O2S2.2ClH.2H2O/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26;;;;/h4-5,7-11,17H,6,12-16H2,1-3H3;2*1H;2*1H2/b19-8-;;;;",MEUAAEMCZUPORO-LRSHZYOCSA-N,CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1.Cl.Cl.O.O,0.4839634305664952,3.0,552.5900000000003,2.6649000000000043,5,0,0,106.86000000000001,-2.5141557131334973,0.6132451891899109,-5.185945799463255,0.9429393410682678,-8.655736652111612,0.8452057838439941,0.3870192885398865,0.8570350766181946,90.49466365110246,-2.4441237010785914,0.12965127825737,0.19082145094871522,0.03672935450449586,0.7725565671920777,0.2763304442167282,-9.441858230212706,33.64613986833589,32.38433738164304,2.835471045857922,0.3925226032733917,0.3560378193855286,0.6295919001102448,0.6423288881778717,0.923963189125061,0.017887423932552337,0.0066107410006225106,0.026533673889935015,0.011427762731909753,0.021682039741426705,0.016768436320126055,0.004167576003237627,0.0022647579316981137,0.01127226511016488,0.023731796257197856,0.007894463185220957,0.5570706486701965,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,214.0,1344199.0,16584.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRIFLUPROMAZINE,CHEMBL570,4.0,1.0,1.0,MOL,9711.0,Small molecule,1957.0,1.0,1.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3",XSCGXQMFQXDFCW-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,0.7410247450790446,3.0,352.42500000000007,5.259800000000004,3,0,0,6.48,-5.013276663150205,0.8963029980659485,-4.483121195247351,0.9994115948677063,-4.587006479127973,0.9660997271537781,0.8753851294517517,0.9978034615516662,97.42450413988455,-9.574964970924537,0.6779766798019409,0.325369256734848,0.02836360950022936,0.6667143940925598,0.22765295058488846,3.327621896828988,60.09453956026508,29.697793906245984,3.20622536110388,0.09591463208198547,0.5027094066143036,0.42494033873081205,0.3380244761705399,0.987263810634613,0.025454527139663695,0.016465453151613473,0.035578617826104164,0.011301303561776877,0.05219774898141623,0.056597675383090976,0.0066194924060255286,0.0014003748423419894,0.011646068887785077,0.30716722905635835,0.06180941462516785,0.5256670355796814,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,215.0,1343777.0,674899.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRIMIPRAMINE MALEATE,CHEMBL1200948,4.0,1.0,1.0,MOL,35030.0,Small molecule,1979.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1966.0,1.0,-pramine,0.0,-pramine,antidepressants (imipramine type),Antidepressant,0.0,0.0,0.0,"InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-",YDGHCKHAXOUQOS-BTJKTKAUSA-N,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O,0.7046653536376639,4.0,410.5140000000001,3.8328000000000024,4,2,1,81.08,-2.9388003653125367,0.7092012763023376,-5.298307411284351,0.697256076335907,-7.366252127025803,0.4625700950622559,0.43009731769561765,0.9500072598457336,83.52644748104058,-3.145536894860168,0.05906730890274048,0.1369289442896843,0.04258885830640793,0.8082733154296875,0.01934386882930994,5.138865855140834,33.85619260341789,4.722199148560774,2.9759037188191084,0.11365099474787713,0.23520667254924774,0.4650790750980377,0.3551902502775192,0.8136472582817078,0.016979585774242877,0.005475365743041039,0.07844319753348827,0.030166613310575484,0.039230515249073505,0.025019333884119987,0.04090144708752632,0.010098627582192422,0.06813456043601036,0.05681743510067463,0.030786020308732988,0.5303964376449585,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,921.0,1343777.0,674899.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TRIMIPRAMINE MALEATE,CHEMBL1200948,4.0,1.0,1.0,MOL,35030.0,Small molecule,1979.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1966.0,1.0,-pramine,0.0,-pramine,antidepressants (imipramine type),Antidepressant,0.0,0.0,0.0,"InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-",YDGHCKHAXOUQOS-BTJKTKAUSA-N,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O,0.7046653536376639,4.0,410.5140000000001,3.8328000000000024,4,2,1,81.08,-2.9388003653125367,0.7092012763023376,-5.298307411284351,0.697256076335907,-7.366252127025803,0.4625700950622559,0.43009731769561765,0.9500072598457336,83.52644748104058,-3.145536894860168,0.05906730890274048,0.1369289442896843,0.04258885830640793,0.8082733154296875,0.01934386882930994,5.138865855140834,33.85619260341789,4.722199148560774,2.9759037188191084,0.11365099474787713,0.23520667254924774,0.4650790750980377,0.3551902502775192,0.8136472582817078,0.016979585774242877,0.005475365743041039,0.07844319753348827,0.030166613310575484,0.039230515249073505,0.025019333884119987,0.04090144708752632,0.010098627582192422,0.06813456043601036,0.05681743510067463,0.030786020308732988,0.5303964376449585,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,611.0,1343777.0,674899.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRIMIPRAMINE MALEATE,CHEMBL1200948,4.0,1.0,1.0,MOL,35030.0,Small molecule,1979.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1966.0,1.0,-pramine,0.0,-pramine,antidepressants (imipramine type),Antidepressant,0.0,0.0,0.0,"InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-",YDGHCKHAXOUQOS-BTJKTKAUSA-N,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O,0.7046653536376639,4.0,410.5140000000001,3.8328000000000024,4,2,1,81.08,-2.9388003653125367,0.7092012763023376,-5.298307411284351,0.697256076335907,-7.366252127025803,0.4625700950622559,0.43009731769561765,0.9500072598457336,83.52644748104058,-3.145536894860168,0.05906730890274048,0.1369289442896843,0.04258885830640793,0.8082733154296875,0.01934386882930994,5.138865855140834,33.85619260341789,4.722199148560774,2.9759037188191084,0.11365099474787713,0.23520667254924774,0.4650790750980377,0.3551902502775192,0.8136472582817078,0.016979585774242877,0.005475365743041039,0.07844319753348827,0.030166613310575484,0.039230515249073505,0.025019333884119987,0.04090144708752632,0.010098627582192422,0.06813456043601036,0.05681743510067463,0.030786020308732988,0.5303964376449585,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2007.0,1344626.0,2261.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CLOZAPINE,CHEMBL42,4.0,1.0,1.0,MOL,3766.0,Small molecule,1989.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",QZUDBNBUXVUHMW-UHFFFAOYSA-N,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,0.8001222420891723,4.0,326.83100000000013,3.7227000000000023,4,1,0,30.869999999999997,-4.2862674700286645,0.9036430239677429,-4.586348046241016,0.9994073629379272,-8.507397095544603,0.9420299172401428,0.6117292821407319,0.9950148224830627,98.61593490694547,5.707917100381761,0.7504688143730164,0.133891761302948,0.015452404227107763,0.8485648036003113,0.148170168697834,2.2502668224890607,13.430259399746749,3.4105033127203157,2.795097915918257,0.40123715698719026,0.13348308354616165,0.5638707220554352,0.7509366273880005,0.9705475211143494,0.015649325959384442,0.006917837169021368,0.035195577144622806,0.007063112407922745,0.23188564777374268,0.08662716150283814,0.006544944224879145,0.006236840994097293,0.0112244906835258,0.07263100035488605,0.05592940971255302,0.604320102930069,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,579.0,1344626.0,2261.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CLOZAPINE,CHEMBL42,4.0,1.0,1.0,MOL,3766.0,Small molecule,1989.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",QZUDBNBUXVUHMW-UHFFFAOYSA-N,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,0.8001222420891723,4.0,326.83100000000013,3.7227000000000023,4,1,0,30.869999999999997,-4.2862674700286645,0.9036430239677429,-4.586348046241016,0.9994073629379272,-8.507397095544603,0.9420299172401428,0.6117292821407319,0.9950148224830627,98.61593490694547,5.707917100381761,0.7504688143730164,0.133891761302948,0.015452404227107763,0.8485648036003113,0.148170168697834,2.2502668224890607,13.430259399746749,3.4105033127203157,2.795097915918257,0.40123715698719026,0.13348308354616165,0.5638707220554352,0.7509366273880005,0.9705475211143494,0.015649325959384442,0.006917837169021368,0.035195577144622806,0.007063112407922745,0.23188564777374268,0.08662716150283814,0.006544944224879145,0.006236840994097293,0.0112244906835258,0.07263100035488605,0.05592940971255302,0.604320102930069,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2010.0,1343601.0,1535336.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CARPHENAZINE MALEATE,CHEMBL2358147,4.0,1.0,1.0,MOL,,Small molecule,1982.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C24H31N3O2S.2C4H4O4/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28;2*5-3(6)1-2-4(7)8/h3-4,6-9,18,28H,2,5,10-17H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-",TVPJGGZLZLUPOB-SPIKMXEPSA-N,CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.16465988984013205,3.0,657.7420000000004,3.3056,10,5,0,196.22,-2.6931751376762896,0.2909639835357666,-5.76834309922856,0.2981554791331291,-11.53041918251927,0.12874714881181717,0.4914020776748657,0.7051970720291137,88.27346304356618,0.7030279671144307,0.06330573670566082,0.38802761137485503,0.14765695631504058,0.6204570949077606,0.027490038052201272,5.587382516560206,-5.676212849129773,25.434415275470762,2.9284003809894914,0.12378696650266648,0.12684954702854156,0.5050749361515046,0.6759319186210633,0.5258911192417145,0.05057007595896721,0.03241336084902287,0.0797010250389576,0.0144052074290812,0.046119484677910806,0.01836466332897544,0.031305258721113206,0.03561864364892244,0.07161240354180336,0.05743416026234627,0.07330634370446205,0.4021729826927185,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,583.0,1343601.0,1535336.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CARPHENAZINE MALEATE,CHEMBL2358147,4.0,1.0,1.0,MOL,,Small molecule,1982.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C24H31N3O2S.2C4H4O4/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28;2*5-3(6)1-2-4(7)8/h3-4,6-9,18,28H,2,5,10-17H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-",TVPJGGZLZLUPOB-SPIKMXEPSA-N,CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.16465988984013205,3.0,657.7420000000004,3.3056,10,5,0,196.22,-2.6931751376762896,0.2909639835357666,-5.76834309922856,0.2981554791331291,-11.53041918251927,0.12874714881181717,0.4914020776748657,0.7051970720291137,88.27346304356618,0.7030279671144307,0.06330573670566082,0.38802761137485503,0.14765695631504058,0.6204570949077606,0.027490038052201272,5.587382516560206,-5.676212849129773,25.434415275470762,2.9284003809894914,0.12378696650266648,0.12684954702854156,0.5050749361515046,0.6759319186210633,0.5258911192417145,0.05057007595896721,0.03241336084902287,0.0797010250389576,0.0144052074290812,0.046119484677910806,0.01836466332897544,0.031305258721113206,0.03561864364892244,0.07161240354180336,0.05743416026234627,0.07330634370446205,0.4021729826927185,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2012.0,1343813.0,7714.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,RISPERIDONE,CHEMBL85,4.0,1.0,1.0,MOL,8871.0,Small molecule,1993.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1989.0,1.0,,0.0,,,Neuroleptic,0.0,0.0,0.0,"InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3",RAPZEAPATHNIPO-UHFFFAOYSA-N,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,0.6577452185749303,4.0,410.4930000000003,3.5904200000000026,6,0,0,64.16,-2.272311865568048,0.8654976844787597,-5.121280896871319,0.9997121453285217,-9.251500655245042,0.9849818706512451,0.9096848011016846,0.9954217314720154,77.13353826811534,1.935630668831709,0.06177341416478157,0.059876596182584764,0.03297534994781017,0.6126883149147033,0.2404838040471077,11.19018748927872,27.58317897421867,14.693374181339895,3.3463099542739423,0.4824920892715454,0.08887484148144723,0.8161575555801391,0.3759313404560089,0.962294626235962,0.0691503867506981,0.009072192199528217,0.10240145027637482,0.006887682899832726,0.018997798208147287,0.026277358271181585,0.0007322274090256542,0.00245051319943741,0.0033188626868650315,0.002583992131985724,0.001974147779401392,0.32007732093334196,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,601.0,1343813.0,7714.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,RISPERIDONE,CHEMBL85,4.0,1.0,1.0,MOL,8871.0,Small molecule,1993.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1989.0,1.0,,0.0,,,Neuroleptic,0.0,0.0,0.0,"InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3",RAPZEAPATHNIPO-UHFFFAOYSA-N,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,0.6577452185749303,4.0,410.4930000000003,3.5904200000000026,6,0,0,64.16,-2.272311865568048,0.8654976844787597,-5.121280896871319,0.9997121453285217,-9.251500655245042,0.9849818706512451,0.9096848011016846,0.9954217314720154,77.13353826811534,1.935630668831709,0.06177341416478157,0.059876596182584764,0.03297534994781017,0.6126883149147033,0.2404838040471077,11.19018748927872,27.58317897421867,14.693374181339895,3.3463099542739423,0.4824920892715454,0.08887484148144723,0.8161575555801391,0.3759313404560089,0.962294626235962,0.0691503867506981,0.009072192199528217,0.10240145027637482,0.006887682899832726,0.018997798208147287,0.026277358271181585,0.0007322274090256542,0.00245051319943741,0.0033188626868650315,0.002583992131985724,0.001974147779401392,0.32007732093334196,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2022.0,1344270.0,1038355.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LURASIDONE HYDROCHLORIDE,CHEMBL1615372,4.0,1.0,1.0,MOL,70732.0,Small molecule,2010.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2005.0,1.0,-sidone,0.0,-sidone,antipsychotic with binding activity on sertonin (5-HT2A) and dopamine (D2) receptors,,0.0,0.0,0.0,"InChI=1S/C28H36N4O2S.ClH/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26;/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2;1H/t18-,19+,20-,21-,24+,25-;/m0./s1",NEKCRUIRPWNMLK-SCIYSFAVSA-N,Cl.O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,0.527448281261016,3.0,529.1500000000002,4.677600000000004,6,0,6,56.75000000000001,-5.662460000017533,0.5157873690128326,-5.063443506922823,0.9976589798927307,-7.317860751880033,0.9017772912979126,0.8605090260505677,0.9755220174789428,107.50551068741652,2.1045946778707174,0.07576056048274041,0.22935383319854735,0.15375478118658065,0.3192528337240219,0.884762191772461,35.74027346351214,53.33637927103067,66.22218253544362,3.036237227072741,0.158637897670269,0.1270755235105753,0.5859514772891998,0.6441727042198181,0.9423162460327148,0.034784580767154696,0.02571087945252657,0.07555191442370415,0.03653427548706532,0.055890945717692375,0.20684462487697602,0.015004040859639644,0.04128496777266264,0.07628432661294937,0.2634382784366608,0.21291439533233641,0.3025049328804016,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,589.0,1344270.0,1038355.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LURASIDONE HYDROCHLORIDE,CHEMBL1615372,4.0,1.0,1.0,MOL,70732.0,Small molecule,2010.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2005.0,1.0,-sidone,0.0,-sidone,antipsychotic with binding activity on sertonin (5-HT2A) and dopamine (D2) receptors,,0.0,0.0,0.0,"InChI=1S/C28H36N4O2S.ClH/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26;/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2;1H/t18-,19+,20-,21-,24+,25-;/m0./s1",NEKCRUIRPWNMLK-SCIYSFAVSA-N,Cl.O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,0.527448281261016,3.0,529.1500000000002,4.677600000000004,6,0,6,56.75000000000001,-5.662460000017533,0.5157873690128326,-5.063443506922823,0.9976589798927307,-7.317860751880033,0.9017772912979126,0.8605090260505677,0.9755220174789428,107.50551068741652,2.1045946778707174,0.07576056048274041,0.22935383319854735,0.15375478118658065,0.3192528337240219,0.884762191772461,35.74027346351214,53.33637927103067,66.22218253544362,3.036237227072741,0.158637897670269,0.1270755235105753,0.5859514772891998,0.6441727042198181,0.9423162460327148,0.034784580767154696,0.02571087945252657,0.07555191442370415,0.03653427548706532,0.055890945717692375,0.20684462487697602,0.015004040859639644,0.04128496777266264,0.07628432661294937,0.2634382784366608,0.21291439533233641,0.3025049328804016,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2024.0,1344332.0,1678284.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,QUETIAPINE FUMARATE,CHEMBL3188993,4.0,1.0,1.0,MOL,8708.0,Small molecule,1997.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1996.0,1.0,-pine; -tiapine,0.0,-pine; -tiapine,tricyclic compounds; antipsychotics (dibenzothiazepine derivatives),,0.0,0.0,0.0,"InChI=1S/2C21H25N3O2S.C4H4O4/c2*25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h2*1-8,25H,9-16H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+",ZTHJULTYCAQOIJ-WXXKFALUSA-N,O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,0.10504270035087793,1.0,883.1059999999994,5.423800000000009,14,4,0,171.2,-4.095049124076114,0.5099495828151703,-5.922455729717173,0.5896039009094238,-11.469363412176916,0.2132771909236908,0.8043312430381775,0.6257178068161011,95.40150838249545,-9.978753787673915,0.07750404179096222,0.30804323852062226,0.20029473602771758,0.3428930968046188,0.09466869607567788,-0.06107231484082689,2.0436344433308946,27.748489539805753,2.9021349698444174,0.07293465659022332,0.08287816941738128,0.440387898683548,0.7172543168067932,0.8915947914123535,0.010318860225379468,0.0034222517744638024,0.05187483057379723,0.014377155620604754,0.059450653940439226,0.0906032107770443,0.0932053081691265,0.015407925844192505,0.06309326142072677,0.11507396921515464,0.05190795883536339,0.4426557183265686,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,599.0,1344332.0,1678284.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,QUETIAPINE FUMARATE,CHEMBL3188993,4.0,1.0,1.0,MOL,8708.0,Small molecule,1997.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1996.0,1.0,-pine; -tiapine,0.0,-pine; -tiapine,tricyclic compounds; antipsychotics (dibenzothiazepine derivatives),,0.0,0.0,0.0,"InChI=1S/2C21H25N3O2S.C4H4O4/c2*25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h2*1-8,25H,9-16H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+",ZTHJULTYCAQOIJ-WXXKFALUSA-N,O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,0.10504270035087793,1.0,883.1059999999994,5.423800000000009,14,4,0,171.2,-4.095049124076114,0.5099495828151703,-5.922455729717173,0.5896039009094238,-11.469363412176916,0.2132771909236908,0.8043312430381775,0.6257178068161011,95.40150838249545,-9.978753787673915,0.07750404179096222,0.30804323852062226,0.20029473602771758,0.3428930968046188,0.09466869607567788,-0.06107231484082689,2.0436344433308946,27.748489539805753,2.9021349698444174,0.07293465659022332,0.08287816941738128,0.440387898683548,0.7172543168067932,0.8915947914123535,0.010318860225379468,0.0034222517744638024,0.05187483057379723,0.014377155620604754,0.059450653940439226,0.0906032107770443,0.0932053081691265,0.015407925844192505,0.06309326142072677,0.11507396921515464,0.05190795883536339,0.4426557183265686,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2029.0,1343179.0,799627.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ZIPRASIDONE HYDROCHLORIDE,CHEMBL1375743,4.0,1.0,1.0,MOL,32314.0,Small molecule,2001.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1994.0,1.0,-sidone,0.0,-sidone,antipsychotic with binding activity on sertonin (5-HT2A) and dopamine (D2) receptors,,0.0,0.0,0.0,"InChI=1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2",ZCBZSCBNOOIHFP-UHFFFAOYSA-N,Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,0.6380527854353831,4.0,467.4220000000002,3.4061000000000012,5,1,0,79.97,-4.038150565164343,0.6089704215526581,-5.126843869224288,0.9924507856369018,-11.027885596229215,0.789718222618103,0.6908613204956054,0.902483069896698,100.0897433313757,0.09349578357965349,0.36691217720508573,0.5493053138256073,0.21669185012578965,0.7319674134254456,0.5522324502468109,49.77073899846787,27.798413053647767,39.22961729630138,2.625116454666597,0.41682485342025755,0.3474301666021347,0.6838714480400085,0.814651894569397,0.9056368231773376,0.026783051900565624,0.03183725066483021,0.11865749210119247,0.06380553841590882,0.4268653571605682,0.13480119854211808,0.021584058180451393,0.03628997504711151,0.07609324976801872,0.187412790954113,0.31499425172805784,0.42436968684196474,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,612.0,1343179.0,799627.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ZIPRASIDONE HYDROCHLORIDE,CHEMBL1375743,4.0,1.0,1.0,MOL,32314.0,Small molecule,2001.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1994.0,1.0,-sidone,0.0,-sidone,antipsychotic with binding activity on sertonin (5-HT2A) and dopamine (D2) receptors,,0.0,0.0,0.0,"InChI=1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2",ZCBZSCBNOOIHFP-UHFFFAOYSA-N,Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,0.6380527854353831,4.0,467.4220000000002,3.4061000000000012,5,1,0,79.97,-4.038150565164343,0.6089704215526581,-5.126843869224288,0.9924507856369018,-11.027885596229215,0.789718222618103,0.6908613204956054,0.902483069896698,100.0897433313757,0.09349578357965349,0.36691217720508573,0.5493053138256073,0.21669185012578965,0.7319674134254456,0.5522324502468109,49.77073899846787,27.798413053647767,39.22961729630138,2.625116454666597,0.41682485342025755,0.3474301666021347,0.6838714480400085,0.814651894569397,0.9056368231773376,0.026783051900565624,0.03183725066483021,0.11865749210119247,0.06380553841590882,0.4268653571605682,0.13480119854211808,0.021584058180451393,0.03628997504711151,0.07609324976801872,0.187412790954113,0.31499425172805784,0.42436968684196474,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2030.0,1344176.0,2197704.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ZIPRASIDONE MESYLATE,CHEMBL3989833,4.0,1.0,1.0,MOL,,Small molecule,2002.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1999.0,1.0,-sidone,0.0,-sidone,antipsychotic with binding activity on sertonin (5-HT2A) and dopamine (D2) receptors,,0.0,0.0,0.0,"InChI=1S/C21H21ClN4OS.CH4O3S.3H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;1-5(2,3)4;;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H3,(H,2,3,4);3*1H2",WLQZEFFFIUHSJB-UHFFFAOYSA-N,CS(=O)(=O)O.O.O.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,0.4386121292054997,3.0,563.0980000000002,0.8389000000000006,7,2,0,197.34,-2.3114155989600174,0.5176860451698303,-5.298677645167361,0.7788291990756988,-12.120893315395715,0.5123595774173737,0.3710232645273209,0.7501967787742615,88.55813907213465,-6.560175336781396,0.09556910470128059,0.2588868707418442,0.1314178913831711,0.37881296277046206,0.13253496065735818,143.02861124475425,-4.161966201927788,-2.416283057128024,2.674381882888958,0.4640996515750885,0.4856705546379089,0.7602136015892029,0.8573744177818299,0.7667990684509277,0.029769467562437056,0.015121125057339669,0.11168126463890075,0.035986988246440886,0.09589368738234043,0.03589443601667881,0.010460835578851402,0.015260992897674441,0.030899676866829394,0.10231886059045792,0.1687248632311821,0.36051391065120697,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,613.0,1344176.0,2197704.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ZIPRASIDONE MESYLATE,CHEMBL3989833,4.0,1.0,1.0,MOL,,Small molecule,2002.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1999.0,1.0,-sidone,0.0,-sidone,antipsychotic with binding activity on sertonin (5-HT2A) and dopamine (D2) receptors,,0.0,0.0,0.0,"InChI=1S/C21H21ClN4OS.CH4O3S.3H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;1-5(2,3)4;;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H3,(H,2,3,4);3*1H2",WLQZEFFFIUHSJB-UHFFFAOYSA-N,CS(=O)(=O)O.O.O.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,0.4386121292054997,3.0,563.0980000000002,0.8389000000000006,7,2,0,197.34,-2.3114155989600174,0.5176860451698303,-5.298677645167361,0.7788291990756988,-12.120893315395715,0.5123595774173737,0.3710232645273209,0.7501967787742615,88.55813907213465,-6.560175336781396,0.09556910470128059,0.2588868707418442,0.1314178913831711,0.37881296277046206,0.13253496065735818,143.02861124475425,-4.161966201927788,-2.416283057128024,2.674381882888958,0.4640996515750885,0.4856705546379089,0.7602136015892029,0.8573744177818299,0.7667990684509277,0.029769467562437056,0.015121125057339669,0.11168126463890075,0.035986988246440886,0.09589368738234043,0.03589443601667881,0.010460835578851402,0.015260992897674441,0.030899676866829394,0.10231886059045792,0.1687248632311821,0.36051391065120697,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2192.0,1343297.0,675105.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROCHLORPERAZINE EDISYLATE,CHEMBL1201154,4.0,1.0,1.0,MOL,,Small molecule,1957.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antipsychotic; Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C20H24ClN3S.C2H6O6S2/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;3-9(4,5)1-2-10(6,7)8/h2-3,5-8,15H,4,9-14H2,1H3;1-2H2,(H,3,4,5)(H,6,7,8)",SWOUGRBFXFILIB-UHFFFAOYSA-N,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=S(=O)(O)CCS(=O)(=O)O,0.48537371554733383,3.0,564.1510000000004,3.342200000000001,8,2,0,118.46,-2.1841997448559995,0.40886279940605164,-5.054046487856401,0.6578056931495666,-7.794392374312684,0.6344793558120727,0.3325124323368073,0.9576817035675049,94.83590912147943,-6.926140393234673,0.18342865630984306,0.1618003763258457,0.01451705559156835,0.7044824004173279,0.03959759324789047,132.07143542739044,8.978646647369349,-18.40424397535262,2.6158738744015446,0.351630699634552,0.5105297565460205,0.6355262994766235,0.7847906470298767,0.8400581836700439,0.02090697782114148,0.0039018922951072456,0.05821543335914612,0.018337585590779783,0.0278036966919899,0.0260136348195374,0.003561031713616103,0.001462911145790713,0.016917236056178807,0.0947442702949047,0.04392693368718028,0.702171266078949,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2348.0,1702682.0,1378030.0,Dopamine D2 receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,BREXPIPRAZOLE,CHEMBL2105760,4.0,1.0,1.0,MOL,,Small molecule,2015.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2011.0,1.0,-prazole,0.0,-prazole,antiulcer agents (benzimidazole derivatives),,0.0,0.0,0.0,"InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)",ZKIAIYBUSXZPLP-UHFFFAOYSA-N,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,0.42845507847371217,4.0,433.5770000000001,4.724000000000004,5,1,0,48.57,-4.151760346397266,0.5399985432624816,-5.203087442333331,0.9879991054534912,-11.19205368211264,0.6699012279510498,0.8361895322799683,0.8297613501548767,103.91883759970942,1.565678215962609,0.6211207747459412,0.5783762395381927,0.3528910279273987,0.7577594995498658,0.716816520690918,-25.046733043368583,86.52244385668939,51.487258066970085,2.7551501660497584,0.351374888420105,0.23251188099384307,0.6655999839305877,0.7971963286399841,0.9488384485244751,0.034307532384991644,0.06626725047826768,0.14844256937503814,0.07571891993284226,0.6629733204841614,0.17866166532039643,0.03550346428528428,0.1124817706644535,0.16261423826217652,0.35228591561317446,0.533264982700348,0.4524815261363983,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,2350.0,1702682.0,1378030.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,BREXPIPRAZOLE,CHEMBL2105760,4.0,1.0,1.0,MOL,,Small molecule,2015.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2011.0,1.0,-prazole,0.0,-prazole,antiulcer agents (benzimidazole derivatives),,0.0,0.0,0.0,"InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)",ZKIAIYBUSXZPLP-UHFFFAOYSA-N,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,0.42845507847371217,4.0,433.5770000000001,4.724000000000004,5,1,0,48.57,-4.151760346397266,0.5399985432624816,-5.203087442333331,0.9879991054534912,-11.19205368211264,0.6699012279510498,0.8361895322799683,0.8297613501548767,103.91883759970942,1.565678215962609,0.6211207747459412,0.5783762395381927,0.3528910279273987,0.7577594995498658,0.716816520690918,-25.046733043368583,86.52244385668939,51.487258066970085,2.7551501660497584,0.351374888420105,0.23251188099384307,0.6655999839305877,0.7971963286399841,0.9488384485244751,0.034307532384991644,0.06626725047826768,0.14844256937503814,0.07571891993284226,0.6629733204841614,0.17866166532039643,0.03550346428528428,0.1124817706644535,0.16261423826217652,0.35228591561317446,0.533264982700348,0.4524815261363983,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2403.0,1702644.0,1339907.0,Dopamine D2 receptor modulator,,MODULATOR,1.0,1.0,1.0,Mixed antagonist/partial agonist,,,,CARIPRAZINE HYDROCHLORIDE,CHEMBL2024517,4.0,1.0,1.0,MOL,,Small molecule,2015.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2011.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H32Cl2N4O.ClH/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23;/h3-5,16-17H,6-15H2,1-2H3,(H,24,28);1H/t16-,17-;",GPPJWWMREQHLQT-BHQIMSFRSA-N,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl,0.6841920435096037,4.0,463.88100000000014,4.757300000000005,3,1,0,38.82000000000001,-4.037586753973199,0.6786399245262146,-4.837298049269771,0.9943911671638489,-7.2339708260555415,0.8923385143280029,0.538712328672409,0.9559958219528198,94.80251414508281,1.772725645352054,0.07312436141073704,0.27495500445365906,0.08706673681735992,0.8107940912246704,0.633239459991455,-2.1572875847075608,9.680296179772178,29.845597141538452,2.789120017926956,0.20879020392894745,0.25435419380664825,0.6430793762207031,0.26759078204631803,0.9222258448600769,0.014230385981500148,0.007930267322808503,0.08637387827038764,0.02343950141221285,0.11561033092439174,0.041983718797564504,0.006381101021543145,0.012152057792991399,0.04914343617856502,0.27377548813819885,0.06531539559364319,0.5482967317104339,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,2402.0,1702644.0,1339907.0,Dopamine D3 receptor modulator,,MODULATOR,1.0,1.0,1.0,Mixed antagonist/partial agonist,,,,CARIPRAZINE HYDROCHLORIDE,CHEMBL2024517,4.0,1.0,1.0,MOL,,Small molecule,2015.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2011.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H32Cl2N4O.ClH/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23;/h3-5,16-17H,6-15H2,1-2H3,(H,24,28);1H/t16-,17-;",GPPJWWMREQHLQT-BHQIMSFRSA-N,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl,0.6841920435096037,4.0,463.88100000000014,4.757300000000005,3,1,0,38.82000000000001,-4.037586753973199,0.6786399245262146,-4.837298049269771,0.9943911671638489,-7.2339708260555415,0.8923385143280029,0.538712328672409,0.9559958219528198,94.80251414508281,1.772725645352054,0.07312436141073704,0.27495500445365906,0.08706673681735992,0.8107940912246704,0.633239459991455,-2.1572875847075608,9.680296179772178,29.845597141538452,2.789120017926956,0.20879020392894745,0.25435419380664825,0.6430793762207031,0.26759078204631803,0.9222258448600769,0.014230385981500148,0.007930267322808503,0.08637387827038764,0.02343950141221285,0.11561033092439174,0.041983718797564504,0.006381101021543145,0.012152057792991399,0.04914343617856502,0.27377548813819885,0.06531539559364319,0.5482967317104339,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,2410.0,1763614.0,1449229.0,Dopamine D2 receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,Prodrug of aripiprazole,,,,ARIPIPRAZOLE LAUROXIL,CHEMBL2219425,4.0,1.0,1.0,MOL,,Small molecule,2015.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,1.0,0.0,2012.0,1.0,-prazole,0.0,-prazole,antiulcer agents (benzimidazole derivatives),,0.0,0.0,0.0,"InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3",DDINXHAORAAYAD-UHFFFAOYSA-N,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,0.11105766675976755,2.0,660.7270000000002,8.675400000000007,6,0,0,62.32000000000001,-5.23620026044485,0.39145050644874574,-4.701965106469276,0.9981104850769043,-6.620003431642333,0.8741274952888489,0.9949183821678161,0.8930637955665588,106.44006008423457,3.3991766109782686,0.0664437785744667,0.7382841467857361,0.3589626014232635,0.30033209919929504,0.8003021836280823,43.389512092614076,112.94584489568032,126.515913473316,3.2103606237624036,0.15140251442790031,0.3029819279909134,0.12296486347913742,0.614323890209198,0.9481282114982605,0.05542178470641375,0.020501411706209182,0.07681619822978973,0.012973946053534746,0.055636972188949585,0.07596447244286537,0.01744629619643092,0.005909758061170578,0.06958407834172249,0.28310902416706085,0.11368048191070557,0.591706782579422,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,2411.0,1763614.0,1449229.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Prodrug of aripiprazole,,,,ARIPIPRAZOLE LAUROXIL,CHEMBL2219425,4.0,1.0,1.0,MOL,,Small molecule,2015.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,1.0,0.0,2012.0,1.0,-prazole,0.0,-prazole,antiulcer agents (benzimidazole derivatives),,0.0,0.0,0.0,"InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3",DDINXHAORAAYAD-UHFFFAOYSA-N,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,0.11105766675976755,2.0,660.7270000000002,8.675400000000007,6,0,0,62.32000000000001,-5.23620026044485,0.39145050644874574,-4.701965106469276,0.9981104850769043,-6.620003431642333,0.8741274952888489,0.9949183821678161,0.8930637955665588,106.44006008423457,3.3991766109782686,0.0664437785744667,0.7382841467857361,0.3589626014232635,0.30033209919929504,0.8003021836280823,43.389512092614076,112.94584489568032,126.515913473316,3.2103606237624036,0.15140251442790031,0.3029819279909134,0.12296486347913742,0.614323890209198,0.9481282114982605,0.05542178470641375,0.020501411706209182,0.07681619822978973,0.012973946053534746,0.055636972188949585,0.07596447244286537,0.01744629619643092,0.005909758061170578,0.06958407834172249,0.28310902416706085,0.11368048191070557,0.591706782579422,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,4457.0,2473698.0,1927237.0,Dopamine D2 receptor modulator,,MODULATOR,1.0,1.0,1.0,"Dopidine (dopaminergic stabilizer), have not found any reference about pharmcology for the compound.",,,,SERIDOPIDINE,CHEMBL3545388,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-dopidine,0.0,-dopidine,dopamine D2 receptor modulator,,0.0,0.0,0.0,"InChI=1S/C14H20FNO2S/c1-3-16-6-4-11(5-7-16)12-8-13(15)10-14(9-12)19(2,17)18/h8-11H,3-7H2,1-2H3",PHRDGRSMZPOCAB-UHFFFAOYSA-N,CCN1CCC(c2cc(F)cc(S(C)(=O)=O)c2)CC1,0.8557194784086185,4.0,285.38400000000007,2.4285000000000005,3,0,0,37.38,-2.2439612724975757,0.9233428120613099,-4.337240904255817,0.9984102845191956,-8.350621887876681,0.9470954060554504,0.14476508647203445,0.9967565417289734,29.29581741459299,-4.618925896798437,0.012937350943684579,0.023923429753631355,0.0015924436564091593,0.36411571502685547,0.0025112312505370937,9.889244742387778,30.55935806161719,-17.139689941649216,2.636957354310883,0.1540140278637409,0.09580592140555381,0.5004560261964798,0.1316918984055519,0.8185937643051148,0.01817093286663294,0.0029479882563464344,0.03360922560095787,0.001017672652960755,0.0008322630310431123,0.0016006156598450615,5.49514256817929e-05,0.00018063820607494563,0.0002054020886134822,0.00026266344939358534,0.00011670655121633899,0.3863220661878586,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,4458.0,2472863.0,1926859.0,Dopamine D2 receptor modulator,,MODULATOR,1.0,1.0,1.0,Dopidine (dopaminergic stabilizer),,,,ORDOPIDINE,CHEMBL3545010,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-dopidine,0.0,-dopidine,dopamine D2 receptor modulator,,0.0,0.0,0.0,"InChI=1S/C14H20FNO2S/c1-3-16-9-7-11(8-10-16)12-5-4-6-13(14(12)15)19(2,17)18/h4-6,11H,3,7-10H2,1-2H3",UKUPJASJNQDHPH-UHFFFAOYSA-N,CCN1CCC(c2cccc(S(C)(=O)=O)c2F)CC1,0.8557194784086185,4.0,285.38400000000007,2.4285000000000005,3,0,0,37.38,-2.0268967268397966,0.9212539315223693,-4.33190655137389,0.9991208553314209,-8.24375224491602,0.9638300180435181,0.1741853326559067,0.9973838090896606,25.096490876881578,-3.67551302333255,0.013936388678848744,0.03413426782935858,0.001641664217459038,0.3613503634929657,0.003676926851039752,6.685926890487119,35.436768051337005,-13.747261789384828,2.653355818461939,0.2866857200860977,0.1209415428340435,0.5145963847637176,0.1292636625468731,0.8481194019317627,0.017225638218224048,0.0033411553595215082,0.03808078318834305,0.0017797473119571805,0.0008349515672307461,0.002454588899854571,7.315123075386509e-05,0.00022492147400043905,0.0002382543287239969,0.00024496510977769506,0.00013907923548686085,0.4704475820064545,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,4912.0,1701295.0,1377134.0,Dopamine D2 receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,APLINDORE FUMARATE,CHEMBL2104864,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2002.0,,-dore,0.0,-dore,dopamine D2D3 receptor modulators,,0.0,0.0,0.0,"InChI=1S/C18H18N2O3.C4H4O4/c21-17-8-14-15(20-17)6-7-16-18(14)23-13(11-22-16)10-19-9-12-4-2-1-3-5-12;5-3(6)1-2-4(7)8/h1-7,13,19H,8-11H2,(H,20,21);1-2H,(H,5,6)(H,7,8)/b;2-1+/t13-;/m0./s1",GELJVTSEGKGLDF-QDSMGTAFSA-N,O=C(O)/C=C/C(=O)O.O=C1Cc2c(ccc3c2O[C@@H](CNCc2ccccc2)CO3)N1,0.5141466025006025,4.0,426.4250000000001,1.8225999999999998,6,4,1,134.19,-2.4546556578588157,0.6683788061141968,-6.217953841142072,0.43920581936836245,-12.394633945703394,0.11138525530695915,0.15457552224397658,0.8225792169570922,74.93608775413654,1.4847466239681413,0.07476751729846001,0.18379456847906112,0.11860181838274002,0.531620728969574,0.10294659361243248,37.12518439784164,-11.64818425444793,-7.0645752768594505,2.434847975422169,0.4340668350458145,0.1778671383857727,0.6742518544197083,0.7563500046730042,0.3625825345516205,0.11567500308156013,0.0421340499073267,0.16370017528533937,0.05402635708451271,0.05341906268149614,0.01829799562692642,0.04387090615928173,0.05857291147112846,0.029432324506342412,0.020749760046601295,0.12108511552214622,0.3805831134319305,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,4978.0,2473030.0,2832045.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SB-773812,CHEMBL5314394,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H26ClNO4S/c1-27-13-11-19-15-24(30-2)25(16-20(19)12-14-27)32(28,29)23-9-7-22(8-10-23)31-17-18-3-5-21(26)6-4-18/h3-10,15-16H,11-14,17H2,1-2H3",HIBWHHQXUSKNOV-UHFFFAOYSA-N,COc1cc2c(cc1S(=O)(=O)c1ccc(OCc3ccc(Cl)cc3)cc1)CCN(C)CC2,0.5169787709281733,4.0,472.0060000000002,4.790800000000004,5,0,0,55.84000000000001,-4.6341393743722135,0.8802070617675781,-4.905956915509467,0.9889906167984008,-6.855916656996861,0.8483157634735108,0.8827992677688599,0.5225500524044037,90.77977941592879,7.056329180946401,0.05885956808924675,0.5599123537540436,0.20713798701763153,0.23988831415772438,0.8196332097053528,82.99387127879707,22.264149216406942,24.567632989316763,3.3790700575341552,0.13543582558631898,0.5741251468658447,0.15653672069311142,0.7617391467094421,0.8352397084236145,0.011909351032227278,0.00551700908690691,0.03302938230335713,0.023445678316056727,0.029209984093904497,0.05074022635817528,0.02535518817603588,0.0017934889416210353,0.033511705696582794,0.217744442820549,0.02672516219317913,0.14093192517757416,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,4977.0,2473030.0,2832045.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SB-773812,CHEMBL5314394,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H26ClNO4S/c1-27-13-11-19-15-24(30-2)25(16-20(19)12-14-27)32(28,29)23-9-7-22(8-10-23)31-17-18-3-5-21(26)6-4-18/h3-10,15-16H,11-14,17H2,1-2H3",HIBWHHQXUSKNOV-UHFFFAOYSA-N,COc1cc2c(cc1S(=O)(=O)c1ccc(OCc3ccc(Cl)cc3)cc1)CCN(C)CC2,0.5169787709281733,4.0,472.0060000000002,4.790800000000004,5,0,0,55.84000000000001,-4.6341393743722135,0.8802070617675781,-4.905956915509467,0.9889906167984008,-6.855916656996861,0.8483157634735108,0.8827992677688599,0.5225500524044037,90.77977941592879,7.056329180946401,0.05885956808924675,0.5599123537540436,0.20713798701763153,0.23988831415772438,0.8196332097053528,82.99387127879707,22.264149216406942,24.567632989316763,3.3790700575341552,0.13543582558631898,0.5741251468658447,0.15653672069311142,0.7617391467094421,0.8352397084236145,0.011909351032227278,0.00551700908690691,0.03302938230335713,0.023445678316056727,0.029209984093904497,0.05074022635817528,0.02535518817603588,0.0017934889416210353,0.033511705696582794,0.217744442820549,0.02672516219317913,0.14093192517757416,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,5366.0,1705114.0,1418061.0,Dopamine D2 receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,"Development discontunued, failed to meet primary efficacy endpoints, no difference between drug and placebo. Newron developing drug for Rett syndrome and received EMA and FDA orphan designation in July 2015. Agonist/partial agonistic/antagonsitic effect depending on dopamine receptor isoform.",,,,SARIZOTAN HYDROCHLORIDE,CHEMBL2146110,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-zotan,0.0,-zotan,5-HT1A receptor agonists/antagonists acting primarily as neuroprotectors,,0.0,0.0,0.0,"InChI=1S/C22H21FN2O.ClH/c23-20-8-5-17(6-9-20)19-11-16(12-24-14-19)13-25-15-21-10-7-18-3-1-2-4-22(18)26-21;/h1-6,8-9,11-12,14,21,25H,7,10,13,15H2;1H/t21-;/m1./s1",QDLVYMYXOLGZOD-ZMBIFBSDSA-N,Cl.Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1,0.6861351023966183,4.0,384.88200000000006,4.792900000000004,3,1,1,34.150000000000006,-4.028389315416993,0.9367670536041259,-5.128533524845958,0.9999691247940063,-8.710545802244669,0.9150701045989991,0.92979496717453,0.9100103974342346,97.23498435694937,-0.5805859417228812,0.9398655891418457,0.8800222873687744,0.454042986035347,0.9807989478111268,0.9669775843620301,29.297404475573085,61.697819576177395,45.57177392600838,2.7618422368921496,0.6849351644515991,0.24194995015859605,0.5339978396892547,0.41234988570213316,0.9772673487663269,0.012054957076907158,0.0074614464771002535,0.16499559432268143,0.026946036145091057,0.5005135178565979,0.35790916681289675,0.022846437990665436,0.015767099894583227,0.1586960345506668,0.29799930453300477,0.03795547336339951,0.33816379606723784,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,5367.0,1705114.0,1418061.0,Dopamine D3 receptor agonist,,AGONIST,1.0,1.0,1.0,"Development discontunued, failed to meet primary efficacy endpoints, no difference between drug and placebo. Newron developing drug for Rett syndrome and received EMA and FDA orphan designation in July 2015. Agonist/partial agonistic/antagonsitic effect depending on dopamine receptor isoform.",,,,SARIZOTAN HYDROCHLORIDE,CHEMBL2146110,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-zotan,0.0,-zotan,5-HT1A receptor agonists/antagonists acting primarily as neuroprotectors,,0.0,0.0,0.0,"InChI=1S/C22H21FN2O.ClH/c23-20-8-5-17(6-9-20)19-11-16(12-24-14-19)13-25-15-21-10-7-18-3-1-2-4-22(18)26-21;/h1-6,8-9,11-12,14,21,25H,7,10,13,15H2;1H/t21-;/m1./s1",QDLVYMYXOLGZOD-ZMBIFBSDSA-N,Cl.Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1,0.6861351023966183,4.0,384.88200000000006,4.792900000000004,3,1,1,34.150000000000006,-4.028389315416993,0.9367670536041259,-5.128533524845958,0.9999691247940063,-8.710545802244669,0.9150701045989991,0.92979496717453,0.9100103974342346,97.23498435694937,-0.5805859417228812,0.9398655891418457,0.8800222873687744,0.454042986035347,0.9807989478111268,0.9669775843620301,29.297404475573085,61.697819576177395,45.57177392600838,2.7618422368921496,0.6849351644515991,0.24194995015859605,0.5339978396892547,0.41234988570213316,0.9772673487663269,0.012054957076907158,0.0074614464771002535,0.16499559432268143,0.026946036145091057,0.5005135178565979,0.35790916681289675,0.022846437990665436,0.015767099894583227,0.1586960345506668,0.29799930453300477,0.03795547336339951,0.33816379606723784,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,5419.0,1702583.0,596524.0,Dopamine D2 receptor modulator,,MODULATOR,1.0,1.0,1.0,Dopaminergic stabilizer,,,,PRIDOPIDINE,CHEMBL596802,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,,-dopidine,0.0,-dopidine,dopamine D2 receptor modulator,,0.0,0.0,0.0,"InChI=1S/C15H23NO2S/c1-3-9-16-10-7-13(8-11-16)14-5-4-6-15(12-14)19(2,17)18/h4-6,12-13H,3,7-11H2,1-2H3",YGKUEOZJFIXDGI-UHFFFAOYSA-N,CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1,0.8512729104236291,4.0,281.42100000000005,2.679500000000001,3,0,0,37.38,-2.179348282775403,0.7795636296272278,-4.697765938989288,0.9958629012107849,-7.693596834314017,0.9355595946311951,0.13383492231369018,0.9922849178314209,36.0696596731535,-3.4751337943289338,0.005154299596324563,0.0194802223239094,0.0009479521540924907,0.4191328644752502,0.0020470021736400668,-3.3293305563331037,28.0452448333169,-12.227601304824928,2.5245908915398556,0.049494598805904386,0.04063615463674068,0.35631425976753234,0.06999854221940041,0.66970574259758,0.015904780477285385,0.001294197648530826,0.048661313205957415,0.0009537505975458771,0.0013087474566418678,0.001058402651688084,5.775446375082538e-05,7.492709137295606e-05,0.0005995007959427312,0.0005634251370793209,9.881925825538929e-05,0.573786836862564,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,5439.0,2472915.0,1768774.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).",,,,LUMATEPERONE,CHEMBL3306803,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2016.0,1.0,-perone,0.0,-perone,antianxiety agents/neuroleptics (4'-fluoro-4-piperidinobutyrophenone derivatives),,0.0,0.0,0.0,"InChI=1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1",HOIIHACBCFLJET-SFTDATJTSA-N,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12,0.7198069073904806,4.0,393.5060000000001,3.9165000000000036,4,0,2,26.79,-3.715914122848846,0.8070461392402649,-4.727129658142525,0.9997839450836181,-7.769782044131911,0.9751228570938111,0.922552764415741,0.9980743050575256,95.15163402968588,11.600947938083607,0.14880458936095237,0.20164757668972016,0.031200984306633473,0.9222055315971375,0.293875427544117,25.976892271249874,79.5688422366832,35.12849645228688,3.000306625644239,0.250032539665699,0.060869774967432025,0.6277132213115693,0.3144706726074219,0.9820039987564086,0.029753511399030687,0.008778683189302684,0.03032008111476898,0.0020580752985551952,0.22625332847237586,0.02394408406689763,0.0017608413298148661,0.00495344316586852,0.008098881039768458,0.028092527762055397,0.013928093947470188,0.2888394296169281,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,5438.0,2472915.0,1768774.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).",,,,LUMATEPERONE,CHEMBL3306803,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2016.0,1.0,-perone,0.0,-perone,antianxiety agents/neuroleptics (4'-fluoro-4-piperidinobutyrophenone derivatives),,0.0,0.0,0.0,"InChI=1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1",HOIIHACBCFLJET-SFTDATJTSA-N,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12,0.7198069073904806,4.0,393.5060000000001,3.9165000000000036,4,0,2,26.79,-3.715914122848846,0.8070461392402649,-4.727129658142525,0.9997839450836181,-7.769782044131911,0.9751228570938111,0.922552764415741,0.9980743050575256,95.15163402968588,11.600947938083607,0.14880458936095237,0.20164757668972016,0.031200984306633473,0.9222055315971375,0.293875427544117,25.976892271249874,79.5688422366832,35.12849645228688,3.000306625644239,0.250032539665699,0.060869774967432025,0.6277132213115693,0.3144706726074219,0.9820039987564086,0.029753511399030687,0.008778683189302684,0.03032008111476898,0.0020580752985551952,0.22625332847237586,0.02394408406689763,0.0017608413298148661,0.00495344316586852,0.008098881039768458,0.028092527762055397,0.013928093947470188,0.2888394296169281,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,5921.0,1704067.0,367160.0,Dopamine D2 receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,"High affinity: D3 and D4 receptors. Low affinity: a1, 5HT2A, 5HT2C, H1 and muscarinic receptors ",,,BIFEPRUNOX,CHEMBL218166,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28)",CYGODHVAJQTCBG-UHFFFAOYSA-N,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,0.574404089941683,4.0,385.4670000000001,4.110300000000003,4,1,0,52.480000000000004,-5.634529876242248,0.7384357333183289,-4.852660529455141,0.9986554622650147,-9.417304183814434,0.8028388619422913,0.8622245550155639,0.961766266822815,107.62689116596894,1.3190152779020718,0.7675633430480957,0.7262126088142395,0.40090405344963076,0.6032036960124969,0.5543564140796662,-44.82733656904751,61.937375014282075,38.30687444498348,2.586329796400104,0.1049211673438549,0.19009310007095337,0.6212725281715393,0.8565578579902648,0.9705483198165894,0.02953369654715061,0.026352234184741974,0.07010711804032325,0.01784793343394995,0.4394568681716919,0.13484132587909697,0.06489337012171745,0.02703782804310322,0.07827765047550202,0.44966986775398254,0.14180698692798616,0.5626254081726074,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,6294.0,1703624.0,27616.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Remoxipride binds specifically to the D2 receptor and has little affinity for other central receptors e.g. adrenergic, muscarinic and 5-HT receptors. Therefore, the incidence of adverse effects is less than with other antipsychotics. Dopamine binding to the D2 receptor inhibits the prolactin release from the pituitary into plasma, and therefore, D2 antagonism induces its release.",,,,REMOXIPRIDE,CHEMBL22242,4.0,1.0,0.0,MOL,,Small molecule,1990.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1985.0,-2.0,-pride,0.0,-pride,sulpride derivatives and analogs,Antipsychotic,1.0,0.0,0.0,"InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1",GUJRSXAPGDDABA-NSHDSACASA-N,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,0.8356024039257242,4.0,371.2750000000001,2.6804000000000006,4,1,1,50.80000000000001,-2.1236201577793414,0.9699215769767762,-4.681368800286931,0.9996915102005005,-10.883992158314687,0.9817644834518433,0.0957123100757599,0.9831355810165405,53.86730997355145,-0.46017683925458763,0.7113993227481842,0.14148942604660988,0.003354878118261695,0.8602657198905945,0.194919840246439,19.97655788757493,38.96167595370217,-0.8394400120580215,2.5554678172759577,0.7425153017044067,0.14469661116600036,0.6544049084186554,0.3287185087800026,0.8709536194801331,0.010147171095013618,0.0021919307415373623,0.055720219016075136,0.0013595093856565653,0.04807038828730583,0.00616234946064651,0.0005049812025390565,0.0017929230351001024,0.0013622066122479736,0.002006069628987461,0.0019523767288774252,0.6687505364418029,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,6295.0,1703401.0,2197427.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Remoxipride binds specifically to the D2 receptor and has little affinity for other central receptors e.g. adrenergic, muscarinic and 5-HT receptors. Therefore, the incidence of adverse effects is less than with other antipsychotics. Dopamine binding to the D2 receptor inhibits the prolactin release from the pituitary into plasma, and therefore, D2 antagonism induces its release.",,,,REMOXIPRIDE HYDROCHLORIDE,CHEMBL3989556,4.0,1.0,1.0,MOL,,Small molecule,1990.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1993.0,-2.0,-pride,0.0,-pride,sulpride derivatives and analogs,,1.0,0.0,0.0,"InChI=1S/C16H23BrN2O3.ClH.H2O/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3;;/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20);1H;1H2/t11-;;/m0../s1",SPFVHFBNXPARTR-IDMXKUIJSA-N,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC.Cl.O,0.7578070422643882,4.0,425.7510000000001,2.277500000000001,4,1,1,82.30000000000001,-1.8716283700050682,0.9573774814605713,-5.043016416797799,0.9980735898017883,-11.269224049216769,0.9178875327110291,0.14015980511903764,0.9187219262123107,58.475008660732854,0.7802233904508677,0.43789638578891754,0.08324786722660064,0.003162333811633289,0.9018444418907166,0.1606145456433296,26.557472292596533,26.64310677911977,-15.183356620186476,2.3926272550433447,0.8309430956840516,0.26336578130722044,0.7453259944915771,0.24691719114780425,0.866051185131073,0.007190402317792177,0.002455669268965721,0.060333534330129626,0.0029493240173906086,0.051283536851406096,0.005567312519997358,0.000687157324864529,0.0035593636333942414,0.002750421944074333,0.00355253629386425,0.0050437258090823885,0.5928300499916077,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,6297.0,1699273.0,10813.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Sertindole was developed as an antipsychotic drug. It is a potent antagonist at dopamine D2, serotonin 5-HT2, and Î±1-adrenergic receptors with high affinity. Additionally, Sertindole suppresses potassium channel in the brain and heart. It also induces both autophagy and ROS generation in neuroblastoma cells.","It has high affinity for dopamine D2, serotonin 5-HT2, and Î±1-adrenergic receptors.",,,SERTINDOLE,CHEMBL12713,4.0,1.0,1.0,MOL,9122.0,Small molecule,1996.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1992.0,-2.0,,0.0,,,Antipsychotic; Neuroleptic,1.0,0.0,0.0,"InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)",GZKLJWGUPQBVJQ-UHFFFAOYSA-N,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,0.6281222024796652,4.0,440.9500000000002,4.627600000000004,3,1,0,40.510000000000005,-4.215507538049781,0.7077086329460144,-4.816628059508042,0.9983445286750794,-9.852259496022171,0.9174598097801209,0.8373570084571839,0.9800525546073914,97.7870601153667,-3.9187093853859523,0.6177312731742859,0.2216809421777725,0.09912312850356102,0.7863782286643982,0.5748479306697846,47.39742237675231,-18.95232073323293,19.954956855008163,3.030935740055302,0.3354984223842621,0.14578033834695817,0.8481892108917236,0.5963520526885986,0.9234604597091675,0.02925059888511896,0.042546200752258304,0.11103779822587967,0.027772745303809642,0.26393412947654726,0.0599377803504467,0.010642607137560845,0.027954094856977463,0.056638524681329724,0.06035287454724312,0.09674711003899575,0.43619304895401,False
HTR2A,104817,SELECTIVITY GROUP,Serotonin 2 receptors; 5-HT2a & 5-HT2c,9606,Homo sapiens,CHEMBL2096662,,0.0,6866.0,1699273.0,10813.0,Serotonin 2 receptors; 5-HT2a & 5-HT2c antagonist,,ANTAGONIST,1.0,1.0,1.0,"Sertindole was developed as an antipsychotic drug. It is a potent antagonist at dopamine D2, serotonin 5-HT2, and Î±1-adrenergic receptors with high affinity. Additionally, Sertindole suppresses potassium channel in the brain and heart. It also induces both autophagy and ROS generation in neuroblastoma cells.","It has high affinity for dopamine D2, serotonin 5-HT2, and Î±1-adrenergic receptors.",,,SERTINDOLE,CHEMBL12713,4.0,1.0,1.0,MOL,9122.0,Small molecule,1996.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1992.0,-2.0,,0.0,,,Antipsychotic; Neuroleptic,1.0,0.0,0.0,"InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)",GZKLJWGUPQBVJQ-UHFFFAOYSA-N,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,0.6281222024796652,4.0,440.9500000000002,4.627600000000004,3,1,0,40.510000000000005,-4.215507538049781,0.7077086329460144,-4.816628059508042,0.9983445286750794,-9.852259496022171,0.9174598097801209,0.8373570084571839,0.9800525546073914,97.7870601153667,-3.9187093853859523,0.6177312731742859,0.2216809421777725,0.09912312850356102,0.7863782286643982,0.5748479306697846,47.39742237675231,-18.95232073323293,19.954956855008163,3.030935740055302,0.3354984223842621,0.14578033834695817,0.8481892108917236,0.5963520526885986,0.9234604597091675,0.02925059888511896,0.042546200752258304,0.11103779822587967,0.027772745303809642,0.26393412947654726,0.0599377803504467,0.010642607137560845,0.027954094856977463,0.056638524681329724,0.06035287454724312,0.09674711003899575,0.43619304895401,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,6320.0,1702081.0,1377851.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Induces prolactin secretion without any estrogenic or progestagenic effects.,,,,VERALIPRIDE,CHEMBL2105581,4.0,1.0,1.0,MOL,,Small molecule,1979.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,-2.0,-pride,0.0,-pride,sulpride derivatives and analogs,,1.0,0.0,0.0,"InChI=1S/C17H25N3O5S/c1-4-7-20-8-5-6-12(20)11-19-17(21)14-9-13(26(18,22)23)10-15(24-2)16(14)25-3/h4,9-10,12H,1,5-8,11H2,2-3H3,(H,19,21)(H2,18,22,23)",RYJXBGGBZJGVQF-UHFFFAOYSA-N,C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC,0.6404695987510074,4.0,383.4700000000002,0.7314000000000015,6,2,1,110.96000000000001,-1.6899772031343776,0.8333269000053406,-5.370997457856199,0.9807764530181885,-11.484490340503456,0.4696840584278107,0.035809433087706566,0.830072033405304,53.81501246504057,3.8277542242996248,0.03332301527261734,0.027937698177993298,0.006637666048482061,0.2696087211370468,0.06728675924241542,-4.723623351150179,23.053980566116998,-9.349455546650333,2.3147585598194182,0.1854090616106987,0.2572735697031021,0.39412635564804077,0.40369898080825806,0.2408769518136978,0.028143506869673728,0.018479727022349835,0.036116551235318185,0.0025819107191637158,0.00478078422602266,0.0010155864409171044,0.00014653820981038734,0.0005933242806349881,0.000989341689273715,0.0013614230207167565,0.0011466600699350238,0.2494649112224579,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,6487.0,1700627.0,34949.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Bromperidol has potent antagonistic effects for dopamine D2 receptors in contrast to very weak affinity for other receptors such as dopamine D1, 5-HT2, norepinephrine, and acetylcholine. It was also reported to be bactericidal and greatly enhanced the activities of several antibiotics and drug combinations against M. tuberculosis. (PMID:21576426)",,,,BROMPERIDOL,CHEMBL28218,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1975.0,-1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",RKLNONIVDFXQRX-UHFFFAOYSA-N,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,0.6983745555932223,4.0,420.3220000000002,4.5347000000000035,3,1,0,40.540000000000006,-3.9206892578044155,0.8700277209281921,-4.957685820926628,0.9985228061676026,-8.123899490753777,0.9276325464248657,0.9403215050697327,0.9818479537963867,86.94939020381578,9.898892479647824,0.13239801563322545,0.19427239000797272,0.09825463891029358,0.9425063252449035,0.08152158223092557,31.238315929517434,45.68562398548838,12.160874682757498,2.9618289913354063,0.07596347127109766,0.09499978870153428,0.49741086065769197,0.0872814454138279,0.9585672497749329,0.03251608125865459,0.042075831443071365,0.10690834969282151,0.007177066942676902,0.040033797919750216,0.026501366030424835,0.002704216865822673,0.0026268226793035865,0.016803164407610892,0.06310283299535513,0.01100407363846898,0.442244553565979,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,6756.0,1699566.0,65455.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Benperidol is a butyrophenone derivative and a specific dopamine antagonist, selective for the D2 receptor. It also binds to serotonin receptors but to a lesser extent. In high doses it has anti histaminergic and alpha-adrenergic properties but its anticholinergic effects are small.",,Benperidol has high affinity and selectivity for binding to central D2-like specific binding sites.,,BENPERIDOL,CHEMBL297302,4.0,1.0,1.0,MOL,,Small molecule,,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1963.0,-1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C22H24FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28)",FEBOTPHFXYHVPL-UHFFFAOYSA-N,O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,0.6615100784619949,4.0,381.4510000000002,3.7687000000000026,4,1,0,58.1,-3.402736098398851,0.7999821782112122,-5.046198486484116,0.9988198280334473,-11.134312711978374,0.7592455625534058,0.8120296120643615,0.9761053919792175,86.44506015963834,2.8326623254369165,0.12495523206889629,0.1437666416168213,0.09724009931087493,0.9087733030319214,0.20587823539972305,-18.82699065635925,51.798061278200976,-6.05381397955838,2.861488658530284,0.13861395418643951,0.09237641766667366,0.793266212940216,0.18295392990112305,0.9647992968559265,0.020381089486181735,0.021932603605091573,0.04655451588332653,0.004926260630600155,0.15238006673753263,0.04212677143514156,0.002151537564350292,0.009490542439743876,0.012553340196609497,0.024635226372629403,0.010565365198999643,0.3297862023115158,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,6890.0,1702161.0,182814.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Clebopride, a D-2 dopamine antagonist with antiemetic and prokinetic properties, can improve the bowel cleansing efficacy. Clebopride also stimulates peripheral 5-HT4 receptors and shortens intestinal transit time.","A receptor binding assay revealed that clebopride bound to the D2 dopamine receptor with a high affinity and to the alpha-2 adrenoceptor and 5-HT2 serotonin receptor with relatively lower affinity, and not to D1 dopamine, alpha-1 adrenergic, muscarinic acetylcholine, H1 histamine, or opioid receptor.",,,CLEBOPRIDE,CHEMBL325109,4.0,1.0,1.0,MOL,,Small molecule,,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1987.0,-1.0,-pride,0.0,-pride,sulpride derivatives and analogs,Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25)",BVPWJMCABCPUQY-UHFFFAOYSA-N,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1,0.78874496828116,4.0,373.8840000000002,3.3252000000000024,4,2,0,67.58999999999999,-4.251366650898385,0.8916964292526245,-4.946500853167012,0.9996855854988098,-10.635406142007039,0.9221858859062195,0.41752749085426333,0.9855880379676819,88.93221226715603,-3.606810809436883,0.17543286457657814,0.5807151973247529,0.17386444658041,0.8532084226608276,0.28341291546821595,-3.759125475611543,45.72389541980904,10.42301746223043,2.690998865070542,0.514070349931717,0.18091369420289993,0.610362309217453,0.31818861663341524,0.959408974647522,0.00847757225856185,0.0034440846648067236,0.07937634214758874,0.004252885514870286,0.19203318357467652,0.056892698258161546,0.002310473029501736,0.008887898828834295,0.01424237471073866,0.029280849546194077,0.01213178327307105,0.49600319266319276,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,7516.0,3132325.0,367153.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,"High affinity for D2, D3, D4, 5-HT2B, and 5-HT1A receptors. Moderate affinity for 5-HT7 and a1 receptors. Weak affinity for 5-HT2A receptors. No affinity at 5-HT4, 5-HT6, a2 (rat), H1 (guinea pig), M1, M4, 5-HT3 receptors, 5-HT transporter.",,,ADOPRAZINE,CHEMBL221692,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H24FN3O2/c25-21-6-4-19(5-7-21)20-14-18(15-26-16-20)17-27-8-10-28(11-9-27)22-2-1-3-23-24(22)30-13-12-29-23/h1-7,14-16H,8-13,17H2",IUVSEUFHPNITEQ-UHFFFAOYSA-N,Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1,0.6564682651141452,4.0,405.47300000000024,3.9811000000000023,5,0,0,37.830000000000005,-4.336862718383737,0.8608001232147217,-4.822507543046349,0.9999162197113037,-8.426425452515163,0.972906231880188,0.9740070223808288,0.9812408924102783,99.27544325286564,1.798846965012873,0.8060625672340394,0.9181380033493042,0.7117883920669555,0.735869562625885,0.9470449805259704,-24.350724565113264,78.40476780458796,57.28279420030316,3.0432354808068203,0.21508182287216188,0.1696299731731415,0.598437237739563,0.8400875329971313,0.987991738319397,0.030742589198052884,0.011351752560585737,0.05126938223838806,0.00893417657352984,0.42731077671051027,0.18528105914592743,0.02476616036146879,0.008161502797156573,0.05590624548494816,0.14006287455558777,0.03461420517414808,0.3257836937904358,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,7517.0,3132325.0,367153.0,Dopamine D3 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,"High affinity for D2, D3, D4, 5-HT2B, and 5-HT1A receptors. Moderate affinity for 5-HT7 and a1 receptors. Weak affinity for 5-HT2A receptors. No affinity at 5-HT4, 5-HT6, a2 (rat), H1 (guinea pig), M1, M4, 5-HT3 receptors, 5-HT transporter.",,,ADOPRAZINE,CHEMBL221692,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H24FN3O2/c25-21-6-4-19(5-7-21)20-14-18(15-26-16-20)17-27-8-10-28(11-9-27)22-2-1-3-23-24(22)30-13-12-29-23/h1-7,14-16H,8-13,17H2",IUVSEUFHPNITEQ-UHFFFAOYSA-N,Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1,0.6564682651141452,4.0,405.47300000000024,3.9811000000000023,5,0,0,37.830000000000005,-4.336862718383737,0.8608001232147217,-4.822507543046349,0.9999162197113037,-8.426425452515163,0.972906231880188,0.9740070223808288,0.9812408924102783,99.27544325286564,1.798846965012873,0.8060625672340394,0.9181380033493042,0.7117883920669555,0.735869562625885,0.9470449805259704,-24.350724565113264,78.40476780458796,57.28279420030316,3.0432354808068203,0.21508182287216188,0.1696299731731415,0.598437237739563,0.8400875329971313,0.987991738319397,0.030742589198052884,0.011351752560585737,0.05126938223838806,0.00893417657352984,0.42731077671051027,0.18528105914592743,0.02476616036146879,0.008161502797156573,0.05590624548494816,0.14006287455558777,0.03461420517414808,0.3257836937904358,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,7526.0,1699725.0,364745.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,DOMPERIDONE,CHEMBL219916,4.0,1.0,1.0,MOL,31515.0,Small molecule,,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1976.0,-1.0,deu-,0.0,deu-,deuterated compounds,Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C22H24ClN5O2/c23-15-6-7-20-18(14-15)25-22(30)28(20)16-8-12-26(13-9-16)10-3-11-27-19-5-2-1-4-17(19)24-21(27)29/h1-2,4-7,14,16H,3,8-13H2,(H,24,29)(H,25,30)",FGXWKSZFVQUSTL-UHFFFAOYSA-N,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,0.514301695573136,4.0,425.92000000000013,3.353200000000002,5,2,0,78.82,-3.6618031559143334,0.5438285350799561,-5.497380709384781,0.9728933095932006,-11.760505214780135,0.43408883213996885,0.4727869987487793,0.7037582516670227,89.43568324617533,-7.884472047976841,0.15687584578990937,0.1855283074080944,0.07642625086009502,0.7504574418067932,0.2939173743128777,13.751954084104128,-3.793773786594386,-11.193204625419344,2.133213076352603,0.132112368196249,0.085899568349123,0.7295581221580505,0.28987090587615966,0.9316110134124755,0.017830855585634707,0.013883092626929282,0.06847952753305435,0.019774191826581956,0.12090579867362976,0.053693412244319914,0.007188833574764431,0.014741212921217084,0.04547888487577438,0.03023161832243204,0.03599440958350897,0.46881608963012694,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,7560.0,1699690.0,300585.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,"Also has high affinity for 5-HT6 receptors. Low affinity for 5-HT2C, adrenergic Î±1, histamine H1, muscarinic (M1) receptors and 5-HT1A receptors. Blonanserin has lower affinity for 5-HT2 receptors (Ki = 0.812 nM) compared to D2 receptors (Ki = 0.142 nM), its active metabolite, AD-6048, has highest affinity for D3 receptors.",,,BLONANSERIN,CHEMBL178803,4.0,0.0,1.0,MOL,,Small molecule,2008.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3",XVGOZDAJGBALKS-UHFFFAOYSA-N,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1,0.7845609545042489,4.0,367.51200000000034,4.6886000000000045,3,0,0,19.37,-3.595255778629516,0.9304323196411133,-4.657742529159657,0.9998894095420837,-7.6838297625457255,0.9873328447341919,0.9555140614509583,0.9951761841773987,91.59811420513135,10.389772866485838,0.6445296883583069,0.41491787135601044,0.11711892783641815,0.5177434146404266,0.31343023777008056,21.489825267924616,47.960827586708675,43.33306704585154,2.86722297385317,0.6577340483665466,0.20916762948036194,0.6493457317352295,0.6423642873764038,0.9864122629165649,0.03654027059674263,0.010648659896105528,0.054739772155880925,0.01128798108547926,0.1865058422088623,0.12247759699821473,0.007099494617432356,0.009846449084579944,0.02195567972958088,0.08908575400710106,0.024930911138653755,0.49942023158073423,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,7573.0,1699690.0,300585.0,Dopamine D3 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,"Also has high affinity for 5-HT6 receptors. Low affinity for 5-HT2C, adrenergic Î±1, histamine H1, muscarinic (M1) receptors and 5-HT1A receptors. Blonanserin has lower affinity for 5-HT2 receptors (Ki = 0.812 nM) compared to D2 receptors (Ki = 0.142 nM), its active metabolite, AD-6048, has highest affinity for D3 receptors.",,,BLONANSERIN,CHEMBL178803,4.0,0.0,1.0,MOL,,Small molecule,2008.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3",XVGOZDAJGBALKS-UHFFFAOYSA-N,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1,0.7845609545042489,4.0,367.51200000000034,4.6886000000000045,3,0,0,19.37,-3.595255778629516,0.9304323196411133,-4.657742529159657,0.9998894095420837,-7.6838297625457255,0.9873328447341919,0.9555140614509583,0.9951761841773987,91.59811420513135,10.389772866485838,0.6445296883583069,0.41491787135601044,0.11711892783641815,0.5177434146404266,0.31343023777008056,21.489825267924616,47.960827586708675,43.33306704585154,2.86722297385317,0.6577340483665466,0.20916762948036194,0.6493457317352295,0.6423642873764038,0.9864122629165649,0.03654027059674263,0.010648659896105528,0.054739772155880925,0.01128798108547926,0.1865058422088623,0.12247759699821473,0.007099494617432356,0.009846449084579944,0.02195567972958088,0.08908575400710106,0.024930911138653755,0.49942023158073423,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,7559.0,1699690.0,300585.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,"Also has high affinity for 5-HT6 receptors. Low affinity for 5-HT2C, adrenergic Î±1, histamine H1, muscarinic (M1) receptors and 5-HT1A receptors. Blonanserin has lower affinity for 5-HT2 receptors (Ki = 0.812 nM) compared to D2 receptors (Ki = 0.142 nM), its active metabolite, AD-6048, has highest affinity for D3 receptors.",,,BLONANSERIN,CHEMBL178803,4.0,0.0,1.0,MOL,,Small molecule,2008.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3",XVGOZDAJGBALKS-UHFFFAOYSA-N,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1,0.7845609545042489,4.0,367.51200000000034,4.6886000000000045,3,0,0,19.37,-3.595255778629516,0.9304323196411133,-4.657742529159657,0.9998894095420837,-7.6838297625457255,0.9873328447341919,0.9555140614509583,0.9951761841773987,91.59811420513135,10.389772866485838,0.6445296883583069,0.41491787135601044,0.11711892783641815,0.5177434146404266,0.31343023777008056,21.489825267924616,47.960827586708675,43.33306704585154,2.86722297385317,0.6577340483665466,0.20916762948036194,0.6493457317352295,0.6423642873764038,0.9864122629165649,0.03654027059674263,0.010648659896105528,0.054739772155880925,0.01128798108547926,0.1865058422088623,0.12247759699821473,0.007099494617432356,0.009846449084579944,0.02195567972958088,0.08908575400710106,0.024930911138653755,0.49942023158073423,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,7639.0,1702118.0,1333.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,Selective for D2 over D1 and D3 receptors.,,,SULPIRIDE,CHEMBL26,4.0,1.0,1.0,MOL,32168.0,Small molecule,,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1968.0,-1.0,,0.0,,,Antidepressant,0.0,0.0,0.0,"InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)",BGRJTUBHPOOWDU-UHFFFAOYSA-N,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,0.7869434425499668,4.0,341.4330000000001,0.5567000000000012,5,2,1,101.73,-1.5543282462433177,0.9303996682167053,-5.4187328747696295,0.9870882630348206,-12.717153855125193,0.5829436779022217,0.009452324733138085,0.8820662379264832,34.66600157294023,2.597387948224867,0.01480052936822176,0.007097905036062002,0.0010769736749352888,0.15099165141582488,0.00827701254747808,-0.13774429772887728,29.376381020950966,-24.928257749443244,2.0032337401612854,0.25832117050886155,0.22013597637414933,0.4446458637714386,0.3540619879961014,0.19853714108467102,0.025780884176492692,0.006087922910228372,0.030688634142279625,0.0010110307368449867,0.0054122177883982655,0.0008518993228790351,3.3412781067454486e-05,0.00018483564817870502,0.00026031279558083045,0.000774008990265429,0.0003633647691458464,0.22855360805988312,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,7775.0,1705213.0,1379727.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ITOPRIDE,CHEMBL2107457,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C20H26N2O4/c1-22(2)11-12-26-17-8-5-15(6-9-17)14-21-20(23)16-7-10-18(24-3)19(13-16)25-4/h5-10,13H,11-12,14H2,1-4H3,(H,21,23)",QQQIECGTIMUVDS-UHFFFAOYSA-N,COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC,0.7465527474075159,4.0,358.4380000000001,2.574200000000001,5,1,0,60.03,-2.2848385386495016,0.9551581144332886,-4.886233797499053,0.9506610274314881,-10.706863015612512,0.9385897517204285,0.2921846866607666,0.7513757109642029,52.910218591213834,-2.045049792139004,0.09692305587232113,0.046485861763358116,0.008159294771030546,0.06870273724198342,0.13071376234292983,8.11177059426405,50.411747813367086,15.675150562012558,2.1193308683190857,0.3206185907125473,0.3007548421621323,0.366212922334671,0.42328477203845977,0.7229829907417298,0.04526685997843742,0.010206129308789969,0.06703604906797409,0.007029435085132718,0.0478270523250103,0.017145047150552272,0.003173029329627752,0.016488868836313487,0.00634709713049233,0.01102917194366455,0.005445885518565774,0.277241450548172,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,7776.0,1705213.0,1379727.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ITOPRIDE,CHEMBL2107457,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C20H26N2O4/c1-22(2)11-12-26-17-8-5-15(6-9-17)14-21-20(23)16-7-10-18(24-3)19(13-16)25-4/h5-10,13H,11-12,14H2,1-4H3,(H,21,23)",QQQIECGTIMUVDS-UHFFFAOYSA-N,COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC,0.7465527474075159,4.0,358.4380000000001,2.574200000000001,5,1,0,60.03,-2.2848385386495016,0.9551581144332886,-4.886233797499053,0.9506610274314881,-10.706863015612512,0.9385897517204285,0.2921846866607666,0.7513757109642029,52.910218591213834,-2.045049792139004,0.09692305587232113,0.046485861763358116,0.008159294771030546,0.06870273724198342,0.13071376234292983,8.11177059426405,50.411747813367086,15.675150562012558,2.1193308683190857,0.3206185907125473,0.3007548421621323,0.366212922334671,0.42328477203845977,0.7229829907417298,0.04526685997843742,0.010206129308789969,0.06703604906797409,0.007029435085132718,0.0478270523250103,0.017145047150552272,0.003173029329627752,0.016488868836313487,0.00634709713049233,0.01102917194366455,0.005445885518565774,0.277241450548172,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,7854.0,1706198.0,208205.0,Dopamine D2 receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,SUMANIROLE,CHEMBL419792,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C11H13N3O/c1-12-8-5-7-3-2-4-9-10(7)14(6-8)11(15)13-9/h2-4,8,12H,5-6H2,1H3,(H,13,15)/t8-/m1/s1",RKZSNTNMEFVBDT-MRVPVSSYSA-N,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,0.7076797496761184,4.0,203.24499999999995,0.4736999999999994,3,2,1,49.82,-1.6411243005800737,0.7065654158592224,-4.684714280322285,0.9959903478622436,-14.085151298268812,0.3576458960771561,0.0215210584923625,0.819752299785614,33.21985268498776,-1.8020841084702284,0.04700903818011284,0.006677444092929363,0.0016204218729399145,0.16696429997682571,0.008629851089790464,-9.181138019428909,-12.929157944313095,-37.03796165817617,2.428635477403053,0.3637967199087143,0.04428930431604385,0.2898706763982773,0.39449114799499513,0.2403103604912758,0.023150326684117317,0.00787530755624175,0.04024921450763941,0.0037904316559433937,0.10309975147247315,0.0036737440736033023,0.0010643897898262368,0.0025776438182219864,0.00886970916762948,0.0027272830484434962,0.010484003648161887,0.5910040676593781,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,7990.0,1703600.0,57186.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ALIZAPRIDE,CHEMBL290194,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)",KSEYRUGYKHXGFW-UHFFFAOYSA-N,C=CCN1CCCC1CNC(=O)c1cc2nn[nH]c2cc1OC,0.7862485122999675,4.0,315.3770000000001,1.3466999999999996,5,2,1,83.14,-2.948553852882898,0.8882694363594055,-4.970729761881318,0.9988112330436707,-14.298324817081241,0.6465449094772339,0.020243319682776928,0.9225366115570068,69.03112129132545,-1.5207203363984734,0.20549242198467255,0.08498375620692969,0.015095865866169334,0.16055100709199904,0.02945812586694956,-0.681482375249254,19.7743133495623,-10.776203988068277,2.5826636281372815,0.5710685670375824,0.18833102136850358,0.6206657111644744,0.40523627400398254,0.6183192312717438,0.004298042831942439,0.0035651827231049536,0.07242976576089859,0.002428787515964359,0.10192299708724022,0.0015839105763006955,0.0008241164512583054,0.00799331571906805,0.0032734536333009602,0.0012086170259863137,0.0119818149600178,0.5502691566944122,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,8174.0,1702121.0,132933.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TIAPRIDE,CHEMBL84158,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C15H24N2O4S/c1-5-17(6-2)10-9-16-15(18)13-11-12(22(4,19)20)7-8-14(13)21-3/h7-8,11H,5-6,9-10H2,1-4H3,(H,16,18)",JTVPZMFULRWINT-UHFFFAOYSA-N,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,0.7751498496172248,4.0,328.4340000000001,1.1702999999999997,5,1,0,75.71000000000001,-1.1856005745561524,0.9267458081245422,-5.120136731521833,0.9836189270019531,-11.841858346443647,0.8216453075408936,0.04670654945075512,0.9570175647735596,22.65144159770644,-2.779366456233175,0.1871216282248497,0.01421376341022551,0.0013004659005673603,0.12286294847726822,0.009023424237966537,33.71924409327636,28.89308886129075,17.49389794523041,2.5453320157586274,0.4305258750915527,0.4205921530723572,0.40941307991743087,0.35038300454616544,0.4401822328567505,0.008413774147629737,0.003921296447515488,0.031588740088045596,0.0019364257575944066,0.005600242456421256,0.0018557614705059678,0.00032725292367103976,0.0009272120194509625,0.0005744849215261639,0.0013710799859836698,0.0005700150562915951,0.4487485259771347,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,8173.0,1702121.0,132933.0,Dopamine D3 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TIAPRIDE,CHEMBL84158,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C15H24N2O4S/c1-5-17(6-2)10-9-16-15(18)13-11-12(22(4,19)20)7-8-14(13)21-3/h7-8,11H,5-6,9-10H2,1-4H3,(H,16,18)",JTVPZMFULRWINT-UHFFFAOYSA-N,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,0.7751498496172248,4.0,328.4340000000001,1.1702999999999997,5,1,0,75.71000000000001,-1.1856005745561524,0.9267458081245422,-5.120136731521833,0.9836189270019531,-11.841858346443647,0.8216453075408936,0.04670654945075512,0.9570175647735596,22.65144159770644,-2.779366456233175,0.1871216282248497,0.01421376341022551,0.0013004659005673603,0.12286294847726822,0.009023424237966537,33.71924409327636,28.89308886129075,17.49389794523041,2.5453320157586274,0.4305258750915527,0.4205921530723572,0.40941307991743087,0.35038300454616544,0.4401822328567505,0.008413774147629737,0.003921296447515488,0.031588740088045596,0.0019364257575944066,0.005600242456421256,0.0018557614705059678,0.00032725292367103976,0.0009272120194509625,0.0005744849215261639,0.0013710799859836698,0.0005700150562915951,0.4487485259771347,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,8179.0,3132557.0,1732748.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,JNJ-37822681,CHEMBL3234237,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H17F5N4/c18-13-2-1-11(9-14(13)19)10-26-7-5-12(6-8-26)23-16-4-3-15(24-25-16)17(20,21)22/h1-4,9,12H,5-8,10H2,(H,23,25)",UVUYWJWYRLJHEN-UHFFFAOYSA-N,Fc1ccc(CN2CCC(Nc3ccc(C(F)(F)F)nn3)CC2)cc1F,0.8281464317462796,4.0,372.3410000000001,3.850100000000003,4,1,0,41.05,-4.405059180347549,0.9147129893302918,-4.846161613948129,0.9996323585510254,-7.34024871360174,0.9426755428314209,0.5506787002086639,0.9861761093139648,84.10907928732888,0.36004382165244114,0.22353051602840424,0.5618592858314514,0.2220940113067627,0.8517023801803589,0.20996656715869905,-10.174561316544125,16.011441768075223,15.804542746749068,3.1983897262864476,0.237440225481987,0.35861213505268097,0.8222023844718933,0.30283395648002626,0.9531429767608642,0.023953904025256635,0.01287256870418787,0.11231911405920983,0.011012071697041392,0.03713075052946806,0.04989672787487507,0.004724949412047863,0.015707123652100564,0.009804938267916442,0.09841867908835411,0.013721980340778827,0.45263928174972534,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,8809.0,1702170.0,4671.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LEVOSULPIRIDE,CHEMBL267044,2.0,0.0,0.0,MOL,64119.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1",BGRJTUBHPOOWDU-NSHDSACASA-N,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,0.7869434425499668,4.0,341.4330000000001,0.5567000000000012,5,2,1,101.73,-1.502973124268316,0.9462252616882324,-5.455691591610925,0.984348464012146,-12.757287694039046,0.6106787204742432,0.009601710364222527,0.8762899279594422,32.627110329592156,2.4362043285336425,0.02179660964757204,0.005151251377537846,0.0007054471294395626,0.13850116059184076,0.01211507678963244,-0.7080989760763323,28.05931126982522,-27.244885635788005,1.999813621480175,0.27954173684120176,0.19010404050350188,0.43994014859199526,0.35859172642230985,0.20809426009655,0.03135884217917919,0.006850842200219631,0.0346560038626194,0.0011107066413387657,0.005880803777836263,0.0010521894204430283,2.74835431810061e-05,0.0002101283083902672,0.00020339706243248655,0.0007834573683794588,0.00035453240852802994,0.21165550798177718,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,8810.0,1700609.0,418421.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,BROMOPRIDE,CHEMBL399510,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,,-pride,0.0,-pride,sulpride derivatives and analogs,,0.0,0.0,0.0,"InChI=1S/C14H22BrN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)",GIYAQDDTCWHPPL-UHFFFAOYSA-N,CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC,0.7437763293597593,4.0,344.2530000000001,2.1115,4,2,0,67.59,-2.4601351661399233,0.98198322057724,-4.989775747648282,0.9981293439865112,-12.615550148085525,0.8913142204284668,0.01739629786461592,0.988536787033081,32.67709519990284,-4.990811137035573,0.560686194896698,0.08471675962209702,0.007321175234392285,0.6707510948181152,0.04861748144030571,6.913656178800267,60.14185655758562,27.5977522775762,2.6560090336336417,0.9211318612098693,0.676118528842926,0.6333730638027191,0.4195107311010361,0.8972265124320984,0.01078184824436903,0.005337494798004628,0.057841356843709946,0.0038914887933060526,0.16568090170621871,0.010274443868547678,0.0009324789774836972,0.027653904631733894,0.002001464494969696,0.00380790987983346,0.010908360965549946,0.7259375154972076,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,8942.0,1703492.0,1449134.0,Dopamine D2 receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,QUINAGOLIDE,CHEMBL2218861,4.0,0.0,1.0,MOL,,Small molecule,2004.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,-1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3",GDFGTRDCCWFXTG-UHFFFAOYSA-N,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,0.7418884276268264,4.0,395.56900000000013,2.136099999999999,4,2,3,72.88000000000001,-3.6522740441600705,0.6364598393440246,-5.443551745971549,0.9991867065429687,-7.400000193775949,0.9151882410049439,0.07323064804077148,0.9675455331802368,71.03712628462537,-4.8508470156596335,0.038794020935893056,0.2917034476995468,0.09255828708410263,0.8422599792480469,0.14249828457832336,-10.880551937030045,54.27327425745615,44.99437342182432,2.7271913226667976,0.39478883147239685,0.21242634281516076,0.5772397965192795,0.11275687739253044,0.9276639223098755,0.00831159446388483,0.0021568925760220735,0.07881938591599465,0.015731927286833525,0.11404822543263435,0.009702797653153539,0.0008793374960077927,0.0019521149108186365,0.011430312227457762,0.07019388824701309,0.008939308440312743,0.7321654796600342,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,8995.0,3132283.0,1145124.0,Dopamine D2 receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,PF-00217830,CHEMBL1774080,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30N4O2/c31-24-12-10-21-11-13-25(28-26(21)27-24)32-19-4-3-14-29-15-17-30(18-16-29)23-9-5-7-20-6-1-2-8-22(20)23/h1-2,5-9,11,13H,3-4,10,12,14-19H2,(H,27,28,31)",QGNOXTFZOLDODX-UHFFFAOYSA-N,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,0.5721395187122433,4.0,430.5520000000001,4.100700000000003,5,1,0,57.7,-3.8335105784696957,0.6376870393753051,-4.988502311535669,0.9946309685707092,-9.945769118070894,0.8749597311019898,0.9311547756195069,0.8833161115646362,96.9640182559829,-1.1989694485609497,0.24956845939159394,0.46094963550567625,0.3122338503599167,0.5080539464950562,0.5393396079540252,19.856214305337353,67.02656207130744,74.17308354291643,3.130136223775439,0.34984161853790285,0.23670906722545623,0.6645175814628601,0.7429174184799194,0.96652911901474,0.04027293473482132,0.03769466392695904,0.11585764884948731,0.0591956939548254,0.4323947012424469,0.13711176216602325,0.02753938306123018,0.048869233950972556,0.09339589402079582,0.36255852580070497,0.4515034079551697,0.3516452550888062,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,9355.0,1699990.0,66238.0,Dopamine D2 receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FLUSPIRILENE,CHEMBL46516,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1970.0,-1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C29H31F2N3O/c30-24-12-8-22(9-13-24)27(23-10-14-25(31)15-11-23)7-4-18-33-19-16-29(17-20-33)28(35)32-21-34(29)26-5-2-1-3-6-26/h1-3,5-6,8-15,27H,4,7,16-21H2,(H,32,35)",QOYHHIBFXOOADH-UHFFFAOYSA-N,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,0.5034442668970902,3.0,475.58300000000014,5.305400000000005,3,1,0,35.580000000000005,-5.060887696450463,0.6699121356010437,-5.160105278862725,0.9974883556365967,-6.992264318583764,0.83271644115448,0.9326241135597229,0.9096880316734314,100.56216454994318,5.843903320862756,0.07333973683416843,0.24109791964292526,0.20367470681667327,0.9042573809623718,0.5189525246620178,25.812505711426077,42.88077381412203,34.767622771268506,3.2674466440633716,0.08547062128782272,0.1960414968430996,0.4086337864398956,0.27415224611759187,0.9827906608581543,0.00650611324235797,0.00770468870177865,0.03406920246779919,0.005000656004995108,0.036365796625614163,0.04200047589838505,0.005466442415490746,0.0021894285921007393,0.07078760266304016,0.23138367533683776,0.029104265198111535,0.5020368933677674,False
DRD2,72,SINGLE PROTEIN,Dopamine D2 receptor,9606,Homo sapiens,CHEMBL217,,0.0,9405.0,3490127.0,2486600.0,Dopamine D2 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRAZPIROBEN,CHEMBL4650340,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C31H39N3O4/c35-28(25-10-3-1-4-11-25)15-8-18-32-19-16-31(17-20-32)30(38)33(23-34(31)27-13-5-2-6-14-27)22-24-9-7-12-26(21-24)29(36)37/h1,3-4,7,9-12,21,27H,2,5-6,8,13-20,22-23H2,(H,36,37)",BDXJYAAYLZTLEK-UHFFFAOYSA-N,O=C(O)c1cccc(CN2CN(C3CCCCC3)C3(CCN(CCCC(=O)c4ccccc4)CC3)C2=O)c1,0.48072545855560894,3.0,517.6700000000004,4.816900000000005,5,1,0,81.16,-3.27259315858509,0.6772868394851684,-5.549510909008477,0.9292880296707153,-8.938016319920111,0.4145362854003906,0.5967275917530059,0.7677932024002075,75.57986701580477,3.280600598376256,0.007851513056084513,0.13656737059354782,0.11134207099676133,0.6013541162014008,0.2083498865365982,-7.077594772974121,63.44670747988073,43.314621383148825,3.186407927430513,0.15649670064449311,0.10420451089739799,0.43691844642162325,0.3414786458015442,0.4184983789920807,0.017418431304395198,0.018987976387143134,0.05944716483354569,0.005683214263990521,0.009726363094523549,0.0077959784306585785,0.02073530196212232,0.012567317904904484,0.031442471966147426,0.05141825191676617,0.011607993301004172,0.4134870171546936,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,9201.0,3490127.0,2486600.0,Dopamine D3 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRAZPIROBEN,CHEMBL4650340,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C31H39N3O4/c35-28(25-10-3-1-4-11-25)15-8-18-32-19-16-31(17-20-32)30(38)33(23-34(31)27-13-5-2-6-14-27)22-24-9-7-12-26(21-24)29(36)37/h1,3-4,7,9-12,21,27H,2,5-6,8,13-20,22-23H2,(H,36,37)",BDXJYAAYLZTLEK-UHFFFAOYSA-N,O=C(O)c1cccc(CN2CN(C3CCCCC3)C3(CCN(CCCC(=O)c4ccccc4)CC3)C2=O)c1,0.48072545855560894,3.0,517.6700000000004,4.816900000000005,5,1,0,81.16,-3.27259315858509,0.6772868394851684,-5.549510909008477,0.9292880296707153,-8.938016319920111,0.4145362854003906,0.5967275917530059,0.7677932024002075,75.57986701580477,3.280600598376256,0.007851513056084513,0.13656737059354782,0.11134207099676133,0.6013541162014008,0.2083498865365982,-7.077594772974121,63.44670747988073,43.314621383148825,3.186407927430513,0.15649670064449311,0.10420451089739799,0.43691844642162325,0.3414786458015442,0.4184983789920807,0.017418431304395198,0.018987976387143134,0.05944716483354569,0.005683214263990521,0.009726363094523549,0.0077959784306585785,0.02073530196212232,0.012567317904904484,0.031442471966147426,0.05141825191676617,0.011607993301004172,0.4134870171546936,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2003.0,1703520.0,59519.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE,CHEMBL831,4.0,1.0,1.0,MOL,50841.0,Small molecule,1975.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pine,0.0,-pine,tricyclic compounds,Tranquilizer (minor),0.0,0.0,0.0,"InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3",XJGVXQDUIWGIRW-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,0.736992877851952,4.0,327.8150000000001,3.7714000000000025,4,0,0,28.07,-4.389922684351153,0.9367965221405029,-4.474184385160248,0.9995817422866822,-6.807408967025512,0.9824536442756653,0.905617094039917,0.9970382452011108,94.72720404083029,2.5562098851733346,0.7688387513160706,0.1420526087284088,0.021667987387627364,0.8831842303276062,0.07824626713991165,1.5073510110247668,26.602091093326294,-0.8066842669079435,3.0973572823380717,0.32811155915260315,0.08537773340940476,0.5116856038570404,0.579511821269989,0.9719436287879943,0.021621385402977467,0.003889871551655233,0.05144236944615841,0.005969714745879174,0.05371143221855164,0.07668165564537048,0.004435117775574327,0.0028768639080226422,0.00489755094749853,0.029939592443406583,0.006999386777170003,0.5508241772651672,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2003.0,1703520.0,59519.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE,CHEMBL831,4.0,1.0,1.0,MOL,50841.0,Small molecule,1975.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pine,0.0,-pine,tricyclic compounds,Tranquilizer (minor),0.0,0.0,0.0,"InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3",XJGVXQDUIWGIRW-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,0.736992877851952,4.0,327.8150000000001,3.7714000000000025,4,0,0,28.07,-4.389922684351153,0.9367965221405029,-4.474184385160248,0.9995817422866822,-6.807408967025512,0.9824536442756653,0.905617094039917,0.9970382452011108,94.72720404083029,2.5562098851733346,0.7688387513160706,0.1420526087284088,0.021667987387627364,0.8831842303276062,0.07824626713991165,1.5073510110247668,26.602091093326294,-0.8066842669079435,3.0973572823380717,0.32811155915260315,0.08537773340940476,0.5116856038570404,0.579511821269989,0.9719436287879943,0.021621385402977467,0.003889871551655233,0.05144236944615841,0.005969714745879174,0.05371143221855164,0.07668165564537048,0.004435117775574327,0.0028768639080226422,0.00489755094749853,0.029939592443406583,0.006999386777170003,0.5508241772651672,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,576.0,1703520.0,59519.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE,CHEMBL831,4.0,1.0,1.0,MOL,50841.0,Small molecule,1975.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pine,0.0,-pine,tricyclic compounds,Tranquilizer (minor),0.0,0.0,0.0,"InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3",XJGVXQDUIWGIRW-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,0.736992877851952,4.0,327.8150000000001,3.7714000000000025,4,0,0,28.07,-4.389922684351153,0.9367965221405029,-4.474184385160248,0.9995817422866822,-6.807408967025512,0.9824536442756653,0.905617094039917,0.9970382452011108,94.72720404083029,2.5562098851733346,0.7688387513160706,0.1420526087284088,0.021667987387627364,0.8831842303276062,0.07824626713991165,1.5073510110247668,26.602091093326294,-0.8066842669079435,3.0973572823380717,0.32811155915260315,0.08537773340940476,0.5116856038570404,0.579511821269989,0.9719436287879943,0.021621385402977467,0.003889871551655233,0.05144236944615841,0.005969714745879174,0.05371143221855164,0.07668165564537048,0.004435117775574327,0.0028768639080226422,0.00489755094749853,0.029939592443406583,0.006999386777170003,0.5508241772651672,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2004.0,1343112.0,674454.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BROMOCRIPTINE MESYLATE,CHEMBL1200503,4.0,1.0,1.0,MOL,3182.0,Small molecule,1978.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1977.0,1.0,,0.0,,,Enzyme Inhibitor (prolactin),0.0,0.0,0.0,"InChI=1S/C32H40BrN5O5.CH4O3S/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18;1-5(2,3)4/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39);1H3,(H,2,3,4)/t18-,23-,24+,25+,31-,32+;/m1./s1",NOJMTMIRQRDZMT-GSPXQYRGSA-N,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O,0.33566016866231274,3.0,750.713,2.6968000000000005,8,4,6,172.57999999999998,-2.5594260314325075,0.536172890663147,-5.367101952845898,0.9801110863685608,-13.09843370556479,0.6295767962932587,0.729538768529892,0.31400222778320314,86.53541840007031,5.216669788167662,0.02728667641058564,0.5492709755897522,0.36264044642448423,0.07521604485809803,0.8790964245796203,119.4971572866538,21.17754442179171,52.16418271003056,4.308723939408118,0.5005949914455414,0.21912461519241333,0.7100155472755432,0.8997392892837525,0.7901238441467285,0.018295941036194564,0.009374243032652885,0.09422783479094506,0.057954772002995016,0.07826307974755764,0.2574490666389465,0.036689591407775876,0.1114039145410061,0.05626109093427658,0.5586776912212372,0.3827649116516113,0.2174827605485916,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2004.0,1343112.0,674454.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BROMOCRIPTINE MESYLATE,CHEMBL1200503,4.0,1.0,1.0,MOL,3182.0,Small molecule,1978.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1977.0,1.0,,0.0,,,Enzyme Inhibitor (prolactin),0.0,0.0,0.0,"InChI=1S/C32H40BrN5O5.CH4O3S/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18;1-5(2,3)4/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39);1H3,(H,2,3,4)/t18-,23-,24+,25+,31-,32+;/m1./s1",NOJMTMIRQRDZMT-GSPXQYRGSA-N,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O,0.33566016866231274,3.0,750.713,2.6968000000000005,8,4,6,172.57999999999998,-2.5594260314325075,0.536172890663147,-5.367101952845898,0.9801110863685608,-13.09843370556479,0.6295767962932587,0.729538768529892,0.31400222778320314,86.53541840007031,5.216669788167662,0.02728667641058564,0.5492709755897522,0.36264044642448423,0.07521604485809803,0.8790964245796203,119.4971572866538,21.17754442179171,52.16418271003056,4.308723939408118,0.5005949914455414,0.21912461519241333,0.7100155472755432,0.8997392892837525,0.7901238441467285,0.018295941036194564,0.009374243032652885,0.09422783479094506,0.057954772002995016,0.07826307974755764,0.2574490666389465,0.036689591407775876,0.1114039145410061,0.05626109093427658,0.5586776912212372,0.3827649116516113,0.2174827605485916,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2005.0,1343313.0,6216.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROMAZINE,CHEMBL71,4.0,1.0,1.0,MOL,3647.0,Small molecule,1957.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antipsychotic; Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,0.7918053413291345,4.0,318.8730000000001,4.894400000000004,3,0,0,6.48,-5.46428730229863,0.8808049201965332,-4.228490597346501,0.9996413707733154,-5.377344901958539,0.9723054051399231,0.7245931506156922,0.9988614916801453,99.34898945705376,14.029060769465545,0.7420631170272827,0.2986199527978897,0.017839766480028628,0.948524558544159,0.06334175691008567,47.05455822963319,104.25750324980308,26.179307130690734,2.7247582985470893,0.22187865078449248,0.15990834832191467,0.4268872946500778,0.4946154415607452,0.9688923120498657,0.01314218258485198,0.006462384900078178,0.0313520273193717,0.008657066151499748,0.11645365357398987,0.07209320291876793,0.004461362725123763,0.0012556218774989248,0.029017109144479036,0.17215899974107743,0.06240456588566303,0.8172236919403076,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2005.0,1343313.0,6216.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROMAZINE,CHEMBL71,4.0,1.0,1.0,MOL,3647.0,Small molecule,1957.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antipsychotic; Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,0.7918053413291345,4.0,318.8730000000001,4.894400000000004,3,0,0,6.48,-5.46428730229863,0.8808049201965332,-4.228490597346501,0.9996413707733154,-5.377344901958539,0.9723054051399231,0.7245931506156922,0.9988614916801453,99.34898945705376,14.029060769465545,0.7420631170272827,0.2986199527978897,0.017839766480028628,0.948524558544159,0.06334175691008567,47.05455822963319,104.25750324980308,26.179307130690734,2.7247582985470893,0.22187865078449248,0.15990834832191467,0.4268872946500778,0.4946154415607452,0.9688923120498657,0.01314218258485198,0.006462384900078178,0.0313520273193717,0.008657066151499748,0.11645365357398987,0.07209320291876793,0.004461362725123763,0.0012556218774989248,0.029017109144479036,0.17215899974107743,0.06240456588566303,0.8172236919403076,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,581.0,1343313.0,6216.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROMAZINE,CHEMBL71,4.0,1.0,1.0,MOL,3647.0,Small molecule,1957.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antipsychotic; Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,0.7918053413291345,4.0,318.8730000000001,4.894400000000004,3,0,0,6.48,-5.46428730229863,0.8808049201965332,-4.228490597346501,0.9996413707733154,-5.377344901958539,0.9723054051399231,0.7245931506156922,0.9988614916801453,99.34898945705376,14.029060769465545,0.7420631170272827,0.2986199527978897,0.017839766480028628,0.948524558544159,0.06334175691008567,47.05455822963319,104.25750324980308,26.179307130690734,2.7247582985470893,0.22187865078449248,0.15990834832191467,0.4268872946500778,0.4946154415607452,0.9688923120498657,0.01314218258485198,0.006462384900078178,0.0313520273193717,0.008657066151499748,0.11645365357398987,0.07209320291876793,0.004461362725123763,0.0012556218774989248,0.029017109144479036,0.17215899974107743,0.06240456588566303,0.8172236919403076,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2006.0,1344072.0,550303.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROMAZINE HYDROCHLORIDE,CHEMBL1713,4.0,1.0,1.0,MOL,3649.0,Small molecule,1957.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antipsychotic; Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C17H19ClN2S.ClH/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H",FBSMERQALIEGJT-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl,0.7332564874299623,3.0,355.3340000000001,5.316200000000005,3,0,0,6.48,-4.903567131280601,0.8855198144912719,-4.422868017111061,0.9989712238311768,-5.908112386858158,0.9355692744255066,0.7977693796157836,0.9975961327552796,100.47424818456281,8.159485739193226,0.6954724729061127,0.25529674291610716,0.01891006585210562,0.9702930808067322,0.05683194622397423,45.429008563234085,81.8420049546165,22.12686752381198,2.4834217741402513,0.3885132372379303,0.28152147233486174,0.5161704659461975,0.4492439180612564,0.9727139592170715,0.010284100472927094,0.007182791456580162,0.04129416458308697,0.013918405398726463,0.1467797987163067,0.09334714189171792,0.005951361125335097,0.002357558347284794,0.04171226788312197,0.2630625456571579,0.09337561130523682,0.8011112093925477,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2006.0,1344072.0,550303.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROMAZINE HYDROCHLORIDE,CHEMBL1713,4.0,1.0,1.0,MOL,3649.0,Small molecule,1957.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antipsychotic; Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C17H19ClN2S.ClH/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H",FBSMERQALIEGJT-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl,0.7332564874299623,3.0,355.3340000000001,5.316200000000005,3,0,0,6.48,-4.903567131280601,0.8855198144912719,-4.422868017111061,0.9989712238311768,-5.908112386858158,0.9355692744255066,0.7977693796157836,0.9975961327552796,100.47424818456281,8.159485739193226,0.6954724729061127,0.25529674291610716,0.01891006585210562,0.9702930808067322,0.05683194622397423,45.429008563234085,81.8420049546165,22.12686752381198,2.4834217741402513,0.3885132372379303,0.28152147233486174,0.5161704659461975,0.4492439180612564,0.9727139592170715,0.010284100472927094,0.007182791456580162,0.04129416458308697,0.013918405398726463,0.1467797987163067,0.09334714189171792,0.005951361125335097,0.002357558347284794,0.04171226788312197,0.2630625456571579,0.09337561130523682,0.8011112093925477,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,578.0,1344072.0,550303.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CHLORPROMAZINE HYDROCHLORIDE,CHEMBL1713,4.0,1.0,1.0,MOL,3649.0,Small molecule,1957.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antipsychotic; Anti-Emetic,0.0,0.0,0.0,"InChI=1S/C17H19ClN2S.ClH/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H",FBSMERQALIEGJT-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl,0.7332564874299623,3.0,355.3340000000001,5.316200000000005,3,0,0,6.48,-4.903567131280601,0.8855198144912719,-4.422868017111061,0.9989712238311768,-5.908112386858158,0.9355692744255066,0.7977693796157836,0.9975961327552796,100.47424818456281,8.159485739193226,0.6954724729061127,0.25529674291610716,0.01891006585210562,0.9702930808067322,0.05683194622397423,45.429008563234085,81.8420049546165,22.12686752381198,2.4834217741402513,0.3885132372379303,0.28152147233486174,0.5161704659461975,0.4492439180612564,0.9727139592170715,0.010284100472927094,0.007182791456580162,0.04129416458308697,0.013918405398726463,0.1467797987163067,0.09334714189171792,0.005951361125335097,0.002357558347284794,0.04171226788312197,0.2630625456571579,0.09337561130523682,0.8011112093925477,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2008.0,1343359.0,2197565.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,OLANZAPINE PAMOATE,CHEMBL3989694,4.0,1.0,1.0,MOL,,Small molecule,2009.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2004.0,1.0,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C23H16O6.C17H20N4S.H2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);3-6,11,19H,7-10H2,1-2H3;1H2",ZIMCQJVMPKQQPB-UHFFFAOYSA-N,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,0.12834612813869903,2.0,718.8320000000004,7.0059200000000095,9,5,0,177.42999999999998,-4.116180212928194,0.7878807067871094,-5.71781386294468,0.8221193313598633,-10.680139012245073,0.20490020662546157,0.6814022958278656,0.2798581659793854,95.5422293911292,-4.2097022499268855,0.09898758456110954,0.2818494766950607,0.2001742646098137,0.08511767499148845,0.04381856620311737,46.53154946028674,-9.680600926025965,13.31984930596874,3.164119516725036,0.23780930340290068,0.2906442925333977,0.44605566263198854,0.9664101362228393,0.7315003573894501,0.008423194196075201,0.0037981633038725706,0.06064826808869839,0.020758110005408524,0.07274618819355964,0.04987960793077946,0.14903123378753663,0.05948093757033348,0.06631289161741734,0.2666675105690956,0.10403466522693634,0.26482718288898466,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2008.0,1343359.0,2197565.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,OLANZAPINE PAMOATE,CHEMBL3989694,4.0,1.0,1.0,MOL,,Small molecule,2009.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2004.0,1.0,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C23H16O6.C17H20N4S.H2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);3-6,11,19H,7-10H2,1-2H3;1H2",ZIMCQJVMPKQQPB-UHFFFAOYSA-N,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,0.12834612813869903,2.0,718.8320000000004,7.0059200000000095,9,5,0,177.42999999999998,-4.116180212928194,0.7878807067871094,-5.71781386294468,0.8221193313598633,-10.680139012245073,0.20490020662546157,0.6814022958278656,0.2798581659793854,95.5422293911292,-4.2097022499268855,0.09898758456110954,0.2818494766950607,0.2001742646098137,0.08511767499148845,0.04381856620311737,46.53154946028674,-9.680600926025965,13.31984930596874,3.164119516725036,0.23780930340290068,0.2906442925333977,0.44605566263198854,0.9664101362228393,0.7315003573894501,0.008423194196075201,0.0037981633038725706,0.06064826808869839,0.020758110005408524,0.07274618819355964,0.04987960793077946,0.14903123378753663,0.05948093757033348,0.06631289161741734,0.2666675105690956,0.10403466522693634,0.26482718288898466,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,595.0,1343359.0,2197565.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,OLANZAPINE PAMOATE,CHEMBL3989694,4.0,1.0,1.0,MOL,,Small molecule,2009.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2004.0,1.0,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C23H16O6.C17H20N4S.H2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);3-6,11,19H,7-10H2,1-2H3;1H2",ZIMCQJVMPKQQPB-UHFFFAOYSA-N,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,0.12834612813869903,2.0,718.8320000000004,7.0059200000000095,9,5,0,177.42999999999998,-4.116180212928194,0.7878807067871094,-5.71781386294468,0.8221193313598633,-10.680139012245073,0.20490020662546157,0.6814022958278656,0.2798581659793854,95.5422293911292,-4.2097022499268855,0.09898758456110954,0.2818494766950607,0.2001742646098137,0.08511767499148845,0.04381856620311737,46.53154946028674,-9.680600926025965,13.31984930596874,3.164119516725036,0.23780930340290068,0.2906442925333977,0.44605566263198854,0.9664101362228393,0.7315003573894501,0.008423194196075201,0.0037981633038725706,0.06064826808869839,0.020758110005408524,0.07274618819355964,0.04987960793077946,0.14903123378753663,0.05948093757033348,0.06631289161741734,0.2666675105690956,0.10403466522693634,0.26482718288898466,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2009.0,1343904.0,1672024.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PRAMIPEXOLE DIHYDROCHLORIDE,CHEMBL3182733,4.0,1.0,1.0,MOL,51147.0,Small molecule,1997.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1997.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C10H17N3S.2ClH.H2O/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H;1H2/t7-;;;/m0.../s1",APVQOOKHDZVJEX-QTPLPEIMSA-N,CCCN[C@H]1CCc2nc(N)sc2C1.Cl.Cl.O,0.8894253848631385,4.0,302.271,1.6010999999999997,4,2,1,82.44,-1.472922399419734,0.9484159111976623,-5.37457206158866,0.9995859503746033,-10.761727156431604,0.39355380535125734,0.05104643441736698,0.9685892105102539,58.02405323355887,20.31091095190706,0.051339710131287575,0.04337626919150352,0.0038952616770984603,0.4843058943748474,0.011650068080052733,40.064632727631626,32.89228806798066,-11.564319855353977,2.417889863156676,0.6391086518764496,0.29693408608436583,0.34698726832866666,0.3224949985742569,0.45272140502929686,0.014259409345686435,0.005559112131595612,0.10804161280393601,0.004627785412594676,0.18495379388332367,0.015778768621385098,0.0004769994455273263,0.007568542659282684,0.008336163638159633,0.01721179112792015,0.007482368242926895,0.370503243803978,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2009.0,1343904.0,1672024.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PRAMIPEXOLE DIHYDROCHLORIDE,CHEMBL3182733,4.0,1.0,1.0,MOL,51147.0,Small molecule,1997.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1997.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C10H17N3S.2ClH.H2O/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H;1H2/t7-;;;/m0.../s1",APVQOOKHDZVJEX-QTPLPEIMSA-N,CCCN[C@H]1CCc2nc(N)sc2C1.Cl.Cl.O,0.8894253848631385,4.0,302.271,1.6010999999999997,4,2,1,82.44,-1.472922399419734,0.9484159111976623,-5.37457206158866,0.9995859503746033,-10.761727156431604,0.39355380535125734,0.05104643441736698,0.9685892105102539,58.02405323355887,20.31091095190706,0.051339710131287575,0.04337626919150352,0.0038952616770984603,0.4843058943748474,0.011650068080052733,40.064632727631626,32.89228806798066,-11.564319855353977,2.417889863156676,0.6391086518764496,0.29693408608436583,0.34698726832866666,0.3224949985742569,0.45272140502929686,0.014259409345686435,0.005559112131595612,0.10804161280393601,0.004627785412594676,0.18495379388332367,0.015778768621385098,0.0004769994455273263,0.007568542659282684,0.008336163638159633,0.01721179112792015,0.007482368242926895,0.370503243803978,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2011.0,1344691.0,152751.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,DROPERIDOL,CHEMBL1108,4.0,1.0,1.0,MOL,4717.0,Small molecule,1970.0,0.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1963.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)",RMEDXOLNCUSCGS-UHFFFAOYSA-N,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,0.6649515564043438,4.0,379.4350000000002,3.6784000000000026,4,1,0,58.1,-3.7190925173180966,0.8506984829902648,-5.051672805405728,0.9975969552993774,-11.013849986739697,0.7739619731903076,0.9202720403671265,0.9663281440734863,90.19624422688054,3.0064429571030296,0.3696072429418564,0.24864688366651536,0.18472920209169388,0.9279210329055786,0.40627909600734713,10.51298890114199,58.712933316607895,15.034010955857372,2.8493412197232226,0.36913501024246215,0.2304987609386444,0.7599435448646545,0.37489503622055054,0.95387362241745,0.03835173174738884,0.05327052697539329,0.058903074637055394,0.012448480445891618,0.28157650828361513,0.07905525788664818,0.00788645597640425,0.028154224343597888,0.028532319888472556,0.1074186097830534,0.057897526398301126,0.34087975025177003,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2011.0,1344691.0,152751.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,DROPERIDOL,CHEMBL1108,4.0,1.0,1.0,MOL,4717.0,Small molecule,1970.0,0.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1963.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)",RMEDXOLNCUSCGS-UHFFFAOYSA-N,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,0.6649515564043438,4.0,379.4350000000002,3.6784000000000026,4,1,0,58.1,-3.7190925173180966,0.8506984829902648,-5.051672805405728,0.9975969552993774,-11.013849986739697,0.7739619731903076,0.9202720403671265,0.9663281440734863,90.19624422688054,3.0064429571030296,0.3696072429418564,0.24864688366651536,0.18472920209169388,0.9279210329055786,0.40627909600734713,10.51298890114199,58.712933316607895,15.034010955857372,2.8493412197232226,0.36913501024246215,0.2304987609386444,0.7599435448646545,0.37489503622055054,0.95387362241745,0.03835173174738884,0.05327052697539329,0.058903074637055394,0.012448480445891618,0.28157650828361513,0.07905525788664818,0.00788645597640425,0.028154224343597888,0.028532319888472556,0.1074186097830534,0.057897526398301126,0.34087975025177003,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,584.0,1344691.0,152751.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,DROPERIDOL,CHEMBL1108,4.0,1.0,1.0,MOL,4717.0,Small molecule,1970.0,0.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1963.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)",RMEDXOLNCUSCGS-UHFFFAOYSA-N,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,0.6649515564043438,4.0,379.4350000000002,3.6784000000000026,4,1,0,58.1,-3.7190925173180966,0.8506984829902648,-5.051672805405728,0.9975969552993774,-11.013849986739697,0.7739619731903076,0.9202720403671265,0.9663281440734863,90.19624422688054,3.0064429571030296,0.3696072429418564,0.24864688366651536,0.18472920209169388,0.9279210329055786,0.40627909600734713,10.51298890114199,58.712933316607895,15.034010955857372,2.8493412197232226,0.36913501024246215,0.2304987609386444,0.7599435448646545,0.37489503622055054,0.95387362241745,0.03835173174738884,0.05327052697539329,0.058903074637055394,0.012448480445891618,0.28157650828361513,0.07905525788664818,0.00788645597640425,0.028154224343597888,0.028532319888472556,0.1074186097830534,0.057897526398301126,0.34087975025177003,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2013.0,1344411.0,675106.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE SUCCINATE,CHEMBL1201155,4.0,1.0,1.0,MOL,6549.0,Small molecule,1975.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pine,0.0,-pine,tricyclic compounds,Tranquilizer (minor),0.0,0.0,0.0,"InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)",YQZBAXDVDZTKEQ-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O,0.7418410346264106,4.0,445.9030000000003,3.707200000000002,6,2,0,102.67,-2.798500417422723,0.84875328540802,-5.376503930005766,0.8141924858093261,-9.144115144667138,0.3439470320940018,0.4291907370090485,0.8209091067314148,88.00084604318204,-4.662096323575596,0.08105484917759895,0.03714696504175663,0.013941303361207247,0.5077513575553894,0.00999187990091741,1.3097122821235652,-47.578695393869644,-22.436921673079826,3.0949728231123315,0.05841006338596344,0.11999636441469193,0.555049079656601,0.7091737270355225,0.5489001899957657,0.031713878735899925,0.002991382614709437,0.10500503778457641,0.01823613988235593,0.00817395569756627,0.014431397803127766,0.02027641599997878,0.0026041143166366963,0.006801469705533236,0.00901093315333128,0.005170286120846868,0.2500024035573006,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2013.0,1344411.0,675106.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE SUCCINATE,CHEMBL1201155,4.0,1.0,1.0,MOL,6549.0,Small molecule,1975.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pine,0.0,-pine,tricyclic compounds,Tranquilizer (minor),0.0,0.0,0.0,"InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)",YQZBAXDVDZTKEQ-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O,0.7418410346264106,4.0,445.9030000000003,3.707200000000002,6,2,0,102.67,-2.798500417422723,0.84875328540802,-5.376503930005766,0.8141924858093261,-9.144115144667138,0.3439470320940018,0.4291907370090485,0.8209091067314148,88.00084604318204,-4.662096323575596,0.08105484917759895,0.03714696504175663,0.013941303361207247,0.5077513575553894,0.00999187990091741,1.3097122821235652,-47.578695393869644,-22.436921673079826,3.0949728231123315,0.05841006338596344,0.11999636441469193,0.555049079656601,0.7091737270355225,0.5489001899957657,0.031713878735899925,0.002991382614709437,0.10500503778457641,0.01823613988235593,0.00817395569756627,0.014431397803127766,0.02027641599997878,0.0026041143166366963,0.006801469705533236,0.00901093315333128,0.005170286120846868,0.2500024035573006,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,588.0,1344411.0,675106.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE SUCCINATE,CHEMBL1201155,4.0,1.0,1.0,MOL,6549.0,Small molecule,1975.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pine,0.0,-pine,tricyclic compounds,Tranquilizer (minor),0.0,0.0,0.0,"InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)",YQZBAXDVDZTKEQ-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O,0.7418410346264106,4.0,445.9030000000003,3.707200000000002,6,2,0,102.67,-2.798500417422723,0.84875328540802,-5.376503930005766,0.8141924858093261,-9.144115144667138,0.3439470320940018,0.4291907370090485,0.8209091067314148,88.00084604318204,-4.662096323575596,0.08105484917759895,0.03714696504175663,0.013941303361207247,0.5077513575553894,0.00999187990091741,1.3097122821235652,-47.578695393869644,-22.436921673079826,3.0949728231123315,0.05841006338596344,0.11999636441469193,0.555049079656601,0.7091737270355225,0.5489001899957657,0.031713878735899925,0.002991382614709437,0.10500503778457641,0.01823613988235593,0.00817395569756627,0.014431397803127766,0.02027641599997878,0.0026041143166366963,0.006801469705533236,0.00901093315333128,0.005170286120846868,0.2500024035573006,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2014.0,1343562.0,674420.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROMAZINE HYDROCHLORIDE,CHEMBL1200469,4.0,1.0,1.0,MOL,8460.0,Small molecule,1956.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C17H20N2S.ClH/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19;/h3-6,8-11H,7,12-13H2,1-2H3;1H",JIVSXRLRGOICGA-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccccc21.Cl,0.808463326754601,4.0,320.88900000000007,4.662800000000004,3,0,0,6.48,-4.030832165241664,0.8962315082550049,-4.403472202780486,0.9962782382965087,-6.298821908542996,0.90733802318573,0.6612271070480347,0.9977743983268738,93.08565744432705,-3.790515185196385,0.5426653563976288,0.16475817710161209,0.013965464010834695,0.9358622908592225,0.018285701423883437,17.45265537469762,87.00885728728983,22.302916288240972,2.4598134501747366,0.4575915813446045,0.2768489450216293,0.4977672338485718,0.4169358044862747,0.9771474003791809,0.011305261682718993,0.007178282551467419,0.04449954964220524,0.011093590687960387,0.09327838942408562,0.06365731656551361,0.0072172755841165784,0.004469717387109995,0.02770933471620083,0.16238921657204627,0.0649924986064434,0.8451367497444153,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2014.0,1343562.0,674420.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROMAZINE HYDROCHLORIDE,CHEMBL1200469,4.0,1.0,1.0,MOL,8460.0,Small molecule,1956.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C17H20N2S.ClH/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19;/h3-6,8-11H,7,12-13H2,1-2H3;1H",JIVSXRLRGOICGA-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccccc21.Cl,0.808463326754601,4.0,320.88900000000007,4.662800000000004,3,0,0,6.48,-4.030832165241664,0.8962315082550049,-4.403472202780486,0.9962782382965087,-6.298821908542996,0.90733802318573,0.6612271070480347,0.9977743983268738,93.08565744432705,-3.790515185196385,0.5426653563976288,0.16475817710161209,0.013965464010834695,0.9358622908592225,0.018285701423883437,17.45265537469762,87.00885728728983,22.302916288240972,2.4598134501747366,0.4575915813446045,0.2768489450216293,0.4977672338485718,0.4169358044862747,0.9771474003791809,0.011305261682718993,0.007178282551467419,0.04449954964220524,0.011093590687960387,0.09327838942408562,0.06365731656551361,0.0072172755841165784,0.004469717387109995,0.02770933471620083,0.16238921657204627,0.0649924986064434,0.8451367497444153,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,598.0,1343562.0,674420.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROMAZINE HYDROCHLORIDE,CHEMBL1200469,4.0,1.0,1.0,MOL,8460.0,Small molecule,1956.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C17H20N2S.ClH/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19;/h3-6,8-11H,7,12-13H2,1-2H3;1H",JIVSXRLRGOICGA-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2Sc2ccccc21.Cl,0.808463326754601,4.0,320.88900000000007,4.662800000000004,3,0,0,6.48,-4.030832165241664,0.8962315082550049,-4.403472202780486,0.9962782382965087,-6.298821908542996,0.90733802318573,0.6612271070480347,0.9977743983268738,93.08565744432705,-3.790515185196385,0.5426653563976288,0.16475817710161209,0.013965464010834695,0.9358622908592225,0.018285701423883437,17.45265537469762,87.00885728728983,22.302916288240972,2.4598134501747366,0.4575915813446045,0.2768489450216293,0.4977672338485718,0.4169358044862747,0.9771474003791809,0.011305261682718993,0.007178282551467419,0.04449954964220524,0.011093590687960387,0.09327838942408562,0.06365731656551361,0.0072172755841165784,0.004469717387109995,0.02770933471620083,0.16238921657204627,0.0649924986064434,0.8451367497444153,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2015.0,1344608.0,674362.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ROPINIROLE HYDROCHLORIDE,CHEMBL1200411,4.0,1.0,1.0,MOL,,Small molecule,1997.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1993.0,1.0,,0.0,,,Antiparkinsonian (D2 receptor agonist),0.0,0.0,0.0,"InChI=1S/C16H24N2O.ClH/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15;/h5-7H,3-4,8-12H2,1-2H3,(H,17,19);1H",XDXHAEQXIBQUEZ-UHFFFAOYSA-N,CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl,0.8374092277395009,4.0,296.8419999999999,3.2675000000000023,2,1,0,32.34,-2.4732235110931526,0.8361663699150086,-4.798940777890026,0.9754533052444458,-8.35064001850332,0.6836467087268829,0.06194794401526451,0.9898245334625244,62.806513974397106,16.790552313674347,0.08747708573937416,0.07008111178874969,0.006486102100461721,0.7621795415878296,0.002911302907159552,90.31378193104044,36.72765032245043,22.43729743406652,2.8336563148708205,0.6462259411811828,0.4690041482448578,0.5010542631149292,0.17440899312496186,0.8433055639266968,0.02027525119483471,0.014493955112993718,0.10137751176953316,0.008384314272552729,0.04706767499446869,0.009283724799752235,0.002064149107900448,0.02255659820511937,0.007682762271724641,0.016481979750096798,0.07910611927509308,0.8777539253234863,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2015.0,1344608.0,674362.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ROPINIROLE HYDROCHLORIDE,CHEMBL1200411,4.0,1.0,1.0,MOL,,Small molecule,1997.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1993.0,1.0,,0.0,,,Antiparkinsonian (D2 receptor agonist),0.0,0.0,0.0,"InChI=1S/C16H24N2O.ClH/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15;/h5-7H,3-4,8-12H2,1-2H3,(H,17,19);1H",XDXHAEQXIBQUEZ-UHFFFAOYSA-N,CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl,0.8374092277395009,4.0,296.8419999999999,3.2675000000000023,2,1,0,32.34,-2.4732235110931526,0.8361663699150086,-4.798940777890026,0.9754533052444458,-8.35064001850332,0.6836467087268829,0.06194794401526451,0.9898245334625244,62.806513974397106,16.790552313674347,0.08747708573937416,0.07008111178874969,0.006486102100461721,0.7621795415878296,0.002911302907159552,90.31378193104044,36.72765032245043,22.43729743406652,2.8336563148708205,0.6462259411811828,0.4690041482448578,0.5010542631149292,0.17440899312496186,0.8433055639266968,0.02027525119483471,0.014493955112993718,0.10137751176953316,0.008384314272552729,0.04706767499446869,0.009283724799752235,0.002064149107900448,0.02255659820511937,0.007682762271724641,0.016481979750096798,0.07910611927509308,0.8777539253234863,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2016.0,1344000.0,583530.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LEVOMEPROMAZINE,CHEMBL1764,4.0,1.0,1.0,MOL,6838.0,Small molecule,1982.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2003.0,0.0,,0.0,,,Analgesic,0.0,0.0,0.0,"InChI=1S/C19H24N2OS/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-/m1/s1",VRQVVMDWGGWHTJ-CQSZACIVSA-N,COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2,0.8027021109078474,4.0,328.481,4.495600000000004,4,0,1,15.71,-4.702583215342339,0.8951599359512329,-4.412836599648317,0.9990495920181275,-5.818720572477967,0.9778852820396423,0.7696229457855225,0.9961824536323547,93.1969532939258,-3.4095579760486374,0.410570453107357,0.10925728976726531,0.014378371182829142,0.9566295504570007,0.4338884115219116,-0.1624491618670259,98.93699526813914,60.16237476914311,2.6610674283252953,0.2060316801071167,0.0872665822505951,0.47099708914756777,0.26250179708003996,0.9838002324104309,0.009674245025962591,0.002204739302396774,0.02954345252364874,0.008326613064855336,0.21693223044276239,0.06484850272536277,0.002414221619255841,0.0025698171462863683,0.02518896646797657,0.10453472882509232,0.023808200657367707,0.49456775188446045,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2016.0,1344000.0,583530.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LEVOMEPROMAZINE,CHEMBL1764,4.0,1.0,1.0,MOL,6838.0,Small molecule,1982.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2003.0,0.0,,0.0,,,Analgesic,0.0,0.0,0.0,"InChI=1S/C19H24N2OS/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-/m1/s1",VRQVVMDWGGWHTJ-CQSZACIVSA-N,COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2,0.8027021109078474,4.0,328.481,4.495600000000004,4,0,1,15.71,-4.702583215342339,0.8951599359512329,-4.412836599648317,0.9990495920181275,-5.818720572477967,0.9778852820396423,0.7696229457855225,0.9961824536323547,93.1969532939258,-3.4095579760486374,0.410570453107357,0.10925728976726531,0.014378371182829142,0.9566295504570007,0.4338884115219116,-0.1624491618670259,98.93699526813914,60.16237476914311,2.6610674283252953,0.2060316801071167,0.0872665822505951,0.47099708914756777,0.26250179708003996,0.9838002324104309,0.009674245025962591,0.002204739302396774,0.02954345252364874,0.008326613064855336,0.21693223044276239,0.06484850272536277,0.002414221619255841,0.0025698171462863683,0.02518896646797657,0.10453472882509232,0.023808200657367707,0.49456775188446045,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2017.0,1343203.0,674937.0,D2-like dopamine receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL DECANOATE,CHEMBL1200986,4.0,1.0,1.0,MOL,,Small molecule,1986.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,1.0,0.0,1980.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3",GUTXTARXLVFHDK-UHFFFAOYSA-N,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,0.13267098764320848,2.0,530.1240000000003,8.11720000000001,4,0,0,46.61,-5.690475268086351,0.5363336980342865,-4.9571725984008825,0.9994998812675476,-5.536540705837568,0.9550156474113465,0.9958358526229858,0.957686972618103,111.07782189906061,5.9736191422681975,0.05807202979922295,0.18177582174539567,0.1880763903260231,0.7669195771217346,0.43149463534355165,22.12634284804527,106.74972119745385,80.31880518162,2.6698204166103574,0.014033187925815583,0.09854494407773018,0.13746766075491906,0.12207681462168693,0.9538031101226807,0.019429461285471916,0.03158465251326561,0.06642415970563889,0.0067584352567791935,0.013153239479288458,0.025619313307106494,0.004174541973043233,0.0006565659336047247,0.045459314808249475,0.06758074983954429,0.00837243078276515,0.5458484351634979,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2017.0,1343203.0,674937.0,D2-like dopamine receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL DECANOATE,CHEMBL1200986,4.0,1.0,1.0,MOL,,Small molecule,1986.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,1.0,0.0,1980.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3",GUTXTARXLVFHDK-UHFFFAOYSA-N,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,0.13267098764320848,2.0,530.1240000000003,8.11720000000001,4,0,0,46.61,-5.690475268086351,0.5363336980342865,-4.9571725984008825,0.9994998812675476,-5.536540705837568,0.9550156474113465,0.9958358526229858,0.957686972618103,111.07782189906061,5.9736191422681975,0.05807202979922295,0.18177582174539567,0.1880763903260231,0.7669195771217346,0.43149463534355165,22.12634284804527,106.74972119745385,80.31880518162,2.6698204166103574,0.014033187925815583,0.09854494407773018,0.13746766075491906,0.12207681462168693,0.9538031101226807,0.019429461285471916,0.03158465251326561,0.06642415970563889,0.0067584352567791935,0.013153239479288458,0.025619313307106494,0.004174541973043233,0.0006565659336047247,0.045459314808249475,0.06758074983954429,0.00837243078276515,0.5458484351634979,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,603.0,1343203.0,674937.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL DECANOATE,CHEMBL1200986,4.0,1.0,1.0,MOL,,Small molecule,1986.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,1.0,0.0,1980.0,1.0,,0.0,,,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3",GUTXTARXLVFHDK-UHFFFAOYSA-N,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,0.13267098764320848,2.0,530.1240000000003,8.11720000000001,4,0,0,46.61,-5.690475268086351,0.5363336980342865,-4.9571725984008825,0.9994998812675476,-5.536540705837568,0.9550156474113465,0.9958358526229858,0.957686972618103,111.07782189906061,5.9736191422681975,0.05807202979922295,0.18177582174539567,0.1880763903260231,0.7669195771217346,0.43149463534355165,22.12634284804527,106.74972119745385,80.31880518162,2.6698204166103574,0.014033187925815583,0.09854494407773018,0.13746766075491906,0.12207681462168693,0.9538031101226807,0.019429461285471916,0.03158465251326561,0.06642415970563889,0.0067584352567791935,0.013153239479288458,0.025619313307106494,0.004174541973043233,0.0006565659336047247,0.045459314808249475,0.06758074983954429,0.00837243078276515,0.5458484351634979,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2018.0,1343417.0,674867.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIORIDAZINE HYDROCHLORIDE,CHEMBL1200916,4.0,1.0,1.0,MOL,48566.0,Small molecule,1962.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Sedative-Hypnotic; Antipsychotic,1.0,0.0,0.0,"InChI=1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H",NZFNXWQNBYZDAQ-UHFFFAOYSA-N,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl,0.5484544915536859,3.0,407.04799999999994,6.307400000000006,4,0,1,6.48,-4.2898756329204275,0.7937883257865905,-4.907436692276864,0.9995251774787903,-5.879570395791135,0.9057690978050232,0.857020092010498,0.9977484703063965,102.472344427748,3.799627165164209,0.4917280077934265,0.17011739313602448,0.014021071325987577,0.9873402953147888,0.10218279510736465,38.54643082481301,74.99992626526348,37.38631052137076,2.274433621577841,0.25615368187427523,0.06923710890114307,0.5488778978586197,0.336929178237915,0.986043906211853,0.00905447844415903,0.0037386582233011724,0.040386629104614255,0.005133438529446721,0.1466209501028061,0.05722328200936318,0.0021172106731683015,0.0013677180628292262,0.03939624540507793,0.07645505294203758,0.020841870084404947,0.7797149538993835,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2018.0,1343417.0,674867.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIORIDAZINE HYDROCHLORIDE,CHEMBL1200916,4.0,1.0,1.0,MOL,48566.0,Small molecule,1962.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Sedative-Hypnotic; Antipsychotic,1.0,0.0,0.0,"InChI=1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H",NZFNXWQNBYZDAQ-UHFFFAOYSA-N,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl,0.5484544915536859,3.0,407.04799999999994,6.307400000000006,4,0,1,6.48,-4.2898756329204275,0.7937883257865905,-4.907436692276864,0.9995251774787903,-5.879570395791135,0.9057690978050232,0.857020092010498,0.9977484703063965,102.472344427748,3.799627165164209,0.4917280077934265,0.17011739313602448,0.014021071325987577,0.9873402953147888,0.10218279510736465,38.54643082481301,74.99992626526348,37.38631052137076,2.274433621577841,0.25615368187427523,0.06923710890114307,0.5488778978586197,0.336929178237915,0.986043906211853,0.00905447844415903,0.0037386582233011724,0.040386629104614255,0.005133438529446721,0.1466209501028061,0.05722328200936318,0.0021172106731683015,0.0013677180628292262,0.03939624540507793,0.07645505294203758,0.020841870084404947,0.7797149538993835,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,607.0,1343417.0,674867.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIORIDAZINE HYDROCHLORIDE,CHEMBL1200916,4.0,1.0,1.0,MOL,48566.0,Small molecule,1962.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Sedative-Hypnotic; Antipsychotic,1.0,0.0,0.0,"InChI=1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H",NZFNXWQNBYZDAQ-UHFFFAOYSA-N,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl,0.5484544915536859,3.0,407.04799999999994,6.307400000000006,4,0,1,6.48,-4.2898756329204275,0.7937883257865905,-4.907436692276864,0.9995251774787903,-5.879570395791135,0.9057690978050232,0.857020092010498,0.9977484703063965,102.472344427748,3.799627165164209,0.4917280077934265,0.17011739313602448,0.014021071325987577,0.9873402953147888,0.10218279510736465,38.54643082481301,74.99992626526348,37.38631052137076,2.274433621577841,0.25615368187427523,0.06923710890114307,0.5488778978586197,0.336929178237915,0.986043906211853,0.00905447844415903,0.0037386582233011724,0.040386629104614255,0.005133438529446721,0.1466209501028061,0.05722328200936318,0.0021172106731683015,0.0013677180628292262,0.03939624540507793,0.07645505294203758,0.020841870084404947,0.7797149538993835,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2019.0,1343767.0,5970.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIORIDAZINE,CHEMBL479,4.0,1.0,1.0,MOL,9566.0,Small molecule,1962.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1962.0,-2.0,,0.0,,,"Antipsychotic; Sedative-Hypnotic,Sedative-Hypnotic; Antipsychotic",1.0,0.0,0.0,"InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3",KLBQZWRITKRQQV-UHFFFAOYSA-N,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,0.6192081845073194,3.0,370.587,5.885600000000005,4,0,1,6.48,-4.865672085948343,0.8003152847290039,-4.761648245813963,0.9997415781021118,-5.922633114510548,0.9451390743255615,0.8024156093597412,0.9985259294509887,97.23078526007386,5.011678162223215,0.5149723947048187,0.1980598509311676,0.015871181339025497,0.9783122777938843,0.14582639932632446,18.713093319876208,86.90589603581503,40.40861527709561,2.43374020487879,0.15758515745401383,0.04253904968500137,0.5141233682632447,0.3918163478374481,0.9784133911132813,0.012251497060060502,0.003595517436042428,0.037844402715563774,0.0039172753458842635,0.17831956446170807,0.0408276192843914,0.002416114672087133,0.0010319571592845023,0.03731568306684494,0.058709340542554854,0.020340372622013093,0.7906725287437439,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2019.0,1343767.0,5970.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIORIDAZINE,CHEMBL479,4.0,1.0,1.0,MOL,9566.0,Small molecule,1962.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1962.0,-2.0,,0.0,,,"Antipsychotic; Sedative-Hypnotic,Sedative-Hypnotic; Antipsychotic",1.0,0.0,0.0,"InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3",KLBQZWRITKRQQV-UHFFFAOYSA-N,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,0.6192081845073194,3.0,370.587,5.885600000000005,4,0,1,6.48,-4.865672085948343,0.8003152847290039,-4.761648245813963,0.9997415781021118,-5.922633114510548,0.9451390743255615,0.8024156093597412,0.9985259294509887,97.23078526007386,5.011678162223215,0.5149723947048187,0.1980598509311676,0.015871181339025497,0.9783122777938843,0.14582639932632446,18.713093319876208,86.90589603581503,40.40861527709561,2.43374020487879,0.15758515745401383,0.04253904968500137,0.5141233682632447,0.3918163478374481,0.9784133911132813,0.012251497060060502,0.003595517436042428,0.037844402715563774,0.0039172753458842635,0.17831956446170807,0.0408276192843914,0.002416114672087133,0.0010319571592845023,0.03731568306684494,0.058709340542554854,0.020340372622013093,0.7906725287437439,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,606.0,1343767.0,5970.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,THIORIDAZINE,CHEMBL479,4.0,1.0,1.0,MOL,9566.0,Small molecule,1962.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1962.0,-2.0,,0.0,,,"Antipsychotic; Sedative-Hypnotic,Sedative-Hypnotic; Antipsychotic",1.0,0.0,0.0,"InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3",KLBQZWRITKRQQV-UHFFFAOYSA-N,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,0.6192081845073194,3.0,370.587,5.885600000000005,4,0,1,6.48,-4.865672085948343,0.8003152847290039,-4.761648245813963,0.9997415781021118,-5.922633114510548,0.9451390743255615,0.8024156093597412,0.9985259294509887,97.23078526007386,5.011678162223215,0.5149723947048187,0.1980598509311676,0.015871181339025497,0.9783122777938843,0.14582639932632446,18.713093319876208,86.90589603581503,40.40861527709561,2.43374020487879,0.15758515745401383,0.04253904968500137,0.5141233682632447,0.3918163478374481,0.9784133911132813,0.012251497060060502,0.003595517436042428,0.037844402715563774,0.0039172753458842635,0.17831956446170807,0.0408276192843914,0.002416114672087133,0.0010319571592845023,0.03731568306684494,0.058709340542554854,0.020340372622013093,0.7906725287437439,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2020.0,1343130.0,2832014.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,APOMORPHINE HYDROCHLORIDE,CHEMBL5314363,4.0,1.0,1.0,MOL,,Small molecule,2001.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H17NO2.2ClH.H2O/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t13-;;;/m1.../s1",BOQNMOQMVACUOG-BXUUEFRQSA-N,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl.Cl.O,0.7114007976017888,4.0,358.265,2.8688000000000033,3,2,1,75.2,-2.514848124643539,0.6694571316242218,-5.342881407813294,0.9943853497505188,-8.489393606246297,0.6133120357990265,0.27008954882621766,0.9308459401130676,85.267059469993,3.132287380328156,0.806757640838623,0.07746288608759641,0.019394484302029013,0.7319264650344849,0.014336424862267449,32.582451967050496,32.43368563377312,16.085847897112007,2.8620308580256677,0.8771163344383239,0.2252408504486084,0.40904698297381403,0.4351614534854889,0.7546531558036804,0.019347759336233138,0.019618596881628036,0.13547270596027375,0.06979002170264721,0.4612545847892761,0.037362247705459595,0.012534236419014633,0.032912259176373485,0.04258233867585659,0.21624587960541247,0.17519317455589772,0.7891433119773865,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2020.0,1343130.0,2832014.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,APOMORPHINE HYDROCHLORIDE,CHEMBL5314363,4.0,1.0,1.0,MOL,,Small molecule,2001.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H17NO2.2ClH.H2O/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t13-;;;/m1.../s1",BOQNMOQMVACUOG-BXUUEFRQSA-N,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl.Cl.O,0.7114007976017888,4.0,358.265,2.8688000000000033,3,2,1,75.2,-2.514848124643539,0.6694571316242218,-5.342881407813294,0.9943853497505188,-8.489393606246297,0.6133120357990265,0.27008954882621766,0.9308459401130676,85.267059469993,3.132287380328156,0.806757640838623,0.07746288608759641,0.019394484302029013,0.7319264650344849,0.014336424862267449,32.582451967050496,32.43368563377312,16.085847897112007,2.8620308580256677,0.8771163344383239,0.2252408504486084,0.40904698297381403,0.4351614534854889,0.7546531558036804,0.019347759336233138,0.019618596881628036,0.13547270596027375,0.06979002170264721,0.4612545847892761,0.037362247705459595,0.012534236419014633,0.032912259176373485,0.04258233867585659,0.21624587960541247,0.17519317455589772,0.7891433119773865,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2021.0,1343678.0,675011.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE HYDROCHLORIDE,CHEMBL1201060,4.0,1.0,1.0,MOL,,Small molecule,1976.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C18H18ClN3O.ClH/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;/h2-7,12H,8-11H2,1H3;1H",JSXBVMKACNEMKY-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl,0.7016802527656446,4.0,364.2760000000001,4.1932000000000045,4,0,0,28.07,-3.9989447731737657,0.9275063037872314,-4.647875604941228,0.9987079858779907,-7.373266980294377,0.9597322463989257,0.9225592613220215,0.9928468346595765,97.89484085173834,-1.1708975666270713,0.6956422924995422,0.12894251570105553,0.02659088037908077,0.9321577310562134,0.0652913697063923,3.1452708347457445,11.780826035408934,0.046784521337146855,2.8313064242282513,0.44465034604072573,0.1702067255973816,0.5755825221538544,0.5263629794120789,0.9758201837539673,0.01555472780019045,0.004774518590420484,0.06927249878644944,0.009884998202323914,0.07295757867395877,0.09552794843912124,0.007425594283267856,0.00502061266452074,0.009389632870443166,0.0625456091016531,0.012800926528871059,0.5556628704071045,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2021.0,1343678.0,675011.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE HYDROCHLORIDE,CHEMBL1201060,4.0,1.0,1.0,MOL,,Small molecule,1976.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C18H18ClN3O.ClH/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;/h2-7,12H,8-11H2,1H3;1H",JSXBVMKACNEMKY-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl,0.7016802527656446,4.0,364.2760000000001,4.1932000000000045,4,0,0,28.07,-3.9989447731737657,0.9275063037872314,-4.647875604941228,0.9987079858779907,-7.373266980294377,0.9597322463989257,0.9225592613220215,0.9928468346595765,97.89484085173834,-1.1708975666270713,0.6956422924995422,0.12894251570105553,0.02659088037908077,0.9321577310562134,0.0652913697063923,3.1452708347457445,11.780826035408934,0.046784521337146855,2.8313064242282513,0.44465034604072573,0.1702067255973816,0.5755825221538544,0.5263629794120789,0.9758201837539673,0.01555472780019045,0.004774518590420484,0.06927249878644944,0.009884998202323914,0.07295757867395877,0.09552794843912124,0.007425594283267856,0.00502061266452074,0.009389632870443166,0.0625456091016531,0.012800926528871059,0.5556628704071045,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,587.0,1343678.0,675011.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LOXAPINE HYDROCHLORIDE,CHEMBL1201060,4.0,1.0,1.0,MOL,,Small molecule,1976.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C18H18ClN3O.ClH/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;/h2-7,12H,8-11H2,1H3;1H",JSXBVMKACNEMKY-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl,0.7016802527656446,4.0,364.2760000000001,4.1932000000000045,4,0,0,28.07,-3.9989447731737657,0.9275063037872314,-4.647875604941228,0.9987079858779907,-7.373266980294377,0.9597322463989257,0.9225592613220215,0.9928468346595765,97.89484085173834,-1.1708975666270713,0.6956422924995422,0.12894251570105553,0.02659088037908077,0.9321577310562134,0.0652913697063923,3.1452708347457445,11.780826035408934,0.046784521337146855,2.8313064242282513,0.44465034604072573,0.1702067255973816,0.5755825221538544,0.5263629794120789,0.9758201837539673,0.01555472780019045,0.004774518590420484,0.06927249878644944,0.009884998202323914,0.07295757867395877,0.09552794843912124,0.007425594283267856,0.00502061266452074,0.009389632870443166,0.0625456091016531,0.012800926528871059,0.5556628704071045,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2023.0,1343604.0,34197.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,OLANZAPINE,CHEMBL715,4.0,1.0,1.0,MOL,7735.0,Small molecule,1996.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1992.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",KVWDHTXUZHCGIO-UHFFFAOYSA-N,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,0.8082561901210404,4.0,312.4420000000001,3.4392200000000033,5,1,0,30.870000000000005,-3.764612941964269,0.8779140114784241,-4.707125610134838,0.9995133757591248,-8.914248377244048,0.933180034160614,0.6334758520126342,0.9939910531044006,90.12639814970296,-2.394497693260791,0.6281075835227966,0.13389908894896507,0.03139514029026032,0.8245824575424194,0.25859039425849917,-18.940406460085445,47.22481536273553,35.87049130058225,2.7160103770717337,0.474419504404068,0.06474576443433762,0.5256354153156281,0.7254640460014343,0.9655880212783814,0.012635032832622527,0.005100637814030052,0.047676274180412294,0.009634500276297331,0.25517857670783994,0.06749392449855804,0.006402127095498145,0.015022009890526534,0.012868360243737697,0.061566649749875066,0.07918710932135582,0.4901372313499451,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2023.0,1343604.0,34197.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,OLANZAPINE,CHEMBL715,4.0,1.0,1.0,MOL,7735.0,Small molecule,1996.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1992.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",KVWDHTXUZHCGIO-UHFFFAOYSA-N,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,0.8082561901210404,4.0,312.4420000000001,3.4392200000000033,5,1,0,30.870000000000005,-3.764612941964269,0.8779140114784241,-4.707125610134838,0.9995133757591248,-8.914248377244048,0.933180034160614,0.6334758520126342,0.9939910531044006,90.12639814970296,-2.394497693260791,0.6281075835227966,0.13389908894896507,0.03139514029026032,0.8245824575424194,0.25859039425849917,-18.940406460085445,47.22481536273553,35.87049130058225,2.7160103770717337,0.474419504404068,0.06474576443433762,0.5256354153156281,0.7254640460014343,0.9655880212783814,0.012635032832622527,0.005100637814030052,0.047676274180412294,0.009634500276297331,0.25517857670783994,0.06749392449855804,0.006402127095498145,0.015022009890526534,0.012868360243737697,0.061566649749875066,0.07918710932135582,0.4901372313499451,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,594.0,1343604.0,34197.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,OLANZAPINE,CHEMBL715,4.0,1.0,1.0,MOL,7735.0,Small molecule,1996.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1992.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",KVWDHTXUZHCGIO-UHFFFAOYSA-N,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,0.8082561901210404,4.0,312.4420000000001,3.4392200000000033,5,1,0,30.870000000000005,-3.764612941964269,0.8779140114784241,-4.707125610134838,0.9995133757591248,-8.914248377244048,0.933180034160614,0.6334758520126342,0.9939910531044006,90.12639814970296,-2.394497693260791,0.6281075835227966,0.13389908894896507,0.03139514029026032,0.8245824575424194,0.25859039425849917,-18.940406460085445,47.22481536273553,35.87049130058225,2.7160103770717337,0.474419504404068,0.06474576443433762,0.5256354153156281,0.7254640460014343,0.9655880212783814,0.012635032832622527,0.005100637814030052,0.047676274180412294,0.009634500276297331,0.25517857670783994,0.06749392449855804,0.006402127095498145,0.015022009890526534,0.012868360243737697,0.061566649749875066,0.07918710932135582,0.4901372313499451,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2025.0,1343541.0,258371.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ROTIGOTINE,CHEMBL1303,4.0,1.0,1.0,MOL,,Small molecule,2007.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,2004.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1",KFQYTPMOWPVWEJ-INIZCTEOSA-N,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,0.8604750415603676,4.0,315.482,4.265700000000003,3,1,1,23.47,-4.088820729420164,0.6500589728355408,-5.09299046000905,0.9991963148117066,-7.256632035950571,0.9131283164024353,0.37543570399284365,0.9859082579612732,86.44037959805769,0.4571578716212185,0.7977254867553711,0.21287474632263184,0.06453681513667106,0.973599660396576,0.06362249962985515,25.195016107220802,119.70483265833732,75.8037050533433,3.043864894807578,0.3503161668777466,0.12015814557671547,0.3949561953544617,0.13130343407392503,0.9335428595542907,0.01372679155319929,0.007268801378086209,0.18466329872608184,0.050235451012849805,0.12426899522542953,0.047054605931043623,0.005100639699958265,0.018657875433564185,0.043349011614918706,0.21890657246112824,0.07893844246864319,0.7799811363220215,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2025.0,1343541.0,258371.0,D2-like dopamine receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ROTIGOTINE,CHEMBL1303,4.0,1.0,1.0,MOL,,Small molecule,2007.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,2004.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1",KFQYTPMOWPVWEJ-INIZCTEOSA-N,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,0.8604750415603676,4.0,315.482,4.265700000000003,3,1,1,23.47,-4.088820729420164,0.6500589728355408,-5.09299046000905,0.9991963148117066,-7.256632035950571,0.9131283164024353,0.37543570399284365,0.9859082579612732,86.44037959805769,0.4571578716212185,0.7977254867553711,0.21287474632263184,0.06453681513667106,0.973599660396576,0.06362249962985515,25.195016107220802,119.70483265833732,75.8037050533433,3.043864894807578,0.3503161668777466,0.12015814557671547,0.3949561953544617,0.13130343407392503,0.9335428595542907,0.01372679155319929,0.007268801378086209,0.18466329872608184,0.050235451012849805,0.12426899522542953,0.047054605931043623,0.005100639699958265,0.018657875433564185,0.043349011614918706,0.21890657246112824,0.07893844246864319,0.7799811363220215,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2026.0,1344273.0,3859.0,D2-like dopamine receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL,CHEMBL54,4.0,1.0,1.0,MOL,5613.0,Small molecule,1967.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1965.0,1.0,,0.0,,,Antidyskinetic (in gilles de la tourette's disease); Antipsychotic,0.0,0.0,0.0,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",LNEPOXFFQSENCJ-UHFFFAOYSA-N,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,0.759345285057915,4.0,375.87100000000015,4.425600000000004,3,1,0,40.540000000000006,-3.879703667659508,0.8849899291992187,-4.8387339312941915,0.9992732048034668,-8.215835374841816,0.9539976239204406,0.9247295141220093,0.9801033020019532,84.41074404958093,11.1631846710849,0.14659912437200545,0.26186898350715637,0.11576612144708634,0.9483474493026733,0.1281372219324112,26.637272560876177,42.232320541837815,4.260111472451518,2.9141911849661843,0.06696763262152672,0.09185117483139038,0.506452402472496,0.07681432887911796,0.9454198598861694,0.03325983583927154,0.042408084869384764,0.12538388073444368,0.012373139336705207,0.043045693822205064,0.045414743945002556,0.0038612178061157463,0.002550131012685597,0.019521156325936317,0.06871676193550229,0.01195238009095192,0.4225801169872284,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2026.0,1344273.0,3859.0,D2-like dopamine receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL,CHEMBL54,4.0,1.0,1.0,MOL,5613.0,Small molecule,1967.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1965.0,1.0,,0.0,,,Antidyskinetic (in gilles de la tourette's disease); Antipsychotic,0.0,0.0,0.0,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",LNEPOXFFQSENCJ-UHFFFAOYSA-N,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,0.759345285057915,4.0,375.87100000000015,4.425600000000004,3,1,0,40.540000000000006,-3.879703667659508,0.8849899291992187,-4.8387339312941915,0.9992732048034668,-8.215835374841816,0.9539976239204406,0.9247295141220093,0.9801033020019532,84.41074404958093,11.1631846710849,0.14659912437200545,0.26186898350715637,0.11576612144708634,0.9483474493026733,0.1281372219324112,26.637272560876177,42.232320541837815,4.260111472451518,2.9141911849661843,0.06696763262152672,0.09185117483139038,0.506452402472496,0.07681432887911796,0.9454198598861694,0.03325983583927154,0.042408084869384764,0.12538388073444368,0.012373139336705207,0.043045693822205064,0.045414743945002556,0.0038612178061157463,0.002550131012685597,0.019521156325936317,0.06871676193550229,0.01195238009095192,0.4225801169872284,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,602.0,1344273.0,3859.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL,CHEMBL54,4.0,1.0,1.0,MOL,5613.0,Small molecule,1967.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1965.0,1.0,,0.0,,,Antidyskinetic (in gilles de la tourette's disease); Antipsychotic,0.0,0.0,0.0,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",LNEPOXFFQSENCJ-UHFFFAOYSA-N,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,0.759345285057915,4.0,375.87100000000015,4.425600000000004,3,1,0,40.540000000000006,-3.879703667659508,0.8849899291992187,-4.8387339312941915,0.9992732048034668,-8.215835374841816,0.9539976239204406,0.9247295141220093,0.9801033020019532,84.41074404958093,11.1631846710849,0.14659912437200545,0.26186898350715637,0.11576612144708634,0.9483474493026733,0.1281372219324112,26.637272560876177,42.232320541837815,4.260111472451518,2.9141911849661843,0.06696763262152672,0.09185117483139038,0.506452402472496,0.07681432887911796,0.9454198598861694,0.03325983583927154,0.042408084869384764,0.12538388073444368,0.012373139336705207,0.043045693822205064,0.045414743945002556,0.0038612178061157463,0.002550131012685597,0.019521156325936317,0.06871676193550229,0.01195238009095192,0.4225801169872284,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2027.0,1344316.0,2335118.0,D2-like dopamine receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL LACTATE,CHEMBL4297147,4.0,1.0,1.0,MOL,,Small molecule,1967.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H23ClFNO2.C3H6O3/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16;1-2(4)3(5)6/h3-10,26H,1-2,11-15H2;2,4H,1H3,(H,5,6)",BVUSNQJCSYDJJG-UHFFFAOYSA-N,CC(O)C(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,0.5367238695195293,4.0,465.9490000000001,3.8774000000000033,5,3,1,98.07,-2.965514879073856,0.7616383075714112,-5.642218485894747,0.9475249409675598,-10.250458614241278,0.47102453708648684,0.5884545624256134,0.5572272360324859,83.43960622674315,6.480855712350076,0.046286838687956335,0.06524641886353492,0.044718165323138236,0.7825008869171143,0.013858014158904553,2.573158800076444,-12.760322568222815,-20.824091918558338,2.977133182670115,0.013875086349435151,0.055712899565696715,0.29246548712253573,0.15478599593043327,0.4143881142139435,0.03644881881773472,0.03764341734349728,0.17244417667388917,0.017190020345151425,0.02117433100938797,0.018735531345009805,0.02703181467950344,0.0017994260997511446,0.02456599660217762,0.020298939710482956,0.00618948636110872,0.23747026771306992,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2027.0,1344316.0,2335118.0,D2-like dopamine receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL LACTATE,CHEMBL4297147,4.0,1.0,1.0,MOL,,Small molecule,1967.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H23ClFNO2.C3H6O3/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16;1-2(4)3(5)6/h3-10,26H,1-2,11-15H2;2,4H,1H3,(H,5,6)",BVUSNQJCSYDJJG-UHFFFAOYSA-N,CC(O)C(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,0.5367238695195293,4.0,465.9490000000001,3.8774000000000033,5,3,1,98.07,-2.965514879073856,0.7616383075714112,-5.642218485894747,0.9475249409675598,-10.250458614241278,0.47102453708648684,0.5884545624256134,0.5572272360324859,83.43960622674315,6.480855712350076,0.046286838687956335,0.06524641886353492,0.044718165323138236,0.7825008869171143,0.013858014158904553,2.573158800076444,-12.760322568222815,-20.824091918558338,2.977133182670115,0.013875086349435151,0.055712899565696715,0.29246548712253573,0.15478599593043327,0.4143881142139435,0.03644881881773472,0.03764341734349728,0.17244417667388917,0.017190020345151425,0.02117433100938797,0.018735531345009805,0.02703181467950344,0.0017994260997511446,0.02456599660217762,0.020298939710482956,0.00618948636110872,0.23747026771306992,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,604.0,1344316.0,2335118.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,HALOPERIDOL LACTATE,CHEMBL4297147,4.0,1.0,1.0,MOL,,Small molecule,1967.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H23ClFNO2.C3H6O3/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16;1-2(4)3(5)6/h3-10,26H,1-2,11-15H2;2,4H,1H3,(H,5,6)",BVUSNQJCSYDJJG-UHFFFAOYSA-N,CC(O)C(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,0.5367238695195293,4.0,465.9490000000001,3.8774000000000033,5,3,1,98.07,-2.965514879073856,0.7616383075714112,-5.642218485894747,0.9475249409675598,-10.250458614241278,0.47102453708648684,0.5884545624256134,0.5572272360324859,83.43960622674315,6.480855712350076,0.046286838687956335,0.06524641886353492,0.044718165323138236,0.7825008869171143,0.013858014158904553,2.573158800076444,-12.760322568222815,-20.824091918558338,2.977133182670115,0.013875086349435151,0.055712899565696715,0.29246548712253573,0.15478599593043327,0.4143881142139435,0.03644881881773472,0.03764341734349728,0.17244417667388917,0.017190020345151425,0.02117433100938797,0.018735531345009805,0.02703181467950344,0.0017994260997511446,0.02456599660217762,0.020298939710482956,0.00618948636110872,0.23747026771306992,False
DRD2,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2028.0,1343976.0,706035.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRIFLUOPERAZINE HYDROCHLORIDE,CHEMBL1257040,4.0,1.0,1.0,MOL,9710.0,Small molecule,1959.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H24F3N3S.2ClH/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24;;/h2-3,5-8,15H,4,9-14H2,1H3;2*1H",BXDAOUXDMHXPDI-UHFFFAOYSA-N,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl,0.5480646397106008,3.0,480.4270000000002,5.7892000000000055,4,0,0,9.72,-4.653671243393603,0.7520502805709839,-4.522703765414674,0.9980556249618531,-5.480597929825526,0.9324524164199829,0.9052163481712341,0.9946714043617249,103.69643039068595,-5.512417182598862,0.3780267179012299,0.2679913997650146,0.020403613150119782,0.9124323964118958,0.5620825111865997,14.27247385652863,32.11872411396168,12.757036374619506,3.5547833170111387,0.2558543920516968,0.5289211869239807,0.7665943384170533,0.3695703387260437,0.9936805129051208,0.011352604161947966,0.006632883218117058,0.01592584028840065,0.006630443036556244,0.043888994678854945,0.03348081894218922,0.003179269016254693,0.0010539161041378975,0.010467504383996129,0.14371674060821532,0.04311028085649014,0.5906406044960022,False
DRD3,105671,PROTEIN FAMILY,D2-like dopamine receptor,9606,Homo sapiens,CHEMBL2331075,,0.0,2028.0,1343976.0,706035.0,D2-like dopamine receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRIFLUOPERAZINE HYDROCHLORIDE,CHEMBL1257040,4.0,1.0,1.0,MOL,9710.0,Small molecule,1959.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H24F3N3S.2ClH/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24;;/h2-3,5-8,15H,4,9-14H2,1H3;2*1H",BXDAOUXDMHXPDI-UHFFFAOYSA-N,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl,0.5480646397106008,3.0,480.4270000000002,5.7892000000000055,4,0,0,9.72,-4.653671243393603,0.7520502805709839,-4.522703765414674,0.9980556249618531,-5.480597929825526,0.9324524164199829,0.9052163481712341,0.9946714043617249,103.69643039068595,-5.512417182598862,0.3780267179012299,0.2679913997650146,0.020403613150119782,0.9124323964118958,0.5620825111865997,14.27247385652863,32.11872411396168,12.757036374619506,3.5547833170111387,0.2558543920516968,0.5289211869239807,0.7665943384170533,0.3695703387260437,0.9936805129051208,0.011352604161947966,0.006632883218117058,0.01592584028840065,0.006630443036556244,0.043888994678854945,0.03348081894218922,0.003179269016254693,0.0010539161041378975,0.010467504383996129,0.14371674060821532,0.04311028085649014,0.5906406044960022,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,610.0,1343976.0,706035.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRIFLUOPERAZINE HYDROCHLORIDE,CHEMBL1257040,4.0,1.0,1.0,MOL,9710.0,Small molecule,1959.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H24F3N3S.2ClH/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24;;/h2-3,5-8,15H,4,9-14H2,1H3;2*1H",BXDAOUXDMHXPDI-UHFFFAOYSA-N,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl,0.5480646397106008,3.0,480.4270000000002,5.7892000000000055,4,0,0,9.72,-4.653671243393603,0.7520502805709839,-4.522703765414674,0.9980556249618531,-5.480597929825526,0.9324524164199829,0.9052163481712341,0.9946714043617249,103.69643039068595,-5.512417182598862,0.3780267179012299,0.2679913997650146,0.020403613150119782,0.9124323964118958,0.5620825111865997,14.27247385652863,32.11872411396168,12.757036374619506,3.5547833170111387,0.2558543920516968,0.5289211869239807,0.7665943384170533,0.3695703387260437,0.9936805129051208,0.011352604161947966,0.006632883218117058,0.01592584028840065,0.006630443036556244,0.043888994678854945,0.03348081894218922,0.003179269016254693,0.0010539161041378975,0.010467504383996129,0.14371674060821532,0.04311028085649014,0.5906406044960022,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,246.0,1343545.0,112655.0,Dopamine D3 receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,LEVODOPA,CHEMBL1009,4.0,1.0,1.0,MOL,15765.0,Small molecule,1970.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1969.0,1.0,-dopa,0.0,-dopa,dopamine receptor agonists,Antiparkinsonian,0.0,0.0,0.0,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",WTDRDQBEARUVNC-LURJTMIESA-N,N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,0.5125069246930146,4.0,197.18999999999997,0.052200000000000135,4,4,1,103.78000000000002,-1.0025996220948297,0.8430655717849731,-6.064060585654497,0.9960970997810363,-13.859021953426137,0.04112419567536563,0.0028728362754918634,0.4945109665393829,54.55328241947537,3.9281294409233767,0.013603381626307965,0.014121982967481017,0.010945223551243544,0.019110057177022098,0.03986762650310993,8.00079281729341,45.218748259906874,-30.160101160017195,1.762331504527051,0.44997239112854004,0.2844250500202179,0.09076081775128841,0.07758519463241101,0.011028629448264837,0.038392477482557294,0.005652834050124511,0.02935467935167253,0.022062510950490832,0.19732770919799805,0.0033018093934515493,0.004957289784215391,0.003035475150682032,0.006727947480976581,0.00451989644789137,0.0034916312200948597,0.5958416759967804,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,4879.0,1702990.0,1173774.0,Dopamine D3 receptor agonist,,AGONIST,1.0,1.0,1.0,Ethyl ester prodrug of of levodopa (PMID:16476809).,,,,ETILEVODOPA,CHEMBL1823681,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2001.0,,-dopa,0.0,-dopa,dopamine receptor agonists,,0.0,0.0,0.0,"InChI=1S/C11H15NO4/c1-2-16-11(15)8(12)5-7-3-4-9(13)10(14)6-7/h3-4,6,8,13-14H,2,5,12H2,1H3/t8-/m0/s1",NULMGOSOSZBEQL-QMMMGPOBSA-N,CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1,0.5131583578304761,4.0,225.24400000000003,0.5306999999999997,5,3,1,92.78,-1.0176328745601504,0.7559988737106323,-5.294633638416196,0.9999037742614746,-11.564981294534652,0.6118973046541214,0.013256808556616307,0.6321671485900879,52.18499549331655,-2.0381483243773957,0.4722235143184662,0.11536067351698875,0.03085334934294224,0.08135379552841186,0.39808411300182345,-1.4378955664771276,127.98708745431898,11.907026483928822,1.8908621641829235,0.502677071094513,0.16023879423737525,0.052672036178410056,0.04334462806582451,0.06787944287061691,0.015033215377479791,0.004505496937781572,0.07437096796929836,0.07661745510995388,0.2607482850551605,0.03317967406474054,0.004339411901310086,0.011380166560411454,0.028373814933001996,0.04614547644741833,0.00815442253369838,0.665043294429779,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,8160.0,3133298.0,336721.0,Dopamine D3 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ABT-925,CHEMBL439338,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H27F3N6OS/c1-19(2,3)17-25-14(20(21,22)23)13-15(26-17)29-10-8-28(9-11-29)7-4-12-31-18-24-6-5-16(30)27-18/h5-6,13H,4,7-12H2,1-3H3,(H,24,27,30)",KXVAICSRMHXLJN-UHFFFAOYSA-N,CC(C)(C)c1nc(N2CCN(CCCSc3nccc(O)n3)CC2)cc(C(F)(F)F)n1,0.40147529379471825,4.0,456.5380000000001,3.592900000000003,8,1,0,78.27000000000001,-4.6339811537914155,0.7430241465568542,-5.204836327270358,0.9975031018257141,-7.354462478084718,0.9529120445251464,0.7541630506515503,0.9231239914894104,96.96693317635786,4.122304214097556,0.13487877324223518,0.49553332924842836,0.38182843923568727,0.3280575513839722,0.5309971630573272,-32.50970364848821,60.759307170411375,92.98852854429465,3.612028777934154,0.29274815768003465,0.319275963306427,0.6457615971565247,0.652209335565567,0.9251045346260071,0.02064391188323498,0.008427518233656884,0.061057887971401215,0.047766896709799764,0.023443764029070734,0.17956129163503648,0.016399273835122585,0.005075137270614505,0.012183855567127467,0.17966370284557343,0.03510594069957733,0.4118135780096054,False
DRD3,130,SINGLE PROTEIN,Dopamine D3 receptor,9606,Homo sapiens,CHEMBL234,,0.0,9200.0,3461117.0,2464878.0,Dopamine D3 receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,Also active against the dopamine D2-type receptor,,,MESDOPETAM,CHEMBL4594447,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C12H18FNO3S/c1-3-4-14-5-6-17-11-7-10(13)8-12(9-11)18(2,15)16/h7-9,14H,3-6H2,1-2H3",OSBPYFBXSLJHCR-UHFFFAOYSA-N,CCCNCCOc1cc(F)cc(S(C)(=O)=O)c1,0.7681075982580442,4.0,275.34499999999997,1.6076,4,1,0,55.4,-1.7571625180512664,0.9443501830101013,-4.633169053187081,0.9995294809341431,-7.999531832819447,0.9035541176795959,0.20051933974027633,0.9642271280288697,50.74202959645637,3.9815857013629534,0.4991003394126892,0.18202571496367453,0.009493359085172414,0.2553251966834068,0.08707712218165398,19.055238460184363,49.81399679436321,10.27306790232305,2.69440179214835,0.10806963257491589,0.596071434020996,0.20490942224860192,0.5365432560443878,0.5434631198644638,0.01222825979348272,0.007559242739807815,0.01985030369833112,0.0019502907292917372,0.005116274650208652,0.0055235250853002075,0.0004091990791494027,0.0007188991075963713,0.0008889857737813145,0.00243842420168221,0.0007564019004348665,0.20155649185180663,False
GRIN2A_NDMAR2A,166,SINGLE PROTEIN,Glutamate [NMDA] receptor subunit epsilon 1,9606,Homo sapiens,CHEMBL1972,,0.0,506.0,1344533.0,705811.0,Glutamate [NMDA] receptor subunit epsilon 1 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,DEXTROMETHORPHAN HYDROBROMIDE,CHEMBL1256818,4.0,1.0,1.0,MOL,,Small molecule,1984.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,2.0,-orphan,0.0,-orphan,narcotic antagonists/agonists (morphinan derivatives),Antitussive,0.0,0.0,0.0,"InChI=1S/C18H25NO.BrH.H2O/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H;1H2/t15-,17+,18+;;/m1../s1",STTADZBLEUMJRG-IKNOHUQMSA-N,Br.COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3.O,0.7624477590834328,4.0,370.33100000000013,3.1366000000000023,2,0,3,43.97,-2.6991191394185274,0.8855489373207093,-4.705038265224593,0.9996718049049378,-6.577650003680676,0.9585171699523926,0.15087983012199402,0.9691405415534973,70.41560993160832,9.515322948670152,0.06493373028934002,0.05126573964953422,0.004024191806092858,0.8771868348121643,0.1780195340514183,22.311677565404505,46.47966760603781,6.820394552502798,2.8055405816194003,0.2908671200275421,0.006607970129698515,0.4585574507713318,0.04740394502878189,0.7993115425109864,0.028399792872369288,0.002951514988671988,0.09751064032316208,0.03109658816829324,0.05904078148305416,0.02463814616203308,0.0007940633513499051,0.005286618648096919,0.009056966472417115,0.009341411478817462,0.006746249960269779,0.3609092324972153,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1126.0,1344881.0,674346.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ORPHENADRINE CITRATE,CHEMBL1200395,4.0,1.0,1.0,MOL,7790.0,Small molecule,1959.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,-drine,0.0,-drine,sympathomimetics,Antihistaminic; Relaxant (skeletal muscle),0.0,0.0,0.0,"InChI=1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)",MMMNTDFSPSQXJP-UHFFFAOYSA-N,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,0.39629023286386356,4.0,461.51100000000025,2.4141199999999996,6,4,1,144.6,-0.763468753337731,0.6390711903572083,-6.255151023719658,0.34503771364688873,-10.725264081823811,0.2921021044254303,0.43330508172512056,0.46656337976455686,66.10988859480275,0.9940668802172317,0.08002115264534951,0.13771236389875413,0.04534866251051426,0.6898129940032959,0.12579104974865912,4.686127305517938,8.307849209799443,12.27804658648812,2.540451852409096,0.08028653487563134,0.12115591391921043,0.4135965913534164,0.19562277048826218,0.5418680489063263,0.04076335839927196,0.008042414207011461,0.1397904261946678,0.05116585232317448,0.01552417790517211,0.016694441623985767,0.021371902897953987,0.0038472726359032095,0.01683582868427038,0.02364931972697377,0.003623845963738859,0.3665471524000168,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1126.0,1344881.0,674346.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ORPHENADRINE CITRATE,CHEMBL1200395,4.0,1.0,1.0,MOL,7790.0,Small molecule,1959.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,-drine,0.0,-drine,sympathomimetics,Antihistaminic; Relaxant (skeletal muscle),0.0,0.0,0.0,"InChI=1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)",MMMNTDFSPSQXJP-UHFFFAOYSA-N,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,0.39629023286386356,4.0,461.51100000000025,2.4141199999999996,6,4,1,144.6,-0.763468753337731,0.6390711903572083,-6.255151023719658,0.34503771364688873,-10.725264081823811,0.2921021044254303,0.43330508172512056,0.46656337976455686,66.10988859480275,0.9940668802172317,0.08002115264534951,0.13771236389875413,0.04534866251051426,0.6898129940032959,0.12579104974865912,4.686127305517938,8.307849209799443,12.27804658648812,2.540451852409096,0.08028653487563134,0.12115591391921043,0.4135965913534164,0.19562277048826218,0.5418680489063263,0.04076335839927196,0.008042414207011461,0.1397904261946678,0.05116585232317448,0.01552417790517211,0.016694441623985767,0.021371902897953987,0.0038472726359032095,0.01683582868427038,0.02364931972697377,0.003623845963738859,0.3665471524000168,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,914.0,1344881.0,674346.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ORPHENADRINE CITRATE,CHEMBL1200395,4.0,1.0,1.0,MOL,7790.0,Small molecule,1959.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,-drine,0.0,-drine,sympathomimetics,Antihistaminic; Relaxant (skeletal muscle),0.0,0.0,0.0,"InChI=1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)",MMMNTDFSPSQXJP-UHFFFAOYSA-N,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,0.39629023286386356,4.0,461.51100000000025,2.4141199999999996,6,4,1,144.6,-0.763468753337731,0.6390711903572083,-6.255151023719658,0.34503771364688873,-10.725264081823811,0.2921021044254303,0.43330508172512056,0.46656337976455686,66.10988859480275,0.9940668802172317,0.08002115264534951,0.13771236389875413,0.04534866251051426,0.6898129940032959,0.12579104974865912,4.686127305517938,8.307849209799443,12.27804658648812,2.540451852409096,0.08028653487563134,0.12115591391921043,0.4135965913534164,0.19562277048826218,0.5418680489063263,0.04076335839927196,0.008042414207011461,0.1397904261946678,0.05116585232317448,0.01552417790517211,0.016694441623985767,0.021371902897953987,0.0038472726359032095,0.01683582868427038,0.02364931972697377,0.003623845963738859,0.3665471524000168,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1127.0,1343571.0,1359038.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ACAMPROSATE CALCIUM,CHEMBL2068724,4.0,1.0,1.0,MOL,51042.0,Small molecule,2004.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/2C5H11NO4S.Ca/c2*1-5(7)6-3-2-4-11(8,9)10;/h2*2-4H2,1H3,(H,6,7)(H,8,9,10);/q;;+2/p-2",BUVGWDNTAWHSKI-UHFFFAOYSA-L,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],0.26064316392202697,4.0,400.48800000000017,-2.2651999999999957,8,2,0,172.6,0.30299448256735967,0.2607429206371307,-5.977391430588841,0.13604275257966947,-12.934026837008687,0.1656246321508661,0.009296060213819147,0.5159019351005554,43.49444188650427,-7.69910110001468,0.0006080847844714299,0.0057734245972824285,0.0004040750369313173,0.0034867217145801987,7.023619123174285e-05,38.47246146326612,18.7604976724382,-0.3505660527628784,1.6745129236050977,0.22747740447521209,0.18892375230789185,0.025515387346968055,0.506586754322052,0.02707733737770468,0.006436121533624828,0.005486876703798771,0.2804668366909027,0.007318975473754108,0.0009726892487378791,0.0003660002893866476,5.8520600214251316e-05,0.00033619679361436284,0.0032960278593236582,0.00397874271229739,0.007107901101699099,0.4329956978559494,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1127.0,1343571.0,1359038.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ACAMPROSATE CALCIUM,CHEMBL2068724,4.0,1.0,1.0,MOL,51042.0,Small molecule,2004.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/2C5H11NO4S.Ca/c2*1-5(7)6-3-2-4-11(8,9)10;/h2*2-4H2,1H3,(H,6,7)(H,8,9,10);/q;;+2/p-2",BUVGWDNTAWHSKI-UHFFFAOYSA-L,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],0.26064316392202697,4.0,400.48800000000017,-2.2651999999999957,8,2,0,172.6,0.30299448256735967,0.2607429206371307,-5.977391430588841,0.13604275257966947,-12.934026837008687,0.1656246321508661,0.009296060213819147,0.5159019351005554,43.49444188650427,-7.69910110001468,0.0006080847844714299,0.0057734245972824285,0.0004040750369313173,0.0034867217145801987,7.023619123174285e-05,38.47246146326612,18.7604976724382,-0.3505660527628784,1.6745129236050977,0.22747740447521209,0.18892375230789185,0.025515387346968055,0.506586754322052,0.02707733737770468,0.006436121533624828,0.005486876703798771,0.2804668366909027,0.007318975473754108,0.0009726892487378791,0.0003660002893866476,5.8520600214251316e-05,0.00033619679361436284,0.0032960278593236582,0.00397874271229739,0.007107901101699099,0.4329956978559494,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1128.0,1344319.0,452635.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Indicated for Parkinson's disease,,,,AMANTADINE HYDROCHLORIDE,CHEMBL1569,4.0,1.0,1.0,MOL,2619.0,Small molecule,1968.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1964.0,1.0,-mantadine,0.0,-mantadine,antivirals/antiparkinsonians (adamantane derivatives),Antiviral,0.0,0.0,0.0,"InChI=1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H",WOLHOYHSEKDWQH-UHFFFAOYSA-N,Cl.NC12CC3CC(CC(C3)C1)C2,0.6192438807936089,4.0,187.71399999999994,2.3357,1,1,0,26.02,-1.7569087673509902,0.9609804153442383,-4.4758620189137,0.9987668514251709,-3.156887857378976,0.792746365070343,0.022986304899677634,0.972892963886261,27.885965850648425,9.6535756350033,0.0014875449782266515,0.053692811913788316,0.003205749741755426,0.02927270084619522,0.0013196553711168236,16.94443871984097,28.923070445657693,-21.903495104044225,2.3459175107070145,0.049500956386327746,0.157748331874609,0.00924176761182025,0.01056172214448452,0.30700593814253807,0.00593672787072137,0.000492871195092448,0.054535096138715745,0.007219679353147513,0.0010000597994803684,0.0020116762054385616,0.00046606159003204084,0.00010719677802200067,0.010928536634310149,0.005408283858560026,0.0004408654631902209,0.5350296974182129,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1128.0,1344319.0,452635.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Indicated for Parkinson's disease,,,,AMANTADINE HYDROCHLORIDE,CHEMBL1569,4.0,1.0,1.0,MOL,2619.0,Small molecule,1968.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1964.0,1.0,-mantadine,0.0,-mantadine,antivirals/antiparkinsonians (adamantane derivatives),Antiviral,0.0,0.0,0.0,"InChI=1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H",WOLHOYHSEKDWQH-UHFFFAOYSA-N,Cl.NC12CC3CC(CC(C3)C1)C2,0.6192438807936089,4.0,187.71399999999994,2.3357,1,1,0,26.02,-1.7569087673509902,0.9609804153442383,-4.4758620189137,0.9987668514251709,-3.156887857378976,0.792746365070343,0.022986304899677634,0.972892963886261,27.885965850648425,9.6535756350033,0.0014875449782266515,0.053692811913788316,0.003205749741755426,0.02927270084619522,0.0013196553711168236,16.94443871984097,28.923070445657693,-21.903495104044225,2.3459175107070145,0.049500956386327746,0.157748331874609,0.00924176761182025,0.01056172214448452,0.30700593814253807,0.00593672787072137,0.000492871195092448,0.054535096138715745,0.007219679353147513,0.0010000597994803684,0.0020116762054385616,0.00046606159003204084,0.00010719677802200067,0.010928536634310149,0.005408283858560026,0.0004408654631902209,0.5350296974182129,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1129.0,1343574.0,545974.0,Glutamate [NMDA] receptor negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,,,,,MEMANTINE HYDROCHLORIDE,CHEMBL1699,4.0,1.0,1.0,MOL,64323.0,Small molecule,2003.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2003.0,1.0,-mantine,0.0,-mantine,antivirals/antiparkinsonians (adamantane derivatives),,0.0,0.0,0.0,"InChI=1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1H",LDDHMLJTFXJGPI-UHFFFAOYSA-N,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl,0.6604659572662127,4.0,215.768,3.1159000000000012,1,1,2,26.02,-2.247258511240693,0.9431302905082702,-4.552720663932319,0.992263913154602,-2.7364592069576927,0.8586127758026123,0.02173053295118734,0.9877495884895324,44.476754289191106,5.479780554048938,0.0003480669127384317,0.019873624434694648,0.002519674880022649,0.029609813028946518,0.0011779320237110368,18.34645919301841,18.02371685418594,-12.256183262988362,2.2905334738579244,0.05576565118972212,0.20027240216732026,0.0412362951785326,0.010365107003599406,0.48707659393548963,0.0026702756877057254,0.00021721241446357454,0.03730806447565556,0.00885861333226785,0.0009742016147356481,0.010942961383261719,0.0006294859137597087,9.081888292712392e-05,0.008786562141904142,0.021358956542098895,0.00045692650019191206,0.8267730355262757,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1129.0,1343574.0,545974.0,Glutamate [NMDA] receptor negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,,,,,MEMANTINE HYDROCHLORIDE,CHEMBL1699,4.0,1.0,1.0,MOL,64323.0,Small molecule,2003.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2003.0,1.0,-mantine,0.0,-mantine,antivirals/antiparkinsonians (adamantane derivatives),,0.0,0.0,0.0,"InChI=1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1H",LDDHMLJTFXJGPI-UHFFFAOYSA-N,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl,0.6604659572662127,4.0,215.768,3.1159000000000012,1,1,2,26.02,-2.247258511240693,0.9431302905082702,-4.552720663932319,0.992263913154602,-2.7364592069576927,0.8586127758026123,0.02173053295118734,0.9877495884895324,44.476754289191106,5.479780554048938,0.0003480669127384317,0.019873624434694648,0.002519674880022649,0.029609813028946518,0.0011779320237110368,18.34645919301841,18.02371685418594,-12.256183262988362,2.2905334738579244,0.05576565118972212,0.20027240216732026,0.0412362951785326,0.010365107003599406,0.48707659393548963,0.0026702756877057254,0.00021721241446357454,0.03730806447565556,0.00885861333226785,0.0009742016147356481,0.010942961383261719,0.0006294859137597087,9.081888292712392e-05,0.008786562141904142,0.021358956542098895,0.00045692650019191206,0.8267730355262757,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1130.0,1344151.0,674974.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ORPHENADRINE HYDROCHLORIDE,CHEMBL1201023,4.0,1.0,1.0,MOL,60902.0,Small molecule,1957.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,-drine,0.0,-drine,sympathomimetics,,0.0,0.0,0.0,"InChI=1S/C18H23NO.ClH/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;/h4-12,18H,13-14H2,1-3H3;1H",UQZKYYIKWZOKKD-UHFFFAOYSA-N,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl,0.7969810851656334,4.0,305.849,4.084420000000004,2,0,1,12.47,-3.115827726351577,0.9649575710296631,-4.6413185075097205,0.9982608795166016,-6.575569132379764,0.9482440233230591,0.2928675562143326,0.9482096076011658,74.7718002019259,8.237378869329115,0.2780775919556618,0.4190469115972519,0.015289556793868541,0.9058928728103638,0.05301659144461155,47.28949827342399,101.47690135345965,19.659372287987942,2.604189105886273,0.40824435353279115,0.26777420938014984,0.32735581547021864,0.059715211018919946,0.942132580280304,0.005705378064885735,0.0016376341227442026,0.09798292666673661,0.0244966272264719,0.010671209776774049,0.028601780906319617,0.003664331522304565,0.0028041846118867396,0.016284170700237154,0.033385255560278895,0.0024028860789258033,0.8797129273414612,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1130.0,1344151.0,674974.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ORPHENADRINE HYDROCHLORIDE,CHEMBL1201023,4.0,1.0,1.0,MOL,60902.0,Small molecule,1957.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,-drine,0.0,-drine,sympathomimetics,,0.0,0.0,0.0,"InChI=1S/C18H23NO.ClH/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;/h4-12,18H,13-14H2,1-3H3;1H",UQZKYYIKWZOKKD-UHFFFAOYSA-N,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl,0.7969810851656334,4.0,305.849,4.084420000000004,2,0,1,12.47,-3.115827726351577,0.9649575710296631,-4.6413185075097205,0.9982608795166016,-6.575569132379764,0.9482440233230591,0.2928675562143326,0.9482096076011658,74.7718002019259,8.237378869329115,0.2780775919556618,0.4190469115972519,0.015289556793868541,0.9058928728103638,0.05301659144461155,47.28949827342399,101.47690135345965,19.659372287987942,2.604189105886273,0.40824435353279115,0.26777420938014984,0.32735581547021864,0.059715211018919946,0.942132580280304,0.005705378064885735,0.0016376341227442026,0.09798292666673661,0.0244966272264719,0.010671209776774049,0.028601780906319617,0.003664331522304565,0.0028041846118867396,0.016284170700237154,0.033385255560278895,0.0024028860789258033,0.8797129273414612,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,913.0,1344151.0,674974.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ORPHENADRINE HYDROCHLORIDE,CHEMBL1201023,4.0,1.0,1.0,MOL,60902.0,Small molecule,1957.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,-drine,0.0,-drine,sympathomimetics,,0.0,0.0,0.0,"InChI=1S/C18H23NO.ClH/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;/h4-12,18H,13-14H2,1-3H3;1H",UQZKYYIKWZOKKD-UHFFFAOYSA-N,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl,0.7969810851656334,4.0,305.849,4.084420000000004,2,0,1,12.47,-3.115827726351577,0.9649575710296631,-4.6413185075097205,0.9982608795166016,-6.575569132379764,0.9482440233230591,0.2928675562143326,0.9482096076011658,74.7718002019259,8.237378869329115,0.2780775919556618,0.4190469115972519,0.015289556793868541,0.9058928728103638,0.05301659144461155,47.28949827342399,101.47690135345965,19.659372287987942,2.604189105886273,0.40824435353279115,0.26777420938014984,0.32735581547021864,0.059715211018919946,0.942132580280304,0.005705378064885735,0.0016376341227442026,0.09798292666673661,0.0244966272264719,0.010671209776774049,0.028601780906319617,0.003664331522304565,0.0028041846118867396,0.016284170700237154,0.033385255560278895,0.0024028860789258033,0.8797129273414612,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1131.0,1343148.0,150451.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,FELBAMATE,CHEMBL1094,4.0,1.0,1.0,MOL,4995.0,Small molecule,1993.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1992.0,1.0,-bamate,0.0,-bamate,tranquilizers/antiepileptics (propanediol and pentanediol groups),Anti-Epileptic,0.0,0.0,0.0,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",WKGXYQFOCVYPAC-UHFFFAOYSA-N,NC(=O)OCC(COC(N)=O)c1ccccc1,0.796471019540729,4.0,238.24300000000002,0.9607999999999993,4,2,0,104.64000000000001,-1.7390617334457232,0.9401418089866638,-4.685679745247361,0.9967708349227905,-13.327994186223899,0.7129852533340454,0.015084594581276178,0.9840287446975708,61.491397722252984,4.764678989874522,0.5019612967967987,0.17645478025078773,0.05410962384194136,0.05389447752386332,0.012625992018729448,10.22648602767281,52.25700660372371,12.59496031766444,2.187475918192516,0.6081576645374298,0.38775656968355177,0.12012245059013367,0.3616140067577362,0.18227549716830255,0.04160236120223999,0.07591161504387856,0.2006892517209053,0.02900208570063114,0.0682548563927412,0.004134069476276636,0.028180279349908233,0.0769567048177123,0.019539858866482972,0.010061327461153268,0.040745308995246886,0.3793419063091278,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1131.0,1343148.0,150451.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,FELBAMATE,CHEMBL1094,4.0,1.0,1.0,MOL,4995.0,Small molecule,1993.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1992.0,1.0,-bamate,0.0,-bamate,tranquilizers/antiepileptics (propanediol and pentanediol groups),Anti-Epileptic,0.0,0.0,0.0,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",WKGXYQFOCVYPAC-UHFFFAOYSA-N,NC(=O)OCC(COC(N)=O)c1ccccc1,0.796471019540729,4.0,238.24300000000002,0.9607999999999993,4,2,0,104.64000000000001,-1.7390617334457232,0.9401418089866638,-4.685679745247361,0.9967708349227905,-13.327994186223899,0.7129852533340454,0.015084594581276178,0.9840287446975708,61.491397722252984,4.764678989874522,0.5019612967967987,0.17645478025078773,0.05410962384194136,0.05389447752386332,0.012625992018729448,10.22648602767281,52.25700660372371,12.59496031766444,2.187475918192516,0.6081576645374298,0.38775656968355177,0.12012245059013367,0.3616140067577362,0.18227549716830255,0.04160236120223999,0.07591161504387856,0.2006892517209053,0.02900208570063114,0.0682548563927412,0.004134069476276636,0.028180279349908233,0.0769567048177123,0.019539858866482972,0.010061327461153268,0.040745308995246886,0.3793419063091278,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1132.0,1344238.0,550657.0,Glutamate [NMDA] receptor negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,,,,,KETAMINE HYDROCHLORIDE,CHEMBL1714,4.0,1.0,1.0,MOL,650657.0,Small molecule,1970.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1966.0,1.0,,0.0,,,Anesthetic,0.0,0.0,0.0,"InChI=1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H",VCMGMSHEPQENPE-UHFFFAOYSA-N,CNC1(c2ccccc2Cl)CCCCC1=O.Cl,0.8959263775791354,4.0,274.19099999999986,3.3196000000000025,2,1,1,29.1,-2.878037070450569,0.9517114639282227,-4.483342684546651,0.9999860048294067,-8.448034865727937,0.9725782036781311,0.03897088002413511,0.9755347609519959,58.878406068720494,7.946331800906544,0.21047961860895156,0.5760515093803406,0.016358376387506722,0.18879242837429047,0.17150259166955947,35.19851846182605,82.26385033923782,9.413753622557019,2.7494709924840106,0.412601175904274,0.19588228166103364,0.10565158873796462,0.14998378306627275,0.06122583411633968,0.006462116958573461,0.0057473642285913226,0.14093549102544783,0.015409629046916961,0.09858164489269257,0.026772711239755154,0.010101399570703506,0.02426479188725352,0.0313844246789813,0.1636008933186531,0.018298920802772047,0.7082247734069824,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,1132.0,1344238.0,550657.0,Glutamate [NMDA] receptor negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,,,,,KETAMINE HYDROCHLORIDE,CHEMBL1714,4.0,1.0,1.0,MOL,650657.0,Small molecule,1970.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1966.0,1.0,,0.0,,,Anesthetic,0.0,0.0,0.0,"InChI=1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H",VCMGMSHEPQENPE-UHFFFAOYSA-N,CNC1(c2ccccc2Cl)CCCCC1=O.Cl,0.8959263775791354,4.0,274.19099999999986,3.3196000000000025,2,1,1,29.1,-2.878037070450569,0.9517114639282227,-4.483342684546651,0.9999860048294067,-8.448034865727937,0.9725782036781311,0.03897088002413511,0.9755347609519959,58.878406068720494,7.946331800906544,0.21047961860895156,0.5760515093803406,0.016358376387506722,0.18879242837429047,0.17150259166955947,35.19851846182605,82.26385033923782,9.413753622557019,2.7494709924840106,0.412601175904274,0.19588228166103364,0.10565158873796462,0.14998378306627275,0.06122583411633968,0.006462116958573461,0.0057473642285913226,0.14093549102544783,0.015409629046916961,0.09858164489269257,0.026772711239755154,0.010101399570703506,0.02426479188725352,0.0313844246789813,0.1636008933186531,0.018298920802772047,0.7082247734069824,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,4541.0,2583573.0,1383254.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Non-competitive antagonist.,,,,DELUCEMINE,CHEMBL2110814,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C16H17F2N/c1-19-9-8-16(12-4-2-6-14(17)10-12)13-5-3-7-15(18)11-13/h2-7,10-11,16,19H,8-9H2,1H3",MUGNLPWYHGOJEG-UHFFFAOYSA-N,CNCCC(c1cccc(F)c1)c1cccc(F)c1,0.8648867810933147,4.0,261.31499999999994,3.7062000000000026,1,1,0,12.03,-3.279714734274242,0.9728603005409241,-4.507591912362438,0.9999363422393799,-6.302274602750401,0.9455069184303284,0.08112260922789574,0.9668835163116455,64.35040145276267,10.430573694772644,0.5788971841335296,0.48730466365814207,0.17166190668940545,0.806565260887146,0.26375121623277664,21.354521839067612,62.70872183548512,-7.337849045448891,2.8383701552602174,0.10774127319455147,0.31260944306850436,0.18121845945715903,0.08724539056420326,0.9425765633583069,0.019519959576427937,0.004970325063914061,0.16302469074726106,0.023042932990938424,0.012087505357339979,0.03755728956311941,0.0015457295579835773,0.001395254989620298,0.004222015640698374,0.14428347237408162,0.004703648621216416,0.5885017275810241,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,4541.0,2583573.0,1383254.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Non-competitive antagonist.,,,,DELUCEMINE,CHEMBL2110814,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C16H17F2N/c1-19-9-8-16(12-4-2-6-14(17)10-12)13-5-3-7-15(18)11-13/h2-7,10-11,16,19H,8-9H2,1H3",MUGNLPWYHGOJEG-UHFFFAOYSA-N,CNCCC(c1cccc(F)c1)c1cccc(F)c1,0.8648867810933147,4.0,261.31499999999994,3.7062000000000026,1,1,0,12.03,-3.279714734274242,0.9728603005409241,-4.507591912362438,0.9999363422393799,-6.302274602750401,0.9455069184303284,0.08112260922789574,0.9668835163116455,64.35040145276267,10.430573694772644,0.5788971841335296,0.48730466365814207,0.17166190668940545,0.806565260887146,0.26375121623277664,21.354521839067612,62.70872183548512,-7.337849045448891,2.8383701552602174,0.10774127319455147,0.31260944306850436,0.18121845945715903,0.08724539056420326,0.9425765633583069,0.019519959576427937,0.004970325063914061,0.16302469074726106,0.023042932990938424,0.012087505357339979,0.03755728956311941,0.0015457295579835773,0.001395254989620298,0.004222015640698374,0.14428347237408162,0.004703648621216416,0.5885017275810241,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5127.0,1705705.0,480532.0,Glutamate [NMDA] receptor blocker,,BLOCKER,1.0,1.0,1.0,"Non-selective, open-channel blocker.",,,,LANICEMINE,CHEMBL467084,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H14N2/c14-13(11-6-2-1-3-7-11)10-12-8-4-5-9-15-12/h1-9,13H,10,14H2/t13-/m0/s1",FWUQWDCOOWEXRY-ZDUSSCGKSA-N,N[C@@H](Cc1ccccn1)c1ccccc1,0.8216420812170326,4.0,198.269,2.3241000000000005,2,1,1,38.91,-0.8533570793587606,0.9416592001914978,-4.4228718254017325,0.9997596025466919,-9.108402711130399,0.8602294683456421,0.0054546976927667854,0.8989526748657226,24.818136819697997,-7.11241475651831,0.2288520887494087,0.10401768162846566,0.010326821310445666,0.16396633051335813,0.09260196015238761,17.02548778349676,60.92006273874604,-1.169592025674762,2.5771111641843447,0.15854530185461044,0.12049640938639641,0.07300133481621743,0.05626899823546409,0.11789858490228652,0.015181080996990204,0.004769896436482668,0.08744614645838737,0.01216835854575038,0.05341871455311775,0.016004011128097774,0.00024976417844300156,0.0019222910865209996,0.0074354518670588735,0.009685886977240443,0.0007378709633485414,0.6407172858715058,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5127.0,1705705.0,480532.0,Glutamate [NMDA] receptor blocker,,BLOCKER,1.0,1.0,1.0,"Non-selective, open-channel blocker.",,,,LANICEMINE,CHEMBL467084,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H14N2/c14-13(11-6-2-1-3-7-11)10-12-8-4-5-9-15-12/h1-9,13H,10,14H2/t13-/m0/s1",FWUQWDCOOWEXRY-ZDUSSCGKSA-N,N[C@@H](Cc1ccccn1)c1ccccc1,0.8216420812170326,4.0,198.269,2.3241000000000005,2,1,1,38.91,-0.8533570793587606,0.9416592001914978,-4.4228718254017325,0.9997596025466919,-9.108402711130399,0.8602294683456421,0.0054546976927667854,0.8989526748657226,24.818136819697997,-7.11241475651831,0.2288520887494087,0.10401768162846566,0.010326821310445666,0.16396633051335813,0.09260196015238761,17.02548778349676,60.92006273874604,-1.169592025674762,2.5771111641843447,0.15854530185461044,0.12049640938639641,0.07300133481621743,0.05626899823546409,0.11789858490228652,0.015181080996990204,0.004769896436482668,0.08744614645838737,0.01216835854575038,0.05341871455311775,0.016004011128097774,0.00024976417844300156,0.0019222910865209996,0.0074354518670588735,0.009685886977240443,0.0007378709633485414,0.6407172858715058,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5129.0,2473039.0,681317.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Selective NMDA glycine site antagonist,,,,GW468816,CHEMBL1207366,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H17ClN2O3/c21-12-6-7-14-16(11-18(20(25)26)22-17(14)10-12)15-8-9-23(19(15)24)13-4-2-1-3-5-13/h1-7,10,18,22H,8-9,11H2,(H,25,26)/b16-15+",XDKRVNKVAKCFGW-FOCLMDBBSA-N,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1,0.7909369042476887,4.0,368.8200000000001,3.7993000000000023,3,2,1,69.64,-4.76082709440852,0.9322976469993591,-5.047437056485888,0.9979352831840516,-11.393805262831778,0.7616591453552246,0.11007115766406059,0.8009658217430115,96.76206047487901,-8.756897061270674,0.3849430441856384,0.6471574306488037,0.6320202827453614,0.06383100748062134,0.16885960400104522,31.602312206621725,19.059298935753624,3.365647146922312,2.9861917879548394,0.0848980575799942,0.32434049248695374,0.2297784373164177,0.9756142973899842,0.1753419205546379,0.05815209075808525,0.018537679640576243,0.16221123337745666,0.020416025072336197,0.4390538573265076,0.1968984767794609,0.5706199288368226,0.10271989405155182,0.11577747240662575,0.24060718715190887,0.18915187418460847,0.428212571144104,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5129.0,2473039.0,681317.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Selective NMDA glycine site antagonist,,,,GW468816,CHEMBL1207366,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H17ClN2O3/c21-12-6-7-14-16(11-18(20(25)26)22-17(14)10-12)15-8-9-23(19(15)24)13-4-2-1-3-5-13/h1-7,10,18,22H,8-9,11H2,(H,25,26)/b16-15+",XDKRVNKVAKCFGW-FOCLMDBBSA-N,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1,0.7909369042476887,4.0,368.8200000000001,3.7993000000000023,3,2,1,69.64,-4.76082709440852,0.9322976469993591,-5.047437056485888,0.9979352831840516,-11.393805262831778,0.7616591453552246,0.11007115766406059,0.8009658217430115,96.76206047487901,-8.756897061270674,0.3849430441856384,0.6471574306488037,0.6320202827453614,0.06383100748062134,0.16885960400104522,31.602312206621725,19.059298935753624,3.365647146922312,2.9861917879548394,0.0848980575799942,0.32434049248695374,0.2297784373164177,0.9756142973899842,0.1753419205546379,0.05815209075808525,0.018537679640576243,0.16221123337745666,0.020416025072336197,0.4390538573265076,0.1968984767794609,0.5706199288368226,0.10271989405155182,0.11577747240662575,0.24060718715190887,0.18915187418460847,0.428212571144104,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5134.0,1705337.0,704821.0,Glutamate [NMDA] receptor positive allosteric modulator,,POSITIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,"PAM of the glycin-site on GRIN1-subunits, binds to other allosteric site?",,,,NEBOGLAMINE,CHEMBL1255840,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H24N2O3/c1-13(2)7-5-9(6-8-13)15-12(18)10(14)3-4-11(16)17/h9-10H,3-8,14H2,1-2H3,(H,15,18)(H,16,17)/t10-/m0/s1",VCRGLZYPNNAVRP-JTQLQIEISA-N,CC1(C)CCC(NC(=O)[C@@H](N)CCC(=O)O)CC1,0.6902059594916257,4.0,256.34599999999995,1.2634999999999998,3,3,1,92.42,-1.249959284188604,0.9357305407524109,-5.062470637806428,0.9691185712814331,-11.375804647088504,0.20413158610463142,0.0010958589613437653,0.824350893497467,52.77060987762178,1.4730407829724907,0.0015380297205410897,0.031027099676430227,0.003875920595601201,0.016048643598333003,0.006166889006271959,-10.396498736761771,19.912355787021184,-10.433880142852114,2.2880327880032985,0.13702173233032228,0.1642871767282486,0.12435538619756699,0.08362717665731907,0.010324236238375306,0.006423684908077121,0.0007367789803538471,0.05761056467890739,0.00735042174346745,0.01786081618629396,0.0007782736385706813,0.0020940983900800346,0.0006245932221645489,0.005477601173333823,0.001193551521282643,0.000767775159329176,0.4321275889873505,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5134.0,1705337.0,704821.0,Glutamate [NMDA] receptor positive allosteric modulator,,POSITIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,"PAM of the glycin-site on GRIN1-subunits, binds to other allosteric site?",,,,NEBOGLAMINE,CHEMBL1255840,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H24N2O3/c1-13(2)7-5-9(6-8-13)15-12(18)10(14)3-4-11(16)17/h9-10H,3-8,14H2,1-2H3,(H,15,18)(H,16,17)/t10-/m0/s1",VCRGLZYPNNAVRP-JTQLQIEISA-N,CC1(C)CCC(NC(=O)[C@@H](N)CCC(=O)O)CC1,0.6902059594916257,4.0,256.34599999999995,1.2634999999999998,3,3,1,92.42,-1.249959284188604,0.9357305407524109,-5.062470637806428,0.9691185712814331,-11.375804647088504,0.20413158610463142,0.0010958589613437653,0.824350893497467,52.77060987762178,1.4730407829724907,0.0015380297205410897,0.031027099676430227,0.003875920595601201,0.016048643598333003,0.006166889006271959,-10.396498736761771,19.912355787021184,-10.433880142852114,2.2880327880032985,0.13702173233032228,0.1642871767282486,0.12435538619756699,0.08362717665731907,0.010324236238375306,0.006423684908077121,0.0007367789803538471,0.05761056467890739,0.00735042174346745,0.01786081618629396,0.0007782736385706813,0.0020940983900800346,0.0006245932221645489,0.005477601173333823,0.001193551521282643,0.000767775159329176,0.4321275889873505,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5135.0,2473609.0,1927200.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Antagonist of the glycin-site on GRIN1-subunits.,,,,AV-101,CHEMBL3545351,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C10H11ClN2O3/c11-5-1-2-6(7(12)3-5)9(14)4-8(13)10(15)16/h1-3,8H,4,12-13H2,(H,15,16)",HQLHZNDJQSRKDT-UHFFFAOYSA-N,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O,0.5373790091098091,4.0,242.66199999999998,0.9069,4,3,1,106.41000000000001,-2.526386297686032,0.9755266785621644,-5.439913878602502,0.9991729497909546,-12.614180669478298,0.1451081834733486,0.008365634176880122,0.7655808687210083,66.60155412253009,6.423036116961097,0.07241778299212456,0.09343577027320862,0.05790086388587952,0.04510301053524017,0.11689373552799225,-30.023201697659157,40.3031483403004,-14.739231724084442,2.216401836574886,0.20765602588653564,0.33014882206916807,0.2225204348564148,0.7163847088813782,0.0053211054764688015,0.03751210533082485,0.021389192063361408,0.03435264565050602,0.008788050338625907,0.3952620267868042,0.006732088373973965,0.021569902822375298,0.013325965404510498,0.015959955751895905,0.01234836750663817,0.02171892940532416,0.3637237161397934,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5135.0,2473609.0,1927200.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Antagonist of the glycin-site on GRIN1-subunits.,,,,AV-101,CHEMBL3545351,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C10H11ClN2O3/c11-5-1-2-6(7(12)3-5)9(14)4-8(13)10(15)16/h1-3,8H,4,12-13H2,(H,15,16)",HQLHZNDJQSRKDT-UHFFFAOYSA-N,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O,0.5373790091098091,4.0,242.66199999999998,0.9069,4,3,1,106.41000000000001,-2.526386297686032,0.9755266785621644,-5.439913878602502,0.9991729497909546,-12.614180669478298,0.1451081834733486,0.008365634176880122,0.7655808687210083,66.60155412253009,6.423036116961097,0.07241778299212456,0.09343577027320862,0.05790086388587952,0.04510301053524017,0.11689373552799225,-30.023201697659157,40.3031483403004,-14.739231724084442,2.216401836574886,0.20765602588653564,0.33014882206916807,0.2225204348564148,0.7163847088813782,0.0053211054764688015,0.03751210533082485,0.021389192063361408,0.03435264565050602,0.008788050338625907,0.3952620267868042,0.006732088373973965,0.021569902822375298,0.013325965404510498,0.015959955751895905,0.01234836750663817,0.02171892940532416,0.3637237161397934,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5184.0,2583407.0,60106.0,Glutamate [NMDA] receptor blocker,,BLOCKER,1.0,1.0,1.0,Being developed as PET scan ligand.,,,,CNS-5161,CHEMBL41306,-1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C16H18ClN3S2/c1-20(11-5-4-6-12(9-11)21-2)16(18)19-15-10-13(22-3)7-8-14(15)17/h4-10H,1-3H3,(H2,18,19)",JHVHEDNLONERHY-UHFFFAOYSA-N,CSc1cccc(N(C)C(=N)Nc2cc(SC)ccc2Cl)c1,0.4470429513922043,3.0,351.9280000000001,5.2668700000000035,3,2,0,39.120000000000005,-4.513041303357028,0.8916097760200501,-5.2459721050085575,0.9992807865142822,-7.572265609790875,0.8905614972114563,0.32824166417121886,0.6887581706047058,85.74471486437714,23.817097196338388,0.8761723279953003,0.7839516997337341,0.21818858310580252,0.9149049997329712,0.5793765544891357,60.14595172573432,69.29636867335168,37.05534850106015,2.598853698480501,0.31267571449279785,0.2972387194633484,0.046692915447056296,0.589042991399765,0.76223384141922,0.018077919073402882,0.00862210439518094,0.20417370796203613,0.03482433967292309,0.4660509526729584,0.08231302574276925,0.023046558536589146,0.017846044152975082,0.15905881971120833,0.39014299511909484,0.1472071759402752,0.739693033695221,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5184.0,2583407.0,60106.0,Glutamate [NMDA] receptor blocker,,BLOCKER,1.0,1.0,1.0,Being developed as PET scan ligand.,,,,CNS-5161,CHEMBL41306,-1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C16H18ClN3S2/c1-20(11-5-4-6-12(9-11)21-2)16(18)19-15-10-13(22-3)7-8-14(15)17/h4-10H,1-3H3,(H2,18,19)",JHVHEDNLONERHY-UHFFFAOYSA-N,CSc1cccc(N(C)C(=N)Nc2cc(SC)ccc2Cl)c1,0.4470429513922043,3.0,351.9280000000001,5.2668700000000035,3,2,0,39.120000000000005,-4.513041303357028,0.8916097760200501,-5.2459721050085575,0.9992807865142822,-7.572265609790875,0.8905614972114563,0.32824166417121886,0.6887581706047058,85.74471486437714,23.817097196338388,0.8761723279953003,0.7839516997337341,0.21818858310580252,0.9149049997329712,0.5793765544891357,60.14595172573432,69.29636867335168,37.05534850106015,2.598853698480501,0.31267571449279785,0.2972387194633484,0.046692915447056296,0.589042991399765,0.76223384141922,0.018077919073402882,0.00862210439518094,0.20417370796203613,0.03482433967292309,0.4660509526729584,0.08231302574276925,0.023046558536589146,0.017846044152975082,0.15905881971120833,0.39014299511909484,0.1472071759402752,0.739693033695221,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5424.0,1705975.0,1380041.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,RALFINAMIDE,CHEMBL2107771,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1",BHJIBOFHEFDSAU-LBPRGKRZSA-N,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O,0.8250455320199923,4.0,302.34900000000005,2.3681,3,2,1,64.35,-3.037582028912313,0.9757533311843872,-4.8171442108555445,0.9999266743659974,-10.061382996913231,0.9494014859199524,0.048252948513254526,0.942760169506073,73.19445571009973,0.15170613317569065,0.9095406889915466,0.8736624836921691,0.2967938229441643,0.3804695844650269,0.7668392896652222,8.171087669817485,69.73183840709554,30.963174042382082,2.55650599707933,0.6710887491703034,0.3930662900209427,0.16342655569314957,0.23685149401426314,0.6050164520740509,0.03844723254442215,0.018443777179345488,0.22168777883052826,0.04772160537540913,0.16905990540981292,0.09053223431110383,0.030944522470235825,0.06604347862303257,0.018170042242854834,0.045800302922725675,0.02930495161563158,0.2990188479423523,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5424.0,1705975.0,1380041.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,RALFINAMIDE,CHEMBL2107771,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1",BHJIBOFHEFDSAU-LBPRGKRZSA-N,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O,0.8250455320199923,4.0,302.34900000000005,2.3681,3,2,1,64.35,-3.037582028912313,0.9757533311843872,-4.8171442108555445,0.9999266743659974,-10.061382996913231,0.9494014859199524,0.048252948513254526,0.942760169506073,73.19445571009973,0.15170613317569065,0.9095406889915466,0.8736624836921691,0.2967938229441643,0.3804695844650269,0.7668392896652222,8.171087669817485,69.73183840709554,30.963174042382082,2.55650599707933,0.6710887491703034,0.3930662900209427,0.16342655569314957,0.23685149401426314,0.6050164520740509,0.03844723254442215,0.018443777179345488,0.22168777883052826,0.04772160537540913,0.16905990540981292,0.09053223431110383,0.030944522470235825,0.06604347862303257,0.018170042242854834,0.045800302922725675,0.02930495161563158,0.2990188479423523,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5581.0,1699723.0,390556.0,Glutamate [NMDA] receptor negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,Noncompetitive binding to NMDA glutamate receptors,NMDA subtype non-selective ,,,ESKETAMINE,CHEMBL395091,4.0,1.0,0.0,MOL,60799.0,Small molecule,2019.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,2013.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1",YQEZLKZALYSWHR-ZDUSSCGKSA-N,CN[C@]1(c2ccccc2Cl)CCCCC1=O,0.8571565291687987,4.0,237.7299999999999,2.897800000000001,2,1,1,29.1,-2.354066501961083,0.9576062798500061,-4.33226422012814,0.9999909162521362,-8.800302368095444,0.9814516186714173,0.009707993490155786,0.9816803216934205,49.62899605376505,7.669313771951487,0.10469187945127487,0.25805276185274123,0.008345112495590001,0.02164224279113114,0.19162352234125138,30.240801671120728,98.09205295002796,16.62988139542386,2.6852215459682727,0.3236227102577686,0.08387268632650376,0.05246579758822918,0.12323277741670609,0.01846484448760748,0.007434838451445103,0.005208371207118034,0.05615374818444252,0.009573188424110413,0.02525629960000515,0.017877949588000774,0.003308164654299617,0.005636361846700311,0.008483347110450267,0.03188239112496376,0.007600085763260722,0.7050456881523133,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5581.0,1699723.0,390556.0,Glutamate [NMDA] receptor negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,Noncompetitive binding to NMDA glutamate receptors,NMDA subtype non-selective ,,,ESKETAMINE,CHEMBL395091,4.0,1.0,0.0,MOL,60799.0,Small molecule,2019.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,2013.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1",YQEZLKZALYSWHR-ZDUSSCGKSA-N,CN[C@]1(c2ccccc2Cl)CCCCC1=O,0.8571565291687987,4.0,237.7299999999999,2.897800000000001,2,1,1,29.1,-2.354066501961083,0.9576062798500061,-4.33226422012814,0.9999909162521362,-8.800302368095444,0.9814516186714173,0.009707993490155786,0.9816803216934205,49.62899605376505,7.669313771951487,0.10469187945127487,0.25805276185274123,0.008345112495590001,0.02164224279113114,0.19162352234125138,30.240801671120728,98.09205295002796,16.62988139542386,2.6852215459682727,0.3236227102577686,0.08387268632650376,0.05246579758822918,0.12323277741670609,0.01846484448760748,0.007434838451445103,0.005208371207118034,0.05615374818444252,0.009573188424110413,0.02525629960000515,0.017877949588000774,0.003308164654299617,0.005636361846700311,0.008483347110450267,0.03188239112496376,0.007600085763260722,0.7050456881523133,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5758.0,1879128.0,1540481.0,Glutamate [NMDA] receptor negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,Noncompetitive binding to NMDA glutamate receptors,NMDA subtype non-selective ,,,ESKETAMINE HYDROCHLORIDE,CHEMBL2364609,4.0,1.0,1.0,MOL,60800.0,Small molecule,2019.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,2013.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H/t13-;/m0./s1",VCMGMSHEPQENPE-ZOWNYOTGSA-N,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl,0.8959263775791354,4.0,274.19099999999986,3.3196000000000025,2,1,1,29.1,-2.898104778567951,0.9545115828514099,-4.504799193297829,0.9999647855758667,-8.502131226922675,0.9627122640609741,0.02862548166885972,0.9668491244316101,59.64973359446035,8.303105293251878,0.13179958015680313,0.28683489859104155,0.011215143441222607,0.11230587214231491,0.16348220854997636,36.657062154024686,84.49648453827794,9.727369405156358,2.7701446067334095,0.5349450051784516,0.17761691361665727,0.15915477722883226,0.1280344158411026,0.06069258786737919,0.007577364519238472,0.012863355362787843,0.10000390857458115,0.018842505663633345,0.06313759163022041,0.034963168948888776,0.009163196850568055,0.023039779625833035,0.022658460400998594,0.11443956419825554,0.02726223049685359,0.6981702506542206,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5758.0,1879128.0,1540481.0,Glutamate [NMDA] receptor negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,Noncompetitive binding to NMDA glutamate receptors,NMDA subtype non-selective ,,,ESKETAMINE HYDROCHLORIDE,CHEMBL2364609,4.0,1.0,1.0,MOL,60800.0,Small molecule,2019.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,2013.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H/t13-;/m0./s1",VCMGMSHEPQENPE-ZOWNYOTGSA-N,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl,0.8959263775791354,4.0,274.19099999999986,3.3196000000000025,2,1,1,29.1,-2.898104778567951,0.9545115828514099,-4.504799193297829,0.9999647855758667,-8.502131226922675,0.9627122640609741,0.02862548166885972,0.9668491244316101,59.64973359446035,8.303105293251878,0.13179958015680313,0.28683489859104155,0.011215143441222607,0.11230587214231491,0.16348220854997636,36.657062154024686,84.49648453827794,9.727369405156358,2.7701446067334095,0.5349450051784516,0.17761691361665727,0.15915477722883226,0.1280344158411026,0.06069258786737919,0.007577364519238472,0.012863355362787843,0.10000390857458115,0.018842505663633345,0.06313759163022041,0.034963168948888776,0.009163196850568055,0.023039779625833035,0.022658460400998594,0.11443956419825554,0.02726223049685359,0.6981702506542206,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5829.0,1704507.0,1379068.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NERAMEXANE MESYLATE,CHEMBL2106798,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2003.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C11H23N.CH4O3S/c1-9(2)6-10(3,4)8-11(5,12)7-9;1-5(2,3)4/h6-8,12H2,1-5H3;1H3,(H,2,3,4)",CLUKHUGGXSIGRX-UHFFFAOYSA-N,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O,0.6592102358981662,4.0,265.419,2.4440999999999997,3,2,0,80.39,-0.8040504856917611,0.850065803527832,-4.909861058123013,0.8949044346809387,-6.201418054933624,0.8304765343666076,0.04192626941949129,0.9814623594284058,44.95609189610472,-4.991345305848816,0.000472594951861538,0.028525880724191665,0.0024358279653824864,0.045856905076652764,0.0017158546048449352,66.91733519936388,12.826380940963457,-15.45524196278888,2.65718764730039,0.041313798353075984,0.525148230791092,0.0813202265650034,0.08473675921559334,0.3420404650270939,0.00047037602053023875,3.605430413244903e-05,0.09044565185904503,0.025515830237418415,0.002331190649420023,0.007995525444857775,0.0002757324640697334,4.238046331010992e-05,0.018573648203164338,0.21182848699390888,0.0005793712014565244,0.8414799451828003,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,5829.0,1704507.0,1379068.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NERAMEXANE MESYLATE,CHEMBL2106798,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2003.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C11H23N.CH4O3S/c1-9(2)6-10(3,4)8-11(5,12)7-9;1-5(2,3)4/h6-8,12H2,1-5H3;1H3,(H,2,3,4)",CLUKHUGGXSIGRX-UHFFFAOYSA-N,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O,0.6592102358981662,4.0,265.419,2.4440999999999997,3,2,0,80.39,-0.8040504856917611,0.850065803527832,-4.909861058123013,0.8949044346809387,-6.201418054933624,0.8304765343666076,0.04192626941949129,0.9814623594284058,44.95609189610472,-4.991345305848816,0.000472594951861538,0.028525880724191665,0.0024358279653824864,0.045856905076652764,0.0017158546048449352,66.91733519936388,12.826380940963457,-15.45524196278888,2.65718764730039,0.041313798353075984,0.525148230791092,0.0813202265650034,0.08473675921559334,0.3420404650270939,0.00047037602053023875,3.605430413244903e-05,0.09044565185904503,0.025515830237418415,0.002331190649420023,0.007995525444857775,0.0002757324640697334,4.238046331010992e-05,0.018573648203164338,0.21182848699390888,0.0005793712014565244,0.8414799451828003,False
GRIN2A_NDMAR2A,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,7930.0,1706057.0,497208.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PERZINFOTEL,CHEMBL452461,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2004.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C9H13N2O5P/c12-8-6-7(9(8)13)11(3-1-2-10-6)4-5-17(14,15)16/h10H,1-5H2,(H2,14,15,16)",BDABGOLMYNHHTR-UHFFFAOYSA-N,O=c1c2c(c1=O)N(CCP(=O)(O)O)CCCN2,0.47636582768306873,4.0,260.1859999999999,-0.9177000000000004,5,3,0,106.94000000000001,-2.408706039465393,0.6254654884338379,-5.133865179747001,0.4607235461473465,-12.941872899926128,0.06953086480498313,0.00805813204497099,0.7557980418205261,49.238016500711964,-5.4187685927705305,0.04363078231108375,0.03107965779490769,0.020585424493765457,0.054237474873662,0.001053419586179416,67.04781593088833,39.24825417166166,-4.566961800797197,2.1162979623512777,0.4673450618982315,0.22139762341976166,0.3589044898748398,0.6950579166412354,0.12859241515398026,0.017159148724749683,0.016015750449150802,0.08876883909106255,0.014764615334570408,0.06166260521858931,0.002803916990524158,0.0017701904365821975,0.00796089720679447,0.01396863916888833,0.032927070697769525,0.1677747003734112,0.4603035807609558,False
GRIN3B,104706,PROTEIN COMPLEX GROUP,Glutamate [NMDA] receptor,9606,Homo sapiens,CHEMBL2094124,,0.0,7930.0,1706057.0,497208.0,Glutamate [NMDA] receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PERZINFOTEL,CHEMBL452461,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2004.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C9H13N2O5P/c12-8-6-7(9(8)13)11(3-1-2-10-6)4-5-17(14,15)16/h10H,1-5H2,(H2,14,15,16)",BDABGOLMYNHHTR-UHFFFAOYSA-N,O=c1c2c(c1=O)N(CCP(=O)(O)O)CCCN2,0.47636582768306873,4.0,260.1859999999999,-0.9177000000000004,5,3,0,106.94000000000001,-2.408706039465393,0.6254654884338379,-5.133865179747001,0.4607235461473465,-12.941872899926128,0.06953086480498313,0.00805813204497099,0.7557980418205261,49.238016500711964,-5.4187685927705305,0.04363078231108375,0.03107965779490769,0.020585424493765457,0.054237474873662,0.001053419586179416,67.04781593088833,39.24825417166166,-4.566961800797197,2.1162979623512777,0.4673450618982315,0.22139762341976166,0.3589044898748398,0.6950579166412354,0.12859241515398026,0.017159148724749683,0.016015750449150802,0.08876883909106255,0.014764615334570408,0.06166260521858931,0.002803916990524158,0.0017701904365821975,0.00796089720679447,0.01396863916888833,0.032927070697769525,0.1677747003734112,0.4603035807609558,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,130.0,1343218.0,675130.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LAPATINIB DITOSYLATE,CHEMBL1201179,4.0,1.0,1.0,MOL,,Small molecule,2007.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2003.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H26ClFN4O4S.2C7H8O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10);1H2",XNRVGTHNYCNCFF-UHFFFAOYSA-N,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O,0.06366431755061283,1.0,943.4940000000003,7.797840000000008,12,4,0,246.58999999999997,-2.6577648930522186,0.7935171842575073,-5.500507123846311,0.9575868129730225,-11.621842848541707,0.2568599969148636,0.8885456681251526,0.30723675191402433,101.70129212051658,-4.896485979491663,0.2331158250570297,0.7893726825714111,0.5757785081863404,0.28572099804878237,0.8303400278091431,343.9803593247746,10.04337711109982,20.78804999276643,3.1738519129672045,0.26683092266321184,0.846392548084259,0.371265584230423,0.967200767993927,0.9627904057502746,0.005839665792882443,0.0023277310450794176,0.03085537850856781,0.006978012714534998,0.03916410841047764,0.09251105226576328,0.02853738535195589,0.004186387325171381,0.02774968687444925,0.38625856935977937,0.03756209276616573,0.11610669791698455,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,130.0,1343218.0,675130.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LAPATINIB DITOSYLATE,CHEMBL1201179,4.0,1.0,1.0,MOL,,Small molecule,2007.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2003.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H26ClFN4O4S.2C7H8O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10);1H2",XNRVGTHNYCNCFF-UHFFFAOYSA-N,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O,0.06366431755061283,1.0,943.4940000000003,7.797840000000008,12,4,0,246.58999999999997,-2.6577648930522186,0.7935171842575073,-5.500507123846311,0.9575868129730225,-11.621842848541707,0.2568599969148636,0.8885456681251526,0.30723675191402433,101.70129212051658,-4.896485979491663,0.2331158250570297,0.7893726825714111,0.5757785081863404,0.28572099804878237,0.8303400278091431,343.9803593247746,10.04337711109982,20.78804999276643,3.1738519129672045,0.26683092266321184,0.846392548084259,0.371265584230423,0.967200767993927,0.9627904057502746,0.005839665792882443,0.0023277310450794176,0.03085537850856781,0.006978012714534998,0.03916410841047764,0.09251105226576328,0.02853738535195589,0.004186387325171381,0.02774968687444925,0.38625856935977937,0.03756209276616573,0.11610669791698455,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,245.0,1343218.0,675130.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LAPATINIB DITOSYLATE,CHEMBL1201179,4.0,1.0,1.0,MOL,,Small molecule,2007.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2003.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H26ClFN4O4S.2C7H8O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10);1H2",XNRVGTHNYCNCFF-UHFFFAOYSA-N,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O,0.06366431755061283,1.0,943.4940000000003,7.797840000000008,12,4,0,246.58999999999997,-2.6577648930522186,0.7935171842575073,-5.500507123846311,0.9575868129730225,-11.621842848541707,0.2568599969148636,0.8885456681251526,0.30723675191402433,101.70129212051658,-4.896485979491663,0.2331158250570297,0.7893726825714111,0.5757785081863404,0.28572099804878237,0.8303400278091431,343.9803593247746,10.04337711109982,20.78804999276643,3.1738519129672045,0.26683092266321184,0.846392548084259,0.371265584230423,0.967200767993927,0.9627904057502746,0.005839665792882443,0.0023277310450794176,0.03085537850856781,0.006978012714534998,0.03916410841047764,0.09251105226576328,0.02853738535195589,0.004186387325171381,0.02774968687444925,0.38625856935977937,0.03756209276616573,0.11610669791698455,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,2257.0,1702610.0,1377982.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",,,,AFATINIB DIMALEATE,CHEMBL2105712,4.0,1.0,1.0,MOL,76003.0,Small molecule,2013.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1",USNRYVNRPYXCSP-JUGPPOIOSA-N,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.1460738272078643,1.0,718.0910000000005,3.8134999999999994,11,6,1,237.80999999999997,-3.4646081485946025,0.6873013734817505,-5.77579665076968,0.20398969501256942,-13.287394947354827,0.22882895469665526,0.2029348388314247,0.582102769613266,85.8144522255671,-2.837298063804744,0.030969691649079322,0.11335917934775352,0.08196071274578572,0.1751680627465248,0.2513360008597374,70.55347813683589,-29.117120550986044,6.019863808771751,3.2674323257858675,0.3552269577980042,0.2515325337648392,0.7933817863464355,0.967763340473175,0.45464280247688293,0.028305456228554248,0.017817667312920095,0.07978451177477837,0.05610198192298412,0.039648279920220374,0.05757171213626862,0.09727843962609768,0.11295319497585296,0.11298509947955608,0.07549164406955242,0.2512330062687397,0.2839751482009888,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,2257.0,1702610.0,1377982.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",,,,AFATINIB DIMALEATE,CHEMBL2105712,4.0,1.0,1.0,MOL,76003.0,Small molecule,2013.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1",USNRYVNRPYXCSP-JUGPPOIOSA-N,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.1460738272078643,1.0,718.0910000000005,3.8134999999999994,11,6,1,237.80999999999997,-3.4646081485946025,0.6873013734817505,-5.77579665076968,0.20398969501256942,-13.287394947354827,0.22882895469665526,0.2029348388314247,0.582102769613266,85.8144522255671,-2.837298063804744,0.030969691649079322,0.11335917934775352,0.08196071274578572,0.1751680627465248,0.2513360008597374,70.55347813683589,-29.117120550986044,6.019863808771751,3.2674323257858675,0.3552269577980042,0.2515325337648392,0.7933817863464355,0.967763340473175,0.45464280247688293,0.028305456228554248,0.017817667312920095,0.07978451177477837,0.05610198192298412,0.039648279920220374,0.05757171213626862,0.09727843962609768,0.11295319497585296,0.11298509947955608,0.07549164406955242,0.2512330062687397,0.2839751482009888,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,2234.0,1702610.0,1377982.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",,,,AFATINIB DIMALEATE,CHEMBL2105712,4.0,1.0,1.0,MOL,76003.0,Small molecule,2013.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1",USNRYVNRPYXCSP-JUGPPOIOSA-N,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.1460738272078643,1.0,718.0910000000005,3.8134999999999994,11,6,1,237.80999999999997,-3.4646081485946025,0.6873013734817505,-5.77579665076968,0.20398969501256942,-13.287394947354827,0.22882895469665526,0.2029348388314247,0.582102769613266,85.8144522255671,-2.837298063804744,0.030969691649079322,0.11335917934775352,0.08196071274578572,0.1751680627465248,0.2513360008597374,70.55347813683589,-29.117120550986044,6.019863808771751,3.2674323257858675,0.3552269577980042,0.2515325337648392,0.7933817863464355,0.967763340473175,0.45464280247688293,0.028305456228554248,0.017817667312920095,0.07978451177477837,0.05610198192298412,0.039648279920220374,0.05757171213626862,0.09727843962609768,0.11295319497585296,0.11298509947955608,0.07549164406955242,0.2512330062687397,0.2839751482009888,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,2258.0,1702610.0,1377982.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",,,,AFATINIB DIMALEATE,CHEMBL2105712,4.0,1.0,1.0,MOL,76003.0,Small molecule,2013.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1",USNRYVNRPYXCSP-JUGPPOIOSA-N,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.1460738272078643,1.0,718.0910000000005,3.8134999999999994,11,6,1,237.80999999999997,-3.4646081485946025,0.6873013734817505,-5.77579665076968,0.20398969501256942,-13.287394947354827,0.22882895469665526,0.2029348388314247,0.582102769613266,85.8144522255671,-2.837298063804744,0.030969691649079322,0.11335917934775352,0.08196071274578572,0.1751680627465248,0.2513360008597374,70.55347813683589,-29.117120550986044,6.019863808771751,3.2674323257858675,0.3552269577980042,0.2515325337648392,0.7933817863464355,0.967763340473175,0.45464280247688293,0.028305456228554248,0.017817667312920095,0.07978451177477837,0.05610198192298412,0.039648279920220374,0.05757171213626862,0.09727843962609768,0.11295319497585296,0.11298509947955608,0.07549164406955242,0.2512330062687397,0.2839751482009888,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,2258.0,1702610.0,1377982.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",,,,AFATINIB DIMALEATE,CHEMBL2105712,4.0,1.0,1.0,MOL,76003.0,Small molecule,2013.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1",USNRYVNRPYXCSP-JUGPPOIOSA-N,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,0.1460738272078643,1.0,718.0910000000005,3.8134999999999994,11,6,1,237.80999999999997,-3.4646081485946025,0.6873013734817505,-5.77579665076968,0.20398969501256942,-13.287394947354827,0.22882895469665526,0.2029348388314247,0.582102769613266,85.8144522255671,-2.837298063804744,0.030969691649079322,0.11335917934775352,0.08196071274578572,0.1751680627465248,0.2513360008597374,70.55347813683589,-29.117120550986044,6.019863808771751,3.2674323257858675,0.3552269577980042,0.2515325337648392,0.7933817863464355,0.967763340473175,0.45464280247688293,0.028305456228554248,0.017817667312920095,0.07978451177477837,0.05610198192298412,0.039648279920220374,0.05757171213626862,0.09727843962609768,0.11295319497585296,0.11298509947955608,0.07549164406955242,0.2512330062687397,0.2839751482009888,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4101.0,2473187.0,1060577.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AC-480,CHEMBL1645462,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1",LUJZZYWHBDHDQX-QFIPXVFZSA-N,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,0.2903374856581191,3.0,530.5640000000002,3.8553200000000016,10,3,1,119.63,-3.9240902962646813,0.8764188766479493,-5.284551975852648,0.9983415961265564,-12.379123810338756,0.7354748666286468,0.8714789152145386,0.582548999786377,93.37222232981563,0.8836523590942077,0.0835508679971099,0.43049713373184206,0.4996959090232849,0.15447503179311753,0.9668337941169739,109.01594660400517,39.767299744886216,62.50703682470229,3.3079461189606443,0.43267073631286623,0.24387550950050355,0.7972219228744507,0.9742548823356628,0.9417447447776794,0.020617149770259857,0.00844455393962562,0.07220837697386742,0.013088680431246757,0.2704471945762634,0.18734190762043,0.08489401787519454,0.09062655344605446,0.03203575797379017,0.5299794137477875,0.3534075289964676,0.11191699132323266,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4101.0,2473187.0,1060577.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AC-480,CHEMBL1645462,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1",LUJZZYWHBDHDQX-QFIPXVFZSA-N,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,0.2903374856581191,3.0,530.5640000000002,3.8553200000000016,10,3,1,119.63,-3.9240902962646813,0.8764188766479493,-5.284551975852648,0.9983415961265564,-12.379123810338756,0.7354748666286468,0.8714789152145386,0.582548999786377,93.37222232981563,0.8836523590942077,0.0835508679971099,0.43049713373184206,0.4996959090232849,0.15447503179311753,0.9668337941169739,109.01594660400517,39.767299744886216,62.50703682470229,3.3079461189606443,0.43267073631286623,0.24387550950050355,0.7972219228744507,0.9742548823356628,0.9417447447776794,0.020617149770259857,0.00844455393962562,0.07220837697386742,0.013088680431246757,0.2704471945762634,0.18734190762043,0.08489401787519454,0.09062655344605446,0.03203575797379017,0.5299794137477875,0.3534075289964676,0.11191699132323266,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4100.0,2473187.0,1060577.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AC-480,CHEMBL1645462,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1",LUJZZYWHBDHDQX-QFIPXVFZSA-N,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,0.2903374856581191,3.0,530.5640000000002,3.8553200000000016,10,3,1,119.63,-3.9240902962646813,0.8764188766479493,-5.284551975852648,0.9983415961265564,-12.379123810338756,0.7354748666286468,0.8714789152145386,0.582548999786377,93.37222232981563,0.8836523590942077,0.0835508679971099,0.43049713373184206,0.4996959090232849,0.15447503179311753,0.9668337941169739,109.01594660400517,39.767299744886216,62.50703682470229,3.3079461189606443,0.43267073631286623,0.24387550950050355,0.7972219228744507,0.9742548823356628,0.9417447447776794,0.020617149770259857,0.00844455393962562,0.07220837697386742,0.013088680431246757,0.2704471945762634,0.18734190762043,0.08489401787519454,0.09062655344605446,0.03203575797379017,0.5299794137477875,0.3534075289964676,0.11191699132323266,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,4102.0,2473187.0,1060577.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AC-480,CHEMBL1645462,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1",LUJZZYWHBDHDQX-QFIPXVFZSA-N,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,0.2903374856581191,3.0,530.5640000000002,3.8553200000000016,10,3,1,119.63,-3.9240902962646813,0.8764188766479493,-5.284551975852648,0.9983415961265564,-12.379123810338756,0.7354748666286468,0.8714789152145386,0.582548999786377,93.37222232981563,0.8836523590942077,0.0835508679971099,0.43049713373184206,0.4996959090232849,0.15447503179311753,0.9668337941169739,109.01594660400517,39.767299744886216,62.50703682470229,3.3079461189606443,0.43267073631286623,0.24387550950050355,0.7972219228744507,0.9742548823356628,0.9417447447776794,0.020617149770259857,0.00844455393962562,0.07220837697386742,0.013088680431246757,0.2704471945762634,0.18734190762043,0.08489401787519454,0.09062655344605446,0.03203575797379017,0.5299794137477875,0.3534075289964676,0.11191699132323266,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,4102.0,2473187.0,1060577.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AC-480,CHEMBL1645462,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1",LUJZZYWHBDHDQX-QFIPXVFZSA-N,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,0.2903374856581191,3.0,530.5640000000002,3.8553200000000016,10,3,1,119.63,-3.9240902962646813,0.8764188766479493,-5.284551975852648,0.9983415961265564,-12.379123810338756,0.7354748666286468,0.8714789152145386,0.582548999786377,93.37222232981563,0.8836523590942077,0.0835508679971099,0.43049713373184206,0.4996959090232849,0.15447503179311753,0.9668337941169739,109.01594660400517,39.767299744886216,62.50703682470229,3.3079461189606443,0.43267073631286623,0.24387550950050355,0.7972219228744507,0.9742548823356628,0.9417447447776794,0.020617149770259857,0.00844455393962562,0.07220837697386742,0.013088680431246757,0.2704471945762634,0.18734190762043,0.08489401787519454,0.09062655344605446,0.03203575797379017,0.5299794137477875,0.3534075289964676,0.11191699132323266,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4127.0,2473340.0,1278597.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Irreversible inhibitor, also potent at ERBB4.",,,,ALLITINIB,CHEMBL1947204,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H18ClFN4O2/c1-2-23(31)29-17-6-8-21-19(11-17)24(28-14-27-21)30-18-7-9-22(20(25)12-18)32-13-15-4-3-5-16(26)10-15/h2-12,14H,1,13H2,(H,29,31)(H,27,28,30)",MVZGYPSXNDCANY-UHFFFAOYSA-N,C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,0.3456878585027919,3.0,448.88500000000016,5.869400000000002,5,2,0,76.14,-6.200848361280425,0.8607083797454834,-5.179528779041995,0.9984470248222351,-10.86886120065829,0.7445896863937378,0.9232954263687134,0.5280750870704651,103.1060608595512,6.005135647632356,0.49145392179489134,0.819628632068634,0.6137034177780152,0.4069138944149017,0.8090320467948914,88.08951202150999,49.35921401680371,75.31608273171973,2.9757235503001853,0.4905430495738983,0.425907039642334,0.21843742728233337,0.9744758009910583,0.8268550872802735,0.02183692418038845,0.013977085752412678,0.20620102286338807,0.042261185497045516,0.7945772051811218,0.3821727931499481,0.17778281271457672,0.13369449079036713,0.41807833313941956,0.7228094100952148,0.6069043934345245,0.19959356486797333,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4127.0,2473340.0,1278597.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Irreversible inhibitor, also potent at ERBB4.",,,,ALLITINIB,CHEMBL1947204,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H18ClFN4O2/c1-2-23(31)29-17-6-8-21-19(11-17)24(28-14-27-21)30-18-7-9-22(20(25)12-18)32-13-15-4-3-5-16(26)10-15/h2-12,14H,1,13H2,(H,29,31)(H,27,28,30)",MVZGYPSXNDCANY-UHFFFAOYSA-N,C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,0.3456878585027919,3.0,448.88500000000016,5.869400000000002,5,2,0,76.14,-6.200848361280425,0.8607083797454834,-5.179528779041995,0.9984470248222351,-10.86886120065829,0.7445896863937378,0.9232954263687134,0.5280750870704651,103.1060608595512,6.005135647632356,0.49145392179489134,0.819628632068634,0.6137034177780152,0.4069138944149017,0.8090320467948914,88.08951202150999,49.35921401680371,75.31608273171973,2.9757235503001853,0.4905430495738983,0.425907039642334,0.21843742728233337,0.9744758009910583,0.8268550872802735,0.02183692418038845,0.013977085752412678,0.20620102286338807,0.042261185497045516,0.7945772051811218,0.3821727931499481,0.17778281271457672,0.13369449079036713,0.41807833313941956,0.7228094100952148,0.6069043934345245,0.19959356486797333,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4126.0,2473340.0,1278597.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Irreversible inhibitor, also potent at ERBB4.",,,,ALLITINIB,CHEMBL1947204,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H18ClFN4O2/c1-2-23(31)29-17-6-8-21-19(11-17)24(28-14-27-21)30-18-7-9-22(20(25)12-18)32-13-15-4-3-5-16(26)10-15/h2-12,14H,1,13H2,(H,29,31)(H,27,28,30)",MVZGYPSXNDCANY-UHFFFAOYSA-N,C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,0.3456878585027919,3.0,448.88500000000016,5.869400000000002,5,2,0,76.14,-6.200848361280425,0.8607083797454834,-5.179528779041995,0.9984470248222351,-10.86886120065829,0.7445896863937378,0.9232954263687134,0.5280750870704651,103.1060608595512,6.005135647632356,0.49145392179489134,0.819628632068634,0.6137034177780152,0.4069138944149017,0.8090320467948914,88.08951202150999,49.35921401680371,75.31608273171973,2.9757235503001853,0.4905430495738983,0.425907039642334,0.21843742728233337,0.9744758009910583,0.8268550872802735,0.02183692418038845,0.013977085752412678,0.20620102286338807,0.042261185497045516,0.7945772051811218,0.3821727931499481,0.17778281271457672,0.13369449079036713,0.41807833313941956,0.7228094100952148,0.6069043934345245,0.19959356486797333,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4192.0,2473192.0,508707.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CP-724714,CHEMBL483321,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,1.0,0.0,"InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+",LLVZBTWPGQVVLW-SNAWJCMRSA-N,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,0.3577138134088356,4.0,469.54500000000024,4.953340000000003,7,2,0,98.26,-4.8049528272539614,0.8663997292518616,-5.304604651396159,0.9964864253997803,-11.052607777761958,0.9037712216377258,0.9168960213661194,0.43777236342430115,97.99232009309608,5.600314477102975,0.18775129243731498,0.5388388097286224,0.36550445556640626,0.21147219687700272,0.9168760180473328,52.35227602209684,46.44079834260791,84.59939103206091,2.5812119181112814,0.644665539264679,0.3081332892179489,0.5270214080810547,0.9310279965400696,0.9219839096069335,0.02633806336671114,0.020564633421599865,0.12123448848724365,0.0637255698442459,0.6714002430438996,0.26278495490550996,0.07069450579583644,0.15146210938692092,0.19040289223194123,0.44788446128368375,0.4615611553192139,0.1266188308596611,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4192.0,2473192.0,508707.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CP-724714,CHEMBL483321,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,1.0,0.0,"InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+",LLVZBTWPGQVVLW-SNAWJCMRSA-N,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,0.3577138134088356,4.0,469.54500000000024,4.953340000000003,7,2,0,98.26,-4.8049528272539614,0.8663997292518616,-5.304604651396159,0.9964864253997803,-11.052607777761958,0.9037712216377258,0.9168960213661194,0.43777236342430115,97.99232009309608,5.600314477102975,0.18775129243731498,0.5388388097286224,0.36550445556640626,0.21147219687700272,0.9168760180473328,52.35227602209684,46.44079834260791,84.59939103206091,2.5812119181112814,0.644665539264679,0.3081332892179489,0.5270214080810547,0.9310279965400696,0.9219839096069335,0.02633806336671114,0.020564633421599865,0.12123448848724365,0.0637255698442459,0.6714002430438996,0.26278495490550996,0.07069450579583644,0.15146210938692092,0.19040289223194123,0.44788446128368375,0.4615611553192139,0.1266188308596611,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4199.0,2473346.0,603809.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits class I (HDAC1 HDAC2 HDAC3 HDAC8) and II (HDAC4 HDAC5 HDAC6 HDAC7 HDAC9 HDAC10) HDACs,,,,CUDC-101,CHEMBL598797,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)",PLIVFNIUGLLCEK-UHFFFAOYSA-N,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,0.17974464562721468,4.0,434.4960000000003,4.198000000000002,7,3,0,105.60000000000001,-4.2177528783307165,0.8812687158584595,-5.194611265052698,0.9983315706253052,-8.80410101548701,0.8515429258346557,0.8696079611778259,0.5960484385490418,96.39276020971819,13.159533024318472,0.3979958713054657,0.6476576924324036,0.5385838806629181,0.49547003507614135,0.9665316104888916,33.05143378206116,46.60913266716317,51.00652304022564,2.3477138502096286,0.945091712474823,0.2719400942325592,0.6910449504852295,0.9038543581962586,0.902775502204895,0.059372279047966006,0.020047540590167046,0.2074907273054123,0.12373304292559624,0.7999460577964783,0.2797127187252045,0.04571602344512939,0.34961278438568116,0.07023815885186195,0.489863908290863,0.6460314393043518,0.2724367409944534,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4199.0,2473346.0,603809.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits class I (HDAC1 HDAC2 HDAC3 HDAC8) and II (HDAC4 HDAC5 HDAC6 HDAC7 HDAC9 HDAC10) HDACs,,,,CUDC-101,CHEMBL598797,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)",PLIVFNIUGLLCEK-UHFFFAOYSA-N,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,0.17974464562721468,4.0,434.4960000000003,4.198000000000002,7,3,0,105.60000000000001,-4.2177528783307165,0.8812687158584595,-5.194611265052698,0.9983315706253052,-8.80410101548701,0.8515429258346557,0.8696079611778259,0.5960484385490418,96.39276020971819,13.159533024318472,0.3979958713054657,0.6476576924324036,0.5385838806629181,0.49547003507614135,0.9665316104888916,33.05143378206116,46.60913266716317,51.00652304022564,2.3477138502096286,0.945091712474823,0.2719400942325592,0.6910449504852295,0.9038543581962586,0.902775502204895,0.059372279047966006,0.020047540590167046,0.2074907273054123,0.12373304292559624,0.7999460577964783,0.2797127187252045,0.04571602344512939,0.34961278438568116,0.07023815885186195,0.489863908290863,0.6460314393043518,0.2724367409944534,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4198.0,2473346.0,603809.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits class I (HDAC1 HDAC2 HDAC3 HDAC8) and II (HDAC4 HDAC5 HDAC6 HDAC7 HDAC9 HDAC10) HDACs,,,,CUDC-101,CHEMBL598797,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)",PLIVFNIUGLLCEK-UHFFFAOYSA-N,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,0.17974464562721468,4.0,434.4960000000003,4.198000000000002,7,3,0,105.60000000000001,-4.2177528783307165,0.8812687158584595,-5.194611265052698,0.9983315706253052,-8.80410101548701,0.8515429258346557,0.8696079611778259,0.5960484385490418,96.39276020971819,13.159533024318472,0.3979958713054657,0.6476576924324036,0.5385838806629181,0.49547003507614135,0.9665316104888916,33.05143378206116,46.60913266716317,51.00652304022564,2.3477138502096286,0.945091712474823,0.2719400942325592,0.6910449504852295,0.9038543581962586,0.902775502204895,0.059372279047966006,0.020047540590167046,0.2074907273054123,0.12373304292559624,0.7999460577964783,0.2797127187252045,0.04571602344512939,0.34961278438568116,0.07023815885186195,0.489863908290863,0.6460314393043518,0.2724367409944534,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4248.0,2473117.0,1614941.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted tyrosine kinase inhibitor,,,,JNJ-26483327,CHEMBL3109738,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H25BrN4O2/c1-27-8-4-3-5-9-29-21-11-17-19(12-20(21)28-2)24-14-25-22(17)26-18-10-16(23)7-6-15(18)13-27/h6-7,10-12,14H,3-5,8-9,13H2,1-2H3,(H,24,25,26)",JXDYOSVKVSQGJM-UHFFFAOYSA-N,COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3,0.5463685565178233,3.0,457.37200000000007,5.139000000000005,6,1,0,59.51000000000001,-3.9103181370617066,0.9277292013168335,-4.96229899153685,0.9987923979759217,-9.979411716358598,0.9233416080474853,0.9114869356155395,0.942847490310669,96.48489804478665,16.746284516440973,0.6922012448310852,0.38008747696876527,0.03666579127311707,0.8439538836479187,0.6512124180793762,77.8504620105834,36.947761282886816,56.22152985900841,3.048656777507282,0.5200015425682067,0.23715535998344422,0.5027701288461686,0.8198017835617065,0.9515348076820374,0.02529505342245102,0.015277634840458632,0.09398397877812385,0.020674239099025726,0.7054108023643494,0.23184792399406434,0.017444649385288356,0.08014497719705105,0.1321496494114399,0.30441153347492217,0.2009439915418625,0.2364248067140579,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4248.0,2473117.0,1614941.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted tyrosine kinase inhibitor,,,,JNJ-26483327,CHEMBL3109738,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H25BrN4O2/c1-27-8-4-3-5-9-29-21-11-17-19(12-20(21)28-2)24-14-25-22(17)26-18-10-16(23)7-6-15(18)13-27/h6-7,10-12,14H,3-5,8-9,13H2,1-2H3,(H,24,25,26)",JXDYOSVKVSQGJM-UHFFFAOYSA-N,COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3,0.5463685565178233,3.0,457.37200000000007,5.139000000000005,6,1,0,59.51000000000001,-3.9103181370617066,0.9277292013168335,-4.96229899153685,0.9987923979759217,-9.979411716358598,0.9233416080474853,0.9114869356155395,0.942847490310669,96.48489804478665,16.746284516440973,0.6922012448310852,0.38008747696876527,0.03666579127311707,0.8439538836479187,0.6512124180793762,77.8504620105834,36.947761282886816,56.22152985900841,3.048656777507282,0.5200015425682067,0.23715535998344422,0.5027701288461686,0.8198017835617065,0.9515348076820374,0.02529505342245102,0.015277634840458632,0.09398397877812385,0.020674239099025726,0.7054108023643494,0.23184792399406434,0.017444649385288356,0.08014497719705105,0.1321496494114399,0.30441153347492217,0.2009439915418625,0.2364248067140579,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4240.0,2473117.0,1614941.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted tyrosine kinase inhibitor,,,,JNJ-26483327,CHEMBL3109738,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H25BrN4O2/c1-27-8-4-3-5-9-29-21-11-17-19(12-20(21)28-2)24-14-25-22(17)26-18-10-16(23)7-6-15(18)13-27/h6-7,10-12,14H,3-5,8-9,13H2,1-2H3,(H,24,25,26)",JXDYOSVKVSQGJM-UHFFFAOYSA-N,COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3,0.5463685565178233,3.0,457.37200000000007,5.139000000000005,6,1,0,59.51000000000001,-3.9103181370617066,0.9277292013168335,-4.96229899153685,0.9987923979759217,-9.979411716358598,0.9233416080474853,0.9114869356155395,0.942847490310669,96.48489804478665,16.746284516440973,0.6922012448310852,0.38008747696876527,0.03666579127311707,0.8439538836479187,0.6512124180793762,77.8504620105834,36.947761282886816,56.22152985900841,3.048656777507282,0.5200015425682067,0.23715535998344422,0.5027701288461686,0.8198017835617065,0.9515348076820374,0.02529505342245102,0.015277634840458632,0.09398397877812385,0.020674239099025726,0.7054108023643494,0.23184792399406434,0.017444649385288356,0.08014497719705105,0.1321496494114399,0.30441153347492217,0.2009439915418625,0.2364248067140579,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,4247.0,2473117.0,1614941.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted tyrosine kinase inhibitor,,,,JNJ-26483327,CHEMBL3109738,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H25BrN4O2/c1-27-8-4-3-5-9-29-21-11-17-19(12-20(21)28-2)24-14-25-22(17)26-18-10-16(23)7-6-15(18)13-27/h6-7,10-12,14H,3-5,8-9,13H2,1-2H3,(H,24,25,26)",JXDYOSVKVSQGJM-UHFFFAOYSA-N,COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3,0.5463685565178233,3.0,457.37200000000007,5.139000000000005,6,1,0,59.51000000000001,-3.9103181370617066,0.9277292013168335,-4.96229899153685,0.9987923979759217,-9.979411716358598,0.9233416080474853,0.9114869356155395,0.942847490310669,96.48489804478665,16.746284516440973,0.6922012448310852,0.38008747696876527,0.03666579127311707,0.8439538836479187,0.6512124180793762,77.8504620105834,36.947761282886816,56.22152985900841,3.048656777507282,0.5200015425682067,0.23715535998344422,0.5027701288461686,0.8198017835617065,0.9515348076820374,0.02529505342245102,0.015277634840458632,0.09398397877812385,0.020674239099025726,0.7054108023643494,0.23184792399406434,0.017444649385288356,0.08014497719705105,0.1321496494114399,0.30441153347492217,0.2009439915418625,0.2364248067140579,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,4247.0,2473117.0,1614941.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted tyrosine kinase inhibitor,,,,JNJ-26483327,CHEMBL3109738,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H25BrN4O2/c1-27-8-4-3-5-9-29-21-11-17-19(12-20(21)28-2)24-14-25-22(17)26-18-10-16(23)7-6-15(18)13-27/h6-7,10-12,14H,3-5,8-9,13H2,1-2H3,(H,24,25,26)",JXDYOSVKVSQGJM-UHFFFAOYSA-N,COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3,0.5463685565178233,3.0,457.37200000000007,5.139000000000005,6,1,0,59.51000000000001,-3.9103181370617066,0.9277292013168335,-4.96229899153685,0.9987923979759217,-9.979411716358598,0.9233416080474853,0.9114869356155395,0.942847490310669,96.48489804478665,16.746284516440973,0.6922012448310852,0.38008747696876527,0.03666579127311707,0.8439538836479187,0.6512124180793762,77.8504620105834,36.947761282886816,56.22152985900841,3.048656777507282,0.5200015425682067,0.23715535998344422,0.5027701288461686,0.8198017835617065,0.9515348076820374,0.02529505342245102,0.015277634840458632,0.09398397877812385,0.020674239099025726,0.7054108023643494,0.23184792399406434,0.017444649385288356,0.08014497719705105,0.1321496494114399,0.30441153347492217,0.2009439915418625,0.2364248067140579,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4289.0,2472853.0,2739455.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MP-412,CHEMBL5095024,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H28ClFN6O.2C7H8O3S/c1-5-24(36)33-23-15-18(8-9-27(2,3)35-12-10-34(4)11-13-35)14-22-25(23)26(31-17-30-22)32-19-6-7-21(29)20(28)16-19;2*1-6-2-4-7(5-3-6)11(8,9)10/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32);2*2-5H,1H3,(H,8,9,10)",BRZCZOWSDKKGGK-UHFFFAOYSA-N,C=CC(=O)Nc1cc(C#CC(C)(C)N2CCN(C)CC2)cc2ncnc(Nc3ccc(F)c(Cl)c3)c12.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1,0.07387881696985779,2.0,851.4230000000003,7.151340000000007,10,4,0,182.13,-2.979021242653711,0.7699430465698243,-5.095620427320246,0.9012055277824402,-12.22518862510169,0.6826637625694275,0.8701944828033448,0.42331303656101227,99.60617832666806,0.8205313447093279,0.041337162256240845,0.6732084512710571,0.35604832172393797,0.25622874349355695,0.6292941510677338,310.59284076617695,-22.46686585602511,16.83844744654816,2.7813177121029713,0.3834349557757378,0.8744351029396057,0.7608696162700653,0.9648195147514343,0.8779048204421998,0.0070680157281458374,0.0022054033703170716,0.03835538066923618,0.010846508154645561,0.03900435445830226,0.0673740714788437,0.01957741640508175,0.011022491194307805,0.024491031281650068,0.3500930517911911,0.06029473282396793,0.21303797960281373,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4289.0,2472853.0,2739455.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MP-412,CHEMBL5095024,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H28ClFN6O.2C7H8O3S/c1-5-24(36)33-23-15-18(8-9-27(2,3)35-12-10-34(4)11-13-35)14-22-25(23)26(31-17-30-22)32-19-6-7-21(29)20(28)16-19;2*1-6-2-4-7(5-3-6)11(8,9)10/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32);2*2-5H,1H3,(H,8,9,10)",BRZCZOWSDKKGGK-UHFFFAOYSA-N,C=CC(=O)Nc1cc(C#CC(C)(C)N2CCN(C)CC2)cc2ncnc(Nc3ccc(F)c(Cl)c3)c12.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1,0.07387881696985779,2.0,851.4230000000003,7.151340000000007,10,4,0,182.13,-2.979021242653711,0.7699430465698243,-5.095620427320246,0.9012055277824402,-12.22518862510169,0.6826637625694275,0.8701944828033448,0.42331303656101227,99.60617832666806,0.8205313447093279,0.041337162256240845,0.6732084512710571,0.35604832172393797,0.25622874349355695,0.6292941510677338,310.59284076617695,-22.46686585602511,16.83844744654816,2.7813177121029713,0.3834349557757378,0.8744351029396057,0.7608696162700653,0.9648195147514343,0.8779048204421998,0.0070680157281458374,0.0022054033703170716,0.03835538066923618,0.010846508154645561,0.03900435445830226,0.0673740714788437,0.01957741640508175,0.011022491194307805,0.024491031281650068,0.3500930517911911,0.06029473282396793,0.21303797960281373,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4288.0,2472853.0,2739455.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MP-412,CHEMBL5095024,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H28ClFN6O.2C7H8O3S/c1-5-24(36)33-23-15-18(8-9-27(2,3)35-12-10-34(4)11-13-35)14-22-25(23)26(31-17-30-22)32-19-6-7-21(29)20(28)16-19;2*1-6-2-4-7(5-3-6)11(8,9)10/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32);2*2-5H,1H3,(H,8,9,10)",BRZCZOWSDKKGGK-UHFFFAOYSA-N,C=CC(=O)Nc1cc(C#CC(C)(C)N2CCN(C)CC2)cc2ncnc(Nc3ccc(F)c(Cl)c3)c12.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1,0.07387881696985779,2.0,851.4230000000003,7.151340000000007,10,4,0,182.13,-2.979021242653711,0.7699430465698243,-5.095620427320246,0.9012055277824402,-12.22518862510169,0.6826637625694275,0.8701944828033448,0.42331303656101227,99.60617832666806,0.8205313447093279,0.041337162256240845,0.6732084512710571,0.35604832172393797,0.25622874349355695,0.6292941510677338,310.59284076617695,-22.46686585602511,16.83844744654816,2.7813177121029713,0.3834349557757378,0.8744351029396057,0.7608696162700653,0.9648195147514343,0.8779048204421998,0.0070680157281458374,0.0022054033703170716,0.03835538066923618,0.010846508154645561,0.03900435445830226,0.0673740714788437,0.01957741640508175,0.011022491194307805,0.024491031281650068,0.3500930517911911,0.06029473282396793,0.21303797960281373,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4298.0,2473687.0,2197739.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TUCATINIB,CHEMBL3989868,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2016.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H24N8O2/c1-16-10-17(5-7-22(16)36-19-8-9-34-23(12-19)28-15-30-34)31-24-20-11-18(4-6-21(20)27-14-29-24)32-25-33-26(2,3)13-35-25/h4-12,14-15H,13H2,1-3H3,(H,32,33)(H,27,29,31)",SDEAXTCZPQIFQM-UHFFFAOYSA-N,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,0.3577237568173836,3.0,480.53200000000027,5.093520000000003,10,2,0,110.85000000000001,-4.6616118517346035,0.9379123568534851,-5.94565108845696,0.9957731246948243,-10.322933989707156,0.8072295308113098,0.9028281450271607,0.3541924387216568,98.74297884587284,3.224591266017788,0.17773346453905106,0.4076459020376205,0.45038671493530275,0.10002977028489113,0.648375517129898,54.88310287846421,-6.631961066482781,32.45273115979318,2.9164321368620594,0.23692997992038728,0.4403333365917206,0.49256324768066406,0.9488141417503357,0.9047624468803406,0.016613446082919835,0.009788474766537547,0.09540188089013099,0.028262982796877622,0.3648769408464432,0.31379284858703616,0.07471642829477787,0.16945675164461135,0.11160245835781098,0.6678526878356934,0.3015624314546585,0.10677320957183838,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4298.0,2473687.0,2197739.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TUCATINIB,CHEMBL3989868,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2016.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H24N8O2/c1-16-10-17(5-7-22(16)36-19-8-9-34-23(12-19)28-15-30-34)31-24-20-11-18(4-6-21(20)27-14-29-24)32-25-33-26(2,3)13-35-25/h4-12,14-15H,13H2,1-3H3,(H,32,33)(H,27,29,31)",SDEAXTCZPQIFQM-UHFFFAOYSA-N,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,0.3577237568173836,3.0,480.53200000000027,5.093520000000003,10,2,0,110.85000000000001,-4.6616118517346035,0.9379123568534851,-5.94565108845696,0.9957731246948243,-10.322933989707156,0.8072295308113098,0.9028281450271607,0.3541924387216568,98.74297884587284,3.224591266017788,0.17773346453905106,0.4076459020376205,0.45038671493530275,0.10002977028489113,0.648375517129898,54.88310287846421,-6.631961066482781,32.45273115979318,2.9164321368620594,0.23692997992038728,0.4403333365917206,0.49256324768066406,0.9488141417503357,0.9047624468803406,0.016613446082919835,0.009788474766537547,0.09540188089013099,0.028262982796877622,0.3648769408464432,0.31379284858703616,0.07471642829477787,0.16945675164461135,0.11160245835781098,0.6678526878356934,0.3015624314546585,0.10677320957183838,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4384.0,1700675.0,1037718.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MUBRITINIB,CHEMBL1614707,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2003.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+",ZTFBIUXIQYRUNT-MDWZMJQESA-N,FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1,0.26491022028969163,3.0,468.47900000000027,6.057200000000006,6,0,0,65.97,-6.626898432591313,0.8679233312606811,-5.158895298045976,0.9997224926948547,-5.1190684432125675,0.8239009380340576,0.9844029545783997,0.6872013449668884,108.2104453193469,2.1264291149251253,0.3057735025882721,0.9082857847213746,0.7986511945724487,0.23050941824913024,0.9002492308616639,-59.264495113161296,41.00706349359994,49.84769503067177,2.687914407371031,0.5703423082828522,0.5410326182842254,0.3024874359369278,0.8567929267883301,0.8820114374160767,0.016293339990079404,0.00521008986979723,0.17670379877090453,0.05615959316492081,0.14564768671989442,0.5075751960277557,0.1257233016192913,0.03614363148808479,0.1944805771112442,0.545366370677948,0.14822586327791215,0.2700046420097351,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4384.0,1700675.0,1037718.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MUBRITINIB,CHEMBL1614707,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2003.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+",ZTFBIUXIQYRUNT-MDWZMJQESA-N,FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1,0.26491022028969163,3.0,468.47900000000027,6.057200000000006,6,0,0,65.97,-6.626898432591313,0.8679233312606811,-5.158895298045976,0.9997224926948547,-5.1190684432125675,0.8239009380340576,0.9844029545783997,0.6872013449668884,108.2104453193469,2.1264291149251253,0.3057735025882721,0.9082857847213746,0.7986511945724487,0.23050941824913024,0.9002492308616639,-59.264495113161296,41.00706349359994,49.84769503067177,2.687914407371031,0.5703423082828522,0.5410326182842254,0.3024874359369278,0.8567929267883301,0.8820114374160767,0.016293339990079404,0.00521008986979723,0.17670379877090453,0.05615959316492081,0.14564768671989442,0.5075751960277557,0.1257233016192913,0.03614363148808479,0.1944805771112442,0.545366370677948,0.14822586327791215,0.2700046420097351,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4385.0,2472714.0,1037736.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TAK-285,CHEMBL1614725,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34)",ZYQXEVJIFYIBHZ-UHFFFAOYSA-N,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,0.24050202338361493,2.0,547.9650000000001,5.916600000000003,7,3,0,101.30000000000001,-5.68014977944126,0.800728714466095,-5.195037177251411,0.9995815515518188,-11.163632444635383,0.8322195768356323,0.9468557238578796,0.6657377362251282,98.09812252715253,8.958208002631826,0.4208328783512115,0.9519346356391907,0.8836569786071777,0.6029432952404022,0.9708966851234436,108.19805644604132,15.4727249215244,75.89534460890707,3.6048051769986116,0.19630944430828096,0.3530331403017044,0.29495634138584137,0.8667697310447693,0.9265655875205994,0.011834725551307202,0.0063984215259552,0.09433781206607819,0.02044027540832758,0.3129007965326309,0.5301023006439209,0.12063389420509338,0.019876637030392885,0.11149291545152665,0.8763871431350708,0.3555305749177933,0.09101400300860404,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4385.0,2472714.0,1037736.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TAK-285,CHEMBL1614725,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34)",ZYQXEVJIFYIBHZ-UHFFFAOYSA-N,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,0.24050202338361493,2.0,547.9650000000001,5.916600000000003,7,3,0,101.30000000000001,-5.68014977944126,0.800728714466095,-5.195037177251411,0.9995815515518188,-11.163632444635383,0.8322195768356323,0.9468557238578796,0.6657377362251282,98.09812252715253,8.958208002631826,0.4208328783512115,0.9519346356391907,0.8836569786071777,0.6029432952404022,0.9708966851234436,108.19805644604132,15.4727249215244,75.89534460890707,3.6048051769986116,0.19630944430828096,0.3530331403017044,0.29495634138584137,0.8667697310447693,0.9265655875205994,0.011834725551307202,0.0063984215259552,0.09433781206607819,0.02044027540832758,0.3129007965326309,0.5301023006439209,0.12063389420509338,0.019876637030392885,0.11149291545152665,0.8763871431350708,0.3555305749177933,0.09101400300860404,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4386.0,2472714.0,1037736.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TAK-285,CHEMBL1614725,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34)",ZYQXEVJIFYIBHZ-UHFFFAOYSA-N,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,0.24050202338361493,2.0,547.9650000000001,5.916600000000003,7,3,0,101.30000000000001,-5.68014977944126,0.800728714466095,-5.195037177251411,0.9995815515518188,-11.163632444635383,0.8322195768356323,0.9468557238578796,0.6657377362251282,98.09812252715253,8.958208002631826,0.4208328783512115,0.9519346356391907,0.8836569786071777,0.6029432952404022,0.9708966851234436,108.19805644604132,15.4727249215244,75.89534460890707,3.6048051769986116,0.19630944430828096,0.3530331403017044,0.29495634138584137,0.8667697310447693,0.9265655875205994,0.011834725551307202,0.0063984215259552,0.09433781206607819,0.02044027540832758,0.3129007965326309,0.5301023006439209,0.12063389420509338,0.019876637030392885,0.11149291545152665,0.8763871431350708,0.3555305749177933,0.09101400300860404,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4526.0,2472761.0,1980188.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PYROTINIB,CHEMBL3647420,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C32H31ClN6O3/c1-3-41-30-17-27-25(16-28(30)38-31(40)12-10-24-8-6-14-39(24)2)32(21(18-34)19-36-27)37-22-9-11-29(26(33)15-22)42-20-23-7-4-5-13-35-23/h4-5,7,9-13,15-17,19,24H,3,6,8,14,20H2,1-2H3,(H,36,37)(H,38,40)/b12-10+/t24-/m1/s1",SADXACCFNXBCFY-IYNHSRRRSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,0.20471883444235622,2.0,583.0919999999999,6.465080000000006,8,2,1,112.39999999999999,-6.199902164152467,0.8211604237556458,-5.3168014420607035,0.9889735341072082,-12.097603410874713,0.7895444154739379,0.9592060089111328,0.3206149980425835,100.47161000734374,10.742493794381097,0.05226668566465378,0.4110558271408081,0.3519993707537651,0.08774603605270385,0.8085314273834229,128.64144571360782,51.72634777951788,61.25867011733783,3.619448775082822,0.4439257025718689,0.352640300989151,0.6135437488555908,0.9595775842666626,0.8901856660842895,0.00918978308327496,0.013416031189262868,0.044937624037265776,0.030163946747779845,0.5068857848644257,0.21180552542209624,0.06320259682834148,0.08121216744184494,0.21253320425748826,0.6220082640647888,0.6399611473083496,0.1965017646551132,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4526.0,2472761.0,1980188.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PYROTINIB,CHEMBL3647420,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C32H31ClN6O3/c1-3-41-30-17-27-25(16-28(30)38-31(40)12-10-24-8-6-14-39(24)2)32(21(18-34)19-36-27)37-22-9-11-29(26(33)15-22)42-20-23-7-4-5-13-35-23/h4-5,7,9-13,15-17,19,24H,3,6,8,14,20H2,1-2H3,(H,36,37)(H,38,40)/b12-10+/t24-/m1/s1",SADXACCFNXBCFY-IYNHSRRRSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,0.20471883444235622,2.0,583.0919999999999,6.465080000000006,8,2,1,112.39999999999999,-6.199902164152467,0.8211604237556458,-5.3168014420607035,0.9889735341072082,-12.097603410874713,0.7895444154739379,0.9592060089111328,0.3206149980425835,100.47161000734374,10.742493794381097,0.05226668566465378,0.4110558271408081,0.3519993707537651,0.08774603605270385,0.8085314273834229,128.64144571360782,51.72634777951788,61.25867011733783,3.619448775082822,0.4439257025718689,0.352640300989151,0.6135437488555908,0.9595775842666626,0.8901856660842895,0.00918978308327496,0.013416031189262868,0.044937624037265776,0.030163946747779845,0.5068857848644257,0.21180552542209624,0.06320259682834148,0.08121216744184494,0.21253320425748826,0.6220082640647888,0.6399611473083496,0.1965017646551132,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4525.0,2472761.0,1980188.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PYROTINIB,CHEMBL3647420,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C32H31ClN6O3/c1-3-41-30-17-27-25(16-28(30)38-31(40)12-10-24-8-6-14-39(24)2)32(21(18-34)19-36-27)37-22-9-11-29(26(33)15-22)42-20-23-7-4-5-13-35-23/h4-5,7,9-13,15-17,19,24H,3,6,8,14,20H2,1-2H3,(H,36,37)(H,38,40)/b12-10+/t24-/m1/s1",SADXACCFNXBCFY-IYNHSRRRSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,0.20471883444235622,2.0,583.0919999999999,6.465080000000006,8,2,1,112.39999999999999,-6.199902164152467,0.8211604237556458,-5.3168014420607035,0.9889735341072082,-12.097603410874713,0.7895444154739379,0.9592060089111328,0.3206149980425835,100.47161000734374,10.742493794381097,0.05226668566465378,0.4110558271408081,0.3519993707537651,0.08774603605270385,0.8085314273834229,128.64144571360782,51.72634777951788,61.25867011733783,3.619448775082822,0.4439257025718689,0.352640300989151,0.6135437488555908,0.9595775842666626,0.8901856660842895,0.00918978308327496,0.013416031189262868,0.044937624037265776,0.030163946747779845,0.5068857848644257,0.21180552542209624,0.06320259682834148,0.08121216744184494,0.21253320425748826,0.6220082640647888,0.6399611473083496,0.1965017646551132,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4612.0,2473287.0,586744.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Also potent inhibitor of SRC, ABL1 and CSF1R",,,,AEE-788,CHEMBL587723,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1",OONFNUWBHFSNBT-HXUWFJFHSA-N,CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,0.42645644344301753,4.0,440.59500000000014,4.935500000000003,5,2,1,60.08,-3.859551088065382,0.7717283487319946,-5.299122570264883,0.9907096743583679,-10.644638771471078,0.8170791864395142,0.6272636592388153,0.879183030128479,99.13800968452585,17.086506955208534,0.45604549050331117,0.1658889427781105,0.0552290678024292,0.6904362380504608,0.44709081053733823,38.14875488121148,26.063916559901912,27.96310179162024,2.789083073849769,0.29661881029605863,0.2610079273581505,0.7746258854866028,0.6693054080009461,0.9875428795814514,0.012211243715137243,0.006617844384163618,0.0450500562787056,0.016768667055293916,0.2664449721574783,0.08723194524645805,0.0028181878093164413,0.008068893058225512,0.02681506788358092,0.1174598716199398,0.037893787026405334,0.4720544844865799,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4612.0,2473287.0,586744.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Also potent inhibitor of SRC, ABL1 and CSF1R",,,,AEE-788,CHEMBL587723,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1",OONFNUWBHFSNBT-HXUWFJFHSA-N,CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,0.42645644344301753,4.0,440.59500000000014,4.935500000000003,5,2,1,60.08,-3.859551088065382,0.7717283487319946,-5.299122570264883,0.9907096743583679,-10.644638771471078,0.8170791864395142,0.6272636592388153,0.879183030128479,99.13800968452585,17.086506955208534,0.45604549050331117,0.1658889427781105,0.0552290678024292,0.6904362380504608,0.44709081053733823,38.14875488121148,26.063916559901912,27.96310179162024,2.789083073849769,0.29661881029605863,0.2610079273581505,0.7746258854866028,0.6693054080009461,0.9875428795814514,0.012211243715137243,0.006617844384163618,0.0450500562787056,0.016768667055293916,0.2664449721574783,0.08723194524645805,0.0028181878093164413,0.008068893058225512,0.02681506788358092,0.1174598716199398,0.037893787026405334,0.4720544844865799,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4611.0,2473287.0,586744.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Also potent inhibitor of SRC, ABL1 and CSF1R",,,,AEE-788,CHEMBL587723,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1",OONFNUWBHFSNBT-HXUWFJFHSA-N,CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,0.42645644344301753,4.0,440.59500000000014,4.935500000000003,5,2,1,60.08,-3.859551088065382,0.7717283487319946,-5.299122570264883,0.9907096743583679,-10.644638771471078,0.8170791864395142,0.6272636592388153,0.879183030128479,99.13800968452585,17.086506955208534,0.45604549050331117,0.1658889427781105,0.0552290678024292,0.6904362380504608,0.44709081053733823,38.14875488121148,26.063916559901912,27.96310179162024,2.789083073849769,0.29661881029605863,0.2610079273581505,0.7746258854866028,0.6693054080009461,0.9875428795814514,0.012211243715137243,0.006617844384163618,0.0450500562787056,0.016768667055293916,0.2664449721574783,0.08723194524645805,0.0028181878093164413,0.008068893058225512,0.02681506788358092,0.1174598716199398,0.037893787026405334,0.4720544844865799,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4626.0,1699831.0,1376112.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Also ERBB4 inhibitor,,,,VARLITINIB,CHEMBL2103842,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1",UWXSAYUXVSFDBQ-CYBMUJFWSA-N,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,0.4005119676234953,3.0,466.9540000000002,5.2489000000000035,9,2,1,93.55,-3.831864376159565,0.9232767820358276,-5.59220861863267,0.9983537554740906,-11.423111570222709,0.7044335722923278,0.8688473224639892,0.4500856876373291,101.23704907687059,0.9991860764861199,0.7631868600845337,0.767482578754425,0.5515708506107331,0.3693226456642151,0.8407234072685241,23.60377160892552,9.062893450496754,22.681562210210252,2.7228592229545017,0.4583928346633911,0.3507047325372696,0.30008237063884735,0.9544423699378968,0.8401914000511169,0.015435636974871159,0.007307867845520377,0.1443343698978424,0.030559620819985867,0.6631031632423401,0.3815334618091583,0.11965773925185204,0.1764826089143753,0.2983604371547699,0.609471595287323,0.32122539579868314,0.2381767600774765,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4626.0,1699831.0,1376112.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Also ERBB4 inhibitor,,,,VARLITINIB,CHEMBL2103842,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1",UWXSAYUXVSFDBQ-CYBMUJFWSA-N,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,0.4005119676234953,3.0,466.9540000000002,5.2489000000000035,9,2,1,93.55,-3.831864376159565,0.9232767820358276,-5.59220861863267,0.9983537554740906,-11.423111570222709,0.7044335722923278,0.8688473224639892,0.4500856876373291,101.23704907687059,0.9991860764861199,0.7631868600845337,0.767482578754425,0.5515708506107331,0.3693226456642151,0.8407234072685241,23.60377160892552,9.062893450496754,22.681562210210252,2.7228592229545017,0.4583928346633911,0.3507047325372696,0.30008237063884735,0.9544423699378968,0.8401914000511169,0.015435636974871159,0.007307867845520377,0.1443343698978424,0.030559620819985867,0.6631031632423401,0.3815334618091583,0.11965773925185204,0.1764826089143753,0.2983604371547699,0.609471595287323,0.32122539579868314,0.2381767600774765,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4625.0,1699831.0,1376112.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Also ERBB4 inhibitor,,,,VARLITINIB,CHEMBL2103842,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1",UWXSAYUXVSFDBQ-CYBMUJFWSA-N,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,0.4005119676234953,3.0,466.9540000000002,5.2489000000000035,9,2,1,93.55,-3.831864376159565,0.9232767820358276,-5.59220861863267,0.9983537554740906,-11.423111570222709,0.7044335722923278,0.8688473224639892,0.4500856876373291,101.23704907687059,0.9991860764861199,0.7631868600845337,0.767482578754425,0.5515708506107331,0.3693226456642151,0.8407234072685241,23.60377160892552,9.062893450496754,22.681562210210252,2.7228592229545017,0.4583928346633911,0.3507047325372696,0.30008237063884735,0.9544423699378968,0.8401914000511169,0.015435636974871159,0.007307867845520377,0.1443343698978424,0.030559620819985867,0.6631031632423401,0.3815334618091583,0.11965773925185204,0.1764826089143753,0.2983604371547699,0.609471595287323,0.32122539579868314,0.2381767600774765,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4649.0,2473015.0,1572454.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SAPITINIB,CHEMBL2408045,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)",DFJSJLGUIXFDJP-UHFFFAOYSA-N,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,0.5397024631329128,4.0,473.9360000000002,3.763700000000002,7,2,0,88.61000000000001,-3.822063371506469,0.8792634963989258,-4.965030360039277,0.9997797727584838,-11.932059981343482,0.9612398862838745,0.7121590971946716,0.9207665920257568,94.09143017687043,10.797052675894522,0.24971559643745422,0.6113375365734101,0.3594989776611328,0.3098386347293854,0.9208013772964477,69.41712386126929,25.878571461887127,37.995315024493756,2.8298370116891975,0.1929979607462883,0.09378428310155869,0.7208790183067322,0.9160525918006897,0.8901334524154663,0.0074649501591920854,0.006566607020795345,0.055310961604118344,0.013853453705087304,0.5032706320285797,0.0914988748729229,0.023973126150667667,0.04446880966424942,0.026441491767764093,0.08030497655272484,0.1056297093629837,0.10710854157805443,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4649.0,2473015.0,1572454.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SAPITINIB,CHEMBL2408045,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)",DFJSJLGUIXFDJP-UHFFFAOYSA-N,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,0.5397024631329128,4.0,473.9360000000002,3.763700000000002,7,2,0,88.61000000000001,-3.822063371506469,0.8792634963989258,-4.965030360039277,0.9997797727584838,-11.932059981343482,0.9612398862838745,0.7121590971946716,0.9207665920257568,94.09143017687043,10.797052675894522,0.24971559643745422,0.6113375365734101,0.3594989776611328,0.3098386347293854,0.9208013772964477,69.41712386126929,25.878571461887127,37.995315024493756,2.8298370116891975,0.1929979607462883,0.09378428310155869,0.7208790183067322,0.9160525918006897,0.8901334524154663,0.0074649501591920854,0.006566607020795345,0.055310961604118344,0.013853453705087304,0.5032706320285797,0.0914988748729229,0.023973126150667667,0.04446880966424942,0.026441491767764093,0.08030497655272484,0.1056297093629837,0.10710854157805443,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4651.0,2473015.0,1572454.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SAPITINIB,CHEMBL2408045,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)",DFJSJLGUIXFDJP-UHFFFAOYSA-N,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,0.5397024631329128,4.0,473.9360000000002,3.763700000000002,7,2,0,88.61000000000001,-3.822063371506469,0.8792634963989258,-4.965030360039277,0.9997797727584838,-11.932059981343482,0.9612398862838745,0.7121590971946716,0.9207665920257568,94.09143017687043,10.797052675894522,0.24971559643745422,0.6113375365734101,0.3594989776611328,0.3098386347293854,0.9208013772964477,69.41712386126929,25.878571461887127,37.995315024493756,2.8298370116891975,0.1929979607462883,0.09378428310155869,0.7208790183067322,0.9160525918006897,0.8901334524154663,0.0074649501591920854,0.006566607020795345,0.055310961604118344,0.013853453705087304,0.5032706320285797,0.0914988748729229,0.023973126150667667,0.04446880966424942,0.026441491767764093,0.08030497655272484,0.1056297093629837,0.10710854157805443,False
EGFR,102678,SINGLE PROTEIN,Receptor tyrosine-protein kinase erbB-3,9606,Homo sapiens,CHEMBL5838,,0.0,4650.0,2473015.0,1572454.0,Receptor tyrosine-protein kinase erbB-3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SAPITINIB,CHEMBL2408045,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)",DFJSJLGUIXFDJP-UHFFFAOYSA-N,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,0.5397024631329128,4.0,473.9360000000002,3.763700000000002,7,2,0,88.61000000000001,-3.822063371506469,0.8792634963989258,-4.965030360039277,0.9997797727584838,-11.932059981343482,0.9612398862838745,0.7121590971946716,0.9207665920257568,94.09143017687043,10.797052675894522,0.24971559643745422,0.6113375365734101,0.3594989776611328,0.3098386347293854,0.9208013772964477,69.41712386126929,25.878571461887127,37.995315024493756,2.8298370116891975,0.1929979607462883,0.09378428310155869,0.7208790183067322,0.9160525918006897,0.8901334524154663,0.0074649501591920854,0.006566607020795345,0.055310961604118344,0.013853453705087304,0.5032706320285797,0.0914988748729229,0.023973126150667667,0.04446880966424942,0.026441491767764093,0.08030497655272484,0.1056297093629837,0.10710854157805443,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4670.0,2473712.0,1927245.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BMS-690514,CHEMBL3545396,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1",CSGQVNMSRKWUSH-IAGOWNOFSA-N,COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,0.6252632540499533,4.0,368.44100000000014,1.3753999999999997,8,3,2,100.94000000000001,-2.224417177243242,0.853691828250885,-5.395450639814288,0.9995995759963989,-14.5569928478561,0.6156546950340271,0.1356496013700962,0.8274991750717163,69.03664667967118,7.524551972381344,0.06774171851575375,0.0339232075959444,0.009296270785853267,0.40232146382331846,0.15683932602405548,11.66290261993355,-1.1597707937009745,0.42062421443073317,2.5443375088554574,0.2084345042705536,0.05970349572598934,0.7940829038619995,0.2895964875817299,0.9248620629310608,0.03012628946453333,0.008501536538824439,0.06556985676288604,0.005427580326795578,0.43253410458564756,0.034723876789212224,0.00024174443096853794,0.00845869854092598,0.0030618879245594144,0.00824685781262815,0.011915132217109204,0.1335103318095207,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4670.0,2473712.0,1927245.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BMS-690514,CHEMBL3545396,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1",CSGQVNMSRKWUSH-IAGOWNOFSA-N,COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,0.6252632540499533,4.0,368.44100000000014,1.3753999999999997,8,3,2,100.94000000000001,-2.224417177243242,0.853691828250885,-5.395450639814288,0.9995995759963989,-14.5569928478561,0.6156546950340271,0.1356496013700962,0.8274991750717163,69.03664667967118,7.524551972381344,0.06774171851575375,0.0339232075959444,0.009296270785853267,0.40232146382331846,0.15683932602405548,11.66290261993355,-1.1597707937009745,0.42062421443073317,2.5443375088554574,0.2084345042705536,0.05970349572598934,0.7940829038619995,0.2895964875817299,0.9248620629310608,0.03012628946453333,0.008501536538824439,0.06556985676288604,0.005427580326795578,0.43253410458564756,0.034723876789212224,0.00024174443096853794,0.00845869854092598,0.0030618879245594144,0.00824685781262815,0.011915132217109204,0.1335103318095207,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4671.0,2473712.0,1927245.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BMS-690514,CHEMBL3545396,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1",CSGQVNMSRKWUSH-IAGOWNOFSA-N,COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,0.6252632540499533,4.0,368.44100000000014,1.3753999999999997,8,3,2,100.94000000000001,-2.224417177243242,0.853691828250885,-5.395450639814288,0.9995995759963989,-14.5569928478561,0.6156546950340271,0.1356496013700962,0.8274991750717163,69.03664667967118,7.524551972381344,0.06774171851575375,0.0339232075959444,0.009296270785853267,0.40232146382331846,0.15683932602405548,11.66290261993355,-1.1597707937009745,0.42062421443073317,2.5443375088554574,0.2084345042705536,0.05970349572598934,0.7940829038619995,0.2895964875817299,0.9248620629310608,0.03012628946453333,0.008501536538824439,0.06556985676288604,0.005427580326795578,0.43253410458564756,0.034723876789212224,0.00024174443096853794,0.00845869854092598,0.0030618879245594144,0.00824685781262815,0.011915132217109204,0.1335103318095207,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,4673.0,2473712.0,1927245.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BMS-690514,CHEMBL3545396,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1",CSGQVNMSRKWUSH-IAGOWNOFSA-N,COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,0.6252632540499533,4.0,368.44100000000014,1.3753999999999997,8,3,2,100.94000000000001,-2.224417177243242,0.853691828250885,-5.395450639814288,0.9995995759963989,-14.5569928478561,0.6156546950340271,0.1356496013700962,0.8274991750717163,69.03664667967118,7.524551972381344,0.06774171851575375,0.0339232075959444,0.009296270785853267,0.40232146382331846,0.15683932602405548,11.66290261993355,-1.1597707937009745,0.42062421443073317,2.5443375088554574,0.2084345042705536,0.05970349572598934,0.7940829038619995,0.2895964875817299,0.9248620629310608,0.03012628946453333,0.008501536538824439,0.06556985676288604,0.005427580326795578,0.43253410458564756,0.034723876789212224,0.00024174443096853794,0.00845869854092598,0.0030618879245594144,0.00824685781262815,0.011915132217109204,0.1335103318095207,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,4673.0,2473712.0,1927245.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BMS-690514,CHEMBL3545396,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1",CSGQVNMSRKWUSH-IAGOWNOFSA-N,COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,0.6252632540499533,4.0,368.44100000000014,1.3753999999999997,8,3,2,100.94000000000001,-2.224417177243242,0.853691828250885,-5.395450639814288,0.9995995759963989,-14.5569928478561,0.6156546950340271,0.1356496013700962,0.8274991750717163,69.03664667967118,7.524551972381344,0.06774171851575375,0.0339232075959444,0.009296270785853267,0.40232146382331846,0.15683932602405548,11.66290261993355,-1.1597707937009745,0.42062421443073317,2.5443375088554574,0.2084345042705536,0.05970349572598934,0.7940829038619995,0.2895964875817299,0.9248620629310608,0.03012628946453333,0.008501536538824439,0.06556985676288604,0.005427580326795578,0.43253410458564756,0.034723876789212224,0.00024174443096853794,0.00845869854092598,0.0030618879245594144,0.00824685781262815,0.011915132217109204,0.1335103318095207,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4740.0,1344125.0,144744.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MASOPROCOL,CHEMBL313972,4.0,1.0,1.0,MOL,73468.0,Small molecule,1992.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1990.0,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H22O4/c1-11(7-13-3-5-15(19)17(21)9-13)12(2)8-14-4-6-16(20)18(22)10-14/h3-6,9-12,19-22H,7-8H2,1-2H3/t11-,12+",HCZKYJDFEPMADG-TXEJJXNPSA-N,C[C@H](Cc1ccc(O)c(O)c1)[C@@H](C)Cc1ccc(O)c(O)c1,0.636536149264244,4.0,302.37,3.5664000000000033,4,4,2,80.92,-3.0473821342289003,0.4330392390489578,-5.118058427326227,0.9987223505973816,-7.09850956578598,0.7114035844802856,0.16678455770015715,0.3839008420705795,88.30655542483812,-2.413299478529626,0.8589428544044495,0.6672909259796143,0.6849913477897644,0.5953576982021331,0.6594392836093903,-26.22665446753914,90.2794644765402,27.103996643773417,2.1184896214845885,0.23547516167163848,0.2924241364002228,0.04051047340035439,0.1924867659807205,0.7763074278831482,0.009918735781684517,0.0050370483193546535,0.3896764352917671,0.47913652658462524,0.3251135408878326,0.2742854356765747,0.09641579389572144,0.03692819438874721,0.48174318075180056,0.8922006249427795,0.2988945424556732,0.8963442802429199,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4740.0,1344125.0,144744.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MASOPROCOL,CHEMBL313972,4.0,1.0,1.0,MOL,73468.0,Small molecule,1992.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1990.0,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H22O4/c1-11(7-13-3-5-15(19)17(21)9-13)12(2)8-14-4-6-16(20)18(22)10-14/h3-6,9-12,19-22H,7-8H2,1-2H3/t11-,12+",HCZKYJDFEPMADG-TXEJJXNPSA-N,C[C@H](Cc1ccc(O)c(O)c1)[C@@H](C)Cc1ccc(O)c(O)c1,0.636536149264244,4.0,302.37,3.5664000000000033,4,4,2,80.92,-3.0473821342289003,0.4330392390489578,-5.118058427326227,0.9987223505973816,-7.09850956578598,0.7114035844802856,0.16678455770015715,0.3839008420705795,88.30655542483812,-2.413299478529626,0.8589428544044495,0.6672909259796143,0.6849913477897644,0.5953576982021331,0.6594392836093903,-26.22665446753914,90.2794644765402,27.103996643773417,2.1184896214845885,0.23547516167163848,0.2924241364002228,0.04051047340035439,0.1924867659807205,0.7763074278831482,0.009918735781684517,0.0050370483193546535,0.3896764352917671,0.47913652658462524,0.3251135408878326,0.2742854356765747,0.09641579389572144,0.03692819438874721,0.48174318075180056,0.8922006249427795,0.2988945424556732,0.8963442802429199,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4854.0,2473100.0,1926832.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TESEVATINIB,CHEMBL3544983,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2014.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13-,14-,15+",HVXKQKFEHMGHSL-QKDCVEJESA-N,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1,0.44055074894174295,3.0,491.39400000000035,5.7945000000000055,6,1,3,59.51,-5.5185619942348945,0.9469316482543946,-4.839791237545251,0.9993993878364563,-8.473025901871718,0.9064297676086426,0.907789433002472,0.9067410469055176,100.96031382872765,10.065197893826076,0.3506478428840637,0.11133783236145973,0.07296829596161843,0.2449601799249649,0.9266304016113281,33.440790202477665,20.88619706281697,41.629157288281725,3.5863639866028763,0.3297056645154953,0.16624267101287843,0.6405100345611572,0.8451113700866699,0.9382524251937866,0.03275855518877506,0.03958577625453472,0.06221624910831451,0.03177963737398386,0.6329468429088593,0.34053321182727814,0.04024077393114567,0.2815763607621193,0.18141604959964752,0.5162061154842377,0.3857030928134918,0.1400442972779274,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,4854.0,2473100.0,1926832.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TESEVATINIB,CHEMBL3544983,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2014.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13-,14-,15+",HVXKQKFEHMGHSL-QKDCVEJESA-N,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1,0.44055074894174295,3.0,491.39400000000035,5.7945000000000055,6,1,3,59.51,-5.5185619942348945,0.9469316482543946,-4.839791237545251,0.9993993878364563,-8.473025901871718,0.9064297676086426,0.907789433002472,0.9067410469055176,100.96031382872765,10.065197893826076,0.3506478428840637,0.11133783236145973,0.07296829596161843,0.2449601799249649,0.9266304016113281,33.440790202477665,20.88619706281697,41.629157288281725,3.5863639866028763,0.3297056645154953,0.16624267101287843,0.6405100345611572,0.8451113700866699,0.9382524251937866,0.03275855518877506,0.03958577625453472,0.06221624910831451,0.03177963737398386,0.6329468429088593,0.34053321182727814,0.04024077393114567,0.2815763607621193,0.18141604959964752,0.5162061154842377,0.3857030928134918,0.1400442972779274,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4853.0,2473100.0,1926832.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TESEVATINIB,CHEMBL3544983,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2014.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13-,14-,15+",HVXKQKFEHMGHSL-QKDCVEJESA-N,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1,0.44055074894174295,3.0,491.39400000000035,5.7945000000000055,6,1,3,59.51,-5.5185619942348945,0.9469316482543946,-4.839791237545251,0.9993993878364563,-8.473025901871718,0.9064297676086426,0.907789433002472,0.9067410469055176,100.96031382872765,10.065197893826076,0.3506478428840637,0.11133783236145973,0.07296829596161843,0.2449601799249649,0.9266304016113281,33.440790202477665,20.88619706281697,41.629157288281725,3.5863639866028763,0.3297056645154953,0.16624267101287843,0.6405100345611572,0.8451113700866699,0.9382524251937866,0.03275855518877506,0.03958577625453472,0.06221624910831451,0.03177963737398386,0.6329468429088593,0.34053321182727814,0.04024077393114567,0.2815763607621193,0.18141604959964752,0.5162061154842377,0.3857030928134918,0.1400442972779274,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,5278.0,1702340.0,547496.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.,,,,CANERTINIB DIHYDROCHLORIDE,CHEMBL545315,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H",JZZFDCXSFTVOJY-UHFFFAOYSA-N,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,0.27442022230969587,2.0,558.8690000000005,5.235100000000005,7,2,0,88.61,-3.9262960896158168,0.7576998353004456,-4.874273099734299,0.9804365277290344,-11.4274802483122,0.5660626351833343,0.8342281699180603,0.6720735192298889,98.17300675007655,7.542603569243866,0.18585835844278337,0.41105045676231383,0.29330512285232546,0.48021696209907533,0.8314680099487305,59.43628690657421,31.943564827702772,46.18554275250834,2.9068446906327217,0.7265984535217285,0.4043459117412567,0.8560979008674622,0.9202846646308899,0.9133566617965698,0.011822095327079295,0.018808570317924024,0.12255611717700958,0.0961424920707941,0.47597252726554873,0.25294698774814606,0.06508085504174232,0.14862677454948425,0.20125618278980256,0.4611828446388245,0.6372733831405639,0.3376351803541183,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,5278.0,1702340.0,547496.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.,,,,CANERTINIB DIHYDROCHLORIDE,CHEMBL545315,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H",JZZFDCXSFTVOJY-UHFFFAOYSA-N,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,0.27442022230969587,2.0,558.8690000000005,5.235100000000005,7,2,0,88.61,-3.9262960896158168,0.7576998353004456,-4.874273099734299,0.9804365277290344,-11.4274802483122,0.5660626351833343,0.8342281699180603,0.6720735192298889,98.17300675007655,7.542603569243866,0.18585835844278337,0.41105045676231383,0.29330512285232546,0.48021696209907533,0.8314680099487305,59.43628690657421,31.943564827702772,46.18554275250834,2.9068446906327217,0.7265984535217285,0.4043459117412567,0.8560979008674622,0.9202846646308899,0.9133566617965698,0.011822095327079295,0.018808570317924024,0.12255611717700958,0.0961424920707941,0.47597252726554873,0.25294698774814606,0.06508085504174232,0.14862677454948425,0.20125618278980256,0.4611828446388245,0.6372733831405639,0.3376351803541183,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,5277.0,1702340.0,547496.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.,,,,CANERTINIB DIHYDROCHLORIDE,CHEMBL545315,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H",JZZFDCXSFTVOJY-UHFFFAOYSA-N,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,0.27442022230969587,2.0,558.8690000000005,5.235100000000005,7,2,0,88.61,-3.9262960896158168,0.7576998353004456,-4.874273099734299,0.9804365277290344,-11.4274802483122,0.5660626351833343,0.8342281699180603,0.6720735192298889,98.17300675007655,7.542603569243866,0.18585835844278337,0.41105045676231383,0.29330512285232546,0.48021696209907533,0.8314680099487305,59.43628690657421,31.943564827702772,46.18554275250834,2.9068446906327217,0.7265984535217285,0.4043459117412567,0.8560979008674622,0.9202846646308899,0.9133566617965698,0.011822095327079295,0.018808570317924024,0.12255611717700958,0.0961424920707941,0.47597252726554873,0.25294698774814606,0.06508085504174232,0.14862677454948425,0.20125618278980256,0.4611828446388245,0.6372733831405639,0.3376351803541183,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,5279.0,1702340.0,547496.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.,,,,CANERTINIB DIHYDROCHLORIDE,CHEMBL545315,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H",JZZFDCXSFTVOJY-UHFFFAOYSA-N,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,0.27442022230969587,2.0,558.8690000000005,5.235100000000005,7,2,0,88.61,-3.9262960896158168,0.7576998353004456,-4.874273099734299,0.9804365277290344,-11.4274802483122,0.5660626351833343,0.8342281699180603,0.6720735192298889,98.17300675007655,7.542603569243866,0.18585835844278337,0.41105045676231383,0.29330512285232546,0.48021696209907533,0.8314680099487305,59.43628690657421,31.943564827702772,46.18554275250834,2.9068446906327217,0.7265984535217285,0.4043459117412567,0.8560979008674622,0.9202846646308899,0.9133566617965698,0.011822095327079295,0.018808570317924024,0.12255611717700958,0.0961424920707941,0.47597252726554873,0.25294698774814606,0.06508085504174232,0.14862677454948425,0.20125618278980256,0.4611828446388245,0.6372733831405639,0.3376351803541183,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,5279.0,1702340.0,547496.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.,,,,CANERTINIB DIHYDROCHLORIDE,CHEMBL545315,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H",JZZFDCXSFTVOJY-UHFFFAOYSA-N,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,0.27442022230969587,2.0,558.8690000000005,5.235100000000005,7,2,0,88.61,-3.9262960896158168,0.7576998353004456,-4.874273099734299,0.9804365277290344,-11.4274802483122,0.5660626351833343,0.8342281699180603,0.6720735192298889,98.17300675007655,7.542603569243866,0.18585835844278337,0.41105045676231383,0.29330512285232546,0.48021696209907533,0.8314680099487305,59.43628690657421,31.943564827702772,46.18554275250834,2.9068446906327217,0.7265984535217285,0.4043459117412567,0.8560979008674622,0.9202846646308899,0.9133566617965698,0.011822095327079295,0.018808570317924024,0.12255611717700958,0.0961424920707941,0.47597252726554873,0.25294698774814606,0.06508085504174232,0.14862677454948425,0.20125618278980256,0.4611828446388245,0.6372733831405639,0.3376351803541183,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,5286.0,1706035.0,299120.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB,CHEMBL180022,4.0,1.0,0.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2006.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+",JWNPDZNEKVCWMY-VQHVLOKHSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,0.21847545958158987,2.0,557.054,5.932480000000005,8,2,0,112.39999999999999,-5.551428635615119,0.8228603005409241,-5.385680403686125,0.9602659702301025,-12.110518944987287,0.728061318397522,0.9450305342674256,0.3266207844018936,95.97807151376364,11.383340257443148,0.05333035178482533,0.4159535229206085,0.2627202048897743,0.1366163671016693,0.7183743000030518,156.02968215899367,62.812646896852755,78.43636284837915,3.3794742510841473,0.4960583567619324,0.5069771111011505,0.5387330412864685,0.9343042492866516,0.8927775502204895,0.012256063800305129,0.017157509736716748,0.039508926868438723,0.03444125726819038,0.4980564832687378,0.2398596853017807,0.05131465531885624,0.062002448737621306,0.17111192047595977,0.5989981591701508,0.5872811138629913,0.21903307288885115,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,5286.0,1706035.0,299120.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB,CHEMBL180022,4.0,1.0,0.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2006.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+",JWNPDZNEKVCWMY-VQHVLOKHSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,0.21847545958158987,2.0,557.054,5.932480000000005,8,2,0,112.39999999999999,-5.551428635615119,0.8228603005409241,-5.385680403686125,0.9602659702301025,-12.110518944987287,0.728061318397522,0.9450305342674256,0.3266207844018936,95.97807151376364,11.383340257443148,0.05333035178482533,0.4159535229206085,0.2627202048897743,0.1366163671016693,0.7183743000030518,156.02968215899367,62.812646896852755,78.43636284837915,3.3794742510841473,0.4960583567619324,0.5069771111011505,0.5387330412864685,0.9343042492866516,0.8927775502204895,0.012256063800305129,0.017157509736716748,0.039508926868438723,0.03444125726819038,0.4980564832687378,0.2398596853017807,0.05131465531885624,0.062002448737621306,0.17111192047595977,0.5989981591701508,0.5872811138629913,0.21903307288885115,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,5285.0,1706035.0,299120.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB,CHEMBL180022,4.0,1.0,0.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2006.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+",JWNPDZNEKVCWMY-VQHVLOKHSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,0.21847545958158987,2.0,557.054,5.932480000000005,8,2,0,112.39999999999999,-5.551428635615119,0.8228603005409241,-5.385680403686125,0.9602659702301025,-12.110518944987287,0.728061318397522,0.9450305342674256,0.3266207844018936,95.97807151376364,11.383340257443148,0.05333035178482533,0.4159535229206085,0.2627202048897743,0.1366163671016693,0.7183743000030518,156.02968215899367,62.812646896852755,78.43636284837915,3.3794742510841473,0.4960583567619324,0.5069771111011505,0.5387330412864685,0.9343042492866516,0.8927775502204895,0.012256063800305129,0.017157509736716748,0.039508926868438723,0.03444125726819038,0.4980564832687378,0.2398596853017807,0.05131465531885624,0.062002448737621306,0.17111192047595977,0.5989981591701508,0.5872811138629913,0.21903307288885115,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,7420.0,1706035.0,299120.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB,CHEMBL180022,4.0,1.0,0.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2006.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+",JWNPDZNEKVCWMY-VQHVLOKHSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,0.21847545958158987,2.0,557.054,5.932480000000005,8,2,0,112.39999999999999,-5.551428635615119,0.8228603005409241,-5.385680403686125,0.9602659702301025,-12.110518944987287,0.728061318397522,0.9450305342674256,0.3266207844018936,95.97807151376364,11.383340257443148,0.05333035178482533,0.4159535229206085,0.2627202048897743,0.1366163671016693,0.7183743000030518,156.02968215899367,62.812646896852755,78.43636284837915,3.3794742510841473,0.4960583567619324,0.5069771111011505,0.5387330412864685,0.9343042492866516,0.8927775502204895,0.012256063800305129,0.017157509736716748,0.039508926868438723,0.03444125726819038,0.4980564832687378,0.2398596853017807,0.05131465531885624,0.062002448737621306,0.17111192047595977,0.5989981591701508,0.5872811138629913,0.21903307288885115,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,7420.0,1706035.0,299120.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB,CHEMBL180022,4.0,1.0,0.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2006.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+",JWNPDZNEKVCWMY-VQHVLOKHSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,0.21847545958158987,2.0,557.054,5.932480000000005,8,2,0,112.39999999999999,-5.551428635615119,0.8228603005409241,-5.385680403686125,0.9602659702301025,-12.110518944987287,0.728061318397522,0.9450305342674256,0.3266207844018936,95.97807151376364,11.383340257443148,0.05333035178482533,0.4159535229206085,0.2627202048897743,0.1366163671016693,0.7183743000030518,156.02968215899367,62.812646896852755,78.43636284837915,3.3794742510841473,0.4960583567619324,0.5069771111011505,0.5387330412864685,0.9343042492866516,0.8927775502204895,0.012256063800305129,0.017157509736716748,0.039508926868438723,0.03444125726819038,0.4980564832687378,0.2398596853017807,0.05131465531885624,0.062002448737621306,0.17111192047595977,0.5989981591701508,0.5872811138629913,0.21903307288885115,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,5312.0,1702618.0,1377989.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB,CHEMBL2105719,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;",BSPLGGCPNTZPIH-IPZCTEOASA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O,0.4797057026950064,4.0,487.9630000000004,4.3304000000000045,6,2,0,110.88000000000001,-4.1198182949480415,0.8005683541297912,-5.050417380612581,0.997089946269989,-11.829780806945143,0.883458161354065,0.85313401222229,0.8466468214988708,99.75933978712081,5.796542145526817,0.30380123257637026,0.5482414722442627,0.3396421879529953,0.5993910551071167,0.7692281603813171,49.17877492360054,9.39226088642238,39.28438584562336,3.0815376013501607,0.4822343707084656,0.22279856353998184,0.8225364804267883,0.8857611179351806,0.8980758786201477,0.012318769469857216,0.026642481423914434,0.142427559196949,0.07309902980923652,0.652170079946518,0.1938148558139801,0.060634695738554,0.2106768473982811,0.2488543301820755,0.3993054360151291,0.5142353564500809,0.2416327714920044,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,5312.0,1702618.0,1377989.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB,CHEMBL2105719,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;",BSPLGGCPNTZPIH-IPZCTEOASA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O,0.4797057026950064,4.0,487.9630000000004,4.3304000000000045,6,2,0,110.88000000000001,-4.1198182949480415,0.8005683541297912,-5.050417380612581,0.997089946269989,-11.829780806945143,0.883458161354065,0.85313401222229,0.8466468214988708,99.75933978712081,5.796542145526817,0.30380123257637026,0.5482414722442627,0.3396421879529953,0.5993910551071167,0.7692281603813171,49.17877492360054,9.39226088642238,39.28438584562336,3.0815376013501607,0.4822343707084656,0.22279856353998184,0.8225364804267883,0.8857611179351806,0.8980758786201477,0.012318769469857216,0.026642481423914434,0.142427559196949,0.07309902980923652,0.652170079946518,0.1938148558139801,0.060634695738554,0.2106768473982811,0.2488543301820755,0.3993054360151291,0.5142353564500809,0.2416327714920044,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,5311.0,1702618.0,1377989.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB,CHEMBL2105719,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;",BSPLGGCPNTZPIH-IPZCTEOASA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O,0.4797057026950064,4.0,487.9630000000004,4.3304000000000045,6,2,0,110.88000000000001,-4.1198182949480415,0.8005683541297912,-5.050417380612581,0.997089946269989,-11.829780806945143,0.883458161354065,0.85313401222229,0.8466468214988708,99.75933978712081,5.796542145526817,0.30380123257637026,0.5482414722442627,0.3396421879529953,0.5993910551071167,0.7692281603813171,49.17877492360054,9.39226088642238,39.28438584562336,3.0815376013501607,0.4822343707084656,0.22279856353998184,0.8225364804267883,0.8857611179351806,0.8980758786201477,0.012318769469857216,0.026642481423914434,0.142427559196949,0.07309902980923652,0.652170079946518,0.1938148558139801,0.060634695738554,0.2106768473982811,0.2488543301820755,0.3993054360151291,0.5142353564500809,0.2416327714920044,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,5313.0,1702618.0,1377989.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB,CHEMBL2105719,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;",BSPLGGCPNTZPIH-IPZCTEOASA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O,0.4797057026950064,4.0,487.9630000000004,4.3304000000000045,6,2,0,110.88000000000001,-4.1198182949480415,0.8005683541297912,-5.050417380612581,0.997089946269989,-11.829780806945143,0.883458161354065,0.85313401222229,0.8466468214988708,99.75933978712081,5.796542145526817,0.30380123257637026,0.5482414722442627,0.3396421879529953,0.5993910551071167,0.7692281603813171,49.17877492360054,9.39226088642238,39.28438584562336,3.0815376013501607,0.4822343707084656,0.22279856353998184,0.8225364804267883,0.8857611179351806,0.8980758786201477,0.012318769469857216,0.026642481423914434,0.142427559196949,0.07309902980923652,0.652170079946518,0.1938148558139801,0.060634695738554,0.2106768473982811,0.2488543301820755,0.3993054360151291,0.5142353564500809,0.2416327714920044,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,5313.0,1702618.0,1377989.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB,CHEMBL2105719,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;",BSPLGGCPNTZPIH-IPZCTEOASA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O,0.4797057026950064,4.0,487.9630000000004,4.3304000000000045,6,2,0,110.88000000000001,-4.1198182949480415,0.8005683541297912,-5.050417380612581,0.997089946269989,-11.829780806945143,0.883458161354065,0.85313401222229,0.8466468214988708,99.75933978712081,5.796542145526817,0.30380123257637026,0.5482414722442627,0.3396421879529953,0.5993910551071167,0.7692281603813171,49.17877492360054,9.39226088642238,39.28438584562336,3.0815376013501607,0.4822343707084656,0.22279856353998184,0.8225364804267883,0.8857611179351806,0.8980758786201477,0.012318769469857216,0.026642481423914434,0.142427559196949,0.07309902980923652,0.652170079946518,0.1938148558139801,0.060634695738554,0.2106768473982811,0.2488543301820755,0.3993054360151291,0.5142353564500809,0.2416327714920044,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,7416.0,2473074.0,1383172.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB ANHYDROUS,CHEMBL2110732,4.0,1.0,0.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+",LVXJQMNHJWSHET-AATRIKPKSA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,0.46544532094051466,3.0,469.9480000000004,5.1551000000000045,6,2,0,79.38000000000001,-4.601824022374219,0.823045289516449,-4.96613344782226,0.9980828523635864,-11.427870388298842,0.9188350558280944,0.8935948610305786,0.882453453540802,100.4218574859654,6.309400776316884,0.36046560406684874,0.5729457020759583,0.3695091426372528,0.5879017233848571,0.7946772456169129,47.52952493536896,14.346677762726358,48.30716465857434,3.156563603916866,0.506511127948761,0.24326851069927216,0.8083118081092835,0.89350825548172,0.8972457647323608,0.013282120600342751,0.03299333248287439,0.14977686181664468,0.070405962318182,0.7096431851387024,0.21798378527164458,0.07300878241658211,0.22166245728731154,0.2818478763103485,0.43688464164733887,0.5260943323373795,0.2617603331804276,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,7416.0,2473074.0,1383172.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB ANHYDROUS,CHEMBL2110732,4.0,1.0,0.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+",LVXJQMNHJWSHET-AATRIKPKSA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,0.46544532094051466,3.0,469.9480000000004,5.1551000000000045,6,2,0,79.38000000000001,-4.601824022374219,0.823045289516449,-4.96613344782226,0.9980828523635864,-11.427870388298842,0.9188350558280944,0.8935948610305786,0.882453453540802,100.4218574859654,6.309400776316884,0.36046560406684874,0.5729457020759583,0.3695091426372528,0.5879017233848571,0.7946772456169129,47.52952493536896,14.346677762726358,48.30716465857434,3.156563603916866,0.506511127948761,0.24326851069927216,0.8083118081092835,0.89350825548172,0.8972457647323608,0.013282120600342751,0.03299333248287439,0.14977686181664468,0.070405962318182,0.7096431851387024,0.21798378527164458,0.07300878241658211,0.22166245728731154,0.2818478763103485,0.43688464164733887,0.5260943323373795,0.2617603331804276,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,7415.0,2473074.0,1383172.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB ANHYDROUS,CHEMBL2110732,4.0,1.0,0.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+",LVXJQMNHJWSHET-AATRIKPKSA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,0.46544532094051466,3.0,469.9480000000004,5.1551000000000045,6,2,0,79.38000000000001,-4.601824022374219,0.823045289516449,-4.96613344782226,0.9980828523635864,-11.427870388298842,0.9188350558280944,0.8935948610305786,0.882453453540802,100.4218574859654,6.309400776316884,0.36046560406684874,0.5729457020759583,0.3695091426372528,0.5879017233848571,0.7946772456169129,47.52952493536896,14.346677762726358,48.30716465857434,3.156563603916866,0.506511127948761,0.24326851069927216,0.8083118081092835,0.89350825548172,0.8972457647323608,0.013282120600342751,0.03299333248287439,0.14977686181664468,0.070405962318182,0.7096431851387024,0.21798378527164458,0.07300878241658211,0.22166245728731154,0.2818478763103485,0.43688464164733887,0.5260943323373795,0.2617603331804276,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,7417.0,2473074.0,1383172.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB ANHYDROUS,CHEMBL2110732,4.0,1.0,0.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+",LVXJQMNHJWSHET-AATRIKPKSA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,0.46544532094051466,3.0,469.9480000000004,5.1551000000000045,6,2,0,79.38000000000001,-4.601824022374219,0.823045289516449,-4.96613344782226,0.9980828523635864,-11.427870388298842,0.9188350558280944,0.8935948610305786,0.882453453540802,100.4218574859654,6.309400776316884,0.36046560406684874,0.5729457020759583,0.3695091426372528,0.5879017233848571,0.7946772456169129,47.52952493536896,14.346677762726358,48.30716465857434,3.156563603916866,0.506511127948761,0.24326851069927216,0.8083118081092835,0.89350825548172,0.8972457647323608,0.013282120600342751,0.03299333248287439,0.14977686181664468,0.070405962318182,0.7096431851387024,0.21798378527164458,0.07300878241658211,0.22166245728731154,0.2818478763103485,0.43688464164733887,0.5260943323373795,0.2617603331804276,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,7417.0,2473074.0,1383172.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Dacomitinib is an irreversible pan-ERBB inhibitor.,,,,DACOMITINIB ANHYDROUS,CHEMBL2110732,4.0,1.0,0.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+",LVXJQMNHJWSHET-AATRIKPKSA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,0.46544532094051466,3.0,469.9480000000004,5.1551000000000045,6,2,0,79.38000000000001,-4.601824022374219,0.823045289516449,-4.96613344782226,0.9980828523635864,-11.427870388298842,0.9188350558280944,0.8935948610305786,0.882453453540802,100.4218574859654,6.309400776316884,0.36046560406684874,0.5729457020759583,0.3695091426372528,0.5879017233848571,0.7946772456169129,47.52952493536896,14.346677762726358,48.30716465857434,3.156563603916866,0.506511127948761,0.24326851069927216,0.8083118081092835,0.89350825548172,0.8972457647323608,0.013282120600342751,0.03299333248287439,0.14977686181664468,0.070405962318182,0.7096431851387024,0.21798378527164458,0.07300878241658211,0.22166245728731154,0.2818478763103485,0.43688464164733887,0.5260943323373795,0.2617603331804276,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,7421.0,2973277.0,2197792.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB MALEATE,CHEMBL3989921,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1-",VXZCUHNJXSIJIM-MEBGWEOYSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O,0.12814999957496084,2.0,673.1260000000001,5.644280000000004,10,4,0,186.99999999999997,-4.52868092532494,0.7889575362205505,-5.792521625707695,0.4747064471244812,-13.410630824323823,0.2872739672660828,0.5213918387889862,0.3544399455189705,87.25364759317601,6.652602060724071,0.045237144082784654,0.18413280844688415,0.16185497865080833,0.12626083344221115,0.2799638420343399,105.58770618440454,3.365378644100592,24.566437919130074,3.3837944310413377,0.3583511009812355,0.4348218828439713,0.7055706739425659,0.9583305954933167,0.6620205163955688,0.017858441080898048,0.016361550986766817,0.051148676127195356,0.05646287798881531,0.24764476120471954,0.16103360503911973,0.17394641637802125,0.11555617451667785,0.13304458558559418,0.2963442325592041,0.48346647024154665,0.2737596720457077,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,7421.0,2973277.0,2197792.0,Receptor protein-tyrosine kinase erbB-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB MALEATE,CHEMBL3989921,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1-",VXZCUHNJXSIJIM-MEBGWEOYSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O,0.12814999957496084,2.0,673.1260000000001,5.644280000000004,10,4,0,186.99999999999997,-4.52868092532494,0.7889575362205505,-5.792521625707695,0.4747064471244812,-13.410630824323823,0.2872739672660828,0.5213918387889862,0.3544399455189705,87.25364759317601,6.652602060724071,0.045237144082784654,0.18413280844688415,0.16185497865080833,0.12626083344221115,0.2799638420343399,105.58770618440454,3.365378644100592,24.566437919130074,3.3837944310413377,0.3583511009812355,0.4348218828439713,0.7055706739425659,0.9583305954933167,0.6620205163955688,0.017858441080898048,0.016361550986766817,0.051148676127195356,0.05646287798881531,0.24764476120471954,0.16103360503911973,0.17394641637802125,0.11555617451667785,0.13304458558559418,0.2963442325592041,0.48346647024154665,0.2737596720457077,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,7422.0,2973277.0,2197792.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB MALEATE,CHEMBL3989921,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1-",VXZCUHNJXSIJIM-MEBGWEOYSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O,0.12814999957496084,2.0,673.1260000000001,5.644280000000004,10,4,0,186.99999999999997,-4.52868092532494,0.7889575362205505,-5.792521625707695,0.4747064471244812,-13.410630824323823,0.2872739672660828,0.5213918387889862,0.3544399455189705,87.25364759317601,6.652602060724071,0.045237144082784654,0.18413280844688415,0.16185497865080833,0.12626083344221115,0.2799638420343399,105.58770618440454,3.365378644100592,24.566437919130074,3.3837944310413377,0.3583511009812355,0.4348218828439713,0.7055706739425659,0.9583305954933167,0.6620205163955688,0.017858441080898048,0.016361550986766817,0.051148676127195356,0.05646287798881531,0.24764476120471954,0.16103360503911973,0.17394641637802125,0.11555617451667785,0.13304458558559418,0.2963442325592041,0.48346647024154665,0.2737596720457077,False
EGFR,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,7423.0,2973277.0,2197792.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB MALEATE,CHEMBL3989921,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1-",VXZCUHNJXSIJIM-MEBGWEOYSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O,0.12814999957496084,2.0,673.1260000000001,5.644280000000004,10,4,0,186.99999999999997,-4.52868092532494,0.7889575362205505,-5.792521625707695,0.4747064471244812,-13.410630824323823,0.2872739672660828,0.5213918387889862,0.3544399455189705,87.25364759317601,6.652602060724071,0.045237144082784654,0.18413280844688415,0.16185497865080833,0.12626083344221115,0.2799638420343399,105.58770618440454,3.365378644100592,24.566437919130074,3.3837944310413377,0.3583511009812355,0.4348218828439713,0.7055706739425659,0.9583305954933167,0.6620205163955688,0.017858441080898048,0.016361550986766817,0.051148676127195356,0.05646287798881531,0.24764476120471954,0.16103360503911973,0.17394641637802125,0.11555617451667785,0.13304458558559418,0.2963442325592041,0.48346647024154665,0.2737596720457077,False
ERBB4_HER4,12699,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-4,9606,Homo sapiens,CHEMBL3009,,0.0,7423.0,2973277.0,2197792.0,Receptor protein-tyrosine kinase erbB-4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,,,NERATINIB MALEATE,CHEMBL3989921,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1-",VXZCUHNJXSIJIM-MEBGWEOYSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O,0.12814999957496084,2.0,673.1260000000001,5.644280000000004,10,4,0,186.99999999999997,-4.52868092532494,0.7889575362205505,-5.792521625707695,0.4747064471244812,-13.410630824323823,0.2872739672660828,0.5213918387889862,0.3544399455189705,87.25364759317601,6.652602060724071,0.045237144082784654,0.18413280844688415,0.16185497865080833,0.12626083344221115,0.2799638420343399,105.58770618440454,3.365378644100592,24.566437919130074,3.3837944310413377,0.3583511009812355,0.4348218828439713,0.7055706739425659,0.9583305954933167,0.6620205163955688,0.017858441080898048,0.016361550986766817,0.051148676127195356,0.05646287798881531,0.24764476120471954,0.16103360503911973,0.17394641637802125,0.11555617451667785,0.13304458558559418,0.2963442325592041,0.48346647024154665,0.2737596720457077,False
EGFR,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,8538.0,3490056.0,2486539.0,Receptor protein-tyrosine kinase erbB-2 negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,"Allosteric, irreversible, ATP competitive inhibitor",Selective for mutants vs. wild-type.,,-1.0,TUXOBERTINIB,CHEMBL4650279,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2022.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H29ClN6O4/c1-2-28(37)35-25-16-22-24(17-27(25)39-14-11-36-9-12-38-13-10-36)32-19-33-29(22)34-20-6-7-26(23(30)15-20)40-18-21-5-3-4-8-31-21/h2-8,15-17,19H,1,9-14,18H2,(H,35,37)(H,32,33,34)",HIBPKFXWOPYJPZ-UHFFFAOYSA-N,C=CC(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1OCCN1CCOCC1,0.24895433035887887,3.0,561.0420000000001,4.836300000000004,9,2,0,110.73,-4.249884289435147,0.814136517047882,-5.1868341489696235,0.9849998593330384,-12.847368255650604,0.7198551416397094,0.8228966355323791,0.43034614324569703,99.65676111433592,9.923321208518345,0.14710669592022896,0.5874148786067963,0.3553176999092102,0.2492475613951683,0.8146340131759644,59.38982272339492,18.637576137534097,54.30663387517817,3.030228614855146,0.4906195878982544,0.32888670861721037,0.758015251159668,0.9617917537689209,0.8704821586608886,0.014481423422694206,0.01591799668967724,0.1072960190474987,0.06986126191914081,0.5483608901500702,0.2628032326698303,0.1012430302798748,0.12360187768936157,0.2640137255191803,0.4531869053840637,0.6126066386699677,0.24422114193439484,False
ERBB2_HER2,188,SINGLE PROTEIN,Receptor protein-tyrosine kinase erbB-2,9606,Homo sapiens,CHEMBL1824,,0.0,8538.0,3490056.0,2486539.0,Receptor protein-tyrosine kinase erbB-2 negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,"Allosteric, irreversible, ATP competitive inhibitor",Selective for mutants vs. wild-type.,,-1.0,TUXOBERTINIB,CHEMBL4650279,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2022.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H29ClN6O4/c1-2-28(37)35-25-16-22-24(17-27(25)39-14-11-36-9-12-38-13-10-36)32-19-33-29(22)34-20-6-7-26(23(30)15-20)40-18-21-5-3-4-8-31-21/h2-8,15-17,19H,1,9-14,18H2,(H,35,37)(H,32,33,34)",HIBPKFXWOPYJPZ-UHFFFAOYSA-N,C=CC(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1OCCN1CCOCC1,0.24895433035887887,3.0,561.0420000000001,4.836300000000004,9,2,0,110.73,-4.249884289435147,0.814136517047882,-5.1868341489696235,0.9849998593330384,-12.847368255650604,0.7198551416397094,0.8228966355323791,0.43034614324569703,99.65676111433592,9.923321208518345,0.14710669592022896,0.5874148786067963,0.3553176999092102,0.2492475613951683,0.8146340131759644,59.38982272339492,18.637576137534097,54.30663387517817,3.030228614855146,0.4906195878982544,0.32888670861721037,0.758015251159668,0.9617917537689209,0.8704821586608886,0.014481423422694206,0.01591799668967724,0.1072960190474987,0.06986126191914081,0.5483608901500702,0.2628032326698303,0.1012430302798748,0.12360187768936157,0.2640137255191803,0.4531869053840637,0.6126066386699677,0.24422114193439484,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8539.0,3490056.0,2486539.0,Epidermal growth factor receptor erbB1 negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,"Allosteric, irreversible, ATP competitive inhibitor",Selective for mutants vs. wild-type.,,-1.0,TUXOBERTINIB,CHEMBL4650279,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2022.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H29ClN6O4/c1-2-28(37)35-25-16-22-24(17-27(25)39-14-11-36-9-12-38-13-10-36)32-19-33-29(22)34-20-6-7-26(23(30)15-20)40-18-21-5-3-4-8-31-21/h2-8,15-17,19H,1,9-14,18H2,(H,35,37)(H,32,33,34)",HIBPKFXWOPYJPZ-UHFFFAOYSA-N,C=CC(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1OCCN1CCOCC1,0.24895433035887887,3.0,561.0420000000001,4.836300000000004,9,2,0,110.73,-4.249884289435147,0.814136517047882,-5.1868341489696235,0.9849998593330384,-12.847368255650604,0.7198551416397094,0.8228966355323791,0.43034614324569703,99.65676111433592,9.923321208518345,0.14710669592022896,0.5874148786067963,0.3553176999092102,0.2492475613951683,0.8146340131759644,59.38982272339492,18.637576137534097,54.30663387517817,3.030228614855146,0.4906195878982544,0.32888670861721037,0.758015251159668,0.9617917537689209,0.8704821586608886,0.014481423422694206,0.01591799668967724,0.1072960190474987,0.06986126191914081,0.5483608901500702,0.2628032326698303,0.1012430302798748,0.12360187768936157,0.2640137255191803,0.4531869053840637,0.6126066386699677,0.24422114193439484,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,243.0,1344174.0,611647.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ERLOTINIB HYDROCHLORIDE,CHEMBL1079742,4.0,1.0,1.0,MOL,53509.0,Small molecule,2004.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2001.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H",GTTBEUCJPZQMDZ-UHFFFAOYSA-N,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl,0.387493846825601,4.0,429.90400000000017,3.8269000000000033,7,1,0,74.73000000000002,-3.051569370219118,0.9157222151756287,-4.9294746167875045,0.988780963420868,-9.354085979997233,0.7551640748977662,0.8106471538543701,0.6985524654388428,93.04465443486598,8.636361376743636,0.5646972894668579,0.27775695621967317,0.21178230494260789,0.23375717476010321,0.773838746547699,45.64732995791227,55.42866480964572,26.41070436748951,1.7864212178250465,0.8276429295539856,0.45079889297485354,0.4772008717060089,0.9019807934761047,0.9267873883247375,0.054109353199601175,0.0397746816277504,0.16093868762254715,0.1103861927986145,0.755936598777771,0.460548135638237,0.0686648316681385,0.27982795238494873,0.12627840638160706,0.3597704887390137,0.37295159697532654,0.33923902213573454,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,244.0,1344994.0,88232.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GEFITINIB,CHEMBL939,4.0,1.0,1.0,MOL,49668.0,Small molecule,2003.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,2002.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)",XGALLCVXEZPNRQ-UHFFFAOYSA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,0.517854527865434,4.0,446.9100000000004,4.275600000000003,7,1,0,68.74000000000001,-3.9408948228934193,0.9118286609649658,-4.613973296269874,0.9993949890136719,-10.81042592267699,0.9225288987159729,0.886959183216095,0.894558846950531,94.4326559512407,14.597365943090674,0.5520127296447754,0.5521563053131103,0.22039895504713058,0.34458800256252287,0.9619534850120545,34.13050640894468,41.69287343484702,43.10948333292401,2.872236790231647,0.5448354244232178,0.22325828969478606,0.7945034623146057,0.9239405632019043,0.9624073147773743,0.016751444526016714,0.01597223151475191,0.07352834641933441,0.057012586295604704,0.7679322004318238,0.4190270841121674,0.056599726900458336,0.11431589275598526,0.09047560542821884,0.31103107035160066,0.3374213814735413,0.227163365483284,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,2424.0,2472960.0,1926912.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion)",,,355.0,OSIMERTINIB MESYLATE,CHEMBL3545063,4.0,1.0,1.0,MOL,,Small molecule,2015.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2015.0,1.0,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H33N7O2.CH4O3S/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24;1-5(2,3)4/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32);1H3,(H,2,3,4)",FUKSNUHSJBTCFJ-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.CS(=O)(=O)O,0.18181920071483845,3.0,595.7260000000005,4.013800000000002,10,3,0,141.92,-1.9466917717366794,0.8192681789398193,-5.299797424685177,0.9579398393630981,-12.604275418805324,0.7587164402008056,0.8665831565856934,0.7417697668075561,84.55145476716982,-4.7417287146237985,0.22693908214569092,0.13402236998081207,0.07335510328412057,0.28430494517087934,0.5124237418174744,152.8380070373547,5.325318841670959,59.5226908164841,3.1384019842998545,0.7435544312000275,0.5203223645687103,0.8592630624771118,0.9170896053314209,0.9510015726089478,0.021520279906690122,0.02337240446358919,0.04371231570839882,0.033764037862420083,0.3266080617904663,0.12136033624410629,0.017219147831201553,0.10038513019680977,0.07176582589745521,0.30878990441560744,0.4659772664308548,0.1669548347592354,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4137.0,2473760.0,263849.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,No further data/studies for the compound found.,,,,AZD-4769,CHEMBL422872,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C28H27NO3S/c30-28(31)20-33-27(12-6-9-21-7-2-1-3-8-21)23-14-17-25(18-15-23)32-19-24-16-13-22-10-4-5-11-26(22)29-24/h1-5,7-8,10-11,13-18,27H,6,9,12,19-20H2,(H,30,31)",JOIXGLLMSDPZDN-UHFFFAOYSA-N,O=C(O)CSC(CCCc1ccccc1)c1ccc(OCc2ccc3ccccc3n2)cc1,0.27165436807943094,3.0,457.5950000000002,6.695600000000006,4,1,1,59.42,-5.105833623618134,0.8897506594657898,-5.763583206825535,0.9971074461936951,-8.23591470475511,0.569302636384964,0.7509366154670716,0.2855272650718689,102.74065156608408,-4.281476090591387,0.48266288042068484,0.7408222079277038,0.7461960554122925,0.129279725253582,0.22936272919178008,2.3507209025002447,46.06278659138858,33.10279356923039,2.720986365843415,0.0786455824971199,0.34479006826877595,0.05595637559890747,0.8327323794364929,0.5193746238946915,0.006904543517157436,0.0065060541033744815,0.20385562628507614,0.07363547123968602,0.15806738287210464,0.2654467776417732,0.8642030477523803,0.01448739911429584,0.3936235249042511,0.37746518552303315,0.05346228592097759,0.3039178907871246,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4162.0,1699687.0,430493.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FALNIDAMOL,CHEMBL258940,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24)",FTFRZXFNZVCRSK-UHFFFAOYSA-N,CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1,0.7091922744684137,4.0,387.85000000000014,3.4620000000000015,7,2,0,78.86,-4.041062708025845,0.9052762269973755,-5.0723192406474364,0.9992286205291748,-11.124499862257633,0.9409735918045044,0.30555344820022584,0.9508070826530457,92.41248850483689,14.563738765890538,0.42672240138053896,0.18328286707401276,0.07954263873398304,0.38589783757925034,0.23419402837753295,36.13243478238274,18.5735836297542,8.819369638917554,2.6599943532140036,0.31264670342206957,0.1293112862855196,0.8328309774398803,0.9229139566421509,0.8351688385009766,0.05891178883612156,0.061983061209321025,0.11722825169563293,0.0366280484944582,0.5768674850463867,0.19083410650491714,0.0448920295573771,0.2103034496307373,0.05418230853974819,0.11549969762563705,0.23287604451179506,0.20818986296653746,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4179.0,2473489.0,1342038.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CEP-32496,CHEMBL2029988,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)",DKNUPRMJNUQNHR-UHFFFAOYSA-N,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,0.3103792866850044,2.0,517.4640000000002,5.911200000000004,8,2,0,120.63000000000001,-6.556401566380979,0.9231156587600708,-4.882732331452629,0.9976501822471618,-9.471570783842811,0.8517094373703002,0.8801780223846436,0.6825120210647583,96.23526923871825,5.099155715791392,0.14318719506263733,0.7318573951721191,0.7659140229225159,0.059959274064749477,0.7038950860500336,96.83393062539857,28.06585498601327,94.91892943786752,3.5986175888328527,0.2503737762570381,0.3795116126537323,0.2824185937643051,0.9789002776145935,0.899782395362854,0.022841789200901984,0.004148971976246685,0.06862986758351326,0.011046868376433849,0.40681086778640746,0.22533526718616487,0.04507759008556604,0.09295670837163925,0.04510567523539066,0.7644387006759643,0.40921531319618226,0.08952124081552029,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,4180.0,2473489.0,1342038.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CEP-32496,CHEMBL2029988,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)",DKNUPRMJNUQNHR-UHFFFAOYSA-N,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,0.3103792866850044,2.0,517.4640000000002,5.911200000000004,8,2,0,120.63000000000001,-6.556401566380979,0.9231156587600708,-4.882732331452629,0.9976501822471618,-9.471570783842811,0.8517094373703002,0.8801780223846436,0.6825120210647583,96.23526923871825,5.099155715791392,0.14318719506263733,0.7318573951721191,0.7659140229225159,0.059959274064749477,0.7038950860500336,96.83393062539857,28.06585498601327,94.91892943786752,3.5986175888328527,0.2503737762570381,0.3795116126537323,0.2824185937643051,0.9789002776145935,0.899782395362854,0.022841789200901984,0.004148971976246685,0.06862986758351326,0.011046868376433849,0.40681086778640746,0.22533526718616487,0.04507759008556604,0.09295670837163925,0.04510567523539066,0.7644387006759643,0.40921531319618226,0.08952124081552029,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,4178.0,2473489.0,1342038.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CEP-32496,CHEMBL2029988,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)",DKNUPRMJNUQNHR-UHFFFAOYSA-N,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,0.3103792866850044,2.0,517.4640000000002,5.911200000000004,8,2,0,120.63000000000001,-6.556401566380979,0.9231156587600708,-4.882732331452629,0.9976501822471618,-9.471570783842811,0.8517094373703002,0.8801780223846436,0.6825120210647583,96.23526923871825,5.099155715791392,0.14318719506263733,0.7318573951721191,0.7659140229225159,0.059959274064749477,0.7038950860500336,96.83393062539857,28.06585498601327,94.91892943786752,3.5986175888328527,0.2503737762570381,0.3795116126537323,0.2824185937643051,0.9789002776145935,0.899782395362854,0.022841789200901984,0.004148971976246685,0.06862986758351326,0.011046868376433849,0.40681086778640746,0.22533526718616487,0.04507759008556604,0.09295670837163925,0.04510567523539066,0.7644387006759643,0.40921531319618226,0.08952124081552029,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4231.0,2795535.0,2077913.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,EGFR mutant selective including both activating mutations and T790M (PMID: 26508839). Covalent binder (PMID: 27357069).,,,355.0,OLMUTINIB,CHEMBL3786343,4.0,1.0,1.0,MOL,,Small molecule,2016.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2016.0,-1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)",FDMQDKQUTRLUBU-UHFFFAOYSA-N,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1,0.3516294002301692,3.0,486.6010000000003,5.103500000000004,8,2,0,82.61999999999999,-5.006788201840779,0.7171598672866821,-5.012777503488044,0.9554874897003174,-10.995086740712551,0.7183823823928833,0.860372257232666,0.6121428072452545,101.7891503801172,3.9765447541155767,0.22828024849295617,0.42509079575538633,0.31003176867961885,0.22225721329450607,0.7236716628074646,47.90819862004347,22.548816003176984,48.17836680297884,2.8366877412043623,0.417450886964798,0.31562442779541017,0.5915570974349975,0.9777154922485352,0.8802673935890197,0.03505624802783132,0.035608530044555664,0.13600767701864241,0.04319546595215797,0.5723555028438568,0.17702653706073762,0.0622863806784153,0.20637114644050597,0.2329001948237419,0.6457989096641541,0.7368735551834107,0.37895412743091583,True
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4236.0,2473193.0,2832061.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,THELIATINIB,CHEMBL5314410,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H26N6O2/c1-4-16-6-5-7-18(10-16)28-24-19-11-21(23(33-3)12-20(19)26-15-27-24)29-25(32)31-13-17-8-9-30(2)22(17)14-31/h1,5-7,10-12,15,17,22H,8-9,13-14H2,2-3H3,(H,29,32)(H,26,27,28)/t17-,22+/m1/s1",FSXCKIBROURMFT-VGSWGCGISA-N,C#Cc1cccc(Nc2ncnc3cc(OC)c(NC(=O)N4C[C@H]5CCN(C)[C@H]5C4)cc23)c1,0.6018286518686119,4.0,442.5230000000003,3.531100000000002,6,2,2,82.62,-3.822761237416253,0.9140938997268677,-4.8341793733759815,0.9958253979682923,-11.613916927617211,0.8286216735839844,0.3934958904981613,0.5350197315216064,79.90133661426023,4.955423965051387,0.2944870054721832,0.024013365805149078,0.019790772069245576,0.17249848768115045,0.8508861422538757,59.61410495667079,2.6402906269189614,8.184744036515834,3.1480950682297744,0.5247111052274704,0.13391960337758063,0.8418411612510681,0.935765516757965,0.7905665278434754,0.11253356970846654,0.06628865264356136,0.14155355095863342,0.043488684110343456,0.4893894553184509,0.0426631361246109,0.02605436621233821,0.16780288517475128,0.016737770475447177,0.1790298879146576,0.42534531354904176,0.08330883458256721,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4238.0,2473058.0,2832062.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,EPITINIB,CHEMBL5314411,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H26N6O2/c1-4-17-7-6-8-18(13-17)27-23-19-14-21(22(32-3)15-20(19)25-16-26-23)28-24(31)30-11-9-29(5-2)10-12-30/h1,6-8,13-16H,5,9-12H2,2-3H3,(H,28,31)(H,25,26,27)",DQAZPZIYEOGZAF-UHFFFAOYSA-N,C#Cc1cccc(Nc2ncnc3cc(OC)c(NC(=O)N4CCN(CC)CC4)cc23)c1,0.6028603287006304,4.0,430.51200000000034,3.532700000000003,6,2,0,82.62,-3.9393011689340645,0.8711951851844788,-4.755459661022611,0.9906463265419007,-11.427425273967668,0.8129644513130188,0.34587557762861254,0.569205641746521,81.7982134800352,7.91482876129803,0.3042448192834854,0.07661326453089715,0.0682256568223238,0.19688222780823708,0.86463303565979,44.283951801722345,8.505216792234283,26.220497015550354,2.8345276131742625,0.6162177920341492,0.21831726282835007,0.877047324180603,0.9579756736755372,0.8743111252784729,0.08334141485393047,0.040511291846632956,0.10373094379901886,0.0406549658626318,0.5046917378902436,0.047092098742723465,0.030378234572708607,0.08871697336435318,0.014576851530000568,0.170389424264431,0.3774277925491333,0.1580133020877838,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4306.0,2473264.0,1927045.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted kinase irreversible inhibitor,,,,PD-0166285,CHEMBL3545196,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H27Cl2N5O2.2ClH/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28;;/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31);2*1H",NADLBPWBFGTESN-UHFFFAOYSA-N,CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1.Cl.Cl,0.23854072774841034,2.0,585.3630000000004,6.610100000000006,7,1,0,72.28,-4.328487204718138,0.9092688083648681,-5.142734380726771,0.9644767999649048,-10.48527801370717,0.7670181155204773,0.9449167013168335,0.5736787557601929,95.63095812789098,19.70107296225528,0.2197791703045368,0.05614381656050682,0.048471792973577975,0.30829173773527146,0.20143414288759232,194.57840300490676,23.45337457358205,44.58568778629805,2.6125901903658844,0.7942415595054626,0.7097066640853882,0.7622846841812134,0.811219334602356,0.940076720714569,0.020612457208335398,0.048334863036870956,0.09084269255399705,0.04117682501673699,0.39586888551712035,0.19248572885990142,0.018233500234782696,0.10048906728625298,0.08134150132536888,0.3134178400039673,0.28833724558353424,0.3561887502670288,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4320.0,2473125.0,1285213.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Also potent against ABL1,,,,PKI-166,CHEMBL1963502,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H18N4O/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(24-20(17)22-12-21-19)15-7-9-16(25)10-8-15/h2-13,25H,1H3,(H2,21,22,23,24)/t13-/m1/s1",XRYJULCDUUATMC-CYBMUJFWSA-N,C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1,0.514782457940999,4.0,330.3910000000001,4.503600000000002,4,3,1,73.83,-5.1192346465354195,0.6973891139030457,-5.422315475537292,0.9995954990386963,-11.39372001841701,0.8297755479812622,0.27220257818698884,0.41184980273246763,99.30327867744403,4.595020660137854,0.970567238330841,0.7930335164070129,0.2940409451723099,0.576482355594635,0.680428659915924,-31.94290793210961,48.60284776578247,43.88517979554304,2.2183798635137157,0.517460286617279,0.12490660101175308,0.09491050839424134,0.8573029041290283,0.7977788209915161,0.029573109373450278,0.0311907896772027,0.6169894337654114,0.43541909754276276,0.8530921697616577,0.2896744549274445,0.03725350312888622,0.43394453525543214,0.2400713309645653,0.8137734889984131,0.48186299204826355,0.3816563576459885,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4488.0,2473005.0,2467403.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",,,,PUQUITINIB MESYLATE DIHYDRATE,CHEMBL4596972,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C17H15N7/c1-2-10-8-12(5-6-13(10)18-7-1)22-17-23-15-14(19-9-20-15)16(24-17)21-11-3-4-11/h1-2,5-9,11H,3-4H2,(H3,19,20,21,22,23,24)",QUTFBURLXCODBH-UHFFFAOYSA-N,c1cnc2ccc(Nc3nc(NC4CC4)c4nc[nH]c4n3)cc2c1,0.5351361440903852,4.0,317.35600000000005,3.219000000000001,6,3,0,91.41000000000001,-4.233453485122841,0.904756510257721,-5.3902160068534695,0.9999779224395752,-13.711784016951501,0.9251455545425415,0.18191006332635878,0.6708949089050293,95.23450704145097,7.346004609130661,0.9920349955558777,0.4021807640790939,0.23682516068220139,0.47032142281532285,0.8773758888244629,22.999388891349586,59.14287908022722,18.186637243727255,2.4924895973848127,0.6676513731479645,0.04903329201042652,0.08118872847408057,0.9780272722244263,0.8213990449905395,0.02452095374464989,0.06778449043631554,0.4382161140441895,0.15130310654640197,0.9811686873435974,0.4951963484287262,0.04174772184342146,0.8160436034202576,0.300673558190465,0.9574685454368591,0.8745540022850037,0.494706529378891,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4487.0,2473005.0,2467403.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",,,,PUQUITINIB MESYLATE DIHYDRATE,CHEMBL4596972,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C17H15N7/c1-2-10-8-12(5-6-13(10)18-7-1)22-17-23-15-14(19-9-20-15)16(24-17)21-11-3-4-11/h1-2,5-9,11H,3-4H2,(H3,19,20,21,22,23,24)",QUTFBURLXCODBH-UHFFFAOYSA-N,c1cnc2ccc(Nc3nc(NC4CC4)c4nc[nH]c4n3)cc2c1,0.5351361440903852,4.0,317.35600000000005,3.219000000000001,6,3,0,91.41000000000001,-4.233453485122841,0.904756510257721,-5.3902160068534695,0.9999779224395752,-13.711784016951501,0.9251455545425415,0.18191006332635878,0.6708949089050293,95.23450704145097,7.346004609130661,0.9920349955558777,0.4021807640790939,0.23682516068220139,0.47032142281532285,0.8773758888244629,22.999388891349586,59.14287908022722,18.186637243727255,2.4924895973848127,0.6676513731479645,0.04903329201042652,0.08118872847408057,0.9780272722244263,0.8213990449905395,0.02452095374464989,0.06778449043631554,0.4382161140441895,0.15130310654640197,0.9811686873435974,0.4951963484287262,0.04174772184342146,0.8160436034202576,0.300673558190465,0.9574685454368591,0.8745540022850037,0.494706529378891,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4623.0,2473542.0,1927160.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits ALK and EGFR gatekeeper mutants. Does not inhibit wild type (native) EGFR.,,,,BRIGATINIB,CHEMBL3545311,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)",AILRADAXUVEEIR-UHFFFAOYSA-N,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,0.3521921877728202,2.0,584.105,5.090000000000003,9,2,0,85.86,-4.001480940792472,0.7762289881706238,-5.351428062632885,0.9926103949546814,-9.277752907578034,0.9303226232528686,0.8880091428756713,0.7782098531723023,97.20841875783022,13.922975205599254,0.15457599684596063,0.2966655343770981,0.06494157910346984,0.516275680065155,0.5363321900367737,37.691450476349026,0.15859878631514307,41.526509027229366,2.7588758295929425,0.10304421409964562,0.2716963097453117,0.666849571466446,0.8581655383110046,0.9507499575614929,0.008298806613311172,0.005362866073846817,0.029011496156454087,0.022984722070395945,0.3626455098390579,0.1826155200600624,0.010125227179378271,0.01613701330497861,0.10120026767253876,0.36893894970417024,0.19571008533239365,0.25521047562360766,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4694.0,2473538.0,1927157.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Irreversible inhibitor, EGFR T790M mutant selective",,,,ROCILETINIB,CHEMBL3545308,3.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)",HUFOZJXAKZVRNJ-UHFFFAOYSA-N,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,0.34067543048991267,3.0,555.5610000000005,4.784200000000004,8,3,0,111.72,-6.026110239705117,0.7455559968948364,-5.0090290409156335,0.9783044219017029,-10.174663219251077,0.7260857701301575,0.8219321727752685,0.43894754648208617,98.45537137134855,1.6273358982657722,0.0830586913973093,0.58206125497818,0.46438326239585875,0.09294289126992225,0.7348425149917602,35.36490306753997,29.368325232617117,71.5850261350563,3.4999042302207615,0.5076099038124084,0.3311343789100647,0.4827437996864319,0.9776560068130493,0.8896009802818299,0.039008977636694905,0.018195900972932576,0.09298168793320656,0.04089670572429895,0.20190622210502623,0.18620987832546235,0.11445335075259208,0.1950366824865341,0.14489569514989853,0.7230155348777771,0.6967662215232849,0.17079712450504303,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,4713.0,1705102.0,604615.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Irreversible inhibitor,,,,PELITINIB,CHEMBL607707,2.0,0.0,0.0,MOL,38927.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2000.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32)/b6-5+",WVUNYSQLFKLYNI-AATRIKPKSA-N,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,0.44792324774633824,3.0,467.9320000000002,5.097580000000004,6,2,0,90.27999999999999,-5.417371684567199,0.849818205833435,-4.97147257010727,0.985103452205658,-12.968208971487389,0.7914740443229675,0.8591150045394897,0.5725534915924072,91.4459098090982,18.939470532480488,0.1661766067147255,0.3525692641735077,0.2784004032611847,0.22245842814445496,0.6640692353248596,158.95000003640192,59.48690806629821,76.66675608393562,3.3768385729589645,0.5436748743057251,0.5055070102214814,0.5149642705917359,0.9376823782920838,0.8618393063545227,0.021051111444830895,0.05045768767595291,0.0430260144174099,0.04186502546072006,0.5290621399879456,0.2943849146366119,0.05923649221658707,0.07644894793629646,0.12421671897172928,0.7237137794494629,0.6190146923065185,0.26515153497457505,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,5179.0,2473324.0,2077912.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,EGF816 is an irreversible TKI that demonstrates selectivity for mutant EGFRs compared with WT EGFR and targets activating and resistance mutations with equal potency (doi: 10.1158/1538-7445.AM2014-1734).,,,,NAZARTINIB,CHEMBL3787344,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2018.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1",IOMMMLWIABWRKL-WUTDNEBXSA-N,Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1,0.515927271936796,4.0,495.0270000000004,4.316820000000003,6,1,1,83.36,-3.5330174296252777,0.687086308002472,-5.010962873754158,0.9974515318870545,-11.7828451594325,0.9650545954704285,0.8786063671112061,0.8313793659210205,86.79125919443199,6.551307709654178,0.02687689196318388,0.3358819276094437,0.21641296446323394,0.42401347756385804,0.8666400909423828,74.55069329063598,36.62488271485315,45.97325561944177,2.819082353522689,0.3430312842130661,0.2525341555476189,0.7940680980682373,0.7466777324676513,0.9016991496086121,0.016522822249680758,0.009596347529441118,0.060242564976215364,0.01247014831751585,0.11083600558340549,0.08455464020371437,0.01162563804537058,0.0190694659948349,0.05896690227091313,0.07311168760061264,0.04586406499147415,0.22044584155082703,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,5260.0,2473534.0,1817518.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion)",,,355.0,OSIMERTINIB,CHEMBL3353410,4.0,1.0,1.0,MOL,,Small molecule,2015.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2015.0,1.0,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)",DUYJMQONPNNFPI-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,0.3105348061023151,4.0,499.6190000000003,4.509800000000003,8,2,0,87.55,-3.63474776106458,0.7861036777496337,-5.083293389981638,0.9898865938186645,-11.635192817691422,0.8766871333122254,0.9510339617729187,0.7369569063186645,91.45792372229793,4.597653105796111,0.374658414721489,0.20983825623989105,0.040884908847510816,0.4662174165248871,0.826210331916809,66.58637312693047,28.353012862045183,90.51260116152676,3.2865028202934554,0.740211820602417,0.31663026511669157,0.6623208880424499,0.9119496941566467,0.9573905229568481,0.028087845630943777,0.07526086270809174,0.04738834798336029,0.05181910991668701,0.7377718448638916,0.27033610492944715,0.031841841340065,0.22351044714450835,0.1817425012588501,0.39225010871887206,0.6148615777492523,0.20261069834232331,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,5330.0,2473325.0,1927084.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SIMOTINIB,CHEMBL3545235,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H26ClFN4O4/c1-32-21-12-20-17(23(29-15-28-20)30-16-2-3-19(27)18(26)10-16)11-22(21)33-7-6-31-13-24(4-5-24)25(14-31)34-8-9-35-25/h2-3,10-12,15H,4-9,13-14H2,1H3,(H,28,29,30)",OXWUWXCJDBRCCG-UHFFFAOYSA-N,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CC2)C2(C1)OCCO2,0.5115078939147606,3.0,500.95800000000054,4.392200000000003,8,1,0,77.97000000000001,-4.545013053183053,0.9306287646293641,-4.864955020215456,0.9998335242271423,-10.032695776460947,0.929381275177002,0.7977513074874878,0.9387724280357361,97.499709950838,7.019255630560474,0.33025685548782346,0.2849442660808563,0.19916208386421203,0.2049932934343815,0.9790251970291137,35.55039777964019,24.00541594379174,44.278544110914105,3.658464391301684,0.3247206062078476,0.09293587058782578,0.6490803539752961,0.8537572622299194,0.9242292642593384,0.02322564534842968,0.022284554364159704,0.08441797271370888,0.03914955910295248,0.572496771812439,0.32311428189277647,0.06026371605694294,0.27177415043115616,0.1345889002084732,0.4546910047531128,0.31709580272436144,0.1236081063747406,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,7766.0,3132824.0,2335229.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Targets variant T790M and activating mutants,,355.0,FIRMONERTINIB,CHEMBL4297258,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H31F3N8O2/c1-6-24(40)33-21-15-22(26(41-17-28(29,30)31)36-25(21)38(4)14-13-37(2)3)35-27-32-12-11-20(34-27)19-16-39(5)23-10-8-7-9-18(19)23/h6-12,15-16H,1,13-14,17H2,2-5H3,(H,33,40)(H,32,34,35)",GHKOONMJXNWOIW-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC(F)(F)F)nc1N(C)CCN(C)C,0.24821484243638506,3.0,568.604,4.8373000000000035,9,2,0,100.44,-4.579258847117751,0.773775291442871,-5.03568956166582,0.9905104637145996,-9.70356697969084,0.8242480993270874,0.9348729252815247,0.796029269695282,90.52190140181153,6.71547581717472,0.32251384258270266,0.15517140924930573,0.041167022893205285,0.543254679441452,0.7398029208183289,112.79221331896818,39.0850025771284,81.65776934174582,3.6525005884373116,0.7701037883758545,0.44314404726028445,0.7864322543144227,0.8727372884750366,0.9608043432235718,0.03484941758215428,0.131803061068058,0.05747495144605637,0.04347449690103531,0.343550044298172,0.3197799623012543,0.0582893967628479,0.1912158101797104,0.07033647447824479,0.5226585805416107,0.4890917241573334,0.15344291627407075,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8101.0,3132824.0,2335229.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Targets variant T790M and activating mutants,,-1.0,FIRMONERTINIB,CHEMBL4297258,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H31F3N8O2/c1-6-24(40)33-21-15-22(26(41-17-28(29,30)31)36-25(21)38(4)14-13-37(2)3)35-27-32-12-11-20(34-27)19-16-39(5)23-10-8-7-9-18(19)23/h6-12,15-16H,1,13-14,17H2,2-5H3,(H,33,40)(H,32,34,35)",GHKOONMJXNWOIW-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC(F)(F)F)nc1N(C)CCN(C)C,0.24821484243638506,3.0,568.604,4.8373000000000035,9,2,0,100.44,-4.579258847117751,0.773775291442871,-5.03568956166582,0.9905104637145996,-9.70356697969084,0.8242480993270874,0.9348729252815247,0.796029269695282,90.52190140181153,6.71547581717472,0.32251384258270266,0.15517140924930573,0.041167022893205285,0.543254679441452,0.7398029208183289,112.79221331896818,39.0850025771284,81.65776934174582,3.6525005884373116,0.7701037883758545,0.44314404726028445,0.7864322543144227,0.8727372884750366,0.9608043432235718,0.03484941758215428,0.131803061068058,0.05747495144605637,0.04347449690103531,0.343550044298172,0.3197799623012543,0.0582893967628479,0.1912158101797104,0.07033647447824479,0.5226585805416107,0.4890917241573334,0.15344291627407075,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,7799.0,3132563.0,2076851.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for T790M-containing EGFR,,355.0,PF-06459988,CHEMBL3786098,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H22ClN7O3/c1-4-15(28)27-7-11(14(9-27)29-3)10-30-18-16-13(20)6-21-17(16)24-19(25-18)23-12-5-22-26(2)8-12/h4-6,8,11,14H,1,7,9-10H2,2-3H3,(H2,21,23,24,25)/t11-,14+/m1/s1",ODMXWZROLKITMS-RISCZKNCSA-N,C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](OC)C1,0.5511036552632873,4.0,431.8840000000001,2.126599999999999,8,2,2,110.19000000000001,-4.254017241892472,0.8849555492401123,-5.101341448829691,0.999065387248993,-11.923291470674737,0.8966773867607116,0.32745420932769775,0.6395322740077972,94.72681996810691,-2.7526124369426332,0.37796697318553923,0.155788604170084,0.10625938400626182,0.039284317567944524,0.6965894103050232,5.896166686558486,47.74117670942796,51.640567255411064,2.8339421812522403,0.3244125694036484,0.07174953278154135,0.36235482394695284,0.9407418608665467,0.8074482321739197,0.010813627671450377,0.01912073725834489,0.07076491490006447,0.038754192739725114,0.5717477023601532,0.0947955995798111,0.03737720176577568,0.29054821729660035,0.07061117589473724,0.11298981532454491,0.5028545081615448,0.17237091958522796,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,7803.0,2973328.0,2197841.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,356.0,MAVELERTINIB,CHEMBL3989970,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1",JYIUNVOCEFIUIU-GHMZBOCLSA-N,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F,0.5650301203796078,4.0,415.43300000000016,0.6778999999999995,10,2,2,115.02000000000002,-3.808810927711703,0.9437853574752808,-5.001631999367482,0.9996772766113281,-11.767804855278161,0.9170316576957702,0.5017539024353027,0.7640055775642395,80.8351351774188,-1.3119476219574833,0.21829966753721236,0.04815333066508174,0.11009995862841607,0.04377810209989548,0.48953741490840913,-2.075517076514477,27.85236044789923,55.58793237026924,3.3264397237891368,0.9574203848838806,0.19815948605537415,0.5270860522985459,0.9690564513206482,0.8704080700874328,0.007204777467995882,0.014077914971858263,0.07389713525772094,0.022209183685481547,0.2003108114004135,0.21378015577793122,0.06226763688027859,0.4818309485912323,0.05346072427928448,0.17239978462457656,0.6392619252204895,0.35358472168445587,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8447.0,2973328.0,2197841.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,-1.0,MAVELERTINIB,CHEMBL3989970,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1",JYIUNVOCEFIUIU-GHMZBOCLSA-N,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F,0.5650301203796078,4.0,415.43300000000016,0.6778999999999995,10,2,2,115.02000000000002,-3.808810927711703,0.9437853574752808,-5.001631999367482,0.9996772766113281,-11.767804855278161,0.9170316576957702,0.5017539024353027,0.7640055775642395,80.8351351774188,-1.3119476219574833,0.21829966753721236,0.04815333066508174,0.11009995862841607,0.04377810209989548,0.48953741490840913,-2.075517076514477,27.85236044789923,55.58793237026924,3.3264397237891368,0.9574203848838806,0.19815948605537415,0.5270860522985459,0.9690564513206482,0.8704080700874328,0.007204777467995882,0.014077914971858263,0.07389713525772094,0.022209183685481547,0.2003108114004135,0.21378015577793122,0.06226763688027859,0.4818309485912323,0.05346072427928448,0.17239978462457656,0.6392619252204895,0.35358472168445587,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8448.0,2973328.0,2197841.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,355.0,MAVELERTINIB,CHEMBL3989970,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1",JYIUNVOCEFIUIU-GHMZBOCLSA-N,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F,0.5650301203796078,4.0,415.43300000000016,0.6778999999999995,10,2,2,115.02000000000002,-3.808810927711703,0.9437853574752808,-5.001631999367482,0.9996772766113281,-11.767804855278161,0.9170316576957702,0.5017539024353027,0.7640055775642395,80.8351351774188,-1.3119476219574833,0.21829966753721236,0.04815333066508174,0.11009995862841607,0.04377810209989548,0.48953741490840913,-2.075517076514477,27.85236044789923,55.58793237026924,3.3264397237891368,0.9574203848838806,0.19815948605537415,0.5270860522985459,0.9690564513206482,0.8704080700874328,0.007204777467995882,0.014077914971858263,0.07389713525772094,0.022209183685481547,0.2003108114004135,0.21378015577793122,0.06226763688027859,0.4818309485912323,0.05346072427928448,0.17239978462457656,0.6392619252204895,0.35358472168445587,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8449.0,2973328.0,2197841.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,354.0,MAVELERTINIB,CHEMBL3989970,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1",JYIUNVOCEFIUIU-GHMZBOCLSA-N,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F,0.5650301203796078,4.0,415.43300000000016,0.6778999999999995,10,2,2,115.02000000000002,-3.808810927711703,0.9437853574752808,-5.001631999367482,0.9996772766113281,-11.767804855278161,0.9170316576957702,0.5017539024353027,0.7640055775642395,80.8351351774188,-1.3119476219574833,0.21829966753721236,0.04815333066508174,0.11009995862841607,0.04377810209989548,0.48953741490840913,-2.075517076514477,27.85236044789923,55.58793237026924,3.3264397237891368,0.9574203848838806,0.19815948605537415,0.5270860522985459,0.9690564513206482,0.8704080700874328,0.007204777467995882,0.014077914971858263,0.07389713525772094,0.022209183685481547,0.2003108114004135,0.21378015577793122,0.06226763688027859,0.4818309485912323,0.05346072427928448,0.17239978462457656,0.6392619252204895,0.35358472168445587,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,7804.0,2794876.0,1996864.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Active against WT and variant EGFR. Increased activity against activating and resistance mutants vs. wild-type target.,,,NAQUOTINIB,CHEMBL3663929,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2015.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H42N8O3/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34)/t24-/m1/s1",QKDCLUARMDUUKN-XMMPIXPASA-N,C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1,0.4436135841954446,3.0,562.7190000000003,2.2634000000000016,9,2,1,120.16000000000001,-2.948784001116264,0.4890156686306,-5.421712514434819,0.9200021505355835,-10.852204279177409,0.709496283531189,0.603684949874878,0.6424566447734833,76.95281628003785,11.424100920557075,0.019734469521790744,0.06585671752691269,0.03613457977771759,0.19349637180566787,0.15563398376107215,4.442193734104535,0.9834740773278312,39.98069376308662,2.483189820684534,0.2335750088095665,0.10685599967837334,0.6302989065647125,0.6727950096130371,0.834698224067688,0.03848836831748485,0.036206679046154024,0.08971517831087113,0.05540984459221363,0.020636863261461257,0.03259148634970188,0.008196896477602422,0.06552371233701706,0.04290048182010651,0.07762080430984497,0.21042148321866988,0.235037362575531,True
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8102.0,3132462.0,1966980.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Some selectivity for EGFR mutants over wild-type.,,,AZD-3759,CHEMBL3623290,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H23ClFN5O3/c1-13-11-28(2)7-8-29(13)22(30)32-19-9-14-17(10-18(19)31-3)25-12-26-21(14)27-16-6-4-5-15(23)20(16)24/h4-6,9-10,12-13H,7-8,11H2,1-3H3,(H,25,26,27)/t13-/m1/s1",MXDSJQHFFDGFDK-CYBMUJFWSA-N,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,0.6223010250054946,4.0,459.90900000000033,4.309200000000003,7,1,1,79.82,-4.426109746356173,0.9118553042411804,-4.59048621846262,0.9991088032722473,-11.629259057411018,0.9608422517776489,0.6701966881752014,0.8043056845664978,94.8591192017766,3.4473071949936127,0.17586298584938048,0.26876434683799744,0.13511281609535217,0.06518894657492638,0.9185307145118713,34.376917353867285,21.43019441276889,46.855176914747815,3.23018023898423,0.2657824754714966,0.1496437057852745,0.8019018173217773,0.9780120491981507,0.8565857529640197,0.025142104551196098,0.009460837813094258,0.04309057332575321,0.01680526239797473,0.3057363122701645,0.07235164418816567,0.03630661815404892,0.03035687478259206,0.011213669506832957,0.13087144121527672,0.12824957370758056,0.08474455028772354,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8143.0,3461024.0,2508805.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Targets EGFR with activating or T790M mutations.,,355.0,AUMOLERTINIB,CHEMBL4761468,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2021.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34)",DOEOECWDNSEFDN-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,0.25676664498036694,2.0,525.6570000000004,5.307700000000005,8,2,0,87.55,-4.331683871422696,0.7986210227012634,-4.894301728058556,0.9945578217506409,-11.583355665457741,0.8825605750083924,0.9127084493637085,0.8594564199447632,95.354159460212,10.130282893817817,0.4247915655374527,0.26905724704265593,0.06171311363577843,0.5660981804132461,0.8812829256057739,52.086513027755096,32.64737035646225,98.31311039158273,3.622604689096181,0.6982901096343994,0.27140518128871916,0.6495709300041199,0.9297541379928589,0.9389301896095276,0.01477123461663723,0.04842917360365391,0.054875316470861434,0.04159350618720055,0.7264976024627685,0.2824573338031769,0.04340943694114685,0.3279208779335022,0.28529765605926516,0.596074891090393,0.7074556887149811,0.25644118189811704,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8387.0,3461024.0,2508805.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Targets EGFR with activating or T790M mutations.,,-1.0,AUMOLERTINIB,CHEMBL4761468,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2021.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34)",DOEOECWDNSEFDN-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,0.25676664498036694,2.0,525.6570000000004,5.307700000000005,8,2,0,87.55,-4.331683871422696,0.7986210227012634,-4.894301728058556,0.9945578217506409,-11.583355665457741,0.8825605750083924,0.9127084493637085,0.8594564199447632,95.354159460212,10.130282893817817,0.4247915655374527,0.26905724704265593,0.06171311363577843,0.5660981804132461,0.8812829256057739,52.086513027755096,32.64737035646225,98.31311039158273,3.622604689096181,0.6982901096343994,0.27140518128871916,0.6495709300041199,0.9297541379928589,0.9389301896095276,0.01477123461663723,0.04842917360365391,0.054875316470861434,0.04159350618720055,0.7264976024627685,0.2824573338031769,0.04340943694114685,0.3279208779335022,0.28529765605926516,0.596074891090393,0.7074556887149811,0.25644118189811704,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8148.0,3131917.0,1365023.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ICOTINIB,CHEMBL2087361,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)",QQLKULDARVNMAL-UHFFFAOYSA-N,C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,0.6727670764195051,4.0,391.4270000000003,3.1591000000000014,7,1,0,74.73000000000002,-4.477796192342492,0.9418740391731262,-4.743488676352794,0.9978009462356567,-9.008224497469481,0.8201396942138672,0.433526211977005,0.6997460722923279,93.18509082988216,8.176340321194079,0.7579772472381592,0.4092708855867386,0.2964617908000946,0.151007042825222,0.8691076159477233,25.325872374167226,29.730905708143744,11.076844496544172,2.4582798275335924,0.46689978837966917,0.2610529996454716,0.18769657462835312,0.9645936369895936,0.7366347074508667,0.10269532799720764,0.0447584331035614,0.18882201313972474,0.06889328407123685,0.7265352725982666,0.3184359587728977,0.06966821290552616,0.21596450209617615,0.12552540004253387,0.3744724377989769,0.3811075881123543,0.2853206962347031,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8193.0,3133506.0,2335837.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Enhanced activity against 'activated' and T790M-type EGFR mutants,,355.0,ABIVERTINIB MALEATE,CHEMBL4297866,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H26FN7O2.C4H4O4.2H2O/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34;5-3(6)1-2-4(7)8;;/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32);1-2H,(H,5,6)(H,7,8);2*1H2/b;2-1-;;",QITOONQVTOGMOJ-IUJXYRIYSA-N,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1.O.O.O=C(O)/C=C\C(=O)O,0.16684976769772972,3.0,639.6410000000004,2.5716,9,5,0,236.00999999999996,-3.8790929533096574,0.7312411904335022,-5.670679157402366,0.46160917580127714,-13.853236938974026,0.17283905595541,0.16748442873358727,0.4224496573209763,83.83082170138393,1.1609889105060804,0.0807572053745389,0.19655746072530747,0.1905834324657917,0.0891136672347784,0.23507405072450638,36.74448944955539,-30.98060845171447,-4.916058796672931,2.9686839076376796,0.28060589283704757,0.3376957312226295,0.8126688241958618,0.9788508772850036,0.7484496474266052,0.04079867471009493,0.014735254365950823,0.06496587134897709,0.028161124512553214,0.12672543227672578,0.04840169176459312,0.09343188926577568,0.19962488412857055,0.03838052796199918,0.14935399889945983,0.3287539094686508,0.19223062247037886,True
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8410.0,3133506.0,2335837.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Enhanced activity against 'activated' and T790M-type EGFR mutants,,-1.0,ABIVERTINIB MALEATE,CHEMBL4297866,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H26FN7O2.C4H4O4.2H2O/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34;5-3(6)1-2-4(7)8;;/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32);1-2H,(H,5,6)(H,7,8);2*1H2/b;2-1-;;",QITOONQVTOGMOJ-IUJXYRIYSA-N,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1.O.O.O=C(O)/C=C\C(=O)O,0.16684976769772972,3.0,639.6410000000004,2.5716,9,5,0,236.00999999999996,-3.8790929533096574,0.7312411904335022,-5.670679157402366,0.46160917580127714,-13.853236938974026,0.17283905595541,0.16748442873358727,0.4224496573209763,83.83082170138393,1.1609889105060804,0.0807572053745389,0.19655746072530747,0.1905834324657917,0.0891136672347784,0.23507405072450638,36.74448944955539,-30.98060845171447,-4.916058796672931,2.9686839076376796,0.28060589283704757,0.3376957312226295,0.8126688241958618,0.9788508772850036,0.7484496474266052,0.04079867471009493,0.014735254365950823,0.06496587134897709,0.028161124512553214,0.12672543227672578,0.04840169176459312,0.09343188926577568,0.19962488412857055,0.03838052796199918,0.14935399889945983,0.3287539094686508,0.19223062247037886,True
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8194.0,3133504.0,2335836.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Enhanced activity against 'activated' and T790M-type EGFR mutants,,355.0,ABIVERTINIB,CHEMBL4297865,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)",UOFYSRZSLXWIQB-UHFFFAOYSA-N,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,0.33007410054157627,4.0,487.53900000000027,4.5092000000000025,7,3,0,98.41,-5.305391512432221,0.8042476415634155,-5.052013827561348,0.9920965552330017,-12.083465136335501,0.7368369460105896,0.7933658957481384,0.5275263637304306,98.71103744347928,11.509352882675959,0.300798799097538,0.5101124763488769,0.3857860296964645,0.1743032641708851,0.8164124608039856,49.0857186255683,33.263235051777386,47.75704960470098,3.256553644055901,0.3568533301353455,0.34947720617055894,0.6932023882865905,0.9828023195266724,0.9550236701965332,0.027306435722857715,0.018172077462077142,0.06833460554480553,0.026506801042705773,0.6220205843448638,0.12695395648479463,0.04396243691444397,0.20520918667316437,0.07978680357336998,0.5958548307418823,0.5960148334503174,0.19191106408834457,True
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8440.0,3133504.0,2335836.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Enhanced activity against 'activated' and T790M-type EGFR mutants,,-1.0,ABIVERTINIB,CHEMBL4297865,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2017.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)",UOFYSRZSLXWIQB-UHFFFAOYSA-N,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,0.33007410054157627,4.0,487.53900000000027,4.5092000000000025,7,3,0,98.41,-5.305391512432221,0.8042476415634155,-5.052013827561348,0.9920965552330017,-12.083465136335501,0.7368369460105896,0.7933658957481384,0.5275263637304306,98.71103744347928,11.509352882675959,0.300798799097538,0.5101124763488769,0.3857860296964645,0.1743032641708851,0.8164124608039856,49.0857186255683,33.263235051777386,47.75704960470098,3.256553644055901,0.3568533301353455,0.34947720617055894,0.6932023882865905,0.9828023195266724,0.9550236701965332,0.027306435722857715,0.018172077462077142,0.06833460554480553,0.026506801042705773,0.6220205843448638,0.12695395648479463,0.04396243691444397,0.20520918667316437,0.07978680357336998,0.5958548307418823,0.5960148334503174,0.19191106408834457,True
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8505.0,3489941.0,2012045.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Inhibits WT and L858R mutant EGFR. Also inhibits FYN, HCK, KDR, PDGFRÎ², CSF1R, FGFR1 and FGFR2 with moderate activity.",,,RUSERONTINIB,CHEMBL3678958,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H29N9/c1-17(2)33-22-21(29-24(33)28-19-5-4-10-25-15-19)16-26-23(30-22)27-18-6-8-20(9-7-18)32-13-11-31(3)12-14-32/h4-10,15-17H,11-14H2,1-3H3,(H,28,29)(H,26,27,30)",WSOHOUHPUOAXIN-UHFFFAOYSA-N,CC(C)n1c(Nc2cccnc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,0.461715138472578,4.0,443.5590000000003,4.041200000000003,9,2,0,87.02999999999999,-3.229892607785563,0.7618894934654236,-5.3613678158289755,0.9778535008430481,-11.829319001736687,0.8416532278060913,0.46609931588172915,0.37944326400756834,88.02741584523221,22.646135438337332,0.33865906298160553,0.15818390250205994,0.1740776225924492,0.2812856242060661,0.5734843254089356,46.49046280538805,28.412893619645978,34.304552227748665,2.410331790903485,0.2595400080084801,0.17564569264650345,0.5485565900802613,0.9445174098014831,0.9442630290985108,0.03412052094936371,0.062438839301466945,0.09498044773936272,0.05517391115427017,0.6803655922412872,0.47515141367912295,0.03009674362838268,0.19667999297380448,0.13152450546622277,0.5848024010658264,0.622765040397644,0.2989284545183182,True
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,8515.0,3489941.0,2012045.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Also inhibits FYN, HCK, KDR, PDGFRÎ², CSF1R, FGFR1 and FGFR2 with moderate activity.",,,RUSERONTINIB,CHEMBL3678958,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H29N9/c1-17(2)33-22-21(29-24(33)28-19-5-4-10-25-15-19)16-26-23(30-22)27-18-6-8-20(9-7-18)32-13-11-31(3)12-14-32/h4-10,15-17H,11-14H2,1-3H3,(H,28,29)(H,26,27,30)",WSOHOUHPUOAXIN-UHFFFAOYSA-N,CC(C)n1c(Nc2cccnc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,0.461715138472578,4.0,443.5590000000003,4.041200000000003,9,2,0,87.02999999999999,-3.229892607785563,0.7618894934654236,-5.3613678158289755,0.9778535008430481,-11.829319001736687,0.8416532278060913,0.46609931588172915,0.37944326400756834,88.02741584523221,22.646135438337332,0.33865906298160553,0.15818390250205994,0.1740776225924492,0.2812856242060661,0.5734843254089356,46.49046280538805,28.412893619645978,34.304552227748665,2.410331790903485,0.2595400080084801,0.17564569264650345,0.5485565900802613,0.9445174098014831,0.9442630290985108,0.03412052094936371,0.062438839301466945,0.09498044773936272,0.05517391115427017,0.6803655922412872,0.47515141367912295,0.03009674362838268,0.19667999297380448,0.13152450546622277,0.5848024010658264,0.622765040397644,0.2989284545183182,True
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,8591.0,3490058.0,2486541.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Increased activity against EGFR mutants vs. wild-type,Increased activity against EGFR mutants vs. wild-type,,-1.0,CLN-081,CHEMBL4650281,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H20N6O/c1-3-18(30)28-16-8-13(2)21-19(15-9-14-6-4-5-7-17(14)25-10-15)20-22(24)26-12-27-23(20)29(21)11-16/h3-10,12,16H,1,11H2,2H3,(H,28,30)(H2,24,26,27)/t16-/m0/s1",MKCYPWYURWOKST-INIZCTEOSA-N,C=CC(=O)N[C@H]1C=C(C)c2c(-c3cnc4ccccc4c3)c3c(N)ncnc3n2C1,0.5177712309188474,4.0,396.4540000000002,3.3164000000000007,6,2,1,98.72,-3.696508228910806,0.6899152040481568,-5.233337206026213,0.9978306293487549,-12.559647503139507,0.8879953622817993,0.5070057451725006,0.7048714697360993,90.2365814185234,-1.899820633351645,0.42500580847263336,0.3131771430373192,0.15709429159760474,0.2126260593533516,0.836621880531311,20.094176842411365,21.5961911111827,68.0217917277097,3.022422440212034,0.7341397643089295,0.17348833084106446,0.5036748826503754,0.9424721837043762,0.7540401577949524,0.05407878756523132,0.1363806650042534,0.2021244391798973,0.18021591603755951,0.5331592977046966,0.5193994343280792,0.07635141983628273,0.13529157862067223,0.18869094252586366,0.3124884366989136,0.6097898721694947,0.41066054105758665,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,9098.0,3490097.0,2486579.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Inhibits EGFR exon 20 insertion mutants at lower concentrations than wild type. Also inhibits HER2, HER4 and BLK kinases.",,-1.0,MOBOCERTINIB,CHEMBL4650319,4.0,1.0,0.0,MOL,,Small molecule,2021.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2020.0,1.0,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36)",AZSRSNUQCUDCGG-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,0.17365909455648496,2.0,585.709,5.075000000000005,10,2,0,113.85,-4.723851546458288,0.6829108953475952,-4.791398992391045,0.9779954075813293,-11.087722172327164,0.8593764066696167,0.9513977289199829,0.5446584403514863,90.05581905012292,8.268717696201291,0.2598692312836647,0.3385395333170891,0.1524186484515667,0.23384093791246413,0.746520483493805,98.689107106529,71.74616900207204,132.0238002772108,3.2813341287730737,0.5669079422950745,0.26085958182811736,0.5636254847049713,0.9282055139541626,0.9265424251556397,0.02952382080256939,0.06872502714395523,0.03371459357440472,0.0420745138078928,0.6032040655612946,0.1876514047384262,0.04309785328805447,0.2578591614961624,0.16311055272817612,0.4936687171459198,0.5822043180465698,0.19944935888051987,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,9248.0,3460881.0,2428752.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,355.0,LAZERTINIB,CHEMBL4558324,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34)",RRMJMHOQSALEJJ-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,0.28004920687310475,3.0,554.6550000000002,4.104200000000003,10,2,0,109.67000000000002,-4.74488741957021,0.8137011528015137,-5.035183427672675,0.9812027931213378,-11.058737890612411,0.8203512072563172,0.8632714629173279,0.4300573468208313,94.00859563562526,4.226536018225981,0.08108591362833976,0.35443376898765566,0.2741595387458801,0.13565138280391692,0.6447767019271851,-1.923333421742813,34.17876619670955,94.80240168349101,3.314076730987984,0.3007922977209091,0.31255523562431337,0.5650783181190491,0.9728821277618408,0.9262939453125,0.017843306995928288,0.017123495042324067,0.05154527500271797,0.034743289090693,0.4786040961742401,0.19707410782575607,0.047110330685973166,0.15603559464216232,0.14492346346378326,0.5803567826747894,0.5848292171955108,0.2060963600873947,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,9249.0,3460881.0,2428752.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,354.0,LAZERTINIB,CHEMBL4558324,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34)",RRMJMHOQSALEJJ-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,0.28004920687310475,3.0,554.6550000000002,4.104200000000003,10,2,0,109.67000000000002,-4.74488741957021,0.8137011528015137,-5.035183427672675,0.9812027931213378,-11.058737890612411,0.8203512072563172,0.8632714629173279,0.4300573468208313,94.00859563562526,4.226536018225981,0.08108591362833976,0.35443376898765566,0.2741595387458801,0.13565138280391692,0.6447767019271851,-1.923333421742813,34.17876619670955,94.80240168349101,3.314076730987984,0.3007922977209091,0.31255523562431337,0.5650783181190491,0.9728821277618408,0.9262939453125,0.017843306995928288,0.017123495042324067,0.05154527500271797,0.034743289090693,0.4786040961742401,0.19707410782575607,0.047110330685973166,0.15603559464216232,0.14492346346378326,0.5803567826747894,0.5848292171955108,0.2060963600873947,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,9503.0,3460881.0,2428752.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,-1.0,LAZERTINIB,CHEMBL4558324,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34)",RRMJMHOQSALEJJ-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,0.28004920687310475,3.0,554.6550000000002,4.104200000000003,10,2,0,109.67000000000002,-4.74488741957021,0.8137011528015137,-5.035183427672675,0.9812027931213378,-11.058737890612411,0.8203512072563172,0.8632714629173279,0.4300573468208313,94.00859563562526,4.226536018225981,0.08108591362833976,0.35443376898765566,0.2741595387458801,0.13565138280391692,0.6447767019271851,-1.923333421742813,34.17876619670955,94.80240168349101,3.314076730987984,0.3007922977209091,0.31255523562431337,0.5650783181190491,0.9728821277618408,0.9262939453125,0.017843306995928288,0.017123495042324067,0.05154527500271797,0.034743289090693,0.4786040961742401,0.19707410782575607,0.047110330685973166,0.15603559464216232,0.14492346346378326,0.5803567826747894,0.5848292171955108,0.2060963600873947,False
EGFR,9,SINGLE PROTEIN,Epidermal growth factor receptor erbB1,9606,Homo sapiens,CHEMBL203,,0.0,9502.0,3841356.0,2537490.0,Epidermal growth factor receptor erbB1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Inhibits EGFR exon 20 insertion mutants at lower concentrations than wild type. Also inhibits HER2, HER4 and BLK kinases.",,-1.0,MOBOCERTINIB SUCCINATE,CHEMBL4802239,4.0,1.0,1.0,MOL,,Small molecule,2021.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib (-ertinib),tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors,,0.0,0.0,0.0,"InChI=1S/C32H39N7O4.C4H6O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26;5-3(6)1-2-4(7)8/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36);1-2H2,(H,5,6)(H,7,8)",YXYAEUMTJQGKHS-UHFFFAOYSA-N,C=CC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.O=C(O)CCC(=O)O,0.0956406084355808,1.0,703.7969999999999,5.010800000000003,12,4,0,188.44999999999996,-3.100853415438029,0.7150780916213989,-5.498918666540659,0.53963982462883,-12.126676428379728,0.44266954660415647,0.6575321912765503,0.4799530625343323,82.9716223624317,1.5738357582659401,0.12384126111865043,0.13222357258200645,0.10600818581879139,0.14303574673831462,0.2746057823300362,80.18209252794105,25.064114897348244,66.4827748451597,3.11506552185511,0.43727092146873475,0.2653967678546906,0.7153970003128052,0.9023489713668823,0.7478762626647949,0.05186848007142544,0.03604943044483662,0.05872493684291839,0.05912184044718742,0.2509651333093643,0.11564609557390212,0.05763777047395706,0.1519909143447876,0.08151072263717651,0.13185081779956817,0.3080671697854996,0.20432212501764296,False
EGFR,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,1546.0,1343277.0,33576.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VANDETANIB,CHEMBL24828,4.0,1.0,1.0,MOL,49960.0,Small molecule,2011.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,2006.0,1.0,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",UHTHHESEBZOYNR-UHFFFAOYSA-N,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,0.593560925290803,4.0,475.3620000000003,4.426100000000003,5,1,0,62.74,-3.90845181842855,0.9441968560218811,-4.761129651805894,0.9995619177818298,-10.307769611844671,0.9318894505500793,0.8976777911186218,0.9674631834030152,97.26850382553361,6.8868374136772825,0.4528655230998993,0.26755266189575194,0.1485746830701828,0.5170084476470947,0.6607233285903931,-3.7412634216237164,9.733376151954058,18.20410625785708,3.1936732974413893,0.23738061785697936,0.17964832112193108,0.7708351850509644,0.6762067794799804,0.9650172352790832,0.01759514641016722,0.00722807515412569,0.04878425151109696,0.007139564910903573,0.6472164511680603,0.08151322901248932,0.006277169077657163,0.062186908721923825,0.04610055088996887,0.115489661693573,0.05564761646091938,0.14995385929942132,False
ERBB2_HER2,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,1546.0,1343277.0,33576.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VANDETANIB,CHEMBL24828,4.0,1.0,1.0,MOL,49960.0,Small molecule,2011.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,2006.0,1.0,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",UHTHHESEBZOYNR-UHFFFAOYSA-N,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,0.593560925290803,4.0,475.3620000000003,4.426100000000003,5,1,0,62.74,-3.90845181842855,0.9441968560218811,-4.761129651805894,0.9995619177818298,-10.307769611844671,0.9318894505500793,0.8976777911186218,0.9674631834030152,97.26850382553361,6.8868374136772825,0.4528655230998993,0.26755266189575194,0.1485746830701828,0.5170084476470947,0.6607233285903931,-3.7412634216237164,9.733376151954058,18.20410625785708,3.1936732974413893,0.23738061785697936,0.17964832112193108,0.7708351850509644,0.6762067794799804,0.9650172352790832,0.01759514641016722,0.00722807515412569,0.04878425151109696,0.007139564910903573,0.6472164511680603,0.08151322901248932,0.006277169077657163,0.062186908721923825,0.04610055088996887,0.115489661693573,0.05564761646091938,0.14995385929942132,False
ERBB4_HER4,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,1546.0,1343277.0,33576.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VANDETANIB,CHEMBL24828,4.0,1.0,1.0,MOL,49960.0,Small molecule,2011.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,2006.0,1.0,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",UHTHHESEBZOYNR-UHFFFAOYSA-N,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,0.593560925290803,4.0,475.3620000000003,4.426100000000003,5,1,0,62.74,-3.90845181842855,0.9441968560218811,-4.761129651805894,0.9995619177818298,-10.307769611844671,0.9318894505500793,0.8976777911186218,0.9674631834030152,97.26850382553361,6.8868374136772825,0.4528655230998993,0.26755266189575194,0.1485746830701828,0.5170084476470947,0.6607233285903931,-3.7412634216237164,9.733376151954058,18.20410625785708,3.1936732974413893,0.23738061785697936,0.17964832112193108,0.7708351850509644,0.6762067794799804,0.9650172352790832,0.01759514641016722,0.00722807515412569,0.04878425151109696,0.007139564910903573,0.6472164511680603,0.08151322901248932,0.006277169077657163,0.062186908721923825,0.04610055088996887,0.115489661693573,0.05564761646091938,0.14995385929942132,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,1519.0,1343277.0,33576.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VANDETANIB,CHEMBL24828,4.0,1.0,1.0,MOL,49960.0,Small molecule,2011.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,2006.0,1.0,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",UHTHHESEBZOYNR-UHFFFAOYSA-N,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,0.593560925290803,4.0,475.3620000000003,4.426100000000003,5,1,0,62.74,-3.90845181842855,0.9441968560218811,-4.761129651805894,0.9995619177818298,-10.307769611844671,0.9318894505500793,0.8976777911186218,0.9674631834030152,97.26850382553361,6.8868374136772825,0.4528655230998993,0.26755266189575194,0.1485746830701828,0.5170084476470947,0.6607233285903931,-3.7412634216237164,9.733376151954058,18.20410625785708,3.1936732974413893,0.23738061785697936,0.17964832112193108,0.7708351850509644,0.6762067794799804,0.9650172352790832,0.01759514641016722,0.00722807515412569,0.04878425151109696,0.007139564910903573,0.6472164511680603,0.08151322901248932,0.006277169077657163,0.062186908721923825,0.04610055088996887,0.115489661693573,0.05564761646091938,0.14995385929942132,False
EGFR,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,4736.0,2473151.0,1927003.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Irreversible inhibitor,,,,POZIOTINIB,CHEMBL3545154,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)",LPFWVDIFUFFKJU-UHFFFAOYSA-N,C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1,0.3685750436003222,3.0,491.3500000000003,5.383700000000005,6,1,0,76.58,-5.663837888593116,0.8562049508094788,-4.703501952622908,0.9996623158454895,-9.610393254145066,0.9661360383033752,0.9255786061286926,0.8933209419250489,102.39762013883771,6.573807833171756,0.25446322560310364,0.8084105134010315,0.7651178002357483,0.08303636685013771,0.9109996557235718,35.01439480808289,49.28406573509288,76.23569900641641,3.200221373366871,0.11114459335803986,0.10797494575381279,0.33022073209285735,0.9628806829452514,0.8414069771766662,0.01460160231217742,0.01073041297495365,0.07882947847247124,0.02276688264682889,0.6643216252326966,0.29192593693733215,0.07953891456127167,0.09893979504704475,0.17275034189224242,0.3735110402107239,0.27792700827121736,0.12411669045686721,False
ERBB2_HER2,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,4736.0,2473151.0,1927003.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Irreversible inhibitor,,,,POZIOTINIB,CHEMBL3545154,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)",LPFWVDIFUFFKJU-UHFFFAOYSA-N,C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1,0.3685750436003222,3.0,491.3500000000003,5.383700000000005,6,1,0,76.58,-5.663837888593116,0.8562049508094788,-4.703501952622908,0.9996623158454895,-9.610393254145066,0.9661360383033752,0.9255786061286926,0.8933209419250489,102.39762013883771,6.573807833171756,0.25446322560310364,0.8084105134010315,0.7651178002357483,0.08303636685013771,0.9109996557235718,35.01439480808289,49.28406573509288,76.23569900641641,3.200221373366871,0.11114459335803986,0.10797494575381279,0.33022073209285735,0.9628806829452514,0.8414069771766662,0.01460160231217742,0.01073041297495365,0.07882947847247124,0.02276688264682889,0.6643216252326966,0.29192593693733215,0.07953891456127167,0.09893979504704475,0.17275034189224242,0.3735110402107239,0.27792700827121736,0.12411669045686721,False
ERBB4_HER4,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,4736.0,2473151.0,1927003.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Irreversible inhibitor,,,,POZIOTINIB,CHEMBL3545154,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)",LPFWVDIFUFFKJU-UHFFFAOYSA-N,C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1,0.3685750436003222,3.0,491.3500000000003,5.383700000000005,6,1,0,76.58,-5.663837888593116,0.8562049508094788,-4.703501952622908,0.9996623158454895,-9.610393254145066,0.9661360383033752,0.9255786061286926,0.8933209419250489,102.39762013883771,6.573807833171756,0.25446322560310364,0.8084105134010315,0.7651178002357483,0.08303636685013771,0.9109996557235718,35.01439480808289,49.28406573509288,76.23569900641641,3.200221373366871,0.11114459335803986,0.10797494575381279,0.33022073209285735,0.9628806829452514,0.8414069771766662,0.01460160231217742,0.01073041297495365,0.07882947847247124,0.02276688264682889,0.6643216252326966,0.29192593693733215,0.07953891456127167,0.09893979504704475,0.17275034189224242,0.3735110402107239,0.27792700827121736,0.12411669045686721,False
EGFR,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,8833.0,3133269.0,2335632.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,HER2 most relevant for the indication NSCLC,Active against exon 20 mutated targets. HER2 most relevant for the indication NSCLC,,,TARLOXOTINIB,CHEMBL4297661,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H23BrClN9O3/c1-33-14-30-24(34(37)38)20(33)12-35(2,3)8-4-5-22(36)32-21-10-16-19(11-27-21)28-13-29-23(16)31-15-6-7-18(26)17(25)9-15/h4-7,9-11,13-14H,8,12H2,1-3H3,(H-,27,28,29,31,32,36)/p+1/b5-4+",MUJMYVFVAWFUJL-SNAWJCMRSA-O,Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1,0.12277558388802808,3.0,601.8729999999999,4.597300000000002,9,2,0,140.76,-3.4671579358352944,0.4933316230773926,-5.799869734153981,0.6509821295738221,-12.633772212496444,0.7005834102630615,0.8287136793136597,0.45270171761512756,90.52326648517041,17.316219061084244,0.13416443541646003,0.3936159074306488,0.09087396785616875,0.8079602599143982,0.6124352991580964,110.25670818521806,50.08248500553392,71.8604165368145,2.885837886442874,0.5993898987770081,0.37195760011672974,0.25523674562573434,0.6953301668167114,0.8567998051643372,0.01754503957927227,0.043515144661068914,0.08242150321602822,0.06337879523634911,0.15979087054729463,0.15243754982948304,0.014897276647388935,0.050815027207136154,0.06818484533578158,0.24059738367795944,0.09082185104489326,0.36810430884361267,False
ERBB2_HER2,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,8833.0,3133269.0,2335632.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,HER2 most relevant for the indication NSCLC,Active against exon 20 mutated targets. HER2 most relevant for the indication NSCLC,,,TARLOXOTINIB,CHEMBL4297661,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H23BrClN9O3/c1-33-14-30-24(34(37)38)20(33)12-35(2,3)8-4-5-22(36)32-21-10-16-19(11-27-21)28-13-29-23(16)31-15-6-7-18(26)17(25)9-15/h4-7,9-11,13-14H,8,12H2,1-3H3,(H-,27,28,29,31,32,36)/p+1/b5-4+",MUJMYVFVAWFUJL-SNAWJCMRSA-O,Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1,0.12277558388802808,3.0,601.8729999999999,4.597300000000002,9,2,0,140.76,-3.4671579358352944,0.4933316230773926,-5.799869734153981,0.6509821295738221,-12.633772212496444,0.7005834102630615,0.8287136793136597,0.45270171761512756,90.52326648517041,17.316219061084244,0.13416443541646003,0.3936159074306488,0.09087396785616875,0.8079602599143982,0.6124352991580964,110.25670818521806,50.08248500553392,71.8604165368145,2.885837886442874,0.5993898987770081,0.37195760011672974,0.25523674562573434,0.6953301668167114,0.8567998051643372,0.01754503957927227,0.043515144661068914,0.08242150321602822,0.06337879523634911,0.15979087054729463,0.15243754982948304,0.014897276647388935,0.050815027207136154,0.06818484533578158,0.24059738367795944,0.09082185104489326,0.36810430884361267,False
ERBB4_HER4,105744,PROTEIN FAMILY,Epidermal growth factor receptor,9606,Homo sapiens,CHEMBL2363049,,0.0,8833.0,3133269.0,2335632.0,Epidermal growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,HER2 most relevant for the indication NSCLC,Active against exon 20 mutated targets. HER2 most relevant for the indication NSCLC,,,TARLOXOTINIB,CHEMBL4297661,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H23BrClN9O3/c1-33-14-30-24(34(37)38)20(33)12-35(2,3)8-4-5-22(36)32-21-10-16-19(11-27-21)28-13-29-23(16)31-15-6-7-18(26)17(25)9-15/h4-7,9-11,13-14H,8,12H2,1-3H3,(H-,27,28,29,31,32,36)/p+1/b5-4+",MUJMYVFVAWFUJL-SNAWJCMRSA-O,Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1,0.12277558388802808,3.0,601.8729999999999,4.597300000000002,9,2,0,140.76,-3.4671579358352944,0.4933316230773926,-5.799869734153981,0.6509821295738221,-12.633772212496444,0.7005834102630615,0.8287136793136597,0.45270171761512756,90.52326648517041,17.316219061084244,0.13416443541646003,0.3936159074306488,0.09087396785616875,0.8079602599143982,0.6124352991580964,110.25670818521806,50.08248500553392,71.8604165368145,2.885837886442874,0.5993898987770081,0.37195760011672974,0.25523674562573434,0.6953301668167114,0.8567998051643372,0.01754503957927227,0.043515144661068914,0.08242150321602822,0.06337879523634911,0.15979087054729463,0.15243754982948304,0.014897276647388935,0.050815027207136154,0.06818484533578158,0.24059738367795944,0.09082185104489326,0.36810430884361267,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,510.0,1344744.0,674436.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SORAFENIB TOSYLATE,CHEMBL1200485,4.0,1.0,1.0,MOL,50928.0,Small molecule,2005.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2007.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)",IVDHYUQIDRJSTI-UHFFFAOYSA-N,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1,0.1703941586464757,2.0,637.0360000000003,6.791420000000006,6,4,0,146.72,-5.1149209188131435,0.8699323892593384,-5.455232940541778,0.9744472622871398,-10.562838124112865,0.5125445663928986,0.9016531825065612,0.4321418821811676,100.02470464379913,-6.3945271870734235,0.12687360793352126,0.6512579321861267,0.45257848501205444,0.15315164178609847,0.5068503946065903,250.52015426060842,7.712462393845472,23.955004145127056,2.6350787735175834,0.3226355716586113,0.8741818070411682,0.5435594379901886,0.9585015177726746,0.7925397872924804,0.013105402514338494,0.0046164397150278095,0.06352498456835746,0.007266352372244001,0.06339812017977238,0.04378206711262465,0.04102304084226489,0.010423489147797227,0.06384100615978242,0.6622654080390931,0.12170127928256988,0.12387290745973586,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,1517.0,1344744.0,674436.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SORAFENIB TOSYLATE,CHEMBL1200485,4.0,1.0,1.0,MOL,50928.0,Small molecule,2005.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2007.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)",IVDHYUQIDRJSTI-UHFFFAOYSA-N,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1,0.1703941586464757,2.0,637.0360000000003,6.791420000000006,6,4,0,146.72,-5.1149209188131435,0.8699323892593384,-5.455232940541778,0.9744472622871398,-10.562838124112865,0.5125445663928986,0.9016531825065612,0.4321418821811676,100.02470464379913,-6.3945271870734235,0.12687360793352126,0.6512579321861267,0.45257848501205444,0.15315164178609847,0.5068503946065903,250.52015426060842,7.712462393845472,23.955004145127056,2.6350787735175834,0.3226355716586113,0.8741818070411682,0.5435594379901886,0.9585015177726746,0.7925397872924804,0.013105402514338494,0.0046164397150278095,0.06352498456835746,0.007266352372244001,0.06339812017977238,0.04378206711262465,0.04102304084226489,0.010423489147797227,0.06384100615978242,0.6622654080390931,0.12170127928256988,0.12387290745973586,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,994.0,1344744.0,674436.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SORAFENIB TOSYLATE,CHEMBL1200485,4.0,1.0,1.0,MOL,50928.0,Small molecule,2005.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2007.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)",IVDHYUQIDRJSTI-UHFFFAOYSA-N,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1,0.1703941586464757,2.0,637.0360000000003,6.791420000000006,6,4,0,146.72,-5.1149209188131435,0.8699323892593384,-5.455232940541778,0.9744472622871398,-10.562838124112865,0.5125445663928986,0.9016531825065612,0.4321418821811676,100.02470464379913,-6.3945271870734235,0.12687360793352126,0.6512579321861267,0.45257848501205444,0.15315164178609847,0.5068503946065903,250.52015426060842,7.712462393845472,23.955004145127056,2.6350787735175834,0.3226355716586113,0.8741818070411682,0.5435594379901886,0.9585015177726746,0.7925397872924804,0.013105402514338494,0.0046164397150278095,0.06352498456835746,0.007266352372244001,0.06339812017977238,0.04378206711262465,0.04102304084226489,0.010423489147797227,0.06384100615978242,0.6622654080390931,0.12170127928256988,0.12387290745973586,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,449.0,1344744.0,674436.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SORAFENIB TOSYLATE,CHEMBL1200485,4.0,1.0,1.0,MOL,50928.0,Small molecule,2005.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2007.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)",IVDHYUQIDRJSTI-UHFFFAOYSA-N,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1,0.1703941586464757,2.0,637.0360000000003,6.791420000000006,6,4,0,146.72,-5.1149209188131435,0.8699323892593384,-5.455232940541778,0.9744472622871398,-10.562838124112865,0.5125445663928986,0.9016531825065612,0.4321418821811676,100.02470464379913,-6.3945271870734235,0.12687360793352126,0.6512579321861267,0.45257848501205444,0.15315164178609847,0.5068503946065903,250.52015426060842,7.712462393845472,23.955004145127056,2.6350787735175834,0.3226355716586113,0.8741818070411682,0.5435594379901886,0.9585015177726746,0.7925397872924804,0.013105402514338494,0.0046164397150278095,0.06352498456835746,0.007266352372244001,0.06339812017977238,0.04378206711262465,0.04102304084226489,0.010423489147797227,0.06384100615978242,0.6622654080390931,0.12170127928256988,0.12387290745973586,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,511.0,1343773.0,450864.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SUNITINIB MALATE,CHEMBL1567,4.0,1.0,1.0,MOL,,Small molecule,2006.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1",LBWFXVZLPYTWQI-IPOVEDGCSA-N,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O,0.25289055079288847,2.0,532.5690000000003,2.24154,6,6,1,172.06,-1.2329599692979505,0.5504412591457367,-6.483750200847036,0.3928079456090927,-15.982626947952667,0.11102637946605683,0.30274742245674136,0.41228082180023196,66.64558174497117,23.098613358069166,0.10419064946472645,0.02320079682394862,0.025887175928801298,0.4886514931917191,0.04327373504638672,107.76248832150853,-47.46186979150027,1.1399437964788888,3.53215555320426,0.6208451598882675,0.3160751760005951,0.7597935795783997,0.6324620962142944,0.7167788863182067,0.0806092455983162,0.03533136621117592,0.11051312237977981,0.022003808803856374,0.13333846032619476,0.0237838814035058,0.0030894015682861207,0.03980150278657675,0.007652682578191161,0.05847492031753063,0.05937443226575852,0.22753501534461976,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,1518.0,1343773.0,450864.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SUNITINIB MALATE,CHEMBL1567,4.0,1.0,1.0,MOL,,Small molecule,2006.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1",LBWFXVZLPYTWQI-IPOVEDGCSA-N,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O,0.25289055079288847,2.0,532.5690000000003,2.24154,6,6,1,172.06,-1.2329599692979505,0.5504412591457367,-6.483750200847036,0.3928079456090927,-15.982626947952667,0.11102637946605683,0.30274742245674136,0.41228082180023196,66.64558174497117,23.098613358069166,0.10419064946472645,0.02320079682394862,0.025887175928801298,0.4886514931917191,0.04327373504638672,107.76248832150853,-47.46186979150027,1.1399437964788888,3.53215555320426,0.6208451598882675,0.3160751760005951,0.7597935795783997,0.6324620962142944,0.7167788863182067,0.0806092455983162,0.03533136621117592,0.11051312237977981,0.022003808803856374,0.13333846032619476,0.0237838814035058,0.0030894015682861207,0.03980150278657675,0.007652682578191161,0.05847492031753063,0.05937443226575852,0.22753501534461976,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,450.0,1343773.0,450864.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SUNITINIB MALATE,CHEMBL1567,4.0,1.0,1.0,MOL,,Small molecule,2006.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1",LBWFXVZLPYTWQI-IPOVEDGCSA-N,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O,0.25289055079288847,2.0,532.5690000000003,2.24154,6,6,1,172.06,-1.2329599692979505,0.5504412591457367,-6.483750200847036,0.3928079456090927,-15.982626947952667,0.11102637946605683,0.30274742245674136,0.41228082180023196,66.64558174497117,23.098613358069166,0.10419064946472645,0.02320079682394862,0.025887175928801298,0.4886514931917191,0.04327373504638672,107.76248832150853,-47.46186979150027,1.1399437964788888,3.53215555320426,0.6208451598882675,0.3160751760005951,0.7597935795783997,0.6324620962142944,0.7167788863182067,0.0806092455983162,0.03533136621117592,0.11051312237977981,0.022003808803856374,0.13333846032619476,0.0237838814035058,0.0030894015682861207,0.03980150278657675,0.007652682578191161,0.05847492031753063,0.05937443226575852,0.22753501534461976,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,3877.0,2472735.0,81913.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ENMD-981693,CHEMBL52885,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28)",OVSKGTONMLKNPZ-UHFFFAOYSA-N,Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21,0.32438740983311387,4.0,400.3940000000001,3.1454000000000013,6,1,0,99.16999999999999,-6.426063171486577,0.7228361129760742,-4.846628564901448,0.9977720737457275,-10.462230185531302,0.9169424772262573,0.8716472625732422,0.8727047324180603,96.40460455217544,-4.708638659717396,0.31876940429210665,0.3970495894551277,0.19101984947919845,0.07790423184633255,0.7669905662536621,109.14115388220655,46.19135544068579,54.286636594198875,3.037889836548128,0.812679934501648,0.31785533726215365,0.16116317361593246,0.9855165839195251,0.6447062969207764,0.010599547997117043,0.05157089866697788,0.06657148823142052,0.07107045203447342,0.4892982721328735,0.29026568233966826,0.04102128297090531,0.04256502538919449,0.27020246535539627,0.8498728275299072,0.3912301540374756,0.7268450617790222,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,3891.0,2472749.0,1102616.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SU-014813,CHEMBL1721885,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1",CTNPALGJUAXMMC-PMFHANACSA-N,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,0.5096580614407035,4.0,442.49100000000027,1.68624,5,4,1,106.69,-2.9099054969749254,0.7233089447021485,-5.010569320031161,0.9923774719238281,-15.858811828850198,0.5756678104400634,0.45698520839214324,0.5384751379489898,81.10774667105196,12.375451571482415,0.07238914594054222,0.0918850876390934,0.08246740400791168,0.1352750428020954,0.4024786502122879,71.23069649063703,-6.4762527947936395,20.752483871663134,3.187423363714195,0.45008150935173036,0.20949859023094178,0.6797061920166015,0.828068208694458,0.9101565718650818,0.02031884528696537,0.018695500493049622,0.035526419430971144,0.004949113074690104,0.31932384669780733,0.03107759337872267,0.0022724125679815187,0.025602232292294504,0.022504219971597194,0.2039370507001877,0.12810380905866622,0.18838496506214142,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,3890.0,2472749.0,1102616.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SU-014813,CHEMBL1721885,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1",CTNPALGJUAXMMC-PMFHANACSA-N,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,0.5096580614407035,4.0,442.49100000000027,1.68624,5,4,1,106.69,-2.9099054969749254,0.7233089447021485,-5.010569320031161,0.9923774719238281,-15.858811828850198,0.5756678104400634,0.45698520839214324,0.5384751379489898,81.10774667105196,12.375451571482415,0.07238914594054222,0.0918850876390934,0.08246740400791168,0.1352750428020954,0.4024786502122879,71.23069649063703,-6.4762527947936395,20.752483871663134,3.187423363714195,0.45008150935173036,0.20949859023094178,0.6797061920166015,0.828068208694458,0.9101565718650818,0.02031884528696537,0.018695500493049622,0.035526419430971144,0.004949113074690104,0.31932384669780733,0.03107759337872267,0.0022724125679815187,0.025602232292294504,0.022504219971597194,0.2039370507001877,0.12810380905866622,0.18838496506214142,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4091.0,2473619.0,2832057.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,4SC-203,CHEMBL5314406,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C33H38N8O4S/c1-21-6-9-27(43-3)26(16-21)37-32(42)39-33-38-24-8-7-22(17-30(24)46-33)36-31-23-18-28(44-4)29(19-25(23)34-20-35-31)45-15-5-10-41-13-11-40(2)12-14-41/h6-9,16-20H,5,10-15H2,1-4H3,(H,34,35,36)(H2,37,38,39,42)",MAFACRSJGNJHCF-UHFFFAOYSA-N,COc1ccc(C)cc1NC(=O)Nc1nc2ccc(Nc3ncnc4cc(OCCCN5CCN(C)CC5)c(OC)cc34)cc2s1,0.14846455343332005,1.0,642.7860000000003,5.969020000000005,11,3,0,126.0,-4.227097079514697,0.8597071409225464,-4.96746471288928,0.9864754557609559,-11.794425715977907,0.6871948719024659,0.9590965986251831,0.5405558973550797,95.10721578650899,6.728876642128197,0.11929751783609391,0.30739850699901583,0.16721233054995538,0.10655111707746982,0.8748797416687012,87.75680190274286,17.011426386320437,54.79694257647683,3.0153234801589703,0.3933228850364685,0.3293808788061142,0.8629763007164002,0.9764391660690308,0.9616293430328369,0.019306689128279687,0.008504680916666984,0.038270189240574834,0.012131053861230612,0.6320228338241577,0.08701016828417778,0.049428092688322066,0.13502952232956886,0.07542843967676163,0.6141641438007355,0.5115448355674743,0.1754143550992012,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4121.0,2473338.0,218011.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AS-602868,CHEMBL129857,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H14N4O3S/c1-10-9-14(23)22(18(10)24)21-17-15-11(5-3-6-12(15)25-2)19-16(20-17)13-7-4-8-26-13/h3-9H,1-2H3,(H,19,20,21)",GZGLPBNOIFLLRE-UHFFFAOYSA-N,COc1cccc2nc(-c3cccs3)nc(NN3C(=O)C=C(C)C3=O)c12,0.7147430205495658,4.0,366.4020000000002,3.0089000000000006,7,1,0,84.42000000000002,-5.644092235881238,0.9289138913154602,-4.664956714783505,0.9999369144439697,-11.797115393267047,0.9792558789253235,0.565977680683136,0.9035092830657959,109.84360546865526,-2.9996970681050423,0.8853137135505676,0.5153236389160156,0.492549991607666,0.03986483123153448,0.8525002956390381,0.8715549116797195,24.17393009874512,50.240442813198555,2.977737970865003,0.6630955576896668,0.1470283031463623,0.1832575298845768,0.9972498893737793,0.5801474750041962,0.01576519347727299,0.009367998410016298,0.2141505390405655,0.02202374264597893,0.891387140750885,0.1980544775724411,0.08288710936903954,0.3187485247850418,0.15470242798328399,0.736246508359909,0.6426577806472779,0.5250974476337433,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4128.0,2472921.0,568339.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Also potent against KDR, FLT4, KIT, and ABL1. Selective inhibitor of mutant FLT3.",,,,AST-487,CHEMBL574738,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30F3N7O2/c1-3-35-10-12-36(13-11-35)16-18-4-5-20(14-22(18)26(27,28)29)34-25(37)33-19-6-8-21(9-7-19)38-24-15-23(30-2)31-17-32-24/h4-9,14-15,17H,3,10-13,16H2,1-2H3,(H,30,31,32)(H2,33,34,37)",ODPGGGTTYSGTGO-UHFFFAOYSA-N,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,0.3733441496106457,2.0,529.5670000000001,5.1109000000000036,7,3,0,94.65,-5.136799443875304,0.8424067854881286,-5.051581118437159,0.9761335372924804,-10.258459642545358,0.7960021257400512,0.6827746987342834,0.8103596925735473,90.78071048933047,2.46847404659998,0.19230199754238128,0.43868648409843447,0.1143238440155983,0.6300364017486573,0.6508928954601287,61.38645158293343,5.054075805933908,31.984987860413288,3.680526582134209,0.40769514441490173,0.6035144448280334,0.9249723553657532,0.8235207915306091,0.9589110493659974,0.018022520840167998,0.00570933185517788,0.028571256250143052,0.009377697948366404,0.06853215247392655,0.03025733008980751,0.0074658126570284365,0.012043626513332129,0.014575439877808094,0.33317672163248063,0.15043582022190094,0.16948384046554565,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,4129.0,2472921.0,568339.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,"Also potent against KDR, FLT4, KIT, and ABL1. Selective inhibitor of mutant FLT3.",,,,AST-487,CHEMBL574738,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30F3N7O2/c1-3-35-10-12-36(13-11-35)16-18-4-5-20(14-22(18)26(27,28)29)34-25(37)33-19-6-8-21(9-7-19)38-24-15-23(30-2)31-17-32-24/h4-9,14-15,17H,3,10-13,16H2,1-2H3,(H,30,31,32)(H2,33,34,37)",ODPGGGTTYSGTGO-UHFFFAOYSA-N,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,0.3733441496106457,2.0,529.5670000000001,5.1109000000000036,7,3,0,94.65,-5.136799443875304,0.8424067854881286,-5.051581118437159,0.9761335372924804,-10.258459642545358,0.7960021257400512,0.6827746987342834,0.8103596925735473,90.78071048933047,2.46847404659998,0.19230199754238128,0.43868648409843447,0.1143238440155983,0.6300364017486573,0.6508928954601287,61.38645158293343,5.054075805933908,31.984987860413288,3.680526582134209,0.40769514441490173,0.6035144448280334,0.9249723553657532,0.8235207915306091,0.9589110493659974,0.018022520840167998,0.00570933185517788,0.028571256250143052,0.009377697948366404,0.06853215247392655,0.03025733008980751,0.0074658126570284365,0.012043626513332129,0.014575439877808094,0.33317672163248063,0.15043582022190094,0.16948384046554565,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4195.0,2472774.0,1344707.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CT-1578,CHEMBL2035185,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30N4O4/c1-2-12-30(11-1)13-16-33-24-7-5-21-17-20(24)18-31-14-3-4-15-32-19-22-6-8-25(34-22)23-9-10-27-26(28-21)29-23/h3-10,17H,1-2,11-16,18-19H2,(H,27,28,29)/b4-3+",NNXDIGHYPZHXTR-ONEGZZNKSA-N,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1,0.5654571212286086,4.0,462.5500000000002,4.557800000000004,8,1,0,81.88000000000001,-4.460789272912273,0.8292984247207642,-5.029885371608371,0.9933253526687622,-9.846141656387672,0.8965492010116577,0.762923514842987,0.8616067171096802,99.70954483627209,13.738935102352121,0.37557974755764006,0.17717566192150117,0.03988507874310017,0.6605639100074768,0.5173073589801789,59.478526978983176,39.47320469225703,48.96033665388809,3.169115739744654,0.31674359515309336,0.1249159649014473,0.5870004594326019,0.843627107143402,0.9627744555473328,0.04057084769010544,0.01442816024646163,0.10502422749996185,0.014123775251209735,0.2830946445465088,0.11766964942216873,0.00841175513342023,0.038642465323209765,0.08711983636021614,0.1403449669480324,0.1268097683787346,0.25328009128570556,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4197.0,2472774.0,1344707.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CT-1578,CHEMBL2035185,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30N4O4/c1-2-12-30(11-1)13-16-33-24-7-5-21-17-20(24)18-31-14-3-4-15-32-19-22-6-8-25(34-22)23-9-10-27-26(28-21)29-23/h3-10,17H,1-2,11-16,18-19H2,(H,27,28,29)/b4-3+",NNXDIGHYPZHXTR-ONEGZZNKSA-N,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1,0.5654571212286086,4.0,462.5500000000002,4.557800000000004,8,1,0,81.88000000000001,-4.460789272912273,0.8292984247207642,-5.029885371608371,0.9933253526687622,-9.846141656387672,0.8965492010116577,0.762923514842987,0.8616067171096802,99.70954483627209,13.738935102352121,0.37557974755764006,0.17717566192150117,0.03988507874310017,0.6605639100074768,0.5173073589801789,59.478526978983176,39.47320469225703,48.96033665388809,3.169115739744654,0.31674359515309336,0.1249159649014473,0.5870004594326019,0.843627107143402,0.9627744555473328,0.04057084769010544,0.01442816024646163,0.10502422749996185,0.014123775251209735,0.2830946445465088,0.11766964942216873,0.00841175513342023,0.038642465323209765,0.08711983636021614,0.1403449669480324,0.1268097683787346,0.25328009128570556,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4254.0,2473118.0,1248758.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,KW-2449,CHEMBL1908397,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+",YYLKKYCXAOBSRM-JXMROGBWSA-N,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,0.7752072726994867,4.0,332.40700000000015,2.7787000000000006,3,2,0,61.02,-3.8309026033696028,0.7556090474128723,-5.153372401796734,0.9942103147506713,-12.651227361329088,0.6564870953559876,0.3309264898300171,0.8037676930427551,74.79337155934452,-4.506060562863896,0.42242236733436583,0.28851592540740967,0.27021960616111756,0.06018490493297577,0.29312445819377897,5.660062339553042,25.34530637108702,6.715277793252925,2.392822639067461,0.1470572218298912,0.13880029767751695,0.4149322330951691,0.8809747695922852,0.8204993605613708,0.038377153873443606,0.024727670662105083,0.160061314702034,0.024201914481818677,0.3041637748479843,0.07301962003111839,0.022078803088515998,0.05568509846925736,0.04373401813209057,0.23242049515247346,0.12587006241083146,0.4740631222724915,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4402.0,2473439.0,1276066.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ZOTIRACICLIB,CHEMBL1944698,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,,-ciclib,0.0,-ciclib,cyclin dependent kinase inhibitors (formerly-cidib),,0.0,0.0,0.0,"InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+",VXBAJLGYBMTJCY-NSCUHMNNSA-N,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1,0.5818841653795377,4.0,372.4720000000001,4.657700000000004,5,1,0,50.28,-4.7592483894440365,0.9085821866989136,-4.895675264993443,0.9991221308708191,-10.055069756716746,0.954320764541626,0.8292406797409058,0.965965473651886,102.20298266303925,8.256705002945415,0.9203206896781921,0.5404352426528931,0.05474577099084854,0.9531398177146911,0.8518406629562378,16.17199644224489,64.2376698171262,74.0242621189039,2.7875671121842087,0.5790757536888123,0.15835566073656082,0.5393976986408233,0.8566671133041381,0.9547113060951233,0.049542146176099776,0.015113107394427061,0.11980798691511155,0.01655419319868088,0.7152789950370788,0.1740513414144516,0.010318562993779779,0.06239625699818134,0.06684827283024788,0.2748091757297516,0.12456455454230309,0.27303943783044815,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4403.0,2473439.0,1276066.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ZOTIRACICLIB,CHEMBL1944698,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,,-ciclib,0.0,-ciclib,cyclin dependent kinase inhibitors (formerly-cidib),,0.0,0.0,0.0,"InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+",VXBAJLGYBMTJCY-NSCUHMNNSA-N,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1,0.5818841653795377,4.0,372.4720000000001,4.657700000000004,5,1,0,50.28,-4.7592483894440365,0.9085821866989136,-4.895675264993443,0.9991221308708191,-10.055069756716746,0.954320764541626,0.8292406797409058,0.965965473651886,102.20298266303925,8.256705002945415,0.9203206896781921,0.5404352426528931,0.05474577099084854,0.9531398177146911,0.8518406629562378,16.17199644224489,64.2376698171262,74.0242621189039,2.7875671121842087,0.5790757536888123,0.15835566073656082,0.5393976986408233,0.8566671133041381,0.9547113060951233,0.049542146176099776,0.015113107394427061,0.11980798691511155,0.01655419319868088,0.7152789950370788,0.1740513414144516,0.010318562993779779,0.06239625699818134,0.06684827283024788,0.2748091757297516,0.12456455454230309,0.27303943783044815,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4481.0,2473699.0,1301682.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted kinase inhibitor,,,,RG-1530,CHEMBL1980391,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)",UOVCGJXDGOGOCZ-UHFFFAOYSA-N,COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2,0.5447286127028788,4.0,356.78800000000007,4.745320000000002,4,2,0,62.300000000000004,-6.253303016903371,0.9715973258018493,-4.6133308558247705,0.9999912261962891,-10.461102988431088,0.940396511554718,0.8721951723098755,0.768674111366272,103.22711722423587,2.2629738085303273,0.9770308136940002,0.8317217350006103,0.8371063590049743,0.22488914653658867,0.8599690079689026,26.07624027043884,30.114578334438885,38.86639415899814,3.106741129714324,0.5141696095466614,0.15831136777997018,0.055832740664482114,0.9769413709640503,0.7762613773345948,0.020824287831783295,0.01208707015030086,0.19198330640792846,0.10092849805951118,0.967926847934723,0.5960889339447022,0.12601987943053244,0.7433124959468842,0.255597411096096,0.9285112857818604,0.6569814503192901,0.2418629616498947,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4495.0,2473579.0,2832041.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CEP-2563 DIHYDROCHLORIDE,CHEMBL5314390,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C36H40N6O6.2ClH/c1-35-36(46-2,19-47-27(43)14-16-39-33(44)23(38)11-7-8-15-37)17-26(48-35)41-24-12-5-3-9-20(24)29-30-22(18-40-34(30)45)28-21-10-4-6-13-25(21)42(35)32(28)31(29)41;;/h3-6,9-10,12-13,23,26H,7-8,11,14-19,37-38H2,1-2H3,(H,39,44)(H,40,45);2*1H/t23?,26-,35+,36+;;/m1../s1",PBEVPBFDKPJIOM-RHIKYVLPSA-N,CO[C@]1(COC(=O)CCNC(=O)C(N)CCCCN)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4.Cl.Cl,0.11438331554824446,3.0,725.6740000000001,4.485600000000004,10,4,4,164.85999999999999,-3.3797171877000975,0.597081059217453,-5.8203776699602034,0.9946153879165649,-11.338977866023267,0.6426436603069305,0.9096715092658997,0.5210997343063355,87.42716064818929,3.6450769578687536,0.43124119341373446,0.7434696078300476,0.646144425868988,0.41734116673469546,0.9293155789375305,196.20753056694826,53.29012750465803,58.26677498016865,3.065107130791257,0.869233500957489,0.0935547761619091,0.628991323709488,0.857980740070343,0.9317634582519532,0.016619377955794334,0.08278320133686065,0.0991198405623436,0.11183022931218148,0.27022726833820343,0.501346230506897,0.15831308364868163,0.4132895261049271,0.1528743639588356,0.5291901528835297,0.6319281041622162,0.4547775089740753,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,4493.0,2473579.0,2832041.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CEP-2563 DIHYDROCHLORIDE,CHEMBL5314390,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C36H40N6O6.2ClH/c1-35-36(46-2,19-47-27(43)14-16-39-33(44)23(38)11-7-8-15-37)17-26(48-35)41-24-12-5-3-9-20(24)29-30-22(18-40-34(30)45)28-21-10-4-6-13-25(21)42(35)32(28)31(29)41;;/h3-6,9-10,12-13,23,26H,7-8,11,14-19,37-38H2,1-2H3,(H,39,44)(H,40,45);2*1H/t23?,26-,35+,36+;;/m1../s1",PBEVPBFDKPJIOM-RHIKYVLPSA-N,CO[C@]1(COC(=O)CCNC(=O)C(N)CCCCN)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4.Cl.Cl,0.11438331554824446,3.0,725.6740000000001,4.485600000000004,10,4,4,164.85999999999999,-3.3797171877000975,0.597081059217453,-5.8203776699602034,0.9946153879165649,-11.338977866023267,0.6426436603069305,0.9096715092658997,0.5210997343063355,87.42716064818929,3.6450769578687536,0.43124119341373446,0.7434696078300476,0.646144425868988,0.41734116673469546,0.9293155789375305,196.20753056694826,53.29012750465803,58.26677498016865,3.065107130791257,0.869233500957489,0.0935547761619091,0.628991323709488,0.857980740070343,0.9317634582519532,0.016619377955794334,0.08278320133686065,0.0991198405623436,0.11183022931218148,0.27022726833820343,0.501346230506897,0.15831308364868163,0.4132895261049271,0.1528743639588356,0.5291901528835297,0.6319281041622162,0.4547775089740753,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4616.0,2473458.0,2526691.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AKN-028,CHEMBL4790100,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H14N6/c18-16-17(22-13-1-2-14-12(9-13)5-8-20-14)23-15(10-21-16)11-3-6-19-7-4-11/h1-10,20H,(H2,18,21)(H,22,23)",JLRIJKVMMZEKDF-UHFFFAOYSA-N,Nc1ncc(-c2ccncc2)nc1Nc1ccc2[nH]ccc2c1,0.5394817286860161,4.0,302.34100000000007,3.345700000000001,5,3,0,92.50999999999999,-3.7345809082947077,0.8629128694534302,-5.371848130517557,0.9999885797500611,-14.527892691004462,0.8788634538650513,0.13929807245731354,0.6377952933311463,97.57307270631142,6.2568905496337015,0.9946946740150452,0.8142300009727478,0.36215234398841856,0.7275398731231689,0.9911595702171325,19.161041780573537,16.15860142617054,3.2558677461911727,2.7734484123533547,0.8067698836326599,0.04709103386849165,0.07272700555622577,0.9688703894615174,0.8795067310333252,0.054068423435091974,0.03834425806999207,0.3926469683647156,0.1348953440785408,0.9914139389991761,0.6192793488502503,0.028472063317894935,0.5762586236000061,0.1856616199016571,0.8447531461715698,0.551063996553421,0.6572429418563843,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4636.0,2473708.0,494066.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AT-9283,CHEMBL495727,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)",LOLPPWBBNUVNQZ-UHFFFAOYSA-N,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1,0.5406836414671591,4.0,381.44000000000017,2.0690999999999997,5,4,0,110.96000000000001,-3.1906856177437626,0.7597568154335022,-5.168770458162894,0.9986566662788391,-14.459579483556173,0.4197122633457184,0.1501498356461525,0.924901807308197,72.32118119026936,1.7052146777388775,0.41024225056171415,0.2393087089061737,0.23802210688591002,0.16341016441583633,0.537372761964798,5.590173984509802,-6.26531186708848,-2.2357166581671444,2.594970266030603,0.4146520793437958,0.07491143122315407,0.5423834800720215,0.8394109606742859,0.8515088438987732,0.010844030044972896,0.008944177255034446,0.09264703840017319,0.015805553086102007,0.6048717617988586,0.06395924612879753,0.0073412631172686815,0.1788317397236824,0.05015271380543709,0.3832952052354813,0.407814621925354,0.37065603733062746,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4637.0,2473708.0,494066.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AT-9283,CHEMBL495727,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)",LOLPPWBBNUVNQZ-UHFFFAOYSA-N,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1,0.5406836414671591,4.0,381.44000000000017,2.0690999999999997,5,4,0,110.96000000000001,-3.1906856177437626,0.7597568154335022,-5.168770458162894,0.9986566662788391,-14.459579483556173,0.4197122633457184,0.1501498356461525,0.924901807308197,72.32118119026936,1.7052146777388775,0.41024225056171415,0.2393087089061737,0.23802210688591002,0.16341016441583633,0.537372761964798,5.590173984509802,-6.26531186708848,-2.2357166581671444,2.594970266030603,0.4146520793437958,0.07491143122315407,0.5423834800720215,0.8394109606742859,0.8515088438987732,0.010844030044972896,0.008944177255034446,0.09264703840017319,0.015805553086102007,0.6048717617988586,0.06395924612879753,0.0073412631172686815,0.1788317397236824,0.05015271380543709,0.3832952052354813,0.407814621925354,0.37065603733062746,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4682.0,2473587.0,1927186.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Intercalates to DNA and following metabolic activation, covalently crosslinks DNA strands (PMID: 12007568, PMID:25896848)",,,,C-1311,CHEMBL3545337,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H22N4O2.2ClH.H2O/c1-3-23(4-2)10-9-21-15-6-7-16-19-18(15)20(26)14-11-13(25)5-8-17(14)24(19)12-22-16;;;/h5-8,11-12,21,25H,3-4,9-10H2,1-2H3;2*1H;1H2",XJYNBZQTAZDMHZ-UHFFFAOYSA-N,CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23.Cl.Cl.O,0.44834461025119576,4.0,441.35900000000026,2.9169000000000027,6,2,0,101.37,-1.5815070372308955,0.6414605498313903,-5.74695852760126,0.9517369270324707,-12.612440696197261,0.3651127338409424,0.5823605537414551,0.6766334116458893,78.71097076056222,23.289705505397464,0.6390727937221528,0.08136120438575745,0.04393237810581922,0.6714479684829712,0.12220164053142071,123.89691422070837,12.381160289897354,13.32920022486093,1.579444028993305,0.9598547697067261,0.4680677235126495,0.6933771014213562,0.6813768208026886,0.8792194247245788,0.015634373016655444,0.08535147681832314,0.1541192427277565,0.10695137679576874,0.6191458940505982,0.09828000888228416,0.010012876754626632,0.171583916246891,0.0670742854475975,0.14468304589390754,0.2595693141222,0.5445953965187073,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4696.0,1702633.0,1377998.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CRENOLANIB,CHEMBL2105728,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2011.0,,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3",DYNHJHQFHQTFTP-UHFFFAOYSA-N,CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1,0.503802926026981,4.0,443.5510000000004,3.916500000000001,7,1,0,78.43,-3.116531119670276,0.8532829523086548,-5.275376474008881,0.9977672815322876,-9.775668376813446,0.8786948919296265,0.7871116042137146,0.7786859631538391,94.75770418440766,3.7150207246789946,0.20373972803354262,0.16367588490247725,0.15878382176160813,0.2779894769191742,0.30519023537635803,-20.584398531518293,39.87938744437973,42.585802931036504,2.677482325697636,0.6700912117958069,0.15211130268871784,0.6730718374252319,0.7064838588237763,0.955599558353424,0.03607628662139177,0.027761943452060223,0.15115396827459335,0.09364709481596947,0.7039078831672668,0.6199752449989319,0.04227540008723736,0.16614650189876556,0.24449509382247925,0.3264638900756836,0.43685912489891054,0.3043238341808319,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4718.0,2473461.0,520121.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Tartrate salt of ENMD-981693,,,,ENMD-2076,CHEMBL482968,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+",BLQYVHBZHAISJM-CMDGGOBGSA-N,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1,0.7136005782754016,4.0,375.48,3.1739200000000016,6,2,0,72.97,-3.686618958679216,0.9057787537574769,-5.390316157125314,0.9977545261383056,-10.570047044900324,0.8734265565872192,0.6215944886207581,0.7700851559638977,89.05286204596074,16.991615868675737,0.6966745972633361,0.3511290907859802,0.16456568166613578,0.2833833783864975,0.5754003942012786,31.513330771197513,43.45838641040517,26.793810361862306,2.741503501127788,0.3731610119342804,0.24737312644720078,0.6749023199081421,0.9296946287155151,0.9477082014083862,0.03660155236721039,0.034876775182783606,0.09233511537313462,0.029890680871903896,0.5856963098049164,0.1417557567358017,0.03200168889015913,0.173178468644619,0.04756141379475594,0.4418608516454697,0.3214209973812103,0.3376648038625717,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4719.0,2473461.0,520121.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Tartrate salt of ENMD-981693,,,,ENMD-2076,CHEMBL482968,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+",BLQYVHBZHAISJM-CMDGGOBGSA-N,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1,0.7136005782754016,4.0,375.48,3.1739200000000016,6,2,0,72.97,-3.686618958679216,0.9057787537574769,-5.390316157125314,0.9977545261383056,-10.570047044900324,0.8734265565872192,0.6215944886207581,0.7700851559638977,89.05286204596074,16.991615868675737,0.6966745972633361,0.3511290907859802,0.16456568166613578,0.2833833783864975,0.5754003942012786,31.513330771197513,43.45838641040517,26.793810361862306,2.741503501127788,0.3731610119342804,0.24737312644720078,0.6749023199081421,0.9296946287155151,0.9477082014083862,0.03660155236721039,0.034876775182783606,0.09233511537313462,0.029890680871903896,0.5856963098049164,0.1417557567358017,0.03200168889015913,0.173178468644619,0.04756141379475594,0.4418608516454697,0.3214209973812103,0.3376648038625717,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4726.0,1702545.0,692959.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FORETINIB,CHEMBL1230609,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2009.0,,-retin-; -tinib,0.0,-retin-; -tinib,retinol derivatives; tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)",CXQHYVUVSFXTMY-UHFFFAOYSA-N,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,0.1496403020296978,2.0,632.6639999999998,5.772400000000005,8,2,0,111.25,-4.934283818654959,0.8775684237480164,-4.828260690669654,0.992231833934784,-10.412552498935614,0.669587230682373,0.8470917582511902,0.7008150815963745,94.30123618446969,12.950252406704076,0.013741470803506673,0.11693152785301208,0.19140437841415406,0.09007633049041033,0.806867265701294,36.49681603877609,50.183881774962146,74.22484628992876,3.202103498236421,0.6376474857330322,0.24755110442638398,0.5867082715034485,0.9398257255554199,0.8911935925483704,0.06016033850610256,0.028065517358481885,0.07479224726557732,0.030270540714263917,0.4869479537010193,0.371951761841774,0.058567631617188455,0.4494767725467682,0.09766407907009125,0.8357657313346862,0.671204251050949,0.09698464348912239,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4728.0,1702545.0,692959.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FORETINIB,CHEMBL1230609,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2009.0,,-retin-; -tinib,0.0,-retin-; -tinib,retinol derivatives; tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)",CXQHYVUVSFXTMY-UHFFFAOYSA-N,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,0.1496403020296978,2.0,632.6639999999998,5.772400000000005,8,2,0,111.25,-4.934283818654959,0.8775684237480164,-4.828260690669654,0.992231833934784,-10.412552498935614,0.669587230682373,0.8470917582511902,0.7008150815963745,94.30123618446969,12.950252406704076,0.013741470803506673,0.11693152785301208,0.19140437841415406,0.09007633049041033,0.806867265701294,36.49681603877609,50.183881774962146,74.22484628992876,3.202103498236421,0.6376474857330322,0.24755110442638398,0.5867082715034485,0.9398257255554199,0.8911935925483704,0.06016033850610256,0.028065517358481885,0.07479224726557732,0.030270540714263917,0.4869479537010193,0.371951761841774,0.058567631617188455,0.4494767725467682,0.09766407907009125,0.8357657313346862,0.671204251050949,0.09698464348912239,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4727.0,1702545.0,692959.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FORETINIB,CHEMBL1230609,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2009.0,,-retin-; -tinib,0.0,-retin-; -tinib,retinol derivatives; tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)",CXQHYVUVSFXTMY-UHFFFAOYSA-N,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,0.1496403020296978,2.0,632.6639999999998,5.772400000000005,8,2,0,111.25,-4.934283818654959,0.8775684237480164,-4.828260690669654,0.992231833934784,-10.412552498935614,0.669587230682373,0.8470917582511902,0.7008150815963745,94.30123618446969,12.950252406704076,0.013741470803506673,0.11693152785301208,0.19140437841415406,0.09007633049041033,0.806867265701294,36.49681603877609,50.183881774962146,74.22484628992876,3.202103498236421,0.6376474857330322,0.24755110442638398,0.5867082715034485,0.9398257255554199,0.8911935925483704,0.06016033850610256,0.028065517358481885,0.07479224726557732,0.030270540714263917,0.4869479537010193,0.371951761841774,0.058567631617188455,0.4494767725467682,0.09766407907009125,0.8357657313346862,0.671204251050949,0.09698464348912239,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4767.0,1701431.0,205165.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TANDUTINIB,CHEMBL124660,2.0,0.0,0.0,MOL,90237.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2000.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)",UXXQOJXBIDBUAC-UHFFFAOYSA-N,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,0.34405253594826724,2.0,562.7150000000001,5.034500000000005,8,1,0,92.29,-3.7760213984088593,0.61518714427948,-4.878668628518184,0.9862274646759033,-9.68977493422673,0.9020017862319947,0.8704374432563782,0.8017761468887329,91.92624102633549,4.797447640551072,0.029389186669141053,0.21095571517944336,0.14664025157690047,0.18676045387983323,0.5133517861366272,7.583005860767498,21.270058769895872,61.403228073441156,3.314670925987025,0.1021019160747528,0.10578361414372921,0.6442710041999817,0.7938636898994446,0.9570167899131775,0.01553202155046165,0.005276195425540209,0.04630246534943581,0.011630386440083384,0.3172276854515076,0.039335233718156816,0.005728977546095848,0.032131191529333594,0.03662751540541649,0.21956295371055604,0.152823343873024,0.18190650939941405,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4768.0,1701431.0,205165.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TANDUTINIB,CHEMBL124660,2.0,0.0,0.0,MOL,90237.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2000.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)",UXXQOJXBIDBUAC-UHFFFAOYSA-N,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,0.34405253594826724,2.0,562.7150000000001,5.034500000000005,8,1,0,92.29,-3.7760213984088593,0.61518714427948,-4.878668628518184,0.9862274646759033,-9.68977493422673,0.9020017862319947,0.8704374432563782,0.8017761468887329,91.92624102633549,4.797447640551072,0.029389186669141053,0.21095571517944336,0.14664025157690047,0.18676045387983323,0.5133517861366272,7.583005860767498,21.270058769895872,61.403228073441156,3.314670925987025,0.1021019160747528,0.10578361414372921,0.6442710041999817,0.7938636898994446,0.9570167899131775,0.01553202155046165,0.005276195425540209,0.04630246534943581,0.011630386440083384,0.3172276854515076,0.039335233718156816,0.005728977546095848,0.032131191529333594,0.03662751540541649,0.21956295371055604,0.152823343873024,0.18190650939941405,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4770.0,1699844.0,1376121.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Inhibits mutant forms of KIT, FLT3 and PDGFRA (http://www.google.com/patents/US20080226747).",,,,AMUVATINIB,CHEMBL2103851,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)",FOFDIMHVKGYHRU-UHFFFAOYSA-N,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,0.4761683339185086,4.0,447.5200000000002,3.301400000000002,7,1,0,75.89,-5.598012982868518,0.6717589378356934,-4.907345095941456,0.9999486207962036,-8.724052645388374,0.964915668964386,0.8804606914520263,0.8469775080680847,107.89649138601787,7.731638414534997,0.9573073863983155,0.9838817834854126,0.8997474193572998,0.677538800239563,0.9915576457977295,66.31037961114225,66.87094986326466,56.68056191062143,2.4819381458817764,0.19848033785820007,0.08893257156014442,0.1970705807209015,0.9777259111404419,0.9468388557434082,0.022872925829142333,0.014283144753426314,0.1378919631242752,0.0394340050406754,0.5722519159317017,0.4741848349571228,0.20003281980752946,0.040972274541854856,0.5227510809898377,0.5168869495391846,0.24680203795433045,0.4938928484916687,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4772.0,1699844.0,1376121.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,"Inhibits mutant forms of KIT, FLT3 and PDGFRA (http://www.google.com/patents/US20080226747).",,,,AMUVATINIB,CHEMBL2103851,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)",FOFDIMHVKGYHRU-UHFFFAOYSA-N,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,0.4761683339185086,4.0,447.5200000000002,3.301400000000002,7,1,0,75.89,-5.598012982868518,0.6717589378356934,-4.907345095941456,0.9999486207962036,-8.724052645388374,0.964915668964386,0.8804606914520263,0.8469775080680847,107.89649138601787,7.731638414534997,0.9573073863983155,0.9838817834854126,0.8997474193572998,0.677538800239563,0.9915576457977295,66.31037961114225,66.87094986326466,56.68056191062143,2.4819381458817764,0.19848033785820007,0.08893257156014442,0.1970705807209015,0.9777259111404419,0.9468388557434082,0.022872925829142333,0.014283144753426314,0.1378919631242752,0.0394340050406754,0.5722519159317017,0.4741848349571228,0.20003281980752946,0.040972274541854856,0.5227510809898377,0.5168869495391846,0.24680203795433045,0.4938928484916687,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4771.0,1699844.0,1376121.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,"Inhibits mutant forms of KIT, FLT3 and PDGFRA (http://www.google.com/patents/US20080226747).",,,,AMUVATINIB,CHEMBL2103851,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)",FOFDIMHVKGYHRU-UHFFFAOYSA-N,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,0.4761683339185086,4.0,447.5200000000002,3.301400000000002,7,1,0,75.89,-5.598012982868518,0.6717589378356934,-4.907345095941456,0.9999486207962036,-8.724052645388374,0.964915668964386,0.8804606914520263,0.8469775080680847,107.89649138601787,7.731638414534997,0.9573073863983155,0.9838817834854126,0.8997474193572998,0.677538800239563,0.9915576457977295,66.31037961114225,66.87094986326466,56.68056191062143,2.4819381458817764,0.19848033785820007,0.08893257156014442,0.1970705807209015,0.9777259111404419,0.9468388557434082,0.022872925829142333,0.014283144753426314,0.1378919631242752,0.0394340050406754,0.5722519159317017,0.4741848349571228,0.20003281980752946,0.040972274541854856,0.5227510809898377,0.5168869495391846,0.24680203795433045,0.4938928484916687,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4797.0,2473155.0,2089491.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEXIDARTINIB,CHEMBL3813873,4.0,1.0,0.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,1.0,2.0,0.0,0.0,2017.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)",JGWRKYUXBBNENE-UHFFFAOYSA-N,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,0.46645765570769304,3.0,417.82200000000006,5.228000000000002,4,2,0,66.49000000000001,-6.245417493999943,0.888002896308899,-5.370675132656486,0.999793016910553,-10.976161691290102,0.9211490631103516,0.5788645923137665,0.6579145014286041,102.19131379198427,8.316959214457425,0.8734205603599549,0.9213432908058167,0.5659593164920806,0.5840124726295471,0.9506397247314453,44.426460216196155,15.450532151278207,38.66141394394053,3.765670042452288,0.3031417399644852,0.4265334397554398,0.49181824922561646,0.8921362400054932,0.9015978217124939,0.011344728525727987,0.009507131576538087,0.17052135318517686,0.09274946674704551,0.70111083984375,0.4800625920295715,0.05894180163741112,0.051816774718463424,0.10325454920530319,0.7523594260215759,0.2813751459121704,0.21795715391635895,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4798.0,2473155.0,2089491.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEXIDARTINIB,CHEMBL3813873,4.0,1.0,0.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,1.0,2.0,0.0,0.0,2017.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)",JGWRKYUXBBNENE-UHFFFAOYSA-N,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,0.46645765570769304,3.0,417.82200000000006,5.228000000000002,4,2,0,66.49000000000001,-6.245417493999943,0.888002896308899,-5.370675132656486,0.999793016910553,-10.976161691290102,0.9211490631103516,0.5788645923137665,0.6579145014286041,102.19131379198427,8.316959214457425,0.8734205603599549,0.9213432908058167,0.5659593164920806,0.5840124726295471,0.9506397247314453,44.426460216196155,15.450532151278207,38.66141394394053,3.765670042452288,0.3031417399644852,0.4265334397554398,0.49181824922561646,0.8921362400054932,0.9015978217124939,0.011344728525727987,0.009507131576538087,0.17052135318517686,0.09274946674704551,0.70111083984375,0.4800625920295715,0.05894180163741112,0.051816774718463424,0.10325454920530319,0.7523594260215759,0.2813751459121704,0.21795715391635895,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4822.0,2472889.0,714130.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted receptor tyrosine kinase inhibitor,,,,FAMITINIB,CHEMBL1278146,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H27FN4O2/c1-4-27(5-2)10-11-28-9-8-19-21(23(28)30)14(3)20(25-19)13-17-16-12-15(24)6-7-18(16)26-22(17)29/h6-7,12-13,25H,4-5,8-11H2,1-3H3,(H,26,29)/b17-13-",GKEYKDOLBLYGRB-LGMDPLHJSA-N,CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O,0.7183641316360367,4.0,410.49300000000017,3.295020000000001,3,2,0,68.44,-3.6255025228465194,0.7609180808067322,-4.869840690212547,0.9909835815429687,-12.975295845923544,0.8713229775428772,0.6405569672584533,0.9609208345413208,77.03836597913785,19.903082087885554,0.5059363782405853,0.15762616395950318,0.07078315205872059,0.6141670346260071,0.3385898441076279,148.06041677294917,11.669756389051438,36.08871571493817,3.4517375255865934,0.8133832216262817,0.3789916157722473,0.7235359072685241,0.7294444441795349,0.9440252423286438,0.02342794630676508,0.03506764806807041,0.057595188915729525,0.01514727994799614,0.45679073333740233,0.039081410691142085,0.004028056346578523,0.07728554010391235,0.017928841151297094,0.11351727992296219,0.13231554478406907,0.49234333634376526,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4820.0,2472889.0,714130.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted receptor tyrosine kinase inhibitor,,,,FAMITINIB,CHEMBL1278146,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H27FN4O2/c1-4-27(5-2)10-11-28-9-8-19-21(23(28)30)14(3)20(25-19)13-17-16-12-15(24)6-7-18(16)26-22(17)29/h6-7,12-13,25H,4-5,8-11H2,1-3H3,(H,26,29)/b17-13-",GKEYKDOLBLYGRB-LGMDPLHJSA-N,CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O,0.7183641316360367,4.0,410.49300000000017,3.295020000000001,3,2,0,68.44,-3.6255025228465194,0.7609180808067322,-4.869840690212547,0.9909835815429687,-12.975295845923544,0.8713229775428772,0.6405569672584533,0.9609208345413208,77.03836597913785,19.903082087885554,0.5059363782405853,0.15762616395950318,0.07078315205872059,0.6141670346260071,0.3385898441076279,148.06041677294917,11.669756389051438,36.08871571493817,3.4517375255865934,0.8133832216262817,0.3789916157722473,0.7235359072685241,0.7294444441795349,0.9440252423286438,0.02342794630676508,0.03506764806807041,0.057595188915729525,0.01514727994799614,0.45679073333740233,0.039081410691142085,0.004028056346578523,0.07728554010391235,0.017928841151297094,0.11351727992296219,0.13231554478406907,0.49234333634376526,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,4859.0,2473466.0,2832042.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Spectrum Selective Kinase Inhibitor (SSKI),,,,XL-999,CHEMBL5314391,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H28FN5O/c1-3-32-11-9-19(10-12-32)30-20-7-8-22-21(14-20)24(26(33)31-22)23(25-28-15-16(2)29-25)17-5-4-6-18(27)13-17/h4-8,13-15,19,30H,3,9-12H2,1-2H3,(H,28,29)(H,31,33)/b24-23-",DMQYDVBIPXAAJA-VHXPQNKSSA-N,CCN1CCC(Nc2ccc3c(c2)/C(=C(\c2cccc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1,0.499479267547332,4.0,445.5420000000002,4.664620000000004,4,3,0,73.05,-4.5236201778676195,0.7477285742759705,-5.325344188088178,0.9971432089805603,-11.93856976887702,0.806662380695343,0.8734317302703858,0.8726457834243775,93.48858523694253,14.327059629658574,0.22039251178503036,0.3368904322385788,0.22724835723638534,0.6662426054477691,0.524125874042511,87.43026391743243,7.949751532560834,12.402131436613242,2.8555999786088138,0.37798880636692045,0.3046991914510727,0.7553624212741852,0.6107610702514649,0.9851971507072449,0.007070068269968033,0.008781440695747733,0.054365024715662,0.008792421128600836,0.32664274871349336,0.13063760697841645,0.0031470230605918914,0.04583236239850521,0.06217607147991657,0.30439371764659884,0.09682428166270256,0.3668216556310654,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4860.0,2473466.0,2832042.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Spectrum Selective Kinase Inhibitor (SSKI),,,,XL-999,CHEMBL5314391,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H28FN5O/c1-3-32-11-9-19(10-12-32)30-20-7-8-22-21(14-20)24(26(33)31-22)23(25-28-15-16(2)29-25)17-5-4-6-18(27)13-17/h4-8,13-15,19,30H,3,9-12H2,1-2H3,(H,28,29)(H,31,33)/b24-23-",DMQYDVBIPXAAJA-VHXPQNKSSA-N,CCN1CCC(Nc2ccc3c(c2)/C(=C(\c2cccc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1,0.499479267547332,4.0,445.5420000000002,4.664620000000004,4,3,0,73.05,-4.5236201778676195,0.7477285742759705,-5.325344188088178,0.9971432089805603,-11.93856976887702,0.806662380695343,0.8734317302703858,0.8726457834243775,93.48858523694253,14.327059629658574,0.22039251178503036,0.3368904322385788,0.22724835723638534,0.6662426054477691,0.524125874042511,87.43026391743243,7.949751532560834,12.402131436613242,2.8555999786088138,0.37798880636692045,0.3046991914510727,0.7553624212741852,0.6107610702514649,0.9851971507072449,0.007070068269968033,0.008781440695747733,0.054365024715662,0.008792421128600836,0.32664274871349336,0.13063760697841645,0.0031470230605918914,0.04583236239850521,0.06217607147991657,0.30439371764659884,0.09682428166270256,0.3668216556310654,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,5110.0,2139037.0,1763584.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits FLT3 signalling and proliferation and induces apoptosis in leukemia cells expressing FLT3-ITD.,Inhibits multiple receptor tyrosine kinases. Active against FLT3 and certain FLT3 variants.,ATP-binding site,,GILTERITINIB,CHEMBL3301622,4.0,1.0,0.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2014.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34)",GYQYAJJFPNQOOW-UHFFFAOYSA-N,CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1,0.4281496579360725,3.0,552.7240000000003,2.6972000000000014,10,3,0,121.10999999999999,-2.28248546521659,0.806004774570465,-5.421960780075928,0.9573200225830079,-10.601812025515056,0.7904789090156555,0.5151292324066162,0.7023855805397033,78.68491697500639,10.594433739995196,0.012432411767076702,0.03830131310969591,0.020188666600733995,0.1097218420356512,0.0666702227666974,24.131507961850016,-21.085022357094044,38.88258385204723,2.6372939554186243,0.3280973732471466,0.10312704816460609,0.709747314453125,0.6556144595146179,0.8830806732177734,0.0218335947021842,0.007232366455718875,0.049699032306671144,0.017337724473327397,0.03367050038650632,0.012657969817519188,0.005740276258438826,0.0247455520555377,0.02334101274609566,0.042293408140540126,0.11648529917001724,0.19489583671092986,True
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,5245.0,1705239.0,371147.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LINIFANIB,CHEMBL223360,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2009.0,,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)",MPVGZUGXCQEXTM-UHFFFAOYSA-N,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,0.4098564168765686,4.0,375.40700000000015,4.903620000000003,3,4,0,95.83,-5.776570956576158,0.9517792344093323,-5.353183010732633,0.9996730208396911,-13.120939053632444,0.652535355091095,0.6982172131538391,0.8025140881538391,100.19053721583934,6.5523237038259365,0.7814092636108398,0.8111931800842285,0.6163316607475281,0.27103325426578523,0.8503207206726074,99.23263459561443,21.957550145567218,27.767430539552286,2.8664387216379303,0.6348280072212219,0.5602956414222717,0.38008369207382203,0.9842599034309387,0.9033537626266479,0.054872751235961914,0.014937163377180696,0.1715147763490677,0.029036945756524803,0.8573743462562561,0.37080435156822206,0.05037701241672039,0.22984831631183625,0.02816429752856493,0.8881328105926514,0.27029749751091003,0.21804261356592178,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,5249.0,1705248.0,573133.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,QUIZARTINIB,CHEMBL576982,4.0,1.0,0.0,MOL,90217.0,Small molecule,2023.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)",CVWXJKQAOSCOAB-UHFFFAOYSA-N,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,0.25694797911853023,2.0,560.6800000000004,5.856500000000005,9,2,0,106.16000000000001,-5.323828755761126,0.7919211983680725,-4.810477050662284,0.9630886197090149,-11.603493728168946,0.5999494075775147,0.9425896406173706,0.41958906054496764,102.20163583292758,3.7606079783703565,0.12965959049761294,0.4913818001747131,0.5226330041885376,0.058951349137350915,0.3938884660601616,95.00804596748753,43.74358628858558,87.05487047220781,2.8839784298702527,0.4916869252920151,0.3275113582611084,0.5807694971561432,0.9613581657409668,0.884309720993042,0.02979847602546215,0.012255864124745131,0.12121943458914756,0.035561016947031024,0.6881864368915558,0.3070928156375885,0.12549185305833815,0.3453980952501297,0.2748235881328583,0.7871083498001099,0.6535831212997436,0.3273658961057663,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,5252.0,1705248.0,573133.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,QUIZARTINIB,CHEMBL576982,4.0,1.0,0.0,MOL,90217.0,Small molecule,2023.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)",CVWXJKQAOSCOAB-UHFFFAOYSA-N,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,0.25694797911853023,2.0,560.6800000000004,5.856500000000005,9,2,0,106.16000000000001,-5.323828755761126,0.7919211983680725,-4.810477050662284,0.9630886197090149,-11.603493728168946,0.5999494075775147,0.9425896406173706,0.41958906054496764,102.20163583292758,3.7606079783703565,0.12965959049761294,0.4913818001747131,0.5226330041885376,0.058951349137350915,0.3938884660601616,95.00804596748753,43.74358628858558,87.05487047220781,2.8839784298702527,0.4916869252920151,0.3275113582611084,0.5807694971561432,0.9613581657409668,0.884309720993042,0.02979847602546215,0.012255864124745131,0.12121943458914756,0.035561016947031024,0.6881864368915558,0.3070928156375885,0.12549185305833815,0.3453980952501297,0.2748235881328583,0.7871083498001099,0.6535831212997436,0.3273658961057663,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,5250.0,1705248.0,573133.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,QUIZARTINIB,CHEMBL576982,4.0,1.0,0.0,MOL,90217.0,Small molecule,2023.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)",CVWXJKQAOSCOAB-UHFFFAOYSA-N,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,0.25694797911853023,2.0,560.6800000000004,5.856500000000005,9,2,0,106.16000000000001,-5.323828755761126,0.7919211983680725,-4.810477050662284,0.9630886197090149,-11.603493728168946,0.5999494075775147,0.9425896406173706,0.41958906054496764,102.20163583292758,3.7606079783703565,0.12965959049761294,0.4913818001747131,0.5226330041885376,0.058951349137350915,0.3938884660601616,95.00804596748753,43.74358628858558,87.05487047220781,2.8839784298702527,0.4916869252920151,0.3275113582611084,0.5807694971561432,0.9613581657409668,0.884309720993042,0.02979847602546215,0.012255864124745131,0.12121943458914756,0.035561016947031024,0.6881864368915558,0.3070928156375885,0.12549185305833815,0.3453980952501297,0.2748235881328583,0.7871083498001099,0.6535831212997436,0.3273658961057663,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,5271.0,1706061.0,597145.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LESTAURTINIB,CHEMBL603469,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2004.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1",UIARLYUEJFELEN-LROUJFHJSA-N,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,0.3732159623688665,4.0,439.47100000000023,3.474400000000002,6,3,3,88.65,-4.411639334592281,0.5019159436225891,-5.127879753283482,0.9939271926879882,-14.358409579713145,0.7192701637744904,0.8386333465576172,0.3082113370299339,87.44649233159436,1.4756388466409978,0.6318382441997528,0.2774215966463089,0.3109517991542816,0.04282891787588596,0.2882162854075432,271.74399746652244,7.514334515586976,35.961567599950264,3.8095038030761073,0.6494227170944213,0.0718606038019061,0.2671946108341217,0.9716215491294861,0.8174700736999512,0.039758685231208804,0.25357651710510254,0.12256564497947693,0.09848276749253274,0.5144562244415283,0.7872034192085267,0.3233484476804733,0.25834159553050995,0.278689306974411,0.8796372652053833,0.8560659408569335,0.5291659712791443,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,5276.0,1706061.0,597145.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LESTAURTINIB,CHEMBL603469,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2004.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1",UIARLYUEJFELEN-LROUJFHJSA-N,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,0.3732159623688665,4.0,439.47100000000023,3.474400000000002,6,3,3,88.65,-4.411639334592281,0.5019159436225891,-5.127879753283482,0.9939271926879882,-14.358409579713145,0.7192701637744904,0.8386333465576172,0.3082113370299339,87.44649233159436,1.4756388466409978,0.6318382441997528,0.2774215966463089,0.3109517991542816,0.04282891787588596,0.2882162854075432,271.74399746652244,7.514334515586976,35.961567599950264,3.8095038030761073,0.6494227170944213,0.0718606038019061,0.2671946108341217,0.9716215491294861,0.8174700736999512,0.039758685231208804,0.25357651710510254,0.12256564497947693,0.09848276749253274,0.5144562244415283,0.7872034192085267,0.3233484476804733,0.25834159553050995,0.278689306974411,0.8796372652053833,0.8560659408569335,0.5291659712791443,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,5272.0,1706061.0,597145.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LESTAURTINIB,CHEMBL603469,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2004.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1",UIARLYUEJFELEN-LROUJFHJSA-N,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,0.3732159623688665,4.0,439.47100000000023,3.474400000000002,6,3,3,88.65,-4.411639334592281,0.5019159436225891,-5.127879753283482,0.9939271926879882,-14.358409579713145,0.7192701637744904,0.8386333465576172,0.3082113370299339,87.44649233159436,1.4756388466409978,0.6318382441997528,0.2774215966463089,0.3109517991542816,0.04282891787588596,0.2882162854075432,271.74399746652244,7.514334515586976,35.961567599950264,3.8095038030761073,0.6494227170944213,0.0718606038019061,0.2671946108341217,0.9716215491294861,0.8174700736999512,0.039758685231208804,0.25357651710510254,0.12256564497947693,0.09848276749253274,0.5144562244415283,0.7872034192085267,0.3233484476804733,0.25834159553050995,0.278689306974411,0.8796372652053833,0.8560659408569335,0.5291659712791443,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,5314.0,1702752.0,608601.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-kinase inhibitor,,,,MIDOSTAURIN,CHEMBL608533,4.0,1.0,1.0,MOL,63452.0,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2004.0,1.0,,0.0,,,,0.0,0.0,1.0,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",BMGQWWVMWDBQGC-IIFHNQTCSA-N,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,0.28721839165619395,2.0,570.6490000000002,5.906800000000007,6,1,4,77.72999999999999,-5.613763112883714,0.6269563913345337,-4.796562023184602,0.9976088285446167,-11.683274184194762,0.8464795589447022,0.9847602367401123,0.390359228849411,91.01402399405069,7.3836688799869705,0.35102808624506,0.7169376373291015,0.6281632900238037,0.037822875380516055,0.72009756565094,299.1288737827546,26.452477624610914,53.126617153315195,3.5000133464827186,0.573823994398117,0.0872464831918478,0.35945687294006345,0.9795894026756287,0.8960636496543884,0.011953904759138823,0.030479148402810095,0.059990096092224124,0.04774018600583076,0.42667284309864045,0.5165658891201019,0.2211194634437561,0.17849371135234832,0.33341692984104154,0.6557636022567749,0.4788734674453735,0.38423184156417844,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,5315.0,1702752.0,608601.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-kinase inhibitor,,,,MIDOSTAURIN,CHEMBL608533,4.0,1.0,1.0,MOL,63452.0,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2004.0,1.0,,0.0,,,,0.0,0.0,1.0,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",BMGQWWVMWDBQGC-IIFHNQTCSA-N,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,0.28721839165619395,2.0,570.6490000000002,5.906800000000007,6,1,4,77.72999999999999,-5.613763112883714,0.6269563913345337,-4.796562023184602,0.9976088285446167,-11.683274184194762,0.8464795589447022,0.9847602367401123,0.390359228849411,91.01402399405069,7.3836688799869705,0.35102808624506,0.7169376373291015,0.6281632900238037,0.037822875380516055,0.72009756565094,299.1288737827546,26.452477624610914,53.126617153315195,3.5000133464827186,0.573823994398117,0.0872464831918478,0.35945687294006345,0.9795894026756287,0.8960636496543884,0.011953904759138823,0.030479148402810095,0.059990096092224124,0.04774018600583076,0.42667284309864045,0.5165658891201019,0.2211194634437561,0.17849371135234832,0.33341692984104154,0.6557636022567749,0.4788734674453735,0.38423184156417844,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,5326.0,1937986.0,714243.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Potent inhibitor of BRD4 (PMID: 24584101).,,,,FEDRATINIB,CHEMBL1287853,4.0,1.0,0.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2013.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)",JOOXLOJCABQBSG-UHFFFAOYSA-N,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,0.3463330582394302,3.0,524.6910000000001,4.823620000000004,8,3,0,108.48000000000002,-4.385826511762519,0.8293847441673279,-5.4738807091185055,0.9864133119583129,-9.63355589595275,0.8728023052215577,0.7228212594985962,0.439443439245224,88.45730978313904,-1.0826728896540376,0.1921860843896866,0.33138676881790163,0.25064537227153777,0.4422850415110588,0.768817400932312,26.522398814298036,29.22301418154901,64.01596187935161,3.068860705800175,0.12157820984721183,0.4831862270832062,0.5653890013694763,0.9002657651901245,0.9213820695877075,0.01750508463010192,0.0171067388728261,0.05414978936314583,0.0289276871830225,0.1746439516544342,0.10913683399558068,0.0182117385789752,0.04092912450432777,0.12180591821670532,0.48904330730438234,0.24076576828956603,0.13469344973564149,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,5327.0,1937986.0,714243.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Potent inhibitor of BRD4 (PMID: 24584101).,,,,FEDRATINIB,CHEMBL1287853,4.0,1.0,0.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2013.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)",JOOXLOJCABQBSG-UHFFFAOYSA-N,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,0.3463330582394302,3.0,524.6910000000001,4.823620000000004,8,3,0,108.48000000000002,-4.385826511762519,0.8293847441673279,-5.4738807091185055,0.9864133119583129,-9.63355589595275,0.8728023052215577,0.7228212594985962,0.439443439245224,88.45730978313904,-1.0826728896540376,0.1921860843896866,0.33138676881790163,0.25064537227153777,0.4422850415110588,0.768817400932312,26.522398814298036,29.22301418154901,64.01596187935161,3.068860705800175,0.12157820984721183,0.4831862270832062,0.5653890013694763,0.9002657651901245,0.9213820695877075,0.01750508463010192,0.0171067388728261,0.05414978936314583,0.0289276871830225,0.1746439516544342,0.10913683399558068,0.0182117385789752,0.04092912450432777,0.12180591821670532,0.48904330730438234,0.24076576828956603,0.13469344973564149,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,5329.0,1976740.0,1344709.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PACRITINIB,CHEMBL2035187,4.0,1.0,0.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+",HWXVIOGONBBTBY-ONEGZZNKSA-N,C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2,0.6655052785203615,4.0,472.58900000000017,4.466800000000004,7,1,0,67.68,-3.935263908275661,0.6962373733520508,-5.0940598903042416,0.9312611579895019,-8.793238837601425,0.7649430394172668,0.6608483076095581,0.6173059940338135,91.75476692768011,1.892636154196746,0.09742425009608269,0.05141034573316574,0.009779834048822522,0.6149776875972748,0.03226039372384548,-48.498328895517474,26.750588332336406,46.4564564646624,3.2331754643993342,0.34083591401576996,0.07896278947591781,0.3036772683262825,0.5788122534751892,0.8582605004310608,0.05020827949047089,0.009422829234972596,0.14657673090696335,0.021011966466903686,0.3257791057229042,0.03025064542889595,0.005193182313814759,0.02873957101255655,0.07062393873929977,0.05542137622833252,0.09699536114931107,0.4039843216538429,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,5328.0,1976740.0,1344709.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PACRITINIB,CHEMBL2035187,4.0,1.0,0.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+",HWXVIOGONBBTBY-ONEGZZNKSA-N,C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2,0.6655052785203615,4.0,472.58900000000017,4.466800000000004,7,1,0,67.68,-3.935263908275661,0.6962373733520508,-5.0940598903042416,0.9312611579895019,-8.793238837601425,0.7649430394172668,0.6608483076095581,0.6173059940338135,91.75476692768011,1.892636154196746,0.09742425009608269,0.05141034573316574,0.009779834048822522,0.6149776875972748,0.03226039372384548,-48.498328895517474,26.750588332336406,46.4564564646624,3.2331754643993342,0.34083591401576996,0.07896278947591781,0.3036772683262825,0.5788122534751892,0.8582605004310608,0.05020827949047089,0.009422829234972596,0.14657673090696335,0.021011966466903686,0.3257791057229042,0.03025064542889595,0.005193182313814759,0.02873957101255655,0.07062393873929977,0.05542137622833252,0.09699536114931107,0.4039843216538429,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,5337.0,2473498.0,494834.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DOVITINIB,CHEMBL522892,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2007.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)",PIQCTGMSNWUMAF-UHFFFAOYSA-N,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,0.4874373998840835,4.0,392.4380000000001,2.5445,5,3,0,94.03999999999999,-3.7737497495899475,0.8142037272453309,-4.878883118165733,0.9855404376983643,-15.514021786052211,0.5418729782104492,0.3541382223367691,0.4552461326122284,84.13739769425204,5.449888336507034,0.36694234013557436,0.14111956506967543,0.10082781463861465,0.12247107364237309,0.42734122574329375,3.9598206070190125,-6.538871469977242,-18.18281639235658,2.5084103317921587,0.7947481513023377,0.4145830512046814,0.7665397882461548,0.967297887802124,0.9381982445716858,0.041540610045194624,0.06810870915651321,0.0785616435110569,0.05535258576273918,0.5496609270572662,0.2161658525466919,0.02087041181512177,0.10670571774244308,0.02040258552879095,0.25459884107112885,0.2877383857965469,0.34655303955078126,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,5338.0,2473498.0,494834.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DOVITINIB,CHEMBL522892,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2007.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)",PIQCTGMSNWUMAF-UHFFFAOYSA-N,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,0.4874373998840835,4.0,392.4380000000001,2.5445,5,3,0,94.03999999999999,-3.7737497495899475,0.8142037272453309,-4.878883118165733,0.9855404376983643,-15.514021786052211,0.5418729782104492,0.3541382223367691,0.4552461326122284,84.13739769425204,5.449888336507034,0.36694234013557436,0.14111956506967543,0.10082781463861465,0.12247107364237309,0.42734122574329375,3.9598206070190125,-6.538871469977242,-18.18281639235658,2.5084103317921587,0.7947481513023377,0.4145830512046814,0.7665397882461548,0.967297887802124,0.9381982445716858,0.041540610045194624,0.06810870915651321,0.0785616435110569,0.05535258576273918,0.5496609270572662,0.2161658525466919,0.02087041181512177,0.10670571774244308,0.02040258552879095,0.25459884107112885,0.2877383857965469,0.34655303955078126,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,7350.0,2139013.0,1763565.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits FLT3 signalling and proliferation and induces apoptosis in leukemia cells expressing FLT3-ITD.,Inhibits multiple receptor tyrosine kinases. Active against FLT3 and certain FLT3 variants.,ATP-binding site,,GILTERITINIB FUMARATE,CHEMBL3301603,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2014.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/2C29H44N8O3.C4H4O4/c2*1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36;5-3(6)1-2-4(7)8/h2*5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34);1-2H,(H,5,6)(H,7,8)/b;;2-1+",UJOUWHLYTQFUCU-WXXKFALUSA-N,CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O,0.053335130937744384,0.0,1221.5199999999993,5.106200000000014,22,8,0,316.82000000000005,-2.981578565768222,0.7906808257102966,-5.878311603721544,0.47096089720726014,-12.495841019787907,0.2703966170549393,0.39628876447677613,0.3915477991104126,75.74492066206861,3.538938980728061,0.016171657713130116,0.07016677893698216,0.07011887393891811,0.05207486907020211,0.03510250598192215,52.74985922313789,-43.476097789809145,13.356537528311327,2.413536896321754,0.3564246594905853,0.14300400242209435,0.7860287070274353,0.8559693455696106,0.6835126161575318,0.025230056419968606,0.011581135727465153,0.077857606112957,0.0471145361661911,0.04593719337135553,0.03271545246243477,0.059997282549738885,0.11006993353366852,0.0668316524475813,0.08255540654063225,0.2973866850137711,0.2714428216218948,True
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,7426.0,2973331.0,2197844.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEXIDARTINIB HYDROCHLORIDE,CHEMBL3989973,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2017.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H15ClF3N5.ClH/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24;/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29);1H",CJLUYLRKLUYCEK-UHFFFAOYSA-N,Cl.FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,0.40921044638970494,3.0,454.2830000000001,5.6498000000000035,4,2,0,66.49000000000001,-5.968603459329683,0.8712857007980347,-5.428414808866513,0.99956773519516,-11.514974116093331,0.8788573503494262,0.6236019432544708,0.61930330991745,101.3249469226316,5.104567312934551,0.8504215002059936,0.8785086631774902,0.609655100107193,0.695656669139862,0.94413081407547,39.574396706724485,5.734252894558653,30.512390826326612,3.441101266209561,0.39002464413642884,0.5189607560634613,0.5629405319690705,0.8549914360046387,0.9162570118904114,0.010109763592481613,0.009955567214637995,0.1596363827586174,0.07521381005644798,0.687019145488739,0.4050076425075531,0.061431729793548585,0.04902612734586,0.11495629996061325,0.7583105683326721,0.28879867792129515,0.2540323048830032,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,7427.0,2973331.0,2197844.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEXIDARTINIB HYDROCHLORIDE,CHEMBL3989973,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2017.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H15ClF3N5.ClH/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24;/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29);1H",CJLUYLRKLUYCEK-UHFFFAOYSA-N,Cl.FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,0.40921044638970494,3.0,454.2830000000001,5.6498000000000035,4,2,0,66.49000000000001,-5.968603459329683,0.8712857007980347,-5.428414808866513,0.99956773519516,-11.514974116093331,0.8788573503494262,0.6236019432544708,0.61930330991745,101.3249469226316,5.104567312934551,0.8504215002059936,0.8785086631774902,0.609655100107193,0.695656669139862,0.94413081407547,39.574396706724485,5.734252894558653,30.512390826326612,3.441101266209561,0.39002464413642884,0.5189607560634613,0.5629405319690705,0.8549914360046387,0.9162570118904114,0.010109763592481613,0.009955567214637995,0.1596363827586174,0.07521381005644798,0.687019145488739,0.4050076425075531,0.061431729793548585,0.04902612734586,0.11495629996061325,0.7583105683326721,0.28879867792129515,0.2540323048830032,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,7452.0,3132781.0,2335187.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Active against wild-type Jak2 and FLT3 and mutationally activated forms (e.g. JAK2V617F and FLT3ITD).
Mutant Jak2 is implicated in myeloproliferative neoplasms (MPNs). 
In cell models, fedratinib reduced signalling associated with these mutant kinases with the overall effect of decreasing cell proliferation and inducing apoptosis.
In animal models, fedratinib improved survival.",,,,FEDRATINIB HYDROCHLORIDE,CHEMBL4297216,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2017.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C27H36N6O3S.2ClH.H2O/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4;;;/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31);2*1H;1H2",QAFZLTVOFJHYDF-UHFFFAOYSA-N,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cl.Cl.O,0.2944525995536509,3.0,615.6280000000002,4.8425200000000075,8,3,0,139.98000000000002,-3.35149173254736,0.8136031866073609,-5.622646782805252,0.9670842885971069,-10.010961300723531,0.6892205595970153,0.6774778246879578,0.3293450683355331,92.163197338267,-2.7917096472369436,0.1836126983165741,0.3627612829208374,0.22639085948467255,0.6104418039321899,0.7001649260520935,49.599601302677726,12.96571646262619,39.46265304757438,2.667905036417301,0.2207392171025276,0.5844567477703094,0.5477487504482269,0.8520618200302124,0.904568874835968,0.01041412684135139,0.011838732101023198,0.0689661405980587,0.028864307887852193,0.10703729093074799,0.09877542182803153,0.018080939538776875,0.03769840858876705,0.12529287189245225,0.38118337392807006,0.2027590200304985,0.18236418813467026,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,7451.0,3132781.0,2335187.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Active against wild-type Jak2 and FLT3 and mutationally activated forms (e.g. JAK2V617F and FLT3ITD).
Mutant Jak2 is implicated in myeloproliferative neoplasms (MPNs). 
In cell models, fedratinib reduced signalling associated with these mutant kinases with the overall effect of decreasing cell proliferation and inducing apoptosis.
In animal models, fedratinib improved survival.","Higher selectivity for JAK2 over family members JAK1, JAK3 and TYK2.",,,FEDRATINIB HYDROCHLORIDE,CHEMBL4297216,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2017.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C27H36N6O3S.2ClH.H2O/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4;;;/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31);2*1H;1H2",QAFZLTVOFJHYDF-UHFFFAOYSA-N,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cl.Cl.O,0.2944525995536509,3.0,615.6280000000002,4.8425200000000075,8,3,0,139.98000000000002,-3.35149173254736,0.8136031866073609,-5.622646782805252,0.9670842885971069,-10.010961300723531,0.6892205595970153,0.6774778246879578,0.3293450683355331,92.163197338267,-2.7917096472369436,0.1836126983165741,0.3627612829208374,0.22639085948467255,0.6104418039321899,0.7001649260520935,49.599601302677726,12.96571646262619,39.46265304757438,2.667905036417301,0.2207392171025276,0.5844567477703094,0.5477487504482269,0.8520618200302124,0.904568874835968,0.01041412684135139,0.011838732101023198,0.0689661405980587,0.028864307887852193,0.10703729093074799,0.09877542182803153,0.018080939538776875,0.03769840858876705,0.12529287189245225,0.38118337392807006,0.2027590200304985,0.18236418813467026,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,8525.0,3489935.0,2193812.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NINGETINIB,CHEMBL3984441,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C31H29FN4O5/c1-19-28(30(38)36(35(19)4)21-8-6-5-7-9-21)29(37)34-20-10-13-27(24(32)16-20)41-26-14-15-33-25-17-22(11-12-23(25)26)40-18-31(2,3)39/h5-17,39H,18H2,1-4H3,(H,34,37)",VQYYQSZNRVQLIS-UHFFFAOYSA-N,Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C,0.2663097948450433,2.0,556.5940000000002,5.366020000000005,8,2,0,107.61000000000001,-5.252874242379379,0.9042256236076355,-4.997749585285334,0.9936152219772338,-10.737002358113852,0.7854919195175171,0.8917905449867248,0.40438552796840666,95.31753667370802,0.6052229864878617,0.014453073777258397,0.15447295904159547,0.35820468962192537,0.02079502195119858,0.4746357262134552,110.52502200832483,42.89994307056712,64.49984731686344,3.158999608449986,0.3810958206653595,0.4390545129776001,0.2817804366350174,0.9321598410606384,0.8349670052528382,0.119319087266922,0.026034395582973956,0.06822551414370537,0.010419281292706728,0.344940322637558,0.32900266349315643,0.07749716266989708,0.08476204574108123,0.0433128047734499,0.7608871459960938,0.19021756201982498,0.054118504375219346,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,8522.0,3489935.0,2193812.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NINGETINIB,CHEMBL3984441,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C31H29FN4O5/c1-19-28(30(38)36(35(19)4)21-8-6-5-7-9-21)29(37)34-20-10-13-27(24(32)16-20)41-26-14-15-33-25-17-22(11-12-23(25)26)40-18-31(2,3)39/h5-17,39H,18H2,1-4H3,(H,34,37)",VQYYQSZNRVQLIS-UHFFFAOYSA-N,Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C,0.2663097948450433,2.0,556.5940000000002,5.366020000000005,8,2,0,107.61000000000001,-5.252874242379379,0.9042256236076355,-4.997749585285334,0.9936152219772338,-10.737002358113852,0.7854919195175171,0.8917905449867248,0.40438552796840666,95.31753667370802,0.6052229864878617,0.014453073777258397,0.15447295904159547,0.35820468962192537,0.02079502195119858,0.4746357262134552,110.52502200832483,42.89994307056712,64.49984731686344,3.158999608449986,0.3810958206653595,0.4390545129776001,0.2817804366350174,0.9321598410606384,0.8349670052528382,0.119319087266922,0.026034395582973956,0.06822551414370537,0.010419281292706728,0.344940322637558,0.32900266349315643,0.07749716266989708,0.08476204574108123,0.0433128047734499,0.7608871459960938,0.19021756201982498,0.054118504375219346,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,8588.0,3490060.0,2486543.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,Covalent inhibitor - to the cysteine residue at 695.,,,,FF-10101,CHEMBL4650283,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C29H38N8O2/c1-6-17-31-27-24(21-33-29(35-27)34-25-15-13-23(20-30)14-16-25)11-8-7-9-18-32-28(39)22(2)37(5)26(38)12-10-19-36(3)4/h10,12-16,21-22H,6-7,9,17-19H2,1-5H3,(H,32,39)(H2,31,33,34,35)/b12-10+/t22-/m0/s1",HJFSVYUFOXAVAA-YUAYGMJFSA-N,CCCNc1nc(Nc2ccc(C#N)cc2)ncc1C#CCCCNC(=O)[C@H](C)N(C)C(=O)/C=C/CN(C)C,0.20488448163320178,3.0,530.6770000000004,3.126380000000001,8,3,1,126.27999999999999,-4.3830761759843915,0.4464112281799316,-5.279856801127849,0.826336944103241,-10.434305033476289,0.8550500988960266,0.7165785551071167,0.4120329737663269,87.8083944355793,14.87107489891309,0.00888097076676786,0.23699172139167785,0.12762473821640014,0.15049332678318023,0.6933184385299682,60.40754070497201,60.19838666378225,88.5154349962099,3.512954227424122,0.2931615084409714,0.2998259276151657,0.4796220541000366,0.6582302331924439,0.908705186843872,0.015989002119749785,0.010850347485393286,0.02587551735341549,0.038862482830882075,0.13104279935359955,0.09610392451286316,0.009690878354012967,0.053028802201151845,0.06576348394155503,0.27018018811941147,0.24833980351686477,0.21713910549879073,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,9592.0,3841459.0,2739480.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PACRITINIB CITRATE,CHEMBL5095049,4.0,1.0,1.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H32N4O3.C6H8O7/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b4-3+;",BAHHBHSHSRTKNK-BJILWQEISA-N,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1.O=C(O)CC(O)(CC(=O)O)C(=O)O,0.20726251573235785,2.0,664.7120000000002,3.7163000000000004,11,5,0,200.86999999999998,-3.181754363435286,0.6754589319229126,-5.912163180111298,0.6721224248409271,-12.840984614978902,0.23630221486091613,0.25821810960769653,0.6065012812614441,82.8925925439955,3.1592877747561903,0.21487462967634202,0.12876508980989457,0.09803328812122344,0.3830109119415283,0.2440991073846817,17.820807669221942,-18.65342137265514,22.854246504842717,3.3370298067924216,0.16425050124526025,0.11943621188402176,0.7644505023956298,0.8504284977912903,0.7181681394577026,0.04422767348587513,0.015613697096705436,0.10779597014188766,0.04227340258657932,0.2553640067577362,0.10574037656188011,0.03329026699066162,0.04794972911477089,0.05387900006026029,0.1304427333176136,0.2623590171337128,0.22254431247711182,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,9591.0,3841459.0,2739480.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PACRITINIB CITRATE,CHEMBL5095049,4.0,1.0,1.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H32N4O3.C6H8O7/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b4-3+;",BAHHBHSHSRTKNK-BJILWQEISA-N,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1.O=C(O)CC(O)(CC(=O)O)C(=O)O,0.20726251573235785,2.0,664.7120000000002,3.7163000000000004,11,5,0,200.86999999999998,-3.181754363435286,0.6754589319229126,-5.912163180111298,0.6721224248409271,-12.840984614978902,0.23630221486091613,0.25821810960769653,0.6065012812614441,82.8925925439955,3.1592877747561903,0.21487462967634202,0.12876508980989457,0.09803328812122344,0.3830109119415283,0.2440991073846817,17.820807669221942,-18.65342137265514,22.854246504842717,3.3370298067924216,0.16425050124526025,0.11943621188402176,0.7644505023956298,0.8504284977912903,0.7181681394577026,0.04422767348587513,0.015613697096705436,0.10779597014188766,0.04227340258657932,0.2553640067577362,0.10574037656188011,0.03329026699066162,0.04794972911477089,0.05387900006026029,0.1304427333176136,0.2623590171337128,0.22254431247711182,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,9593.0,3841459.0,2739480.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,592.0,PACRITINIB CITRATE,CHEMBL5095049,4.0,1.0,1.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H32N4O3.C6H8O7/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b4-3+;",BAHHBHSHSRTKNK-BJILWQEISA-N,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1.O=C(O)CC(O)(CC(=O)O)C(=O)O,0.20726251573235785,2.0,664.7120000000002,3.7163000000000004,11,5,0,200.86999999999998,-3.181754363435286,0.6754589319229126,-5.912163180111298,0.6721224248409271,-12.840984614978902,0.23630221486091613,0.25821810960769653,0.6065012812614441,82.8925925439955,3.1592877747561903,0.21487462967634202,0.12876508980989457,0.09803328812122344,0.3830109119415283,0.2440991073846817,17.820807669221942,-18.65342137265514,22.854246504842717,3.3370298067924216,0.16425050124526025,0.11943621188402176,0.7644505023956298,0.8504284977912903,0.7181681394577026,0.04422767348587513,0.015613697096705436,0.10779597014188766,0.04227340258657932,0.2553640067577362,0.10574037656188011,0.03329026699066162,0.04794972911477089,0.05387900006026029,0.1304427333176136,0.2623590171337128,0.22254431247711182,False
FLT3,12670,SINGLE PROTEIN,Tyrosine-protein kinase receptor FLT3,9606,Homo sapiens,CHEMBL1974,,0.0,9805.0,1706433.0,13048.0,Tyrosine-protein kinase receptor FLT3 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SUNITINIB,CHEMBL535,4.0,1.0,1.0,MOL,38940.0,Small molecule,2006.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-",WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,0.6263032743124629,4.0,398.48200000000014,3.3349400000000013,3,3,0,77.23,-3.531910664729788,0.8696355581283569,-5.074621973371424,0.9932968020439148,-12.748965263512156,0.8509592175483703,0.6600301384925842,0.9477871656417847,78.87961593566283,29.427431851075664,0.5137695431709289,0.14233944416046143,0.050484773889184,0.585032993555069,0.29889113306999204,168.05376330566853,2.331896828432916,28.710153760279987,3.443756434339447,0.8245324730873108,0.4827370882034302,0.7444677829742432,0.7179584205150604,0.937355124950409,0.019694039970636366,0.027590232342481612,0.04632672108709812,0.012444155476987361,0.4139900177717209,0.03580223880708218,0.003140616969903931,0.05986670404672623,0.01851615570485592,0.11382696628570557,0.11052237078547478,0.4882646143436432,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,9806.0,1706433.0,13048.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SUNITINIB,CHEMBL535,4.0,1.0,1.0,MOL,38940.0,Small molecule,2006.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-",WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,0.6263032743124629,4.0,398.48200000000014,3.3349400000000013,3,3,0,77.23,-3.531910664729788,0.8696355581283569,-5.074621973371424,0.9932968020439148,-12.748965263512156,0.8509592175483703,0.6600301384925842,0.9477871656417847,78.87961593566283,29.427431851075664,0.5137695431709289,0.14233944416046143,0.050484773889184,0.585032993555069,0.29889113306999204,168.05376330566853,2.331896828432916,28.710153760279987,3.443756434339447,0.8245324730873108,0.4827370882034302,0.7444677829742432,0.7179584205150604,0.937355124950409,0.019694039970636366,0.027590232342481612,0.04632672108709812,0.012444155476987361,0.4139900177717209,0.03580223880708218,0.003140616969903931,0.05986670404672623,0.01851615570485592,0.11382696628570557,0.11052237078547478,0.4882646143436432,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,9800.0,1706433.0,13048.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SUNITINIB,CHEMBL535,4.0,1.0,1.0,MOL,38940.0,Small molecule,2006.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-",WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,0.6263032743124629,4.0,398.48200000000014,3.3349400000000013,3,3,0,77.23,-3.531910664729788,0.8696355581283569,-5.074621973371424,0.9932968020439148,-12.748965263512156,0.8509592175483703,0.6600301384925842,0.9477871656417847,78.87961593566283,29.427431851075664,0.5137695431709289,0.14233944416046143,0.050484773889184,0.585032993555069,0.29889113306999204,168.05376330566853,2.331896828432916,28.710153760279987,3.443756434339447,0.8245324730873108,0.4827370882034302,0.7444677829742432,0.7179584205150604,0.937355124950409,0.019694039970636366,0.027590232342481612,0.04632672108709812,0.012444155476987361,0.4139900177717209,0.03580223880708218,0.003140616969903931,0.05986670404672623,0.01851615570485592,0.11382696628570557,0.11052237078547478,0.4882646143436432,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,1516.0,1679381.0,1277553.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,REGORAFENIB,CHEMBL1946170,4.0,1.0,1.0,MOL,68647.0,Small molecule,2012.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,2011.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)",FNHKPVJBJVTLMP-UHFFFAOYSA-N,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,0.40735964520341955,3.0,482.82100000000014,5.688800000000002,4,3,0,92.35000000000001,-7.067307461840086,0.8921070098876953,-5.05671733463128,0.9960593700408935,-10.79509653351515,0.6806607127189637,0.757573401927948,0.6593227505683898,95.0424334165768,4.003547774127533,0.4335181176662445,0.6604785323143005,0.6304134964942932,0.125840862095356,0.59864182472229,137.122679393356,40.14646624560662,34.84323904521749,2.9459603883062058,0.3215853124856949,0.6207245528697968,0.3542162448167801,0.9552808165550232,0.7861979126930236,0.018906810507178306,0.00855191657319665,0.0641159750521183,0.012984502129256725,0.2571668565273285,0.1443071410059929,0.0905737191438675,0.025348270870745183,0.14842998385429382,0.8180395722389221,0.3882056474685669,0.1901822179555893,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,993.0,1679381.0,1277553.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,Also active against BRAFV600E,,,REGORAFENIB,CHEMBL1946170,4.0,1.0,1.0,MOL,68647.0,Small molecule,2012.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,2011.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)",FNHKPVJBJVTLMP-UHFFFAOYSA-N,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,0.40735964520341955,3.0,482.82100000000014,5.688800000000002,4,3,0,92.35000000000001,-7.067307461840086,0.8921070098876953,-5.05671733463128,0.9960593700408935,-10.79509653351515,0.6806607127189637,0.757573401927948,0.6593227505683898,95.0424334165768,4.003547774127533,0.4335181176662445,0.6604785323143005,0.6304134964942932,0.125840862095356,0.59864182472229,137.122679393356,40.14646624560662,34.84323904521749,2.9459603883062058,0.3215853124856949,0.6207245528697968,0.3542162448167801,0.9552808165550232,0.7861979126930236,0.018906810507178306,0.00855191657319665,0.0641159750521183,0.012984502129256725,0.2571668565273285,0.1443071410059929,0.0905737191438675,0.025348270870745183,0.14842998385429382,0.8180395722389221,0.3882056474685669,0.1901822179555893,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,448.0,1679381.0,1277553.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,REGORAFENIB,CHEMBL1946170,4.0,1.0,1.0,MOL,68647.0,Small molecule,2012.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,2011.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)",FNHKPVJBJVTLMP-UHFFFAOYSA-N,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,0.40735964520341955,3.0,482.82100000000014,5.688800000000002,4,3,0,92.35000000000001,-7.067307461840086,0.8921070098876953,-5.05671733463128,0.9960593700408935,-10.79509653351515,0.6806607127189637,0.757573401927948,0.6593227505683898,95.0424334165768,4.003547774127533,0.4335181176662445,0.6604785323143005,0.6304134964942932,0.125840862095356,0.59864182472229,137.122679393356,40.14646624560662,34.84323904521749,2.9459603883062058,0.3215853124856949,0.6207245528697968,0.3542162448167801,0.9552808165550232,0.7861979126930236,0.018906810507178306,0.00855191657319665,0.0641159750521183,0.012984502129256725,0.2571668565273285,0.1443071410059929,0.0905737191438675,0.025348270870745183,0.14842998385429382,0.8180395722389221,0.3882056474685669,0.1901822179555893,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,2432.0,2583412.0,2039291.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ALECTINIB HYDROCHLORIDE,CHEMBL3707320,4.0,1.0,1.0,MOL,,Small molecule,2015.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H34N4O2.ClH/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29;/h5-6,15-17,21,32H,4,7-14H2,1-3H3;1H",GYABBVHSRIHYJR-UHFFFAOYSA-N,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O.Cl,0.5159745662157008,2.0,519.0890000000003,5.195080000000006,5,1,0,72.36,-3.9816239681306174,0.7450338721275329,-4.876486430887405,0.9958361625671387,-10.253824632164292,0.6502754211425781,0.9573290109634399,0.8405046820640564,98.84940161600855,10.674849710398146,0.2949297562241554,0.41366838216781615,0.32548415958881377,0.20763476192951202,0.47517024278640746,114.71213917544856,24.499409071604923,47.76320014393616,2.5458382053668114,0.4677616894245148,0.23838986158370973,0.5553430318832397,0.6689222931861878,0.965085756778717,0.014689252059906722,0.10479336977005005,0.09501189440488815,0.15821826569736003,0.5577221691608429,0.4395612865686417,0.02482074610888958,0.3135761544108391,0.23935548216104507,0.8108846426010132,0.6878636002540588,0.4286614716053009,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,5435.0,1699778.0,568338.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-kinase inhibitor,,,,MOTESANIB,CHEMBL572881,3.0,0.0,0.0,MOL,51098.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)",RAHBGWKEPAQNFF-UHFFFAOYSA-N,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,0.6289061542065445,4.0,373.4600000000001,4.044100000000002,5,3,0,78.94,-4.82204364512513,0.824767017364502,-5.291384089307077,0.9999488115310669,-11.818545796239864,0.9500450134277344,0.779313600063324,0.8018417596817017,97.34305273928807,4.556502890898445,0.9124632239341736,0.9691942691802978,0.9263432025909424,0.8464792370796204,0.9907540440559387,81.21375732207467,50.16423896355119,54.2264037386125,2.818932966393771,0.385562589764595,0.15897430032491683,0.45724329352378845,0.8400549530982971,0.9395156025886535,0.013383805379271507,0.009932278376072644,0.1370970368385315,0.036674408987164495,0.8047260761260986,0.592616868019104,0.052074574679136273,0.07022292241454124,0.2511328488588333,0.8479908227920532,0.2306416243314743,0.4114373683929443,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,5434.0,1699778.0,568338.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-kinase inhibitor,,,,MOTESANIB,CHEMBL572881,3.0,0.0,0.0,MOL,51098.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)",RAHBGWKEPAQNFF-UHFFFAOYSA-N,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,0.6289061542065445,4.0,373.4600000000001,4.044100000000002,5,3,0,78.94,-4.82204364512513,0.824767017364502,-5.291384089307077,0.9999488115310669,-11.818545796239864,0.9500450134277344,0.779313600063324,0.8018417596817017,97.34305273928807,4.556502890898445,0.9124632239341736,0.9691942691802978,0.9263432025909424,0.8464792370796204,0.9907540440559387,81.21375732207467,50.16423896355119,54.2264037386125,2.818932966393771,0.385562589764595,0.15897430032491683,0.45724329352378845,0.8400549530982971,0.9395156025886535,0.013383805379271507,0.009932278376072644,0.1370970368385315,0.036674408987164495,0.8047260761260986,0.592616868019104,0.052074574679136273,0.07022292241454124,0.2511328488588333,0.8479908227920532,0.2306416243314743,0.4114373683929443,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,7624.0,3460682.0,2429562.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Selpercatinib inhibited wild-type RET and multiple mutated RET isoforms (inc. RET V804M, and RET M918T). Mutations and rearrangements in RET can drive cancers. Selpercatinib also inhibited VEGFR1 and VEGFR3 (IC50 values 0.92 - 67.8 nM) and FGFR 1, 2, and 3 at higher concentrations. Active against RET in cell assays at 60-fold lower concentration than FGFR1/2 and 8-fold lower concentration than VEGFR3. ",,,SELPERCATINIB,CHEMBL4559134,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H31N7O3/c1-29(2,37)18-39-24-9-25(28-21(10-30)13-33-36(28)17-24)20-5-6-26(31-12-20)34-15-22-8-23(16-34)35(22)14-19-4-7-27(38-3)32-11-19/h4-7,9,11-13,17,22-23,37H,8,14-16,18H2,1-3H3",XIIOFHFUYBLOLW-UHFFFAOYSA-N,COc1ccc(CN2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1,0.37031895024634764,3.0,525.6130000000003,3.2843800000000023,10,1,2,112.03999999999999,-4.628690096723574,0.696226966381073,-5.078637630356749,0.9969194531440735,-10.558857536540334,0.9431161522865296,0.7308045625686646,0.5602011442184448,92.59015891235244,5.940807911881746,0.031076503451913595,0.5076579332351685,0.6214547514915466,0.1265789456665516,0.6624406218528748,-50.22809903401594,37.097794675105604,97.01717051658117,3.577409490736983,0.17948489934206008,0.1530337106436491,0.7181278705596924,0.8864638686180115,0.9733804821968078,0.011918056849390268,0.00906679118052125,0.028820573911070825,0.023861822485923768,0.4337362229824066,0.18648771643638612,0.012067611049860715,0.03369582183659077,0.033476381376385686,0.4526257961988449,0.49663925766944883,0.13390062600374222,False
RET,109645,CHIMERIC PROTEIN,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL3430888,,0.0,7657.0,3460682.0,2429562.0,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Selpercatinib inhibited wild-type RET and multiple mutated RET isoforms (inc. RET V804M, and RET M918T). Mutations and rearrangements in RET can drive cancers. Selpercatinib also inhibited VEGFR1 and VEGFR3 (IC50 values 0.92 - 67.8 nM) and FGFR 1, 2, and 3 at higher concentrations. Active against RET in cell assays at 60-fold lower concentration than FGFR1/2 and 8-fold lower concentration than VEGFR3. ",,,SELPERCATINIB,CHEMBL4559134,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H31N7O3/c1-29(2,37)18-39-24-9-25(28-21(10-30)13-33-36(28)17-24)20-5-6-26(31-12-20)34-15-22-8-23(16-34)35(22)14-19-4-7-27(38-3)32-11-19/h4-7,9,11-13,17,22-23,37H,8,14-16,18H2,1-3H3",XIIOFHFUYBLOLW-UHFFFAOYSA-N,COc1ccc(CN2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1,0.37031895024634764,3.0,525.6130000000003,3.2843800000000023,10,1,2,112.03999999999999,-4.628690096723574,0.696226966381073,-5.078637630356749,0.9969194531440735,-10.558857536540334,0.9431161522865296,0.7308045625686646,0.5602011442184448,92.59015891235244,5.940807911881746,0.031076503451913595,0.5076579332351685,0.6214547514915466,0.1265789456665516,0.6624406218528748,-50.22809903401594,37.097794675105604,97.01717051658117,3.577409490736983,0.17948489934206008,0.1530337106436491,0.7181278705596924,0.8864638686180115,0.9733804821968078,0.011918056849390268,0.00906679118052125,0.028820573911070825,0.023861822485923768,0.4337362229824066,0.18648771643638612,0.012067611049860715,0.03369582183659077,0.033476381376385686,0.4526257961988449,0.49663925766944883,0.13390062600374222,False
RET,109661,CHIMERIC PROTEIN,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL3430904,,0.0,7658.0,3460682.0,2429562.0,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Selpercatinib inhibited wild-type RET and multiple mutated RET isoforms (inc. RET V804M, and RET M918T). Mutations and rearrangements in RET can drive cancers. Selpercatinib also inhibited VEGFR1 and VEGFR3 (IC50 values 0.92 - 67.8 nM) and FGFR 1, 2, and 3 at higher concentrations. Active against RET in cell assays at 60-fold lower concentration than FGFR1/2 and 8-fold lower concentration than VEGFR3. ",,,SELPERCATINIB,CHEMBL4559134,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H31N7O3/c1-29(2,37)18-39-24-9-25(28-21(10-30)13-33-36(28)17-24)20-5-6-26(31-12-20)34-15-22-8-23(16-34)35(22)14-19-4-7-27(38-3)32-11-19/h4-7,9,11-13,17,22-23,37H,8,14-16,18H2,1-3H3",XIIOFHFUYBLOLW-UHFFFAOYSA-N,COc1ccc(CN2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1,0.37031895024634764,3.0,525.6130000000003,3.2843800000000023,10,1,2,112.03999999999999,-4.628690096723574,0.696226966381073,-5.078637630356749,0.9969194531440735,-10.558857536540334,0.9431161522865296,0.7308045625686646,0.5602011442184448,92.59015891235244,5.940807911881746,0.031076503451913595,0.5076579332351685,0.6214547514915466,0.1265789456665516,0.6624406218528748,-50.22809903401594,37.097794675105604,97.01717051658117,3.577409490736983,0.17948489934206008,0.1530337106436491,0.7181278705596924,0.8864638686180115,0.9733804821968078,0.011918056849390268,0.00906679118052125,0.028820573911070825,0.023861822485923768,0.4337362229824066,0.18648771643638612,0.012067611049860715,0.03369582183659077,0.033476381376385686,0.4526257961988449,0.49663925766944883,0.13390062600374222,False
RET,100079,SINGLE PROTEIN,Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL2041,,0.0,7700.0,3133191.0,2453082.0,Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,"Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, RET V804L, RET V804M, RET M918T) with IC50s < 0.5 nM. Mutations can drive tumorigenesis. ","Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, KIF5B-RET, RET V804L, RET V804M, C634W, RET V804E and RET M918T). Also inhibited DDR1, TRKC, FLT3, JAK1-2, TRKA, VEGFR2, PDGFRb, and FGFR1 in vitro at clinically relevant concentrations. In cellular assays, inhibited RET at approximately 14-, 40-, and 12-fold lower concentrations than VEGFR2, FGFR2, and JAK2, respectively.",,,PRALSETINIB,CHEMBL4582651,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2019.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19-,27+/m0/s1",GBLBJPZSROAGMF-RWYJCYHVSA-N,CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1,0.30667835077500394,3.0,533.6120000000002,4.200140000000003,9,3,1,135.53,-4.427419339664875,0.9315722346305847,-5.252379491848781,0.9995216608047486,-11.105739422499742,0.9011139631271362,0.7370314955711365,0.6018090367317199,91.41510612059668,7.529278059777222,0.02223850474692881,0.25473216772079466,0.454997256398201,0.03673088904470205,0.9495967745780944,61.4434764706245,30.716262259087586,52.0763464465291,3.4053871651667236,0.42834133505821226,0.22240613996982575,0.6402963280677796,0.8784536123275757,0.8498799085617066,0.03104348909109831,0.011982432147487999,0.08803802579641343,0.01808337615802884,0.07811837047338485,0.1548780918121338,0.02056492604315281,0.12937168255448342,0.026541517674922945,0.4442318260669708,0.17101231962442398,0.07474608309566974,False
RET,109645,CHIMERIC PROTEIN,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL3430888,,0.0,7737.0,3133191.0,2453082.0,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,"Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, RET V804L, RET V804M, RET M918T) with IC50s < 0.5 nM. Mutations can drive tumorigenesis. ","Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, KIF5B-RET, RET V804L, RET V804M, C634W, RET V804E and RET M918T). Also inhibited DDR1, TRKC, FLT3, JAK1-2, TRKA, VEGFR2, PDGFRb, and FGFR1 in vitro at clinically relevant concentrations. In cellular assays, inhibited RET at approximately 14-, 40-, and 12-fold lower concentrations than VEGFR2, FGFR2, and JAK2, respectively.",,,PRALSETINIB,CHEMBL4582651,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2019.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19-,27+/m0/s1",GBLBJPZSROAGMF-RWYJCYHVSA-N,CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1,0.30667835077500394,3.0,533.6120000000002,4.200140000000003,9,3,1,135.53,-4.427419339664875,0.9315722346305847,-5.252379491848781,0.9995216608047486,-11.105739422499742,0.9011139631271362,0.7370314955711365,0.6018090367317199,91.41510612059668,7.529278059777222,0.02223850474692881,0.25473216772079466,0.454997256398201,0.03673088904470205,0.9495967745780944,61.4434764706245,30.716262259087586,52.0763464465291,3.4053871651667236,0.42834133505821226,0.22240613996982575,0.6402963280677796,0.8784536123275757,0.8498799085617066,0.03104348909109831,0.011982432147487999,0.08803802579641343,0.01808337615802884,0.07811837047338485,0.1548780918121338,0.02056492604315281,0.12937168255448342,0.026541517674922945,0.4442318260669708,0.17101231962442398,0.07474608309566974,False
RET,109661,CHIMERIC PROTEIN,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET,9606,Homo sapiens,CHEMBL3430904,,0.0,7736.0,3133191.0,2453082.0,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor,,INHIBITOR,1.0,1.0,1.0,"Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, RET V804L, RET V804M, RET M918T) with IC50s < 0.5 nM. Mutations can drive tumorigenesis. ","Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, KIF5B-RET, RET V804L, RET V804M, C634W, RET V804E and RET M918T). Also inhibited DDR1, TRKC, FLT3, JAK1-2, TRKA, VEGFR2, PDGFRb, and FGFR1 in vitro at clinically relevant concentrations. In cellular assays, inhibited RET at approximately 14-, 40-, and 12-fold lower concentrations than VEGFR2, FGFR2, and JAK2, respectively.",,,PRALSETINIB,CHEMBL4582651,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2019.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19-,27+/m0/s1",GBLBJPZSROAGMF-RWYJCYHVSA-N,CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1,0.30667835077500394,3.0,533.6120000000002,4.200140000000003,9,3,1,135.53,-4.427419339664875,0.9315722346305847,-5.252379491848781,0.9995216608047486,-11.105739422499742,0.9011139631271362,0.7370314955711365,0.6018090367317199,91.41510612059668,7.529278059777222,0.02223850474692881,0.25473216772079466,0.454997256398201,0.03673088904470205,0.9495967745780944,61.4434764706245,30.716262259087586,52.0763464465291,3.4053871651667236,0.42834133505821226,0.22240613996982575,0.6402963280677796,0.8784536123275757,0.8498799085617066,0.03104348909109831,0.011982432147487999,0.08803802579641343,0.01808337615802884,0.07811837047338485,0.1548780918121338,0.02056492604315281,0.12937168255448342,0.026541517674922945,0.4442318260669708,0.17101231962442398,0.07474608309566974,False
BRAF,109740,PROTEIN FAMILY,RAF serine/threonine protein kinase,9606,Homo sapiens,CHEMBL3559685,,0.0,4286.0,2473563.0,1797534.0,RAF serine/threonine protein kinase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TOVORAFENIB,CHEMBL3348923,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2021.0,,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1",VWMJHAFYPMOMGF-ZCFIWIBFSA-N,C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1,0.476447317615037,3.0,506.2970000000001,3.9792000000000014,8,3,1,135.78000000000003,-5.288772546069149,0.871643316745758,-5.321836793390314,0.99626225233078,-11.813744092421105,0.7595159530639648,0.4866735637187958,0.6229137182235718,85.11924615427424,6.528112544233376,0.23144052922725677,0.6757832646369935,0.6578194856643677,0.11712913662195205,0.8701249599456787,68.56302789996451,16.701052499846362,22.032015863275983,2.4256230060461,0.4850632160902023,0.4508138239383698,0.5078547537326813,0.9618730664253234,0.6722959637641907,0.02271592989563942,0.011558789247646927,0.12504972219467164,0.027120817545801403,0.324998614192009,0.27781930565834045,0.09623151198029518,0.08858923204243183,0.06698527261614799,0.5817188382148742,0.24446234107017517,0.3192710757255554,False
BRAF,109740,PROTEIN FAMILY,RAF serine/threonine protein kinase,9606,Homo sapiens,CHEMBL3559685,,0.0,8541.0,3489931.0,2186914.0,RAF serine/threonine protein kinase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BELVARAFENIB,CHEMBL3977543,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H16ClFN6OS/c1-11-5-6-13-12(7-8-27-22(13)30-16-4-2-3-15(24)17(16)25)18(11)31-23(32)14-9-33-20-19(14)28-10-29-21(20)26/h2-10H,1H3,(H,27,30)(H,31,32)(H2,26,28,29)",KVCQTKNUUQOELD-UHFFFAOYSA-N,Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1csc2c(N)ncnc12,0.2958944500506462,3.0,478.9400000000002,5.918520000000001,7,3,0,105.82000000000001,-4.302303441808776,0.8539627671241761,-5.552528043658329,0.9965902447700501,-13.474196907809098,0.7476204395294189,0.8335868835449218,0.5066148728132248,97.29726526389405,5.243005506947439,0.19664791375398635,0.6787399291992188,0.4986743092536926,0.23005084693431854,0.811376941204071,138.21595230949865,33.124925614358744,37.90171161149284,3.1081312102289105,0.619045227766037,0.43886817097663877,0.39781067669391634,0.98094562292099,0.8787119030952454,0.022145588137209415,0.024269815348088742,0.1337396502494812,0.028521491400897502,0.7223352432250977,0.5203797519207001,0.07946202456951142,0.153135284781456,0.08364734053611755,0.7710571050643921,0.395780485868454,0.3656331807374954,False
BRAF,117030,PROTEIN FAMILY,B-raf/RAF proto-oncogene serine/threonine-protein kinase,9606,Homo sapiens,CHEMBL3883317,,0.0,8586.0,3489934.0,2454122.0,B-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for b-RAF/c-RAF vs. a-RAF.,,,LXH254,CHEMBL4583691,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H25F3N4O4/c1-16-2-3-19(30-24(34)17-4-5-29-21(12-17)25(26,27)28)15-20(16)18-13-22(32-6-9-35-10-7-32)31-23(14-18)36-11-8-33/h2-5,12-15,33H,6-11H2,1H3,(H,30,34)",UEPXBTCUIIGYCY-UHFFFAOYSA-N,Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1,0.5054374600826907,3.0,502.4930000000004,3.9308200000000033,7,2,0,96.81,-5.111219328342477,0.9164210438728333,-4.7655918057771185,0.999236011505127,-11.271825123454505,0.8927006125450134,0.8301116943359375,0.4181533753871918,93.77567464299148,3.0842930539322477,0.052136238850653174,0.31586838364601133,0.46722055673599244,0.020325314067304135,0.619332754611969,4.569027043371073,21.200728796814865,49.45358781356546,3.4225350367432568,0.42373926043510435,0.42318207025527954,0.46341145038604736,0.9726858377456665,0.8664808869361877,0.031106694601476192,0.007600029883906245,0.06558036245405674,0.007351435720920563,0.3083648979663849,0.19439145624637605,0.04215211197733879,0.04090148322284222,0.04192603453993797,0.8141007781028747,0.4451731532812119,0.061704812198877336,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,992.0,1702634.0,1377999.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,421.0,DABRAFENIB MESYLATE,CHEMBL2105729,4.0,1.0,1.0,MOL,75048.0,Small molecule,2013.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2011.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H20F3N5O2S2.CH4O3S/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25;1-5(2,3)4/h4-11,31H,1-3H3,(H2,27,28,29);1H3,(H,2,3,4)",YKGMKSIHIVVYKY-UHFFFAOYSA-N,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O,0.2656647783779417,3.0,615.6810000000003,4.868900000000004,9,3,0,165.23,-2.7069108721753095,0.8033224701881408,-5.298058020523273,0.978241765499115,-10.045575048536852,0.6556565880775451,0.39664745032787324,0.4432018041610718,101.57744655278718,-3.8046926522378657,0.10473177880048752,0.4688752472400665,0.4921695709228516,0.096442486718297,0.7378271222114563,126.39109866742183,12.830190783799386,30.537587546073137,2.0013114497392706,0.19271264225244522,0.7887219071388245,0.2754370480775833,0.9759920954704284,0.7685328483581543,0.09200087264180183,0.030279054865241052,0.10096595659852028,0.029996387660503387,0.06566485948860645,0.23013677969574928,0.05658085010945797,0.02145116226747632,0.012424042820930481,0.44245763421058654,0.04583535492420197,0.1822067379951477,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,995.0,1392864.0,691867.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,Indicated for mutated form - V600E,,,421.0,VEMURAFENIB,CHEMBL1229517,4.0,1.0,1.0,MOL,63637.0,Small molecule,2011.0,1.0,0.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,2010.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)",GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,0.33309063319660087,3.0,489.9310000000001,5.544200000000004,4,2,0,91.92,-5.823052720077529,0.8790834426879883,-4.913017923573998,0.9992436051368714,-11.384296112762197,0.9097021460533142,0.579331225156784,0.5787067413330078,107.08436195091194,23.692495089055654,0.7134502053260803,0.5605329811573029,0.5544550240039825,0.30867002308368685,0.8759684443473816,145.4243656806058,31.589685193954153,42.77165262103834,2.6382803537194177,0.06699848994612694,0.2966039925813675,0.15003979653120042,0.9681617140769958,0.7532823085784912,0.1770283341407776,0.17993887960910798,0.1286807671189308,0.036230625584721565,0.5492953538894654,0.4271560192108154,0.1268376365303993,0.08490049242973327,0.04817085098475218,0.7003680467605591,0.24628892838954924,0.10717111825942993,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,4114.0,2473484.0,2832058.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ARQ-736,CHEMBL5314407,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H27N8O8PS.2Na/c1-31-11-8-21(30-31)43(37,38)32-10-3-5-18(15-32)27-24-26-9-7-20(28-24)23-22(29-25-33(23)12-13-39-25)17-4-2-6-19(14-17)40-16-41-42(34,35)36;;/h2,4,6-9,11-14,18H,3,5,10,15-16H2,1H3,(H,26,27,28)(H2,34,35,36);;/q;2*+1/p-2/t18-;;/m1../s1",HXINDCTZKGGRDE-JPKZNVRTSA-L,Cn1ccc(S(=O)(=O)N2CCC[C@@H](Nc3nccc(-c4c(-c5cccc(OCOP(=O)([O-])[O-])c5)nc5occn45)n3)C2)n1.[Na+].[Na+],0.08407259323430734,2.0,674.5440000000001,-4.760399999999995,15,1,1,205.10000000000002,-0.8012795050617226,0.5972605288028717,-5.8197325501214845,0.9949289202690125,-11.562753666304324,0.8108051180839538,0.5491927057504654,0.6540267825126648,78.52800807785357,-11.9439629223167,0.0979769129306078,0.35654660761356355,0.3932715907692909,0.4561877876520157,0.7524585843086242,-0.7553197463409248,44.894874952987905,47.030993621580905,2.560267648003804,0.10940986312925816,0.05266266018152237,0.44742860198020934,0.885469388961792,0.9132383227348327,0.043774361908435824,0.013497527944855392,0.15297053158283233,0.034513592906296256,0.07304113619029522,0.25237482190132143,0.017410384304821492,0.016814390034414827,0.009491931134834885,0.09378742408007383,0.06192365437746048,0.1112915739417076,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,4160.0,2473343.0,2287308.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LIFIRAFENIB,CHEMBL4209157,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2018.0,,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1",NGFFVZQXSRKHBM-FKBYEOEOSA-N,O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4cc(C(F)(F)F)ccc4[nH]3)ccnc2N1,0.41748841799008996,3.0,478.43000000000006,5.295700000000003,5,2,3,89.13000000000001,-6.081202564677676,0.9038035154342652,-4.942334513345604,0.9990806460380555,-11.848827363636689,0.7477580785751343,0.7419949889183044,0.7579981803894043,96.94406923833117,1.127764316422963,0.44150891005992887,0.5337066799402237,0.4952893555164337,0.3318174973130226,0.6878782391548157,1.5300088176854003,22.900325620490573,28.205635195540275,4.471399443337631,0.5314400613307952,0.27230548560619355,0.46195722222328184,0.876632571220398,0.897108542919159,0.09456884488463402,0.04161303918808699,0.2322298765182495,0.04691688064485788,0.3290954530239105,0.301065993309021,0.06396206691861153,0.3223321497440338,0.11485256105661393,0.854087746143341,0.7105244398117065,0.09063452556729316,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,4270.0,2473263.0,1945430.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LY-3009120,CHEMBL3577124,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H29FN6O/c1-13-9-18(24)19(29-22(31)26-8-7-23(3,4)5)11-16(13)17-10-15-12-27-21(25-6)30-20(15)28-14(17)2/h9-12H,7-8H2,1-6H3,(H2,26,29,31)(H,25,27,28,30)",HHCBMISMPSAZBF-UHFFFAOYSA-N,CNc1ncc2cc(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)c(C)nc2n1,0.5332094831993508,3.0,424.52400000000017,5.047140000000004,5,3,0,91.83,-5.851184939244399,0.9559831738471984,-4.783349054206978,0.9991934895515442,-8.913203279942456,0.9548615336418151,0.6854785680770874,0.8497425317764282,96.5181425395132,16.023089566020168,0.30090398639440535,0.22517486214637755,0.17141057103872298,0.08367613293230533,0.47676438093185425,131.8899995600334,24.787625807723167,89.68778901942676,3.0170591796763198,0.36512565314769746,0.5299407005310058,0.4148619264364243,0.877751624584198,0.8664794325828552,0.03259035758674145,0.04131703339517116,0.08320134580135345,0.034039254486560824,0.588652503490448,0.24131618440151215,0.01833532201126218,0.16827817410230636,0.03263619933277369,0.7398704528808594,0.2680244445800781,0.10986498892307281,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,4329.0,2472856.0,2341600.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PLIXORAFENIB,CHEMBL4303729,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H21F3N6O3S/c26-16-5-6-34(12-16)38(36,37)33-20-4-3-19(27)21(22(20)28)23(35)18-11-32-25-17(18)7-14(8-31-25)15-9-29-24(30-10-15)13-1-2-13/h3-4,7-11,13,16,33H,1-2,5-6,12H2,(H,31,32)/t16-/m1/s1",YYACLQUDUDXAPA-MRXNPFEDSA-N,O=C(c1c(F)ccc(NS(=O)(=O)N2CC[C@@H](F)C2)c1F)c1c[nH]c2ncc(-c3cnc(C4CC4)nc3)cc12,0.33933185887567396,3.0,542.5430000000002,4.107000000000003,6,2,1,120.94000000000001,-5.734526287983834,0.9043345808982849,-5.210050854954896,0.999668025970459,-11.711188422965126,0.8958008289337158,0.18890710696578025,0.7672167181968689,92.5924698375856,-0.386591773414505,0.40087862461805346,0.129850647225976,0.1691433571279049,0.14492245502769946,0.9035441040992737,51.42625744018943,43.13888438337763,32.529275282347676,3.1170419528368556,0.5601871550083161,0.2127278044819832,0.5855380535125733,0.9514334321022033,0.8724814295768738,0.16055444329977037,0.1170838162302971,0.1525583326816559,0.044168797135353086,0.32004048228263854,0.5624780833721161,0.0309347378090024,0.2803772181272507,0.03135224636644125,0.7577519536018371,0.3786085307598114,0.16260327398777008,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,4806.0,2473591.0,568340.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RAF-265,CHEMBL558752,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34)",YABJJWZLRMPFSI-UHFFFAOYSA-N,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,0.24673078257718173,2.0,518.421,6.931900000000003,6,2,0,80.65,-6.595756657939122,0.885952377319336,-5.2399289910067495,0.9969489216804505,-8.93362951154352,0.6792900800704956,0.9718960642814636,0.48992722034454345,93.95565389120205,3.2240838245555166,0.43454961478710175,0.5043429791927337,0.3478644400835037,0.32912807501852515,0.5200126826763153,30.47984877574076,7.1396250413181885,20.093067923134484,3.669595855637012,0.35881263613700864,0.49282641112804415,0.28646250665187833,0.8941795587539673,0.9749688982963562,0.029805523343384266,0.01973249427974224,0.12226434126496315,0.02914205938577652,0.5683847010135651,0.45623058676719663,0.07669917866587639,0.11884578317403793,0.11951198056340218,0.8205092549324036,0.45583661198616027,0.10265911668539048,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,4850.0,2472892.0,1926876.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,"Selectively targets RAF kinases including BRAF, RAF1 and the BRAF mutant (V600E) (http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf)",,,,XL-281,CHEMBL3545027,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H19ClN4O4/c1-13-7-9-15(25)12-20(13)29-21(30)16-5-3-4-6-17(16)24(29,32)14-8-10-18-19(11-14)27-22(26-18)28-23(31)33-2/h3-12,32H,1-2H3,(H2,26,27,28,31)",MMNNTJYFHUDSKL-UHFFFAOYSA-N,COC(=O)Nc1nc2cc(C3(O)c4ccccc4C(=O)N3c3cc(Cl)ccc3C)ccc2[nH]1,0.4135089104322443,4.0,462.8930000000002,4.556820000000003,5,3,1,107.55000000000001,-5.498895503490166,0.8696515679359436,-5.119422813401949,0.9992439389228821,-13.408848322155873,0.8011340975761414,0.8365197300910949,0.49363781213760377,96.7264750490132,4.764865948525012,0.18726318180561066,0.7223829567432404,0.8801070928573609,0.1654641855508089,0.728315281867981,96.42757110490956,38.27317221529279,53.88642655330561,2.9067369489490638,0.17274967730045318,0.25868280678987504,0.19482821375131607,0.9614393830299377,0.8815994977951049,0.02752028089016676,0.007016903115436434,0.08314892202615738,0.008594508096575738,0.5715076923370361,0.18237235844135286,0.025976205989718438,0.06736004017293454,0.06901258789002895,0.874494981765747,0.445389398932457,0.11151987165212632,False
BRAF,100126,SINGLE PROTEIN,Serine/threonine-protein kinase B-raf,9606,Homo sapiens,CHEMBL5145,,0.0,5298.0,2139024.0,1763574.0,Serine/threonine-protein kinase B-raf inhibitor,,INHIBITOR,1.0,1.0,1.0,Selective for mutation containing BRAF (V600E mutation) with little or no activity against wild-type BRAF.,,,421.0,ENCORAFENIB,CHEMBL3301612,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2014.0,1.0,-rafenib,0.0,-rafenib,rapidly accelerated fibrosarcoma (RAF) kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1",CMJCXYNUCSMDBY-ZDUSSCGKSA-N,COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,0.37159842204424726,3.0,540.0210000000002,3.908400000000002,9,3,1,140.13,-4.7481943541956415,0.881946611404419,-5.108484829749143,0.9994780898094178,-10.596289205829073,0.9555420756340027,0.27587607204914094,0.6541176438331604,92.87182777094917,3.750975702723527,0.47869942933320997,0.4287316590547562,0.3170221894979477,0.2522156395018101,0.9892189502716064,67.88615408315783,34.79778898443029,73.5675585010708,2.2934523874999306,0.08360235840082168,0.19506390392780304,0.3952026188373566,0.9652556657791138,0.6973927259445191,0.06604172363877296,0.061416177451610564,0.03809284549206495,0.014505471661686897,0.14248141050338745,0.1033957064151764,0.03280155174434185,0.011329797096550465,0.010766173107549548,0.1681218072772026,0.06782321333885193,0.06545869372785092,False
KRAS,105451,SINGLE PROTEIN,GTPase KRas,9606,Homo sapiens,CHEMBL2189121,,0.0,8492.0,3489912.0,2406188.0,GTPase KRas inhibitor,,INHIBITOR,1.0,1.0,1.0,Covalent inhibitor,,,1359.0,SOTORASIB,CHEMBL4535757,4.0,1.0,1.0,MOL,,Small molecule,2021.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2021.0,1.0,-rasib,0.0,-rasib,Kirsten rat sarcoma (KRAS) inhibitors,,0.0,1.0,0.0,"InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1",NXQKSXLFSAEQCZ-SFHVURJKSA-N,C=CC(=O)N1CCN(c2nc(=O)n(-c3c(C)ccnc3C(C)C)c3nc(-c4c(O)cccc4F)c(F)cc23)[C@@H](C)C1,0.3590679168093476,3.0,560.6050000000001,4.4814200000000035,8,1,1,104.45000000000002,-6.468610440173592,0.7089597105979919,-5.083697169530305,0.9973204016685486,-8.557643936314118,0.9076748728752136,0.6896308302879334,0.4595795005559921,101.42848676235408,7.216563486154311,0.013508657366037369,0.14805911630392074,0.33082761615514755,0.01884031817317009,0.5378385782241821,-21.17360601431442,64.81717964270585,126.41065663344827,3.0150098797652802,0.2926827073097229,0.1957411028444767,0.20646348595619202,0.9510866284370423,0.6870055437088013,0.1944226861000061,0.06493617221713066,0.17202886193990707,0.04938829056918621,0.045288892649114135,0.1674586609005928,0.10039058327674866,0.1318321257829666,0.030556800402700902,0.581076467037201,0.33918972313404083,0.0780506543815136,False
KRAS,105451,SINGLE PROTEIN,GTPase KRas,9606,Homo sapiens,CHEMBL2189121,,0.0,8840.0,3461020.0,2464781.0,GTPase KRas inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,1359.0,ADAGRASIB,CHEMBL4594350,4.0,1.0,1.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2021.0,1.0,-rasib,0.0,-rasib,Kirsten rat sarcoma (KRAS) inhibitors,,0.0,1.0,0.0,"InChI=1S/C32H35ClFN7O2/c1-21(34)31(42)41-17-16-40(18-23(41)11-13-35)30-25-12-15-39(28-10-4-7-22-6-3-9-26(33)29(22)28)19-27(25)36-32(37-30)43-20-24-8-5-14-38(24)2/h3-4,6-7,9-10,23-24H,1,5,8,11-12,14-20H2,2H3/t23-,24-/m0/s1",PEMUGDMSUDYLHU-ZEQRLZLVSA-N,C=C(F)C(=O)N1CCN(c2nc(OC[C@@H]3CCCN3C)nc3c2CCN(c2cccc4cccc(Cl)c24)C3)C[C@@H]1CC#N,0.35821331010446944,3.0,604.1299999999999,4.732980000000004,8,0,2,88.83000000000001,-6.2162692545842555,0.6673501610755921,-4.73041917999087,0.998280668258667,-9.784003823905,0.9138894438743591,0.9775312185287476,0.8153680562973022,99.83374324250565,3.479085311312031,0.08900312781333923,0.6621573209762573,0.5299135327339173,0.1127509355545044,0.9435294389724731,93.56981740544327,40.797091448783775,63.77509028960846,3.8155233181013424,0.323450094461441,0.24288871139287949,0.7033215165138245,0.949942660331726,0.9628509998321533,0.011140775913372637,0.010057143494486808,0.022530469484627245,0.0224533183965832,0.09850498139858246,0.19783617109060286,0.07496303506195545,0.024814807623624802,0.03698129691183567,0.46999184489250184,0.330243718624115,0.22060156166553496,False
KRAS,119723,PROTEIN FAMILY,RAS,9606,Homo sapiens,CHEMBL4524006,,0.0,8727.0,1705113.0,30247.0,RAS inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SALIRASIB,CHEMBL23293,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,-rasib; sal-,0.0,-rasib; sal-,Kirsten rat sarcoma (KRAS) inhibitors; anti-inflammatory agents (salicylic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+",WUILNKCFCLNXOK-CFBAGHHKSA-N,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O,0.365073939528556,3.0,358.547,6.896100000000007,2,1,0,37.3,-5.218381447752351,0.8007037401199341,-5.285595366366996,0.9867050528526307,-4.361579036162161,0.6172197759151459,0.29040769636631014,0.4772323966026306,98.9352568006526,1.8276342273408062,0.4514827400445938,0.18728332668542863,0.29954104125499725,0.37913447618484497,0.1027050644159317,1.042995711802836,63.342391132533876,59.62972793042111,1.8454871281477214,0.06537702567875385,0.4338776797056198,0.0906950630247593,0.44503644704818723,0.34617257714271543,0.012512247823178769,0.010392980370670556,0.15496317744255067,0.06519504934549332,0.01729426793754101,0.037074963003396987,0.4667333006858826,0.008175672637298704,0.38161125779151917,0.23386524468660355,0.039372360333800316,0.8264961838722229,False
HRAS,119723,PROTEIN FAMILY,RAS,9606,Homo sapiens,CHEMBL4524006,,0.0,8727.0,1705113.0,30247.0,RAS inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SALIRASIB,CHEMBL23293,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,-rasib; sal-,0.0,-rasib; sal-,Kirsten rat sarcoma (KRAS) inhibitors; anti-inflammatory agents (salicylic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+",WUILNKCFCLNXOK-CFBAGHHKSA-N,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O,0.365073939528556,3.0,358.547,6.896100000000007,2,1,0,37.3,-5.218381447752351,0.8007037401199341,-5.285595366366996,0.9867050528526307,-4.361579036162161,0.6172197759151459,0.29040769636631014,0.4772323966026306,98.9352568006526,1.8276342273408062,0.4514827400445938,0.18728332668542863,0.29954104125499725,0.37913447618484497,0.1027050644159317,1.042995711802836,63.342391132533876,59.62972793042111,1.8454871281477214,0.06537702567875385,0.4338776797056198,0.0906950630247593,0.44503644704818723,0.34617257714271543,0.012512247823178769,0.010392980370670556,0.15496317744255067,0.06519504934549332,0.01729426793754101,0.037074963003396987,0.4667333006858826,0.008175672637298704,0.38161125779151917,0.23386524468660355,0.039372360333800316,0.8264961838722229,False
MET_HGFR,11379,SINGLE PROTEIN,Macrophage-stimulating protein receptor,9606,Homo sapiens,CHEMBL2689,,0.0,4279.0,2473120.0,1517937.0,Macrophage-stimulating protein receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MK-8033,CHEMBL2323775,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,1.0,0.0,"InChI=1S/C25H21N5O3S/c1-30-15-20(13-28-30)19-11-23-24(27-12-19)8-7-18-6-5-17(10-22(18)25(23)31)16-34(32,33)29-14-21-4-2-3-9-26-21/h2-13,15,29H,14,16H2,1H3",VMJFTOSOFDEKTM-UHFFFAOYSA-N,Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,0.40770976276043064,4.0,471.5420000000002,3.1633000000000013,7,1,0,106.83999999999999,-3.879802106098773,0.8469600558280945,-5.705591363087825,0.9869799852371216,-10.864990271645363,0.7949183344841003,0.559833312034607,0.4911395967006683,84.20976612735053,-8.374292207466425,0.3963587611913681,0.20900720581412316,0.23053577169775963,0.11137082651257516,0.8483410835266113,48.12419974174591,55.18240474437785,53.04499583633195,2.72588024299129,0.13930966556072236,0.3121103227138519,0.3849720537662506,0.9460862636566162,0.8556965708732605,0.11666828766465187,0.15640497207641602,0.0744690828025341,0.039413322880864146,0.1311611145734787,0.2178732931613922,0.09758403412997722,0.056382006406784056,0.03226185138337314,0.21277057230472565,0.14474260583519935,0.15856031626462935,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4278.0,2473120.0,1517937.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MK-8033,CHEMBL2323775,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,1.0,0.0,"InChI=1S/C25H21N5O3S/c1-30-15-20(13-28-30)19-11-23-24(27-12-19)8-7-18-6-5-17(10-22(18)25(23)31)16-34(32,33)29-14-21-4-2-3-9-26-21/h2-13,15,29H,14,16H2,1H3",VMJFTOSOFDEKTM-UHFFFAOYSA-N,Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,0.40770976276043064,4.0,471.5420000000002,3.1633000000000013,7,1,0,106.83999999999999,-3.879802106098773,0.8469600558280945,-5.705591363087825,0.9869799852371216,-10.864990271645363,0.7949183344841003,0.559833312034607,0.4911395967006683,84.20976612735053,-8.374292207466425,0.3963587611913681,0.20900720581412316,0.23053577169775963,0.11137082651257516,0.8483410835266113,48.12419974174591,55.18240474437785,53.04499583633195,2.72588024299129,0.13930966556072236,0.3121103227138519,0.3849720537662506,0.9460862636566162,0.8556965708732605,0.11666828766465187,0.15640497207641602,0.0744690828025341,0.039413322880864146,0.1311611145734787,0.2178732931613922,0.09758403412997722,0.056382006406784056,0.03226185138337314,0.21277057230472565,0.14474260583519935,0.15856031626462935,False
MET_HGFR,11379,SINGLE PROTEIN,Macrophage-stimulating protein receptor,9606,Homo sapiens,CHEMBL2689,,0.0,7262.0,2973270.0,2197785.0,Macrophage-stimulating protein receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GLESATINIB,CHEMBL3989914,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2016.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)",YRCHYHRCBXNYNU-UHFFFAOYSA-N,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1,0.11849908273621894,2.0,619.7190000000002,6.220500000000005,8,3,0,97.39999999999999,-5.095765159759559,0.6986732602119445,-5.441628711964915,0.9782776474952698,-10.908038350801558,0.6573835015296936,0.9545244812965393,0.48154722452163695,97.41456724456738,8.472618864338266,0.059551920741796494,0.4929900527000427,0.5730269312858581,0.2274201974272728,0.9075865149497986,106.50108327245354,82.58304831472053,68.6389377534388,2.8856419714443167,0.5173973381519318,0.3431986778974533,0.3640875667333603,0.9242777585983276,0.9158754229545594,0.06267691813409329,0.030832944437861443,0.11711208075284958,0.02716138120740652,0.40929502844810484,0.24989351332187654,0.09580859392881394,0.14814996272325515,0.2108301728963852,0.7224378824234009,0.4896279662847519,0.2149849385023117,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,7261.0,2973270.0,2197785.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GLESATINIB,CHEMBL3989914,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2016.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)",YRCHYHRCBXNYNU-UHFFFAOYSA-N,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1,0.11849908273621894,2.0,619.7190000000002,6.220500000000005,8,3,0,97.39999999999999,-5.095765159759559,0.6986732602119445,-5.441628711964915,0.9782776474952698,-10.908038350801558,0.6573835015296936,0.9545244812965393,0.48154722452163695,97.41456724456738,8.472618864338266,0.059551920741796494,0.4929900527000427,0.5730269312858581,0.2274201974272728,0.9075865149497986,106.50108327245354,82.58304831472053,68.6389377534388,2.8856419714443167,0.5173973381519318,0.3431986778974533,0.3640875667333603,0.9242777585983276,0.9158754229545594,0.06267691813409329,0.030832944437861443,0.11711208075284958,0.02716138120740652,0.40929502844810484,0.24989351332187654,0.09580859392881394,0.14814996272325515,0.2108301728963852,0.7224378824234009,0.4896279662847519,0.2149849385023117,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,954.0,1699873.0,1376138.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,"Multi-kinase inhibitor; Cabozantinib (XL184) is a potent inhibitor of MET and VEGFR2 that also inhibits RET, KIT, AXL, and FLT3, all of which have been implicated in tumor pathogenesis (PMID: 21926191)",,,,CABOZANTINIB S-MALATE,CHEMBL2103868,4.0,1.0,1.0,MOL,72319.0,Small molecule,2012.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2011.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H24FN3O5.C4H6O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18;5-2(4(8)9)1-3(6)7/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34);2,5H,1H2,(H,6,7)(H,8,9)/t;2-/m.0/s1",HFCFMRYTXDINDK-WNQIDUERSA-N,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC.O=C(O)C[C@H](O)C(=O)O,0.1462428828442669,3.0,635.6010000000003,4.447400000000002,9,5,1,193.60999999999999,-3.9221848552728034,0.8926168799400329,-5.716702088115197,0.895718228816986,-12.663615739057974,0.26743751764297485,0.32271088659763336,0.42171399891376493,81.95920105301812,9.007517426154994,0.04668094404041767,0.07459836639463902,0.17790497541427613,0.05995849650353193,0.19177606403827668,60.38109647855693,-22.24701343963536,21.832587130620844,3.2787070554541002,0.208428555727005,0.28275037705898287,0.5007062673568725,0.9724965333938599,0.651378458738327,0.05347383841872215,0.017244546627625822,0.0446562435477972,0.008729768521152436,0.3695481508970261,0.15702495127916336,0.0867209829390049,0.14505075216293334,0.03941044525709003,0.44125287532806395,0.28024993985891344,0.06257868632674217,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,955.0,1392861.0,602271.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CRIZOTINIB,CHEMBL601719,4.0,1.0,1.0,MOL,64310.0,Small molecule,2011.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,2009.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1",KTEIFNKAUNYNJU-GFCCVEGCSA-N,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,0.533055458733566,3.0,450.34500000000014,5.037700000000004,6,2,1,77.99,-3.8475503326933707,0.9315286159515381,-5.352127580023595,0.9998963952064515,-10.407446977296757,0.9502961039543152,0.742916715145111,0.8516871571540833,88.3139901331788,11.631113581902406,0.37672742605209353,0.8323334932327271,0.7807501673698425,0.5709382951259613,0.9750691890716553,22.797460611864018,0.5789901155637296,16.394750742673693,2.838126460526516,0.20264560580253602,0.23650658428668975,0.7533625483512878,0.783696973323822,0.8960570573806763,0.014936610404402018,0.00969344275072217,0.08071945756673812,0.030790697038173675,0.5223704397678375,0.624931812286377,0.034595027565956116,0.017631673812866212,0.0529005367308855,0.30268600285053254,0.047276577539741994,0.23929961621761323,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,3898.0,2473055.0,1415543.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BMS-794833,CHEMBL2143592,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H15ClF2N4O3/c24-20-19(7-8-29-22(20)27)33-18-6-5-14(9-17(18)26)30-23(32)16-11-28-10-15(21(16)31)12-1-3-13(25)4-2-12/h1-11H,(H2,27,29)(H,28,31)(H,30,32)",PDYXPCKITKHFOZ-UHFFFAOYSA-N,Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,0.38174716708942713,4.0,468.8470000000001,4.995300000000002,5,3,0,110.1,-6.164070016657832,0.8729153156280518,-5.3574260711751425,0.9956146597862243,-14.36115796973927,0.6278074502944946,0.7387669086456299,0.4907239854335785,95.46972659065474,11.529352003397886,0.2531925439834595,0.7653238415718079,0.7981017231941223,0.1909818395972252,0.7381257772445678,102.07823234364785,43.38990006451836,7.6118791076682015,2.567215442742315,0.39928352236747744,0.42846986949443816,0.3534629315137863,0.9810417413711547,0.868845546245575,0.019548343494534492,0.010844175470992923,0.08419316336512565,0.025528065487742425,0.5652158498764038,0.3411245822906494,0.05361212864518165,0.029841237515211106,0.06009821593761444,0.6601236939430237,0.17789496779441832,0.24919766634702684,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4107.0,2473336.0,486594.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AMG-208,CHEMBL496102,2.0,0.0,0.0,MOL,90626.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H17N5O2/c1-28-16-7-8-17-19(13-16)23-12-11-20(17)29-14-22-25-24-21-10-9-18(26-27(21)22)15-5-3-2-4-6-15/h2-13H,14H2,1H3",HEAIZQNMNCHNFD-UHFFFAOYSA-N,COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1,0.457824714706536,4.0,383.41100000000006,3.927100000000002,7,0,0,74.43,-5.6353684940136,0.9439033031463623,-5.110855244630551,0.9997616052627564,-7.941315781246217,0.9573353886604309,0.8825203895568847,0.7120605826377868,99.49400166579248,-6.009429253260225,0.8241604924201965,0.8624412298202515,0.727453863620758,0.0465885141864419,0.9061350464820862,-31.762285731494124,57.422504816684274,35.858780176461515,2.0914488429791125,0.4513327836990356,0.19479406028985977,0.2175007075071335,0.9613489389419556,0.7080621719360352,0.01961131449788809,0.013511607889086008,0.1369108885526657,0.03495695274323225,0.5999301552772522,0.20658018589019775,0.18404754251241684,0.21392376720905304,0.10504356771707535,0.22378092259168625,0.148952354490757,0.23967184126377106,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4207.0,2473663.0,1927214.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ALTIRATINIB,CHEMBL3545365,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)",GNNDEPIMDAZHRQ-UHFFFAOYSA-N,O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1,0.3698654229111989,3.0,510.4720000000002,4.997100000000003,5,3,0,109.42,-5.892858819619397,0.8409910440444947,-4.7423487317114335,0.9808960676193237,-9.697810799077985,0.5343134760856628,0.7830849409103393,0.7169346928596496,94.19125201261363,10.810659624434603,0.0891802130267024,0.3450740545988083,0.538397279381752,0.22233000695705413,0.5945222496986389,90.12226149276219,37.56186297636607,42.72185451531985,2.8609558348950883,0.5293731063604354,0.36722164750099184,0.29240153431892396,0.9051249504089356,0.6639211177825928,0.04270584806799889,0.0370806647464633,0.1086824968457222,0.0287512781098485,0.09570075124502182,0.17250728309154512,0.06315791048109531,0.23120979070663453,0.20163557976484298,0.7604036927223206,0.4883685946464539,0.14995091706514357,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4214.0,2472928.0,2169859.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,EMD-1204831,CHEMBL3960488,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H27N7O3/c1-30-18-21(14-28-30)23-5-6-24(33)32(29-23)17-19-3-2-4-20(13-19)25-26-15-22(16-27-25)35-12-9-31-7-10-34-11-8-31/h2-6,13-16,18H,7-12,17H2,1H3",CIUKPBWULKEZMF-UHFFFAOYSA-N,Cn1cc(-c2ccc(=O)n(Cc3cccc(-c4ncc(OCCN5CCOCC5)cn4)c3)n2)cn1,0.38237365906312276,4.0,473.5370000000003,1.8600999999999996,10,0,0,100.19,-2.669217138337834,0.9183684110641479,-5.288817926092359,0.9938490748405456,-10.351012166376183,0.8480653285980224,0.7688340425491333,0.6650408267974853,84.18260110652577,0.04061125025669217,0.09814344756305218,0.11383167952299118,0.11596194356679916,0.08062124727293848,0.8910716295242309,-39.12016687639125,33.230420590350136,43.762604535077784,2.4611887107318258,0.26474821716547015,0.22382576167583465,0.7436009645462036,0.9274917006492615,0.886552369594574,0.01653874758630991,0.009223513817414642,0.04281217567622662,0.01571485251188278,0.03797319084405899,0.058948348835110666,0.015483192075043917,0.022768255230039357,0.0261576758697629,0.04053998254239559,0.03567587286233902,0.2146628051996231,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4249.0,2472702.0,1405757.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,JNJ-38877605,CHEMBL2133806,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H13F2N7/c1-27-11-13(10-23-27)16-6-7-17-24-25-18(28(17)26-16)19(20,21)14-4-5-15-12(9-14)3-2-8-22-15/h2-11H,1H3",JRWCBEOAFGHNNU-UHFFFAOYSA-N,Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1,0.48270131804589156,4.0,377.358,3.2131000000000016,7,0,0,73.79,-5.314359510365039,0.9776206970214844,-4.784158486956182,0.9995537161827087,-6.414909889388234,0.9405205607414245,0.4172321349382401,0.9462937355041504,86.82972236548986,-11.146610781436348,0.1837141878902912,0.05535510070621967,0.028489090595394374,0.011908036516979336,0.5316808015108109,-20.93122569043343,50.73349111155785,41.656599478226056,2.326374607205155,0.5460263013839721,0.36430483758449556,0.43961796164512634,0.9211128115653991,0.3030945956707001,0.2788756608963013,0.06816290579736232,0.15537851303815842,0.045845060236752035,0.13385578244924545,0.11759382411837578,0.024948140140622854,0.10366773307323456,0.005850380193442107,0.056368739902973176,0.05667574852705002,0.14168856143951417,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4267.0,2473536.0,1927156.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MERESTINIB,CHEMBL3545307,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H22F2N6O3/c1-17-3-9-23(30(40)38(17)22-7-4-20(31)5-8-22)29(39)36-21-6-10-27(25(32)12-21)41-28-11-18-16-35-37(2)26(18)13-24(28)19-14-33-34-15-19/h3-16H,1-2H3,(H,33,34)(H,36,39)",QHADVLVFMKEIIP-UHFFFAOYSA-N,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1,0.27390839006022377,2.0,552.5410000000003,5.7455200000000035,7,2,0,106.82999999999998,-6.201902263615922,0.9129035472869873,-5.449910343811647,0.9962757349014282,-12.021619849929158,0.6236771464347839,0.895452880859375,0.30304226875305174,95.12366488793934,-2.3596611647821377,0.0626588936895132,0.24830167591571808,0.4677397310733795,0.051893987134099005,0.7707965254783631,115.00032335473384,36.245788188156425,36.57358093502311,2.8145039721332252,0.26409316062927246,0.5035092651844024,0.33610691130161285,0.973420774936676,0.9030622482299805,0.08470447733998299,0.019982769200578333,0.0757106140255928,0.012509921751916408,0.4159943997859955,0.2606301099061966,0.053809746913611886,0.11711255311965943,0.045726805739104745,0.7676904201507568,0.21695656776428224,0.07128929495811462,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4317.0,2473689.0,1322310.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PF-04217903,CHEMBL2001019,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2",PDMUGYOXRHVNMO-UHFFFAOYSA-N,OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,0.49990712286055866,4.0,372.39200000000005,1.6735999999999995,9,1,0,107.42999999999999,-3.0307506378351943,0.8612123727798462,-5.503638512774532,0.9980213046073914,-11.500286572702596,0.8317992925643921,0.1883593738079071,0.5131421446800232,86.22151409629615,1.5267619763961846,0.5821592211723328,0.18669237792491913,0.15281466767191887,0.06753354500979185,0.5825498640537262,-17.084669483358844,34.61887181891601,53.66847645446289,1.773575223764404,0.28495340049266815,0.18406196534633637,0.4363348841667175,0.9485523700714111,0.5317892849445343,0.02429059278219938,0.027861422300338744,0.06899981684982777,0.017156612314283847,0.3105661690235138,0.10637524649500847,0.07692195363342762,0.0544588815420866,0.028250705869868397,0.0901251956820488,0.17438980489969252,0.3499020516872406,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4368.0,2473570.0,2368079.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SAR-125844,CHEMBL4461070,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H23FN8O2S2/c26-17-3-1-16(2-4-17)19-7-8-22-30-31-25(34(22)32-19)37-18-5-6-20-21(15-18)38-24(28-20)29-23(35)27-9-10-33-11-13-36-14-12-33/h1-8,15H,9-14H2,(H2,27,28,29,35)",ODIUNTQOXRXOIV-UHFFFAOYSA-N,O=C(NCCN1CCOCC1)Nc1nc2ccc(Sc3nnc4ccc(-c5ccc(F)cc5)nn34)cc2s1,0.3112245244115032,3.0,550.6450000000002,4.145000000000003,10,2,0,109.57000000000001,-4.789737467435172,0.8202258348464966,-4.837849129556811,0.9845635771751404,-11.296472017802298,0.5624792098999023,0.8164337038993835,0.6984735786914825,100.95305208911229,4.697557881316553,0.12877955213189124,0.41740064024925233,0.436168771982193,0.1015285775065422,0.8148544907569886,71.31199643336262,33.00286298027853,71.76211728849461,2.4300734533757216,0.33273925483226774,0.2978023707866669,0.7512122988700867,0.9732880353927612,0.8234599113464356,0.03430460952222347,0.023763263970613478,0.10616727024316788,0.02414950281381607,0.3487151026725769,0.09206158593297005,0.11998974978923797,0.20317725241184234,0.07202134430408477,0.5720126509666443,0.5354698121547699,0.2627754420042038,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4379.0,2472995.0,698457.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SGX-523,CHEMBL1236107,1.0,0.0,0.0,MOL,90624.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,1.0,0.0,"InChI=1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3",BCZUAADEACICHN-UHFFFAOYSA-N,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,0.49235603543853707,4.0,359.41800000000006,3.2242000000000006,8,0,0,73.79,-3.6585528317699003,0.9286725759506226,-5.257166942605942,0.9979577779769897,-8.366661894471793,0.9345955967903137,0.6389098465442657,0.7923803091049194,90.34313989907908,-9.67464922335516,0.420142337679863,0.3200345277786255,0.13873520419001578,0.05272414442151785,0.5472222059965134,-16.121521931479258,54.32977666279709,36.2888405276265,1.7400461299107886,0.21674057543277742,0.20434443950653075,0.3678269684314728,0.9313614010810852,0.3033906787633896,0.05987649783492088,0.05019460991024971,0.16475144326686858,0.060779187083244327,0.3198474317789078,0.10453521981835365,0.07122721709311008,0.11585750728845597,0.06469172779470682,0.0774310700595379,0.10399783663451671,0.2886074036359787,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4394.0,2473133.0,2069108.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TAS-115,CHEMBL3764045,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H23FN4O4S/c1-29-26(34)19-14-18-21(15-24(19)35-2)30-11-10-22(18)36-23-9-8-17(13-20(23)28)31-27(37)32-25(33)12-16-6-4-3-5-7-16/h3-11,13-15H,12H2,1-2H3,(H,29,34)(H2,31,32,33,37)",ORRNXRYWGDUDOG-UHFFFAOYSA-N,CNC(=O)c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2cc1OC,0.30774927537777796,3.0,518.5700000000003,4.590100000000003,6,3,0,101.58000000000001,-5.527176495587834,0.8455627679824829,-5.267291774215821,0.9930304765701294,-12.339070957145651,0.8212615013122558,0.9523415207862854,0.37616169452667236,94.29254790594675,10.686479923263189,0.11971606016159057,0.694883155822754,0.8489593029022217,0.05754541307687759,0.7777467250823975,150.05017834857964,54.09314258090298,69.59326355286456,2.887310267144436,0.3260312557220459,0.44003995060920714,0.17561371475458146,0.9809360980987549,0.880702793598175,0.01906980723142624,0.010354411881417036,0.06948968246579171,0.008617454674094915,0.38272983133792876,0.1289342872798443,0.08179426118731499,0.040774884074926375,0.18511827737092973,0.6453595101833344,0.2445821136236191,0.2042927175760269,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4621.0,2473288.0,2077026.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AMG-337,CHEMBL3785909,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5,8-14H,6-7H2,1-3H3/t14-/m1/s1",DWHXUGDWKAIASB-CQSZACIVSA-N,COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(-c5cnn(C)c5)cn34)c(=O)c2c1,0.34206712734155514,4.0,463.4730000000002,2.6133000000000006,10,0,1,101.35999999999999,-2.529938446318257,0.9509402990341187,-4.936455392162129,0.9950449585914611,-9.13737093322391,0.9245334982872009,0.8872778415679932,0.7234425902366638,82.0328232831411,-1.2423257797559157,0.013115853210911155,0.027738431189209222,0.09807979743927717,0.007883318047970534,0.6634422957897186,-2.073854203063109,46.24394046756383,44.46462274894902,2.9804964692028477,0.5268675297498703,0.347765052318573,0.4488008588552475,0.9317131519317627,0.8524376749992371,0.03468914069235325,0.01036538379266858,0.04033167250454426,0.01054938668385148,0.057046794518828395,0.060994995012879374,0.010239975713193416,0.03392869420349598,0.004186528490390628,0.018160696793347596,0.04196416549384594,0.07933807671070099,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4646.0,2473586.0,1790692.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SAVOLITINIB,CHEMBL3334567,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2016.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1",XYDNMOZJKOGZLS-NSHDSACASA-N,C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21,0.4956856543229866,4.0,345.37000000000006,1.8787999999999996,9,0,1,91.61,-2.3311354783942795,0.9264451861381531,-5.362714008647684,0.9990766644477844,-9.952666508945487,0.914507246017456,0.2687951743602753,0.6465811967849732,74.3908801927075,-1.756510439622538,0.5748116374015808,0.12682887390255929,0.11528672687709332,0.06538837580010295,0.5204212427139282,-39.512828261163875,36.812339449307984,36.07191090704711,1.8676464319904145,0.5515458226203919,0.14324478209018707,0.4439255714416504,0.9102941632270813,0.5052229821681976,0.025048442557454108,0.026787474192678927,0.11039142236113549,0.044559364579617976,0.24835271388292313,0.1760862834751606,0.03971239160746336,0.10856317281723023,0.026429317705333234,0.03086112914606929,0.1102182351052761,0.4161887109279633,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4676.0,2472733.0,455596.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,"Also potent inhibitor of MST1R, AXL and TYRO3.",,,,BMS-777607,CHEMBL460702,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H19ClF2N4O4/c1-2-35-19-10-12-32(16-6-3-14(27)4-7-16)25(34)21(19)24(33)31-15-5-8-18(17(28)13-15)36-20-9-11-30-23(29)22(20)26/h3-13H,2H2,1H3,(H2,29,30)(H,31,33)",VNBRGSXVFBYQNN-UHFFFAOYSA-N,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,0.35261522150953784,2.0,512.9000000000002,5.189600000000002,7,2,0,108.47,-5.557719265280712,0.8844719648361206,-5.044123547870285,0.9926920533180237,-12.564793494993287,0.7334905862808228,0.870300579071045,0.5149151504039764,94.20078438644641,2.707105243531424,0.07964033037424087,0.6422556400299072,0.7239331483840943,0.1170172467827797,0.6833517193794251,113.28972318672177,36.73085080372049,26.269845284116947,2.2268140665789313,0.36294778883457185,0.4408586800098419,0.29116809368133545,0.9763455390930176,0.8126124978065491,0.014965488575398922,0.009850232908502222,0.05779071971774101,0.01287958649918437,0.3366354197263718,0.2853632092475891,0.06712824776768685,0.017639234848320483,0.06359627917408943,0.5025425910949707,0.11196635216474533,0.19424413293600082,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4711.0,1937975.0,1592343.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GOLVATINIB,CHEMBL3039525,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2011.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45)",UQRCJCNVNUFYDX-UHFFFAOYSA-N,CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1,0.3065210007436868,3.0,633.6999999999999,4.753200000000003,7,3,0,119.14,-5.200590230531672,0.7262087345123291,-4.938491482981819,0.9466045141220093,-9.8724752630144,0.6547583341598511,0.3947060763835907,0.7761491775512696,86.11720503195053,2.6991780118363025,0.017069605691358448,0.07579795122146607,0.07944975197315216,0.20320701077580453,0.5149137914180756,25.827383227937684,10.669095581878327,24.003025841265142,3.118194416637208,0.2457599312067032,0.16132988035678864,0.8322188019752502,0.7862055540084839,0.7403577923774719,0.055206145718693735,0.02458810489624739,0.06770473420619964,0.01854161312803626,0.08805392310023308,0.028633741848170757,0.009628090471960605,0.16758182048797607,0.044312267750501635,0.3564135581254959,0.27826792001724243,0.10802565813064575,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4766.0,2472736.0,1172876.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MK-2461,CHEMBL1822792,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1",JGEBLDKNWBUGRZ-HXUWFJFHSA-N,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,0.4357716303065281,4.0,495.56100000000026,2.1525999999999987,8,1,1,115.65,-4.255406957264182,0.857387387752533,-4.803712145308217,0.9965118169784546,-11.219510093808601,0.833661162853241,0.6429729998111725,0.6858291864395142,82.26354938038456,-7.211820886267813,0.26673939526081086,0.09274019449949264,0.08348781950771808,0.02355956370010972,0.8737284779548645,96.7107786805106,53.391421693965285,24.879702521660807,2.3945542038534406,0.517217367887497,0.20703445822000505,0.6527195394039154,0.9688021183013916,0.7981628775596619,0.03699960857629776,0.036551383882761,0.054519128426909445,0.04186273887753487,0.2530339971184731,0.31071782410144805,0.13222975581884383,0.13512976616621017,0.0737686600536108,0.34247828722000123,0.4279658704996109,0.22587807476520538,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4865.0,2473261.0,1832976.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TEPOTINIB,CHEMBL3402762,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H28N6O2/c1-34-12-10-21(11-13-34)20-37-26-17-31-29(32-18-26)25-7-3-5-23(15-25)19-35-28(36)9-8-27(33-35)24-6-2-4-22(14-24)16-30/h2-9,14-15,17-18,21H,10-13,19-20H2,1H3",AHYMHWXQRWRBKT-UHFFFAOYSA-N,CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1,0.3845344905374436,4.0,492.58300000000025,4.007880000000003,8,0,0,96.92999999999999,-4.574151949199404,0.8762847423553467,-5.627983939841386,0.9924631237983703,-9.02985980367579,0.907236385345459,0.929558515548706,0.7238463401794434,87.80278759799648,1.338955495198596,0.07841666042804718,0.13776184022426605,0.32659215331077573,0.10625805668532848,0.7648189067840576,-43.64789876331315,24.37944338578604,36.07120568658877,2.797150804319199,0.12282753586769105,0.2540400505065918,0.7435306429862976,0.8288763880729675,0.9588728427886963,0.012450930196791887,0.011975850723683835,0.022809405438601972,0.009831156791187822,0.08561855927109718,0.07349857538938523,0.010864907409995794,0.030169458501040934,0.05321486778557301,0.17171499133110046,0.05470485165715218,0.20758512616157532,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,4867.0,2473024.0,1677558.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CAPMATINIB,CHEMBL3188267,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2016.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31)",LIOLIMKSCNQPLV-UHFFFAOYSA-N,CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,0.48889130178176626,4.0,412.42800000000005,3.429000000000002,6,1,0,85.07000000000001,-4.234554544208846,0.9321686267852783,-5.088577211262301,0.9987689614295959,-12.491619978392553,0.8862850069999695,0.633017635345459,0.5990156471729279,88.13913011833259,-6.010269239595418,0.25498258620500563,0.3590239405632019,0.4688036859035492,0.09164247289299965,0.7905741572380066,26.103589260130796,30.003400660416293,49.87959641815619,2.763497112592875,0.6249629497528076,0.40032805800437926,0.6670223832130432,0.9621793627738953,0.8775283694267273,0.03023696653544903,0.012393368408083916,0.08196594938635826,0.014143505599349737,0.3583426058292389,0.2461120903491974,0.03565229047089815,0.09819449335336686,0.02371668517589569,0.16489386707544326,0.08896708935499191,0.2121231213212013,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,5253.0,1699897.0,1376152.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,"Mechanism of action is still unclear, it is thought that Tivantinib displays cytotoxic activity via mechanisms other than only cMET inhibition (PMID:23712183)",,,,TIVANTINIB,CHEMBL2103882,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2011.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1",UCEQXRCJXIVODC-PMACEKPBSA-N,O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12,0.5303973124628919,4.0,369.42400000000004,3.592600000000002,3,2,2,66.89,-5.155317645652814,0.7569205284118652,-5.319592166528792,0.9968497276306152,-11.356085661538451,0.6738891839981079,0.6781038045883179,0.8784538745880127,99.68695332142379,-5.631736123042818,0.4923439800739288,0.4678566038608551,0.2076402124017477,0.0607186121866107,0.59378302693367,70.52348755630433,36.638358607048346,38.12749302607073,3.160159475108765,0.29431907534599305,0.14468069970607758,0.3945312678813934,0.9312744379043579,0.4216155022382736,0.03512018509209156,0.03185177221894264,0.11862807124853134,0.07029081359505654,0.23850318938493728,0.15267940163612365,0.07798398137092591,0.057492072507739064,0.22733977288007737,0.27596367299556734,0.3439840942621231,0.4645140528678894,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,7763.0,2973295.0,2197808.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Certain mutations in MET can lead to exon 14 skipping and reduced negative regulation of the MET kinase. Capmatinib exhibits anticancer activity in MET-driven cancer cell lines by inhibiting downstream MET signalling.,Active against MET and MET mutants that cause exon 14 skipping. Indicated for metastatic tumors with a confirmed MET mutation that can lead to exon 14 skipping.,,,CAPMATINIB HYDROCHLORIDE,CHEMBL3989937,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2016.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H17FN6O.2ClH.H2O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20;;;/h2-9,11-13H,10H2,1H3,(H,25,31);2*1H;1H2",COWBUPJEEDYWKD-UHFFFAOYSA-N,CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F.Cl.Cl.O,0.40341942293272026,3.0,503.3650000000001,3.4479000000000037,6,1,0,116.57000000000001,-3.594598201802081,0.8946933507919311,-5.293013055003728,0.9811554431915284,-12.74441617224059,0.6716507911682129,0.6426273465156556,0.4138563871383667,87.22056262643454,-5.1506157535191255,0.11929002702236176,0.22397495955228805,0.39907882511615755,0.12040156945586204,0.6380039274692535,56.46750538146914,3.7148249907643676,21.2207912729559,2.3512720804823957,0.6361175894737243,0.5708114326000213,0.7049176692962646,0.949614417552948,0.8676831483840942,0.01147499904036522,0.007848754432052374,0.07341214343905449,0.012444931408390402,0.31045520305633545,0.14088576510548592,0.027793124318122864,0.06724423915147781,0.037087234854698184,0.16056682020425797,0.1041093036532402,0.22281599193811416,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,7764.0,3460939.0,2464723.0,Hepatocyte growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TEPOTINIB HYDROCHLORIDE,CHEMBL4594292,4.0,1.0,1.0,MOL,,Small molecule,2021.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H28N6O2.ClH.H2O/c1-34-12-10-21(11-13-34)20-37-26-17-31-29(32-18-26)25-7-3-5-23(15-25)19-35-28(36)9-8-27(33-35)24-6-2-4-22(14-24)16-30;;/h2-9,14-15,17-18,21H,10-13,19-20H2,1H3;1H;1H2",KZVOMLRKFJUTLK-UHFFFAOYSA-N,CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1.Cl.O,0.3460598030871131,3.0,547.0590000000003,3.604980000000004,8,0,0,128.43,-3.678087599576237,0.8624187231063842,-5.810506776732209,0.9733568429946899,-9.606865215348702,0.7247387290000915,0.9017423033714295,0.56784086227417,86.06624580922826,-4.204224179482881,0.06486256588250398,0.12840743809938432,0.24453912377357484,0.19140143245458602,0.7330465316772461,-25.41895366768214,9.014717985250837,13.42266306392471,2.4432555536112934,0.18476661145687104,0.3513962119817734,0.746380615234375,0.7774014353752137,0.9470313668251038,0.0075510647147893906,0.011624338198453188,0.03587518073618412,0.01482736561447382,0.07519504725933075,0.06932794824242591,0.0129167340695858,0.04094384592026472,0.06231441907584667,0.1709566630423069,0.06984045207500458,0.2295385479927063,False
MET_HGFR,11451,SINGLE PROTEIN,Hepatocyte growth factor receptor,9606,Homo sapiens,CHEMBL3717,,0.0,9112.0,3490107.0,2486586.0,Hepatocyte growth factor receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TEREVALEFIM,CHEMBL4650326,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2021.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C9H8N2S/c1-2-9(12-7-1)4-3-8-5-6-10-11-8/h1-7H,(H,10,11)/b4-3+",FOHWAQGURRYJFK-ONEGZZNKSA-N,C(=C/c1cccs1)\c1cc[nH]n1,0.7482850797287325,4.0,176.244,2.6416000000000004,2,1,0,28.68,-3.036317271156231,0.7771742343902588,-4.949243102057999,0.9998567342758179,-9.32293806957897,0.9305002212524414,0.052092510275542736,0.869038724899292,77.64229872770362,-13.025287701035703,0.966711163520813,0.6941572368144989,0.47797839641571044,0.24952842593193053,0.44032987356185915,-16.394681691929822,69.93925941691892,38.92768260558139,2.287494868754436,0.33091647624969484,0.10496494919061661,0.0383697547018528,0.8765211582183838,0.18894961178302766,0.06764858961105347,0.05461590588092804,0.42517274618148804,0.10828112959861755,0.7749820411205292,0.17466437220573425,0.11130633056163788,0.5494995355606079,0.5523144960403442,0.6450641393661499,0.4311569035053253,0.8614527583122253,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4139.0,2472771.0,1428626.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AZD-6482,CHEMBL2165191,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,1.0,0.0,"InChI=1S/C22H24N4O4/c1-14-11-17(15(2)23-18-6-4-3-5-16(18)22(28)29)21-24-19(12-20(27)26(21)13-14)25-7-9-30-10-8-25/h3-6,11-13,15,23H,7-10H2,1-2H3,(H,28,29)/t15-/m1/s1",IRTDIKMSKMREGO-OAHLLOKOSA-N,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,0.6700364833304305,4.0,408.45800000000025,2.710820000000001,7,2,1,96.16999999999999,-3.9439583275302694,0.9521695017814636,-5.045580808632129,0.9671717047691345,-11.871421566840423,0.4644793689250946,0.03677722159773111,0.2833644777536392,69.95270777785981,5.883223385880056,0.012073894776403905,0.03401700332760811,0.14717395529150962,0.0069440752267837524,0.062010163068771364,26.53845477553144,44.706522347177234,-2.0241125130011084,2.5360977260884328,0.27284352481365204,0.3062739044427872,0.5126362144947052,0.9835657715797425,0.19843101799488067,0.09763596430420876,0.017079580575227737,0.08753614723682404,0.011812006682157516,0.09956231564283372,0.04358479231595993,0.04986479245126248,0.04043602123856545,0.011197228543460369,0.11907737404108047,0.08744541332125663,0.1239683210849762,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4219.0,2472778.0,1926815.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GSK-1059615,CHEMBL3544966,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H11N3O2S/c22-17-16(24-18(23)21-17)10-11-1-2-15-14(9-11)13(5-8-20-15)12-3-6-19-7-4-12/h1-10H,(H,21,22,23)/b16-10-",QDITZBLZQQZVEE-YBEGLDIGSA-N,O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1,0.7252671646649843,4.0,333.372,3.620700000000002,5,1,0,71.95,-5.774974822302264,0.9290488719940185,-4.779187991424711,0.9998910665512085,-12.872599600708671,0.9165091991424561,0.15703157782554628,0.9329133272171021,101.14440898147211,-3.127390711812477,0.9310384750366211,0.38903848528862,0.24557148814201354,0.023692668415606022,0.8421231746673584,24.69211113170446,26.882403329647627,25.432569674686505,2.2701469659513425,0.3941414326429367,0.05508135408163071,0.44847514629364016,0.9906653881072998,0.2550060600042343,0.017659240402281284,0.05500580221414566,0.2100456476211548,0.05278186053037644,0.48782781660556795,0.2482979953289032,0.22667414247989653,0.1581484541296959,0.26156732738018035,0.5043300122022629,0.5426236271858216,0.6967881560325623,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4222.0,1976765.0,699312.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,,,OMIPALISIB,CHEMBL1236962,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3",CGBJSGAELGCMKE-UHFFFAOYSA-N,COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,0.351854488430201,3.0,505.50600000000014,4.841400000000003,7,1,0,106.96000000000001,-4.846214682927824,0.9375522136688232,-5.0962700289961,0.9993463397026062,-10.88397080825386,0.88562091588974,0.5957128167152405,0.3611292034387589,101.10003643494699,-0.3498940835329723,0.6423606753349305,0.5938977837562561,0.76017165184021,0.1265273243188858,0.9600998401641846,84.4083758377847,30.15449355995088,38.93009470705018,2.896960297823882,0.09205020442605019,0.444655767083168,0.3150526523590088,0.9938760280609131,0.9238850116729737,0.03564607799053192,0.021366562321782114,0.03130125254392624,0.006611476326361299,0.17763158679008484,0.17386182695627211,0.06015694756060839,0.013520520832389592,0.014705113647505642,0.3982058703899384,0.10468732938170433,0.07847403101623059,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4296.0,1763609.0,1449225.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RECILISIB,CHEMBL2219421,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2012.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H13ClO4S/c17-15-7-3-13(4-8-15)11-22(20,21)10-9-12-1-5-14(6-2-12)16(18)19/h1-10H,11H2,(H,18,19)/b10-9+",KBEKQQJUNVQLDZ-MDZDMXLPSA-N,O=C(O)c1ccc(/C=C/S(=O)(=O)Cc2ccc(Cl)cc2)cc1,0.9046960481931947,4.0,336.79599999999994,3.6239000000000017,3,1,0,71.44,-4.365847702460167,0.8850548028945923,-4.705018594253922,0.9799280524253845,-8.82159780300255,0.38824347257614134,0.0598619494587183,0.3511368170380592,92.01708633556193,-2.8359028350611757,0.17213431596755982,0.4679331660270691,0.39254285395145416,0.05163913778960705,0.03885791972279549,13.951109614004372,12.883163437413392,6.542892706060497,2.5232014624694767,0.02055382337421179,0.5231681197881699,0.07991849929094315,0.9556596517562866,0.05196672435849905,0.04877857938408851,0.027970196679234505,0.19534408301115036,0.052190565317869184,0.02542622908949852,0.032697749137878415,0.4810662239789963,0.08464086055755615,0.08238628581166267,0.2037735641002655,0.038050024211406706,0.33179941177368166,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4301.0,2473566.0,2739456.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,ATP-competitive mTORC1/mTORC2 inhibitor,,,,PANULISIB,CHEMBL5095025,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C27H20F3N9/c1-26(2,13-31)22-7-5-17(11-35-22)39-23-18-8-15(16-9-19(27(28,29)30)24(33)36-10-16)4-6-20(18)34-12-21(23)38(3)25(39)37-14-32/h4-12H,1-3H3,(H2,33,36)/b37-25+",VJLRLTSXTLICIR-AUGOTPMTSA-N,Cn1/c(=N\C#N)n(-c2ccc(C(C)(C)C#N)nc2)c2c3cc(-c4cnc(N)c(C(F)(F)F)c4)ccc3ncc21,0.33636535639455767,3.0,527.5140000000002,4.758160000000003,9,1,0,134.49,-6.331444124809332,0.8046221256256103,-4.996831829321823,0.9795681834220886,-9.412168241945837,0.770454204082489,0.8018581986427307,0.48038831949234007,88.36182079639899,3.589000480300277,0.03390515521168709,0.13333662748336791,0.10852311290800572,0.09985299780964851,0.5304387629032135,-3.614024344099852,2.332863125355351,35.01469395135968,3.628084093565371,0.6309879183769226,0.5573461890220642,0.6484995663166047,0.8708295106887818,0.9438094019889831,0.03403826449066401,0.04418616741895676,0.07786744311451912,0.06874654404819011,0.26097408682107925,0.5893644988536835,0.037501702457666396,0.12183326780796051,0.038332355208694935,0.5291088879108429,0.4674229621887207,0.16301792562007905,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4304.0,2472988.0,1075318.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IZORLISIB,CHEMBL1684984,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C15H19N7O3S/c1-26(23,24)22-3-2-11-12(10-8-17-14(16)18-9-10)19-15(20-13(11)22)21-4-6-25-7-5-21/h8-9H,2-7H2,1H3,(H2,16,17,18)",JEGHXKRHKHPBJD-UHFFFAOYSA-N,CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21,0.7647015137770611,4.0,377.4300000000003,-0.3254999999999997,9,1,0,127.43,-3.121310054181424,0.9318636178970336,-4.780511082599211,0.9993221998214722,-12.328967858505994,0.8924628257751465,0.006610022438690066,0.9181318998336792,68.41780746081845,-5.123166736544989,0.18778332993388175,0.013670583581551909,0.013574271509423853,0.004344136774307117,0.13328771553933622,-53.825395588019184,-9.968332981006737,12.39020897146783,2.204502256967625,0.23062034845352172,0.06412313580513,0.1475644152611494,0.9820719838142395,0.3692569315433502,0.03258643448352814,0.02148130815476179,0.07496978640556336,0.018376315757632256,0.060977480560541156,0.07247118214145302,0.0024591333698481322,0.0170865791849792,0.006668136571533978,0.013819708721712232,0.09808550365269184,0.2563662976026535,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4351.0,2473569.0,2089439.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,Thought to be a dual PI3K/mTOR inhibitor but no binding/selectivity/assay data found for any of the targets.,,,,PAXALISIB,CHEMBL3813842,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2020.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H22N8O2/c1-18(2)16-22-12-14(25-3-6-27-7-4-25)23-13(11-9-20-17(19)21-10-11)24-15(12)26(16)5-8-28-18/h9-10H,3-8H2,1-2H3,(H2,19,20,21)",LGWACEZVCMBSKW-UHFFFAOYSA-N,CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,0.6914404462909833,4.0,382.4280000000001,0.9674,10,1,0,117.1,-2.9348793860157194,0.9281562566757202,-4.806715069284321,0.9986597418785095,-11.232331795573632,0.9091188311576843,0.014842790737748145,0.8245112419128418,68.3210742748103,2.6993631647846996,0.2636431522667408,0.026231358153745533,0.02707912204787135,0.01167238267371431,0.14434208273887633,-29.234665041284728,0.24852888456345,8.154084705557691,2.7584443563193264,0.5255388081073761,0.04888781821355224,0.2356365207582712,0.9608937740325928,0.6630884408950806,0.025856680981814862,0.012983495090156793,0.13596247956156732,0.042300689965486526,0.2817367672920227,0.2587910138070583,0.006337024550884962,0.12096148282289505,0.0225275662727654,0.03233765522018075,0.2836214877665043,0.37532824873924253,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4376.0,2473437.0,1521160.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Prodrug - active metabolite is LY-294002. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor.",,,,SF-1126,CHEMBL2326966,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C39H48N8O14/c40-39(41)42-13-5-10-26(36(55)43-20-31(51)45-27(18-33(52)53)37(56)46-28(21-48)38(57)58)44-30(50)11-12-34(54)60-22-47(14-16-59-17-15-47)32-19-29(49)25-9-4-8-24(35(25)61-32)23-6-2-1-3-7-23/h1-4,6-9,19,26-28,48H,5,10-18,20-22H2,(H9-,40,41,42,43,44,45,46,50,51,52,53,55,56,57,58)/t26-,27-,28-/m0/s1",SVNJBEMPMKWDCO-KCHLEUMXSA-N,N=C(N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(c2cc(=O)c3cccc(-c4ccccc4)c3o2)CCOCC1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-],0.016126753098203973,1.0,852.855,-2.870829999999992,14,9,3,341.69999999999993,-1.3487885456421425,0.06651329770684242,-7.49223223623275,0.0016055511077865958,-16.274810013431356,0.026024902053177357,0.03314504604786635,0.025095465965569018,46.320361104216985,-5.113943860643595,0.000973332735884469,0.002610353007912636,0.0009160397792584262,0.049499624967575075,0.022785645537078382,-17.96998206605145,13.890947122820407,27.399820129682773,2.968121944832516,0.23545839190483092,0.04028556300327182,0.007934133312664926,0.31009857952594755,0.4555730283260345,0.20990027487277985,0.10097736120223999,0.2195492133498192,0.16998184025287627,0.0038769375532865524,0.009264105930924416,0.0036673138616606592,0.030125293787568806,0.0032575324905337764,0.0018517221789807082,0.024271305464208127,0.18661461025476456,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4409.0,2473134.0,611731.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Inhibitor of class I phosphoinositide 3-kinase (PI3K) isoforms, ATP-competitive mTORC1/mTORC2 inhibitor",,,,VS-5584,CHEMBL1079593,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H14F2N6O2/c22-11-4-5-14-17(8-11)28(10-25-14)20-24-9-15-19(27-20)29(21(30)26-15)16-6-7-31-18-12(16)2-1-3-13(18)23/h1-5,8-10,16H,6-7H2,(H,26,30)/t16-/m1/s1",DBXGGXLBTWZXBB-MRXNPFEDSA-N,O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21,0.47399128461235496,4.0,420.3790000000002,3.108600000000002,7,1,1,90.62000000000002,-5.3313790044,0.9046701908111572,-4.864022478726036,0.9990620732307434,-10.40688596863511,0.779604721069336,0.5497090518474579,0.6977470993995667,92.06054158412589,-7.152893497460684,0.4923380732536316,0.3185952439904213,0.5002683222293853,0.1484835295006633,0.7468959927558899,-19.588331865833478,37.58615276777884,37.71753706232533,3.256391944260409,0.2271627217531204,0.11244592517614364,0.403509595990181,0.9784478664398193,0.8945915579795838,0.05566597897559404,0.01899440321139991,0.061392844468355176,0.0196329683996737,0.4944843649864197,0.2523749560117722,0.034254688397049905,0.20640964657068253,0.023367004189640283,0.35673108100891116,0.31971693187952044,0.1520441174507141,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4663.0,1937964.0,1220034.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,,,DACTOLISIB,CHEMBL1879463,3.0,0.0,0.0,MOL,71952.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2013.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3",JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,0.3236299364019045,3.0,469.5480000000002,5.893780000000005,6,0,0,76.5,-6.549274376205462,0.7549237370491028,-5.0060932935432465,0.9935831189155578,-8.538591585076663,0.8133249640464782,0.9447236895561218,0.43645782470703126,93.55006987249901,-3.6934930034392535,0.13479443974792957,0.09677340723574161,0.20417516976594924,0.017540245689451693,0.32514469027519227,25.172352778386347,38.74955732992665,40.11736644439499,3.097495778064009,0.22427345514297486,0.5254355549812317,0.5612716436386108,0.879895555973053,0.9377158522605896,0.020794880203902723,0.10417995601892471,0.05490361303091049,0.09797908067703247,0.2566873893141747,0.35901559591293336,0.12615445107221604,0.09944386556744575,0.1549699530005455,0.5561624884605407,0.4459862023591995,0.22643430829048156,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4665.0,2473016.0,1926945.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,,,BGT-226,CHEMBL3545096,2.0,0.0,0.0,MOL,71953.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C28H25F3N6O2.C4H4O4/c1-35-24-16-33-22-6-3-17(18-4-8-25(39-2)34-15-18)13-20(22)26(24)37(27(35)38)19-5-7-23(21(14-19)28(29,30)31)36-11-9-32-10-12-36;5-3(6)1-2-4(7)8/h3-8,13-16,32H,9-12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-",YUXMAKUNSXIEKN-BTJKTKAUSA-N,COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1.O=C(O)/C=C\C(=O)O,0.22935734743647077,3.0,650.6140000000004,4.088200000000002,10,3,0,151.81,-3.77488715097452,0.7726861000061035,-5.266928039273642,0.7404684782028198,-11.159754034308131,0.3666249454021454,0.47661384046077726,0.4388878673315048,81.68773648084435,-4.936497892168571,0.055513618513941765,0.12281241565942765,0.13876335322856903,0.0685925843194127,0.24350717663764954,-7.539119297924257,-32.39805262299668,3.2560730042123973,3.416180470026859,0.2372486710548401,0.3613955855369568,0.7423175692558288,0.9656689643859864,0.8161048054695129,0.04820733033120632,0.02173560708761215,0.060465825349092485,0.030927723087370396,0.12421931251883507,0.138786119222641,0.1138804167509079,0.1140780821442604,0.06471757534891368,0.14220220372080802,0.2926654517650604,0.14284479171037673,True
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4668.0,1879120.0,1335704.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BUPARLISIB,CHEMBL2017974,3.0,0.0,0.0,MOL,71954.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2013.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)",CWHUFRVAEUJCEF-UHFFFAOYSA-N,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,0.8197353914743168,4.0,410.4000000000002,1.8128000000000002,8,1,0,89.63,-3.930658976489682,0.9587547540664673,-4.619096429071532,0.9974951624870301,-10.284433705489992,0.9354418516159058,0.01853774543851614,0.8634044170379639,72.96538205320901,3.3942947779896535,0.2745234102010727,0.10852836072444916,0.05509194470942021,0.00597174814902246,0.10267161726951599,-31.060362090743787,-0.7701003870634537,16.25715180546763,3.485947980081684,0.4457679957151413,0.2465985596179962,0.44525398015975953,0.9460132002830506,0.6693315625190734,0.07133149281144142,0.047808021679520606,0.059325332567095754,0.023950883001089097,0.09132110029459,0.17235033214092255,0.022333139181137086,0.11397964749485254,0.007723751757293939,0.05859278477728367,0.30268874652683736,0.10969759151339531,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4786.0,2473020.0,696704.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,,,PF-04691502,CHEMBL1234354,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H27N5O4/c1-13-17-11-18(14-3-8-19(30-2)24-12-14)21(29)27(20(17)26-22(23)25-13)15-4-6-16(7-5-15)31-10-9-28/h3,8,11-12,15-16,28H,4-7,9-10H2,1-2H3,(H2,23,25,26)/t15-,16-",XDLYKKIQACFMJG-WKILWMFISA-N,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1,0.6158991705318289,4.0,425.48900000000026,2.2453200000000004,9,2,0,125.38000000000001,-3.19103227082975,0.9561484932899476,-4.856749072361613,0.9995842218399048,-12.567803901786107,0.9232535123825073,0.07381390072405339,0.6058016896247864,75.07399887095438,10.396413371958008,0.03799698101356626,0.010078206798061729,0.03789515737444162,0.00521093369461596,0.482632777094841,17.98907072758769,16.528569974612857,35.052169199170976,2.895895759640384,0.4481316149234772,0.10652217864990235,0.34515499174594877,0.9372360229492187,0.8861287474632263,0.10322634428739548,0.04394951425492764,0.07040217295289039,0.015652061998844148,0.20100158751010894,0.2440578579902649,0.006844287971034646,0.12603002712130545,0.005338346539065242,0.1869065374135971,0.27997114360332487,0.06673653796315193,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4788.0,1976763.0,596528.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,,,GEDATOLISIB,CHEMBL592445,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2013.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C32H41N9O4/c1-38(2)27-11-13-39(14-12-27)29(42)24-5-9-26(10-6-24)34-32(43)33-25-7-3-23(4-8-25)28-35-30(40-15-19-44-20-16-40)37-31(36-28)41-17-21-45-22-18-41/h3-10,27H,11-22H2,1-2H3,(H2,33,34,43)",DWZAEMINVBZMHQ-UHFFFAOYSA-N,CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1,0.4094623914233721,3.0,615.7390000000003,3.022000000000001,10,2,0,128.29,-4.079273479395102,0.7107866048812866,-4.991457092650092,0.8237565517425537,-11.74988042338424,0.7274471402168274,0.21477815210819245,0.5508777916431427,78.7882298003481,-2.041176067803038,0.029612059611827134,0.056532667577266695,0.08012175187468529,0.03992201117798686,0.10752815529704093,54.692146546616776,-2.152027017231441,15.816735771913901,2.784051193593267,0.12659364566206932,0.21818736344575881,0.5914791524410248,0.9273008823394775,0.8098126411437988,0.020662069134414197,0.022636565193533898,0.0660021748393774,0.01324455188587308,0.12999150454998015,0.04170278310775757,0.009023052267730236,0.08325616866350175,0.04645739607512951,0.4269279032945633,0.46327548325061796,0.20886933356523513,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4799.0,2473719.0,441100.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SONOLISIB,CHEMBL411907,2.0,0.0,0.0,MOL,65345.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H35NO8/c1-7-11-30(12-8-2)14-17-23-26(34)25(33)22-18-9-10-20(32)28(18,4)13-19(37-16(3)31)24(22)29(23,5)21(15-36-6)38-27(17)35/h7-8,14,18-19,21,34H,1-2,9-13,15H2,3-6H3/b17-14+/t18-,19+,21+,28-,29-/m0/s1",QIUASFSNWYMDFS-NILGECQDSA-N,C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C,0.28951216469183333,3.0,525.5980000000004,3.1346000000000016,9,1,5,119.44,-4.280679372038152,0.6011503279209137,-4.989078275615087,0.9944172501564026,-8.18610660980644,0.8265844702720642,0.7839079022407531,0.5375180572271347,81.08808983864932,7.238245077975239,0.002849435608368367,0.06080489233136177,0.06292002573609352,0.07299240417778492,0.8565789580345153,-1.5250385441870211,103.53734800109753,94.6275288701556,3.5012555024235845,0.5890243887901306,0.08275795541703701,0.22244691848754883,0.7374243378639221,0.2619692087173462,0.11412812769412994,0.23423590660095214,0.09631881788372994,0.03536176048219204,0.01683101588860154,0.3557131618261337,0.04662288203835487,0.15419045686721802,0.11391482055187226,0.6326025247573852,0.40913347601890565,0.40263439118862154,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4808.0,1699898.0,470511.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PICTILISIB,CHEMBL521851,2.0,0.0,0.0,MOL,65326.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2011.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)",LHNIIDJUOCFXAP-UHFFFAOYSA-N,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,0.4326446499729263,3.0,513.6490000000003,2.1483999999999996,9,1,0,107.55000000000001,-4.063197063615528,0.5961744070053101,-5.0546808246974955,0.9984605073928833,-10.79774329854553,0.8509249210357666,0.40916558504104616,0.8465806007385254,99.17620964257017,-7.35557632567144,0.7189044952392578,0.6960512042045593,0.7550215125083923,0.4041087329387665,0.9561349153518677,-88.9584118365269,52.18693689287678,59.07213578843498,2.532309269293719,0.22502887696027757,0.11138742193579673,0.53187775015831,0.9708159327507019,0.9525581359863281,0.018331068567931652,0.028345448337495326,0.08209459483623505,0.06382724363356829,0.35768755376338957,0.20664791464805604,0.0487724918872118,0.05992344580590725,0.06789501309394837,0.3941139101982117,0.4887987315654755,0.44107086658477784,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4810.0,1937984.0,1265685.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,,,APITOLISIB,CHEMBL1922094,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2013.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1",YOVVNQKCSKSHKT-HNNXBMFYSA-N,Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,0.5224751743548602,3.0,498.61300000000034,0.9005200000000009,11,2,1,133.82999999999998,-2.0641730453242033,0.6738266468048095,-5.070098832352642,0.95330308675766,-13.113033432441261,0.7020710825920105,0.16998085826635362,0.6519483745098114,80.40330883959788,-1.3425848426218399,0.012973044766113162,0.039391567930579185,0.07119611129164696,0.03758084252476692,0.23397812098264695,-24.006503955965886,-7.797058749146194,49.75191247833806,2.692602427297997,0.28688695579767226,0.1570956826210022,0.607254022359848,0.9340825796127319,0.8573258876800537,0.02748027965426445,0.017861351557075977,0.08222508653998375,0.014852986205369234,0.09272709712386132,0.06555263176560402,0.0038587176008149982,0.024445878714323042,0.008209848334081471,0.06440005041658878,0.220735764503479,0.19285216331481933,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4812.0,2139042.0,1563853.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,Developed as an isoform-specific PI3K inhibitor with compound exhibiting high affinity for mutated PI3Ka )doi:10.1158/1538-7445.AM2013-DDT02-01).,,,,TASELISIB,CHEMBL2387080,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2014.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)",BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1,0.48860192989753515,4.0,460.5420000000003,3.174220000000002,9,1,0,118.67,-3.4823004512470304,0.9091992139816284,-5.445405609936664,0.9978426337242127,-10.529938922822655,0.9471857428550721,0.8322609543800354,0.4780716061592102,88.85341811411445,2.7516376457342004,0.04460697453469038,0.25051360167562964,0.37409099712967875,0.10327655300498009,0.7277276575565338,-37.322195542170206,-9.903579105554686,74.81034314624053,2.890637880112723,0.4472232758998871,0.1752864897251129,0.48113455772399905,0.7455468535423279,0.8053529381752014,0.030681141838431358,0.015064345113933087,0.08354835584759712,0.05181559287011624,0.14034278839826583,0.2140110969543457,0.02829523365944624,0.05464469138532877,0.03537828102707863,0.054864386841654775,0.07994914650917054,0.09274189323186874,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4815.0,2472679.0,1824379.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PILARALISIB,CHEMBL3360203,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H25ClN6O4S/c1-25(2,27)24(33)28-15-7-6-8-17(13-15)37(34,35)32-23-22(29-19-9-4-5-10-20(19)30-23)31-21-14-16(36-3)11-12-18(21)26/h4-14H,27H2,1-3H3,(H,28,33)(H,29,31)(H,30,32)",QINPEPAQOBZPOF-UHFFFAOYSA-N,COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1,0.25488749640756786,3.0,541.0330000000002,4.512000000000002,8,4,0,148.33,-3.5317480773963994,0.8926522493362427,-5.561966490628924,0.999468195438385,-11.390672131589454,0.8609934449195862,0.8181636214256287,0.4058204680681229,94.48248679991374,-5.512218765584437,0.5552462697029114,0.943562638759613,0.9625606179237366,0.4108804166316986,0.9750757098197937,121.05054618628769,22.149806675089007,39.252031430581276,2.787073930683182,0.08925457000732422,0.40499852001667025,0.14365507513284684,0.9747831463813782,0.9145524263381958,0.017586162872612478,0.00956737995147705,0.04145552664995193,0.008631787402555347,0.2466635823249817,0.25094867646694186,0.1251409098505974,0.015254618227481842,0.06734053827822209,0.5985276103019714,0.09741700440645218,0.11698575392365455,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4817.0,2473665.0,1927215.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VOXTALISIB,CHEMBL3545366,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2014.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17)",RGHYDLZMTYDBDT-UHFFFAOYSA-N,CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21,0.7253100324170814,4.0,270.296,1.0921199999999998,6,2,0,102.48,-2.978649975976078,0.9747652292251587,-5.089366206125773,0.9999501228332519,-15.616067419993977,0.8759671449661255,0.005000164289958775,0.692691195011139,71.56050194325958,-5.418462189414406,0.6185029029846192,0.037061306461691854,0.025547008123248817,0.014593731332570314,0.25145879238843916,-15.530732048056063,0.9939989120730232,7.5007693078492155,2.7447867986198373,0.5233766198158264,0.12695893570780753,0.09659444913268089,0.9649600505828857,0.3651694118976593,0.06421234719455242,0.019094632752239705,0.1657956913113594,0.020636167749762534,0.5938173711299897,0.03471138793975115,0.0015736222034320236,0.11114155128598213,0.003975611692294478,0.03180877324193716,0.09928566664457321,0.2446491912007332,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4863.0,2473726.0,528559.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ZSTK-474,CHEMBL586702,2.0,0.0,0.0,MOL,90545.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2",HGVNLRPZOWWDKD-UHFFFAOYSA-N,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,0.6360644905312034,4.0,417.4200000000003,1.8212999999999995,9,0,0,81.43,-4.096383742421587,0.9398866653442383,-4.291221522500949,0.9998073697090148,-8.253023492256622,0.9830915451049804,0.26517553478479383,0.9611544013023376,79.7321725648147,-0.8179054845679185,0.6554080128669739,0.35558670163154604,0.3393040120601654,0.02520846389234066,0.28017750978469846,-28.976689028685644,36.04664911961436,55.90270286643956,3.407631654556257,0.5622533977031707,0.1234145186841488,0.24437319934368135,0.9823190927505493,0.8966754317283631,0.019661603681743144,0.010644594975747167,0.036698203161358835,0.009440072951838374,0.2417640820145607,0.2928126145154238,0.023958966322243213,0.11778898537158966,0.02529376996681094,0.11266047172248364,0.22012494765222074,0.33811802566051485,False
PIK3CA,109750,PROTEIN COMPLEX GROUP,PI3-kinase class I,9606,Homo sapiens,CHEMBL3559703,,0.0,4870.0,2472849.0,2335152.0,PI3-kinase class I inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,,,SAMOTOLISIB,CHEMBL4297181,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2018.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H26N4O3/c1-14(30-5)13-27-21-18-9-15(16-8-17(11-24-10-16)23(2,3)29)6-7-19(18)25-12-20(21)26(4)22(27)28/h6-12,14,29H,13H2,1-5H3/t14-/m0/s1",ACCFLVVUVBJNGT-AWEZNQCLSA-N,CO[C@@H](C)Cn1c(=O)n(C)c2cnc3ccc(-c4cncc(C(C)(C)O)c4)cc3c21,0.5503348028461785,4.0,406.48600000000016,3.2125000000000012,7,1,1,82.17,-3.236145964669224,0.8726337790489197,-4.667665086678317,0.9991765022277832,-11.1135306181043,0.9530261039733887,0.7437019944190979,0.6657104134559632,70.27634014880582,-5.936752034798848,0.5588190495967865,0.19431475400924683,0.3480435788631439,0.2095034196972847,0.9226564884185791,11.546388897464343,9.233717562168597,29.860372032613817,2.3946801585816853,0.5352525532245636,0.11732913404703141,0.7644434690475463,0.5637196481227875,0.8953405022621155,0.03761313371360302,0.050573740154504776,0.057059460878372194,0.06747020110487938,0.43770178258419035,0.3775216042995453,0.02901669591665268,0.06751208342611789,0.10434577465057374,0.15378695875406265,0.1476059712469578,0.18885225802659988,False
PIK3CA,11362,SINGLE PROTEIN,PI3-kinase p110-alpha subunit,9606,Homo sapiens,CHEMBL4005,,0.0,4155.0,2473342.0,1977413.0,PI3-kinase p110-alpha subunit inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BAY-1082439,CHEMBL3644672,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H30N6O5/c1-16-18(4-3-7-26-16)24(33)29-25-28-21-19(23-27-8-9-31(23)25)5-6-20(22(21)34-2)36-15-17(32)14-30-10-12-35-13-11-30/h3-7,17,32H,8-15H2,1-2H3,(H,28,29,33)/t17-/m1/s1",JGNRMIWLBBNSMU-QGZVFWFLSA-N,COc1c(OC[C@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cccnc1C)N1CCN=C21,0.5841210992537703,4.0,494.5520000000002,0.9638200000000003,10,2,1,121.11,-1.5196722987633549,0.8337167501449585,-5.488441041630685,0.9858696937561036,-13.618672514057176,0.778846549987793,0.7604748725891113,0.17462681010365486,61.729166510636944,5.99929305346936,0.0059473113622516395,0.01950729638338089,0.05226651057600975,0.1261844739317894,0.3348230868577957,-1.9855467991827518,-42.64079962836074,23.610858464117346,2.9876362742196676,0.29171594977378845,0.06479455083608628,0.45621111392974856,0.8240360260009766,0.8497729539871216,0.01841585021466017,0.007526858849450946,0.05739249549806118,0.006445965263992548,0.10515874288976193,0.011425610724836588,0.00217702315421775,0.019925682991743087,0.009477637056261302,0.06522896438837052,0.10744054205715656,0.07011301666498185,False
PIK3CA,11362,SINGLE PROTEIN,PI3-kinase p110-alpha subunit,9606,Homo sapiens,CHEMBL4005,,0.0,4203.0,2472927.0,1966216.0,PI3-kinase p110-alpha subunit inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits mainly class I and IIb HDACS (PMID:22693356),,,,FIMEPINOSTAT,CHEMBL3622533,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2017.0,,-stat,0.0,-stat (-inostat),enzyme inhibitors: histone deacetylase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)",JOWXJLIFIIOYMS-UHFFFAOYSA-N,COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1,0.2803341719216954,2.0,508.5640000000002,2.1439000000000004,12,2,0,138.72000000000003,-3.0791046503582122,0.9005921244621277,-5.109273902708577,0.9961503744125366,-12.461493842599483,0.9246192932128906,0.1799769401550293,0.5058922231197357,88.76559262790622,-2.956955155791312,0.24324571639299392,0.1319582059979439,0.18008600771427155,0.07829267010092736,0.7158086657524109,-25.585920394191138,29.918726357032277,48.73323725812628,2.7632657998165016,0.72189861536026,0.1022887222468853,0.5836978614330292,0.9817447185516357,0.8072547078132629,0.004375350382179022,0.00897120162844658,0.06770450994372368,0.019487196952104567,0.4857448399066925,0.08490158654749394,0.018720910511910917,0.1285773366689682,0.03707205429673195,0.25030517578125,0.624079167842865,0.36525531113147736,False
PIK3CA,11362,SINGLE PROTEIN,PI3-kinase p110-alpha subunit,9606,Homo sapiens,CHEMBL4005,,0.0,4285.0,2473685.0,2145228.0,PI3-kinase p110-alpha subunit inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SERABELISIB,CHEMBL3935857,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C19H17N5O3/c20-19-22-14-9-12(1-3-16(14)27-19)13-2-4-17-21-10-15(24(17)11-13)18(25)23-5-7-26-8-6-23/h1-4,9-11H,5-8H2,(H2,20,22)",BLGWHBSBBJNKJO-UHFFFAOYSA-N,Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1,0.586109558603709,4.0,363.37700000000007,2.1971,7,1,0,98.89,-3.3761022794998796,0.9352366089820862,-4.908130787556665,0.9994984269142151,-15.111967196481867,0.9137801051139831,0.14333151802420616,0.6695750832557679,72.45195553563094,0.825080199815582,0.38142316937446596,0.17017286717891694,0.16990856677293778,0.009044616483151913,0.32685125172138213,-7.798396762082648,18.996432201310483,2.680884170216436,2.0811532250592952,0.5112324774265289,0.1300231773406267,0.4397703051567078,0.9809977889060975,0.7959447503089905,0.05688994899392128,0.027519379183650015,0.19023122191429137,0.04340936616063118,0.5038629531860351,0.44499804973602297,0.037280676513910295,0.24129129946231842,0.014940051571466028,0.1758664920926094,0.2522348791360855,0.29600038528442385,False
PIK3CA,11362,SINGLE PROTEIN,PI3-kinase p110-alpha subunit,9606,Homo sapiens,CHEMBL4005,,0.0,4322.0,2473265.0,707528.0,PI3-kinase p110-alpha subunit inhibitor,,INHIBITOR,1.0,1.0,1.0,ATP-competitive PI3K/mTOR inhibitor,,,,PKI-179,CHEMBL1258517,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H28N8O3/c34-25(28-19-7-9-26-10-8-19)27-18-3-1-17(2-4-18)22-29-23(32-11-13-35-14-12-32)31-24(30-22)33-20-5-6-21(33)16-36-15-20/h1-4,7-10,20-21H,5-6,11-16H2,(H2,26,27,28,34)",WXUUCRLKXQMWRY-UHFFFAOYSA-N,O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1,0.5588978350185634,4.0,488.55200000000036,2.7818000000000005,9,2,2,117.63,-4.923636431285566,0.8976535797119141,-4.830057298162446,0.9925479173660279,-10.952518659919921,0.8364031434059143,0.143203404545784,0.480210280418396,84.34413288819914,1.6274723032620106,0.1907389409840107,0.24741249680519103,0.383477059006691,0.03851140588521958,0.7172563791275024,45.73606151270299,21.140714632704437,56.33995152904821,3.0587261632642493,0.09433889575302601,0.10860583223402501,0.5007500588893891,0.9828406929969787,0.8332965850830079,0.03538531865924597,0.018270657397806644,0.058307422697544097,0.018088162411004305,0.5284695446491241,0.1429314285516739,0.0350737601518631,0.15410378575325012,0.05872259195894003,0.610907781124115,0.6534815311431885,0.18819312751293182,False
PIK3CA,11362,SINGLE PROTEIN,PI3-kinase p110-alpha subunit,9606,Homo sapiens,CHEMBL4005,,0.0,4681.0,2473714.0,1567700.0,PI3-kinase p110-alpha subunit inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ALPELISIB,CHEMBL2396661,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2016.0,1.0,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,1.0,0.0,"InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1",STUWGJZDJHPWGZ-LBPRGKRZSA-N,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,0.7528280893178394,4.0,441.4790000000001,3.835020000000002,5,2,1,101.21,-5.145207964722482,0.9060153484344482,-4.802829683272447,0.9998700380325317,-9.974791997156583,0.9637385129928588,0.4408546328544617,0.9228200793266297,90.85363236353355,4.183082593878481,0.11671439260244369,0.6702106475830079,0.5325046002864837,0.022480447962880134,0.864128589630127,-12.897222143460578,25.796043913322173,48.29099198883069,2.8848885978948826,0.09651624113321304,0.18185442686080933,0.2711558401584625,0.8222720503807068,0.531034654378891,0.10371415093541145,0.02552740853279829,0.1882275640964508,0.028766975551843644,0.06905710101127624,0.1728270635008812,0.05603632777929306,0.054161225259304044,0.05004110261797905,0.47549477219581604,0.1907268390059471,0.09644222632050514,False
PIK3CA,11362,SINGLE PROTEIN,PI3-kinase p110-alpha subunit,9606,Homo sapiens,CHEMBL4005,,0.0,6902.0,2472970.0,1926917.0,PI3-kinase p110-alpha subunit inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,COPANLISIB HYDROCHLORIDE,CHEMBL3545068,4.0,1.0,1.0,MOL,,Small molecule,2017.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,2015.0,1.0,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H28N8O4.2ClH/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15;;/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32);2*1H",STGQPVQAAFJJFX-UHFFFAOYSA-N,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21.Cl.Cl,0.4885737991294415,2.0,553.4510000000002,1.5053999999999998,11,2,0,139.79000000000002,-1.0736034763533575,0.788159966468811,-5.60978868956733,0.7568037867546081,-12.933030097380481,0.3454571157693863,0.34558624029159546,0.5474304139614106,67.18218858194142,3.7339850363705387,0.008156108343973756,0.030255054775625467,0.024785886518657207,0.3476534239947796,0.1898245245218277,-28.080543892604084,-16.086359938509748,15.073739557927647,2.512890137994563,0.787660562992096,0.1427227795124054,0.6564471423625946,0.7844086050987243,0.8570657014846802,0.013433618936687708,0.007063799956813455,0.12994899675250055,0.04564174842089415,0.04737437032163143,0.02459556646645069,0.0011001833365298808,0.06442910768091678,0.005267925234511495,0.027782588079571725,0.2044853612780571,0.28942505419254305,False
PIK3CA,11362,SINGLE PROTEIN,PI3-kinase p110-alpha subunit,9606,Homo sapiens,CHEMBL4005,,0.0,7412.0,2473104.0,1724957.0,PI3-kinase p110-alpha subunit inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,COPANLISIB,CHEMBL3218576,4.0,1.0,0.0,MOL,,Small molecule,2017.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,2015.0,1.0,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32)",PZBCKZWLPGJMAO-UHFFFAOYSA-N,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,0.5470559666602671,3.0,480.5290000000002,0.661800000000002,11,2,0,139.79000000000002,-1.810989669283806,0.7630585312843323,-5.598188320253135,0.8844520568847656,-13.484161465933473,0.4739307701587677,0.28480236828327177,0.5914203941822052,62.478418518908235,3.737059563132756,0.006874161714222282,0.01867671702057123,0.021735125780105592,0.23561542741954328,0.15748259872198106,-37.32602869149429,-17.532340201830372,25.47463424516439,2.7242141217414604,0.5784097909927368,0.06371210664510726,0.5886174380779267,0.8327440619468689,0.8714275121688843,0.01978960372507572,0.006071348022669554,0.10394249632954597,0.03058707546442747,0.0592705313116312,0.02322725038975477,0.0009040302771609277,0.04969491697847843,0.004926873883232474,0.03696386702358723,0.2123135194182396,0.23021492063999177,False
PIK3CA,11362,SINGLE PROTEIN,PI3-kinase p110-alpha subunit,9606,Homo sapiens,CHEMBL4005,,0.0,8223.0,3133380.0,2486475.0,PI3-kinase p110-alpha subunit inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,-1.0,INAVOLISIB,CHEMBL4650215,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2020.0,,-lisib,0.0,-lisib,phosphatidylinositol 3-kinase (PI3K) inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11)24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26)/t9-,12-/m0/s1",SGEUNORSOZVTOL-CABZTGNLSA-N,C[C@H](Nc1ccc2c(c1)OCCn1cc(N3C(=O)OC[C@H]3C(F)F)nc1-2)C(N)=O,0.782117244605261,4.0,407.37700000000007,1.8184999999999996,7,2,2,111.71000000000001,-4.030902044142282,0.9640002489089966,-4.942241885282804,0.998627495765686,-13.409202729572323,0.7536779046058655,0.1824377417564392,0.8404333710670471,77.80191208707849,-5.0037760310865504,0.10357224941253662,0.09709836766123772,0.1042416088283062,0.0612574502825737,0.37057626247406006,-38.41139812733062,22.135407120142368,7.828767887692029,2.911713020409598,0.8230128049850464,0.16985540688037873,0.7734445214271546,0.9405442357063294,0.6071037352085114,0.03366171605885029,0.03001263812184334,0.1965295448899269,0.03738614059984684,0.03267134912312031,0.20417574048042297,0.06785010397434235,0.13817816413939,0.021484596095979212,0.0735394835472107,0.47104820013046267,0.21819415539503098,False
GCK_HK4,20095,SINGLE PROTEIN,Hexokinase type IV,9606,Homo sapiens,CHEMBL3820,,0.0,7897.0,3132460.0,1725511.0,Hexokinase type IV activator,,ACTIVATOR,1.0,1.0,1.0,,,,,AZD-1656,CHEMBL3219124,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C24H26N6O5/c1-15-10-27-21(12-25-15)29-23(31)17-7-18(34-16(2)14-33-3)9-19(8-17)35-22-13-26-20(11-28-22)24(32)30-5-4-6-30/h7-13,16H,4-6,14H2,1-3H3,(H,27,29,31)/t16-/m0/s1",FJEJHJINOKKDCW-INIZCTEOSA-N,COC[C@H](C)Oc1cc(Oc2cnc(C(=O)N3CCC3)cn2)cc(C(=O)Nc2cnc(C)cn2)c1,0.49342590755726884,4.0,478.50900000000024,2.879220000000001,9,1,1,128.66,-4.392410519932605,0.9287569046020507,-4.919881724906001,0.9941570043563843,-10.96237423286403,0.8968303203582764,0.6836990118026733,0.3718802213668823,87.4594842928893,6.069563259816027,0.007444685569498688,0.037212494388222696,0.15716925412416458,0.004610816482454538,0.4909272015094757,1.3080827162439477,47.516921982349984,49.04208267916414,2.5775850220779213,0.25250548124313354,0.12439841702580452,0.37499000430107116,0.978272819519043,0.6392287373542785,0.01491604493930936,0.00329365722136572,0.03940464705228806,0.005362886493094266,0.05358334556221962,0.026434647850692272,0.006477465480566024,0.027554328739643096,0.01666851043701172,0.051394307613372804,0.09693861454725265,0.07712124921381473,False
GCK_HK4,20095,SINGLE PROTEIN,Hexokinase type IV,9606,Homo sapiens,CHEMBL3820,,0.0,8424.0,3133081.0,2335479.0,Hexokinase type IV activator,,ACTIVATOR,1.0,1.0,1.0,,,,,DORZAGLIATIN,CHEMBL4297508,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,,-gliatin,0.0,-gliatin,glucokinase activator,,0.0,0.0,0.0,"InChI=1S/C22H27ClN4O5/c1-14(2)9-18(22(31)24-20-7-8-26(25-20)11-15(29)13-28)27-12-16(10-21(27)30)32-19-6-4-3-5-17(19)23/h3-8,10,14-15,18,28-29H,9,11-13H2,1-2H3,(H,24,25,31)/t15-,18+/m1/s1",HMUMWSORCUWQJO-QAPCUYQASA-N,CC(C)C[C@@H](C(=O)Nc1ccn(C[C@@H](O)CO)n1)N1CC(Oc2ccccc2Cl)=CC1=O,0.49719934168978597,4.0,462.93400000000025,2.047999999999999,7,3,2,116.92000000000002,-4.274126541087132,0.7798694968223572,-5.2161468617564966,0.9983764529228211,-10.666483323332075,0.791261637210846,0.8455054759979248,0.4340009093284607,85.91384223522451,5.115353270014408,0.02624645736068487,0.47230943739414216,0.37231701612472534,0.14580178558826445,0.894166088104248,17.825067612175044,50.46382447056175,53.81321195272225,2.7326661185515326,0.392068076133728,0.37722425162792206,0.23557865023612976,0.7950539350509643,0.5994678497314453,0.016837448067963123,0.009765441995114088,0.04125455059111118,0.00886064525693655,0.14830929189920425,0.2659085154533386,0.05233035609126091,0.010972743574529886,0.06252160817384719,0.30847386717796327,0.08490971475839615,0.15124790817499162,False
GCK_HK4,20095,SINGLE PROTEIN,Hexokinase type IV,9606,Homo sapiens,CHEMBL3820,,0.0,8819.0,3132561.0,1429054.0,Hexokinase type IV activator,,ACTIVATOR,1.0,1.0,1.0,Partial activator,,,,NERIGLIATIN,CHEMBL2165615,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-gliatin,0.0,-gliatin,glucokinase activator,,0.0,0.0,0.0,"InChI=1S/C22H20N6O4/c1-12-8-24-19(11-23-12)27-21(29)14-6-17-16(5-13(2)31-17)18(7-14)32-15-9-25-20(26-10-15)22(30)28(3)4/h5-11H,1-4H3,(H,24,27,29)",MASKQITXHVYVFL-UHFFFAOYSA-N,Cc1cnc(NC(=O)c2cc(Oc3cnc(C(=O)N(C)C)nc3)c3cc(C)oc3c2)cn1,0.5090603932790663,4.0,432.44000000000017,3.3760400000000015,8,1,0,123.34,-4.223230693407929,0.9457487463951111,-4.8288909345321,0.9942497611045837,-12.153555786675232,0.9381439447402954,0.6007645070552826,0.48977587223052976,95.89915144492988,0.5654209755520301,0.09239425919950009,0.08791552558541298,0.1966308981180191,0.0159735806286335,0.4409643217921257,99.19118443101218,27.525152795324182,60.074326061164335,3.0619887401695087,0.3556678771972656,0.2127680152654648,0.23668106496334076,0.9890316128730774,0.7775588631629944,0.0342768307775259,0.00788018829189241,0.06383310556411743,0.012148968549445272,0.33934574723243716,0.11484119966626168,0.013871541153639555,0.10939023718237877,0.029755181260406972,0.2254984363913536,0.14894386790692807,0.15453849732875824,False
GCK_HK4,20095,SINGLE PROTEIN,Hexokinase type IV,9606,Homo sapiens,CHEMBL3820,,0.0,8860.0,3132423.0,1429059.0,Hexokinase type IV activator,,ACTIVATOR,1.0,1.0,1.0,,,,,PF-04991532,CHEMBL2165620,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H19F3N4O3/c19-18(20,21)14-9-25(10-23-14)13(7-11-3-1-2-4-11)16(26)24-15-6-5-12(8-22-15)17(27)28/h5-6,8-11,13H,1-4,7H2,(H,27,28)(H,22,24,26)/t13-/m0/s1",GKMLFBRLRVQVJO-ZDUSSCGKSA-N,O=C(O)c1ccc(NC(=O)[C@H](CC2CCCC2)n2cnc(C(F)(F)F)c2)nc1,0.7750512857245738,4.0,396.36899999999997,3.755200000000003,5,2,1,97.11000000000001,-4.5742140027105265,0.9347848892211914,-5.156816241169613,0.9935701966285706,-8.607190207688308,0.2545018970966339,0.12048138752579689,0.7382915019989014,77.52795406108528,4.300433157092305,0.03297835662961006,0.2209089457988739,0.4560034215450287,0.1715261697769165,0.3309772819280624,-9.46837268401303,38.88245513028611,14.174900699574067,2.825032440845269,0.5398069620132446,0.36570408642292024,0.5193313837051392,0.8483420133590698,0.19061949104070663,0.04019490592181683,0.030077578872442244,0.15412414968013763,0.023986701108515262,0.07668487206101418,0.2955801397562027,0.08130227550864219,0.15967678278684616,0.06839461755007506,0.3396616593003273,0.12156103402376175,0.21967936158180237,False
GCK_HK4,20095,SINGLE PROTEIN,Hexokinase type IV,9606,Homo sapiens,CHEMBL3820,,0.0,8951.0,3132869.0,2335273.0,Hexokinase type IV activator,,ACTIVATOR,1.0,1.0,1.0,,,,,MK-0941,CHEMBL4297302,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H24N4O6S.CH4O3S/c1-4-32(28,29)20-6-5-16(12-22-20)31-18-10-15(9-17(11-18)30-14(2)13-26)21(27)23-19-7-8-25(3)24-19;1-5(2,3)4/h5-12,14,26H,4,13H2,1-3H3,(H,23,24,27);1H3,(H,2,3,4)/t14-;/m0./s1",PIDNRTWDGDJKSQ-UQKRIMTDSA-N,CCS(=O)(=O)c1ccc(Oc2cc(O[C@@H](C)CO)cc(C(=O)Nc3ccn(C)n3)c2)cn1.CS(=O)(=O)O,0.3267393249324382,2.0,556.6190000000003,1.9168999999999998,11,3,1,187.01,-1.7853314152376867,0.7091960668563843,-5.555135183479772,0.8322742819786072,-13.99974306016947,0.33319049775600434,0.5705509066581727,0.3023254364728928,76.31978413379508,-0.32021128254515363,0.032765463041141626,0.0890347620472312,0.1801774322986603,0.06865901425480843,0.3177627772092819,170.15156700954813,-4.495482743182571,9.844937414573732,2.22094076479065,0.31335574984550474,0.5539656043052673,0.42238226532936096,0.9044171571731567,0.720356547832489,0.019444215670228006,0.009259535861201585,0.03834100179374218,0.008255932957399636,0.01887801680713892,0.03691117558628321,0.010291794897057116,0.009217708685901016,0.019439435144886375,0.16408707797527314,0.05027972720563412,0.053907549008727074,False
GCK_HK4,20095,SINGLE PROTEIN,Hexokinase type IV,9606,Homo sapiens,CHEMBL3820,,0.0,9361.0,3132967.0,2335370.0,Hexokinase type IV activator,,ACTIVATOR,1.0,1.0,1.0,,,,,LY-2608204,CHEMBL4297399,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-gliatin,0.0,-gliatin,glucokinase activator,,0.0,0.0,0.0,"InChI=1S/C28H37N3O3S3/c32-26(30-27-29-19-25(36-27)35-17-16-31-14-4-5-15-31)28(18-24(28)20-6-2-1-3-7-20)21-8-10-22(11-9-21)37(33,34)23-12-13-23/h8-11,19-20,23-24H,1-7,12-18H2,(H,29,30,32)/t24-,28-/m0/s1",QIIVJLHCZUTGSD-CUBQBAPOSA-N,O=C(Nc1ncc(SCCN2CCCC2)s1)[C@]1(c2ccc(S(=O)(=O)C3CC3)cc2)C[C@H]1C1CCCCC1,0.37393585393254414,2.0,559.823,5.7438000000000065,7,1,2,79.37,-5.173460231849898,0.7279523968696594,-5.524143918084265,0.9939048409461975,-7.762743327877833,0.5961576044559479,0.8471167087554932,0.8076472401618957,91.0859680795482,2.9636727234989118,0.03334448020905256,0.5417853534221649,0.34045029282569883,0.45313954055309297,0.9579948782920837,36.39452675968367,41.10978448069491,57.53246179610917,2.8542757087211426,0.15016320571303368,0.3559351921081543,0.4886780589818954,0.6637242197990417,0.6981286764144897,0.016660670284181833,0.014251210819929838,0.05746784396469593,0.022973297350108623,0.03430463187396526,0.06048345267772674,0.054692011699080466,0.05129820927977562,0.16240341067314149,0.472131735086441,0.11543922647833824,0.23746377974748611,False
ABCC8,104737,PROTEIN COMPLEX GROUP,Sulfonylurea receptors; K-ATP channels,9606,Homo sapiens,CHEMBL2095152,,0.0,4540.0,1700874.0,1376719.0,Sulfonylurea receptors; K-ATP channels opener,,OPENER,1.0,1.0,1.0,,,,,SARAKALIM,CHEMBL2104449,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-kalim,0.0,-kalim,potassium channel agonists,,0.0,0.0,0.0,"InChI=1S/C20H19F3N2O4/c1-12(26)25(28)11-15-18(24-9-5-4-6-17(24)27)14-10-13(20(21,22)23)7-8-16(14)29-19(15,2)3/h4-10,28H,11H2,1-3H3",FXRJKZVWFJSKGI-UHFFFAOYSA-N,CC(=O)N(O)CC1=C(n2ccccc2=O)c2cc(C(F)(F)F)ccc2OC1(C)C,0.6230929412376602,4.0,408.37600000000015,3.5352000000000032,5,1,0,71.77000000000001,-4.022128176929554,0.9399631142616272,-4.682825974730319,0.999769639968872,-8.995415088772353,0.9721747636795044,0.4718647003173828,0.9385919213294983,88.69225724143809,3.0308372000453643,0.11368072777986526,0.5076554358005524,0.5568566262722016,0.13081171363592148,0.5957186937332153,0.6350176419961564,14.996626045455361,24.869561761850314,3.6352616880939834,0.8337552070617675,0.5016532003879547,0.572110402584076,0.7516828060150147,0.755478048324585,0.028902152180671693,0.009311060700565577,0.083161960542202,0.021631555259227754,0.05087500475347042,0.22658182084560394,0.013091426296159624,0.016723173670470715,0.012163844658061862,0.30377998650074006,0.17475850880146027,0.14447252303361893,False
ABCC8,104737,PROTEIN COMPLEX GROUP,Sulfonylurea receptors; K-ATP channels,9606,Homo sapiens,CHEMBL2095152,,0.0,5202.0,1701649.0,1377430.0,Sulfonylurea receptors; K-ATP channels opener,,OPENER,1.0,1.0,1.0,,,,,NAMINIDIL,CHEMBL2105160,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2002.0,,-dil,0.0,-dil,vasodilators (undefined group),,0.0,0.0,0.0,"InChI=1S/C15H19N5/c1-11(15(2,3)4)19-14(18-10-17)20-13-7-5-12(9-16)6-8-13/h5-8,11H,1-4H3,(H2,18,19,20)/t11-/m1/s1",PGYDRGZVXVVZQC-LLVKDONJSA-N,C[C@@H](N/C(=N\C#N)Nc1ccc(C#N)cc1)C(C)(C)C,0.490975106572508,4.0,269.35200000000003,2.8314600000000016,3,2,1,84.0,-3.7824821841221152,0.8781516671180725,-4.629619394863627,0.993484616279602,-8.125157152061783,0.9327980279922485,0.017515327781438828,0.5672903448343277,72.0238125938053,-1.4018940795935244,0.22906691506505011,0.1987118497490883,0.10596776455640793,0.24519656244665383,0.09435045085847378,11.289314045895969,13.876390512704422,16.242884571490297,2.7390113263376916,0.12444323301315308,0.45535133481025697,0.0271948259556666,0.25469299852848054,0.44608510434627535,0.01042957855388522,0.001345939771272242,0.158901147544384,0.06531381644308568,0.15150756388902664,0.0266708429902792,0.0029920981964096428,0.015219589415937661,0.0383136298507452,0.24891271591186523,0.04977729730308056,0.5752214431762696,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1245.0,1344849.0,405366.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,GLIMEPIRIDE,CHEMBL1481,4.0,1.0,1.0,MOL,5383.0,Small molecule,1995.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1992.0,1.0,gli-,0.0,gli-,antidiabetics,Hypoglycemic,0.0,0.0,0.0,"InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-",WIGIZIANZCJQQY-RUCARUNLSA-N,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O,0.5417624275928407,4.0,490.6260000000003,3.0740000000000016,5,3,0,124.68,-4.325431048254327,0.7544935822486878,-5.04384582109145,0.9951395630836487,-8.594584243002108,0.7748348832130432,0.47906051874160765,0.7950963616371155,100.7084015095073,-0.006831458972474014,0.054253410920500754,0.3296907812356949,0.541851383447647,0.08834988065063953,0.8148358464241028,46.727541983907415,8.551816139074347,30.902773306653934,2.926689814488838,0.025117554888129234,0.41523948311805725,0.18236957341432572,0.8542923092842102,0.24159230291843414,0.048830969259142876,0.010482049779966474,0.07798145189881325,0.006748775718733668,0.004927305481396615,0.005122395697981119,0.0278130526188761,0.003601780952885747,0.056157096102833745,0.1793828308582306,0.03016876019537449,0.20461070835590361,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1246.0,1343096.0,5582.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,GLYBURIDE,CHEMBL472,4.0,1.0,1.0,MOL,5441.0,Small molecule,1984.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1969.0,1.0,,0.0,,,Antidiabetic,0.0,1.0,1.0,"InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)",ZNNLBTZKUZBEKO-UHFFFAOYSA-N,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,0.51917970894521,4.0,494.0130000000003,3.641700000000003,5,3,0,113.6,-4.11969187926241,0.9124699831008911,-5.07048199990387,0.9994807958602905,-10.392706764705977,0.8752057790756226,0.6206388831138611,0.7403897523880005,94.52973589254609,-7.043251860064034,0.3329318940639496,0.9241139888763428,0.9437185049057006,0.23630164563655853,0.9335743665695191,59.01117104827912,9.794789294563252,34.06312086910321,2.665081810174317,0.028696101158857346,0.4625782698392868,0.13533447235822677,0.9388290882110596,0.36505845189094543,0.02411892618983984,0.0065695159835740926,0.041435908153653146,0.0035981606342829764,0.008938595047220587,0.011724227434024214,0.06999476924538613,0.005708029586821794,0.032518934644758704,0.3339560925960541,0.024846212938427925,0.13139921724796294,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1247.0,1343407.0,8516.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,CHLORPROPAMIDE,CHEMBL498,4.0,1.0,1.0,MOL,3650.0,Small molecule,1958.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,1.0,-pamide,0.0,-pamide,diuretics (sulfamoylbenzoic acid derivatives),Antidiabetic,0.0,0.0,0.0,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",RKWGIWYCVPQPMF-UHFFFAOYSA-N,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,0.8794576573550539,4.0,276.745,1.7379,3,2,0,75.27000000000001,-3.0262490045629034,0.8857293725013733,-4.584438280481086,0.999052619934082,-11.409113800406114,0.6879566490650177,0.019431733805686236,0.576916652917862,89.54916674912451,-0.385663869336718,0.01836630590260029,0.1099295649677515,0.029918345622718334,0.0026205549424048514,0.0024990222998894753,34.57138387908081,-15.48804973027615,-5.432739224958466,1.9780926728864021,0.0019318884355016054,0.5092046797275543,0.006517120357602835,0.9589105248451233,0.006860525824595243,0.019560229405760764,0.007992003299295902,0.029420454055070877,0.0006819613379775546,0.0011055655486416072,0.00028382925083860757,0.0004237502973410301,0.00013786209092359059,0.002943396591581404,0.013332363869994878,0.0006942745705600828,0.19519055783748626,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1248.0,1343858.0,674825.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,"TOLBUTAMIDE SODIUM, STERILE",CHEMBL1200874,4.0,1.0,1.0,MOL,,Small molecule,1961.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,Diagnostic Aid (diabetes),0.0,0.0,0.0,"InChI=1S/C12H18N2O3S.Na/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11;/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15);/q;+1/p-1",QKHDBRQBSNZFAK-UHFFFAOYSA-M,CCCCNC(=O)[N-]S(=O)(=O)c1ccc(C)cc1.[Na+],0.5908213798715167,4.0,292.33599999999996,-0.4288799999999995,3,1,0,77.34,-1.0845201247412362,0.8657327890396118,-4.52993226853078,0.9931399106979371,-8.653682877647343,0.7137897491455079,0.06965249367058277,0.8453506708145142,93.667526969588,3.956859794899425,0.006238324218429625,0.16500611491501332,0.04706690758466721,0.0021621546475216746,0.003193997834750917,-2.1486306895495866,58.824323849451545,22.158977391927472,2.531855793457428,0.011081768525764346,0.6239345073699951,0.008477518940344453,0.8715856075286865,0.02196748903952539,0.021260273642838,0.004116278979927302,0.04510012194514275,0.0006366426532622427,0.0007737353560514748,0.00039262046993826516,0.00038703948666807264,0.00032288975780829786,0.0007409069512505084,0.006779611296951771,0.0003150697419187054,0.2623101994395256,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1249.0,1343354.0,139286.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,GLIPIZIDE,CHEMBL1073,4.0,1.0,1.0,MOL,5384.0,Small molecule,1984.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1974.0,1.0,gli-,0.0,gli-,antidiabetics,Antidiabetic,0.0,0.0,0.0,"InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)",ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,0.5981616815314104,4.0,445.54500000000024,2.0781199999999993,6,3,0,130.14999999999998,-3.818986622208654,0.8915173172950744,-5.1008606535226715,0.9915456175804138,-11.515452280202798,0.6650684714317322,0.36720098853111266,0.7531991839408875,89.11362140444382,-4.996871625261342,0.04083633255213499,0.3207221418619156,0.5459261655807495,0.03395312521606684,0.5133569210767746,83.99538571533165,15.84688248334785,19.9073844358017,2.402050945078599,0.03487034253776074,0.36303354501724244,0.2361060842871666,0.942836320400238,0.13151878118515015,0.03456478081643581,0.009817733988165855,0.05323447771370411,0.0028771121345926077,0.0034780979971401394,0.0028105588397011163,0.0088712636847049,0.005827151983976364,0.011694605089724064,0.06234660297632218,0.00869614714756608,0.15292106121778487,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1250.0,1344660.0,454070.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,ACETOHEXAMIDE,CHEMBL1589,4.0,1.0,1.0,MOL,28052.0,Small molecule,1964.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1962.0,1.0,,0.0,,,Antidiabetic,0.0,0.0,0.0,"InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)",VGZSUPCWNCWDAN-UHFFFAOYSA-N,CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,0.8305743326907693,4.0,324.4020000000001,2.2098000000000004,4,2,0,92.34,-3.3219249856494644,0.9401995539665222,-4.700247985014075,0.9979885935783386,-10.915290875976627,0.737318217754364,0.11997638680040837,0.8569151163101196,89.46777821240609,-1.9944591630088653,0.016725378949195145,0.17592932507395745,0.08434331454336644,0.003274499933468178,0.013583630812354386,7.968536638316134,29.79405256884045,-5.925882592311971,2.06258907859373,0.006573269073851406,0.49258769750595094,0.029926815629005434,0.9532221794128418,0.0057914610486477615,0.03936227411031723,0.010256193135865033,0.05298300124704838,0.0007117063127225265,0.0014965711015975103,0.0005689392579370178,0.0013425634882878513,0.0011769107048166915,0.0031102374661713837,0.050891068577766416,0.0016894833301194013,0.1549236737191677,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1251.0,1344544.0,56131.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,TOLAZAMIDE,CHEMBL817,4.0,1.0,1.0,MOL,9613.0,Small molecule,1966.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1964.0,1.0,,0.0,,,Antidiabetic,0.0,0.0,0.0,"InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)",OUDSBRTVNLOZBN-UHFFFAOYSA-N,Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1,0.8915880432277354,4.0,311.4070000000001,1.7739199999999995,4,2,0,78.50999999999999,-2.925779458354555,0.9495577931404113,-4.825648284268587,0.9942999124526978,-10.919871206655419,0.7715038895606995,0.033542797854170206,0.6229952931404114,81.59932881837541,0.23763033449419185,0.012502152496017516,0.15080133005976676,0.07948467899113894,0.008651382406242192,0.02433069683611393,16.37915957459337,-11.5842519704515,-19.98065501921055,1.6503880817920547,0.05917172078043222,0.709626066684723,0.13833340853452683,0.9245264410972596,0.07881049849092961,0.054753794148564336,0.0031603660434484484,0.10060197785496712,0.0010274627304170281,0.0047220185864716765,0.0009529745351755991,0.0009838390367804095,0.0005613128319964744,0.0018547304207459092,0.021034927852451802,0.0009800047177122907,0.3811929523944855,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1252.0,1343624.0,248669.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,REPAGLINIDE,CHEMBL1272,4.0,1.0,1.0,MOL,8805.0,Small molecule,1997.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1998.0,1.0,-glinide,0.0,-glinide,"antidiabetic, sodium glucose co-transporter 2 (SGLT2) inhibitors, not phlorozin derivatives",,0.0,1.0,0.0,"InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1",FAEKWTJYAYMJKF-QHCPKHFHSA-N,CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,0.5166893132340431,3.0,452.5950000000003,5.219900000000005,4,2,1,78.87,-4.819654235487679,0.8353644490242005,-5.201813376431164,0.9679945588111878,-6.400508494178908,0.533291471004486,0.5767111659049988,0.4835698425769806,93.39869424722616,4.311311991758017,0.024103435687720776,0.31979801058769225,0.3926861047744751,0.06320212483406067,0.5556139051914215,4.730947350852583,62.8766550533576,66.02396945322042,2.850227416463984,0.21895973682403563,0.29907389879226687,0.21499972939491271,0.7726043820381164,0.3660567730665207,0.04761331640183926,0.008739724289625883,0.08418733924627304,0.025666211917996406,0.07135226055979729,0.0637243114411831,0.23670427203178407,0.04012947827577591,0.17563596069812776,0.2106114223599434,0.12587075382471086,0.28278286159038546,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1253.0,1343927.0,46727.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,Selective,,,NATEGLINIDE,CHEMBL783,4.0,1.0,1.0,MOL,31897.0,Small molecule,2000.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2000.0,1.0,-glinide,0.0,-glinide,"antidiabetic, sodium glucose co-transporter 2 (SGLT2) inhibitors, not phlorozin derivatives",,0.0,0.0,0.0,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",OELFLUMRDSZNSF-BRWVUGGUSA-N,CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,0.8460610896604897,4.0,317.42900000000014,3.2609000000000012,2,2,1,66.4,-3.2741904563918696,0.9570682525634766,-4.798972081178983,0.9929862976074219,-8.389974226225608,0.6201425433158875,0.024023483227938413,0.6829455852508545,92.49708828024038,-4.324381673613424,0.010307278763502837,0.09840989485383034,0.062310414388775826,0.02907607986126095,0.04955688863992691,-1.531725090580266,38.18601168500666,17.267451592805934,2.3100323618804204,0.12442537397146225,0.37010728418827055,0.17818593680858613,0.5229003548622131,0.04094655867666006,0.029298723489046097,0.005180506175383926,0.1781846508383751,0.03784886803478003,0.05696735791862011,0.017576281540095808,0.2509398624300957,0.01832340080291033,0.03962935656309128,0.03689492680132389,0.013438656087964773,0.33668445348739623,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,1254.0,1343307.0,46726.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,TOLBUTAMIDE,CHEMBL782,4.0,1.0,1.0,MOL,27999.0,Small molecule,1961.0,1.0,1.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,"Antidiabetic,Diagnostic Aid (diabetes)",0.0,0.0,0.0,"InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)",JLRGJRBPOGGCBT-UHFFFAOYSA-N,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,0.8008194430489943,4.0,270.354,1.78302,3,2,0,75.27000000000001,-2.8321575270168156,0.9077542424201965,-4.657768268089844,0.9986854076385498,-9.28020567818265,0.8081561207771302,0.035637817438691856,0.7402383327484131,95.84782454903012,0.22632023386123024,0.022197014093399046,0.16132202371954918,0.08984998762607574,0.0014985032932600007,0.003938984725391492,-0.25691392001402813,23.220771652390653,8.55616088196444,1.7626417829740995,0.004241734801325947,0.640025156736374,0.007740285340696573,0.9223369836807251,0.017444005981087685,0.02617568913847208,0.004108983790501952,0.04409491494297981,0.000603177426091861,0.0008831651270156726,0.00035111026008962656,0.00047820202089496886,0.00023614453530171887,0.001903600082732737,0.015590112749487161,0.000606123823672533,0.26705874800682067,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,9155.0,1705325.0,346895.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,GLICLAZIDE,CHEMBL427216,4.0,1.0,1.0,MOL,31654.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,-1.0,gli-,0.0,gli-,antidiabetics,,0.0,0.0,0.0,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)",BOVGTQGAOIONJV-UHFFFAOYSA-N,Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1,0.8860379615947155,4.0,323.4180000000001,1.6298199999999994,4,2,2,78.50999999999999,-3.410683297252754,0.9567386984825135,-4.71222163001511,0.9982030153274536,-9.405400578493566,0.748750114440918,0.08431179909966886,0.8669060349464417,88.86663155328924,-0.027454637096466783,0.006366048287600279,0.162049750238657,0.05554152205586434,0.019126173574477434,0.0606622364372015,37.11923540818377,-7.501112885374489,-5.513944140903675,1.8839948540747002,0.07751441150903701,0.5874978303909302,0.1820089876651764,0.8363273859024047,0.12255660183727742,0.0834996335208416,0.003328249286278151,0.10638113059103489,0.0014642603433458134,0.00911925472319126,0.0013321513892151416,0.0006861157155071851,0.0010605622548609972,0.0025144106708467006,0.03521578274667263,0.0011652720044367016,0.2504509657621384,False
ABCC8,104852,PROTEIN COMPLEX,"Sulfonylurea receptor 1, Kir6.2",9606,Homo sapiens,CHEMBL2096972,,0.0,9270.0,1702329.0,451662.0,"Sulfonylurea receptor 1, Kir6.2 blocker",,BLOCKER,1.0,1.0,1.0,,,,,MITIGLINIDE,CHEMBL471498,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-glinide,0.0,-glinide,"antidiabetic, sodium glucose co-transporter 2 (SGLT2) inhibitors, not phlorozin derivatives",,0.0,0.0,0.0,"InChI=1S/C19H25NO3/c21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13H2,(H,22,23)/t15-,16+,17-/m0/s1",WPGGHFDDFPHPOB-BBWFWOEESA-N,O=C(O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1,0.9085767639353318,4.0,315.41299999999995,2.9686000000000012,2,1,3,57.61,-2.949599727124152,0.9106858611106873,-4.717180256575523,0.9964796900749207,-8.923297431685373,0.5648677885532379,0.050208548083901405,0.8230589270591736,76.23418242160123,-3.6618109008718904,0.009845414943993092,0.11894322037696839,0.03041863990947604,0.05619912128895521,0.1376170665025711,-1.5670061640065156,35.653912097134366,9.997456552901784,2.562797062975261,0.0960360236465931,0.049100028723478316,0.20138414353132247,0.27653456926345826,0.0675439078360796,0.07102287039160729,0.010309642273932695,0.13193164616823197,0.01521583143621683,0.03843921776860952,0.011459574289619922,0.026798239443451166,0.0068045619409531355,0.011188994301483035,0.006171691580675542,0.003597171790897846,0.4107873886823654,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,452.0,1343762.0,675138.0,C-C chemokine receptor type 5 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,MARAVIROC,CHEMBL1201187,4.0,1.0,1.0,MOL,63608.0,Small molecule,2007.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,,1.0,-vir-; -viroc,0.0,-vir-; -viroc,"antivirals; antivirals, chemokine receptor (CCR) antagonists",,0.0,0.0,0.0,"InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25-,26-/m0/s1",GSNHKUDZZFZSJB-QYOOZWMWSA-N,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,0.473786196640125,2.0,513.6770000000002,5.950920000000006,5,1,4,63.050000000000004,-3.8011138073668094,0.8791026711463928,-5.677789719329086,0.9954970002174377,-6.5339284597647875,0.9023186087608337,0.7495962500572204,0.9399487257003785,84.22964852401483,0.7456735587406493,0.002201304191839881,0.01640416872687638,0.022331069270148874,0.2699342392385006,0.5458882749080658,43.15609812092349,-1.9178593024201773,17.118714457676717,3.9642053574056675,0.7674286127090454,0.18423834145069123,0.7389064788818359,0.15244281589984893,0.8460117101669311,0.026444374397397042,0.007642526924610138,0.10599115043878556,0.03257186226546764,0.007873928500339389,0.05921381562948227,0.0010459982615429908,0.013227264117449521,0.021176246646791696,0.07573151029646397,0.023722062073647975,0.3618127107620239,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,4913.0,1701397.0,1383167.0,C-C chemokine receptor type 5 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CENICRIVIROC,CHEMBL2110727,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2009.0,,-vir-; -viroc,0.0,-vir-; -viroc (-criviroc),"antivirals; antivirals, chemokine receptor (CCR) antagonists: immunomodulators",,0.0,0.0,0.0,"InChI=1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1",PNDKCRDVVKJPKG-WHERJAGFSA-N,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1,0.08772925128576144,2.0,696.9579999999999,8.741700000000005,7,1,1,91.67999999999999,-4.907933895236321,0.7424262166023254,-5.244391406585228,0.9971193313598633,-8.739091638140286,0.6595005035400391,0.9981072545051575,0.32025760412216187,104.80921105486645,4.252087712036647,0.06814738586544991,0.7877771854400635,0.8269983053207397,0.34222222566604615,0.8431157350540162,96.04336611115906,72.64723360958627,93.44041461761313,3.388820330653359,0.5629201233386993,0.4591937780380249,0.1840077355504036,0.8469939470291138,0.9771760106086731,0.008705045375972987,0.004846089729107916,0.07232986539602279,0.01634120037779212,0.5317160308361053,0.49244433641433716,0.06187755465507507,0.0880158044397831,0.3836788982152939,0.7642595767974854,0.20759271681308747,0.2474295377731323,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,4959.0,2472898.0,2739460.0,C-C chemokine receptor type 5 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PF-04634817,CHEMBL5095029,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H36F3N5O3/c1-15(2)24(6-4-16(10-24)31-19-5-7-36-13-20(19)35-3)23(34)33-12-17-8-18(33)11-32(17)22-9-21(25(26,27)28)29-14-30-22/h9,14-20,31H,4-8,10-13H2,1-3H3/t16-,17+,18+,19+,20-,24+/m1/s1",MCRWZBYTLVCCJJ-DKALBXGISA-N,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2C[C@@H]3C[C@H]2CN3c2cc(C(F)(F)F)ncn2)(C(C)C)C1,0.6293139689951421,3.0,511.5890000000002,2.8733000000000013,7,1,6,79.82000000000001,-4.003184395486274,0.7998957633972168,-4.9569794860649825,0.9998647451400757,-8.142264294319085,0.9714318752288819,0.30306096374988556,0.9328089833259583,79.48436096956068,5.9092965126398305,0.0015496620821068064,0.0815840508788824,0.06323651187121868,0.02767223808914423,0.9593400478363037,8.7448396727732,44.402616414886374,57.6912134529432,4.312747393880445,0.4461354106664658,0.04241303373128176,0.6482165277004241,0.3566189169883728,0.9042847752571106,0.03794710040092468,0.006546070845797658,0.050407087057828905,0.012978836055845022,0.01670223204419017,0.12080368027091026,0.003305774205364287,0.017643242608755827,0.005632876325398684,0.06447399407625198,0.056829506903886794,0.07012204304337502,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,4980.0,2473303.0,1280906.0,C-C chemokine receptor type 5 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,AZD5672,CHEMBL1951914,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C31H43F2N3O5S2/c1-4-36(31(37)19-23-5-7-29(8-6-23)42(2,38)39)28-11-14-34(15-12-28)16-13-30(25-20-26(32)22-27(33)21-25)24-9-17-35(18-10-24)43(3,40)41/h5-8,20-22,24,28,30H,4,9-19H2,1-3H3/t30-/m1/s1",QOSMEMHKXNNIGG-SSEXGKCCSA-N,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1,0.368198245061752,3.0,639.831,4.069200000000003,6,0,1,95.07,-2.9956780108236645,0.6739565014839173,-5.369467908822772,0.9918771028518677,-8.688621484420688,0.9495192766189575,0.7593147993087769,0.9214473485946655,70.13867484935427,-4.55867876820404,0.015141695737838745,0.15553578436374665,0.10827495083212853,0.5287679255008697,0.7816145658493042,30.54491457160543,26.283981381913577,17.818663094897026,3.0696597649578616,0.15502627491950988,0.23203380703926085,0.3370582848787308,0.44067216515541074,0.9069495439529419,0.03342255242168903,0.009698656480759382,0.023396717943251134,0.00414085101801902,0.00215613815234974,0.009234634041786195,0.0013619392819236964,0.0010415349155664445,0.003281373647041619,0.020399518311023712,0.0015962745412252844,0.2296791359782219,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,5175.0,2473476.0,1075798.0,C-C chemokine receptor type 5 antagonist,,ANTAGONIST,1.0,1.0,1.0,"HIV-1 entry inhibitor, noncompetitive CCR5 allosteric antagonist. Indication: HIV infections",,,,INCB-9471,CHEMBL1688243,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C30H40F3N5O2/c1-6-40-25-16-22-15-23(30(31,32)33)7-8-24(22)27(25)38-14-13-37(17-19(38)2)29(5)9-11-36(12-10-29)28(39)26-20(3)34-18-35-21(26)4/h7-8,15,18-19,25,27H,6,9-14,16-17H2,1-5H3/t19-,25+,27+/m0/s1",ZMCJFJZOSKEMOM-DNKZPPIMSA-N,CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,0.5239785340867569,3.0,559.6770000000002,4.815540000000005,6,0,3,61.800000000000004,-3.489094169564491,0.7543623566627502,-4.820523369387921,0.9996065378189087,-7.223203300273832,0.9876388072967529,0.8764010310173035,0.990161907672882,85.16108356784102,-2.11388549596993,0.014727967721410096,0.10979882553219796,0.1347286406904459,0.4286175608634949,0.7758432626724243,24.466176778233276,8.63795148503458,41.577640928315375,4.254912242926414,0.4411073446273804,0.1541617676615715,0.8179297924041748,0.21479894667863847,0.9860344767570496,0.02867140732705593,0.004504488920792938,0.03631981536746025,0.008367652259767055,0.015204638941213489,0.03856665901839733,0.00040041191095951945,0.0031865981058217586,0.004350468725897371,0.05826139524579048,0.006083606230095029,0.24896754175424576,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,5345.0,1705038.0,1066574.0,C-C chemokine receptor type 5 antagonist,,ANTAGONIST,1.0,1.0,1.0,Discontinueddue to liver toxicity concerns.,,,,APLAVIROC HYDROCHLORIDE,CHEMBL1668019,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-vir-; -viroc,0.0,-vir-; -viroc,"antivirals; antivirals, chemokine receptor (CCR) antagonists",,0.0,0.0,0.0,"InChI=1S/C33H43N3O6.ClH/c1-2-3-19-36-30(38)28(29(37)24-7-5-4-6-8-24)34-32(41)33(36)17-20-35(21-18-33)22-23-9-13-26(14-10-23)42-27-15-11-25(12-16-27)31(39)40;/h9-16,24,28-29,37H,2-8,17-22H2,1H3,(H,34,41)(H,39,40);1H/t28-,29-;/m1./s1",QNNBMSGFNQRUEH-PQQSRXGVSA-N,CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2.Cl,0.3448862987418084,2.0,614.1830000000002,5.001800000000005,6,3,2,119.41000000000001,-4.744811868883914,0.6128685116767884,-5.522594674420634,0.5443410813808441,-8.57917233972287,0.09741345718502999,0.5667926728725433,0.16522595137357712,89.62125224523709,-1.5984460904603572,0.005046700080856681,0.134858600795269,0.12180720120668412,0.09730922132730484,0.2710714370012283,-15.861538564755751,7.279700116077288,52.51119368248936,2.942296956228957,0.217391699552536,0.1954351544380188,0.29836835861206057,0.6430383086204529,0.3420088142156601,0.029789104871451855,0.015007523866370321,0.14023685902357103,0.02534878719598055,0.01243397369980812,0.017035637516528368,0.07709155939519405,0.04793158508837223,0.11162298619747162,0.18400718420743942,0.10602314248681069,0.270930689573288,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,5362.0,1705138.0,1379654.0,C-C chemokine receptor type 5 antagonist,,ANTAGONIST,1.0,1.0,1.0,Discontinueddue to disappointing results in Ph2 and Ph3 studies.,,,,VICRIVIROC MALEATE,CHEMBL2107384,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-vir-; -viroc,0.0,-vir-; -viroc (-criviroc),"antivirals; antivirals, chemokine receptor (CCR) antagonists: immunomodulators",,0.0,0.0,0.0,"InChI=1S/C28H38F3N5O2.C4H4O4/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3;5-3(6)1-2-4(7)8/h6-9,18-19,24H,10-17H2,1-5H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t19-,24-;/m0./s1",GXINKQQWHLIBJA-UCIBKFKQSA-N,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C.O=C(O)/C=C\C(=O)O,0.4004849999264386,3.0,649.7110000000005,4.212540000000003,8,2,2,136.4,-2.9091156276793604,0.7408771991729737,-5.561771732453585,0.7913208723068237,-9.904986882401433,0.7166677832603454,0.5317936778068543,0.8691786527633667,77.75750611458349,-1.77468962691514,0.0024102797731757166,0.041177865210920574,0.07969516664743423,0.18130904138088227,0.15910377502441406,16.669845487580886,-32.759858015776956,4.363735097991406,3.258938698242712,0.2764606699347496,0.19007486552000047,0.6908794283866883,0.4012569963932037,0.7183144927024842,0.012433905061334372,0.004315617028623819,0.1032668985426426,0.01875236872583628,0.0058759619714692235,0.012774947844445706,0.004581700544804335,0.010265350970439614,0.01289002299308777,0.010126668540760875,0.013583572395145894,0.27430355697870257,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,7796.0,3461089.0,2464850.0,C-C chemokine receptor type 5 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,BMS-813160,CHEMBL4594419,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H40N8O2/c1-15(34)28-18-12-16(30-25(5,6)7)8-9-19(18)32-11-10-17(22(32)35)29-23-27-14-26-21-13-20(24(2,3)4)31-33(21)23/h13-14,16-19,30H,8-12H2,1-7H3,(H,28,34)(H,26,27,29)/t16-,17+,18-,19+/m1/s1",CMVHFGNTABZQJU-HCXYKTFWSA-N,CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O,0.595925134338097,4.0,484.64900000000017,2.2485,8,3,4,116.55000000000001,-3.2286503369617052,0.6692685484886169,-5.6730137501359055,0.9730603814125061,-11.444631427140425,0.8753590226173401,0.13598651215434074,0.8188484191894532,69.2790521899397,4.926055551488123,0.0009531268151476979,0.0415784323355183,0.021634245407767594,0.018639136268757284,0.3163110762834549,45.08163361816271,31.342703274241252,58.894893577093264,3.5953034949160583,0.35667587667703626,0.08638473153114319,0.3809346556663513,0.6830291032791138,0.5195821225643158,0.015139780100435018,0.005703865550458431,0.07158063910901546,0.023139875009655954,0.014892455283552408,0.07528626695275306,0.005480697262100875,0.02783208731561899,0.014617993496358395,0.04898462891578674,0.0910292211920023,0.14622125029563904,False
CCR5,10580,SINGLE PROTEIN,C-C chemokine receptor type 5,9606,Homo sapiens,CHEMBL274,,0.0,8090.0,3132520.0,1061272.0,C-C chemokine receptor type 5 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PF-232798,CHEMBL1649931,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C29H40FN5O2/c1-18(2)29(37)33-12-11-28-27(17-33)31-19(3)35(28)25-15-23-8-9-24(16-25)34(23)13-10-26(32-20(4)36)21-6-5-7-22(30)14-21/h5-7,14,18,23-26H,8-13,15-17H2,1-4H3,(H,32,36)/t23-,24+,25+,26-/m0/s1",QETUKYDWZIRTEI-QUMGSSFMSA-N,CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@@H](n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1,0.6040874564892635,3.0,509.67000000000036,4.306720000000003,5,1,4,70.47,-2.065829407254636,0.6859586358070373,-5.585307647859125,0.9906790733337403,-9.106602660666104,0.91291663646698,0.8056205987930298,0.8590527415275574,74.12705868840337,-1.365232498433129,0.0011873539537191392,0.012615079106763006,0.02091124504804611,0.44435718059539797,0.4120091378688812,18.57369777076668,14.38201525621738,40.76817801705103,3.1360873623146355,0.5118194103240967,0.057530181109905244,0.6922616600990296,0.08890193477272987,0.9312181949615479,0.05402776096016169,0.009051282610744237,0.1087700791656971,0.027367963828146456,0.01457840478979051,0.06711856797337531,0.00030911955254850907,0.004474612977355718,0.008500421326607466,0.008099620067514478,0.00772992130368948,0.2606586143374443,False
CYP3A4,106175,PROTEIN FAMILY,Cytochrome P450 3A,9606,Homo sapiens,CHEMBL2364675,,0.0,1394.0,1679373.0,1369604.0,Cytochrome P450 3A inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,COBICISTAT,CHEMBL2095208,4.0,1.0,1.0,MOL,72291.0,Small molecule,2012.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,1.0,-stat,0.0,-stat,enzyme inhibitors,,0.0,0.0,0.0,"InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1",ZCIGNRJZKPOIKD-CQXVEOKZSA-N,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,0.10557201660303792,2.0,776.0420000000001,6.000700000000006,10,3,3,138.02,-4.997543253836106,0.6797784686088562,-5.173474369792231,0.9973428606986999,-11.368498265399833,0.7296551764011383,0.8723006844520569,0.4132420927286148,97.35288593627514,-0.3433377804319278,0.10696544423699379,0.955066466331482,0.9203148722648621,0.5275296270847321,0.9932748794555664,60.67724438121231,67.95637519477927,91.42137642797259,3.039728056957265,0.35556883811950685,0.12569638937711716,0.5732911884784698,0.8770668506622314,0.8644990563392639,0.004671091469936073,0.002479248167946935,0.06155295819044113,0.018885859102010728,0.15740890577435493,0.05310647711157799,0.05046718046069145,0.02303860131651163,0.09092817604541778,0.4575619876384735,0.1632228285074234,0.23374861776828765,False
CYP3A5,106175,PROTEIN FAMILY,Cytochrome P450 3A,9606,Homo sapiens,CHEMBL2364675,,0.0,1394.0,1679373.0,1369604.0,Cytochrome P450 3A inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,COBICISTAT,CHEMBL2095208,4.0,1.0,1.0,MOL,72291.0,Small molecule,2012.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,1.0,-stat,0.0,-stat,enzyme inhibitors,,0.0,0.0,0.0,"InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1",ZCIGNRJZKPOIKD-CQXVEOKZSA-N,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,0.10557201660303792,2.0,776.0420000000001,6.000700000000006,10,3,3,138.02,-4.997543253836106,0.6797784686088562,-5.173474369792231,0.9973428606986999,-11.368498265399833,0.7296551764011383,0.8723006844520569,0.4132420927286148,97.35288593627514,-0.3433377804319278,0.10696544423699379,0.955066466331482,0.9203148722648621,0.5275296270847321,0.9932748794555664,60.67724438121231,67.95637519477927,91.42137642797259,3.039728056957265,0.35556883811950685,0.12569638937711716,0.5732911884784698,0.8770668506622314,0.8644990563392639,0.004671091469936073,0.002479248167946935,0.06155295819044113,0.018885859102010728,0.15740890577435493,0.05310647711157799,0.05046718046069145,0.02303860131651163,0.09092817604541778,0.4575619876384735,0.1632228285074234,0.23374861776828765,False
CYP3A4,106175,PROTEIN FAMILY,Cytochrome P450 3A,9606,Homo sapiens,CHEMBL2364675,,0.0,8613.0,1344978.0,88100.0,Cytochrome P450 3A inhibitor,,INHIBITOR,1.0,1.0,1.0,This drug is a viral protease inhibitor but in new co-formulations is used to inhibit cytochrome P450s and boost concentration of co-administered antivirals.,,,,RITONAVIR,CHEMBL163,4.0,1.0,1.0,MOL,45409.0,Small molecule,1996.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1995.0,1.0,-vir,0.0,-vir (-navir),antivirals: HIV protease inhibitors (saquinavir type),Antiviral,0.0,0.0,0.0,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,0.10624046585910327,2.0,720.9620000000001,5.905200000000005,9,4,4,145.77999999999997,-5.502664444747987,0.6501427888870239,-5.213374454655182,0.9992312788963318,-11.242016165722253,0.7044352889060974,0.9145047903060913,0.21091120541095734,104.67844857146754,-3.641340362684199,0.2530102789402008,0.9651636362075806,0.9725803732872009,0.44668128490448,0.9960165143013,69.04919174135452,63.33160768814785,112.39471554604022,2.8012803120319987,0.14941649585962297,0.13090015426278115,0.13391367346048355,0.8784408569335938,0.8762161374092102,0.006491876067593693,0.002778749284334481,0.0468379944562912,0.008023646473884583,0.22553055584430695,0.09251123368740082,0.06080229468643665,0.012484433734789491,0.08004204481840134,0.6769227743148803,0.07775583043694496,0.10142784267663955,False
CYP3A5,106175,PROTEIN FAMILY,Cytochrome P450 3A,9606,Homo sapiens,CHEMBL2364675,,0.0,8613.0,1344978.0,88100.0,Cytochrome P450 3A inhibitor,,INHIBITOR,1.0,1.0,1.0,This drug is a viral protease inhibitor but in new co-formulations is used to inhibit cytochrome P450s and boost concentration of co-administered antivirals.,,,,RITONAVIR,CHEMBL163,4.0,1.0,1.0,MOL,45409.0,Small molecule,1996.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1995.0,1.0,-vir,0.0,-vir (-navir),antivirals: HIV protease inhibitors (saquinavir type),Antiviral,0.0,0.0,0.0,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,0.10624046585910327,2.0,720.9620000000001,5.905200000000005,9,4,4,145.77999999999997,-5.502664444747987,0.6501427888870239,-5.213374454655182,0.9992312788963318,-11.242016165722253,0.7044352889060974,0.9145047903060913,0.21091120541095734,104.67844857146754,-3.641340362684199,0.2530102789402008,0.9651636362075806,0.9725803732872009,0.44668128490448,0.9960165143013,69.04919174135452,63.33160768814785,112.39471554604022,2.8012803120319987,0.14941649585962297,0.13090015426278115,0.13391367346048355,0.8784408569335938,0.8762161374092102,0.006491876067593693,0.002778749284334481,0.0468379944562912,0.008023646473884583,0.22553055584430695,0.09251123368740082,0.06080229468643665,0.012484433734789491,0.08004204481840134,0.6769227743148803,0.07775583043694496,0.10142784267663955,False
CYP3A4,17045,SINGLE PROTEIN,Cytochrome P450 3A4,9606,Homo sapiens,CHEMBL340,,0.0,5066.0,1701461.0,32222.0,Cytochrome P450 3A4 inhibitor,,INHIBITOR,1.0,1.0,1.0,Ghrelin mimetic. Discontinued lack of efficacy and possible side effects due to CYP3A4 inhibition.,,,,TABIMORELIN,CHEMBL281764,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-relin,0.0,-relin (-morelin),prehormones or hormone-release stimulating peptides: growth hormone-release stimulating peptides,,0.0,0.0,0.0,"InChI=1S/C32H40N4O3/c1-32(2,33)19-11-16-29(37)35(4)28(22-24-17-18-25-14-9-10-15-26(25)20-24)31(39)36(5)27(30(38)34-3)21-23-12-7-6-8-13-23/h6-18,20,27-28H,19,21-22,33H2,1-5H3,(H,34,38)/b16-11+/t27-,28-/m1/s1",WURGZWOTGMLDJP-ZCYANPAGSA-N,CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)/C=C/CC(C)(C)N,0.3710895828912651,3.0,528.6970000000001,3.7086000000000015,4,2,2,95.74,-3.517822622658586,0.6888413429260254,-5.331145742341681,0.9676778793334961,-10.694662825826816,0.8790588617324829,0.9029167294502258,0.6191705107688904,81.84384108811247,4.6581736599192265,0.037301586009562016,0.501117718219757,0.1981272041797638,0.29515300989151,0.967337429523468,95.53867460676481,34.680291054324144,77.40436138054979,3.5182799090377137,0.23163188993930817,0.39995503425598145,0.32977416813373567,0.50886772274971,0.8773223876953125,0.01714244969189167,0.018132785521447658,0.0438521908596158,0.03334221430122852,0.09004545360803604,0.05194878950715065,0.01815632050856948,0.014892724761739373,0.03889934271574021,0.09846148453652859,0.013604520726948977,0.23920242190361024,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,1440.0,1343733.0,250908.0,Toll-like receptor 7 agonist,,AGONIST,1.0,1.0,1.0,,,,,IMIQUIMOD,CHEMBL1282,4.0,1.0,1.0,MOL,36704.0,Small molecule,1997.0,0.0,0.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1991.0,1.0,-imod,0.0,-imod,immunomodulators,Immunomodulator,0.0,0.0,0.0,"InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)",DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)Cn1cnc2c(N)nc3ccccc3c21,0.7489707109733231,4.0,240.30999999999997,2.8227,4,1,0,56.730000000000004,-2.360539986972482,0.8565007328987122,-4.715277624109476,0.9999971866607666,-9.722091463355765,0.9839432120323182,0.36431990563869476,0.9708576798439026,80.59996450540915,4.632410048758836,0.9662302970886231,0.5730266034603119,0.3035659283399582,0.49663603901863096,0.5861623287200928,28.516899645309497,40.315694927047645,18.72640962047592,2.8681593399277987,0.8663981437683106,0.15175045020878314,0.09178371578454972,0.7241143763065339,0.7537696719169616,0.02194257006049156,0.017797660268843173,0.2258352220058441,0.04168461412191391,0.9100889563560486,0.4309716999530792,0.02150596007704735,0.1842265859246254,0.1828109547495842,0.3016791522502899,0.14846654385328292,0.6421045541763306,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,1441.0,1344184.0,529987.0,Toll-like receptor 7 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,HYDROXYCHLOROQUINE SULFATE,CHEMBL1690,4.0,1.0,1.0,MOL,,Small molecule,1955.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Antimalarial; Suppressant (lupus erythematosus),0.0,0.0,0.0,"InChI=1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)",JCBIVZZPXRZKTI-UHFFFAOYSA-N,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O,0.4445646399161154,4.0,433.95800000000014,3.1302000000000003,6,4,1,122.99000000000001,-0.5981445365271908,0.607669186592102,-5.5087469217098715,0.7688744008541107,-13.408998973608576,0.2930685102939606,0.1521846890449524,0.6934095203876496,83.3876422312177,88.25015397927841,0.45129403471946716,0.11352869495749474,0.03201055484823882,0.6691345632076263,0.03174309618771076,407.57851575156695,-18.37997218166364,-6.8986970247238615,2.064585105028205,0.3213131859898567,0.4392896622419357,0.8486671328544617,0.5514709293842316,0.5774674832820892,0.02536560334265232,0.019207961671054364,0.1315501794219017,0.026738303154706954,0.11733835078775882,0.0096889803186059,0.0013849112088792025,0.006179371848702431,0.015858301147818565,0.13878883197903633,0.08982675075531006,0.31458759009838105,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,7524.0,3133234.0,2335602.0,Toll-like receptor 7 agonist,,AGONIST,0.0,1.0,0.0,,,,,TELRATOLIMOD,CHEMBL4297631,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-imod,0.0,-imod (-tolimod),"immunomodulators: immunomodulators, toll-like receptor agonists",,0.0,0.0,0.0,"InChI=1S/C36H59N5O2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-27-33(42)38-28-22-23-29-43-41-32(26-6-4-2)40-34-35(41)30-24-20-21-25-31(30)39-36(34)37/h20-21,24-25H,3-19,22-23,26-29H2,1-2H3,(H2,37,39)(H,38,42)",RRTPWQXEERTRRK-UHFFFAOYSA-N,CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c(N)nc3ccccc3c21,0.0955446379351377,2.0,593.9010000000003,9.095800000000006,6,2,0,95.06,-4.675388255871151,0.5607706159353256,-5.802738584407291,0.9985183119773865,-7.681541707438138,0.8961734175682068,0.9972030043601989,0.829564893245697,98.65980810633403,29.61538941564472,0.06259372960776091,0.6429967641830444,0.42142892479896543,0.5187664568424225,0.6586020529270172,107.31662485466055,89.02400503495457,120.2148526174636,3.380524305167769,0.33576545417308806,0.3007479429244995,0.23985015153884887,0.5436466574668884,0.9812382817268371,0.02079609241336584,0.009164135996252298,0.04975025281310082,0.012841905280947686,0.33541572988033297,0.5032552123069763,0.023989680968225003,0.018717990443110465,0.08583866879343986,0.21175999641418458,0.1128009743988514,0.5354821622371674,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,7612.0,2973241.0,1579887.0,Toll-like receptor 7 activator,,ACTIVATOR,1.0,1.0,1.0,,,,,VESATOLIMOD,CHEMBL2424780,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2016.0,,-imod,0.0,-imod (-tolimod),"immunomodulators: immunomodulators, toll-like receptor agonists",,0.0,0.0,0.0,"InChI=1S/C22H30N6O2/c1-2-3-11-30-22-25-20(23)19-21(26-22)28(15-18(29)24-19)14-17-8-6-7-16(12-17)13-27-9-4-5-10-27/h6-8,12H,2-5,9-11,13-15H2,1H3,(H,24,29)(H2,23,25,26)",VFOKSTCIRGDTBR-UHFFFAOYSA-N,CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC(=O)N2,0.6460437677402352,4.0,410.52200000000033,2.7922000000000002,7,2,0,96.60999999999999,-4.34169892164773,0.6048008441925049,-5.0530239422061305,0.9975796937942505,-9.117451557577445,0.808612048625946,0.5702081561088562,0.9663267493247986,90.69676734230164,5.788686778654661,0.16491081416606904,0.3558190703392029,0.22416141480207444,0.6976200759410858,0.7176349282264709,-10.578460611244614,60.039089134509666,59.97426599446321,3.2582515968143375,0.21252915114164353,0.08441737592220307,0.7622873544692993,0.4139962673187256,0.9364931464195252,0.021657205559313296,0.008563443087041378,0.043818152695894244,0.01365122077986598,0.25439621806144713,0.06889745816588402,0.0037627112586051227,0.022529894858598708,0.021993156522512436,0.08878726437687874,0.0893254555761814,0.3556015133857727,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,7856.0,3131965.0,565032.0,Toll-like receptor 7 agonist,,AGONIST,1.0,1.0,1.0,,,,,CPG-52852,CHEMBL549344,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H23N5O2S/c1-3-14-21-15-16(12-8-4-5-9-13(12)20-17(15)18)22(14)11-7-6-10-19-25(2,23)24/h4-5,8-9,19H,3,6-7,10-11H2,1-2H3,(H2,18,20)",YZOQZEXYFLXNKA-UHFFFAOYSA-N,CCc1nc2c(N)nc3ccccc3c2n1CCCCNS(C)(=O)=O,0.6270940217932659,4.0,361.47100000000006,2.0584999999999996,6,2,0,102.89999999999998,-2.516118708942904,0.8246979355812073,-5.527027824828081,0.9998620748519897,-11.080604671434527,0.9421621561050415,0.6068795680999756,0.956881868839264,74.06630029654772,-1.1837405306831428,0.48540758192539213,0.35068836212158205,0.3296156734228134,0.2699341863393784,0.7876059174537658,-9.849801578431284,59.762409958272904,41.67880514279676,2.6148533564737066,0.805192768573761,0.2382092371582985,0.4139091968536377,0.8344858169555665,0.8883630990982055,0.019338402524590494,0.03890633173286915,0.08177392929792404,0.05191261470317841,0.42021883130073545,0.3923192203044891,0.024898992013186218,0.022537084016948938,0.07035506069660187,0.11587717048823834,0.13003913015127183,0.5102901220321655,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,8108.0,3133061.0,2335463.0,Toll-like receptor 7 agonist,,AGONIST,1.0,1.0,1.0,,,,,GSK-2245035,CHEMBL4297492,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C20H34N6O2/c1-3-10-15(2)28-19-23-17(21)16-18(24-19)26(20(27)22-16)14-9-5-8-13-25-11-6-4-7-12-25/h15H,3-14H2,1-2H3,(H,22,27)(H2,21,23,24)/t15-/m0/s1",LFMPVTVPXHNXOT-HNNXBMFYSA-N,CCC[C@H](C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1,0.6048662290986332,4.0,390.53200000000027,2.9254000000000016,7,2,1,102.06,-3.2275209961270668,0.639006906747818,-5.370359152718756,0.9980226874351501,-10.212441756830247,0.7981873512268066,0.6153379023075104,0.9696629643440247,76.35155348375969,3.739164113490157,0.08782858215272427,0.07723089940845966,0.07504853196442127,0.769849693775177,0.33729633688926697,-36.61120968048553,37.144180303323346,15.619994842375274,2.7723594182685645,0.29902450293302535,0.09698700457811356,0.8816349625587463,0.18149544894695283,0.980379867553711,0.014827357511967421,0.004292888497002423,0.054642793536186215,0.013085252279415727,0.1605070497840643,0.0994838036596775,0.0008711147107533179,0.02304988317191601,0.018701427336782216,0.028914624825119972,0.026017648354172706,0.4343041718006134,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,8149.0,3132923.0,2335327.0,Toll-like receptor 7 agonist,,AGONIST,1.0,1.0,1.0,,,,,AZD-8848,CHEMBL4297356,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C29H43N7O5/c1-3-4-16-41-28-32-26(30)25-27(33-28)36(29(38)31-25)13-7-12-35(11-6-10-34-14-17-40-18-15-34)21-23-9-5-8-22(19-23)20-24(37)39-2/h5,8-9,19H,3-4,6-7,10-18,20-21H2,1-2H3,(H,31,38)(H2,30,32,33)",FEFIBEHSXLKJGI-UHFFFAOYSA-N,CCCCOc1nc(N)c2[nH]c(=O)n(CCCN(CCCN3CCOCC3)Cc3cccc(CC(=O)OC)c3)c2n1,0.19483149699458,2.0,569.7070000000003,2.2108000000000017,11,2,0,140.83,-2.8773033307398883,0.5008895218372345,-5.4404394981480495,0.9751120328903198,-11.02012820081985,0.6756761550903321,0.7562691926956177,0.8396706700325012,72.75470457347282,10.364974379948285,0.060015779733657834,0.28423366546630857,0.33879935145378115,0.6947003722190856,0.9239587306976318,-16.442556420358667,67.2646741640433,81.09256665777146,2.657101395406138,0.5245779573917388,0.1401960253715515,0.8707497119903564,0.42348830997943876,0.9883850574493408,0.013983756583184005,0.010425452888011933,0.02975162211805582,0.02163206860423088,0.1590379558503628,0.11529396772384644,0.00280426568351686,0.042617912590503695,0.022153541445732117,0.10783461183309555,0.14648158252239227,0.46820924878120423,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,9161.0,1699198.0,340939.0,Toll-like receptor 7 agonist,,AGONIST,1.0,1.0,1.0,,,,,RESIQUIMOD,CHEMBL383322,2.0,0.0,0.0,MOL,36706.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-imod,0.0,-imod,immunomodulators,,0.0,0.0,0.0,"InChI=1S/C17H22N4O2/c1-4-23-9-13-20-14-15(21(13)10-17(2,3)22)11-7-5-6-8-12(11)19-16(14)18/h5-8,22H,4,9-10H2,1-3H3,(H2,18,19)",BXNMTOQRYBFHNZ-UHFFFAOYSA-N,CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O,0.7553148452346293,4.0,314.38900000000007,2.4741000000000013,6,2,0,86.19000000000001,-2.83726731212367,0.8542216300964356,-4.951673149337229,0.9999306797981262,-12.259381747465175,0.9719381690025329,0.4300652205944061,0.9504666090011596,65.78060572075208,5.348721159592589,0.6203452497720718,0.722373652458191,0.5580371439456939,0.3695774286985397,0.5581578135490417,30.19815598403404,19.484108898800365,1.623723515358145,2.530513904269763,0.6963375389575959,0.1201847679913044,0.22060005068778993,0.6263277649879455,0.7893066287040711,0.013187418505549432,0.012095750635489821,0.17150455117225646,0.06622748896479606,0.7669824659824371,0.6313280642032624,0.03460705056786537,0.06584477052092552,0.1439499042928219,0.33946642130613325,0.146922068297863,0.33169751763343813,False
TLR7,101608,SINGLE PROTEIN,Toll-like receptor 7,9606,Homo sapiens,CHEMBL5936,,0.0,9432.0,3589937.0,2537410.0,Toll-like receptor 7 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ENPATORAN,CHEMBL4802159,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2021.0,,-toran,0.0,-toran,toll-like receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C16H15F3N4/c17-16(18,19)11-6-12(21)9-23(8-11)14-4-3-10(7-20)15-13(14)2-1-5-22-15/h1-5,11-12H,6,8-9,21H2/t11-,12+/m0/s1",BJXYHBKEQFQVES-NWDGAFQWSA-N,N#Cc1ccc(N2C[C@H](N)C[C@H](C(F)(F)F)C2)c2cccnc12,0.8772739001114964,4.0,320.3179999999999,2.8223800000000008,4,1,2,65.94,-3.737823579080967,0.9657147288322449,-4.671358039024808,0.9999782323837281,-10.447882130990203,0.9747267246246338,0.15201199650764466,0.9859244585037231,71.95051595876821,1.1030227609715315,0.7134498000144959,0.5403979897499085,0.2779120743274689,0.21006841510534285,0.7433835744857789,33.12965219403732,31.17187642519973,-3.500835616424804,3.2358098240745385,0.5726755261421204,0.13933126702904702,0.8196780323982239,0.48934743404388426,0.9298332571983338,0.06307954788208008,0.09074569679796696,0.09331496953964233,0.08308076523244382,0.49383220076560974,0.5833571970462799,0.022938787192106246,0.2015982076525688,0.014713739883154631,0.26465881764888766,0.24181665182113649,0.17057838141918183,False
ADRB1,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1120.0,1344102.0,36662.0,Adrenergic receptor beta antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CARVEDILOL,CHEMBL723,4.0,1.0,1.0,MOL,3441.0,Small molecule,1995.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1988.0,1.0,-dil-,0.0,-dil-,vasodilators (undefined group),Antihypertensive; Anti-Anginal,0.0,0.0,0.0,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",OGHNVEJMJSYVRP-UHFFFAOYSA-N,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,0.3499607634429391,4.0,406.482,3.738000000000002,5,3,1,75.74000000000001,-4.354614312370872,0.765068769454956,-5.511207835889072,0.9993741512298584,-13.002684090981623,0.8658296465873718,0.9668204545974731,0.563946932554245,96.23125609243803,6.987928986575829,0.9324361205101013,0.927422022819519,0.6648973941802978,0.8310613036155701,0.9250727891921997,29.6652604845783,28.160904736429252,31.341796081476275,2.7117973732946137,0.22075012177228928,0.1900289073586464,0.3509694695472717,0.7488694071769715,0.9849855780601502,0.015808321721851825,0.011783355288207531,0.04440724812448025,0.012473622430115938,0.8347227692604064,0.314392563700676,0.05124171487987041,0.023683230206370354,0.1658444344997406,0.5388454854488373,0.10064272806048394,0.2767908811569214,False
ADRB2,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1120.0,1344102.0,36662.0,Adrenergic receptor beta antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CARVEDILOL,CHEMBL723,4.0,1.0,1.0,MOL,3441.0,Small molecule,1995.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1988.0,1.0,-dil-,0.0,-dil-,vasodilators (undefined group),Antihypertensive; Anti-Anginal,0.0,0.0,0.0,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",OGHNVEJMJSYVRP-UHFFFAOYSA-N,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,0.3499607634429391,4.0,406.482,3.738000000000002,5,3,1,75.74000000000001,-4.354614312370872,0.765068769454956,-5.511207835889072,0.9993741512298584,-13.002684090981623,0.8658296465873718,0.9668204545974731,0.563946932554245,96.23125609243803,6.987928986575829,0.9324361205101013,0.927422022819519,0.6648973941802978,0.8310613036155701,0.9250727891921997,29.6652604845783,28.160904736429252,31.341796081476275,2.7117973732946137,0.22075012177228928,0.1900289073586464,0.3509694695472717,0.7488694071769715,0.9849855780601502,0.015808321721851825,0.011783355288207531,0.04440724812448025,0.012473622430115938,0.8347227692604064,0.314392563700676,0.05124171487987041,0.023683230206370354,0.1658444344997406,0.5388454854488373,0.10064272806048394,0.2767908811569214,False
ADRB1,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1121.0,1344235.0,675118.0,Adrenergic receptor beta antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CARVEDILOL PHOSPHATE,CHEMBL1201167,4.0,1.0,1.0,MOL,,Small molecule,2006.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2004.0,1.0,-dil-,0.0,-dil-,vasodilators (undefined group),,0.0,0.0,0.0,"InChI=1S/C24H26N2O4.H3O4P/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20;1-5(2,3)4/h2-12,17,25-27H,13-16H2,1H3;(H3,1,2,3,4)",XCPXNPBILMXKNX-UHFFFAOYSA-N,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O,0.14134546747121424,2.0,504.47600000000006,2.8094000000000015,6,6,1,153.5,-1.889917820382476,0.5961858034133911,-6.161200625370239,0.6485319197177887,-13.794754936757744,0.34211237281560897,0.6622257590293884,0.364881694316864,92.87489645057948,-1.5934946484232788,0.6131166368722916,0.4678436636924744,0.25677766650915146,0.7350167393684387,0.28932448774576186,53.10054530123428,2.2288291296684952,21.82188769573863,1.6908712045601688,0.031390334293246266,0.14928919449448586,0.675434684753418,0.6170764625072479,0.9313469767570496,0.037378679402172564,0.029880245169624686,0.07998524941504001,0.04537796974182129,0.24362476915121078,0.0544027291238308,0.01290532941929996,0.014401850965805351,0.021264364407397807,0.1445203259587288,0.05666001103818417,0.14934072494506836,False
ADRB2,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1121.0,1344235.0,675118.0,Adrenergic receptor beta antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CARVEDILOL PHOSPHATE,CHEMBL1201167,4.0,1.0,1.0,MOL,,Small molecule,2006.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2004.0,1.0,-dil-,0.0,-dil-,vasodilators (undefined group),,0.0,0.0,0.0,"InChI=1S/C24H26N2O4.H3O4P/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20;1-5(2,3)4/h2-12,17,25-27H,13-16H2,1H3;(H3,1,2,3,4)",XCPXNPBILMXKNX-UHFFFAOYSA-N,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O,0.14134546747121424,2.0,504.47600000000006,2.8094000000000015,6,6,1,153.5,-1.889917820382476,0.5961858034133911,-6.161200625370239,0.6485319197177887,-13.794754936757744,0.34211237281560897,0.6622257590293884,0.364881694316864,92.87489645057948,-1.5934946484232788,0.6131166368722916,0.4678436636924744,0.25677766650915146,0.7350167393684387,0.28932448774576186,53.10054530123428,2.2288291296684952,21.82188769573863,1.6908712045601688,0.031390334293246266,0.14928919449448586,0.675434684753418,0.6170764625072479,0.9313469767570496,0.037378679402172564,0.029880245169624686,0.07998524941504001,0.04537796974182129,0.24362476915121078,0.0544027291238308,0.01290532941929996,0.014401850965805351,0.021264364407397807,0.1445203259587288,0.05666001103818417,0.14934072494506836,False
ADRB1,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1123.0,1343103.0,2197392.0,Adrenergic receptor beta agonist,,AGONIST,1.0,1.0,1.0,,,,,ISOPROTERENOL SULFATE,CHEMBL3989521,4.0,1.0,1.0,MOL,,Small molecule,1956.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/2C11H17NO3.H2O4S.2H2O/c2*1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;1-5(2,3)4;;/h2*3-5,7,11-15H,6H2,1-2H3;(H2,1,2,3,4);2*1H2",CUQPTVCVZLUXJB-UHFFFAOYSA-N,CC(C)NCC(O)c1ccc(O)c(O)c1.CC(C)NCC(O)c1ccc(O)c(O)c1.O.O.O=S(=O)(O)O,0.15126839613026719,2.0,556.6310000000003,-0.04380000000000017,10,10,2,283.04,0.38634299532758043,0.1965332642197609,-7.368416133640489,0.15560110174119474,-12.526758698391399,0.08511012345552445,0.06584877744317055,0.057225636392831805,52.12301968322417,-7.356341545569625,0.08131411764770746,0.07942197434604167,0.020958994422107934,0.368078288435936,0.026009311340749262,73.11431154302953,-22.826324666206972,-7.128247837809783,1.60723527747382,0.10355339124798775,0.2815203219652176,0.3136555768549442,0.08397969007492065,0.6514717936515808,0.04335666373372078,0.015010261023417116,0.1314689911901951,0.047419816814363004,0.018465828197076917,0.005534681177232414,0.0010004358635342214,0.002066176761582028,0.007266902481205761,0.06490099290385842,0.007555265026167035,0.24264320731163025,False
ADRB2,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1123.0,1343103.0,2197392.0,Adrenergic receptor beta agonist,,AGONIST,1.0,1.0,1.0,,,,,ISOPROTERENOL SULFATE,CHEMBL3989521,4.0,1.0,1.0,MOL,,Small molecule,1956.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/2C11H17NO3.H2O4S.2H2O/c2*1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;1-5(2,3)4;;/h2*3-5,7,11-15H,6H2,1-2H3;(H2,1,2,3,4);2*1H2",CUQPTVCVZLUXJB-UHFFFAOYSA-N,CC(C)NCC(O)c1ccc(O)c(O)c1.CC(C)NCC(O)c1ccc(O)c(O)c1.O.O.O=S(=O)(O)O,0.15126839613026719,2.0,556.6310000000003,-0.04380000000000017,10,10,2,283.04,0.38634299532758043,0.1965332642197609,-7.368416133640489,0.15560110174119474,-12.526758698391399,0.08511012345552445,0.06584877744317055,0.057225636392831805,52.12301968322417,-7.356341545569625,0.08131411764770746,0.07942197434604167,0.020958994422107934,0.368078288435936,0.026009311340749262,73.11431154302953,-22.826324666206972,-7.128247837809783,1.60723527747382,0.10355339124798775,0.2815203219652176,0.3136555768549442,0.08397969007492065,0.6514717936515808,0.04335666373372078,0.015010261023417116,0.1314689911901951,0.047419816814363004,0.018465828197076917,0.005534681177232414,0.0010004358635342214,0.002066176761582028,0.007266902481205761,0.06490099290385842,0.007555265026167035,0.24264320731163025,False
ADRB1,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1124.0,1343602.0,674953.0,Adrenergic receptor beta antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CARTEOLOL HYDROCHLORIDE,CHEMBL1201002,4.0,1.0,1.0,MOL,3438.0,Small molecule,1988.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1976.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C16H24N2O3.ClH/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13;/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20);1H",FYBXRCFPOTXTJF-UHFFFAOYSA-N,CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2.Cl,0.7740481999052915,4.0,328.84,2.1209000000000002,4,3,1,70.58999999999999,-1.4879376978680496,0.9234651803970337,-5.179044068177068,0.9918084621429444,-12.42333302066094,0.6128435373306275,0.07179983165115118,0.8018197059631348,57.956518713079824,11.753791151060948,0.03947704043239355,0.043445491790771486,0.004025323837413453,0.6367401897907257,0.008082668855786323,50.58238069605971,-16.88562187693003,-13.00006941947758,2.5242995945033884,0.3929098308086395,0.3421957015991211,0.3232675075531006,0.06123819574713707,0.5549432575702667,0.027848491817712782,0.00661690142005682,0.09099822118878365,0.004639106569811702,0.051801874116063115,0.0022831444279290737,0.0005242952618573326,0.0011787219962570816,0.004202286922372877,0.005848852975759655,0.004754008294548839,0.27079215943813323,False
ADRB2,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1124.0,1343602.0,674953.0,Adrenergic receptor beta antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CARTEOLOL HYDROCHLORIDE,CHEMBL1201002,4.0,1.0,1.0,MOL,3438.0,Small molecule,1988.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1976.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C16H24N2O3.ClH/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13;/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20);1H",FYBXRCFPOTXTJF-UHFFFAOYSA-N,CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2.Cl,0.7740481999052915,4.0,328.84,2.1209000000000002,4,3,1,70.58999999999999,-1.4879376978680496,0.9234651803970337,-5.179044068177068,0.9918084621429444,-12.42333302066094,0.6128435373306275,0.07179983165115118,0.8018197059631348,57.956518713079824,11.753791151060948,0.03947704043239355,0.043445491790771486,0.004025323837413453,0.6367401897907257,0.008082668855786323,50.58238069605971,-16.88562187693003,-13.00006941947758,2.5242995945033884,0.3929098308086395,0.3421957015991211,0.3232675075531006,0.06123819574713707,0.5549432575702667,0.027848491817712782,0.00661690142005682,0.09099822118878365,0.004639106569811702,0.051801874116063115,0.0022831444279290737,0.0005242952618573326,0.0011787219962570816,0.004202286922372877,0.005848852975759655,0.004754008294548839,0.27079215943813323,False
ADRB1,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1125.0,1344094.0,550053.0,Adrenergic receptor beta agonist,,AGONIST,1.0,1.0,1.0,,,,,ISOPROTERENOL HYDROCHLORIDE,CHEMBL1711,4.0,1.0,1.0,MOL,,Small molecule,1956.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Bronchodilator,0.0,0.0,0.0,"InChI=1S/C11H17NO3.ClH/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;/h3-5,7,11-15H,6H2,1-2H3;1H",IROWCYIEJAOFOW-UHFFFAOYSA-N,CC(C)NCC(O)c1ccc(O)c(O)c1.Cl,0.6095123828277141,4.0,247.722,1.5510000000000004,4,4,1,72.72,-0.6261421147852007,0.672483766078949,-5.967260039910588,0.9884501695632935,-11.724946686176839,0.11895487010478974,0.02567760469391942,0.1198791902512312,30.562431867816507,7.391041266873866,0.06033179424703121,0.026234503276646136,0.005998478751280345,0.21897536367177964,0.003853408741997555,10.384687238873775,-3.006345910369963,-42.0531714193819,2.5837363170869088,0.4003241240978241,0.4675283282995224,0.08844394832849503,0.014141508564352989,0.18401664942502977,0.019066292978823184,0.008832691004499793,0.062019306048750875,0.01676665972918272,0.03411706453189254,0.0020941558526828886,0.0008235293895268115,0.0009389882761752233,0.005469353054650128,0.008685316087212413,0.002584815604495816,0.6844192385673523,False
ADRB2,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,1125.0,1344094.0,550053.0,Adrenergic receptor beta agonist,,AGONIST,1.0,1.0,1.0,,,,,ISOPROTERENOL HYDROCHLORIDE,CHEMBL1711,4.0,1.0,1.0,MOL,,Small molecule,1956.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Bronchodilator,0.0,0.0,0.0,"InChI=1S/C11H17NO3.ClH/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;/h3-5,7,11-15H,6H2,1-2H3;1H",IROWCYIEJAOFOW-UHFFFAOYSA-N,CC(C)NCC(O)c1ccc(O)c(O)c1.Cl,0.6095123828277141,4.0,247.722,1.5510000000000004,4,4,1,72.72,-0.6261421147852007,0.672483766078949,-5.967260039910588,0.9884501695632935,-11.724946686176839,0.11895487010478974,0.02567760469391942,0.1198791902512312,30.562431867816507,7.391041266873866,0.06033179424703121,0.026234503276646136,0.005998478751280345,0.21897536367177964,0.003853408741997555,10.384687238873775,-3.006345910369963,-42.0531714193819,2.5837363170869088,0.4003241240978241,0.4675283282995224,0.08844394832849503,0.014141508564352989,0.18401664942502977,0.019066292978823184,0.008832691004499793,0.062019306048750875,0.01676665972918272,0.03411706453189254,0.0020941558526828886,0.0008235293895268115,0.0009389882761752233,0.005469353054650128,0.008685316087212413,0.002584815604495816,0.6844192385673523,False
ADRB1,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,6237.0,1703561.0,678116.0,Adrenergic receptor beta antagonist,,ANTAGONIST,1.0,1.0,1.0,"Dilevalol is a nonselective, Beta-adrenergic receptor antagonist with, Beta 2-adrenergic receptor agonist activity. It has three to six times the activity of labetalol at the Beta-receptor, but unlike labetalol, little activity at the Alpha 1-receptor. In animal studies, it causes vasodilation even in denervated limbs, which is blocked by propranolol, suggesting that these vasodilator effects are due to Beta 2-adrenergic receptor agonism. It lowers blood pressure, both in normal and hypertensive subjects. Because the fall in blood pressure correlates with a fall in peripheral vascular resistance rather than a decrease in cardiac index, it is thought to be due to the Beta 2-adrenergic receptor agonist induced vasodilation, rather than to non-specific, Beta-adrenergic receptor antagonist effects.",,,,DILEVALOL HYDROCHLORIDE,CHEMBL1204165,4.0,0.0,1.0,MOL,,Small molecule,1990.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1984.0,-2.0,-alol,0.0,-alol,combined alpha and beta blockers,Anti-Adrenergic (beta-receptor); Antihypertensive,1.0,0.0,0.0,"InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H/t13-,18+;/m1./s1",WQVZLXWQESQGIF-WJKBNZMCSA-N,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1.Cl,0.5785210057280791,4.0,364.8730000000001,2.5572000000000004,4,4,2,95.57999999999998,-2.5430979167445553,0.884696114063263,-5.614738963694526,0.9897730469703674,-12.062792923059774,0.32582091689109804,0.2902418881654739,0.26543564796447755,70.68707430337982,1.1938785810789398,0.31383658945560455,0.102783203125,0.030485437670722603,0.8413894295692443,0.08761871606111526,12.325767877808719,19.421102024071995,-0.3267031787933504,2.5149225804542756,0.45240282118320463,0.44883953332901,0.3097299784421921,0.04398279367014766,0.6708524227142334,0.028991057351231576,0.020552314631640912,0.09081563428044319,0.02077547460794449,0.022559829242527484,0.008128894306719304,0.0046550283208489415,0.002305010019335896,0.020685710571706296,0.03737304187379777,0.007860491634346545,0.33428474366664884,False
ADRB2,104700,PROTEIN FAMILY,Adrenergic receptor beta,9606,Homo sapiens,CHEMBL2094118,,0.0,6237.0,1703561.0,678116.0,Adrenergic receptor beta antagonist,,ANTAGONIST,1.0,1.0,1.0,"Dilevalol is a nonselective, Beta-adrenergic receptor antagonist with, Beta 2-adrenergic receptor agonist activity. It has three to six times the activity of labetalol at the Beta-receptor, but unlike labetalol, little activity at the Alpha 1-receptor. In animal studies, it causes vasodilation even in denervated limbs, which is blocked by propranolol, suggesting that these vasodilator effects are due to Beta 2-adrenergic receptor agonism. It lowers blood pressure, both in normal and hypertensive subjects. Because the fall in blood pressure correlates with a fall in peripheral vascular resistance rather than a decrease in cardiac index, it is thought to be due to the Beta 2-adrenergic receptor agonist induced vasodilation, rather than to non-specific, Beta-adrenergic receptor antagonist effects.",,,,DILEVALOL HYDROCHLORIDE,CHEMBL1204165,4.0,0.0,1.0,MOL,,Small molecule,1990.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1984.0,-2.0,-alol,0.0,-alol,combined alpha and beta blockers,Anti-Adrenergic (beta-receptor); Antihypertensive,1.0,0.0,0.0,"InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H/t13-,18+;/m1./s1",WQVZLXWQESQGIF-WJKBNZMCSA-N,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1.Cl,0.5785210057280791,4.0,364.8730000000001,2.5572000000000004,4,4,2,95.57999999999998,-2.5430979167445553,0.884696114063263,-5.614738963694526,0.9897730469703674,-12.062792923059774,0.32582091689109804,0.2902418881654739,0.26543564796447755,70.68707430337982,1.1938785810789398,0.31383658945560455,0.102783203125,0.030485437670722603,0.8413894295692443,0.08761871606111526,12.325767877808719,19.421102024071995,-0.3267031787933504,2.5149225804542756,0.45240282118320463,0.44883953332901,0.3097299784421921,0.04398279367014766,0.6708524227142334,0.028991057351231576,0.020552314631640912,0.09081563428044319,0.02077547460794449,0.022559829242527484,0.008128894306719304,0.0046550283208489415,0.002305010019335896,0.020685710571706296,0.03737304187379777,0.007860491634346545,0.33428474366664884,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,6876.0,1703561.0,678116.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,"Dilevalol is a nonselective, Beta-adrenergic receptor antagonist with, Beta 2-adrenergic receptor agonist activity. It has three to six times the activity of labetalol at the Beta-receptor, but unlike labetalol, little activity at the Alpha 1-receptor. In animal studies, it causes vasodilation even in denervated limbs, which is blocked by propranolol, suggesting that these vasodilator effects are due to Beta 2-adrenergic receptor agonism. It lowers blood pressure, both in normal and hypertensive subjects. Because the fall in blood pressure correlates with a fall in peripheral vascular resistance rather than a decrease in cardiac index, it is thought to be due to the Beta 2-adrenergic receptor agonist induced vasodilation, rather than to non-specific, Beta-adrenergic receptor antagonist effects.",,,,DILEVALOL HYDROCHLORIDE,CHEMBL1204165,4.0,0.0,1.0,MOL,,Small molecule,1990.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1984.0,-2.0,-alol,0.0,-alol,combined alpha and beta blockers,Anti-Adrenergic (beta-receptor); Antihypertensive,1.0,0.0,0.0,"InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H/t13-,18+;/m1./s1",WQVZLXWQESQGIF-WJKBNZMCSA-N,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1.Cl,0.5785210057280791,4.0,364.8730000000001,2.5572000000000004,4,4,2,95.57999999999998,-2.5430979167445553,0.884696114063263,-5.614738963694526,0.9897730469703674,-12.062792923059774,0.32582091689109804,0.2902418881654739,0.26543564796447755,70.68707430337982,1.1938785810789398,0.31383658945560455,0.102783203125,0.030485437670722603,0.8413894295692443,0.08761871606111526,12.325767877808719,19.421102024071995,-0.3267031787933504,2.5149225804542756,0.45240282118320463,0.44883953332901,0.3097299784421921,0.04398279367014766,0.6708524227142334,0.028991057351231576,0.020552314631640912,0.09081563428044319,0.02077547460794449,0.022559829242527484,0.008128894306719304,0.0046550283208489415,0.002305010019335896,0.020685710571706296,0.03737304187379777,0.007860491634346545,0.33428474366664884,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,309.0,1344114.0,1279.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ATENOLOL,CHEMBL24,4.0,1.0,1.0,MOL,2904.0,Small molecule,1981.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1976.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)",METKIMKYRPQLGS-UHFFFAOYSA-N,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,0.637673978167625,4.0,266.34099999999995,0.45210000000000006,4,3,1,84.57999999999998,-1.1907913260622691,0.9237570285797119,-5.34654465202734,0.9904521942138672,-14.958648435661217,0.4758636772632599,0.0059577025240287185,0.44640218615531924,16.475561384332963,-2.8762067779319205,0.010767525201663375,0.011743835685774685,0.001288280297012534,0.05649772845208645,0.001637565460987389,-11.979531581517394,-7.85344164193282,-27.922018785059812,1.9380319481293349,0.0597303494811058,0.23811848908662797,0.07751435488462448,0.011133666150271893,0.10404697954654693,0.058496012538671496,0.009856033604592085,0.09875466264784336,0.004038163821678609,0.002693797624669969,0.000436320648441324,0.0004609651499777101,0.0002655498010426527,0.0009235698380507529,0.00021691613965231228,0.00037929933314444496,0.20890262573957444,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,310.0,1344947.0,674788.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LEVOBETAXOLOL HYDROCHLORIDE,CHEMBL1200837,4.0,1.0,1.0,MOL,59256.0,Small molecule,2000.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1989.0,0.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C18H29NO3.ClH/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16;/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3;1H/t17-;/m0./s1",CHDPSNLJFOQTRK-LMOVPXPDSA-N,CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1.Cl,0.606569080084936,4.0,343.89500000000004,2.8152000000000013,4,2,1,50.72,-1.957816067967343,0.9166650295257568,-4.71213175481447,0.9990482091903686,-8.143634818993775,0.7154505133628846,0.41861897706985474,0.653772497177124,65.04180307101333,6.713046370454191,0.3298128604888916,0.10129678249359131,0.011175965890288353,0.950647521018982,0.23449100703001022,15.665351003366329,39.76565952916333,16.839553600668907,2.506831192345815,0.40926032662391665,0.2884388089179993,0.3754866003990173,0.01563650732859969,0.8399817109107971,0.007485039532184601,0.004358423396479338,0.07842340990900994,0.013258709385991097,0.06021921038627624,0.014712233282625675,0.0023018109844997526,0.002667012496385723,0.038779770396649836,0.04510122872889042,0.004168327007209882,0.5188480883836746,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,311.0,1343572.0,674764.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ACEBUTOLOL HYDROCHLORIDE,CHEMBL1200813,4.0,1.0,1.0,MOL,2380.0,Small molecule,1984.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C18H28N2O4.ClH/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3;/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23);1H",KTUFKADDDORSSI-UHFFFAOYSA-N,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1.Cl,0.5495300295286293,4.0,372.8930000000001,2.7873000000000014,5,3,1,87.66,-1.7254073241991001,0.913722014427185,-5.35459068731965,0.9948319554328918,-12.017673792440064,0.7144189357757569,0.31016087532043457,0.6739533424377442,59.243305079104516,18.32885706165966,0.25220906138420107,0.14651190340518952,0.032068468444049356,0.7274705648422242,0.053504491597414015,23.290425984915483,9.45272374325009,10.004998998481081,2.2778171221566135,0.4031894147396088,0.49550763368606565,0.2163380652666092,0.17306819558143616,0.38558988869190214,0.03888105489313602,0.04634821061044932,0.09213118553161621,0.0046446897555142645,0.14165087640285492,0.006742697814479471,0.003524184605339542,0.0065312460064888,0.010905447881668806,0.03229083577170968,0.020258717332035305,0.18831835687160492,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,312.0,1344658.0,675066.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ESMOLOL HYDROCHLORIDE,CHEMBL1201115,4.0,1.0,1.0,MOL,4857.0,Small molecule,1986.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1983.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),1.0,0.0,0.0,"InChI=1S/C16H25NO4.ClH/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3;/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3;1H",GEKNCWBANDDJJL-UHFFFAOYSA-N,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1.Cl,0.6769599099506719,4.0,331.84,1.9516999999999993,5,2,1,67.79,-1.5005787911574155,0.9033271431922912,-4.789885567691304,0.9984534621238709,-10.324525155728034,0.821283483505249,0.19781800508499145,0.42323274314403536,55.13709426216569,-0.4081548462218191,0.2852390453219414,0.3218372315168381,0.016492000315338373,0.8221587061882019,0.08190224319696426,9.649491487631852,34.67665031405935,20.066329334118052,2.679835504904832,0.18183280080556868,0.3079873979091644,0.22794170379638673,0.03714989544823766,0.6072503626346588,0.01512843817472458,0.008421724196523428,0.08273308649659157,0.009111229469999671,0.012754123751074075,0.003348243539221585,0.004507707827724516,0.0013803555615595543,0.0095668182708323,0.0028477661267970688,0.001983697807736462,0.4983937978744507,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1367.0,1344658.0,675066.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ESMOLOL HYDROCHLORIDE,CHEMBL1201115,4.0,1.0,1.0,MOL,4857.0,Small molecule,1986.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1983.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),1.0,0.0,0.0,"InChI=1S/C16H25NO4.ClH/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3;/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3;1H",GEKNCWBANDDJJL-UHFFFAOYSA-N,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1.Cl,0.6769599099506719,4.0,331.84,1.9516999999999993,5,2,1,67.79,-1.5005787911574155,0.9033271431922912,-4.789885567691304,0.9984534621238709,-10.324525155728034,0.821283483505249,0.19781800508499145,0.42323274314403536,55.13709426216569,-0.4081548462218191,0.2852390453219414,0.3218372315168381,0.016492000315338373,0.8221587061882019,0.08190224319696426,9.649491487631852,34.67665031405935,20.066329334118052,2.679835504904832,0.18183280080556868,0.3079873979091644,0.22794170379638673,0.03714989544823766,0.6072503626346588,0.01512843817472458,0.008421724196523428,0.08273308649659157,0.009111229469999671,0.012754123751074075,0.003348243539221585,0.004507707827724516,0.0013803555615595543,0.0095668182708323,0.0028477661267970688,0.001983697807736462,0.4983937978744507,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,313.0,1343931.0,674696.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,OXPRENOLOL HYDROCHLORIDE,CHEMBL1200745,4.0,1.0,1.0,MOL,,Small molecule,1983.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1968.0,0.0,-olol,0.0,-olol,beta-blockers (propranolol type),Vasodilator (coronary),0.0,0.0,0.0,"InChI=1S/C15H23NO3.ClH/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3;/h4-8,12-13,16-17H,1,9-11H2,2-3H3;1H",COAJXCLTPGGDAJ-UHFFFAOYSA-N,C=CCOc1ccccc1OCC(O)CNC(C)C.Cl,0.687851007974509,4.0,301.8139999999999,2.410900000000001,4,2,1,50.72,-1.0753390012630883,0.932933759689331,-4.974375297054708,0.9992823123931884,-8.91964374119498,0.865268349647522,0.1762258380651474,0.6678934335708618,57.331114727756855,7.19201252725837,0.6245261490345001,0.23966133296489717,0.008163716876879334,0.8895646214485169,0.02578640226274729,25.428418949314885,10.856621586990242,1.940353503534115,2.5531648020989754,0.1875934347510338,0.44652884006500243,0.2887932449579239,0.03474539592862129,0.7069108247756958,0.00864325650036335,0.00322983970399946,0.074228785187006,0.003516755672171712,0.01458852905780077,0.006076166592538357,0.004011419997550547,0.0006780733019695617,0.008309644460678101,0.004429371375590563,0.0008564020215999335,0.5718696236610412,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1356.0,1343931.0,674696.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,OXPRENOLOL HYDROCHLORIDE,CHEMBL1200745,4.0,1.0,1.0,MOL,,Small molecule,1983.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1968.0,0.0,-olol,0.0,-olol,beta-blockers (propranolol type),Vasodilator (coronary),0.0,0.0,0.0,"InChI=1S/C15H23NO3.ClH/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3;/h4-8,12-13,16-17H,1,9-11H2,2-3H3;1H",COAJXCLTPGGDAJ-UHFFFAOYSA-N,C=CCOc1ccccc1OCC(O)CNC(C)C.Cl,0.687851007974509,4.0,301.8139999999999,2.410900000000001,4,2,1,50.72,-1.0753390012630883,0.932933759689331,-4.974375297054708,0.9992823123931884,-8.91964374119498,0.865268349647522,0.1762258380651474,0.6678934335708618,57.331114727756855,7.19201252725837,0.6245261490345001,0.23966133296489717,0.008163716876879334,0.8895646214485169,0.02578640226274729,25.428418949314885,10.856621586990242,1.940353503534115,2.5531648020989754,0.1875934347510338,0.44652884006500243,0.2887932449579239,0.03474539592862129,0.7069108247756958,0.00864325650036335,0.00322983970399946,0.074228785187006,0.003516755672171712,0.01458852905780077,0.006076166592538357,0.004011419997550547,0.0006780733019695617,0.008309644460678101,0.004429371375590563,0.0008564020215999335,0.5718696236610412,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,314.0,1343110.0,896873.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,BISOPROLOL FUMARATE,CHEMBL1472989,4.0,1.0,1.0,MOL,3128.0,Small molecule,1992.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1987.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/2C18H31NO4.C4H4O4/c2*1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4;5-3(6)1-2-4(7)8/h2*5-8,14-15,17,19-20H,9-13H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+",VMDFASMUILANOL-WXXKFALUSA-N,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.O=C(O)/C=C/C(=O)O,0.05811919108233005,1.0,766.9700000000001,4.443600000000004,12,6,2,194.5,-2.1889803238336554,0.5149498403072357,-6.373763716297414,0.2663786768913269,-12.038703537596207,0.2611114144325256,0.40262350142002107,0.08290421441197396,78.50717519418018,-0.0034053847436483764,0.034658664651215074,0.1524411454796791,0.06385942697525024,0.21337038278579712,0.12744695767760278,3.7124994029244407,-17.651117914742173,13.005786164588756,2.104504550101745,0.038627240993082526,0.09046372100710869,0.07077207192778587,0.2629247814416885,0.7280396044254303,0.020374145545065402,0.007958421716466546,0.09983840733766555,0.03593131545931101,0.02550782188773155,0.03254037741571665,0.04872237332165241,0.0037014459958299994,0.0710667248815298,0.05518126059323549,0.012891896720975637,0.3011657953262329,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,315.0,1344396.0,675128.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LEVOBUNOLOL HYDROCHLORIDE,CHEMBL1201177,4.0,1.0,1.0,MOL,6439.0,Small molecule,1985.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1979.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20;/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3;1H/t12-;/m0./s1",DNTDOBSIBZKFCP-YDALLXLXSA-N,CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl,0.8727683349581873,4.0,327.85200000000003,2.7552000000000016,4,2,1,58.559999999999995,-2.3024479594834473,0.9630616307258606,-4.893278561840082,0.9995555520057678,-10.239628771152125,0.8736840844154358,0.33820185363292693,0.8202438354492188,71.26654214608561,12.878988116338586,0.33567190170288086,0.14659351035952567,0.009790766751393676,0.8551968574523926,0.026695295539684593,47.64133415708301,23.63919619227952,9.342905414382646,2.62172867280858,0.44328310787677766,0.27124171555042265,0.3875252723693848,0.06690085530281067,0.5072089999914169,0.010315764229744673,0.007291335915215314,0.10072762072086335,0.005797156132757664,0.12519005984067916,0.006882211123593151,0.0022585618047742174,0.0034131379099562762,0.009800751786679029,0.037985905166715385,0.004141585825709626,0.358619287610054,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1363.0,1344396.0,675128.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LEVOBUNOLOL HYDROCHLORIDE,CHEMBL1201177,4.0,1.0,1.0,MOL,6439.0,Small molecule,1985.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1979.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20;/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3;1H/t12-;/m0./s1",DNTDOBSIBZKFCP-YDALLXLXSA-N,CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl,0.8727683349581873,4.0,327.85200000000003,2.7552000000000016,4,2,1,58.559999999999995,-2.3024479594834473,0.9630616307258606,-4.893278561840082,0.9995555520057678,-10.239628771152125,0.8736840844154358,0.33820185363292693,0.8202438354492188,71.26654214608561,12.878988116338586,0.33567190170288086,0.14659351035952567,0.009790766751393676,0.8551968574523926,0.026695295539684593,47.64133415708301,23.63919619227952,9.342905414382646,2.62172867280858,0.44328310787677766,0.27124171555042265,0.3875252723693848,0.06690085530281067,0.5072089999914169,0.010315764229744673,0.007291335915215314,0.10072762072086335,0.005797156132757664,0.12519005984067916,0.006882211123593151,0.0022585618047742174,0.0034131379099562762,0.009800751786679029,0.037985905166715385,0.004141585825709626,0.358619287610054,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,316.0,1344562.0,8543.0,Beta-1 adrenergic receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,PINDOLOL,CHEMBL500,4.0,1.0,1.0,MOL,8214.0,Small molecule,1982.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1970.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Vasodilator,0.0,0.0,0.0,"InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3",JZQKKSLKJUAGIC-UHFFFAOYSA-N,CC(C)NCC(O)COc1cccc2[nH]ccc12,0.7315916457547719,4.0,248.32600000000002,1.9055999999999995,3,3,1,57.279999999999994,-2.7613586361939064,0.879167902469635,-4.986898713186685,0.9998690605163574,-14.882615843959224,0.7877031445503235,0.06343289762735367,0.7477618932724,58.06760784579939,21.419573828360523,0.6503650903701782,0.08036063462495804,0.008511978248134256,0.4870634198188782,0.03371245879679918,24.494042457180246,-2.038778802221137,-21.384686585023115,2.6307429443737425,0.07399297058582306,0.13621647506952286,0.20911301523447037,0.11131520867347718,0.49280861020088196,0.01654747501015663,0.004338009562343359,0.0590981125831604,0.0049458230845630165,0.32608772814273834,0.0038497478701174257,0.0004043251188704744,0.0007276800577528774,0.00600188197568059,0.004773950576782227,0.0013831324235070498,0.34625858068466187,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1360.0,1344562.0,8543.0,Beta-2 adrenergic receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,PINDOLOL,CHEMBL500,4.0,1.0,1.0,MOL,8214.0,Small molecule,1982.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1970.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Vasodilator,0.0,0.0,0.0,"InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3",JZQKKSLKJUAGIC-UHFFFAOYSA-N,CC(C)NCC(O)COc1cccc2[nH]ccc12,0.7315916457547719,4.0,248.32600000000002,1.9055999999999995,3,3,1,57.279999999999994,-2.7613586361939064,0.879167902469635,-4.986898713186685,0.9998690605163574,-14.882615843959224,0.7877031445503235,0.06343289762735367,0.7477618932724,58.06760784579939,21.419573828360523,0.6503650903701782,0.08036063462495804,0.008511978248134256,0.4870634198188782,0.03371245879679918,24.494042457180246,-2.038778802221137,-21.384686585023115,2.6307429443737425,0.07399297058582306,0.13621647506952286,0.20911301523447037,0.11131520867347718,0.49280861020088196,0.01654747501015663,0.004338009562343359,0.0590981125831604,0.0049458230845630165,0.32608772814273834,0.0038497478701174257,0.0004043251188704744,0.0007276800577528774,0.00600188197568059,0.004773950576782227,0.0013831324235070498,0.34625858068466187,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,317.0,1344982.0,674898.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,METIPRANOLOL HYDROCHLORIDE,CHEMBL1200947,4.0,1.0,1.0,MOL,34845.0,Small molecule,1989.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,1.0,0.0,0.0,"InChI=1S/C17H27NO4.ClH/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4;/h7,10,15,18,20H,8-9H2,1-6H3;1H",BLWNYSZZZWQCKO-UHFFFAOYSA-N,CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C.Cl,0.5871658160322472,4.0,345.867,2.696660000000001,5,2,1,67.79,-1.6796791132607223,0.9202919840812683,-4.87034909947326,0.9978073000907898,-9.397957829351723,0.9002020478248596,0.3627558499574661,0.5114641308784484,63.28734490040372,3.954340266078167,0.7462163031101227,0.1983015790581703,0.021227928437292577,0.8579479217529297,0.11908192411065102,13.750240297848956,26.480662096000863,16.594690889516148,2.9310600762550827,0.1441953584551811,0.37947592735290525,0.18835629448294638,0.09933577105402946,0.7096749186515808,0.03394286688417196,0.010181768448092043,0.10501206517219544,0.014856441179290414,0.053317402862012385,0.00462303759995848,0.0036598466220311822,0.0016449265705887229,0.00935452412813902,0.014881058968603611,0.0037747151698567906,0.43797817826271057,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1353.0,1344982.0,674898.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,METIPRANOLOL HYDROCHLORIDE,CHEMBL1200947,4.0,1.0,1.0,MOL,34845.0,Small molecule,1989.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,1.0,0.0,0.0,"InChI=1S/C17H27NO4.ClH/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4;/h7,10,15,18,20H,8-9H2,1-6H3;1H",BLWNYSZZZWQCKO-UHFFFAOYSA-N,CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C.Cl,0.5871658160322472,4.0,345.867,2.696660000000001,5,2,1,67.79,-1.6796791132607223,0.9202919840812683,-4.87034909947326,0.9978073000907898,-9.397957829351723,0.9002020478248596,0.3627558499574661,0.5114641308784484,63.28734490040372,3.954340266078167,0.7462163031101227,0.1983015790581703,0.021227928437292577,0.8579479217529297,0.11908192411065102,13.750240297848956,26.480662096000863,16.594690889516148,2.9310600762550827,0.1441953584551811,0.37947592735290525,0.18835629448294638,0.09933577105402946,0.7096749186515808,0.03394286688417196,0.010181768448092043,0.10501206517219544,0.014856441179290414,0.053317402862012385,0.00462303759995848,0.0036598466220311822,0.0016449265705887229,0.00935452412813902,0.014881058968603611,0.0037747151698567906,0.43797817826271057,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,318.0,1343201.0,674369.0,Beta-1 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DOBUTAMINE HYDROCHLORIDE,CHEMBL1200418,4.0,1.0,1.0,MOL,4671.0,Small molecule,1978.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1974.0,1.0,,0.0,,,Cardiotonic,0.0,0.0,0.0,"InChI=1S/C18H23NO3.ClH/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15;/h4-9,12-13,19-22H,2-3,10-11H2,1H3;1H",BQKADKWNRWCIJL-UHFFFAOYSA-N,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.Cl,0.5844061453967062,4.0,337.84700000000004,3.3786000000000036,4,4,1,72.72,-1.2392001450828638,0.658394968509674,-5.8488049454241775,0.9659193396568299,-8.42936433145486,0.31352647989988325,0.26905382722616195,0.2839354306459427,68.01621263004583,-0.6161350932630937,0.5535723805427551,0.3115147680044174,0.11747797876596451,0.8892122864723205,0.11056304927915335,25.527791590847606,40.98339019984517,-8.772217601888295,2.463136757044749,0.48650042414665223,0.4603124618530273,0.1436823397874832,0.0732456784695387,0.8362298965454101,0.010619003139436246,0.01357432957738638,0.21084498316049577,0.11862079873681068,0.051256534084677695,0.054660608619451524,0.025170827144756915,0.01178657840937376,0.10715898275375366,0.22230551950633526,0.06577815767377615,0.8310944080352783,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1366.0,1343201.0,674369.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DOBUTAMINE HYDROCHLORIDE,CHEMBL1200418,4.0,1.0,1.0,MOL,4671.0,Small molecule,1978.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1974.0,1.0,,0.0,,,Cardiotonic,0.0,0.0,0.0,"InChI=1S/C18H23NO3.ClH/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15;/h4-9,12-13,19-22H,2-3,10-11H2,1H3;1H",BQKADKWNRWCIJL-UHFFFAOYSA-N,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.Cl,0.5844061453967062,4.0,337.84700000000004,3.3786000000000036,4,4,1,72.72,-1.2392001450828638,0.658394968509674,-5.8488049454241775,0.9659193396568299,-8.42936433145486,0.31352647989988325,0.26905382722616195,0.2839354306459427,68.01621263004583,-0.6161350932630937,0.5535723805427551,0.3115147680044174,0.11747797876596451,0.8892122864723205,0.11056304927915335,25.527791590847606,40.98339019984517,-8.772217601888295,2.463136757044749,0.48650042414665223,0.4603124618530273,0.1436823397874832,0.0732456784695387,0.8362298965454101,0.010619003139436246,0.01357432957738638,0.21084498316049577,0.11862079873681068,0.051256534084677695,0.054660608619451524,0.025170827144756915,0.01178657840937376,0.10715898275375366,0.22230551950633526,0.06577815767377615,0.8310944080352783,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,319.0,1344209.0,444077.0,Beta-1 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DOPAMINE HYDROCHLORIDE,CHEMBL1557,4.0,1.0,1.0,MOL,,Small molecule,1974.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1969.0,1.0,-pamine,0.0,-pamine,dopaminergics (butopamine type),Adrenergic,0.0,0.0,0.0,"InChI=1S/C8H11NO2.ClH/c9-4-3-6-1-2-7(10)8(11)5-6;/h1-2,5,10-11H,3-4,9H2;1H",CTENFNNZBMHDDG-UHFFFAOYSA-N,Cl.NCCc1ccc(O)c(O)c1,0.6089986479968319,4.0,189.642,1.0208,3,3,0,66.48,-0.014313931079252828,0.6520400166511535,-5.618006418986492,0.9911066055297851,-9.118744937939622,0.13323503360152245,0.02467813678085804,0.31105946004390717,28.891799349931183,-0.3507326727271437,0.172202967107296,0.04384455420076847,0.033655020967125894,0.1885891243815422,0.06501937946304678,11.782185339760138,48.6245004160319,-42.44835329992543,2.4906109626394892,0.850082802772522,0.6094223588705063,0.053364023193717004,0.041851498931646344,0.20554727762937547,0.0205001019872725,0.017177377454936506,0.07158807590603829,0.11341645866632462,0.21285876035690307,0.02067135153338313,0.009993028640747071,0.030272717773914336,0.06800410114228725,0.05994217861443758,0.07760763093829155,0.8568896412849426,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,320.0,1343142.0,461225.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NADOLOL,CHEMBL521606,4.0,1.0,1.0,MOL,,Small molecule,1979.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1976.0,1.0,-adol-; -olol,0.0,-adol-; -olol,analgesics (mixed opiate receptor agonists/antagonists); beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3",VWPOSFSPZNDTMJ-UHFFFAOYSA-N,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,0.641468123492022,4.0,309.406,0.6347999999999998,5,4,3,81.95,-1.0228805070372826,0.8847484469413758,-5.175630880289795,0.9964404106140137,-12.224868417297369,0.7003306865692138,0.03676044065505266,0.6654753684997559,37.40371406764326,-4.0462421806557405,0.01308433385565877,0.05796906985342502,0.002998545108130202,0.1697656989097595,0.003908883943222463,-3.408782955612041,1.5645378075337604,-2.2607658202183187,2.4895217277963138,0.08846603333950043,0.13335075825452805,0.07553580701351166,0.013073285948485136,0.3801587402820587,0.008836593572050333,0.0011667746643070132,0.05272888988256454,0.003988603362813592,0.02981955911964178,0.0014866633457131684,0.00036849180978606457,0.00012583103070937796,0.002127605036366731,0.0036201908573275433,0.00044781325395888417,0.31248410046100616,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1354.0,1343142.0,461225.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NADOLOL,CHEMBL521606,4.0,1.0,1.0,MOL,,Small molecule,1979.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1976.0,1.0,-adol-; -olol,0.0,-adol-; -olol,analgesics (mixed opiate receptor agonists/antagonists); beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3",VWPOSFSPZNDTMJ-UHFFFAOYSA-N,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,0.641468123492022,4.0,309.406,0.6347999999999998,5,4,3,81.95,-1.0228805070372826,0.8847484469413758,-5.175630880289795,0.9964404106140137,-12.224868417297369,0.7003306865692138,0.03676044065505266,0.6654753684997559,37.40371406764326,-4.0462421806557405,0.01308433385565877,0.05796906985342502,0.002998545108130202,0.1697656989097595,0.003908883943222463,-3.408782955612041,1.5645378075337604,-2.2607658202183187,2.4895217277963138,0.08846603333950043,0.13335075825452805,0.07553580701351166,0.013073285948485136,0.3801587402820587,0.008836593572050333,0.0011667746643070132,0.05272888988256454,0.003988603362813592,0.02981955911964178,0.0014866633457131684,0.00036849180978606457,0.00012583103070937796,0.002127605036366731,0.0036201908573275433,0.00044781325395888417,0.31248410046100616,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,321.0,1343430.0,505776.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROPRANOLOL HYDROCHLORIDE,CHEMBL1671,4.0,1.0,1.0,MOL,8500.0,Small molecule,1967.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1965.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Cardiac Depressant (anti-arrhythmic); Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H",ZMRUPTIKESYGQW-UHFFFAOYSA-N,CC(C)NCC(O)COc1cccc2ccccc12.Cl,0.8606826609080008,4.0,295.81,2.999300000000001,3,2,1,41.489999999999995,-2.2398537698002463,0.9335279941558838,-4.88402785217887,0.9995209455490113,-10.784726133667073,0.8800011992454528,0.3404832124710083,0.788152551651001,81.94771415963196,12.991830810691349,0.9556195855140686,0.35683580935001374,0.03512192415073514,0.957810389995575,0.052748287096619606,56.47808499016101,15.178373661969278,9.641268111068163,2.5480798091226315,0.4100359588861465,0.47112409472465516,0.5206219911575317,0.16842304915189743,0.8939883708953857,0.016599676012992857,0.009357292717322708,0.11584107726812362,0.013220446184277534,0.2419554442167282,0.024454748444259166,0.010692266514524817,0.004512993386015296,0.018494695611298084,0.04993555136024952,0.0098812346579507,0.5110678970813751,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1359.0,1343430.0,505776.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROPRANOLOL HYDROCHLORIDE,CHEMBL1671,4.0,1.0,1.0,MOL,8500.0,Small molecule,1967.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1965.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Cardiac Depressant (anti-arrhythmic); Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H",ZMRUPTIKESYGQW-UHFFFAOYSA-N,CC(C)NCC(O)COc1cccc2ccccc12.Cl,0.8606826609080008,4.0,295.81,2.999300000000001,3,2,1,41.489999999999995,-2.2398537698002463,0.9335279941558838,-4.88402785217887,0.9995209455490113,-10.784726133667073,0.8800011992454528,0.3404832124710083,0.788152551651001,81.94771415963196,12.991830810691349,0.9556195855140686,0.35683580935001374,0.03512192415073514,0.957810389995575,0.052748287096619606,56.47808499016101,15.178373661969278,9.641268111068163,2.5480798091226315,0.4100359588861465,0.47112409472465516,0.5206219911575317,0.16842304915189743,0.8939883708953857,0.016599676012992857,0.009357292717322708,0.11584107726812362,0.013220446184277534,0.2419554442167282,0.024454748444259166,0.010692266514524817,0.004512993386015296,0.018494695611298084,0.04993555136024952,0.0098812346579507,0.5110678970813751,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,322.0,1344220.0,1538559.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PENBUTOLOL SULFATE,CHEMBL2361370,4.0,1.0,1.0,MOL,,Small molecule,1987.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1977.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/2C18H29NO2.H2O4S/c2*1-18(2,3)19-12-15(20)13-21-17-11-7-6-10-16(17)14-8-4-5-9-14;1-5(2,3)4/h2*6-7,10-11,14-15,19-20H,4-5,8-9,12-13H2,1-3H3;(H2,1,2,3,4)/t2*15-;/m00./s1",FEDSNBHHWZEYTP-ZFQYHYQMSA-N,CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.O=S(=O)(O)O,0.14081997100478783,1.0,680.9490000000003,6.291200000000006,8,6,2,157.57999999999998,-2.3334741994800465,0.7134778141975403,-5.5455411467431,0.8199657678604126,-8.71650339441673,0.6554240345954895,0.7831791996955871,0.438897705078125,88.28683174114533,-8.062221939915087,0.024829467944800853,0.09171069040894508,0.008029566053301096,0.5324444085359573,0.13028526939451696,81.20323816123721,-9.810735972035921,54.88989935782648,3.2786594814728884,0.15297291576862335,0.3619122087955475,0.3048059940338135,0.11776726692914963,0.8302039980888367,0.0026240649865940215,0.002105438197031617,0.0707696745172143,0.012747952248901129,0.011847853008657695,0.010846431693062186,0.002834300487302244,0.0005855306560988538,0.05670915637165308,0.31796770691871645,0.00962361516430974,0.501554200053215,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1357.0,1344220.0,1538559.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PENBUTOLOL SULFATE,CHEMBL2361370,4.0,1.0,1.0,MOL,,Small molecule,1987.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1977.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/2C18H29NO2.H2O4S/c2*1-18(2,3)19-12-15(20)13-21-17-11-7-6-10-16(17)14-8-4-5-9-14;1-5(2,3)4/h2*6-7,10-11,14-15,19-20H,4-5,8-9,12-13H2,1-3H3;(H2,1,2,3,4)/t2*15-;/m00./s1",FEDSNBHHWZEYTP-ZFQYHYQMSA-N,CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.O=S(=O)(O)O,0.14081997100478783,1.0,680.9490000000003,6.291200000000006,8,6,2,157.57999999999998,-2.3334741994800465,0.7134778141975403,-5.5455411467431,0.8199657678604126,-8.71650339441673,0.6554240345954895,0.7831791996955871,0.438897705078125,88.28683174114533,-8.062221939915087,0.024829467944800853,0.09171069040894508,0.008029566053301096,0.5324444085359573,0.13028526939451696,81.20323816123721,-9.810735972035921,54.88989935782648,3.2786594814728884,0.15297291576862335,0.3619122087955475,0.3048059940338135,0.11776726692914963,0.8302039980888367,0.0026240649865940215,0.002105438197031617,0.0707696745172143,0.012747952248901129,0.011847853008657695,0.010846431693062186,0.002834300487302244,0.0005855306560988538,0.05670915637165308,0.31796770691871645,0.00962361516430974,0.501554200053215,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,323.0,1344317.0,546564.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SOTALOL HYDROCHLORIDE,CHEMBL1700,4.0,1.0,1.0,MOL,9207.0,Small molecule,1992.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1967.0,1.0,-alol,0.0,-alol,combined alpha and beta blockers,Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H",VIDRYROWYFWGSY-UHFFFAOYSA-N,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl,0.7441948773332322,4.0,308.83099999999996,1.5112999999999999,4,3,1,78.43,-1.2033248710120652,0.8966155052185059,-5.847524789474166,0.9885807275772095,-12.061821764194267,0.4481929004192352,0.029164105653762817,0.4017094373703003,37.071241457569975,7.073011214254973,0.04437543898820877,0.05039094872772694,0.00803755831439048,0.4001661419868469,0.007620690669864416,-3.7938668293473525,-17.272459335539757,-37.21549036785746,2.198036164953703,0.0855869084596634,0.5898443281650543,0.164465294778347,0.3093354791402817,0.3480950206518173,0.07311001606285572,0.03380539417266846,0.059997362270951274,0.0014686322421766818,0.012138845445588232,0.0013723506272071972,0.0003749780886664666,0.0005370030663470971,0.0018195016498793847,0.011347313330043107,0.0023231839659274556,0.2445949509739876,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1361.0,1344317.0,546564.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SOTALOL HYDROCHLORIDE,CHEMBL1700,4.0,1.0,1.0,MOL,9207.0,Small molecule,1992.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1967.0,1.0,-alol,0.0,-alol,combined alpha and beta blockers,Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H",VIDRYROWYFWGSY-UHFFFAOYSA-N,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl,0.7441948773332322,4.0,308.83099999999996,1.5112999999999999,4,3,1,78.43,-1.2033248710120652,0.8966155052185059,-5.847524789474166,0.9885807275772095,-12.061821764194267,0.4481929004192352,0.029164105653762817,0.4017094373703003,37.071241457569975,7.073011214254973,0.04437543898820877,0.05039094872772694,0.00803755831439048,0.4001661419868469,0.007620690669864416,-3.7938668293473525,-17.272459335539757,-37.21549036785746,2.198036164953703,0.0855869084596634,0.5898443281650543,0.164465294778347,0.3093354791402817,0.3480950206518173,0.07311001606285572,0.03380539417266846,0.059997362270951274,0.0014686322421766818,0.012138845445588232,0.0013723506272071972,0.0003749780886664666,0.0005370030663470971,0.0018195016498793847,0.011347313330043107,0.0023231839659274556,0.2445949509739876,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,324.0,1344496.0,2197437.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,METOPROLOL FUMARATE,CHEMBL3989566,4.0,1.0,1.0,MOL,,Small molecule,1989.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1990.0,0.0,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/2C15H25NO3.C4H4O4/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-3(6)1-2-4(7)8/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+",BRIPGNJWPCKDQZ-WXXKFALUSA-N,COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)/C=C/C(=O)O,0.11579457408912262,2.0,650.8100000000005,2.938200000000002,10,6,2,176.04,-1.8636251403978839,0.6074347138404846,-6.558895895508253,0.3388437405228615,-12.962106956601104,0.2964151918888092,0.3865654319524765,0.13709528222680092,66.10887874442027,-2.5373996189130965,0.04633908588439226,0.14668954759836197,0.05036165826022625,0.33470445573329927,0.06068180128931999,-24.484419474343053,-43.63389206287932,10.795143002550216,1.8588646885835947,0.03161978218704462,0.07361359484493732,0.13369311541318893,0.26609862595796585,0.6701210737228394,0.03803625153377652,0.010233428794890642,0.09773110151290894,0.026894106529653072,0.03416184186935425,0.012975590582937003,0.02743370197713375,0.0044732984155416485,0.04394026324152946,0.023993236385285853,0.009091062098741531,0.23596862852573394,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,325.0,1344570.0,543228.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,Selective,,,BETAXOLOL HYDROCHLORIDE,CHEMBL1691,4.0,1.0,1.0,MOL,643228.0,Small molecule,1985.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1983.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Antihypertensive; Anti-Anginal,0.0,0.0,0.0,"InChI=1S/C18H29NO3.ClH/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16;/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3;1H",CHDPSNLJFOQTRK-UHFFFAOYSA-N,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1.Cl,0.606569080084936,4.0,343.89500000000004,2.8152000000000013,4,2,1,50.72,-1.8510807280540835,0.9081644535064697,-4.711970841877332,0.9991610407829284,-8.187746610671804,0.7136730670928955,0.4105863630771637,0.6658125221729279,62.94733462904351,7.13790485783653,0.33546494543552396,0.1317356511950493,0.013002827414311469,0.9541919827461243,0.19669272229075432,15.799539342411492,37.78446387273529,14.908803056553547,2.529645995023398,0.3591003745794296,0.30932638943195345,0.3585657894611359,0.01623994344845414,0.8454089999198914,0.006720344116911292,0.003808486368507147,0.07429205253720284,0.01141828065738082,0.05532399863004685,0.013114573899656534,0.0025910849333740773,0.002348982682451606,0.040171441808342936,0.041542704496532676,0.003758018754888326,0.5351823210716248,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,326.0,1344583.0,674821.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TIMOLOL MALEATE,CHEMBL1200870,4.0,1.0,1.0,MOL,9600.0,Small molecule,1978.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1973.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m0./s1",WLRMANUAADYWEA-NWASOUNVSA-N,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\C(=O)O,0.41680426386933456,4.0,432.4990000000003,0.21430000000000204,10,4,1,154.34,-1.346169824798008,0.7494392037391663,-6.104847032308454,0.4771615743637085,-15.310107303929147,0.09265992566943168,0.006708816671743989,0.5802833914756775,51.479383392304726,9.83161548453442,0.005880097579210997,0.03769008405506611,0.0333532927557826,0.08878403753042222,0.005806414515245706,-28.08600159882551,-41.29813470695118,-21.86133492521809,1.851861553341442,0.2064186803996563,0.1647817760705948,0.5454145908355713,0.7340665578842163,0.16642339378595353,0.01581353321671486,0.006415316974744201,0.09074616879224777,0.010532846860587596,0.008337871101684869,0.005944378336425871,0.006057009228970856,0.00763078187010251,0.01722590746358037,0.008304488402791322,0.042653996916487816,0.21148386746644973,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1364.0,1344583.0,674821.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TIMOLOL MALEATE,CHEMBL1200870,4.0,1.0,1.0,MOL,9600.0,Small molecule,1978.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1973.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m0./s1",WLRMANUAADYWEA-NWASOUNVSA-N,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\C(=O)O,0.41680426386933456,4.0,432.4990000000003,0.21430000000000204,10,4,1,154.34,-1.346169824798008,0.7494392037391663,-6.104847032308454,0.4771615743637085,-15.310107303929147,0.09265992566943168,0.006708816671743989,0.5802833914756775,51.479383392304726,9.83161548453442,0.005880097579210997,0.03769008405506611,0.0333532927557826,0.08878403753042222,0.005806414515245706,-28.08600159882551,-41.29813470695118,-21.86133492521809,1.851861553341442,0.2064186803996563,0.1647817760705948,0.5454145908355713,0.7340665578842163,0.16642339378595353,0.01581353321671486,0.006415316974744201,0.09074616879224777,0.010532846860587596,0.008337871101684869,0.005944378336425871,0.006057009228970856,0.00763078187010251,0.01722590746358037,0.008304488402791322,0.042653996916487816,0.21148386746644973,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,327.0,1343910.0,1533286.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,METOPROLOL SUCCINATE,CHEMBL2356097,4.0,1.0,1.0,MOL,,Small molecule,1992.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1991.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/2C15H25NO3.C4H6O4/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-3(6)1-2-4(7)8/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2H2,(H,5,6)(H,7,8)",RGHAZVBIOOEVQX-UHFFFAOYSA-N,COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)CCC(=O)O,0.11637307539916843,2.0,652.8260000000004,3.162200000000002,10,6,2,176.04,-1.9344615317515477,0.6070881843566894,-6.523946692595769,0.2712895661592484,-12.333062610671973,0.23291801214218139,0.2888498991727829,0.09790129810571671,62.562500956443344,-3.2466826096743815,0.026115391310304402,0.05800689160823822,0.01996786007657647,0.20728668123483657,0.043883529305458066,-12.7906903775618,-38.16270740557877,9.19029118851661,1.9524017069772739,0.0284287478774786,0.05984234660863876,0.11259035896509886,0.12204778902232646,0.613177216053009,0.03417707197368145,0.006817715195938945,0.12259010523557663,0.023784935753792525,0.023922117426991463,0.007590701384469867,0.010602921922691166,0.001540072039642837,0.02141821142286062,0.01680747317150235,0.005184300802648067,0.21335422098636628,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,328.0,1343068.0,1355926.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,METOPROLOL TARTRATE,CHEMBL2062335,4.0,1.0,1.0,MOL,,Small molecule,1978.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1978.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/2C15H25NO3.C4H6O6/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-1(3(7)8)2(6)4(9)10/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)",YGULWPYYGQCFMP-UHFFFAOYSA-N,COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)C(O)C(O)C(=O)O,0.09246786420474246,1.0,684.8240000000006,1.103800000000005,12,8,4,216.49999999999997,-0.8438543482363701,0.5548496723175049,-6.852096266284191,0.295405900478363,-13.62151072723152,0.26137016266584395,0.3280774727463722,0.08137110322713852,61.07421327643382,1.9321122404886388,0.05984643157571554,0.10781099535524845,0.0295700266957283,0.4448886811733246,0.08342934250831605,-10.124259115504922,-48.25390570900407,10.234974200679167,1.8973663222311994,0.01709172911942005,0.05012718252837658,0.12183694764971734,0.19012051671743393,0.7015651106834412,0.05842230785638094,0.014827088359743357,0.1056678608059883,0.030981744173914194,0.03541311249136925,0.013765426538884639,0.019388316944241524,0.002600432847975753,0.018002663063816725,0.016772758215665817,0.004408171179238707,0.15814979672431945,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,329.0,1343513.0,675682.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NEBIVOLOL HYDROCHLORIDE,CHEMBL1201731,4.0,1.0,1.0,MOL,,Small molecule,2007.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2004.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H",JWEXHQAEWHKGCW-UHFFFAOYSA-N,Cl.OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,0.6427524422622982,4.0,441.9020000000002,2.785400000000001,5,3,4,70.95,-2.6816311197614233,0.8457376003265381,-5.144602171949552,0.9963595271110535,-8.911416280825499,0.6774657249450684,0.9118138432502747,0.4806566596031189,86.37088765242348,1.2327027424258266,0.1919143170118332,0.6293992102146149,0.4206361711025238,0.8426878571510314,0.5568322598934173,21.589063536085597,-14.641119640877628,13.382622543553051,2.9833562306142913,0.1974649026989937,0.38431872725486754,0.07874729409813881,0.3171326756477356,0.9430589795112609,0.026201805099844933,0.006408145511522889,0.08690911456942559,0.006943814689293504,0.13440620452165603,0.02913288176059723,0.01933620609343052,0.0020605687634088097,0.05041729249060154,0.25382951349020005,0.025658714957535265,0.16908515691757203,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1355.0,1343513.0,675682.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NEBIVOLOL HYDROCHLORIDE,CHEMBL1201731,4.0,1.0,1.0,MOL,,Small molecule,2007.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2004.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H",JWEXHQAEWHKGCW-UHFFFAOYSA-N,Cl.OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,0.6427524422622982,4.0,441.9020000000002,2.785400000000001,5,3,4,70.95,-2.6816311197614233,0.8457376003265381,-5.144602171949552,0.9963595271110535,-8.911416280825499,0.6774657249450684,0.9118138432502747,0.4806566596031189,86.37088765242348,1.2327027424258266,0.1919143170118332,0.6293992102146149,0.4206361711025238,0.8426878571510314,0.5568322598934173,21.589063536085597,-14.641119640877628,13.382622543553051,2.9833562306142913,0.1974649026989937,0.38431872725486754,0.07874729409813881,0.3171326756477356,0.9430589795112609,0.026201805099844933,0.006408145511522889,0.08690911456942559,0.006943814689293504,0.13440620452165603,0.02913288176059723,0.01933620609343052,0.0020605687634088097,0.05041729249060154,0.25382951349020005,0.025658714957535265,0.16908515691757203,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,330.0,1343238.0,675014.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROPAFENONE HYDROCHLORIDE,CHEMBL1201063,4.0,1.0,1.0,MOL,8466.0,Small molecule,1989.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1988.0,1.0,-afenone,0.0,-afenone,antiarrhythmics (propafenone derivatives),Cardiac Depressant (anti-arrhythmic),0.0,0.0,0.0,"InChI=1S/C21H27NO3.ClH/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17;/h3-11,18,22-23H,2,12-16H2,1H3;1H",XWIHRGFIPXWGEF-UHFFFAOYSA-N,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl,0.46314783038411317,4.0,377.9120000000001,3.663200000000003,4,2,1,58.559999999999995,-3.1457661360676594,0.8280466794967651,-4.920399501952974,0.9994717240333557,-8.196374924172101,0.8689059853553772,0.9721400141716003,0.4279139041900635,91.70340154789768,2.164087119492707,0.624729335308075,0.7860828161239624,0.3094243139028549,0.9428925395011902,0.6444972276687622,39.925869108027484,60.41521186680743,35.04514653882282,2.482128107583501,0.17880617082118988,0.3860266149044037,0.1150211401283741,0.08611997663974762,0.8740893244743347,0.011906311847269535,0.017307293135672808,0.11906990259885789,0.008852458279579877,0.05621199458837509,0.05765911564230919,0.06709539517760277,0.003907632129266858,0.12882748395204544,0.1912935569882393,0.020056810416281223,0.37250791788101195,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1358.0,1343238.0,675014.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PROPAFENONE HYDROCHLORIDE,CHEMBL1201063,4.0,1.0,1.0,MOL,8466.0,Small molecule,1989.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1988.0,1.0,-afenone,0.0,-afenone,antiarrhythmics (propafenone derivatives),Cardiac Depressant (anti-arrhythmic),0.0,0.0,0.0,"InChI=1S/C21H27NO3.ClH/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17;/h3-11,18,22-23H,2,12-16H2,1H3;1H",XWIHRGFIPXWGEF-UHFFFAOYSA-N,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl,0.46314783038411317,4.0,377.9120000000001,3.663200000000003,4,2,1,58.559999999999995,-3.1457661360676594,0.8280466794967651,-4.920399501952974,0.9994717240333557,-8.196374924172101,0.8689059853553772,0.9721400141716003,0.4279139041900635,91.70340154789768,2.164087119492707,0.624729335308075,0.7860828161239624,0.3094243139028549,0.9428925395011902,0.6444972276687622,39.925869108027484,60.41521186680743,35.04514653882282,2.482128107583501,0.17880617082118988,0.3860266149044037,0.1150211401283741,0.08611997663974762,0.8740893244743347,0.011906311847269535,0.017307293135672808,0.11906990259885789,0.008852458279579877,0.05621199458837509,0.05765911564230919,0.06709539517760277,0.003907632129266858,0.12882748395204544,0.1912935569882393,0.020056810416281223,0.37250791788101195,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,331.0,1343364.0,8531.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TIMOLOL,CHEMBL499,4.0,1.0,1.0,MOL,9599.0,Small molecule,1978.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1973.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1",BLJRIMJGRPQVNF-JTQLQIEISA-N,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,0.790985307512128,4.0,316.4270000000002,0.5024999999999997,8,2,1,79.74,-1.3912095781334208,0.9624493241310119,-4.828256477940016,0.9991396427154541,-14.609499548052847,0.8388603448867797,0.009544715704396366,0.7550707340240479,39.89473152070624,5.862532845489308,0.0358004990965128,0.06610291264951229,0.015583814913406968,0.06981353536248207,0.013373819109983743,-12.377542213026695,21.050576970001753,-3.3388995999386366,2.1867618263256063,0.2029919557273388,0.22349512949585915,0.3490141570568085,0.4385015845298767,0.3786408960819244,0.004504501819610596,0.0020464541361434386,0.03598567973822355,0.0031423646258190276,0.03815628821030259,0.006785211188253015,0.0006243512496439507,0.0013023441526456736,0.004100415715947747,0.005312421900453046,0.005448323560267454,0.23510555624961854,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1365.0,1343364.0,8531.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TIMOLOL,CHEMBL499,4.0,1.0,1.0,MOL,9599.0,Small molecule,1978.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1973.0,1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1",BLJRIMJGRPQVNF-JTQLQIEISA-N,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,0.790985307512128,4.0,316.4270000000002,0.5024999999999997,8,2,1,79.74,-1.3912095781334208,0.9624493241310119,-4.828256477940016,0.9991396427154541,-14.609499548052847,0.8388603448867797,0.009544715704396366,0.7550707340240479,39.89473152070624,5.862532845489308,0.0358004990965128,0.06610291264951229,0.015583814913406968,0.06981353536248207,0.013373819109983743,-12.377542213026695,21.050576970001753,-3.3388995999386366,2.1867618263256063,0.2029919557273388,0.22349512949585915,0.3490141570568085,0.4385015845298767,0.3786408960819244,0.004504501819610596,0.0020464541361434386,0.03598567973822355,0.0031423646258190276,0.03815628821030259,0.006785211188253015,0.0006243512496439507,0.0013023441526456736,0.004100415715947747,0.005312421900453046,0.005448323560267454,0.23510555624961854,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,4885.0,2473026.0,1333580.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Phase 2 study in 2011 terminated.,,,,LY377604,CHEMBL2012520,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C31H32N4O4/c1-31(2,16-20-10-13-23(14-11-20)39-28-15-12-21(17-33-28)30(32)37)34-18-22(36)19-38-27-9-5-8-26-29(27)24-6-3-4-7-25(24)35-26/h3-15,17,22,34-36H,16,18-19H2,1-2H3,(H2,32,37)/t22-/m0/s1",RBSGUQYXRDKPAE-QFIPXVFZSA-N,CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12,0.19377695520375138,3.0,524.6210000000001,4.957900000000004,6,4,1,122.49000000000001,-4.2833750901905905,0.8243012070655823,-5.920849613101201,0.9971364736557007,-14.465747532767413,0.8508336424827576,0.9331614732742309,0.3684347003698349,94.33360327313748,5.333672822188843,0.5421830892562867,0.8178327560424805,0.661939001083374,0.7485345721244812,0.7943127632141114,-12.97621293782322,10.009480754420117,80.01741230101827,3.1179183083536066,0.17300051599740982,0.21847198754549027,0.5939979672431945,0.6704043388366699,0.9589488744735718,0.011514347791671754,0.011317127384245396,0.037583140470087525,0.015830231830477715,0.5153748869895936,0.10236080139875411,0.020159428659826516,0.012761871470138431,0.07828317880630493,0.36424625515937803,0.07118291296064853,0.10091389417648315,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,4884.0,2473026.0,1333580.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Phase 2 study in 2011 terminated.,,,,LY377604,CHEMBL2012520,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C31H32N4O4/c1-31(2,16-20-10-13-23(14-11-20)39-28-15-12-21(17-33-28)30(32)37)34-18-22(36)19-38-27-9-5-8-26-29(27)24-6-3-4-7-25(24)35-26/h3-15,17,22,34-36H,16,18-19H2,1-2H3,(H2,32,37)/t22-/m0/s1",RBSGUQYXRDKPAE-QFIPXVFZSA-N,CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12,0.19377695520375138,3.0,524.6210000000001,4.957900000000004,6,4,1,122.49000000000001,-4.2833750901905905,0.8243012070655823,-5.920849613101201,0.9971364736557007,-14.465747532767413,0.8508336424827576,0.9331614732742309,0.3684347003698349,94.33360327313748,5.333672822188843,0.5421830892562867,0.8178327560424805,0.661939001083374,0.7485345721244812,0.7943127632141114,-12.97621293782322,10.009480754420117,80.01741230101827,3.1179183083536066,0.17300051599740982,0.21847198754549027,0.5939979672431945,0.6704043388366699,0.9589488744735718,0.011514347791671754,0.011317127384245396,0.037583140470087525,0.015830231830477715,0.5153748869895936,0.10236080139875411,0.020159428659826516,0.012761871470138431,0.07828317880630493,0.36424625515937803,0.07118291296064853,0.10091389417648315,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,6290.0,1705374.0,18271.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Non-selective beta blocker clinical candidate. It was never used clinically.,,,,PRONETALOL,CHEMBL16476,4.0,0.0,1.0,MOL,8463.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,-2.0,-alol,0.0,-alol,combined alpha and beta blockers,,1.0,0.0,0.0,"InChI=1S/C15H19NO/c1-11(2)16-10-15(17)14-8-7-12-5-3-4-6-13(12)9-14/h3-9,11,15-17H,10H2,1-2H3",HRSANNODOVBCST-UHFFFAOYSA-N,CC(C)NCC(O)c1ccc2ccccc2c1,0.8446052195209154,4.0,229.323,2.871200000000001,2,2,1,32.26,-2.5176052721177666,0.91250981092453,-4.7714419064983575,0.9996247887611389,-10.161970087490358,0.8434122920036315,0.0911990873515606,0.9078570961952209,65.90516463796817,26.160473487056652,0.6800231337547302,0.0698421448469162,0.005736064980737865,0.6329759299755097,0.009502953803166746,60.8842331455128,25.018046015456797,-9.784503763199634,2.4918360274181945,0.08598929643630981,0.2454298511147499,0.23205050677061081,0.0806775614619255,0.5789292633533478,0.03918781876564026,0.005103653203696013,0.06715066581964493,0.005326932109892368,0.1456020839512348,0.0030769599135965107,0.0009587074528099038,0.0004830412450246513,0.0037117469124495982,0.011051808902993798,0.0010598832333926112,0.6177682280540466,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,6897.0,1705374.0,18271.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Non-selective beta blocker clinical candidate. It was never used clinically.,,,,PRONETALOL,CHEMBL16476,4.0,0.0,1.0,MOL,8463.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,-2.0,-alol,0.0,-alol,combined alpha and beta blockers,,1.0,0.0,0.0,"InChI=1S/C15H19NO/c1-11(2)16-10-15(17)14-8-7-12-5-3-4-6-13(12)9-14/h3-9,11,15-17H,10H2,1-2H3",HRSANNODOVBCST-UHFFFAOYSA-N,CC(C)NCC(O)c1ccc2ccccc2c1,0.8446052195209154,4.0,229.323,2.871200000000001,2,2,1,32.26,-2.5176052721177666,0.91250981092453,-4.7714419064983575,0.9996247887611389,-10.161970087490358,0.8434122920036315,0.0911990873515606,0.9078570961952209,65.90516463796817,26.160473487056652,0.6800231337547302,0.0698421448469162,0.005736064980737865,0.6329759299755097,0.009502953803166746,60.8842331455128,25.018046015456797,-9.784503763199634,2.4918360274181945,0.08598929643630981,0.2454298511147499,0.23205050677061081,0.0806775614619255,0.5789292633533478,0.03918781876564026,0.005103653203696013,0.06715066581964493,0.005326932109892368,0.1456020839512348,0.0030769599135965107,0.0009587074528099038,0.0004830412450246513,0.0037117469124495982,0.011051808902993798,0.0010598832333926112,0.6177682280540466,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,6879.0,2792101.0,36502.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Celiprolol was developed as a third-generation Î²-adrenoceptor antagonist with selective Î²1-antagonist, partial Î²2-agonist, and mild Î±2-antagonist actions. Given this combination of effects, celiprolol may be better described as a selective adrenoreceptor modulator. It has antihypertensive and antianginal properties.",,,,CELIPROLOL,CHEMBL27810,4.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1981.0,-1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C20H33N3O4/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26)",JOATXPAWOHTVSZ-UHFFFAOYSA-N,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,0.5740604449563793,4.0,379.5010000000002,2.8907000000000007,5,3,1,90.9,-1.4045446622445268,0.9034043669700622,-4.974000569835095,0.9939899325370789,-13.104930265813852,0.9014315724372863,0.20727806985378266,0.7627827048301696,50.607543020569935,4.440609824107525,0.03993543498218059,0.040523359179496767,0.012826226884499192,0.19125022292137145,0.03194660684093833,0.36069909765795527,-1.0935490086886759,22.4734306385485,2.537613482531167,0.15926096886396407,0.31637068688869474,0.2075829952955246,0.11846463233232499,0.4648130714893341,0.037292675208300353,0.01222032499499619,0.03855451475828886,0.0015764826093800366,0.1200299721211195,0.0022039452975150197,0.0005606896251265425,0.0009278921817895025,0.0029015968670137227,0.018611022050026804,0.0019863224850269036,0.0943325974047184,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,6661.0,2792101.0,36502.0,Beta-2 adrenergic receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,"Celiprolol was developed as a third-generation Î²-adrenoceptor antagonist with selective Î²1-antagonist, partial Î²2-agonist, and mild Î±2-antagonist actions. Given this combination of effects, celiprolol may be better described as a selective adrenoreceptor modulator. It has antihypertensive and antianginal properties.",,,,CELIPROLOL,CHEMBL27810,4.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1981.0,-1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C20H33N3O4/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26)",JOATXPAWOHTVSZ-UHFFFAOYSA-N,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,0.5740604449563793,4.0,379.5010000000002,2.8907000000000007,5,3,1,90.9,-1.4045446622445268,0.9034043669700622,-4.974000569835095,0.9939899325370789,-13.104930265813852,0.9014315724372863,0.20727806985378266,0.7627827048301696,50.607543020569935,4.440609824107525,0.03993543498218059,0.040523359179496767,0.012826226884499192,0.19125022292137145,0.03194660684093833,0.36069909765795527,-1.0935490086886759,22.4734306385485,2.537613482531167,0.15926096886396407,0.31637068688869474,0.2075829952955246,0.11846463233232499,0.4648130714893341,0.037292675208300353,0.01222032499499619,0.03855451475828886,0.0015764826093800366,0.1200299721211195,0.0022039452975150197,0.0005606896251265425,0.0009278921817895025,0.0029015968670137227,0.018611022050026804,0.0019863224850269036,0.0943325974047184,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,7753.0,1706156.0,1121337.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,The selectivity for beta-1-receptor blockade is 255 times higher than for beta-2-receptor.,,,LANDIOLOL,CHEMBL1742466,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2022.0,,-olol,0.0,-olol,beta-blockers (propranolol type),,0.0,0.0,0.0,"InChI=1S/C25H39N3O8/c1-25(2)35-18-22(36-25)17-34-23(30)8-5-19-3-6-21(7-4-19)33-16-20(29)15-26-9-10-27-24(31)28-11-13-32-14-12-28/h3-4,6-7,20,22,26,29H,5,8-18H2,1-2H3,(H,27,31)/t20-,22+/m0/s1",WMDSZGFJQKSLLH-RBBKRZOGSA-N,CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1,0.2598475664508193,3.0,509.60000000000036,0.6850000000000034,9,3,2,127.82000000000001,-0.6950681753482597,0.6642743706703186,-5.318692069336091,0.9425589084625244,-12.379368976597203,0.6263484358787537,0.2589791566133499,0.30879002511501313,62.14699840276992,2.1913651673249244,0.002137544995639473,0.03032338749617338,0.006632107263430953,0.07610863447189331,0.3508924901485443,1.1287963070994629,31.59984397839498,50.594802769016354,3.0915982430129505,0.5267198950052261,0.153457111120224,0.36374234557151797,0.14953927397727967,0.685464209318161,0.04483715258538723,0.023345670104026793,0.0650716632604599,0.00862196460366249,0.007749348459765315,0.010495704598724842,0.0026827499037608503,0.0051756590721197425,0.00614591094199568,0.015047367149963974,0.020141369942575694,0.25466407686471937,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,8330.0,1706191.0,122859.0,Beta-1 adrenergic receptor partial agonist,,PARTIAL AGONIST,1.0,1.0,1.0,,,,,XAMOTEROL,CHEMBL75753,4.0,1.0,0.0,MOL,10055.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1984.0,-1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),Stimulant (cardiac),0.0,0.0,0.0,"InChI=1S/C16H25N3O5/c20-13-1-3-15(4-2-13)24-12-14(21)11-17-5-6-18-16(22)19-7-9-23-10-8-19/h1-4,14,17,20-21H,5-12H2,(H,18,22)",DXPOSRCHIDYWHW-UHFFFAOYSA-N,O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1,0.48774191921086135,4.0,339.3920000000002,-0.23669999999999924,6,4,1,103.29,-0.6264378491891041,0.44791373014450075,-5.5670796113913585,0.8866936922073364,-17.14476885608267,0.21177632063627244,0.009477754635736347,0.36672360002994536,40.94103616955967,-0.7467144690072158,0.008447193168103695,0.05604717582464218,0.012322380091063678,0.047018051519989966,0.0068940832279622555,-4.826734946309754,21.818981712888412,-32.626381532576815,2.310496943043003,0.2756219543516636,0.1316741041839123,0.38312565088272094,0.06582931131124496,0.4044347792863846,0.024783001840114595,0.013901672139763833,0.08402690142393113,0.01005108542740345,0.014642957178875805,0.0016751148039475083,0.0014897088520228862,0.003855836042203009,0.003912203945219517,0.0018005112942773849,0.013211442320607603,0.2722441226243973,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,8353.0,1703458.0,1380.0,Beta-1 adrenergic receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PRACTOLOL,CHEMBL6995,4.0,1.0,1.0,MOL,258351.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1969.0,-1.0,-olol,0.0,-olol,beta-blockers (propranolol type),Anti-Adrenergic (beta-receptor),0.0,0.0,0.0,"InChI=1S/C14H22N2O3/c1-10(2)15-8-13(18)9-19-14-6-4-12(5-7-14)16-11(3)17/h4-7,10,13,15,18H,8-9H2,1-3H3,(H,16,17)",DURULFYMVIFBIR-UHFFFAOYSA-N,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,0.697114394276545,4.0,266.34099999999995,1.3826999999999992,4,3,1,70.59,-1.039057181614239,0.9025003552436829,-5.145848999989904,0.9924991965293884,-14.033706871250988,0.6571685314178467,0.01661751561332494,0.7245741128921509,20.73616035394142,1.985504471789556,0.0741775244474411,0.02756691724061966,0.004250244481954724,0.16374769061803818,0.0018965126306284218,-18.937579558205744,-17.965308190417687,-20.908337427547462,2.0603790215796454,0.13395952582359313,0.27545549273490905,0.14752316623926162,0.06581485867500306,0.31161692142486574,0.08185091018676757,0.012578696757555009,0.1371587947010994,0.003147757635451853,0.03569259904325008,0.0016604954609647394,0.00036442674572754183,0.0010088886730954983,0.001378060842398554,0.0012994582415558399,0.0015970523410942406,0.23473904132843018,False
ADRB1,50,SINGLE PROTEIN,Beta-1 adrenergic receptor,9606,Homo sapiens,CHEMBL213,,0.0,8998.0,1705604.0,1379816.0,Beta-1 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,BUCINDOLOL HYDROCHLORIDE,CHEMBL2107546,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1979.0,,-olol,0.0,-olol,beta-blockers (propranolol type),Antihypertensive,0.0,0.0,0.0,"InChI=1S/C22H25N3O2.ClH/c1-22(2,11-17-13-24-20-9-5-4-8-19(17)20)25-14-18(26)15-27-21-10-6-3-7-16(21)12-23;/h3-10,13,18,24-26H,11,14-15H2,1-2H3;1H",NCEAPFRHADKEHP-UHFFFAOYSA-N,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N.Cl,0.5376029915293016,4.0,399.9220000000001,3.8119800000000024,4,3,1,81.07,-3.404065478396715,0.8202742218971253,-5.51933577082852,0.9994415760040283,-12.971172352261846,0.8555235624313354,0.8286145567893982,0.5966964095830918,90.7496329792802,4.42767973262188,0.6998340845108032,0.7680627107620239,0.2382192611694336,0.9825125932693481,0.81310054063797,33.41789644313578,24.715492605564258,29.156090934091537,3.5486230669523273,0.2059035450220108,0.3521523654460907,0.5883963406085968,0.1890896588563919,0.9738893389701844,0.0032877534395083785,0.003594963578507304,0.026476906985044478,0.015764296427369116,0.5122255444526672,0.10344312936067582,0.0070228909607976675,0.002445911639370024,0.08138426728546619,0.33938139081001284,0.0198024058714509,0.2810261696577072,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,8874.0,1705604.0,1379816.0,Beta-2 adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,BUCINDOLOL HYDROCHLORIDE,CHEMBL2107546,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1979.0,,-olol,0.0,-olol,beta-blockers (propranolol type),Antihypertensive,0.0,0.0,0.0,"InChI=1S/C22H25N3O2.ClH/c1-22(2,11-17-13-24-20-9-5-4-8-19(17)20)25-14-18(26)15-27-21-10-6-3-7-16(21)12-23;/h3-10,13,18,24-26H,11,14-15H2,1-2H3;1H",NCEAPFRHADKEHP-UHFFFAOYSA-N,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N.Cl,0.5376029915293016,4.0,399.9220000000001,3.8119800000000024,4,3,1,81.07,-3.404065478396715,0.8202742218971253,-5.51933577082852,0.9994415760040283,-12.971172352261846,0.8555235624313354,0.8286145567893982,0.5966964095830918,90.7496329792802,4.42767973262188,0.6998340845108032,0.7680627107620239,0.2382192611694336,0.9825125932693481,0.81310054063797,33.41789644313578,24.715492605564258,29.156090934091537,3.5486230669523273,0.2059035450220108,0.3521523654460907,0.5883963406085968,0.1890896588563919,0.9738893389701844,0.0032877534395083785,0.003594963578507304,0.026476906985044478,0.015764296427369116,0.5122255444526672,0.10344312936067582,0.0070228909607976675,0.002445911639370024,0.08138426728546619,0.33938139081001284,0.0198024058714509,0.2810261696577072,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,1996.0,1343326.0,674274.0,Adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LABETALOL HYDROCHLORIDE,CHEMBL1200323,4.0,1.0,1.0,MOL,,Small molecule,1984.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1976.0,1.0,-alol,0.0,-alol,combined alpha and beta blockers,Anti-Adrenergic (beta-receptor); Anti-Adrenergic (alpha-receptor),0.0,0.0,0.0,"InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H",WQVZLXWQESQGIF-UHFFFAOYSA-N,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl,0.5785210057280791,4.0,364.8730000000001,2.5572000000000004,4,4,2,95.57999999999998,-2.3877792723283062,0.8782401204109191,-5.630108675672528,0.9928125262260437,-12.07214138242901,0.31603705883026123,0.2810394436120987,0.3007007598876953,68.71524691224597,1.9230734375233767,0.3254175901412964,0.16470191329717637,0.041374671179801224,0.8901462316513061,0.06958009246736765,14.186411875873642,16.12460537286237,-2.4912801808499134,2.5771918523549884,0.4254749059677124,0.4979137420654297,0.2818498402833939,0.0458711402490735,0.7124478220939636,0.022232963144779204,0.014697695709764957,0.08042191565036774,0.015284542366862297,0.021027350146323443,0.006422447692602873,0.004662728612311184,0.0015519603388383985,0.020450566615909337,0.04093990267720073,0.005684769555227831,0.36595389246940613,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,1996.0,1343326.0,674274.0,Adrenergic receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,LABETALOL HYDROCHLORIDE,CHEMBL1200323,4.0,1.0,1.0,MOL,,Small molecule,1984.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1976.0,1.0,-alol,0.0,-alol,combined alpha and beta blockers,Anti-Adrenergic (beta-receptor); Anti-Adrenergic (alpha-receptor),0.0,0.0,0.0,"InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H",WQVZLXWQESQGIF-UHFFFAOYSA-N,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl,0.5785210057280791,4.0,364.8730000000001,2.5572000000000004,4,4,2,95.57999999999998,-2.3877792723283062,0.8782401204109191,-5.630108675672528,0.9928125262260437,-12.07214138242901,0.31603705883026123,0.2810394436120987,0.3007007598876953,68.71524691224597,1.9230734375233767,0.3254175901412964,0.16470191329717637,0.041374671179801224,0.8901462316513061,0.06958009246736765,14.186411875873642,16.12460537286237,-2.4912801808499134,2.5771918523549884,0.4254749059677124,0.4979137420654297,0.2818498402833939,0.0458711402490735,0.7124478220939636,0.022232963144779204,0.014697695709764957,0.08042191565036774,0.015284542366862297,0.021027350146323443,0.006422447692602873,0.004662728612311184,0.0015519603388383985,0.020450566615909337,0.04093990267720073,0.005684769555227831,0.36595389246940613,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,1997.0,1343714.0,674784.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DIPIVEFRIN HYDROCHLORIDE,CHEMBL1200833,4.0,1.0,1.0,MOL,4647.0,Small molecule,1980.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,,1.0,,0.0,,,Antiglaucoma Agent,0.0,0.0,0.0,"InChI=1S/C19H29NO5.ClH/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6;/h8-10,13,20-21H,11H2,1-7H3;1H",VKFAUCPBMAGVRG-UHFFFAOYSA-N,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1.Cl,0.5954504399580883,4.0,387.90400000000005,3.264200000000003,6,2,1,84.85999999999999,-2.581949397580137,0.6997004747390747,-4.756719428482599,0.9404879808425903,-8.44308414745905,0.7098461866378785,0.20727119892835616,0.15345072671771048,72.67745416613101,7.836232668605644,0.13063060790300368,0.10071321725845336,0.017841144697740674,0.2821535289287567,0.3664871633052826,44.327289865342145,35.20798526717019,38.7324869173291,2.291898550334235,0.2018394000828266,0.5577121675014496,0.10187601894140244,0.09862177297472954,0.3404782474040985,0.05638111811131239,0.019868374057114124,0.08696217462420464,0.041267696768045425,0.03800427634268999,0.029840944148600102,0.008825960499234498,0.003887693880824372,0.012812062725424766,0.060684180725365876,0.007127972040325403,0.33364562392234803,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,1997.0,1343714.0,674784.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DIPIVEFRIN HYDROCHLORIDE,CHEMBL1200833,4.0,1.0,1.0,MOL,4647.0,Small molecule,1980.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,,1.0,,0.0,,,Antiglaucoma Agent,0.0,0.0,0.0,"InChI=1S/C19H29NO5.ClH/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6;/h8-10,13,20-21H,11H2,1-7H3;1H",VKFAUCPBMAGVRG-UHFFFAOYSA-N,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1.Cl,0.5954504399580883,4.0,387.90400000000005,3.264200000000003,6,2,1,84.85999999999999,-2.581949397580137,0.6997004747390747,-4.756719428482599,0.9404879808425903,-8.44308414745905,0.7098461866378785,0.20727119892835616,0.15345072671771048,72.67745416613101,7.836232668605644,0.13063060790300368,0.10071321725845336,0.017841144697740674,0.2821535289287567,0.3664871633052826,44.327289865342145,35.20798526717019,38.7324869173291,2.291898550334235,0.2018394000828266,0.5577121675014496,0.10187601894140244,0.09862177297472954,0.3404782474040985,0.05638111811131239,0.019868374057114124,0.08696217462420464,0.041267696768045425,0.03800427634268999,0.029840944148600102,0.008825960499234498,0.003887693880824372,0.012812062725424766,0.060684180725365876,0.007127972040325403,0.33364562392234803,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,1998.0,1344098.0,705952.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,EPINEPHRINE BITARTRATE,CHEMBL1256958,4.0,1.0,1.0,MOL,,Small molecule,1965.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,Adrenergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;/m0./s1",YLXIPWWIOISBDD-FVGYRXGTSA-N,CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O,0.2765547370412865,3.0,333.29300000000006,-1.7719999999999998,8,8,3,187.77999999999997,-0.40688102253199343,0.25877639204263686,-7.3594287154805915,0.28226525634527205,-18.101181906985325,0.007654330960940569,0.005561579694040119,0.12757642455399038,32.66341363085036,3.1257682719570576,0.020632277242839336,0.013072332460433244,0.005130879144417122,0.06351362727582455,0.001186143499216996,-8.604964710735235,-18.731441196925505,-37.925685135622516,1.2770341422296347,0.0323758015409112,0.07560603991150856,0.2307804800570011,0.16084713190793992,0.03303842768073082,0.06028640866279602,0.007087169867008925,0.06311749145388604,0.014867514185607434,0.01665793703868985,0.0005144872528035193,0.0010310952784493566,0.0013957947267044801,0.002879494529042859,0.0017926440807059408,0.0030367818573722614,0.1365895837545395,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,1998.0,1344098.0,705952.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,EPINEPHRINE BITARTRATE,CHEMBL1256958,4.0,1.0,1.0,MOL,,Small molecule,1965.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,Adrenergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;/m0./s1",YLXIPWWIOISBDD-FVGYRXGTSA-N,CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O,0.2765547370412865,3.0,333.29300000000006,-1.7719999999999998,8,8,3,187.77999999999997,-0.40688102253199343,0.25877639204263686,-7.3594287154805915,0.28226525634527205,-18.101181906985325,0.007654330960940569,0.005561579694040119,0.12757642455399038,32.66341363085036,3.1257682719570576,0.020632277242839336,0.013072332460433244,0.005130879144417122,0.06351362727582455,0.001186143499216996,-8.604964710735235,-18.731441196925505,-37.925685135622516,1.2770341422296347,0.0323758015409112,0.07560603991150856,0.2307804800570011,0.16084713190793992,0.03303842768073082,0.06028640866279602,0.007087169867008925,0.06311749145388604,0.014867514185607434,0.01665793703868985,0.0005144872528035193,0.0010310952784493566,0.0013957947267044801,0.002879494529042859,0.0017926440807059408,0.0030367818573722614,0.1365895837545395,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,1999.0,1344068.0,28976.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,EPINEPHRINE,CHEMBL679,4.0,1.0,1.0,MOL,28918.0,Small molecule,1976.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,2.0,,0.0,,,"Adrenergic (ophthalmic),Adrenergic (vasoconstrictor)",0.0,0.0,0.0,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",UCTWMZQNUQWSLP-VIFPVBQESA-N,CNC[C@H](O)c1ccc(O)c(O)c1,0.5101568892419974,4.0,183.207,0.35060000000000013,4,4,1,72.72,-0.6518951892961998,0.4951849579811096,-6.080638372385282,0.9881048202514648,-14.982707894752139,0.0701652267947793,0.007754039869178086,0.06327386274933815,5.914201749161523,5.162632856124414,0.007844887161627411,0.0020844816463068128,0.0008936809477745556,0.006371630891226232,0.0023623243730980905,3.706965819166812,14.469985363023643,-44.289869784273705,2.017329139718093,0.235057333111763,0.22104814648628235,0.0278350044041872,0.02614713255316019,0.02470259591937065,0.03997501954436302,0.008877256698906422,0.019648932479321958,0.005052885599434375,0.04059520605951548,0.0013138672016793861,0.00032399655028712,0.0003273304580943659,0.0027729768306016924,0.002268145466223359,0.0018725345027633012,0.6444478809833527,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,1999.0,1344068.0,28976.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,EPINEPHRINE,CHEMBL679,4.0,1.0,1.0,MOL,28918.0,Small molecule,1976.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,2.0,,0.0,,,"Adrenergic (ophthalmic),Adrenergic (vasoconstrictor)",0.0,0.0,0.0,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",UCTWMZQNUQWSLP-VIFPVBQESA-N,CNC[C@H](O)c1ccc(O)c(O)c1,0.5101568892419974,4.0,183.207,0.35060000000000013,4,4,1,72.72,-0.6518951892961998,0.4951849579811096,-6.080638372385282,0.9881048202514648,-14.982707894752139,0.0701652267947793,0.007754039869178086,0.06327386274933815,5.914201749161523,5.162632856124414,0.007844887161627411,0.0020844816463068128,0.0008936809477745556,0.006371630891226232,0.0023623243730980905,3.706965819166812,14.469985363023643,-44.289869784273705,2.017329139718093,0.235057333111763,0.22104814648628235,0.0278350044041872,0.02614713255316019,0.02470259591937065,0.03997501954436302,0.008877256698906422,0.019648932479321958,0.005052885599434375,0.04059520605951548,0.0013138672016793861,0.00032399655028712,0.0003273304580943659,0.0027729768306016924,0.002268145466223359,0.0018725345027633012,0.6444478809833527,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,2000.0,1343106.0,1674090.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,MEPHENTERMINE SULFATE,CHEMBL3184799,4.0,1.0,1.0,MOL,,Small molecule,1951.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/2C11H17N.H2O4S/c2*1-11(2,12-3)9-10-7-5-4-6-8-10;1-5(2,3)4/h2*4-8,12H,9H2,1-3H3;(H2,1,2,3,4)",DNKCFBJMFIUNRS-UHFFFAOYSA-N,CNC(C)(C)Cc1ccccc1.CNC(C)(C)Cc1ccccc1.O=S(=O)(O)O,0.5266242990991414,4.0,424.6070000000001,3.801400000000002,4,4,0,98.66,-0.5173248749497027,0.6371219038963318,-5.9552528509947456,0.5071038782596589,-8.40824956490719,0.6849591612815857,0.11140047982335091,0.6558114528656006,67.15823756701045,-1.0392782154388285,0.014520215732045472,0.04555526208132506,0.005311832236475311,0.8221545457839966,0.03955734067130834,162.7547249998368,-4.714012496308078,-10.820898246999434,2.4178170626298074,0.043467115983366965,0.4700841188430786,0.2864775776863098,0.07310449993237852,0.7363397061824799,0.004267145646736026,0.0005373372026951983,0.13382886499166488,0.024259939976036548,0.003596082585863769,0.004059462057193741,0.0008663105401865324,0.0001690921037152293,0.007128667677170597,0.10946755036711693,0.0010025356445112267,0.7387915253639221,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,2000.0,1343106.0,1674090.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,MEPHENTERMINE SULFATE,CHEMBL3184799,4.0,1.0,1.0,MOL,,Small molecule,1951.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/2C11H17N.H2O4S/c2*1-11(2,12-3)9-10-7-5-4-6-8-10;1-5(2,3)4/h2*4-8,12H,9H2,1-3H3;(H2,1,2,3,4)",DNKCFBJMFIUNRS-UHFFFAOYSA-N,CNC(C)(C)Cc1ccccc1.CNC(C)(C)Cc1ccccc1.O=S(=O)(O)O,0.5266242990991414,4.0,424.6070000000001,3.801400000000002,4,4,0,98.66,-0.5173248749497027,0.6371219038963318,-5.9552528509947456,0.5071038782596589,-8.40824956490719,0.6849591612815857,0.11140047982335091,0.6558114528656006,67.15823756701045,-1.0392782154388285,0.014520215732045472,0.04555526208132506,0.005311832236475311,0.8221545457839966,0.03955734067130834,162.7547249998368,-4.714012496308078,-10.820898246999434,2.4178170626298074,0.043467115983366965,0.4700841188430786,0.2864775776863098,0.07310449993237852,0.7363397061824799,0.004267145646736026,0.0005373372026951983,0.13382886499166488,0.024259939976036548,0.003596082585863769,0.004059462057193741,0.0008663105401865324,0.0001690921037152293,0.007128667677170597,0.10946755036711693,0.0010025356445112267,0.7387915253639221,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,2001.0,1344763.0,858397.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,NOREPINEPHRINE BITARTRATE,CHEMBL1434513,4.0,1.0,1.0,MOL,,Small molecule,1950.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1980.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C8H11NO3.C4H6O6.H2O/c9-4-8(12)5-1-2-6(10)7(11)3-5;5-1(3(7)8)2(6)4(9)10;/h1-3,8,10-12H,4,9H2;1-2,5-6H,(H,7,8)(H,9,10);1H2/t8-;;/m0../s1",LNBCGLZYLJMGKP-JZGIKJSDSA-N,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O,0.25574305772230493,3.0,337.281,-2.8574000000000006,8,8,3,233.26999999999995,-0.6165296941651268,0.1996600478887558,-7.365403106246633,0.2961646616458893,-17.76293787597972,0.006619296397548169,0.008691498404368758,0.2033599652349949,39.63285435545862,2.779599071761579,0.01949629969894886,0.021944814128801227,0.011803878471255302,0.05953521765768528,0.0026251746458001435,-1.1097015960130512,-2.5487949741185076,-37.35376687220487,1.3812535583999748,0.08796803466975689,0.1119222991168499,0.23403754867613316,0.10209735557436943,0.06005106410011649,0.06740295924246312,0.016872270870953797,0.06574014723300933,0.03788820933550596,0.022521743457764386,0.0018014225410297514,0.00271018611965701,0.003020164609188214,0.005583910127461423,0.003409562772139907,0.007131333653524053,0.1968195430934429,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,2001.0,1344763.0,858397.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,NOREPINEPHRINE BITARTRATE,CHEMBL1434513,4.0,1.0,1.0,MOL,,Small molecule,1950.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1980.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C8H11NO3.C4H6O6.H2O/c9-4-8(12)5-1-2-6(10)7(11)3-5;5-1(3(7)8)2(6)4(9)10;/h1-3,8,10-12H,4,9H2;1-2,5-6H,(H,7,8)(H,9,10);1H2/t8-;;/m0../s1",LNBCGLZYLJMGKP-JZGIKJSDSA-N,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O,0.25574305772230493,3.0,337.281,-2.8574000000000006,8,8,3,233.26999999999995,-0.6165296941651268,0.1996600478887558,-7.365403106246633,0.2961646616458893,-17.76293787597972,0.006619296397548169,0.008691498404368758,0.2033599652349949,39.63285435545862,2.779599071761579,0.01949629969894886,0.021944814128801227,0.011803878471255302,0.05953521765768528,0.0026251746458001435,-1.1097015960130512,-2.5487949741185076,-37.35376687220487,1.3812535583999748,0.08796803466975689,0.1119222991168499,0.23403754867613316,0.10209735557436943,0.06005106410011649,0.06740295924246312,0.016872270870953797,0.06574014723300933,0.03788820933550596,0.022521743457764386,0.0018014225410297514,0.00271018611965701,0.003020164609188214,0.005583910127461423,0.003409562772139907,0.007131333653524053,0.1968195430934429,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,2002.0,1344661.0,674656.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROXYAMPHETAMINE HYDROBROMIDE,CHEMBL1200705,4.0,1.0,1.0,MOL,,Small molecule,1969.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Adrenergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C9H13NO.BrH/c1-7(10)6-8-2-4-9(11)5-3-8;/h2-5,7,11H,6,10H2,1H3;1H",RZCJLMTXBMNRAD-UHFFFAOYSA-N,Br.CC(N)Cc1ccc(O)cc1,0.8169680230982767,4.0,232.121,1.8598,2,2,1,46.25,-0.836389579875223,0.7849181175231934,-4.962542357643763,0.9983503699302674,-8.615541055605032,0.359293095767498,0.011526796873658896,0.4201923757791519,34.35300389046334,-3.087293513497188,0.11362850442528724,0.07677121139131486,0.026049370970577003,0.6314063310623169,0.022928852844052015,8.774593155287741,54.45951020970332,-23.79168660521919,2.758279718017337,0.2776091367006302,0.5157735288143158,0.03912548124790192,0.010941145196557044,0.4176303267478943,0.006230215495452285,0.002416098676621914,0.11522369608283042,0.04323593080043793,0.024176768865436314,0.007894099451368675,0.0022554643830517305,0.0024163552501704545,0.015586685156449676,0.051951122283935544,0.008019332005642355,0.7317755222320557,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,2002.0,1344661.0,674656.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,HYDROXYAMPHETAMINE HYDROBROMIDE,CHEMBL1200705,4.0,1.0,1.0,MOL,,Small molecule,1969.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Adrenergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C9H13NO.BrH/c1-7(10)6-8-2-4-9(11)5-3-8;/h2-5,7,11H,6,10H2,1H3;1H",RZCJLMTXBMNRAD-UHFFFAOYSA-N,Br.CC(N)Cc1ccc(O)cc1,0.8169680230982767,4.0,232.121,1.8598,2,2,1,46.25,-0.836389579875223,0.7849181175231934,-4.962542357643763,0.9983503699302674,-8.615541055605032,0.359293095767498,0.011526796873658896,0.4201923757791519,34.35300389046334,-3.087293513497188,0.11362850442528724,0.07677121139131486,0.026049370970577003,0.6314063310623169,0.022928852844052015,8.774593155287741,54.45951020970332,-23.79168660521919,2.758279718017337,0.2776091367006302,0.5157735288143158,0.03912548124790192,0.010941145196557044,0.4176303267478943,0.006230215495452285,0.002416098676621914,0.11522369608283042,0.04323593080043793,0.024176768865436314,0.007894099451368675,0.0022554643830517305,0.0024163552501704545,0.015586685156449676,0.051951122283935544,0.008019332005642355,0.7317755222320557,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,2267.0,1699803.0,1376097.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DROXIDOPA,CHEMBL2103827,4.0,1.0,1.0,MOL,31524.0,Small molecule,2014.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,2008.0,1.0,-dopa,0.0,-dopa,dopamine receptor agonists,,0.0,0.0,0.0,"InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1",QXWYKJLNLSIPIN-JGVFFNPUSA-N,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1,0.43276084275847376,4.0,213.189,-0.4569000000000002,5,5,2,124.01000000000002,-0.9695280519604019,0.5981155097484588,-6.544102901309865,0.9709880113601684,-17.47192636675689,0.01892761616036296,0.004904607916250825,0.1738422304391861,44.95203676759506,4.960209066782322,0.01931090224534273,0.009939575847238303,0.012442205101251602,0.01149224063847214,0.009756111120805145,7.228824096463162,27.782886641381673,-32.2451658244011,1.6179946292304996,0.17865603566169738,0.16129546463489533,0.10802817568182946,0.08114481009542943,0.013568350952118636,0.09055448770523071,0.015599175030365587,0.025615741312503815,0.015659111831337214,0.1154730848968029,0.003075255127623677,0.0028001480968669057,0.001997598074376583,0.006243686738889665,0.007570938067510724,0.008132342738099397,0.42636356353759763,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,2267.0,1699803.0,1376097.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DROXIDOPA,CHEMBL2103827,4.0,1.0,1.0,MOL,31524.0,Small molecule,2014.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,2008.0,1.0,-dopa,0.0,-dopa,dopamine receptor agonists,,0.0,0.0,0.0,"InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1",QXWYKJLNLSIPIN-JGVFFNPUSA-N,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1,0.43276084275847376,4.0,213.189,-0.4569000000000002,5,5,2,124.01000000000002,-0.9695280519604019,0.5981155097484588,-6.544102901309865,0.9709880113601684,-17.47192636675689,0.01892761616036296,0.004904607916250825,0.1738422304391861,44.95203676759506,4.960209066782322,0.01931090224534273,0.009939575847238303,0.012442205101251602,0.01149224063847214,0.009756111120805145,7.228824096463162,27.782886641381673,-32.2451658244011,1.6179946292304996,0.17865603566169738,0.16129546463489533,0.10802817568182946,0.08114481009542943,0.013568350952118636,0.09055448770523071,0.015599175030365587,0.025615741312503815,0.015659111831337214,0.1154730848968029,0.003075255127623677,0.0028001480968669057,0.001997598074376583,0.006243686738889665,0.007570938067510724,0.008132342738099397,0.42636356353759763,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,7494.0,1702954.0,947848.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,"Alpha and beta-adrenergic receptor agonist with direct effects that increase arterial pressures, cardiac output, and peripheral resistance. Indirectly causes release of norepinephrine from sympathetic neurons.",,,,EPHEDRINE SULFATE,CHEMBL1523964,4.0,1.0,1.0,MOL,,Small molecule,2016.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-drine,0.0,-drine,sympathomimetics,Adrenergic,0.0,0.0,0.0,"InChI=1S/2C10H15NO.H2O4S/c2*1-8(11-2)10(12)9-6-4-3-5-7-9;1-5(2,3)4/h2*3-8,10-12H,1-2H3;(H2,1,2,3,4)/t2*8-,10-;/m00./s1",CAVQBDOACNULDN-KHFUBBAMSA-N,CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O,0.38415562637133444,3.0,428.5510000000001,2.003,6,6,4,139.12,-0.0789801605948579,0.41756661534309386,-6.577179340946782,0.1445021487772465,-13.797663556810544,0.15794672295451165,0.08748572468757629,0.0670545943081379,50.72171962017394,0.3727653123211002,0.03758735228329897,0.02808475838974118,0.003849737986456603,0.5188506722450257,0.011692545562982559,124.09926431495003,-10.376794321172945,-15.37834616805399,1.7072776752144,0.022757498384453356,0.25517724454402924,0.27874435633420946,0.0737895704805851,0.4059529840946198,0.06108323223888874,0.015558589482679963,0.16788772642612457,0.015491504315286874,0.0074319006642326714,0.0017224214563611895,0.00038366680637409446,0.0006205416525972395,0.003187510990392184,0.03894355474039912,0.0025837737746769564,0.24853921234607695,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,7494.0,1702954.0,947848.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,"Alpha and beta-adrenergic receptor agonist with direct effects that increase arterial pressures, cardiac output, and peripheral resistance. Indirectly causes release of norepinephrine from sympathetic neurons.",,,,EPHEDRINE SULFATE,CHEMBL1523964,4.0,1.0,1.0,MOL,,Small molecule,2016.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-drine,0.0,-drine,sympathomimetics,Adrenergic,0.0,0.0,0.0,"InChI=1S/2C10H15NO.H2O4S/c2*1-8(11-2)10(12)9-6-4-3-5-7-9;1-5(2,3)4/h2*3-8,10-12H,1-2H3;(H2,1,2,3,4)/t2*8-,10-;/m00./s1",CAVQBDOACNULDN-KHFUBBAMSA-N,CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O,0.38415562637133444,3.0,428.5510000000001,2.003,6,6,4,139.12,-0.0789801605948579,0.41756661534309386,-6.577179340946782,0.1445021487772465,-13.797663556810544,0.15794672295451165,0.08748572468757629,0.0670545943081379,50.72171962017394,0.3727653123211002,0.03758735228329897,0.02808475838974118,0.003849737986456603,0.5188506722450257,0.011692545562982559,124.09926431495003,-10.376794321172945,-15.37834616805399,1.7072776752144,0.022757498384453356,0.25517724454402924,0.27874435633420946,0.0737895704805851,0.4059529840946198,0.06108323223888874,0.015558589482679963,0.16788772642612457,0.015491504315286874,0.0074319006642326714,0.0017224214563611895,0.00038366680637409446,0.0006205416525972395,0.003187510990392184,0.03894355474039912,0.0025837737746769564,0.24853921234607695,False
ADRB1,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,8978.0,1704291.0,1418053.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,EPHEDRINE HYDROCHLORIDE,CHEMBL2146102,4.0,1.0,1.0,MOL,,Small molecule,2021.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-drine,0.0,-drine,sympathomimetics,Bronchodilator,0.0,0.0,0.0,"InChI=1S/C10H15NO.ClH/c1-8(11-2)10(12)9-6-4-3-5-7-9;/h3-8,10-12H,1-2H3;1H/t8-,10-;/m0./s1",BALXUFOVQVENIU-GNAZCLTHSA-N,CN[C@@H](C)[C@H](O)c1ccccc1.Cl,0.7813001545014681,4.0,201.697,1.7496999999999998,2,2,2,32.26,-0.7614062153697391,0.9182251930236817,-5.114761385174963,0.9961681008338928,-11.341297695570281,0.47093096375465393,0.011290949443355203,0.3641918957233429,21.984676233304246,17.697524738967807,0.026890438795089722,0.011679447907954454,0.0003647530946182087,0.3195106953382492,0.0007098921458236873,23.332455287504345,4.537407388053922,-41.14340631363603,2.4952149235079673,0.11564939469099045,0.277783140540123,0.11264923699200154,0.011594460345804691,0.10581422969698906,0.028103230707347392,0.004728343477472663,0.07165362164378167,0.0016083224909380078,0.002633593580685556,0.0003878068266203627,0.00019583948173931275,0.00014523794525302946,0.0006907898590725381,0.0005323427634721156,0.00018120732352144842,0.6114212572574615,False
ADRB2,105670,PROTEIN FAMILY,Adrenergic receptor,9606,Homo sapiens,CHEMBL2331074,,0.0,8978.0,1704291.0,1418053.0,Adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,EPHEDRINE HYDROCHLORIDE,CHEMBL2146102,4.0,1.0,1.0,MOL,,Small molecule,2021.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-drine,0.0,-drine,sympathomimetics,Bronchodilator,0.0,0.0,0.0,"InChI=1S/C10H15NO.ClH/c1-8(11-2)10(12)9-6-4-3-5-7-9;/h3-8,10-12H,1-2H3;1H/t8-,10-;/m0./s1",BALXUFOVQVENIU-GNAZCLTHSA-N,CN[C@@H](C)[C@H](O)c1ccccc1.Cl,0.7813001545014681,4.0,201.697,1.7496999999999998,2,2,2,32.26,-0.7614062153697391,0.9182251930236817,-5.114761385174963,0.9961681008338928,-11.341297695570281,0.47093096375465393,0.011290949443355203,0.3641918957233429,21.984676233304246,17.697524738967807,0.026890438795089722,0.011679447907954454,0.0003647530946182087,0.3195106953382492,0.0007098921458236873,23.332455287504345,4.537407388053922,-41.14340631363603,2.4952149235079673,0.11564939469099045,0.277783140540123,0.11264923699200154,0.011594460345804691,0.10581422969698906,0.028103230707347392,0.004728343477472663,0.07165362164378167,0.0016083224909380078,0.002633593580685556,0.0003878068266203627,0.00019583948173931275,0.00014523794525302946,0.0006907898590725381,0.0005323427634721156,0.00018120732352144842,0.6114212572574615,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1337.0,1702558.0,631810.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,VILANTEROL TRIFENATATE,CHEMBL1084172,4.0,1.0,1.0,MOL,75040.0,Small molecule,2013.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C24H33Cl2NO5.C20H16O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;21-19(22)20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-15H,(H,21,22)/t24-;/m0./s1",KLOLZALDXGTNQE-JIDHJSLPSA-N,O=C(O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,0.03927590509539919,2.0,774.7820000000002,8.713700000000003,7,5,1,128.48000000000002,-4.391278756648818,0.5016794800758362,-6.09409042542207,0.9186750054359436,-11.342693063349547,0.21450605988502502,0.6844773530960083,0.020553029980510472,102.0848496984901,-2.19344798336752,0.16644348353147506,0.5329971671104431,0.46134363412857055,0.3190471015870571,0.31263767927885056,32.485872306140244,-4.720030886014612,9.58984908685925,3.205579822463874,0.024102659523487092,0.19160236567258834,0.02036742540076375,0.3170516639947891,0.7369350135326386,0.0041441026143729685,0.004825117182917893,0.21630756556987762,0.13315986134111882,0.05296320952475071,0.29006015211343766,0.3535433053970337,0.001175699580926448,0.25585742443799975,0.6026328563690185,0.0653825517743826,0.25070236921310424,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1338.0,1343195.0,34094.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ALBUTEROL,CHEMBL714,4.0,1.0,1.0,MOL,2549.0,Small molecule,1981.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1971.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),Bronchodilator,0.0,0.0,0.0,"InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3",NDAUXUAQIAJITI-UHFFFAOYSA-N,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,0.6389509580864461,4.0,239.315,1.3059999999999998,4,4,1,72.72,-1.2179985238788271,0.6799237608909607,-5.233677155054789,0.9922751069068909,-12.808795308234114,0.30540831536054613,0.006344034569337964,0.14994239658117295,21.348391198931324,1.5995631884921664,0.004165335436118767,0.008898819051682948,0.0011032387599698267,0.06334096863865853,0.0021310931580956092,-7.020837216953858,3.1142889172704344,-9.218350589708074,2.4011411282558366,0.09753621481359005,0.21688104048371315,0.03524676132947206,0.002339984942227602,0.09719169735908509,0.008158713206648826,0.0007173425983637571,0.07410227693617344,0.008798093581572176,0.011244342988356948,0.0007807947637047619,7.980506734384107e-05,3.4995947953575526e-05,0.0010070322547107934,0.0024848510744050144,0.00017470748271080082,0.5254230499267578,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1339.0,1343984.0,674395.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PIRBUTEROL ACETATE,CHEMBL1200444,4.0,1.0,1.0,MOL,,Small molecule,1986.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1978.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),Bronchodilator,0.0,0.0,0.0,"InChI=1S/C12H20N2O3.C2H4O2/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8;1-2(3)4/h4-5,11,13,15-17H,6-7H2,1-3H3;1H3,(H,3,4)",QSXMZJGGEWYVCN-UHFFFAOYSA-N,CC(=O)O.CC(C)(C)NCC(O)c1ccc(O)c(CO)n1,0.556809182356454,4.0,300.355,0.7918999999999998,6,5,1,122.91000000000001,-0.4674656132161529,0.7867745518684387,-6.15427950381331,0.7730168163776397,-16.450175145585685,0.05558915873989463,0.0033740757731720804,0.18381221890449523,30.62284540180321,9.373654121950059,0.0007189620417193509,0.0045439328765496615,0.0016406795592047274,0.017398021556437014,0.00017595334443285538,-17.87917151739455,-33.815708098728834,-36.60200804513205,1.898541993473716,0.11152407564222813,0.11247254461050034,0.13111029490828513,0.04573060609400272,0.018611629493534565,0.017161962389945985,0.0023730535176582634,0.12082243412733078,0.0069108877796679735,0.006950104772113263,0.0003676000953419134,0.00032215305345744126,0.00015754164942336502,0.0014898867346346378,0.0002718004674534313,0.00017069353416445665,0.11851979643106461,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1340.0,1344008.0,674844.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PROTOKYLOL HYDROCHLORIDE,CHEMBL1200893,4.0,1.0,1.0,MOL,,Small molecule,1982.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H21NO5.ClH/c1-11(6-12-2-5-17-18(7-12)24-10-23-17)19-9-16(22)13-3-4-14(20)15(21)8-13;/h2-5,7-8,11,16,19-22H,6,9-10H2,1H3;1H",LOVXREQUMZKFCM-UHFFFAOYSA-N,CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1.Cl,0.5863619126972902,4.0,367.829,2.5025000000000017,6,4,2,91.18,-1.604357523744055,0.5948677659034729,-5.970473072143242,0.9975995421409607,-11.196361587950479,0.4022968620061874,0.22667717486619948,0.3209239184856415,68.9508489366383,8.32136273766481,0.7878209233283997,0.6678403139114379,0.24898234009742737,0.9881513237953186,0.6335350155830384,6.386332624824814,9.27369098352872,-4.798851415437396,2.6091493513428086,0.3190627723932266,0.18191597908735274,0.19816840663552285,0.13721966743469238,0.7543820261955261,0.01322912834584713,0.014727258868515492,0.13005902767181396,0.04545358195900917,0.25535177886486055,0.03840056732296944,0.005168381112162024,0.005647225445136428,0.04501260481774807,0.13821465224027635,0.03938201554119587,0.4947932720184326,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1341.0,1344239.0,675012.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,LEVALBUTEROL HYDROCHLORIDE,CHEMBL1201061,4.0,1.0,1.0,MOL,,Small molecule,1999.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1997.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),Bronchodilator; Asthma Prophylactic,0.0,0.0,0.0,"InChI=1S/C13H21NO3.ClH/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;/h4-6,12,14-17H,7-8H2,1-3H3;1H/t12-;/m0./s1",OWNWYCOLFIFTLK-YDALLXLXSA-N,CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.Cl,0.6752822895943631,4.0,275.776,1.7278,4,4,1,72.72,-1.0995946988642977,0.770702576637268,-5.439706183934926,0.9805767059326171,-11.744846724562345,0.2256184920668602,0.018627824913710355,0.10988233499228954,36.77141848318557,5.68341085790454,0.010633487883023918,0.018207589024677874,0.0018061097358440747,0.3039710491895676,0.005587601166917011,4.784481797893712,-5.766526211733256,-17.61262697430159,2.625065140924629,0.387853741645813,0.38293246626853944,0.11847787201404572,0.004428450460545718,0.21069492399692535,0.008023833949118852,0.00195720175979659,0.0871490217745304,0.015823526307940483,0.016576554346829652,0.0020020420430228113,0.00026251634001255296,0.00022209398302948103,0.0029762325808405875,0.006857252855843399,0.0007296295940250275,0.5157145440578461,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1342.0,1343282.0,1280054.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,Long acting,,,,ARFORMOTEROL TARTRATE,CHEMBL1951071,4.0,1.0,1.0,MOL,,Small molecule,2006.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,2003.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C19H24N2O4.C4H6O6/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-1(3(7)8)2(6)4(9)10/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2,5-6H,(H,7,8)(H,9,10)/t13-,19+;/m1./s1",FCSXYHUNDAXDRH-QVRIGTRMSA-N,COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)C(O)C(O)C(=O)O,0.1466315351477121,3.0,494.4970000000002,0.10070000000000023,9,8,4,205.87999999999994,-0.742130513434309,0.3285074979066849,-7.261608662614679,0.2400347799062729,-15.035180682407509,0.07448600549250842,0.05510092843323946,0.17842039167881013,53.23411600383366,5.9158030563757205,0.11158661991357803,0.10986568182706832,0.06181569956243038,0.5616124510765076,0.050741308555006984,-7.40955974039594,-25.09964940249138,-7.352784712551845,1.6663598585749515,0.17318052649497986,0.0972373478114605,0.3534920088946819,0.24611229747533797,0.47676621079444886,0.14243418201804162,0.03651905357837677,0.13025224581360817,0.039920957572758195,0.07586576323956251,0.01012614881619811,0.00960933193564415,0.008357652183622121,0.010493848082842306,0.01694114860147238,0.028501595417037607,0.10824801847338676,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1343.0,1344117.0,674356.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BITOLTEROL MESYLATE,CHEMBL1200405,4.0,1.0,1.0,MOL,3134.0,Small molecule,1984.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1975.0,0.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),Bronchodilator,0.0,0.0,0.0,"InChI=1S/C28H31NO5.CH4O3S/c1-18-6-10-20(11-7-18)26(31)33-24-15-14-22(23(30)17-29-28(3,4)5)16-25(24)34-27(32)21-12-8-19(2)9-13-21;1-5(2,3)4/h6-16,23,29-30H,17H2,1-5H3;1H3,(H,2,3,4)",HODFCFXCOMKRCG-UHFFFAOYSA-N,CS(=O)(=O)O.Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1,0.21482513052033347,3.0,557.6650000000003,4.667340000000005,8,3,1,139.23000000000002,-2.5704253454504027,0.6846975564956665,-5.513140233199449,0.9042675614356994,-9.153763538555015,0.5855606138706207,0.9173189520835876,0.1410906881093979,93.59858400589651,0.3009865042956755,0.07226079478859901,0.33905741274356843,0.22673558741807937,0.3403927743434906,0.3298843830823898,111.3542550481116,16.832821167067642,60.8753477058789,2.346404120940935,0.05401437506079674,0.7275981903076172,0.2580476298928261,0.7084218800067902,0.8950018525123596,0.025114607252180576,0.010548363626003265,0.045961777493357656,0.012918744212947786,0.03887657839804888,0.01903145983815193,0.006502790655940771,0.0021739520714618267,0.021011192165315152,0.47433584928512573,0.010502851230558007,0.2173970341682434,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1344.0,1344101.0,631502.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,SALMETEROL XINAFOATE,CHEMBL1082607,4.0,1.0,1.0,MOL,,Small molecule,1994.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1990.0,1.0,sal-; -terol,0.0,sal-; -terol,anti-inflammatory agents (salicylic acid derivatives); bronchodilators (phenethylamine derivatives),Bronchodilator,0.0,0.0,0.0,"InChI=1S/C25H37NO4.C11H8O3/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21;12-10-8-4-2-1-3-7(8)5-6-9(10)11(13)14/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2;1-6,12H,(H,13,14)",XTZNCVSCVHTPAI-UHFFFAOYSA-N,O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,0.07677266135666631,1.0,603.7560000000007,6.351000000000008,7,6,1,139.48000000000002,-4.040557407321974,0.4670555770397186,-6.145628328965441,0.8425468325614929,-11.681537966658864,0.17161635011434556,0.8907633423805237,0.07092182151973248,98.21807117781307,1.1681090456810752,0.24312081187963486,0.3694212079048157,0.2774448454380035,0.44224209785461427,0.0857912503182888,27.18077868234787,37.288006290691285,45.28947956072208,2.7459424654390294,0.29662889391183855,0.19808914586901666,0.09631178490817546,0.4552771210670471,0.8581615924835205,0.01990488972514868,0.009301365073770284,0.1405526265501976,0.04800800308585167,0.10709711536765099,0.07808546349406242,0.1472532220184803,0.006357180164195597,0.14244487658143043,0.2771728813648224,0.03129541110247373,0.3439541906118393,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1345.0,1344248.0,791489.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,RITODRINE HYDROCHLORIDE,CHEMBL1367605,4.0,1.0,1.0,MOL,,Small molecule,1991.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1981.0,0.0,-drine,0.0,-drine,sympathomimetics,,0.0,0.0,0.0,"InChI=1S/C17H21NO3.ClH/c1-12(17(21)14-4-8-16(20)9-5-14)18-11-10-13-2-6-15(19)7-3-13;/h2-9,12,17-21H,10-11H2,1H3;1H",IDLSITKDRVDKRV-UHFFFAOYSA-N,CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1.Cl,0.6593893940238814,4.0,323.82,2.773800000000001,4,4,2,72.72,-1.6566562319295297,0.6027510166168213,-5.623504224597611,0.9853131294250488,-11.50658220676119,0.20789134800434111,0.08457799293100834,0.05894521251320839,55.32759446021244,-0.7642460123504807,0.320358082652092,0.3199208125472069,0.11852312907576561,0.8430088520050049,0.06129875932820141,-9.179722281191108,17.509264119566314,-28.337274217354707,2.35475140228636,0.20170462429523467,0.35801278352737426,0.10720898993313313,0.028761732578277587,0.7013332605361938,0.008885694947093726,0.009085586853325367,0.18354079723358155,0.048637520708143714,0.02680989447981119,0.01681935745291412,0.008426408353261649,0.0013248745468445121,0.03629389079287648,0.15701354742050172,0.015617586625739931,0.6486178159713745,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1346.0,1392857.0,1153493.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,Long acting,,,,INDACATEROL MALEATE,CHEMBL1789842,4.0,1.0,1.0,MOL,68573.0,Small molecule,2009.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,2008.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C24H28N2O3.C4H4O4/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24;5-3(6)1-2-4(7)8/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29);1-2H,(H,5,6)(H,7,8)/b;2-1-/t22-;/m0./s1",IREJFXIHXRZFER-PCBAQXHCSA-N,CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2.O=C(O)/C=C\C(=O)O,0.25335915824570626,2.0,508.57100000000025,2.8607000000000005,6,6,1,159.95,-3.0332613214490056,0.5037809848785401,-6.837060587618872,0.6880293250083923,-15.041157746858568,0.19745649695396422,0.1987050563097,0.36832727789878844,79.66565055302897,5.5511701957726824,0.2773824095726013,0.3909164905548096,0.2561070263385773,0.33482574224472045,0.052006491273641584,-13.036913461511332,-18.838203189940607,20.72829125227662,2.5478117711373605,0.243483504652977,0.16610954105854034,0.4276552140712738,0.5083653271198273,0.5831947267055512,0.040253189578652385,0.0371087197214365,0.15932331830263138,0.06081532947719097,0.15733007490634918,0.04943512305617333,0.04156371653079986,0.048213521018624306,0.08374307900667191,0.14644628316164016,0.11864216402173042,0.28051677644252776,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1347.0,1344339.0,739751.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TERBUTALINE SULFATE,CHEMBL1315867,4.0,1.0,1.0,MOL,,Small molecule,1974.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1970.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/2C12H19NO3.H2O4S/c2*1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8;1-5(2,3)4/h2*4-6,11,13-16H,7H2,1-3H3;(H2,1,2,3,4)",KFVSLSTULZVNPG-UHFFFAOYSA-N,CC(C)(C)NCC(O)c1cc(O)cc(O)c1.CC(C)(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O,0.23514857195132333,2.0,548.6550000000003,2.3857999999999993,10,10,2,220.03999999999996,-0.07141542310325093,0.25412082970142363,-7.05648187648293,0.2616104755550623,-12.361747318049387,0.16755249425768853,0.0790113341063261,0.05254954807460308,56.87076924569682,-6.256903988159371,0.04503848599269986,0.06885114498436451,0.014718550932593643,0.38779694139957427,0.0248280658503063,84.6350678928942,-30.88953915348,-1.4492018032043787,1.7548922500420698,0.0339747023768723,0.21645622104406356,0.25719799771904944,0.04601025655865669,0.6755568385124207,0.017304161749780177,0.006831213925033807,0.12921554148197173,0.0425836025737226,0.012039283104240895,0.003952751663746312,0.0003506364048917021,0.0003467876248123503,0.008877275499980897,0.07216338824946433,0.0033775058043829633,0.2166666343808174,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1348.0,1343284.0,2197564.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,LEVALBUTEROL TARTRATE,CHEMBL3989693,4.0,1.0,1.0,MOL,,Small molecule,2005.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,2004.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/2C13H21NO3.C4H6O6/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;5-1(3(7)8)2(6)4(9)10/h2*4-6,12,14-17H,7-8H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t2*12-;/m00./s1",VNVNZKCCDVFGAP-NMFAMCKASA-N,CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.O=C(O)C(O)C(O)C(=O)O,0.16164308468817462,1.0,628.7160000000005,0.48940000000000056,12,12,4,260.49999999999994,-0.3401398955248681,0.29633955657482147,-7.377257346593926,0.10585282146930694,-15.053473103935536,0.08698972016572952,0.05389796439558268,0.030961452424526213,57.417356728946835,0.41655230807472554,0.022375559154897928,0.03404261833056808,0.007253776682773605,0.35668325424194336,0.017655394040048122,1.0580051770355197,-53.08178832201226,-0.06921019143597817,2.049897510683644,0.038628587126731874,0.04316011592745781,0.13668650202453136,0.0449597779661417,0.4636818766593933,0.04951713178306818,0.012741523422300815,0.18798335939645766,0.053370611555874345,0.01670548440888524,0.006460589496418834,0.0031008299527456986,0.0009625902675907128,0.00818580953637138,0.01011040669400245,0.0017077900221920573,0.12371568977832795,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1349.0,1343139.0,2197669.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,Long acting,,,,FORMOTEROL FUMARATE,CHEMBL3989798,4.0,1.0,1.0,MOL,,Small molecule,2001.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1997.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/2C19H24N2O4.C4H4O4.2H2O/c2*1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-3(6)1-2-4(7)8;;/h2*3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2H,(H,5,6)(H,7,8);2*1H2/b;;2-1+;;",RATSWNOMCHFQGJ-XODSYJLDSA-N,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.O.O.O=C(O)/C=C/C(=O)O,0.03475161642357529,1.0,840.9240000000004,2.5090000000000003,12,10,4,319.24,-1.6041947014039333,0.35762850344181063,-6.8704641868117236,0.2878489464521408,-14.366869393685743,0.1099259216338396,0.19351309388875962,0.09540863931179047,70.8078658402466,3.912381082223285,0.07233292497694492,0.3252105683088303,0.2954128056764603,0.3960252463817596,0.06654173769056797,12.513035529195003,-38.22231958023318,12.920343849982448,1.830408559059681,0.24091886579990388,0.13258443847298623,0.20563964396715165,0.4661274790763855,0.6876347064971924,0.049409798346459866,0.015999302081763745,0.11240906417369842,0.02576150167733431,0.10370129831135273,0.012698892690241336,0.02422312991693616,0.012684747669845819,0.037795858550816776,0.06039091572165489,0.05142569094896317,0.14158182442188263,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1350.0,1343067.0,991941.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,METAPROTERENOL SULFATE,CHEMBL1568057,4.0,1.0,1.0,MOL,,Small molecule,1973.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1964.0,1.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/2C11H17NO3.H2O4S/c2*1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8;1-5(2,3)4/h2*3-5,7,11-15H,6H2,1-2H3;(H2,1,2,3,4)",MKFFGUZYVNDHIH-UHFFFAOYSA-N,CC(C)NCC(O)c1cc(O)cc(O)c1.CC(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O,0.2243124846110386,2.0,520.6010000000002,1.6055999999999997,10,10,2,220.03999999999996,-0.2128435735422955,0.1949668899178505,-7.219388815064204,0.21625425964593886,-12.915834597977163,0.10758520606905222,0.06420471705496311,0.04277455098927021,55.39916182010925,-6.6197210385956,0.14673960506916045,0.11947594732046127,0.027261479664593934,0.5101915955543518,0.03170308745466173,91.4242232491854,-18.378178349357206,-6.502239683606246,1.6813310975702254,0.039324436150491235,0.2570576906204224,0.28943321779370307,0.09319190867245197,0.6822546362876892,0.04569562673568726,0.016257473407313226,0.13942926935851574,0.047892411891371015,0.0175571134313941,0.005217850120970979,0.0006793560809455812,0.0011099808954895707,0.0067966761242132636,0.0788653998170048,0.006194641679758206,0.20158564150333405,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1351.0,1343607.0,864943.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ALBUTEROL SULFATE,CHEMBL1441059,4.0,1.0,1.0,MOL,,Small molecule,1982.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1974.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/2C13H21NO3.H2O4S/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h2*4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)",BNPSSFBOAGDEEL-UHFFFAOYSA-N,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)O,0.20383832583508968,2.0,576.7090000000004,1.9592000000000003,10,10,2,220.03999999999996,0.36229525642886207,0.3021820068359375,-6.842792783149872,0.15316593162715436,-12.251805327928214,0.15750154852867126,0.0963862594217062,0.04482581466436386,56.059592059787875,-8.751895043625918,0.01226823494071141,0.04621456507593393,0.006993376178434119,0.3340466022491455,0.0245585780357942,79.6839954172626,-33.16544382103027,7.058862596819442,2.270838456278885,0.0936460830271244,0.22132883965969086,0.2400505781173706,0.0328135646879673,0.6265002489089966,0.014421109296381473,0.004647527216002345,0.135231427103281,0.032361796405166385,0.00849729129113257,0.0033277792972512543,0.0004456012232367357,0.0004165288841250003,0.007085945823928341,0.056689921591896564,0.00308414944447577,0.22478376179933549,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1352.0,1343862.0,675104.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ISOETHARINE MESYLATE,CHEMBL1201153,4.0,1.0,1.0,MOL,,Small molecule,1984.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,Bronchodilator,0.0,0.0,0.0,"InChI=1S/C13H21NO3.CH4O3S/c1-4-10(14-8(2)3)13(17)9-5-6-11(15)12(16)7-9;1-5(2,3)4/h5-8,10,13-17H,4H2,1-3H3;1H3,(H,2,3,4)",SOYAGMVKMXZVNZ-UHFFFAOYSA-N,CCC(NC(C)C)C(O)c1ccc(O)c(O)c1.CS(=O)(=O)O,0.4065001200115543,4.0,335.422,1.4118,6,5,2,127.08999999999999,-0.34179529458132374,0.4491375207901001,-6.608005250169238,0.8576801896095276,-12.551151984910899,0.19436916783452035,0.055023208074271676,0.23016077727079393,36.65534848042098,-5.854903145474625,0.04096742030233145,0.048735490813851354,0.011934566171839833,0.23532224148511888,0.0036005274567287417,30.54351563578242,-12.647880981540904,-34.517336814648914,2.004210193526604,0.09733876660466194,0.5181705296039582,0.1764181762933731,0.08067286983132363,0.25693149715662,0.029134496115148067,0.007359348610043526,0.12181499525904656,0.017949373088777067,0.017449818132445217,0.0038495995278935878,0.0006233594860532321,0.00037943190545774996,0.006470549467485398,0.05189571874216199,0.0025983213883591814,0.33849499225616453,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,1362.0,1343861.0,674871.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ISOETHARINE HYDROCHLORIDE,CHEMBL1200920,4.0,1.0,1.0,MOL,,Small molecule,1979.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,Bronchodilator,0.0,0.0,0.0,"InChI=1S/C13H21NO3.ClH/c1-4-10(14-8(2)3)13(17)9-5-6-11(15)12(16)7-9;/h5-8,10,13-17H,4H2,1-3H3;1H",MUFDLGGSOCHQOC-UHFFFAOYSA-N,CCC(NC(C)C)C(O)c1ccc(O)c(O)c1.Cl,0.622563164204719,4.0,275.776,2.3296000000000014,4,4,2,72.72,-1.1279666572891796,0.650443720817566,-5.904845082420134,0.9931025862693786,-11.004852101518455,0.21631281971931457,0.03078441272955388,0.14308710545301437,39.20752231679314,7.41765938168609,0.10425627157092095,0.06418869942426682,0.014959354035090655,0.44685138761997223,0.010948243446182459,9.522786342181465,-3.8457357260768132,-34.74663275298785,2.484523586251877,0.2493443712592125,0.38176427483558656,0.07673252075910568,0.012319877184927464,0.27603438049554824,0.007379971165210009,0.0032317719887942076,0.0922867476940155,0.026321953162550926,0.028997898753732442,0.004054940491914749,0.0011580238176975399,0.0005354311055270955,0.011162122013047338,0.034912099107168616,0.0025849065306829287,0.7247450351715088,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,2281.0,1702654.0,1378013.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,Long-acting,,,,OLODATEROL HYDROCHLORIDE,CHEMBL2105743,4.0,1.0,1.0,MOL,83309.0,Small molecule,2014.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,2011.0,1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C21H26N2O5.ClH/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17;/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26);1H/t18-;/m0./s1",KCEHVJZZIGJAAW-FERBBOLQSA-N,COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1.Cl,0.5471876300655486,4.0,422.90900000000016,2.797800000000001,6,4,1,100.05000000000001,-2.322563877901801,0.7483792304992676,-5.838246973936859,0.987125837802887,-12.055276412023002,0.48022009134292604,0.5514079213142395,0.4137566745281219,79.34189847341062,7.219619520352663,0.11960832942277193,0.31106449365615846,0.08453572727739811,0.8847575426101685,0.2538924843072891,43.57113607623126,2.6086822273420487,9.80793437947971,2.739969230826114,0.33594764173030855,0.3061086267232895,0.3352814823389053,0.1069706991314888,0.8818887948989869,0.015543259307742118,0.008710258640348911,0.08114950507879257,0.009382922807708383,0.08817731365561485,0.007105531310662628,0.0018383070244453847,0.002940703323110938,0.015167792234569788,0.06474714418873191,0.010535631328821182,0.23626850545406342,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,4468.0,2473447.0,2126071.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,Dual acting MABA (beta 2 adrenergic receptor agonists; Muscarinic receptor antagonists),,,,LAS190792,CHEMBL3916700,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C39H43ClN4O9S2/c1-44(24-7-9-25(10-8-24)53-37(48)39(50,33-5-3-17-54-33)34-6-4-18-55-34)15-16-52-38(49)42-29-20-32(51-2)23(19-28(29)40)21-41-22-31(46)26-11-13-30(45)36-27(26)12-14-35(47)43-36/h3-6,11-14,17-20,24-25,31,41,45-46,50H,7-10,15-16,21-22H2,1-2H3,(H,42,49)(H,43,47)/t24-,25-,31-/m0/s1",SNXJYSXRLKUBSZ-WBXFWKJNSA-N,COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,0.06713829138509862,0.0,811.379,6.112700000000007,13,6,1,182.67999999999998,-4.57811244445702,0.6632053256034851,-5.825920918257763,0.986638605594635,-14.825163151612347,0.5175094723701477,0.5638693749904633,0.28371055126190187,94.03070688279902,19.940768801194288,0.24820840656757354,0.5484873652458191,0.4533118516206741,0.7001555919647217,0.8706160545349121,60.44612936145277,62.23788578156818,74.8514554647383,2.9482335109506552,0.45215326845645903,0.17367973625659944,0.518470972776413,0.7109861850738526,0.8633329033851623,0.019600598886609078,0.030890139192342757,0.08608570769429207,0.027638438623398542,0.1696404129266739,0.06591254025697708,0.014332286454737187,0.10094461292028427,0.05487332846969366,0.7665392637252808,0.5573068737983704,0.16889295876026153,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,4881.0,2472795.0,1275690.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,MILVETEROL,CHEMBL1940832,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C25H29N3O4/c29-17-28-22-14-20(8-11-23(22)30)24(31)15-26-13-12-18-6-9-21(10-7-18)27-16-25(32)19-4-2-1-3-5-19/h1-11,14,17,24-27,30-32H,12-13,15-16H2,(H,28,29)/t24-,25-/m0/s1",BMKINZUHKYLSKI-DQEYMECFSA-N,O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O,0.1481297562874804,3.0,435.52400000000006,2.9717000000000016,6,6,2,113.85000000000001,-2.6245651435425086,0.33677937388420104,-6.19134659744868,0.7678451538085938,-12.301803607632584,0.21688356399536132,0.40955809950828553,0.0964315414428711,69.07731882543345,2.079770514930589,0.3019832596182823,0.5069452524185181,0.2793272599577904,0.6615682482719422,0.2799426674842834,-2.165979501634731,15.566565356740806,9.163001638851814,2.08893626435258,0.3490894705057144,0.3150677978992462,0.12575988620519638,0.2870049774646759,0.8806626319885253,0.04093022923916578,0.027562803775072097,0.08204142302274704,0.017508728057146074,0.20203763246536255,0.028153760731220244,0.00890492219477892,0.008008152525871993,0.0517221350222826,0.2084574043750763,0.06055975332856178,0.3291189521551132,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,4925.0,1937962.0,1592336.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BATEFENTEROL,CHEMBL3039518,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2013.0,,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C40H42ClN5O7/c1-52-36-22-33(31(41)21-26(36)23-42-24-35(48)29-11-13-34(47)39-30(29)12-14-37(49)45-39)43-38(50)17-20-46-18-15-27(16-19-46)53-40(51)44-32-10-6-5-9-28(32)25-7-3-2-4-8-25/h2-14,21-22,27,35,42,47-48H,15-20,23-24H2,1H3,(H,43,50)(H,44,51)(H,45,49)/t35-/m0/s1",URWYQGVSPQJGGB-DHUJRADRSA-N,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,0.07987250470509627,1.0,740.2570000000002,6.427600000000007,9,6,1,165.25,-5.526406358826382,0.4364891231060028,-5.888725365740891,0.9911015391349792,-14.010046787099341,0.5208934903144836,0.8642969012260437,0.2619873121380806,98.66079444429593,6.267652809817006,0.2804627299308777,0.8180606484413147,0.7343745350837707,0.6353233158588409,0.712922990322113,28.42405695922081,9.88803625114816,43.73084580511986,2.90126300741836,0.1621571570634842,0.10307302176952363,0.5008319914340973,0.7416266918182373,0.9511096119880676,0.00953809954226017,0.015228561032563448,0.07910125032067299,0.02545595709234476,0.36218339800834654,0.07947049587965012,0.03229868486523628,0.027490053325891495,0.11356115937232972,0.5563408672809601,0.42357426285743716,0.15019493103027343,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,4929.0,1937981.0,1592348.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ABEDITEROL,CHEMBL3039530,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2011.0,,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C25H30F2N2O4/c26-25(27,18-8-4-3-5-9-18)17-33-15-7-2-1-6-14-28-16-22(31)19-10-12-21(30)24-20(19)11-13-23(32)29-24/h3-5,8-13,22,28,30-31H,1-2,6-7,14-17H2,(H,29,32)/t22-/m0/s1",SFYAXIFVXBKRPK-QFIPXVFZSA-N,O=c1ccc2c([C@@H](O)CNCCCCCCOCC(F)(F)c3ccccc3)ccc(O)c2[nH]1,0.28659287618302753,4.0,460.521,4.225700000000004,5,4,1,94.58000000000001,-4.815974788194294,0.6101089060306549,-5.877755202855292,0.998069429397583,-12.183980274319996,0.6600652217864991,0.9265926957130433,0.5409605801105499,95.32337786084773,14.021908565796537,0.5223633646965027,0.7356045007705688,0.6672081708908081,0.8264986157417298,0.913454794883728,25.67562241038197,56.363819076222434,31.93012114816879,2.8088788001557736,0.4690003752708435,0.5218890637159348,0.4275426805019379,0.3183685392141342,0.9838945865631104,0.016524879820644857,0.019456132501363754,0.0905428983271122,0.03436644272878766,0.2216920003294945,0.2575427979230881,0.01790577583014965,0.015568570420145988,0.09769342839717865,0.8280907392501831,0.10659250169992447,0.25694285035133363,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,5052.0,1705043.0,1449166.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BEDORADRINE SULFATE,CHEMBL2218893,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2006.0,,-drine,0.0,-drine,sympathomimetics,,0.0,0.0,0.0,"InChI=1S/2C24H32N2O5.H2O4S/c2*1-26(2)24(30)15-31-21-7-4-16-3-6-20(12-19(16)13-21)25-14-23(29)17-5-8-22(28)18(11-17)9-10-27;1-5(2,3)4/h2*4-5,7-8,11,13,20,23,25,27-29H,3,6,9-10,12,14-15H2,1-2H3;(H2,1,2,3,4)/t2*20-,23-;/m00./s1",VPCOODFYDJWLHD-YMZXMBPUSA-N,CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2.CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2.O=S(=O)(O)O,0.06419068298983512,1.0,955.1370000000001,2.496200000000003,14,10,4,279.11999999999995,-0.5511429323360566,0.5593880414962769,-6.463076167776235,0.4904118686914444,-13.600730846695274,0.22860014736652373,0.6809370040893554,0.08086614459753036,69.85893987129225,-9.466682577168218,0.08387333117425441,0.14377749487757682,0.08071263544261456,0.26958124786615373,0.2152950033545494,158.67263271187298,-28.005451770727255,26.58876853770222,2.2363818923127035,0.49800664782524107,0.28705508559942244,0.4418689638376236,0.3871009826660156,0.7935964584350585,0.038274578750133514,0.016831438336521388,0.13247726261615753,0.028645244194194674,0.03273706138134003,0.013447161391377449,0.004404734540730715,0.014156016474589705,0.016837065387517215,0.1841808922588825,0.049313246831297876,0.17411042004823685,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,5056.0,1706063.0,625730.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,Discontinued does not have competitive profile (http://www.chiesi.es/Assets/docs/Annual_report_2010.pdf),,,,CARMOTEROL,CHEMBL1094785,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C21H24N2O4/c1-13(11-14-3-5-15(27-2)6-4-14)22-12-19(25)16-7-9-18(24)21-17(16)8-10-20(26)23-21/h3-10,13,19,22,24-25H,11-12H2,1-2H3,(H,23,26)/t13-,19+/m1/s1",IHOXNOQMRZISPV-YJYMSZOUSA-N,COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1,0.514022449588338,4.0,368.4330000000001,2.4965,5,4,2,94.57999999999998,-3.7744749743923647,0.6161837637424469,-5.802778638999444,0.9918342113494873,-15.578336685897645,0.6322728812694549,0.19936119318008422,0.18303302824497222,68.61222955672767,10.301727921896461,0.40056986808776857,0.45664011836051943,0.2637517660856247,0.7090983033180237,0.6011378169059753,-21.33049605386298,21.637711544159277,3.8566154141138673,2.428618148990619,0.15603017508983613,0.09534143768250943,0.30284122228622434,0.11533448249101638,0.7998693704605102,0.025421756505966186,0.025956809893250464,0.1201421707868576,0.048461209237575534,0.43622379899024966,0.039149214327335355,0.00325990270357579,0.01149875009432435,0.039048705622553824,0.12737505435943602,0.035832656919956206,0.19018996506929398,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,6247.0,1699911.0,49226.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,"Beta-2 adrenergic receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow.",,,,FENOTEROL,CHEMBL32800,4.0,1.0,1.0,MOL,149226.0,Small molecule,,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1971.0,-2.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),Bronchodilator,1.0,0.0,0.0,"InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3",LSLYOANBFKQKPT-UHFFFAOYSA-N,CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1,0.5631106475775396,4.0,303.358,2.0576,5,5,2,92.95,-1.5157868596928565,0.4082355201244354,-5.859142735846824,0.9812722086906434,-13.474631178050775,0.2617302268743515,0.04773812480270863,0.06438699886202812,43.76001130075896,-0.6990177294959576,0.31401343643665314,0.2752377063035965,0.09949865862727165,0.5871566116809845,0.07324012741446495,-4.254273563039694,24.69781914721494,-24.425717082286987,2.2498123730558186,0.06297824829816819,0.18789176121354104,0.10454089157283306,0.021904457174241544,0.5581914901733398,0.024581796303391457,0.011428187973797322,0.13944617211818694,0.04750726222991943,0.06146733071655035,0.016126693366095422,0.0020566427847370505,0.0007067452068440616,0.016044620843604206,0.0626062486320734,0.004843176284339279,0.5303399085998535,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,6678.0,1704068.0,74690.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,"Clenbuterol is a Î²2-adrenergic receptor agonist that causes relaxation of airway smooth muscle by binding to the receptor and activating adenylyl cyclase. Activation of adenylyl cyclase leads to an increase in intracellular concentrations of cyclic adenosine monophosphate (cAMP) and ultimately activation of protein kinase A (PKA). In the airways this inhibits smooth muscle contraction by opening K+ channels and down-regulating myosin light chain kinase activity. In addition, evidence indicates that clenbuterol induces production of neurotrophic factors, and promotes anti-inflammatory and neuroprotective effects.",Clenbuterol is a moderately selective Î²2-adrenergic receptor agonist.,,,CLENBUTEROL,CHEMBL49080,4.0,1.0,1.0,MOL,174690.0,Small molecule,,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,-1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C12H18Cl2N2O/c1-12(2,3)16-6-10(17)7-4-8(13)11(15)9(14)5-7/h4-5,10,16-17H,6,15H2,1-3H3",STJMRWALKKWQGH-UHFFFAOYSA-N,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,0.7442931078481675,4.0,277.195,2.9971000000000005,3,3,1,58.28,-2.7865113037628726,0.9683378458023071,-4.857419440765611,0.9993239998817444,-10.446529041007043,0.7260784149169922,0.013254182133823633,0.7566228032112121,48.98381659816861,33.67441055429071,0.019291683787014336,0.055368822254240516,0.007045326486695558,0.21283162832260133,0.01796050410484895,57.58128534863778,6.147081051495057,-6.473649394899843,2.3937797640524634,0.1633326679468155,0.6156273484230042,0.17066930755972862,0.04478182159364223,0.5008515149354935,0.012747875228524209,0.0018535828392487019,0.042985578253865245,0.003848582552745938,0.033674877136945724,0.004373897938057781,0.00030275936801444915,0.0002002014191020862,0.0020235015283105893,0.007594304770464078,0.0005602749912213767,0.6372515857219696,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,6887.0,1705291.0,549033.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,"Isoxsuprine is a beta-adrenoreceptor agonist and an alpha-adrenoreceptor antagonist, with both characteristics contributing to vasodilation and uterine relaxation.","Isoxsuprine has a higher affinity of Î±1-adrenoreceptors (Kd=59+-15nM, adrenoreceptors in rat vas deferens) than for Î²2-adrenoceptors ( Kd=3900+-500nM adrenoreceptors in rat vas deferens).",,,ISOXSUPRINE HYDROCHLORIDE,CHEMBL559180,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,-1.0,,0.0,,,Vasodilator,0.0,0.0,0.0,"InChI=1S/C18H23NO3.ClH/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15;/h3-11,13-14,18-21H,12H2,1-2H3;1H",QVPSGVSNYPRFAS-UHFFFAOYSA-N,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl,0.7251993344095784,4.0,337.84700000000004,3.2930000000000024,4,3,3,61.72,-2.212239941193642,0.6054739356040955,-5.311121057037162,0.9961400508880616,-10.321381890651349,0.5376744031906128,0.22455286234617233,0.12444075234234334,67.81061162557967,-3.3969861145703377,0.6186474204063416,0.547383975982666,0.18994083255529404,0.9542587876319886,0.159114358574152,2.590867703058003,50.058105771786884,2.1553220886407254,2.287514231576515,0.09899709150195121,0.2743002139031887,0.09155837185680867,0.026682353019714354,0.8567438125610352,0.0074548634700477125,0.0059466348495334385,0.17537073493003846,0.0618100956082344,0.028225581534206866,0.03700919523835182,0.020131783001124857,0.00114770142827183,0.0568132609128952,0.22629936560988426,0.01431231265887618,0.4977678179740906,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,7551.0,1702761.0,453827.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,BAMBUTEROL,CHEMBL521589,3.0,0.0,0.0,MOL,553827.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,,,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3",ANZXOIAKUNOVQU-UHFFFAOYSA-N,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1,0.8292335988195222,4.0,367.4460000000001,2.2288999999999994,6,2,1,91.34,-0.2491608248181067,0.7603841423988342,-4.54771945488148,0.9141072392463684,-14.748372303796796,0.8258131146430969,0.06848999597132206,0.5845970332622528,42.076763039896186,-2.587576728444713,0.014013699442148208,0.011623081611469388,0.0030455596861429513,0.1387576200067997,0.013142108544707298,-26.137468439001942,-28.840990365860584,3.976499810112389,3.37552123642572,0.17096996828913688,0.22175369262695313,0.3104453980922699,0.07307745888829231,0.5639343380928039,0.05429788157343864,0.0062386162346228955,0.06420646719634533,0.00844624130986631,0.0342272313311696,0.00219117752276361,0.0001907768584715086,0.0004495943927395274,0.0014048086479306221,0.0024077283509541304,0.0009312113179476,0.12833878993988038,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,7821.0,3133052.0,2335454.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,NAVAFENTEROL,CHEMBL4297483,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2020.0,,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C38H42N6O6S2/c1-43(25-8-10-26(11-9-25)50-37(48)38(49,33-5-2-19-51-33)34-6-3-20-52-34)17-4-18-44-30-14-7-24(21-29(30)41-42-44)22-39-23-32(46)27-12-15-31(45)36-28(27)13-16-35(47)40-36/h2-3,5-7,12-16,19-21,25-26,32,39,45-46,49H,4,8-11,17-18,22-23H2,1H3,(H,40,47)/t25-,26-,32-/m0/s1",ZNKWRAKPQQZLNX-ZDQHWEPJSA-N,CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1,0.09558249088773221,1.0,742.9240000000002,5.0370000000000035,13,5,1,165.82999999999998,-3.841578613709686,0.5292207539081574,-6.388107607693238,0.9727793455123901,-14.62874667715486,0.4116420090198517,0.48836960792541506,0.23731245398521422,92.4676853957031,0.5143793986224217,0.22305825650691985,0.5815137803554535,0.4931956589221954,0.7007429838180542,0.8767967343330383,0.41501681784781114,76.00850255355257,91.02365071623016,2.9854506751953127,0.39329713582992554,0.1276039443910122,0.4940667927265167,0.5715296864509583,0.830696988105774,0.023281827569007874,0.060399343818426134,0.11409951150417327,0.04840346686542034,0.06259587705135346,0.05849845893681049,0.01784650282934308,0.08756107911467552,0.05581068880856037,0.6330289244651794,0.38358921110630034,0.17701121866703035,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,8269.0,3132282.0,700180.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PF-00610355,CHEMBL1240967,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C34H39N3O6S/c1-34(2,36-22-32(40)28-12-15-31(39)30(19-28)37-44(3,42)43)20-24-7-4-6-23(16-24)18-33(41)35-21-25-8-5-9-27(17-25)26-10-13-29(38)14-11-26/h4-17,19,32,36-40H,18,20-22H2,1-3H3,(H,35,41)/t32-/m0/s1",YPHDIMUXXABSSO-YTTGMZPUSA-N,CC(C)(Cc1cccc(CC(=O)NCc2cccc(-c3ccc(O)cc3)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,0.11982589740417729,2.0,617.7680000000003,4.6395000000000035,7,6,1,147.99,-3.5914114673026476,0.38748025298118594,-6.12290162264016,0.966358768939972,-11.403215177474259,0.4102738380432129,0.5927636981010437,0.11149506419897079,91.12104436134177,-0.6766005051328363,0.4248306840658188,0.7509431719779969,0.6671383738517761,0.7609097957611084,0.737108302116394,28.165289191337017,5.53108046470297,69.13727902517056,2.5349618070644717,0.12263907641172409,0.35410694777965546,0.11305086016654968,0.6161622285842896,0.952065908908844,0.02152637839317322,0.015572121925652027,0.05642049014568329,0.012086503766477108,0.0575491838157177,0.040488727018237115,0.016072796564549206,0.002215274574700743,0.05647281110286713,0.3633339315652847,0.02777849156409502,0.16904750764369963,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,8351.0,2795421.0,262509.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PROCATEROL,CHEMBL160519,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1980.0,,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),Bronchodilator,0.0,0.0,0.0,"InChI=1S/C16H22N2O3/c1-4-12(17-9(2)3)16(21)11-5-7-13(19)15-10(11)6-8-14(20)18-15/h5-9,12,16-17,19,21H,4H2,1-3H3,(H,18,20)",FKNXQNWAXFXVNW-UHFFFAOYSA-N,CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12,0.6786748472348153,4.0,290.363,2.0436999999999994,4,4,2,85.35,-2.96016537931106,0.5787991762161255,-5.848468522507018,0.993937349319458,-16.807339116696802,0.3477350682020187,0.01697169067338109,0.20600199699401855,47.48716851735843,20.47591410644242,0.09529594331979752,0.07382825203239918,0.05060976259410381,0.23246318399906157,0.026805511303246023,4.840274879803233,17.728210583273057,-28.27420796076772,2.522751059561075,0.054599408991634846,0.08109972067177296,0.1571604609489441,0.05568433552980423,0.2905286192893982,0.020321725867688656,0.011264965310692788,0.09295422211289406,0.028995735757052898,0.2163251407444477,0.007262869412079454,0.0006292032208875753,0.0017258884268812834,0.010779338795691729,0.04272534642368555,0.00877014473080635,0.2647616058588028,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,8390.0,1702297.0,641256.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TULOBUTEROL,CHEMBL1159717,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,-1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3",YREYLAVBNPACJM-UHFFFAOYSA-N,CC(C)(C)NCC(O)c1ccccc1Cl,0.8325282375400225,4.0,227.735,2.7615000000000007,2,2,1,32.26,-1.922573641482358,0.956531310081482,-4.396610229073305,0.999877679347992,-8.304581420831866,0.8903615355491639,0.01319241626188159,0.8320333123207092,46.57718445987052,23.589646627524665,0.03154866565018892,0.0727692149579525,0.001366679256898351,0.416380786895752,0.004629281462985091,49.47747640341862,19.101273443911307,-4.540390331183607,2.2938057551438904,0.027907281182706356,0.318424665927887,0.11144116055220366,0.006143504101783037,0.30653710663318634,0.00558143793605268,0.00046864739415468647,0.0533016312867403,0.0032549040392041207,0.003700976655818522,0.0006983224273426458,0.00016180874132487588,2.6236827784487106e-05,0.001438042093650438,0.0025763651981833393,6.05030803342288e-05,0.7661646008491516,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,8873.0,2792062.0,140105.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,RIMITEROL,CHEMBL88055,4.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1971.0,-1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2",IYMMESGOJVNCKV-UHFFFAOYSA-N,Oc1ccc(C(O)C2CCCCN2)cc1O,0.5697472536667831,4.0,223.27199999999996,1.2732999999999999,4,4,2,72.72,-1.3231321776940776,0.41135290265083313,-5.868312867867987,0.9951012134552002,-13.269430668852724,0.08345480635762215,0.0123321742285043,0.3539561778306961,14.329839375356588,-0.6449645191031295,0.007548113027587533,0.01640144381672144,0.004324951890157536,0.04889392480254173,0.0007891030516475439,0.5258886029782304,1.490696130392059,-50.37348389238192,2.2843920157654853,0.2782631695270538,0.06981568261981011,0.0719272393733263,0.01627271706238389,0.12608497962355614,0.017754395958036184,0.005699196411296725,0.06625615805387497,0.007384830014780163,0.03347482727840543,0.0032110614236444237,0.0005069062899565324,0.0005686667427653447,0.00722985495813191,0.0050141042796894904,0.003036567405797541,0.7857566058635712,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,9379.0,3132493.0,631811.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,VILANTEROL .ALPHA.-PHENYL CINNAMATE,CHEMBL1084173,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),,0.0,0.0,0.0,"InChI=1S/C24H33Cl2NO5.C15H12O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;16-15(17)14(13-9-5-2-6-10-13)11-12-7-3-1-4-8-12/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-11H,(H,16,17)/b;14-11+/t24-;/m0./s1",KAMFDHLRBHTIMJ-AZDLLSQWSA-N,O=C(O)/C(=C/c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,0.03774773363407031,2.0,710.6950000000005,7.919900000000007,7,5,1,128.48000000000002,-3.9367821788138952,0.5115797996520997,-6.198404748949917,0.9480842232704163,-12.16721756966644,0.23092515170574188,0.7299398899078369,0.04355007335543633,102.31623979559151,-1.4609109844148138,0.46287618279457093,0.6742300868034363,0.6072303593158722,0.46496769189834597,0.31418311446905134,14.77572428868982,-4.517079029497111,20.09719802554444,2.9100352021759486,0.02452724054455757,0.18645802438259124,0.02890319274738431,0.5647459626197815,0.7482572972774506,0.006651206593960524,0.0048469255678355696,0.1852792024612427,0.08483418077230453,0.11710634976625442,0.3070312261581421,0.5126046657562255,0.0034008084796369074,0.35168351233005524,0.5168110966682434,0.05995733067393303,0.2977858930826187,False
ADRB2,43,SINGLE PROTEIN,Beta-2 adrenergic receptor,9606,Homo sapiens,CHEMBL210,,0.0,9429.0,2792065.0,624233.0,Beta-2 adrenergic receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,REPROTEROL,CHEMBL1095607,4.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1977.0,-1.0,-terol,0.0,-terol,bronchodilators (phenethylamine derivatives),Bronchodilator,0.0,0.0,0.0,"InChI=1S/C18H23N5O5/c1-21-16-15(17(27)22(2)18(21)28)23(10-20-16)5-3-4-19-9-14(26)11-6-12(24)8-13(25)7-11/h6-8,10,14,19,24-26H,3-5,9H2,1-2H3",WVLAAKXASPCBGT-UHFFFAOYSA-N,Cn1c(=O)c2c(ncn2CCCNCC(O)c2cc(O)cc(O)c2)n(C)c1=O,0.4024151692498397,4.0,389.4120000000001,-0.44180000000000064,10,4,1,134.54,-1.2818713281683796,0.6181858301162719,-6.206290683959747,0.8930400609970093,-15.431057104588671,0.08653565943241119,0.1457301378250122,0.23696113377809525,59.560092920092416,-0.7630939639587443,0.014739435445517302,0.016818942781537772,0.03587491977959871,0.09534831382334233,0.06071065105497837,12.78397235906945,29.999779255506894,-8.868664821214317,2.1270815997884656,0.15596802085638045,0.17329995855689048,0.33621923327445985,0.2556391656398773,0.7378543972969055,0.027202000468969346,0.015274269692599773,0.048157599568367,0.007576588960364461,0.029824594408273696,0.005280630104243756,0.0007721946167293936,0.001808568276464939,0.007140627503395081,0.007205916941165924,0.0040933690965175625,0.19263412207365035,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1171.0,1679366.0,2197279.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IBUPROFEN SODIUM,CHEMBL3989408,4.0,1.0,1.0,MOL,,Small molecule,2012.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2010.0,2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C13H18O2.Na.2H2O/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;;;/h4-7,9-10H,8H2,1-3H3,(H,14,15);;2*1H2/q;+1;;/p-1",VTGPMVCGAVZLQI-UHFFFAOYSA-M,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+],0.5441183661251003,4.0,264.2969999999999,-2.906899999999997,2,0,1,103.13,-0.6611766415792314,0.9419976592063903,-4.56368609956432,0.9904872179031372,-8.876954465912387,0.2542052179574966,0.006075993715785444,0.5076251566410065,77.24127630385634,5.578695163643281,0.0011122131225420162,0.024247715063393117,0.029618933238089083,0.006857169792056084,0.001423823891673237,-4.516743328484113,3.420999314308149,-17.197902762879636,2.36459741138374,0.012215333431959153,0.35337583273649215,0.014731967495754361,0.3427324667572975,0.011503014620393515,0.004498265706934035,0.0005230429087532684,0.07520884200930596,0.005503032519482076,0.004013033304363489,0.0015599256963469087,0.026397577486932278,0.000910473613475915,0.004113325057551265,0.004478728410322219,0.0004830210062209517,0.339094740152359,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1171.0,1679366.0,2197279.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IBUPROFEN SODIUM,CHEMBL3989408,4.0,1.0,1.0,MOL,,Small molecule,2012.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2010.0,2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C13H18O2.Na.2H2O/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;;;/h4-7,9-10H,8H2,1-3H3,(H,14,15);;2*1H2/q;+1;;/p-1",VTGPMVCGAVZLQI-UHFFFAOYSA-M,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+],0.5441183661251003,4.0,264.2969999999999,-2.906899999999997,2,0,1,103.13,-0.6611766415792314,0.9419976592063903,-4.56368609956432,0.9904872179031372,-8.876954465912387,0.2542052179574966,0.006075993715785444,0.5076251566410065,77.24127630385634,5.578695163643281,0.0011122131225420162,0.024247715063393117,0.029618933238089083,0.006857169792056084,0.001423823891673237,-4.516743328484113,3.420999314308149,-17.197902762879636,2.36459741138374,0.012215333431959153,0.35337583273649215,0.014731967495754361,0.3427324667572975,0.011503014620393515,0.004498265706934035,0.0005230429087532684,0.07520884200930596,0.005503032519482076,0.004013033304363489,0.0015599256963469087,0.026397577486932278,0.000910473613475915,0.004113325057551265,0.004478728410322219,0.0004830210062209517,0.339094740152359,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1172.0,1343835.0,16450.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ACETAMINOPHEN,CHEMBL112,4.0,1.0,1.0,MOL,46195.0,Small molecule,1968.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,,2.0,,0.0,,,Analgesic; Antipyretic,0.0,0.0,0.0,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",RZVAJINKPMORJF-UHFFFAOYSA-N,CC(=O)Nc1ccc(O)cc1,0.5950261967780849,4.0,151.165,1.3505999999999998,2,2,0,49.33,-1.171959565791826,0.7195717692375183,-4.815674904579979,0.9948197722434997,-10.877933905848314,0.5327711522579193,0.006760123989079147,0.8292774319648742,39.20476241764786,0.32193157061536953,0.15454559102654458,0.04603266566991806,0.039682614244520666,0.044333999417722224,0.013214908912777901,-6.235376144894634,38.258509174271886,-4.322624573420799,1.6940212212862371,0.24667609930038453,0.14389676675200463,0.012042094487696886,0.2851865977048874,0.07934044077992439,0.04694660156965256,0.009432941349223256,0.14761522114276887,0.022030162252485753,0.10524493604898452,0.006321897823363542,0.0009235460951458663,0.009215549984946846,0.02039686869829893,0.042414455022662875,0.026777056232094764,0.56399564743042,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1172.0,1343835.0,16450.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ACETAMINOPHEN,CHEMBL112,4.0,1.0,1.0,MOL,46195.0,Small molecule,1968.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,,2.0,,0.0,,,Analgesic; Antipyretic,0.0,0.0,0.0,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",RZVAJINKPMORJF-UHFFFAOYSA-N,CC(=O)Nc1ccc(O)cc1,0.5950261967780849,4.0,151.165,1.3505999999999998,2,2,0,49.33,-1.171959565791826,0.7195717692375183,-4.815674904579979,0.9948197722434997,-10.877933905848314,0.5327711522579193,0.006760123989079147,0.8292774319648742,39.20476241764786,0.32193157061536953,0.15454559102654458,0.04603266566991806,0.039682614244520666,0.044333999417722224,0.013214908912777901,-6.235376144894634,38.258509174271886,-4.322624573420799,1.6940212212862371,0.24667609930038453,0.14389676675200463,0.012042094487696886,0.2851865977048874,0.07934044077992439,0.04694660156965256,0.009432941349223256,0.14761522114276887,0.022030162252485753,0.10524493604898452,0.006321897823363542,0.0009235460951458663,0.009215549984946846,0.02039686869829893,0.042414455022662875,0.026777056232094764,0.56399564743042,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1173.0,1343332.0,51056.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NAPROXEN,CHEMBL154,4.0,1.0,1.0,MOL,7476.0,Small molecule,1976.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1970.0,2.0,,0.0,,,"Anti-Inflammatory; Antipyretic; Analgesic,Antipyretic; Anti-Inflammatory; Analgesic",0.0,0.0,0.0,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",CMWTZPSULFXXJA-VIFPVBQESA-N,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,0.8810778082204156,4.0,230.26299999999998,3.036500000000001,2,1,1,46.53,-3.544175796824485,0.9624994277954102,-4.5405517191470635,0.9984886884689331,-10.132402116510425,0.5680681586265564,0.00958723119692877,0.6789486527442932,98.39706515060568,1.319954554333389,0.22146447598934174,0.03441153056919575,0.0355803731828928,0.007400314928963781,0.011066205706447363,9.552375314956496,28.840216766254837,7.94717936899106,2.4447928411155497,0.07264526002109051,0.2246613547205925,0.08187025710940361,0.9450063824653625,0.01642938619479537,0.06410893052816391,0.005978157999925316,0.12454955279827118,0.021520514599978925,0.15885164514183997,0.007256624707952142,0.19714781045913696,0.042521311715245244,0.005145935900509357,0.008939656056463718,0.01977499611675739,0.1995854064822197,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1173.0,1343332.0,51056.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NAPROXEN,CHEMBL154,4.0,1.0,1.0,MOL,7476.0,Small molecule,1976.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1970.0,2.0,,0.0,,,"Anti-Inflammatory; Antipyretic; Analgesic,Antipyretic; Anti-Inflammatory; Analgesic",0.0,0.0,0.0,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",CMWTZPSULFXXJA-VIFPVBQESA-N,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,0.8810778082204156,4.0,230.26299999999998,3.036500000000001,2,1,1,46.53,-3.544175796824485,0.9624994277954102,-4.5405517191470635,0.9984886884689331,-10.132402116510425,0.5680681586265564,0.00958723119692877,0.6789486527442932,98.39706515060568,1.319954554333389,0.22146447598934174,0.03441153056919575,0.0355803731828928,0.007400314928963781,0.011066205706447363,9.552375314956496,28.840216766254837,7.94717936899106,2.4447928411155497,0.07264526002109051,0.2246613547205925,0.08187025710940361,0.9450063824653625,0.01642938619479537,0.06410893052816391,0.005978157999925316,0.12454955279827118,0.021520514599978925,0.15885164514183997,0.007256624707952142,0.19714781045913696,0.042521311715245244,0.005145935900509357,0.008939656056463718,0.01977499611675739,0.1995854064822197,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1174.0,1344797.0,674757.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NAPROXEN SODIUM,CHEMBL1200806,4.0,1.0,1.0,MOL,7477.0,Small molecule,1980.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1973.0,2.0,,0.0,,,Antipyretic; Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1",CDBRNDSHEYLDJV-FVGYRXGTSA-M,COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+],0.6383938847282047,4.0,252.24499999999998,-1.2941999999999987,3,0,1,49.36,-1.8194575980618577,0.9534505009651184,-4.390662757802178,0.9949591040611268,-9.886657225031453,0.4568035125732422,0.013877504318952561,0.7382063627243042,89.64732510727524,4.169814024180073,0.05244753509759903,0.02261585583910346,0.022975154500454665,0.002421976369805634,0.0026770291500724853,-0.7516675357512899,13.264019558569334,-0.76573564237438,2.3297818342379832,0.07212600708007813,0.18807424753904342,0.03921047523617745,0.9046762824058533,0.015090012550354004,0.02983304103836417,0.007149226556066424,0.07955608665943145,0.008165558381006122,0.07309592328965664,0.006330005545169115,0.11047949641942978,0.027212675847113132,0.003278194856829941,0.0020031321386341006,0.009380575618706644,0.20234357714653015,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1174.0,1344797.0,674757.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NAPROXEN SODIUM,CHEMBL1200806,4.0,1.0,1.0,MOL,7477.0,Small molecule,1980.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1973.0,2.0,,0.0,,,Antipyretic; Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1",CDBRNDSHEYLDJV-FVGYRXGTSA-M,COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+],0.6383938847282047,4.0,252.24499999999998,-1.2941999999999987,3,0,1,49.36,-1.8194575980618577,0.9534505009651184,-4.390662757802178,0.9949591040611268,-9.886657225031453,0.4568035125732422,0.013877504318952561,0.7382063627243042,89.64732510727524,4.169814024180073,0.05244753509759903,0.02261585583910346,0.022975154500454665,0.002421976369805634,0.0026770291500724853,-0.7516675357512899,13.264019558569334,-0.76573564237438,2.3297818342379832,0.07212600708007813,0.18807424753904342,0.03921047523617745,0.9046762824058533,0.015090012550354004,0.02983304103836417,0.007149226556066424,0.07955608665943145,0.008165558381006122,0.07309592328965664,0.006330005545169115,0.11047949641942978,0.027212675847113132,0.003278194856829941,0.0020031321386341006,0.009380575618706644,0.20234357714653015,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1175.0,1344967.0,675131.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DICLOFENAC EPOLAMINE,CHEMBL1201180,4.0,1.0,1.0,MOL,48296.0,Small molecule,2007.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2.C6H13NO/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;8-6-5-7-3-1-2-4-7/h1-7,17H,8H2,(H,18,19);8H,1-6H2",DCERVXIINVUMKU-UHFFFAOYSA-N,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1,0.6557239740557527,4.0,411.3290000000003,4.438600000000004,4,3,0,72.8,-3.2370393512244098,0.7965048670768737,-5.3719585080091745,0.9110848307609558,-10.416544450418275,0.23529154658317566,0.16487735360860825,0.5714183211326599,82.99940164698793,5.430579465389377,0.07654838487505913,0.14146970957517624,0.03317971788346767,0.7122049808502198,0.01243093735538423,9.370028262265578,-4.815013294243917,-15.33878180341764,2.8159806361083213,0.08202375024557114,0.1370464891195297,0.5491487503051757,0.21969060003757476,0.641412764787674,0.023104492761194705,0.005722684971988201,0.07605741620063781,0.010559184942394495,0.10032742619514465,0.016226264648139477,0.03267849199473858,0.0032530900556594134,0.04331714529544115,0.04369076695293188,0.015618686005473137,0.472037798166275,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1175.0,1344967.0,675131.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DICLOFENAC EPOLAMINE,CHEMBL1201180,4.0,1.0,1.0,MOL,48296.0,Small molecule,2007.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2.C6H13NO/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;8-6-5-7-3-1-2-4-7/h1-7,17H,8H2,(H,18,19);8H,1-6H2",DCERVXIINVUMKU-UHFFFAOYSA-N,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1,0.6557239740557527,4.0,411.3290000000003,4.438600000000004,4,3,0,72.8,-3.2370393512244098,0.7965048670768737,-5.3719585080091745,0.9110848307609558,-10.416544450418275,0.23529154658317566,0.16487735360860825,0.5714183211326599,82.99940164698793,5.430579465389377,0.07654838487505913,0.14146970957517624,0.03317971788346767,0.7122049808502198,0.01243093735538423,9.370028262265578,-4.815013294243917,-15.33878180341764,2.8159806361083213,0.08202375024557114,0.1370464891195297,0.5491487503051757,0.21969060003757476,0.641412764787674,0.023104492761194705,0.005722684971988201,0.07605741620063781,0.010559184942394495,0.10032742619514465,0.016226264648139477,0.03267849199473858,0.0032530900556594134,0.04331714529544115,0.04369076695293188,0.015618686005473137,0.472037798166275,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1176.0,1343686.0,123693.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DICLOFENAC SODIUM,CHEMBL1034,4.0,1.0,1.0,MOL,4509.0,Small molecule,1988.0,1.0,1.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,1973.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1",KPHWPUGNDIVLNH-UHFFFAOYSA-M,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+],0.8097576266403491,4.0,318.135,0.03339999999999904,3,1,0,52.16,-2.325980841066161,0.9560786843299866,-4.487651881154008,0.9874961137771606,-9.018064566396774,0.3281688690185547,0.013061339920386671,0.6911441326141358,87.94595185511344,-2.617747840278464,0.04205926973372698,0.16272277683019637,0.15710342526435853,0.029312866926193237,0.005869148764759302,-10.157486197796036,36.37538364399953,3.921399401269574,2.2998402859227682,0.04606164544820786,0.3895583271980286,0.05259225498884916,0.8877776265144348,0.04418929591774941,0.026899886131286622,0.011551340110599995,0.08257454633712769,0.01204157485626638,0.08181174173951149,0.02210073368623853,0.42758305966854093,0.041296087019145486,0.019120844453573226,0.02812864873558283,0.059608000330626965,0.2789823651313782,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1176.0,1343686.0,123693.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DICLOFENAC SODIUM,CHEMBL1034,4.0,1.0,1.0,MOL,4509.0,Small molecule,1988.0,1.0,1.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,1973.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1",KPHWPUGNDIVLNH-UHFFFAOYSA-M,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+],0.8097576266403491,4.0,318.135,0.03339999999999904,3,1,0,52.16,-2.325980841066161,0.9560786843299866,-4.487651881154008,0.9874961137771606,-9.018064566396774,0.3281688690185547,0.013061339920386671,0.6911441326141358,87.94595185511344,-2.617747840278464,0.04205926973372698,0.16272277683019637,0.15710342526435853,0.029312866926193237,0.005869148764759302,-10.157486197796036,36.37538364399953,3.921399401269574,2.2998402859227682,0.04606164544820786,0.3895583271980286,0.05259225498884916,0.8877776265144348,0.04418929591774941,0.026899886131286622,0.011551340110599995,0.08257454633712769,0.01204157485626638,0.08181174173951149,0.02210073368623853,0.42758305966854093,0.041296087019145486,0.019120844453573226,0.02812864873558283,0.059608000330626965,0.2789823651313782,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1177.0,1343089.0,1376006.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FENOPROFEN CALCIUM,CHEMBL2103736,4.0,1.0,1.0,MOL,5005.0,Small molecule,1976.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1974.0,1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/2C15H14O3.Ca.2H2O/c2*1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13;;;/h2*2-11H,1H3,(H,16,17);;2*1H2/q;;+2;;/p-2",LZPBLUATTGKZBH-UHFFFAOYSA-L,CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2],0.3019903715539743,3.0,558.6400000000002,2.634400000000002,6,0,2,161.72000000000003,-3.3650553110825436,0.8562568783760071,-5.399492991769036,0.9543294191360474,-8.90289900597903,0.4595949649810791,0.24627093225717545,0.13097008615732192,92.3133133586301,-1.482553876259936,0.03424554672092199,0.30067202150821687,0.5550098121166229,0.025377022754400968,0.04404079811647534,4.311062948404324,12.66141616721911,-28.646572043358844,2.5300504613905472,0.006714060623198748,0.28989455103874207,0.018708950094878673,0.9251487970352172,0.2646466210484505,0.00969172166660428,0.0032368282089009883,0.10331734046339988,0.019170057494193316,0.025517278350889683,0.02073653005063534,0.40487977862358093,0.0017512707854621112,0.029449886456131936,0.07663260474801063,0.008601928199641406,0.08091109842061997,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1177.0,1343089.0,1376006.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FENOPROFEN CALCIUM,CHEMBL2103736,4.0,1.0,1.0,MOL,5005.0,Small molecule,1976.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1974.0,1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/2C15H14O3.Ca.2H2O/c2*1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13;;;/h2*2-11H,1H3,(H,16,17);;2*1H2/q;;+2;;/p-2",LZPBLUATTGKZBH-UHFFFAOYSA-L,CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2],0.3019903715539743,3.0,558.6400000000002,2.634400000000002,6,0,2,161.72000000000003,-3.3650553110825436,0.8562568783760071,-5.399492991769036,0.9543294191360474,-8.90289900597903,0.4595949649810791,0.24627093225717545,0.13097008615732192,92.3133133586301,-1.482553876259936,0.03424554672092199,0.30067202150821687,0.5550098121166229,0.025377022754400968,0.04404079811647534,4.311062948404324,12.66141616721911,-28.646572043358844,2.5300504613905472,0.006714060623198748,0.28989455103874207,0.018708950094878673,0.9251487970352172,0.2646466210484505,0.00969172166660428,0.0032368282089009883,0.10331734046339988,0.019170057494193316,0.025517278350889683,0.02073653005063534,0.40487977862358093,0.0017512707854621112,0.029449886456131936,0.07663260474801063,0.008601928199641406,0.08091109842061997,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1178.0,1343647.0,77652.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DIFLUNISAL,CHEMBL898,4.0,1.0,1.0,MOL,39669.0,Small molecule,1982.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1975.0,1.0,-sal,0.0,-sal,anti-inflammatory agents (salicylic acid derivatives),Analgesic; Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)",HUPFGZXOMWLGNK-UHFFFAOYSA-N,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,0.860782458230497,4.0,250.19999999999996,3.035600000000001,2,2,0,57.53,-3.994268024140093,0.9553147315979004,-4.405323549037687,0.9994378566741944,-9.358598304656264,0.26099503636360166,0.019267730042338373,0.3518651306629181,99.2401013960513,3.6779751123166484,0.25481910556554793,0.04630647823214531,0.26133629977703093,0.028940127789974214,0.015738548804074527,-2.128147784873145,31.636406353609363,26.86273495586072,2.7093599768366707,0.13821984678506852,0.38221929371356966,0.025715173035860062,0.9520793795585633,0.043165491707623,0.07801070138812065,0.006331824557855725,0.2700670659542084,0.08698436841368676,0.21285649240016938,0.013004916161298752,0.08440981656312943,0.06777570322155953,0.00932302512228489,0.11335729137063026,0.02547952588647604,0.2642480581998825,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1178.0,1343647.0,77652.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DIFLUNISAL,CHEMBL898,4.0,1.0,1.0,MOL,39669.0,Small molecule,1982.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1975.0,1.0,-sal,0.0,-sal,anti-inflammatory agents (salicylic acid derivatives),Analgesic; Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)",HUPFGZXOMWLGNK-UHFFFAOYSA-N,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,0.860782458230497,4.0,250.19999999999996,3.035600000000001,2,2,0,57.53,-3.994268024140093,0.9553147315979004,-4.405323549037687,0.9994378566741944,-9.358598304656264,0.26099503636360166,0.019267730042338373,0.3518651306629181,99.2401013960513,3.6779751123166484,0.25481910556554793,0.04630647823214531,0.26133629977703093,0.028940127789974214,0.015738548804074527,-2.128147784873145,31.636406353609363,26.86273495586072,2.7093599768366707,0.13821984678506852,0.38221929371356966,0.025715173035860062,0.9520793795585633,0.043165491707623,0.07801070138812065,0.006331824557855725,0.2700670659542084,0.08698436841368676,0.21285649240016938,0.013004916161298752,0.08440981656312943,0.06777570322155953,0.00932302512228489,0.11335729137063026,0.02547952588647604,0.2642480581998825,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1179.0,1343909.0,1223.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SULFASALAZINE,CHEMBL421,4.0,1.0,1.0,MOL,9334.0,Small molecule,1950.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1975.0,1.0,-lazine; -sal-; sulfa-,0.0,-lazine; -sal-; sulfa-,"antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure; anti-inflammatory agents (salicylic acid derivatives); antimicrobials (sulfonamides derivatives)",Antibacterial,0.0,0.0,0.0,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",NCEXYHBECQHGNR-QZQOTICOSA-N,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,0.5405882217196541,4.0,398.4000000000001,3.7016000000000013,7,3,0,141.31,-5.585266237435189,0.8891540884971618,-5.576819487579005,0.8360781908035279,-12.376316354095705,0.10692892819643021,0.027916631661355495,0.04656450562179089,100.8914374200784,2.2105573129027505,0.0869359940290451,0.025552088115364312,0.09152728542685509,0.00660829603439197,0.00288973682327196,40.34285375816669,28.83256427310845,-29.094094160882072,1.8156139798960822,0.05555276274681091,0.7298843383789062,0.13146150819957256,0.9815651297569274,0.08434209898114205,0.07127125635743141,0.008603166462853551,0.1422385185956955,0.011463627871125936,0.13650606125593184,0.0044453507172875105,0.004227933543734253,0.018227864243090152,0.004312394780572504,0.07117993757128716,0.005521984910592437,0.08325187116861343,True
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1179.0,1343909.0,1223.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SULFASALAZINE,CHEMBL421,4.0,1.0,1.0,MOL,9334.0,Small molecule,1950.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1975.0,1.0,-lazine; -sal-; sulfa-,0.0,-lazine; -sal-; sulfa-,"antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure; anti-inflammatory agents (salicylic acid derivatives); antimicrobials (sulfonamides derivatives)",Antibacterial,0.0,0.0,0.0,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",NCEXYHBECQHGNR-QZQOTICOSA-N,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,0.5405882217196541,4.0,398.4000000000001,3.7016000000000013,7,3,0,141.31,-5.585266237435189,0.8891540884971618,-5.576819487579005,0.8360781908035279,-12.376316354095705,0.10692892819643021,0.027916631661355495,0.04656450562179089,100.8914374200784,2.2105573129027505,0.0869359940290451,0.025552088115364312,0.09152728542685509,0.00660829603439197,0.00288973682327196,40.34285375816669,28.83256427310845,-29.094094160882072,1.8156139798960822,0.05555276274681091,0.7298843383789062,0.13146150819957256,0.9815651297569274,0.08434209898114205,0.07127125635743141,0.008603166462853551,0.1422385185956955,0.011463627871125936,0.13650606125593184,0.0044453507172875105,0.004227933543734253,0.018227864243090152,0.004312394780572504,0.07117993757128716,0.005521984910592437,0.08325187116861343,True
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1180.0,1343587.0,11674.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IBUPROFEN,CHEMBL521,4.0,1.0,1.0,MOL,5855.0,Small molecule,1974.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1968.0,2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",HEFNNWSXXWATRW-UHFFFAOYSA-N,CC(C)Cc1ccc(C(C)C(=O)O)cc1,0.8215995486924976,4.0,206.28499999999997,3.073200000000001,1,1,1,37.3,-2.9543563413777774,0.944992470741272,-4.285483007584077,0.999234402179718,-6.95224861921931,0.6075587213039398,0.002627878956263885,0.510697990655899,90.74887904448548,1.1175621152252895,0.004451633431017399,0.07548706121742725,0.09479938633739948,0.007718964549712837,0.002579934801906347,8.318586030184239,22.049390265042096,0.6778620264490058,2.3940460739494176,0.005829149787314236,0.47697150707244873,0.011836074478924274,0.48682999014854433,0.008396035339683295,0.005815609218552708,0.00024240182392532006,0.1353850856423378,0.018857120536267757,0.004711603559553623,0.0016660836874507368,0.072256201505661,0.000914440699853003,0.005994067899882794,0.04204748305492103,0.0007096500077750534,0.3926186442375183,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1180.0,1343587.0,11674.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IBUPROFEN,CHEMBL521,4.0,1.0,1.0,MOL,5855.0,Small molecule,1974.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1968.0,2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",HEFNNWSXXWATRW-UHFFFAOYSA-N,CC(C)Cc1ccc(C(C)C(=O)O)cc1,0.8215995486924976,4.0,206.28499999999997,3.073200000000001,1,1,1,37.3,-2.9543563413777774,0.944992470741272,-4.285483007584077,0.999234402179718,-6.95224861921931,0.6075587213039398,0.002627878956263885,0.510697990655899,90.74887904448548,1.1175621152252895,0.004451633431017399,0.07548706121742725,0.09479938633739948,0.007718964549712837,0.002579934801906347,8.318586030184239,22.049390265042096,0.6778620264490058,2.3940460739494176,0.005829149787314236,0.47697150707244873,0.011836074478924274,0.48682999014854433,0.008396035339683295,0.005815609218552708,0.00024240182392532006,0.1353850856423378,0.018857120536267757,0.004711603559553623,0.0016660836874507368,0.072256201505661,0.000914440699853003,0.005994067899882794,0.04204748305492103,0.0007096500077750534,0.3926186442375183,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1181.0,1344052.0,986494.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MECLOFENAMATE SODIUM,CHEMBL1562610,4.0,1.0,1.0,MOL,76232.0,Small molecule,1980.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1978.0,1.0,-fenamate,0.0,-fenamate,anti-inflammatory agents (anthranilic acid derivatives) and their salts or esters,,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2.Na.H2O/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19;;/h2-7,17H,1H3,(H,18,19);;1H2/q;+1;/p-1",QHJLLDJTVQAFAN-UHFFFAOYSA-M,Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+],0.7736411069131022,4.0,336.15000000000003,-0.411779999999999,3,1,0,83.66,-3.012360252047282,0.9746381640434265,-4.5473762395023565,0.9954881548881531,-8.608425015507812,0.26217658519744874,0.019643294741399586,0.3347442090511322,81.99898824403235,-2.027401064277325,0.07085263431072235,0.11189986318349839,0.3253510296344757,0.029193422477692365,0.02129781600087881,-17.660313633500962,61.20719022773649,15.089025426824554,2.3387772132336964,0.12146775424480438,0.4818405985832214,0.0345249991863966,0.9139770984649658,0.04496586434543133,0.03210010603070259,0.00500275322701782,0.07981468439102173,0.00998281380161643,0.2387738883495331,0.019427079893648624,0.13592588901519775,0.036446513049304484,0.03142508305609226,0.11875218749046326,0.042427129484713076,0.37025142312049864,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1181.0,1344052.0,986494.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MECLOFENAMATE SODIUM,CHEMBL1562610,4.0,1.0,1.0,MOL,76232.0,Small molecule,1980.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1978.0,1.0,-fenamate,0.0,-fenamate,anti-inflammatory agents (anthranilic acid derivatives) and their salts or esters,,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2.Na.H2O/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19;;/h2-7,17H,1H3,(H,18,19);;1H2/q;+1;/p-1",QHJLLDJTVQAFAN-UHFFFAOYSA-M,Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+],0.7736411069131022,4.0,336.15000000000003,-0.411779999999999,3,1,0,83.66,-3.012360252047282,0.9746381640434265,-4.5473762395023565,0.9954881548881531,-8.608425015507812,0.26217658519744874,0.019643294741399586,0.3347442090511322,81.99898824403235,-2.027401064277325,0.07085263431072235,0.11189986318349839,0.3253510296344757,0.029193422477692365,0.02129781600087881,-17.660313633500962,61.20719022773649,15.089025426824554,2.3387772132336964,0.12146775424480438,0.4818405985832214,0.0345249991863966,0.9139770984649658,0.04496586434543133,0.03210010603070259,0.00500275322701782,0.07981468439102173,0.00998281380161643,0.2387738883495331,0.019427079893648624,0.13592588901519775,0.036446513049304484,0.03142508305609226,0.11875218749046326,0.042427129484713076,0.37025142312049864,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1183.0,1344568.0,119162.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NEPAFENAC,CHEMBL1021,4.0,1.0,1.0,MOL,75922.0,Small molecule,2005.0,0.0,0.0,1.0,0.0,1.0,0.0,2.0,0.0,0.0,1997.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)",QEFAQIPZVLVERP-UHFFFAOYSA-N,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,0.6404218695353087,4.0,254.289,1.5276,3,2,0,86.18,-3.636177854951144,0.9437735319137573,-4.7578928183658675,0.9981334567070007,-12.84690042077528,0.7577629446983337,0.03866531644016504,0.9786650776863098,54.194946615344485,-7.769997678637317,0.09869892671704292,0.15572725757956504,0.07626616507768631,0.010767542291432619,0.044458316266536714,-5.947824918851521,23.356015864639836,0.08293118994810485,2.1438243927463203,0.31241409480571747,0.3791028708219528,0.09305463470518589,0.5886072516441345,0.11358924806118012,0.12918806672096253,0.05093422457575798,0.21713178902864455,0.022407318092882635,0.06568258181214333,0.027219617553055287,0.0055234010331332685,0.025978104304522277,0.00596447242423892,0.03322262652218342,0.02084879009053111,0.38192775249481203,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1183.0,1344568.0,119162.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NEPAFENAC,CHEMBL1021,4.0,1.0,1.0,MOL,75922.0,Small molecule,2005.0,0.0,0.0,1.0,0.0,1.0,0.0,2.0,0.0,0.0,1997.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)",QEFAQIPZVLVERP-UHFFFAOYSA-N,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,0.6404218695353087,4.0,254.289,1.5276,3,2,0,86.18,-3.636177854951144,0.9437735319137573,-4.7578928183658675,0.9981334567070007,-12.84690042077528,0.7577629446983337,0.03866531644016504,0.9786650776863098,54.194946615344485,-7.769997678637317,0.09869892671704292,0.15572725757956504,0.07626616507768631,0.010767542291432619,0.044458316266536714,-5.947824918851521,23.356015864639836,0.08293118994810485,2.1438243927463203,0.31241409480571747,0.3791028708219528,0.09305463470518589,0.5886072516441345,0.11358924806118012,0.12918806672096253,0.05093422457575798,0.21713178902864455,0.022407318092882635,0.06568258181214333,0.027219617553055287,0.0055234010331332685,0.025978104304522277,0.00596447242423892,0.03322262652218342,0.02084879009053111,0.38192775249481203,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1184.0,1345000.0,2197547.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OXYPHENBUTAZONE,CHEMBL3989676,4.0,1.0,1.0,MOL,,Small molecule,1960.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,-2.0,-butazone,0.0,-butazone,anti-inflammatory analgesics (phenylbutazone type),,1.0,0.0,0.0,"InChI=1S/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2",CNDQSXOVEQXJOE-UHFFFAOYSA-N,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O,0.8467081117527829,4.0,342.3950000000001,2.668700000000001,3,1,1,92.35,-3.4676153497112536,0.8940226316452027,-4.784813301074442,0.9969054698944092,-9.440707393934167,0.7565445899963379,0.1491610363125801,0.5734141647815705,87.23308755196409,5.522605489731428,0.0774735663086176,0.49899463057518006,0.638877660036087,0.018960995133966208,0.19561544731259345,0.37644016746462794,21.643018600313702,-11.368570744942925,2.3175910667608215,0.43723151087760925,0.7184822916984558,0.11872825771570206,0.8824283599853515,0.4331919729709625,0.05737254545092583,0.006922608974855393,0.3686605304479599,0.05067854262888431,0.20255839824676514,0.11050409823656082,0.05121156387031078,0.055329001508653164,0.1601611152291298,0.6777923047542572,0.16825023293495178,0.4686071157455444,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1184.0,1345000.0,2197547.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OXYPHENBUTAZONE,CHEMBL3989676,4.0,1.0,1.0,MOL,,Small molecule,1960.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,-2.0,-butazone,0.0,-butazone,anti-inflammatory analgesics (phenylbutazone type),,1.0,0.0,0.0,"InChI=1S/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2",CNDQSXOVEQXJOE-UHFFFAOYSA-N,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O,0.8467081117527829,4.0,342.3950000000001,2.668700000000001,3,1,1,92.35,-3.4676153497112536,0.8940226316452027,-4.784813301074442,0.9969054698944092,-9.440707393934167,0.7565445899963379,0.1491610363125801,0.5734141647815705,87.23308755196409,5.522605489731428,0.0774735663086176,0.49899463057518006,0.638877660036087,0.018960995133966208,0.19561544731259345,0.37644016746462794,21.643018600313702,-11.368570744942925,2.3175910667608215,0.43723151087760925,0.7184822916984558,0.11872825771570206,0.8824283599853515,0.4331919729709625,0.05737254545092583,0.006922608974855393,0.3686605304479599,0.05067854262888431,0.20255839824676514,0.11050409823656082,0.05121156387031078,0.055329001508653164,0.1601611152291298,0.6777923047542572,0.16825023293495178,0.4686071157455444,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1186.0,1343845.0,2197625.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FLURBIPROFEN SODIUM,CHEMBL3989754,4.0,1.0,1.0,MOL,,Small molecule,1986.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C15H13FO2.Na.2H2O/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11;;;/h2-10H,1H3,(H,17,18);;2*1H2/q;+1;;/p-1",GNMBMOULKUXEQF-UHFFFAOYSA-M,CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1.O.O.[Na+],0.5951251079741019,4.0,302.2770000000001,-2.2992999999999992,2,0,1,103.13,-1.3181135999393678,0.9808461666107178,-4.492029180300991,0.9940436124801636,-10.000345847081736,0.4017273634672165,0.016458308976143598,0.6744104385375976,82.75113019660787,1.6210762163980181,0.018539042957127095,0.05130487084388733,0.11712651029229164,0.0024152878497261552,0.0022441213368438184,-28.48332382249739,-5.840759267466423,-9.621987651448299,2.6563477266227373,0.0506936252117157,0.4882157057523727,0.039107803627848624,0.9027141094207763,0.027634654939174653,0.025682775024324655,0.002841775451088324,0.10585635453462601,0.0073220642982050775,0.018666605278849602,0.013013362791389227,0.12798833400011062,0.01088965879753232,0.0014102090033702552,0.0024905858328565953,0.001998111850116402,0.14361616224050522,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1186.0,1343845.0,2197625.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FLURBIPROFEN SODIUM,CHEMBL3989754,4.0,1.0,1.0,MOL,,Small molecule,1986.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C15H13FO2.Na.2H2O/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11;;;/h2-10H,1H3,(H,17,18);;2*1H2/q;+1;;/p-1",GNMBMOULKUXEQF-UHFFFAOYSA-M,CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1.O.O.[Na+],0.5951251079741019,4.0,302.2770000000001,-2.2992999999999992,2,0,1,103.13,-1.3181135999393678,0.9808461666107178,-4.492029180300991,0.9940436124801636,-10.000345847081736,0.4017273634672165,0.016458308976143598,0.6744104385375976,82.75113019660787,1.6210762163980181,0.018539042957127095,0.05130487084388733,0.11712651029229164,0.0024152878497261552,0.0022441213368438184,-28.48332382249739,-5.840759267466423,-9.621987651448299,2.6563477266227373,0.0506936252117157,0.4882157057523727,0.039107803627848624,0.9027141094207763,0.027634654939174653,0.025682775024324655,0.002841775451088324,0.10585635453462601,0.0073220642982050775,0.018666605278849602,0.013013362791389227,0.12798833400011062,0.01088965879753232,0.0014102090033702552,0.0024905858328565953,0.001998111850116402,0.14361616224050522,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1187.0,1343081.0,1280.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ASPIRIN,CHEMBL25,4.0,1.0,1.0,MOL,15365.0,Small molecule,1950.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,2.0,,0.0,,,Analgesic; Antirheumatic; Antipyretic,0.0,0.0,0.0,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",BSYNRYMUTXBXSQ-UHFFFAOYSA-N,CC(=O)Oc1ccccc1C(=O)O,0.5501217966938848,4.0,180.15899999999996,1.3101,3,1,0,63.60000000000001,-1.418994387582296,0.8728528261184693,-4.406400501068553,0.9971104025840759,-8.788301692308234,0.2673666998744011,0.008252925821579993,0.8109905123710632,73.18028455364863,6.688882190998617,0.015933021996170284,0.01203170632943511,0.03166418168693781,0.00694212676025927,0.000235858036467107,3.5387607386474604,22.27286034226973,29.698104911143695,2.214422704961032,0.050855766981840134,0.25335290729999543,0.13706260044127702,0.8547624945640564,0.003373288526199758,0.02305667269974947,0.0021974523551762104,0.029106762260198593,0.003623103233985603,0.0074217281304299835,0.0006330778007395566,0.004367552418261767,0.0012725533801130951,0.006973762670531869,0.0017703494988381863,0.001996007445268333,0.3067779153585434,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1187.0,1343081.0,1280.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ASPIRIN,CHEMBL25,4.0,1.0,1.0,MOL,15365.0,Small molecule,1950.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,2.0,,0.0,,,Analgesic; Antirheumatic; Antipyretic,0.0,0.0,0.0,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",BSYNRYMUTXBXSQ-UHFFFAOYSA-N,CC(=O)Oc1ccccc1C(=O)O,0.5501217966938848,4.0,180.15899999999996,1.3101,3,1,0,63.60000000000001,-1.418994387582296,0.8728528261184693,-4.406400501068553,0.9971104025840759,-8.788301692308234,0.2673666998744011,0.008252925821579993,0.8109905123710632,73.18028455364863,6.688882190998617,0.015933021996170284,0.01203170632943511,0.03166418168693781,0.00694212676025927,0.000235858036467107,3.5387607386474604,22.27286034226973,29.698104911143695,2.214422704961032,0.050855766981840134,0.25335290729999543,0.13706260044127702,0.8547624945640564,0.003373288526199758,0.02305667269974947,0.0021974523551762104,0.029106762260198593,0.003623103233985603,0.0074217281304299835,0.0006330778007395566,0.004367552418261767,0.0012725533801130951,0.006973762670531869,0.0017703494988381863,0.001996007445268333,0.3067779153585434,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1188.0,1344545.0,674564.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TOLMETIN SODIUM,CHEMBL1200613,4.0,1.0,1.0,MOL,9619.0,Small molecule,1976.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1976.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C15H15NO3.Na/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18;/h3-8H,9H2,1-2H3,(H,17,18);/q;+1/p-1",QGUALMNFRILWRA-UHFFFAOYSA-M,Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+],0.4739303092496801,4.0,279.27099999999996,-2.139079999999997,4,0,0,62.13,-1.0060338898767582,0.9545072317123413,-4.428838174939419,0.9729527115821839,-10.626022116394651,0.4584460288286209,0.014612949546426534,0.6146687984466552,78.84618454516809,5.375227720991122,0.011893071373924613,0.09014658257365227,0.05168293640017509,0.003533626871649176,0.0029925246955826877,-5.276776780178743,7.185509865480311,-9.421668030258084,2.4593247095659145,0.047165491804480555,0.31723320186138154,0.030605371482670306,0.9061221122741699,0.007853146409615874,0.05323224849998951,0.017376557737588883,0.13733038827776908,0.011813988862559199,0.024637196585536,0.006260759895667434,0.05925995483994484,0.021330374479293823,0.004953256482258439,0.002351775113493204,0.007284454628825187,0.22720151841640474,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1188.0,1344545.0,674564.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TOLMETIN SODIUM,CHEMBL1200613,4.0,1.0,1.0,MOL,9619.0,Small molecule,1976.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1976.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C15H15NO3.Na/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18;/h3-8H,9H2,1-2H3,(H,17,18);/q;+1/p-1",QGUALMNFRILWRA-UHFFFAOYSA-M,Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+],0.4739303092496801,4.0,279.27099999999996,-2.139079999999997,4,0,0,62.13,-1.0060338898767582,0.9545072317123413,-4.428838174939419,0.9729527115821839,-10.626022116394651,0.4584460288286209,0.014612949546426534,0.6146687984466552,78.84618454516809,5.375227720991122,0.011893071373924613,0.09014658257365227,0.05168293640017509,0.003533626871649176,0.0029925246955826877,-5.276776780178743,7.185509865480311,-9.421668030258084,2.4593247095659145,0.047165491804480555,0.31723320186138154,0.030605371482670306,0.9061221122741699,0.007853146409615874,0.05323224849998951,0.017376557737588883,0.13733038827776908,0.011813988862559199,0.024637196585536,0.006260759895667434,0.05925995483994484,0.021330374479293823,0.004953256482258439,0.002351775113493204,0.007284454628825187,0.22720151841640474,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1189.0,1343952.0,674755.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DICLOFENAC POTASSIUM,CHEMBL1200804,4.0,1.0,1.0,MOL,4508.0,Small molecule,1993.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1992.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2.K/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1",KXZOIWWTXOCYKR-UHFFFAOYSA-M,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+],0.8032598436330827,4.0,334.243,0.03339999999999904,3,1,0,52.16,-2.4497560043812223,0.9516978859901428,-4.52033041446079,0.988964569568634,-9.1317766315618,0.35921592116355894,0.016631305194459857,0.6840153694152832,88.53527918327313,-2.9135475979435523,0.0717727117240429,0.22742361426353455,0.2309750497341156,0.05370930656790733,0.010288040060549975,-11.176731400972164,37.57679769635421,3.747547815230059,2.324613825917924,0.04369086548686028,0.37833148837089536,0.06219838000833988,0.887485945224762,0.0642298512160778,0.025729933008551597,0.011972665693610907,0.08482025116682053,0.01384630836546421,0.09586406946182251,0.026435409486293793,0.5075150847434997,0.04089352302253246,0.0250382537022233,0.04228591714054346,0.07130761966109275,0.2805305391550064,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1189.0,1343952.0,674755.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DICLOFENAC POTASSIUM,CHEMBL1200804,4.0,1.0,1.0,MOL,4508.0,Small molecule,1993.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1992.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2.K/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1",KXZOIWWTXOCYKR-UHFFFAOYSA-M,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+],0.8032598436330827,4.0,334.243,0.03339999999999904,3,1,0,52.16,-2.4497560043812223,0.9516978859901428,-4.52033041446079,0.988964569568634,-9.1317766315618,0.35921592116355894,0.016631305194459857,0.6840153694152832,88.53527918327313,-2.9135475979435523,0.0717727117240429,0.22742361426353455,0.2309750497341156,0.05370930656790733,0.010288040060549975,-11.176731400972164,37.57679769635421,3.747547815230059,2.324613825917924,0.04369086548686028,0.37833148837089536,0.06219838000833988,0.887485945224762,0.0642298512160778,0.025729933008551597,0.011972665693610907,0.08482025116682053,0.01384630836546421,0.09586406946182251,0.026435409486293793,0.5075150847434997,0.04089352302253246,0.0250382537022233,0.04228591714054346,0.07130761966109275,0.2805305391550064,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1191.0,1344418.0,674711.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BALSALAZIDE DISODIUM,CHEMBL1200760,4.0,1.0,1.0,MOL,,Small molecule,2000.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,1994.0,1.0,-sal-,0.0,-sal-,anti-inflammatory agents (salicylic acid derivatives),Anti-Inflammatory (gastrointestinal),0.0,0.0,0.0,"InChI=1S/C17H15N3O6.2Na/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23;;/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26);;/q;2*+1/p-2/b20-19+;;",CKMOQBVBEGCJGW-LLIZZRELSA-L,O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+],0.3478142835246101,4.0,401.2860000000001,-5.951099999999998,8,2,0,154.31,-1.5724952254030231,0.7629079580307007,-5.828276853956072,0.49523473531007767,-13.841510895145998,0.037206697091460225,0.012264182092621922,0.10608487874269486,71.42163697966203,2.017839227966874,0.020987038780003787,0.00474450180772692,0.022013866622000933,0.002929453528486192,0.0011312514194287359,23.864837388540348,2.7040644752005414,-43.58721658177482,1.9093973328605351,0.4024006247520447,0.5058104515075683,0.04628345649689436,0.8386390089988709,0.09537078589200973,0.03626548163592815,0.0038862138811964543,0.15912705957889556,0.007450217893347144,0.15975602418184282,0.0014060763671295718,0.0013665678328834475,0.009544025361537933,0.0025685356580652297,0.017951378010911866,0.002781245284131728,0.4243291974067688,True
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1191.0,1344418.0,674711.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BALSALAZIDE DISODIUM,CHEMBL1200760,4.0,1.0,1.0,MOL,,Small molecule,2000.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,1994.0,1.0,-sal-,0.0,-sal-,anti-inflammatory agents (salicylic acid derivatives),Anti-Inflammatory (gastrointestinal),0.0,0.0,0.0,"InChI=1S/C17H15N3O6.2Na/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23;;/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26);;/q;2*+1/p-2/b20-19+;;",CKMOQBVBEGCJGW-LLIZZRELSA-L,O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+],0.3478142835246101,4.0,401.2860000000001,-5.951099999999998,8,2,0,154.31,-1.5724952254030231,0.7629079580307007,-5.828276853956072,0.49523473531007767,-13.841510895145998,0.037206697091460225,0.012264182092621922,0.10608487874269486,71.42163697966203,2.017839227966874,0.020987038780003787,0.00474450180772692,0.022013866622000933,0.002929453528486192,0.0011312514194287359,23.864837388540348,2.7040644752005414,-43.58721658177482,1.9093973328605351,0.4024006247520447,0.5058104515075683,0.04628345649689436,0.8386390089988709,0.09537078589200973,0.03626548163592815,0.0038862138811964543,0.15912705957889556,0.007450217893347144,0.15975602418184282,0.0014060763671295718,0.0013665678328834475,0.009544025361537933,0.0025685356580652297,0.017951378010911866,0.002781245284131728,0.4243291974067688,True
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1192.0,1343317.0,173.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,INDOMETHACIN,CHEMBL6,4.0,1.0,1.0,MOL,49662.0,Small molecule,1965.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1963.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",CGIGDMFJXJATDK-UHFFFAOYSA-N,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,0.7678065120522066,4.0,357.793,3.9273200000000026,4,1,0,68.53,-4.672573684057737,0.967554235458374,-4.650921805192151,0.994447124004364,-10.265710285462069,0.7794628381729126,0.10358728915452957,0.6454257607460022,96.59282442931797,-1.9742407889450824,0.2154465913772583,0.20571435242891312,0.36989825963974,0.016221056692302227,0.1189479723572731,18.441536771177148,14.823122692381622,7.027541803649695,3.70890424771937,0.05099570043385029,0.2461811751127243,0.14116985201835633,0.9782098054885864,0.0869639091193676,0.040654604136943814,0.012279136525467037,0.10578830316662788,0.03546404018998146,0.2072271943092346,0.08588629812002183,0.41672717332839965,0.03893889356404543,0.029725501500070094,0.052379151061177256,0.10626723468303681,0.10366532951593399,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1192.0,1343317.0,173.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,INDOMETHACIN,CHEMBL6,4.0,1.0,1.0,MOL,49662.0,Small molecule,1965.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1963.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",CGIGDMFJXJATDK-UHFFFAOYSA-N,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,0.7678065120522066,4.0,357.793,3.9273200000000026,4,1,0,68.53,-4.672573684057737,0.967554235458374,-4.650921805192151,0.994447124004364,-10.265710285462069,0.7794628381729126,0.10358728915452957,0.6454257607460022,96.59282442931797,-1.9742407889450824,0.2154465913772583,0.20571435242891312,0.36989825963974,0.016221056692302227,0.1189479723572731,18.441536771177148,14.823122692381622,7.027541803649695,3.70890424771937,0.05099570043385029,0.2461811751127243,0.14116985201835633,0.9782098054885864,0.0869639091193676,0.040654604136943814,0.012279136525467037,0.10578830316662788,0.03546404018998146,0.2072271943092346,0.08588629812002183,0.41672717332839965,0.03893889356404543,0.029725501500070094,0.052379151061177256,0.10626723468303681,0.10366532951593399,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1193.0,1344779.0,1671238.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BROMFENAC SODIUM,CHEMBL3181947,4.0,1.0,1.0,MOL,59176.0,Small molecule,1997.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,1986.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),,1.0,0.0,0.0,"InChI=1S/2C15H12BrNO3.2Na.3H2O/c2*16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19;;;;;/h2*1-7H,8,17H2,(H,18,19);;;3*1H2/q;;2*+1;;;/p-2",PPOSVVJOVKVBPW-UHFFFAOYSA-L,Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.O.O.O.[Na+].[Na+],0.09917801793012647,3.0,766.3470000000002,-5.356699999999995,8,2,0,260.94,-1.517636133365525,0.8412969708442688,-5.801362313234632,0.786372721195221,-10.966392341819347,0.15935269892215728,0.3096455216407776,0.6551552057266236,77.80167784573182,-1.571063914340683,0.03204054911620915,0.2966983675956726,0.32104248404502866,0.09050583131611348,0.14401472210884095,78.23611490985851,-7.472655160807925,-16.184709619276845,2.5980108909198414,0.0314500511623919,0.1619840994477272,0.09258397109806538,0.926222825050354,0.34165789783000944,0.0472714938223362,0.019993401993997396,0.0650793956592679,0.010893341433256865,0.028662199154496193,0.030404068529605865,0.22097895294427872,0.007905009808018804,0.01846523191779852,0.04695636704564095,0.024986711982637643,0.14973099082708358,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1193.0,1344779.0,1671238.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BROMFENAC SODIUM,CHEMBL3181947,4.0,1.0,1.0,MOL,59176.0,Small molecule,1997.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,1986.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),,1.0,0.0,0.0,"InChI=1S/2C15H12BrNO3.2Na.3H2O/c2*16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19;;;;;/h2*1-7H,8,17H2,(H,18,19);;;3*1H2/q;;2*+1;;;/p-2",PPOSVVJOVKVBPW-UHFFFAOYSA-L,Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.O.O.O.[Na+].[Na+],0.09917801793012647,3.0,766.3470000000002,-5.356699999999995,8,2,0,260.94,-1.517636133365525,0.8412969708442688,-5.801362313234632,0.786372721195221,-10.966392341819347,0.15935269892215728,0.3096455216407776,0.6551552057266236,77.80167784573182,-1.571063914340683,0.03204054911620915,0.2966983675956726,0.32104248404502866,0.09050583131611348,0.14401472210884095,78.23611490985851,-7.472655160807925,-16.184709619276845,2.5980108909198414,0.0314500511623919,0.1619840994477272,0.09258397109806538,0.926222825050354,0.34165789783000944,0.0472714938223362,0.019993401993997396,0.0650793956592679,0.010893341433256865,0.028662199154496193,0.030404068529605865,0.22097895294427872,0.007905009808018804,0.01846523191779852,0.04695636704564095,0.024986711982637643,0.14973099082708358,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1194.0,1344555.0,16308.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FLURBIPROFEN,CHEMBL563,4.0,1.0,1.0,MOL,5130.0,Small molecule,1986.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1976.0,1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),"Anti-Inflammatory; Analgesic,Inhibitor (prostaglandin synthesis)",0.0,0.0,0.0,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",SYTBZMRGLBWNTM-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,0.8937504426107861,4.0,244.265,3.6808000000000023,1,1,1,37.3,-3.8395834988388913,0.9857722759246826,-4.213516731898736,0.9996794819831848,-7.8069837529910355,0.7054333090782166,0.007936770969536155,0.6934967875480652,98.91965071666594,-0.13380975626019875,0.11046135872602462,0.1614387884736061,0.2581418722867966,0.0027261275914497673,0.005391443194821477,-8.94109194774767,12.892990377919585,20.125921414241624,2.981274774661031,0.04413406476378441,0.6033723294734955,0.031545568630099295,0.963310718536377,0.018640129547566175,0.048829948902130126,0.0032785941031761466,0.29345365464687345,0.03683602251112461,0.05990256778895855,0.0216466860845685,0.4202945947647095,0.06782867703586817,0.0033340191934257747,0.02058196794241667,0.010582725051790476,0.2045402780175209,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1194.0,1344555.0,16308.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FLURBIPROFEN,CHEMBL563,4.0,1.0,1.0,MOL,5130.0,Small molecule,1986.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1976.0,1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),"Anti-Inflammatory; Analgesic,Inhibitor (prostaglandin synthesis)",0.0,0.0,0.0,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",SYTBZMRGLBWNTM-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,0.8937504426107861,4.0,244.265,3.6808000000000023,1,1,1,37.3,-3.8395834988388913,0.9857722759246826,-4.213516731898736,0.9996794819831848,-7.8069837529910355,0.7054333090782166,0.007936770969536155,0.6934967875480652,98.91965071666594,-0.13380975626019875,0.11046135872602462,0.1614387884736061,0.2581418722867966,0.0027261275914497673,0.005391443194821477,-8.94109194774767,12.892990377919585,20.125921414241624,2.981274774661031,0.04413406476378441,0.6033723294734955,0.031545568630099295,0.963310718536377,0.018640129547566175,0.048829948902130126,0.0032785941031761466,0.29345365464687345,0.03683602251112461,0.05990256778895855,0.0216466860845685,0.4202945947647095,0.06782867703586817,0.0033340191934257747,0.02058196794241667,0.010582725051790476,0.2045402780175209,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1195.0,1344870.0,675075.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,KETOROLAC TROMETHAMINE,CHEMBL1201124,4.0,1.0,1.0,MOL,6130.0,Small molecule,1989.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1984.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Analgesic,0.0,0.0,0.0,"InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2",BWHLPLXXIDYSNW-UHFFFAOYSA-N,NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,0.4443374725320323,4.0,376.40900000000016,-0.048200000000000076,7,5,1,146.01,-2.346983786507053,0.6695148587226868,-6.210129876987362,0.30985545217990873,-14.834927713123227,0.03498115697875619,0.010632521426305174,0.33059005439281464,53.579141240940444,5.504647762778694,0.004329569602850825,0.011036439123563469,0.0063947179703973235,0.03716548141092062,0.001940898399334401,17.76352744278505,4.6502517182607,-9.215820027724629,2.4557353241156568,0.04194695046171546,0.08696779757738113,0.17242545858025551,0.17676569521427155,0.047091851755976674,0.09184157028794289,0.02301939520984888,0.10462604835629463,0.01801316733472049,0.025426746625453234,0.0025400906568393113,0.0018604569748276844,0.0014132837863144233,0.0017505065246950836,0.0010819315451954027,0.0035387874231673777,0.11239350512623787,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1195.0,1344870.0,675075.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,KETOROLAC TROMETHAMINE,CHEMBL1201124,4.0,1.0,1.0,MOL,6130.0,Small molecule,1989.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1984.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Analgesic,0.0,0.0,0.0,"InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2",BWHLPLXXIDYSNW-UHFFFAOYSA-N,NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,0.4443374725320323,4.0,376.40900000000016,-0.048200000000000076,7,5,1,146.01,-2.346983786507053,0.6695148587226868,-6.210129876987362,0.30985545217990873,-14.834927713123227,0.03498115697875619,0.010632521426305174,0.33059005439281464,53.579141240940444,5.504647762778694,0.004329569602850825,0.011036439123563469,0.0063947179703973235,0.03716548141092062,0.001940898399334401,17.76352744278505,4.6502517182607,-9.215820027724629,2.4557353241156568,0.04194695046171546,0.08696779757738113,0.17242545858025551,0.17676569521427155,0.047091851755976674,0.09184157028794289,0.02301939520984888,0.10462604835629463,0.01801316733472049,0.025426746625453234,0.0025400906568393113,0.0018604569748276844,0.0014132837863144233,0.0017505065246950836,0.0010819315451954027,0.0035387874231673777,0.11239350512623787,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1196.0,1343145.0,16510.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SULINDAC,CHEMBL15770,4.0,1.0,1.0,MOL,9352.0,Small molecule,1978.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1975.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-",MLKXDPUZXIRXEP-MFOYZWKCSA-N,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1,0.8279102305740682,4.0,356.41800000000006,4.365500000000003,2,1,1,60.36,-4.443826391243322,0.9060962796211243,-4.75270214908136,0.9948322415351868,-8.295112100844442,0.6086641311645508,0.18425150066614152,0.6887896418571472,94.1710075380885,0.8805385397026914,0.5432955920696259,0.3124925851821899,0.3586486607789993,0.11126651018857955,0.10756798386573792,11.89354156910128,14.680132174638473,4.8524130111340416,3.4094546733835545,0.25032438039779664,0.453983736038208,0.1552468091249466,0.9257297873497009,0.19754096269607543,0.1026286743581295,0.07210856601595879,0.3292692333459854,0.10901165753602982,0.3300303965806961,0.22616000175476075,0.6178881168365479,0.15968407541513444,0.12140417248010635,0.42601191997528076,0.21471524238586426,0.5018167942762375,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1196.0,1343145.0,16510.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SULINDAC,CHEMBL15770,4.0,1.0,1.0,MOL,9352.0,Small molecule,1978.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1975.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-",MLKXDPUZXIRXEP-MFOYZWKCSA-N,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1,0.8279102305740682,4.0,356.41800000000006,4.365500000000003,2,1,1,60.36,-4.443826391243322,0.9060962796211243,-4.75270214908136,0.9948322415351868,-8.295112100844442,0.6086641311645508,0.18425150066614152,0.6887896418571472,94.1710075380885,0.8805385397026914,0.5432955920696259,0.3124925851821899,0.3586486607789993,0.11126651018857955,0.10756798386573792,11.89354156910128,14.680132174638473,4.8524130111340416,3.4094546733835545,0.25032438039779664,0.453983736038208,0.1552468091249466,0.9257297873497009,0.19754096269607543,0.1026286743581295,0.07210856601595879,0.3292692333459854,0.10901165753602982,0.3300303965806961,0.22616000175476075,0.6178881168365479,0.15968407541513444,0.12140417248010635,0.42601191997528076,0.21471524238586426,0.5018167942762375,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1197.0,1343285.0,674964.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OLSALAZINE SODIUM,CHEMBL1201013,4.0,1.0,1.0,MOL,,Small molecule,1990.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,1987.0,1.0,-lazine; -sal-,0.0,-lazine; -sal-,"antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure; anti-inflammatory agents (salicylic acid derivatives)",Anti-Inflammatory (gastrointestinal),0.0,0.0,0.0,"InChI=1S/C14H10N2O6.2Na/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22;;/h1-6,17-18H,(H,19,20)(H,21,22);;/q;2*+1/p-2/b16-15+;;",ZJEFYLVGGFISGT-VRZXRVJBSA-L,O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+],0.4166705858351059,4.0,346.206,-5.751799999999998,8,2,0,145.44,-2.034792037397845,0.7946379780769348,-5.3113354565723485,0.8673311591148376,-12.159417330339085,0.06914923451840878,0.013156190305016935,0.055404061637818816,75.62415440469204,6.8473860392895265,0.10079820193350315,0.00825873299036175,0.06054999828338623,0.0027774345478974284,0.0022474701632745563,26.161342644734788,9.89812497889958,-43.29821549660507,1.802790224858515,0.4561019837856293,0.4729393243789673,0.017007068288512527,0.9238205194473267,0.10062396693974733,0.03421241715550423,0.0036771990460692907,0.2537034034729004,0.015637778025120497,0.5634566485881806,0.0025827736128121613,0.0017736334702931345,0.034077463857829574,0.003824261529371142,0.1752708699554205,0.004419432813301682,0.6478180050849914,True
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1197.0,1343285.0,674964.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OLSALAZINE SODIUM,CHEMBL1201013,4.0,1.0,1.0,MOL,,Small molecule,1990.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,1987.0,1.0,-lazine; -sal-,0.0,-lazine; -sal-,"antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure; anti-inflammatory agents (salicylic acid derivatives)",Anti-Inflammatory (gastrointestinal),0.0,0.0,0.0,"InChI=1S/C14H10N2O6.2Na/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22;;/h1-6,17-18H,(H,19,20)(H,21,22);;/q;2*+1/p-2/b16-15+;;",ZJEFYLVGGFISGT-VRZXRVJBSA-L,O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+],0.4166705858351059,4.0,346.206,-5.751799999999998,8,2,0,145.44,-2.034792037397845,0.7946379780769348,-5.3113354565723485,0.8673311591148376,-12.159417330339085,0.06914923451840878,0.013156190305016935,0.055404061637818816,75.62415440469204,6.8473860392895265,0.10079820193350315,0.00825873299036175,0.06054999828338623,0.0027774345478974284,0.0022474701632745563,26.161342644734788,9.89812497889958,-43.29821549660507,1.802790224858515,0.4561019837856293,0.4729393243789673,0.017007068288512527,0.9238205194473267,0.10062396693974733,0.03421241715550423,0.0036771990460692907,0.2537034034729004,0.015637778025120497,0.5634566485881806,0.0025827736128121613,0.0017736334702931345,0.034077463857829574,0.003824261529371142,0.1752708699554205,0.004419432813301682,0.6478180050849914,True
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1199.0,1343387.0,2197281.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,INDOMETHACIN SODIUM,CHEMBL3989410,4.0,1.0,1.0,MOL,,Small molecule,1985.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1987.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H16ClNO4.Na.3H2O/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12;;;;/h3-9H,10H2,1-2H3,(H,22,23);;3*1H2/q;+1;;;/p-1",UHYAQBLOGVNWNT-UHFFFAOYSA-M,COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.O.O.O.[Na+],0.4032147817182383,4.0,433.8200000000001,-2.877479999999999,5,0,0,165.86,-1.950603657703068,0.94723482131958,-5.155565298640717,0.9526914238929749,-11.62260649449939,0.4805361688137054,0.09119412750005722,0.5540672540664673,80.76873052067214,0.8684996137587155,0.04823476374149323,0.0772084940224886,0.16655890494585038,0.013330240081995726,0.06158721968531609,33.26405633876401,-16.043432055152547,-13.232952415571503,3.2641521100848694,0.04255216997116804,0.12492306083440781,0.148885390907526,0.9569127678871154,0.12554622441530228,0.026147402264177798,0.010194768896326423,0.05087837520986795,0.014240706712007523,0.06827523410320283,0.04099297374486923,0.09130577594041825,0.009073921921662986,0.015203080233186483,0.014312800136394799,0.03765107449144125,0.08015160709619522,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1199.0,1343387.0,2197281.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,INDOMETHACIN SODIUM,CHEMBL3989410,4.0,1.0,1.0,MOL,,Small molecule,1985.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1987.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H16ClNO4.Na.3H2O/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12;;;;/h3-9H,10H2,1-2H3,(H,22,23);;3*1H2/q;+1;;;/p-1",UHYAQBLOGVNWNT-UHFFFAOYSA-M,COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.O.O.O.[Na+],0.4032147817182383,4.0,433.8200000000001,-2.877479999999999,5,0,0,165.86,-1.950603657703068,0.94723482131958,-5.155565298640717,0.9526914238929749,-11.62260649449939,0.4805361688137054,0.09119412750005722,0.5540672540664673,80.76873052067214,0.8684996137587155,0.04823476374149323,0.0772084940224886,0.16655890494585038,0.013330240081995726,0.06158721968531609,33.26405633876401,-16.043432055152547,-13.232952415571503,3.2641521100848694,0.04255216997116804,0.12492306083440781,0.148885390907526,0.9569127678871154,0.12554622441530228,0.026147402264177798,0.010194768896326423,0.05087837520986795,0.014240706712007523,0.06827523410320283,0.04099297374486923,0.09130577594041825,0.009073921921662986,0.015203080233186483,0.014312800136394799,0.03765107449144125,0.08015160709619522,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1200.0,1343796.0,674414.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OXAPROZIN POTASSIUM,CHEMBL1200463,4.0,1.0,1.0,MOL,,Small molecule,2002.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H15NO3.K/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14;/h1-10H,11-12H2,(H,20,21);/q;+1/p-1",QTAQWNSMRSLSCG-UHFFFAOYSA-M,O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.[K+],0.6020061182062483,4.0,331.4120000000001,-0.30489999999999995,4,0,0,66.16,-0.8971646822209873,0.9315579414367676,-4.86776055199626,0.9924705147743225,-9.83500924536291,0.6307656645774842,0.13797318190336227,0.6136037886142731,91.50334537862469,6.504123996163787,0.1367454469203949,0.1886315479874611,0.2452628195285797,0.010053788358345628,0.003215672611258924,-14.118744548770072,10.531802682242827,-8.041968247922043,2.034117402211994,0.012762947287410498,0.26073524057865144,0.048112794011831286,0.9362616419792176,0.03079605773091316,0.02446819096803665,0.013614740129560233,0.19276273846626282,0.02084678029641509,0.021586978621780873,0.02645152769982815,0.5519599258899689,0.01631009643897414,0.01900716871023178,0.011665995139628649,0.00570785345043987,0.32848864495754243,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1200.0,1343796.0,674414.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OXAPROZIN POTASSIUM,CHEMBL1200463,4.0,1.0,1.0,MOL,,Small molecule,2002.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H15NO3.K/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14;/h1-10H,11-12H2,(H,20,21);/q;+1/p-1",QTAQWNSMRSLSCG-UHFFFAOYSA-M,O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.[K+],0.6020061182062483,4.0,331.4120000000001,-0.30489999999999995,4,0,0,66.16,-0.8971646822209873,0.9315579414367676,-4.86776055199626,0.9924705147743225,-9.83500924536291,0.6307656645774842,0.13797318190336227,0.6136037886142731,91.50334537862469,6.504123996163787,0.1367454469203949,0.1886315479874611,0.2452628195285797,0.010053788358345628,0.003215672611258924,-14.118744548770072,10.531802682242827,-8.041968247922043,2.034117402211994,0.012762947287410498,0.26073524057865144,0.048112794011831286,0.9362616419792176,0.03079605773091316,0.02446819096803665,0.013614740129560233,0.19276273846626282,0.02084678029641509,0.021586978621780873,0.02645152769982815,0.5519599258899689,0.01631009643897414,0.01900716871023178,0.011665995139628649,0.00570785345043987,0.32848864495754243,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1201.0,1344524.0,29989.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MEFENAMIC ACID,CHEMBL686,4.0,1.0,1.0,MOL,6717.0,Small molecule,1967.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1962.0,1.0,-fenamic acid,0.0,-fenamic acid,anti-inflammatory agents (anthranilic acid derivatives) and their salts or esters,Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)",HYYBABOKPJLUIN-UHFFFAOYSA-N,Cc1cccc(Nc2ccccc2C(=O)O)c1C,0.8600549198257493,4.0,241.29,3.7452400000000017,2,2,0,49.33,-4.565768420992852,0.978310489654541,-4.506043111885433,0.999557638168335,-7.509845024834419,0.46728594303131105,0.007937777822371572,0.44290889501571656,90.32348076437714,1.5510088451989652,0.39837926030159,0.16893724948167801,0.2651142179965973,0.09158865287899971,0.05714593678712845,-16.85676792752805,61.09235860108653,29.220893198020008,2.447071397872038,0.2099754512310028,0.510643994808197,0.04023082964122295,0.9396961450576782,0.0727517306804657,0.07018873989582061,0.004754484829027206,0.2816537767648697,0.0420136846601963,0.6042159676551819,0.032816948182880876,0.1828416794538498,0.11814925745129586,0.04436839483678341,0.5228127419948578,0.06068114303052426,0.4591634750366211,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1201.0,1344524.0,29989.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MEFENAMIC ACID,CHEMBL686,4.0,1.0,1.0,MOL,6717.0,Small molecule,1967.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1962.0,1.0,-fenamic acid,0.0,-fenamic acid,anti-inflammatory agents (anthranilic acid derivatives) and their salts or esters,Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)",HYYBABOKPJLUIN-UHFFFAOYSA-N,Cc1cccc(Nc2ccccc2C(=O)O)c1C,0.8600549198257493,4.0,241.29,3.7452400000000017,2,2,0,49.33,-4.565768420992852,0.978310489654541,-4.506043111885433,0.999557638168335,-7.509845024834419,0.46728594303131105,0.007937777822371572,0.44290889501571656,90.32348076437714,1.5510088451989652,0.39837926030159,0.16893724948167801,0.2651142179965973,0.09158865287899971,0.05714593678712845,-16.85676792752805,61.09235860108653,29.220893198020008,2.447071397872038,0.2099754512310028,0.510643994808197,0.04023082964122295,0.9396961450576782,0.0727517306804657,0.07018873989582061,0.004754484829027206,0.2816537767648697,0.0420136846601963,0.6042159676551819,0.032816948182880876,0.1828416794538498,0.11814925745129586,0.04436839483678341,0.5228127419948578,0.06068114303052426,0.4591634750366211,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1202.0,1344958.0,33202.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MESALAMINE,CHEMBL704,4.0,1.0,1.0,MOL,6775.0,Small molecule,1987.0,1.0,0.0,1.0,0.0,1.0,0.0,2.0,0.0,0.0,1986.0,1.0,-sal-,0.0,-sal-,anti-inflammatory agents (salicylic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",KBOPZPXVLCULAV-UHFFFAOYSA-N,Nc1ccc(O)c(C(=O)O)c1,0.4087158551274257,4.0,153.137,0.6726000000000001,3,3,0,83.55,-1.9100107767145638,0.7893235087394714,-5.48217396595888,0.9967845797538757,-12.61285930912962,0.028260079864412545,0.003903436567634344,0.3388363867998123,64.5874064258775,4.566682425440708,0.03412038031965494,0.027342851832509042,0.10657779648900031,0.07186451554298401,0.05021141488105059,-6.510136394635651,23.87339652884233,-12.255869077515833,1.5545012469357773,0.3893381953239441,0.2505014449357986,0.0798421025276184,0.6767826020717621,0.018610556423664094,0.0663940504193306,0.003948434369522147,0.09837862476706505,0.01706511676311493,0.39243256449699404,0.0033562526339665057,0.00445239269756712,0.010331179667264222,0.009337600786238909,0.05032205730676651,0.00691639359574765,0.5242771863937378,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1202.0,1344958.0,33202.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MESALAMINE,CHEMBL704,4.0,1.0,1.0,MOL,6775.0,Small molecule,1987.0,1.0,0.0,1.0,0.0,1.0,0.0,2.0,0.0,0.0,1986.0,1.0,-sal-,0.0,-sal-,anti-inflammatory agents (salicylic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",KBOPZPXVLCULAV-UHFFFAOYSA-N,Nc1ccc(O)c(C(=O)O)c1,0.4087158551274257,4.0,153.137,0.6726000000000001,3,3,0,83.55,-1.9100107767145638,0.7893235087394714,-5.48217396595888,0.9967845797538757,-12.61285930912962,0.028260079864412545,0.003903436567634344,0.3388363867998123,64.5874064258775,4.566682425440708,0.03412038031965494,0.027342851832509042,0.10657779648900031,0.07186451554298401,0.05021141488105059,-6.510136394635651,23.87339652884233,-12.255869077515833,1.5545012469357773,0.3893381953239441,0.2505014449357986,0.0798421025276184,0.6767826020717621,0.018610556423664094,0.0663940504193306,0.003948434369522147,0.09837862476706505,0.01706511676311493,0.39243256449699404,0.0033562526339665057,0.00445239269756712,0.010331179667264222,0.009337600786238909,0.05032205730676651,0.00691639359574765,0.5242771863937378,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1203.0,1344707.0,675092.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IBUPROFEN LYSINE,CHEMBL1201141,4.0,1.0,1.0,MOL,,Small molecule,2006.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2005.0,1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C13H18O2.C6H14N2O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;7-4-2-1-3-5(8)6(9)10/h4-7,9-10H,8H2,1-3H3,(H,14,15);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1",IHHXIUAEPKVVII-ZSCHJXSPSA-N,CC(C)Cc1ccc(C(C)C(=O)O)cc1.NCCCC[C@H](N)C(=O)O,0.5059749112310754,4.0,352.4750000000001,2.6005,4,4,2,126.64,-2.264099055739099,0.8487353205680848,-5.99748896665856,0.9180018544197083,-10.041551647319798,0.32424530386924744,0.07940621599555016,0.4131377190351486,66.46545861813938,7.2450098237059475,0.06148479953408241,0.1276412010192871,0.12656525000929833,0.47638198733329773,0.25020786225795744,4.306539528396582,38.3309914275653,-17.579984207096196,2.405947295475986,0.13564488142728806,0.2740565001964569,0.3848218023777008,0.1138112224638462,0.4386161923408508,0.025589914992451668,0.00655338610522449,0.19297315180301666,0.12601468414068223,0.0665109096094966,0.0372436223551631,0.11268007457256317,0.010393351316452026,0.04549620039761067,0.05870092790573835,0.01269063213840127,0.49714490175247195,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1203.0,1344707.0,675092.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IBUPROFEN LYSINE,CHEMBL1201141,4.0,1.0,1.0,MOL,,Small molecule,2006.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2005.0,1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C13H18O2.C6H14N2O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;7-4-2-1-3-5(8)6(9)10/h4-7,9-10H,8H2,1-3H3,(H,14,15);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1",IHHXIUAEPKVVII-ZSCHJXSPSA-N,CC(C)Cc1ccc(C(C)C(=O)O)cc1.NCCCC[C@H](N)C(=O)O,0.5059749112310754,4.0,352.4750000000001,2.6005,4,4,2,126.64,-2.264099055739099,0.8487353205680848,-5.99748896665856,0.9180018544197083,-10.041551647319798,0.32424530386924744,0.07940621599555016,0.4131377190351486,66.46545861813938,7.2450098237059475,0.06148479953408241,0.1276412010192871,0.12656525000929833,0.47638198733329773,0.25020786225795744,4.306539528396582,38.3309914275653,-17.579984207096196,2.405947295475986,0.13564488142728806,0.2740565001964569,0.3848218023777008,0.1138112224638462,0.4386161923408508,0.025589914992451668,0.00655338610522449,0.19297315180301666,0.12601468414068223,0.0665109096094966,0.0372436223551631,0.11268007457256317,0.010393351316452026,0.04549620039761067,0.05870092790573835,0.01269063213840127,0.49714490175247195,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1204.0,1344768.0,139225.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OXAPROZIN,CHEMBL1071,4.0,1.0,1.0,MOL,7822.0,Small molecule,1992.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1973.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)",OFPXSFXSNFPTHF-UHFFFAOYSA-N,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,0.7711850955719793,4.0,293.32200000000006,4.025800000000003,3,1,0,63.33,-3.6343860868933886,0.9369938015937805,-4.69036831215662,0.9965816736221313,-8.826547429381437,0.7080668807029724,0.15093638151884078,0.5996499598026276,104.20515879820273,-0.5704403981356256,0.23848624676465988,0.1913937583565712,0.2299656093120575,0.0111947828438133,0.005726367235183716,-13.082671574450988,21.033076388628,8.510302725190149,2.188849199892896,0.014713865984231234,0.3673640310764313,0.11595830842852592,0.9424463391304017,0.036506510153412816,0.038395778834819795,0.013168448489159346,0.384428346157074,0.06368361562490463,0.06140830516815186,0.05833673737943172,0.6751495003700256,0.03864457607269287,0.034738531336188316,0.027733203768730164,0.013335127476602792,0.348801851272583,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1204.0,1344768.0,139225.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OXAPROZIN,CHEMBL1071,4.0,1.0,1.0,MOL,7822.0,Small molecule,1992.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1973.0,1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)",OFPXSFXSNFPTHF-UHFFFAOYSA-N,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,0.7711850955719793,4.0,293.32200000000006,4.025800000000003,3,1,0,63.33,-3.6343860868933886,0.9369938015937805,-4.69036831215662,0.9965816736221313,-8.826547429381437,0.7080668807029724,0.15093638151884078,0.5996499598026276,104.20515879820273,-0.5704403981356256,0.23848624676465988,0.1913937583565712,0.2299656093120575,0.0111947828438133,0.005726367235183716,-13.082671574450988,21.033076388628,8.510302725190149,2.188849199892896,0.014713865984231234,0.3673640310764313,0.11595830842852592,0.9424463391304017,0.036506510153412816,0.038395778834819795,0.013168448489159346,0.384428346157074,0.06368361562490463,0.06140830516815186,0.05833673737943172,0.6751495003700256,0.03864457607269287,0.034738531336188316,0.027733203768730164,0.013335127476602792,0.348801851272583,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1205.0,1344221.0,12417.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PHENYLBUTAZONE,CHEMBL101,4.0,1.0,1.0,MOL,48574.0,Small molecule,1980.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-butazone,0.0,-butazone,anti-inflammatory analgesics (phenylbutazone type),Antirheumatic,1.0,0.0,0.0,"InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3",VYMDGNCVAMGZFE-UHFFFAOYSA-N,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,0.7885515763199019,4.0,308.3810000000001,3.7878000000000025,2,0,0,40.620000000000005,-4.057769041323393,0.9445301651954651,-4.464765287303388,0.9998165965080261,-7.965436306756212,0.9651665210723877,0.31645370423793795,0.9533782243728638,82.17076781095315,9.383656822871036,0.17662219405174256,0.7902621865272522,0.8142812967300415,0.005464065168052912,0.25665798783302307,27.95202986370682,14.213451750928325,6.837623690403349,2.6026686763755205,0.2047096312046051,0.8004255533218384,0.10056834444403648,0.925986135005951,0.47075671553611753,0.09511000588536263,0.008605061518028378,0.2303555950522423,0.015381082752719521,0.15263459086418152,0.1280244804918766,0.04887764230370521,0.04576180651783943,0.08039358630776405,0.6238965272903443,0.1119242250919342,0.5702770352363586,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1205.0,1344221.0,12417.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PHENYLBUTAZONE,CHEMBL101,4.0,1.0,1.0,MOL,48574.0,Small molecule,1980.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-butazone,0.0,-butazone,anti-inflammatory analgesics (phenylbutazone type),Antirheumatic,1.0,0.0,0.0,"InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3",VYMDGNCVAMGZFE-UHFFFAOYSA-N,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,0.7885515763199019,4.0,308.3810000000001,3.7878000000000025,2,0,0,40.620000000000005,-4.057769041323393,0.9445301651954651,-4.464765287303388,0.9998165965080261,-7.965436306756212,0.9651665210723877,0.31645370423793795,0.9533782243728638,82.17076781095315,9.383656822871036,0.17662219405174256,0.7902621865272522,0.8142812967300415,0.005464065168052912,0.25665798783302307,27.95202986370682,14.213451750928325,6.837623690403349,2.6026686763755205,0.2047096312046051,0.8004255533218384,0.10056834444403648,0.925986135005951,0.47075671553611753,0.09511000588536263,0.008605061518028378,0.2303555950522423,0.015381082752719521,0.15263459086418152,0.1280244804918766,0.04887764230370521,0.04576180651783943,0.08039358630776405,0.6238965272903443,0.1119242250919342,0.5702770352363586,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1206.0,1344127.0,11968.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PIROXICAM,CHEMBL527,4.0,1.0,1.0,MOL,8249.0,Small molecule,1982.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1974.0,1.0,-icam,0.0,-icam,anti-inflammatory agents (isoxicam type),"Anti-Inflammatory,Anti-Inflammatory; Analgesic",0.0,0.0,0.0,"InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)",QYSPLQLAKJAUJT-UHFFFAOYSA-N,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,0.8701839218107902,4.0,331.35300000000007,1.5809999999999997,5,2,0,99.6,-4.216429841727207,0.8829839348793029,-4.638307626041362,0.9994245052337647,-16.078567710595184,0.7280158758163452,0.05216634012758732,0.39002745449542997,86.11562425729052,5.170301640378564,0.03430922329425812,0.057959305495023726,0.15217346586287023,0.005223589716479182,0.012949925940483808,33.15046096884996,51.82865185049909,19.67519831965848,3.169111597890156,0.030133903957903385,0.16956665068864823,0.031133394874632358,0.9725916743278503,0.06477111130952835,0.04970499910414219,0.012077821139246225,0.09178129881620407,0.001860874833073467,0.08864170797169209,0.018583617080003022,0.006250557862222195,0.0036414382513612507,0.004797949828207493,0.303594583272934,0.009314210712909698,0.19787648022174836,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1206.0,1344127.0,11968.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PIROXICAM,CHEMBL527,4.0,1.0,1.0,MOL,8249.0,Small molecule,1982.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1974.0,1.0,-icam,0.0,-icam,anti-inflammatory agents (isoxicam type),"Anti-Inflammatory,Anti-Inflammatory; Analgesic",0.0,0.0,0.0,"InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)",QYSPLQLAKJAUJT-UHFFFAOYSA-N,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,0.8701839218107902,4.0,331.35300000000007,1.5809999999999997,5,2,0,99.6,-4.216429841727207,0.8829839348793029,-4.638307626041362,0.9994245052337647,-16.078567710595184,0.7280158758163452,0.05216634012758732,0.39002745449542997,86.11562425729052,5.170301640378564,0.03430922329425812,0.057959305495023726,0.15217346586287023,0.005223589716479182,0.012949925940483808,33.15046096884996,51.82865185049909,19.67519831965848,3.169111597890156,0.030133903957903385,0.16956665068864823,0.031133394874632358,0.9725916743278503,0.06477111130952835,0.04970499910414219,0.012077821139246225,0.09178129881620407,0.001860874833073467,0.08864170797169209,0.018583617080003022,0.006250557862222195,0.0036414382513612507,0.004797949828207493,0.303594583272934,0.009314210712909698,0.19787648022174836,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1207.0,1343774.0,93117.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SUPROFEN,CHEMBL956,4.0,1.0,1.0,MOL,9362.0,Small molecule,1985.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1974.0,-2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)",MDKGKXOCJGEUJW-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1,0.8589607719574609,4.0,260.31399999999996,3.167200000000001,3,1,1,54.37,-3.0917672476278133,0.9021858215332031,-4.42965298759619,0.9884902238845825,-10.03751321063626,0.47172062993049624,0.009843946201726794,0.4569209963083267,92.15575247805987,-4.726862029225336,0.03572760634124279,0.1433963268995285,0.21350409984588622,0.022865343280136584,0.007848088629543781,0.9999081861992082,18.12901972033379,12.867585505930908,3.1266801274775715,0.035251972079277036,0.34646966457366946,0.061147161200642584,0.9497761607170105,0.005635073035955429,0.06798716932535172,0.010293153626844288,0.30151754915714263,0.055246980488300325,0.07056190744042397,0.018146617338061333,0.22184554040431975,0.07121138870716096,0.014851492736488581,0.031360307708382607,0.031698718667030334,0.3293549656867981,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1207.0,1343774.0,93117.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SUPROFEN,CHEMBL956,4.0,1.0,1.0,MOL,9362.0,Small molecule,1985.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1974.0,-2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)",MDKGKXOCJGEUJW-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1,0.8589607719574609,4.0,260.31399999999996,3.167200000000001,3,1,1,54.37,-3.0917672476278133,0.9021858215332031,-4.42965298759619,0.9884902238845825,-10.03751321063626,0.47172062993049624,0.009843946201726794,0.4569209963083267,92.15575247805987,-4.726862029225336,0.03572760634124279,0.1433963268995285,0.21350409984588622,0.022865343280136584,0.007848088629543781,0.9999081861992082,18.12901972033379,12.867585505930908,3.1266801274775715,0.035251972079277036,0.34646966457366946,0.061147161200642584,0.9497761607170105,0.005635073035955429,0.06798716932535172,0.010293153626844288,0.30151754915714263,0.055246980488300325,0.07056190744042397,0.018146617338061333,0.22184554040431975,0.07121138870716096,0.014851492736488581,0.031360307708382607,0.031698718667030334,0.3293549656867981,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1208.0,1344276.0,16591.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,KETOPROFEN,CHEMBL571,4.0,1.0,1.0,MOL,6128.0,Small molecule,1986.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1972.0,2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)",DKYWVDODHFEZIM-UHFFFAOYSA-N,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,0.8528036890699656,4.0,254.285,3.1057000000000015,2,1,1,54.37,-3.4663272837099877,0.9552370071411133,-4.2661828115998635,0.9957077503204346,-9.755818443145142,0.49364802837371824,0.010323362378403544,0.409600093960762,95.3479047085032,1.9100320374162307,0.020311209792271256,0.06629653051495552,0.11788596659898758,0.003412637673318386,0.0021241621929220856,4.5785282215424905,15.246680252290805,2.238558470611784,2.6585870940974776,0.004715743940323591,0.4243834525346756,0.022394977416843175,0.9336420655250549,0.0045284571591764685,0.04585105963051319,0.005070922779850662,0.29856803715229036,0.025474369898438452,0.013612051866948605,0.0055137370247393845,0.20650215744972228,0.01617127824574709,0.0028341483557596803,0.013935960363596678,0.0028177340980619194,0.25120702385902405,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,1208.0,1344276.0,16591.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,KETOPROFEN,CHEMBL571,4.0,1.0,1.0,MOL,6128.0,Small molecule,1986.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1972.0,2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)",DKYWVDODHFEZIM-UHFFFAOYSA-N,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,0.8528036890699656,4.0,254.285,3.1057000000000015,2,1,1,54.37,-3.4663272837099877,0.9552370071411133,-4.2661828115998635,0.9957077503204346,-9.755818443145142,0.49364802837371824,0.010323362378403544,0.409600093960762,95.3479047085032,1.9100320374162307,0.020311209792271256,0.06629653051495552,0.11788596659898758,0.003412637673318386,0.0021241621929220856,4.5785282215424905,15.246680252290805,2.238558470611784,2.6585870940974776,0.004715743940323591,0.4243834525346756,0.022394977416843175,0.9336420655250549,0.0045284571591764685,0.04585105963051319,0.005070922779850662,0.29856803715229036,0.025474369898438452,0.013612051866948605,0.0055137370247393845,0.20650215744972228,0.01617127824574709,0.0028341483557596803,0.013935960363596678,0.0028177340980619194,0.25120702385902405,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,2254.0,1937947.0,29890.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DICLOFENAC,CHEMBL139,4.0,1.0,1.0,MOL,47381.0,Small molecule,1988.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1973.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",DCOPUUMXTXDBNB-UHFFFAOYSA-N,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,0.8807285394160607,4.0,296.153,4.364100000000001,2,2,0,49.33,-4.3653765789003725,0.9596242785453797,-4.319295929935328,0.9964683651924133,-8.412145659619986,0.46185877323150637,0.010503875208087265,0.6119112730026245,96.62394475178681,-4.6665302050240625,0.13053265064954758,0.19879066646099092,0.20232820957899095,0.04533629789948464,0.013351674377918243,-0.991877060258943,46.12552489226029,23.431738559672944,2.6521707282647626,0.06807048693299293,0.5071340203285217,0.0868936862796545,0.9327516913414001,0.046297121420502664,0.03889092206954956,0.011055482970550656,0.1292026996612549,0.04112525098025799,0.1772547960281372,0.04546338059008122,0.6496361553668976,0.06859911233186722,0.047929083183407786,0.16089982986450196,0.19758606925606728,0.41907103061676027,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,2254.0,1937947.0,29890.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DICLOFENAC,CHEMBL139,4.0,1.0,1.0,MOL,47381.0,Small molecule,1988.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1973.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",DCOPUUMXTXDBNB-UHFFFAOYSA-N,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,0.8807285394160607,4.0,296.153,4.364100000000001,2,2,0,49.33,-4.3653765789003725,0.9596242785453797,-4.319295929935328,0.9964683651924133,-8.412145659619986,0.46185877323150637,0.010503875208087265,0.6119112730026245,96.62394475178681,-4.6665302050240625,0.13053265064954758,0.19879066646099092,0.20232820957899095,0.04533629789948464,0.013351674377918243,-0.991877060258943,46.12552489226029,23.431738559672944,2.6521707282647626,0.06807048693299293,0.5071340203285217,0.0868936862796545,0.9327516913414001,0.046297121420502664,0.03889092206954956,0.011055482970550656,0.1292026996612549,0.04112525098025799,0.1772547960281372,0.04546338059008122,0.6496361553668976,0.06859911233186722,0.047929083183407786,0.16089982986450196,0.19758606925606728,0.41907103061676027,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,5601.0,1699811.0,1376101.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NAPROXCINOD,CHEMBL2103831,3.0,0.0,0.0,MOL,76254.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2008.0,,-nod,0.0,-nod,"nitrogen oxide (eg., nitrxyl and nitric oxide) donors",,0.0,0.0,0.0,"InChI=1S/C18H21NO6/c1-13(18(20)24-9-3-4-10-25-19(21)22)14-5-6-16-12-17(23-2)8-7-15(16)11-14/h5-8,11-13H,3-4,9-10H2,1-2H3/t13-/m0/s1",AKFJWRDCWYYTIG-ZDUSSCGKSA-N,COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1,0.29856981845389224,4.0,347.36699999999996,3.4836000000000027,6,0,1,87.9,-5.32396983893914,0.8197476625442505,-4.456659739138651,0.9995227813720703,-6.19012699028457,0.9576128721237183,0.38604689836502076,0.8678799510002136,96.08963101350541,-2.3217951681101914,0.9114316463470459,0.8845214128494263,0.7455474138259888,0.17168397605419158,0.8737452626228333,-21.120222132988353,136.7148892423116,78.00915864155562,2.4637962015659687,0.555773788690567,0.21495211869478226,0.14192419946193696,0.8148550629615784,0.8117838144302368,0.019346765987575055,0.02000309806317091,0.16378359049558638,0.06465154644101859,0.3511373817920685,0.11292386502027511,0.04035025555640459,0.06494222953915596,0.044708820059895515,0.10799475610256196,0.062334902584552765,0.527328097820282,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,5601.0,1699811.0,1376101.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NAPROXCINOD,CHEMBL2103831,3.0,0.0,0.0,MOL,76254.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2008.0,,-nod,0.0,-nod,"nitrogen oxide (eg., nitrxyl and nitric oxide) donors",,0.0,0.0,0.0,"InChI=1S/C18H21NO6/c1-13(18(20)24-9-3-4-10-25-19(21)22)14-5-6-16-12-17(23-2)8-7-15(16)11-14/h5-8,11-13H,3-4,9-10H2,1-2H3/t13-/m0/s1",AKFJWRDCWYYTIG-ZDUSSCGKSA-N,COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1,0.29856981845389224,4.0,347.36699999999996,3.4836000000000027,6,0,1,87.9,-5.32396983893914,0.8197476625442505,-4.456659739138651,0.9995227813720703,-6.19012699028457,0.9576128721237183,0.38604689836502076,0.8678799510002136,96.08963101350541,-2.3217951681101914,0.9114316463470459,0.8845214128494263,0.7455474138259888,0.17168397605419158,0.8737452626228333,-21.120222132988353,136.7148892423116,78.00915864155562,2.4637962015659687,0.555773788690567,0.21495211869478226,0.14192419946193696,0.8148550629615784,0.8117838144302368,0.019346765987575055,0.02000309806317091,0.16378359049558638,0.06465154644101859,0.3511373817920685,0.11292386502027511,0.04035025555640459,0.06494222953915596,0.044708820059895515,0.10799475610256196,0.062334902584552765,0.527328097820282,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,5667.0,1702574.0,1377953.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NAPROXEN ETEMESIL,CHEMBL2105683,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H20O5S/c1-12(17(18)22-8-9-23(3,19)20)13-4-5-15-11-16(21-2)7-6-14(15)10-13/h4-7,10-12H,8-9H2,1-3H3/t12-/m0/s1",JGBUBSOKFSVXKS-LBPRGKRZSA-N,COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1,0.7583141712345316,4.0,336.409,2.5397000000000007,5,0,1,69.67,-4.208519188979507,0.8925271272659302,-4.480350148022653,0.9989608526229858,-8.209930920305707,0.9714883685111999,0.28906833976507185,0.9425007820129394,84.83206122220703,0.761395098355717,0.8897536277770997,0.4379307240247726,0.24570727497339248,0.02610501954331994,0.5504744410514831,15.58010439631924,78.78476675758226,72.02016822759182,2.6877195954195408,0.36363057494163514,0.22088196277618408,0.18496429324150085,0.8918074369430542,0.5902806639671325,0.03489551804959774,0.07848181426525117,0.09062097817659379,0.07711935564875602,0.11716855838894844,0.10106914937496185,0.10746317356824875,0.08904991522431374,0.02288769595324993,0.07086394093930722,0.07767354436218739,0.2539216369390488,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,5667.0,1702574.0,1377953.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NAPROXEN ETEMESIL,CHEMBL2105683,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2009.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H20O5S/c1-12(17(18)22-8-9-23(3,19)20)13-4-5-15-11-16(21-2)7-6-14(15)10-13/h4-7,10-12H,8-9H2,1-3H3/t12-/m0/s1",JGBUBSOKFSVXKS-LBPRGKRZSA-N,COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1,0.7583141712345316,4.0,336.409,2.5397000000000007,5,0,1,69.67,-4.208519188979507,0.8925271272659302,-4.480350148022653,0.9989608526229858,-8.209930920305707,0.9714883685111999,0.28906833976507185,0.9425007820129394,84.83206122220703,0.761395098355717,0.8897536277770997,0.4379307240247726,0.24570727497339248,0.02610501954331994,0.5504744410514831,15.58010439631924,78.78476675758226,72.02016822759182,2.6877195954195408,0.36363057494163514,0.22088196277618408,0.18496429324150085,0.8918074369430542,0.5902806639671325,0.03489551804959774,0.07848181426525117,0.09062097817659379,0.07711935564875602,0.11716855838894844,0.10106914937496185,0.10746317356824875,0.08904991522431374,0.02288769595324993,0.07086394093930722,0.07767354436218739,0.2539216369390488,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,5900.0,1700651.0,317909.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dexibuprofen works by blocking the cyclo-oxygenase (COX-1, COX2) enzymes. These enzymes are involved in the production of prostaglandins. Some prostaglandins are produced at sites of injury or damage, and cause pain and inflammation. By blocking the effect of COX enzymes, fewer prostaglandins are produced, which means pain and inflammation are eased.",,,,DEXIBUPROFEN,CHEMBL175,4.0,1.0,1.0,MOL,43415.0,Small molecule,1994.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1997.0,-1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1",HEFNNWSXXWATRW-JTQLQIEISA-N,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1,0.8215995486924976,4.0,206.28499999999997,3.073200000000001,1,1,1,37.3,-2.916091714735743,0.9417072534561157,-4.308071371613053,0.9980796694755554,-7.033095039541346,0.5459229469299316,0.003803756280103698,0.5085536897182464,90.37552109810063,1.2735894967681938,0.003901276527903974,0.040661688521504404,0.06891732551157474,0.007055409112945199,0.003041728725656867,8.814316703569922,22.649917133335457,0.49708910010645296,2.37284693233642,0.009340146300382912,0.4716645210981369,0.017882881872355937,0.4863452047109604,0.00904824985191226,0.007307378156110644,0.0003942615207051858,0.11569752320647239,0.01852258760482073,0.004975313087925315,0.0024776156758889558,0.059626499004662034,0.0010347135306801648,0.006304102763533592,0.03612279905937612,0.0011026826861780137,0.4035088121891022,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,5900.0,1700651.0,317909.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dexibuprofen works by blocking the cyclo-oxygenase (COX-1, COX2) enzymes. These enzymes are involved in the production of prostaglandins. Some prostaglandins are produced at sites of injury or damage, and cause pain and inflammation. By blocking the effect of COX enzymes, fewer prostaglandins are produced, which means pain and inflammation are eased.",,,,DEXIBUPROFEN,CHEMBL175,4.0,1.0,1.0,MOL,43415.0,Small molecule,1994.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1997.0,-1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1",HEFNNWSXXWATRW-JTQLQIEISA-N,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1,0.8215995486924976,4.0,206.28499999999997,3.073200000000001,1,1,1,37.3,-2.916091714735743,0.9417072534561157,-4.308071371613053,0.9980796694755554,-7.033095039541346,0.5459229469299316,0.003803756280103698,0.5085536897182464,90.37552109810063,1.2735894967681938,0.003901276527903974,0.040661688521504404,0.06891732551157474,0.007055409112945199,0.003041728725656867,8.814316703569922,22.649917133335457,0.49708910010645296,2.37284693233642,0.009340146300382912,0.4716645210981369,0.017882881872355937,0.4863452047109604,0.00904824985191226,0.007307378156110644,0.0003942615207051858,0.11569752320647239,0.01852258760482073,0.004975313087925315,0.0024776156758889558,0.059626499004662034,0.0010347135306801648,0.006304102763533592,0.03612279905937612,0.0011026826861780137,0.4035088121891022,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6227.0,1706201.0,11685.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Non steroidal antiinflamatory drug.,,,,CLOMETACIN,CHEMBL13376,4.0,0.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,-2.0,-metacin,0.0,-metacin,anti-inflammatory agents (indomethacin type),,1.0,0.0,0.0,"InChI=1S/C19H16ClNO4/c1-11-18(19(24)12-3-5-13(20)6-4-12)15-8-7-14(25-2)9-16(15)21(11)10-17(22)23/h3-9H,10H2,1-2H3,(H,22,23)",DGMZLCLHHVYDIS-UHFFFAOYSA-N,COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1,0.7023986860653546,4.0,357.7930000000001,3.9273200000000026,4,1,0,68.53,-4.831292867978303,0.964417290687561,-4.632134133460957,0.9966500043869019,-9.945656383193684,0.8315828919410706,0.17799722477793695,0.5429949045181275,96.60412769658706,-0.3283655800309465,0.4142966002225876,0.3294276505708694,0.4567795395851135,0.03273012861609459,0.19928742945194244,40.66232303458298,2.1296750450751816,3.545068212912125,3.3483384994950454,0.014157929597422481,0.11308888867497444,0.0663854256272316,0.9713276386260986,0.06659597232937813,0.034225675649940966,0.016393484082072973,0.12077686972916127,0.03956074006855488,0.308225879073143,0.13987091332674026,0.5440714240074158,0.033694954589009285,0.03876629676669836,0.06589078269898892,0.07435279563069344,0.09595261514186859,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6227.0,1706201.0,11685.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Non steroidal antiinflamatory drug.,,,,CLOMETACIN,CHEMBL13376,4.0,0.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,-2.0,-metacin,0.0,-metacin,anti-inflammatory agents (indomethacin type),,1.0,0.0,0.0,"InChI=1S/C19H16ClNO4/c1-11-18(19(24)12-3-5-13(20)6-4-12)15-8-7-14(25-2)9-16(15)21(11)10-17(22)23/h3-9H,10H2,1-2H3,(H,22,23)",DGMZLCLHHVYDIS-UHFFFAOYSA-N,COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1,0.7023986860653546,4.0,357.7930000000001,3.9273200000000026,4,1,0,68.53,-4.831292867978303,0.964417290687561,-4.632134133460957,0.9966500043869019,-9.945656383193684,0.8315828919410706,0.17799722477793695,0.5429949045181275,96.60412769658706,-0.3283655800309465,0.4142966002225876,0.3294276505708694,0.4567795395851135,0.03273012861609459,0.19928742945194244,40.66232303458298,2.1296750450751816,3.545068212912125,3.3483384994950454,0.014157929597422481,0.11308888867497444,0.0663854256272316,0.9713276386260986,0.06659597232937813,0.034225675649940966,0.016393484082072973,0.12077686972916127,0.03956074006855488,0.308225879073143,0.13987091332674026,0.5440714240074158,0.033694954589009285,0.03876629676669836,0.06589078269898892,0.07435279563069344,0.09595261514186859,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6238.0,1705385.0,2197674.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"The pharmacologically active dipyrone metabolite, 4-methylamino-antipyrine (MAA), targets the initiation of the catalytic reaction of both COX isoforms by reducing the higher oxidation states of COX or sequestering activating peroxides. It does not compete with arachidonic acid for the catalytic site of COX. Instead it binds to the Fe3+ in the haem. In the next step, the Fe3+ is reduced and an MAA radical is formed.",,,,DIPYRONE,CHEMBL3989803,4.0,0.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,-2.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/C13H17N3O4S.Na.H2O/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11;;/h4-8H,9H2,1-3H3,(H,18,19,20);;1H2/q;+1;/p-1",UNZIDPIPYUMVPA-UHFFFAOYSA-M,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+],0.42017995367920763,4.0,351.36000000000007,-3.3973799999999974,7,0,0,118.87,0.02915542844396768,0.8595948457717896,-4.776806185252694,0.7763962864875793,-11.875052172065324,0.44158536195755005,0.03173879091627896,0.7943530440330505,65.5336774550016,5.59787893260038,0.0021991027839249,0.010236506967339664,0.007059956155717373,0.004178020762628876,0.0016149216637131758,44.96775926143031,27.843417079344164,-7.964811469612238,3.0064093089487587,0.27478827685117724,0.568717074394226,0.19926968589425087,0.7384981393814087,0.183209066092968,0.03076994642615318,0.017080349382013083,0.07508095088414848,0.0059341306216083465,0.006716909888200462,0.005575766484253108,0.0016187670174986125,0.001833471671852749,0.003509755292907357,0.004187119170092046,0.004856333055067807,0.258939203619957,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6238.0,1705385.0,2197674.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"The pharmacologically active dipyrone metabolite, 4-methylamino-antipyrine (MAA), targets the initiation of the catalytic reaction of both COX isoforms by reducing the higher oxidation states of COX or sequestering activating peroxides. It does not compete with arachidonic acid for the catalytic site of COX. Instead it binds to the Fe3+ in the haem. In the next step, the Fe3+ is reduced and an MAA radical is formed.",,,,DIPYRONE,CHEMBL3989803,4.0,0.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,-2.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/C13H17N3O4S.Na.H2O/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11;;/h4-8H,9H2,1-3H3,(H,18,19,20);;1H2/q;+1;/p-1",UNZIDPIPYUMVPA-UHFFFAOYSA-M,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+],0.42017995367920763,4.0,351.36000000000007,-3.3973799999999974,7,0,0,118.87,0.02915542844396768,0.8595948457717896,-4.776806185252694,0.7763962864875793,-11.875052172065324,0.44158536195755005,0.03173879091627896,0.7943530440330505,65.5336774550016,5.59787893260038,0.0021991027839249,0.010236506967339664,0.007059956155717373,0.004178020762628876,0.0016149216637131758,44.96775926143031,27.843417079344164,-7.964811469612238,3.0064093089487587,0.27478827685117724,0.568717074394226,0.19926968589425087,0.7384981393814087,0.183209066092968,0.03076994642615318,0.017080349382013083,0.07508095088414848,0.0059341306216083465,0.006716909888200462,0.005575766484253108,0.0016187670174986125,0.001833471671852749,0.003509755292907357,0.004187119170092046,0.004856333055067807,0.258939203619957,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6244.0,1699737.0,16521.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"It acts by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions.",,,,FENCLOFENAC,CHEMBL15677,4.0,1.0,1.0,MOL,,Small molecule,1978.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1978.0,-2.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C14H10Cl2O3/c15-10-5-6-13(11(16)8-10)19-12-4-2-1-3-9(12)7-14(17)18/h1-6,8H,7H2,(H,17,18)",IDKAXRLETRCXKS-UHFFFAOYSA-N,O=C(O)Cc1ccccc1Oc1ccc(Cl)cc1Cl,0.9086831715038638,4.0,297.13699999999994,4.4128000000000025,2,1,0,46.53,-4.096051786019311,0.9626771211624146,-4.142558074398905,0.9993674755096436,-7.562180757926535,0.7296042144298553,0.013428834918886422,0.5856550872325897,102.23932845660866,-4.148192987367811,0.4157938718795776,0.36153207421302797,0.41056129336357117,0.027040248177945612,0.005663570738397539,9.80947402897841,54.37962063997115,22.251822458823373,2.652157873736625,0.01300378143787384,0.501778119802475,0.038438665121793746,0.9521084904670716,0.029597567208111287,0.025454425998032094,0.004545958410017192,0.13249689042568208,0.03244601469486952,0.08159659206867217,0.03426005505025387,0.695287573337555,0.020237360522150992,0.040637407824397086,0.1849294438958168,0.06208377499133348,0.21591560542583466,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6244.0,1699737.0,16521.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"It acts by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions.",,,,FENCLOFENAC,CHEMBL15677,4.0,1.0,1.0,MOL,,Small molecule,1978.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1978.0,-2.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C14H10Cl2O3/c15-10-5-6-13(11(16)8-10)19-12-4-2-1-3-9(12)7-14(17)18/h1-6,8H,7H2,(H,17,18)",IDKAXRLETRCXKS-UHFFFAOYSA-N,O=C(O)Cc1ccccc1Oc1ccc(Cl)cc1Cl,0.9086831715038638,4.0,297.13699999999994,4.4128000000000025,2,1,0,46.53,-4.096051786019311,0.9626771211624146,-4.142558074398905,0.9993674755096436,-7.562180757926535,0.7296042144298553,0.013428834918886422,0.5856550872325897,102.23932845660866,-4.148192987367811,0.4157938718795776,0.36153207421302797,0.41056129336357117,0.027040248177945612,0.005663570738397539,9.80947402897841,54.37962063997115,22.251822458823373,2.652157873736625,0.01300378143787384,0.501778119802475,0.038438665121793746,0.9521084904670716,0.029597567208111287,0.025454425998032094,0.004545958410017192,0.13249689042568208,0.03244601469486952,0.08159659206867217,0.03426005505025387,0.695287573337555,0.020237360522150992,0.040637407824397086,0.1849294438958168,0.06208377499133348,0.21591560542583466,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6252.0,1703294.0,244737.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Glafenine is a nonsteroidal anti-inflammatory drug that inhibits both COX isoforms.,,,,GLAFENINE,CHEMBL146095,4.0,0.0,1.0,MOL,31653.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,-2.0,-fenine,0.0,-fenine,analgesics (fenamic acid subgroup),,1.0,0.0,0.0,"InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)",GWOFUCIGLDBNKM-UHFFFAOYSA-N,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12,0.575646202626094,4.0,372.80800000000005,3.141800000000001,6,3,1,91.68,-4.392496040352761,0.872299063205719,-4.956870870451527,0.9996852040290832,-13.38995045026013,0.9510563492774964,0.29139481484889984,0.7098431706428527,98.97584296394115,38.43988199517507,0.9529799461364746,0.8167598843574524,0.5479353606700897,0.2610016405582428,0.5982332408428193,139.68820736087008,94.84466941342782,56.19745763377663,2.5783513929175634,0.10851812064647674,0.1267101787030697,0.17974978387355806,0.9486554622650146,0.45278419852256774,0.014221628196537495,0.03851067274808884,0.08746196702122688,0.019361079670488834,0.7661652565002441,0.3303688198328018,0.15537092387676238,0.03373281676322222,0.14778497703373433,0.5582675933837891,0.24413046836853028,0.13915067464113234,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6252.0,1703294.0,244737.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Glafenine is a nonsteroidal anti-inflammatory drug that inhibits both COX isoforms.,,,,GLAFENINE,CHEMBL146095,4.0,0.0,1.0,MOL,31653.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,-2.0,-fenine,0.0,-fenine,analgesics (fenamic acid subgroup),,1.0,0.0,0.0,"InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)",GWOFUCIGLDBNKM-UHFFFAOYSA-N,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12,0.575646202626094,4.0,372.80800000000005,3.141800000000001,6,3,1,91.68,-4.392496040352761,0.872299063205719,-4.956870870451527,0.9996852040290832,-13.38995045026013,0.9510563492774964,0.29139481484889984,0.7098431706428527,98.97584296394115,38.43988199517507,0.9529799461364746,0.8167598843574524,0.5479353606700897,0.2610016405582428,0.5982332408428193,139.68820736087008,94.84466941342782,56.19745763377663,2.5783513929175634,0.10851812064647674,0.1267101787030697,0.17974978387355806,0.9486554622650146,0.45278419852256774,0.014221628196537495,0.03851067274808884,0.08746196702122688,0.019361079670488834,0.7661652565002441,0.3303688198328018,0.15537092387676238,0.03373281676322222,0.14778497703373433,0.5582675933837891,0.24413046836853028,0.13915067464113234,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6253.0,1699729.0,228897.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IBUFENAC,CHEMBL341812,4.0,0.0,1.0,MOL,76158.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1966.0,-2.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Analgesic; Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C12H16O2/c1-9(2)7-10-3-5-11(6-4-10)8-12(13)14/h3-6,9H,7-8H2,1-2H3,(H,13,14)",CYWFCPPBTWOZSF-UHFFFAOYSA-N,CC(C)Cc1ccc(CC(=O)O)cc1,0.795449500750072,4.0,192.25799999999998,2.5122,1,1,0,37.3,-2.792109106005472,0.9160247325897217,-4.222849444100705,0.9956345081329345,-6.924053157030599,0.41868536472320556,0.004930747707840055,0.5552875816822052,91.24478863776883,-0.2710775465303817,0.004561500350246206,0.057536581158638,0.0542527511715889,0.008692822372540831,0.001666956185363233,9.173200812946636,20.500804791108557,0.5956012320236127,2.2250546111409824,0.014530528336763382,0.5112412333488464,0.030539262760430574,0.49263148605823515,0.010494029149413109,0.007627371558919549,0.0006411021342501045,0.17026968151330948,0.023943909257650376,0.004528099671006203,0.0017570839845575392,0.09332710206508636,0.001927268086001277,0.01188572058454156,0.030576185183599593,0.001795060676522553,0.5239145278930664,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6253.0,1699729.0,228897.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IBUFENAC,CHEMBL341812,4.0,0.0,1.0,MOL,76158.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1966.0,-2.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Analgesic; Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C12H16O2/c1-9(2)7-10-3-5-11(6-4-10)8-12(13)14/h3-6,9H,7-8H2,1-2H3,(H,13,14)",CYWFCPPBTWOZSF-UHFFFAOYSA-N,CC(C)Cc1ccc(CC(=O)O)cc1,0.795449500750072,4.0,192.25799999999998,2.5122,1,1,0,37.3,-2.792109106005472,0.9160247325897217,-4.222849444100705,0.9956345081329345,-6.924053157030599,0.41868536472320556,0.004930747707840055,0.5552875816822052,91.24478863776883,-0.2710775465303817,0.004561500350246206,0.057536581158638,0.0542527511715889,0.008692822372540831,0.001666956185363233,9.173200812946636,20.500804791108557,0.5956012320236127,2.2250546111409824,0.014530528336763382,0.5112412333488464,0.030539262760430574,0.49263148605823515,0.010494029149413109,0.007627371558919549,0.0006411021342501045,0.17026968151330948,0.023943909257650376,0.004528099671006203,0.0017570839845575392,0.09332710206508636,0.001927268086001277,0.01188572058454156,0.030576185183599593,0.001795060676522553,0.5239145278930664,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6255.0,1699932.0,16599.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"It is a cyclooxygenase inhibitor. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever.",,,,INDOPROFEN,CHEMBL15870,4.0,0.0,1.0,MOL,76162.0,Small molecule,1979.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1976.0,-2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Analgesic; Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C17H15NO3/c1-11(17(20)21)12-6-8-14(9-7-12)18-10-13-4-2-3-5-15(13)16(18)19/h2-9,11H,10H2,1H3,(H,20,21)",RJMIEHBSYVWVIN-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1,0.94038427563492,4.0,281.311,3.0351000000000017,2,1,1,57.61,-3.5679100098421896,0.9551701307296753,-4.44298427318366,0.9874156713485718,-11.656329623151105,0.3835414916276932,0.016914397990331054,0.7971823811531067,83.67507512105203,1.128618296928332,0.03232112058904022,0.08054055199027062,0.18488268852233886,0.01055215708911419,0.007369137811474502,8.797356886193885,20.042762507989508,0.3081371822117795,2.83214597062006,0.09808973222970963,0.46680088341236115,0.13859113901853562,0.9279826998710632,0.04544690102338791,0.08366516977548599,0.009803865570574999,0.3217821419239044,0.01685648076236248,0.10639037638902664,0.021235931664705276,0.10922109112143516,0.06580658294260502,0.007865740545094013,0.03249585181474686,0.024031899869441986,0.26885569989681246,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6255.0,1699932.0,16599.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"It is a cyclooxygenase inhibitor. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever.",,,,INDOPROFEN,CHEMBL15870,4.0,0.0,1.0,MOL,76162.0,Small molecule,1979.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1976.0,-2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Analgesic; Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C17H15NO3/c1-11(17(20)21)12-6-8-14(9-7-12)18-10-13-4-2-3-5-15(13)16(18)19/h2-9,11H,10H2,1H3,(H,20,21)",RJMIEHBSYVWVIN-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1,0.94038427563492,4.0,281.311,3.0351000000000017,2,1,1,57.61,-3.5679100098421896,0.9551701307296753,-4.44298427318366,0.9874156713485718,-11.656329623151105,0.3835414916276932,0.016914397990331054,0.7971823811531067,83.67507512105203,1.128618296928332,0.03232112058904022,0.08054055199027062,0.18488268852233886,0.01055215708911419,0.007369137811474502,8.797356886193885,20.042762507989508,0.3081371822117795,2.83214597062006,0.09808973222970963,0.46680088341236115,0.13859113901853562,0.9279826998710632,0.04544690102338791,0.08366516977548599,0.009803865570574999,0.3217821419239044,0.01685648076236248,0.10639037638902664,0.021235931664705276,0.10922109112143516,0.06580658294260502,0.007865740545094013,0.03249585181474686,0.024031899869441986,0.26885569989681246,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6257.0,1705266.0,78364.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"It inhibits the action of cyclooxygenase enzyme (COX), which produces the pro-inflammatory prostaglandins from arachidonic acids.",,,,ISOXICAM,CHEMBL53292,4.0,0.0,1.0,MOL,76163.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1974.0,-2.0,-icam,0.0,-icam,anti-inflammatory agents (isoxicam type),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C14H13N3O5S/c1-8-7-11(16-22-8)15-14(19)12-13(18)9-5-3-4-6-10(9)23(20,21)17(12)2/h3-7,18H,1-2H3,(H,15,16,19)",YYUAYBYLJSNDCX-UHFFFAOYSA-N,Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1,0.8593888562486871,4.0,335.3410000000001,1.48242,6,2,0,112.74,-3.9816810374183556,0.9126567602157593,-4.591022608014347,0.9998233318328857,-15.087583058887855,0.7624489784240722,0.10290517956018448,0.407407158613205,92.53585649331536,1.5011655564136794,0.043098023533821105,0.057408512383699414,0.1365885201841593,0.003966748085804284,0.02926282789558172,33.47952491194404,42.85412205773244,32.51857933734146,2.8621742230490095,0.04657320231199265,0.17755928933620452,0.025467043556272984,0.9820168614387512,0.07543057724833488,0.06885047890245914,0.014439491368830205,0.11786692664027214,0.0020250909845344724,0.09071467369794846,0.01416522953659296,0.007411723467521369,0.004463416477665305,0.0062080240342766045,0.3017628088593483,0.012494324054569007,0.24223807007074355,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6257.0,1705266.0,78364.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"It inhibits the action of cyclooxygenase enzyme (COX), which produces the pro-inflammatory prostaglandins from arachidonic acids.",,,,ISOXICAM,CHEMBL53292,4.0,0.0,1.0,MOL,76163.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1974.0,-2.0,-icam,0.0,-icam,anti-inflammatory agents (isoxicam type),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C14H13N3O5S/c1-8-7-11(16-22-8)15-14(19)12-13(18)9-5-3-4-6-10(9)23(20,21)17(12)2/h3-7,18H,1-2H3,(H,15,16,19)",YYUAYBYLJSNDCX-UHFFFAOYSA-N,Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1,0.8593888562486871,4.0,335.3410000000001,1.48242,6,2,0,112.74,-3.9816810374183556,0.9126567602157593,-4.591022608014347,0.9998233318328857,-15.087583058887855,0.7624489784240722,0.10290517956018448,0.407407158613205,92.53585649331536,1.5011655564136794,0.043098023533821105,0.057408512383699414,0.1365885201841593,0.003966748085804284,0.02926282789558172,33.47952491194404,42.85412205773244,32.51857933734146,2.8621742230490095,0.04657320231199265,0.17755928933620452,0.025467043556272984,0.9820168614387512,0.07543057724833488,0.06885047890245914,0.014439491368830205,0.11786692664027214,0.0020250909845344724,0.09071467369794846,0.01416522953659296,0.007411723467521369,0.004463416477665305,0.0062080240342766045,0.3017628088593483,0.012494324054569007,0.24223807007074355,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6284.0,1705451.0,314827.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits the conversion of arachidonic acid into prostaglandin E2 by prostaglandin synthase in a competitive and reversible way.,,,,PIRPROFEN,CHEMBL188952,4.0,0.0,1.0,MOL,,Small molecule,1987.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1974.0,-2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C13H14ClNO2/c1-9(13(16)17)10-4-5-12(11(14)8-10)15-6-2-3-7-15/h2-5,8-9H,6-7H2,1H3,(H,16,17)",PIDSZXPFGCURGN-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1,0.8401271804776066,4.0,251.71299999999997,2.904300000000001,2,1,1,40.54,-3.466006216151886,0.9553377985954284,-4.444263624804122,0.9980952978134155,-8.76279067016957,0.5436697840690613,0.006117192748934031,0.7624447226524353,83.15927145485257,0.9846689981817958,0.02008359767496586,0.19961931556463242,0.11828828528523445,0.023668047972023487,0.013051168899983168,-8.335511776685117,34.3729263665466,20.446693293544545,2.9731408518377984,0.10075846463441848,0.39393002539873123,0.08667279556393623,0.7938649177551269,0.01637170501053333,0.025634908676147462,0.00618082694709301,0.11045854166150093,0.013739471789449453,0.05410933271050453,0.016204124549403787,0.3287677139043808,0.029838491603732108,0.026060019992291926,0.019022815767675637,0.04978552646934986,0.5781323790550232,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6284.0,1705451.0,314827.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits the conversion of arachidonic acid into prostaglandin E2 by prostaglandin synthase in a competitive and reversible way.,,,,PIRPROFEN,CHEMBL188952,4.0,0.0,1.0,MOL,,Small molecule,1987.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1974.0,-2.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C13H14ClNO2/c1-9(13(16)17)10-4-5-12(11(14)8-10)15-6-2-3-7-15/h2-5,8-9H,6-7H2,1H3,(H,16,17)",PIDSZXPFGCURGN-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1,0.8401271804776066,4.0,251.71299999999997,2.904300000000001,2,1,1,40.54,-3.466006216151886,0.9553377985954284,-4.444263624804122,0.9980952978134155,-8.76279067016957,0.5436697840690613,0.006117192748934031,0.7624447226524353,83.15927145485257,0.9846689981817958,0.02008359767496586,0.19961931556463242,0.11828828528523445,0.023668047972023487,0.013051168899983168,-8.335511776685117,34.3729263665466,20.446693293544545,2.9731408518377984,0.10075846463441848,0.39393002539873123,0.08667279556393623,0.7938649177551269,0.01637170501053333,0.025634908676147462,0.00618082694709301,0.11045854166150093,0.013739471789449453,0.05410933271050453,0.016204124549403787,0.3287677139043808,0.029838491603732108,0.026060019992291926,0.019022815767675637,0.04978552646934986,0.5781323790550232,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6441.0,1699588.0,314587.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Non-steroidal anti-inflammatory drug. Acemetacin works by blocking the effect of natural substances called cyclo-oxygenase (COX) enzymes. These enzymes help to make other chemicals in the body, called prostaglandins. Some prostaglandins are produced at sites of injury or damage, and cause pain and inflammation. By blocking the effect of COX enzymes, fewer prostaglandins are produced, which means pain and inflammation are eased.",It has modest selectivity for COX-1.,,,ACEMETACIN,CHEMBL189171,4.0,1.0,1.0,MOL,31162.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-metacin,0.0,-metacin,anti-inflammatory agents (indomethacin type),,0.0,0.0,0.0,"InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)",FSQKKOOTNAMONP-UHFFFAOYSA-N,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,0.6192570573143896,4.0,415.82900000000006,3.4705200000000014,6,1,0,94.82999999999998,-3.973911878407671,0.9391317486763,-5.003615121338465,0.9857652068138123,-10.016322025499678,0.7530022144317627,0.17812689170241355,0.6750900983810425,93.15027934492747,2.76475292242561,0.17734563946723939,0.27711571753025055,0.4426345109939575,0.019689866341650486,0.1408032551407814,14.933112425725852,22.820387224905453,27.470107009831356,3.5090670082401303,0.015611374750733376,0.1070818118751049,0.09515484422445297,0.9799186587333679,0.13189155161380767,0.02954776082187891,0.014431426813825966,0.06754096783697605,0.021484413463622332,0.09422306269407273,0.058932258188724516,0.24301326870918274,0.013942617550492286,0.017362972162663935,0.02326538795605302,0.04029452204704285,0.09441753327846528,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6441.0,1699588.0,314587.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Non-steroidal anti-inflammatory drug. Acemetacin works by blocking the effect of natural substances called cyclo-oxygenase (COX) enzymes. These enzymes help to make other chemicals in the body, called prostaglandins. Some prostaglandins are produced at sites of injury or damage, and cause pain and inflammation. By blocking the effect of COX enzymes, fewer prostaglandins are produced, which means pain and inflammation are eased.",It has modest selectivity for COX-1.,,,ACEMETACIN,CHEMBL189171,4.0,1.0,1.0,MOL,31162.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-metacin,0.0,-metacin,anti-inflammatory agents (indomethacin type),,0.0,0.0,0.0,"InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)",FSQKKOOTNAMONP-UHFFFAOYSA-N,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,0.6192570573143896,4.0,415.82900000000006,3.4705200000000014,6,1,0,94.82999999999998,-3.973911878407671,0.9391317486763,-5.003615121338465,0.9857652068138123,-10.016322025499678,0.7530022144317627,0.17812689170241355,0.6750900983810425,93.15027934492747,2.76475292242561,0.17734563946723939,0.27711571753025055,0.4426345109939575,0.019689866341650486,0.1408032551407814,14.933112425725852,22.820387224905453,27.470107009831356,3.5090670082401303,0.015611374750733376,0.1070818118751049,0.09515484422445297,0.9799186587333679,0.13189155161380767,0.02954776082187891,0.014431426813825966,0.06754096783697605,0.021484413463622332,0.09422306269407273,0.058932258188724516,0.24301326870918274,0.013942617550492286,0.017362972162663935,0.02326538795605302,0.04029452204704285,0.09441753327846528,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6461.0,1699589.0,989360.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Apazone is a non-steroidal antiinflammatory drug that has a weak anti-cyclooxygenase-1 and anti-cyclooxygenase-2 activity.,Apazone has a weak anti-cyclooxygenase-1 and anti-cyclooxygenase-2 activity.,,,APAZONE,CHEMBL1565476,4.0,1.0,1.0,MOL,38010.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1969.0,-1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C16H20N4O2/c1-5-6-11-14(21)19-13-9-10(2)7-8-12(13)17-16(18(3)4)20(19)15(11)22/h7-9,11H,5-6H2,1-4H3",MPHPHYZQRGLTBO-UHFFFAOYSA-N,CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O,0.7856488020836657,4.0,300.3620000000001,2.0642199999999997,4,0,1,56.220000000000006,-3.486913729789559,0.9100435495376586,-4.504615776130249,0.9997203707695007,-10.24805753398293,0.9778217673301697,0.10269736349582673,0.8279609680175781,68.6233637970801,7.201240307688321,0.4086892753839493,0.3662028551101685,0.3001496076583862,0.014074472431093454,0.03230535909533501,10.305764593843563,-14.753473151460398,22.751671158925298,2.392274023148076,0.41221190690994264,0.3689948707818985,0.045865966193377974,0.9357835650444031,0.46263728141784666,0.08992128167301416,0.004453495383495465,0.19513577222824097,0.008974686870351434,0.2257651850581169,0.03398135490715504,0.0039039588533341884,0.029125098325312137,0.020952393859624864,0.1706949695944786,0.1266292691230774,0.6179352700710297,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6461.0,1699589.0,989360.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Apazone is a non-steroidal antiinflammatory drug that has a weak anti-cyclooxygenase-1 and anti-cyclooxygenase-2 activity.,Apazone has a weak anti-cyclooxygenase-1 and anti-cyclooxygenase-2 activity.,,,APAZONE,CHEMBL1565476,4.0,1.0,1.0,MOL,38010.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1969.0,-1.0,,0.0,,,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C16H20N4O2/c1-5-6-11-14(21)19-13-9-10(2)7-8-12(13)17-16(18(3)4)20(19)15(11)22/h7-9,11H,5-6H2,1-4H3",MPHPHYZQRGLTBO-UHFFFAOYSA-N,CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O,0.7856488020836657,4.0,300.3620000000001,2.0642199999999997,4,0,1,56.220000000000006,-3.486913729789559,0.9100435495376586,-4.504615776130249,0.9997203707695007,-10.24805753398293,0.9778217673301697,0.10269736349582673,0.8279609680175781,68.6233637970801,7.201240307688321,0.4086892753839493,0.3662028551101685,0.3001496076583862,0.014074472431093454,0.03230535909533501,10.305764593843563,-14.753473151460398,22.751671158925298,2.392274023148076,0.41221190690994264,0.3689948707818985,0.045865966193377974,0.9357835650444031,0.46263728141784666,0.08992128167301416,0.004453495383495465,0.19513577222824097,0.008974686870351434,0.2257651850581169,0.03398135490715504,0.0039039588533341884,0.029125098325312137,0.020952393859624864,0.1706949695944786,0.1266292691230774,0.6179352700710297,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6476.0,2793356.0,9913.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Benzydamine is a nonsteroidal anti-inflammatory drug that acts partly through an inhibitory effect on the phospholipase A2 by diminishing the liberation of arachidonic acid from phospholipids, and partly as a weak inhibitor of prostaglandin G/H synthase 1 and 2 by reducing the production of prostaglandins.",Weak inhibitotor of COX-1 and COX-2,,,BENZYDAMINE,CHEMBL12610,4.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1965.0,-1.0,,0.0,,,Anti-Inflammatory; Antipyretic; Analgesic,0.0,0.0,0.0,"InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3",CNBGNNVCVSKAQZ-UHFFFAOYSA-N,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,0.6265558693074326,4.0,309.413,3.4151000000000016,4,0,0,30.29,-3.3082898176807887,0.7967251777648926,-4.4587352936692115,0.996630871295929,-7.362162348786702,0.9563814997673035,0.6347482442855835,0.9851697087287903,85.15619597600153,-1.7523958991079311,0.4017906427383423,0.21001261174678804,0.03193138614296913,0.8463232636451721,0.1412845715880394,-28.135075223074104,79.3620274720221,36.25579506373772,2.641490194345468,0.268293759226799,0.11138027384877205,0.5191611260175705,0.1980307273566723,0.9313662052154541,0.014215613715350628,0.0038799802772700787,0.053896031156182286,0.014755016844719648,0.08983020409941674,0.05693581029772758,0.0035841727047227325,0.003520388808101416,0.02409408111125231,0.025445174798369406,0.00712280732113868,0.6011464893817902,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6476.0,2793356.0,9913.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Benzydamine is a nonsteroidal anti-inflammatory drug that acts partly through an inhibitory effect on the phospholipase A2 by diminishing the liberation of arachidonic acid from phospholipids, and partly as a weak inhibitor of prostaglandin G/H synthase 1 and 2 by reducing the production of prostaglandins.",Weak inhibitotor of COX-1 and COX-2,,,BENZYDAMINE,CHEMBL12610,4.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1965.0,-1.0,,0.0,,,Anti-Inflammatory; Antipyretic; Analgesic,0.0,0.0,0.0,"InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3",CNBGNNVCVSKAQZ-UHFFFAOYSA-N,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,0.6265558693074326,4.0,309.413,3.4151000000000016,4,0,0,30.29,-3.3082898176807887,0.7967251777648926,-4.4587352936692115,0.996630871295929,-7.362162348786702,0.9563814997673035,0.6347482442855835,0.9851697087287903,85.15619597600153,-1.7523958991079311,0.4017906427383423,0.21001261174678804,0.03193138614296913,0.8463232636451721,0.1412845715880394,-28.135075223074104,79.3620274720221,36.25579506373772,2.641490194345468,0.268293759226799,0.11138027384877205,0.5191611260175705,0.1980307273566723,0.9313662052154541,0.014215613715350628,0.0038799802772700787,0.053896031156182286,0.014755016844719648,0.08983020409941674,0.05693581029772758,0.0035841727047227325,0.003520388808101416,0.02409408111125231,0.025445174798369406,0.00712280732113868,0.6011464893817902,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6477.0,1705846.0,952018.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Benzydamine is a nonsteroidal anti-inflammatory drug that acts partly through an inhibitory effect on the phospholipase A2 by diminishing the liberation of arachidonic acid from phospholipids, and partly as a weak inhibitor of prostaglandin G/H synthase 1 and 2 by reducing the production of prostaglandins.",Weak inhibitotor of COX-1 and COX-2.,,,BENZYDAMINE HYDROCHLORIDE,CHEMBL1528134,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1965.0,-1.0,,0.0,,,Anti-Inflammatory; Antipyretic; Analgesic,0.0,0.0,0.0,"InChI=1S/C19H23N3O.ClH/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16;/h3-7,9-12H,8,13-15H2,1-2H3;1H",HNNIWKQLJSNAEQ-UHFFFAOYSA-N,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl,0.6094354627280297,4.0,345.87399999999997,3.836900000000003,4,0,0,30.29,-2.723790985106451,0.8377716779708863,-4.631244743926129,0.9947559356689453,-7.794171980132363,0.9113540172576904,0.7735278844833374,0.9767248153686523,89.5638933380167,-4.357940072072716,0.43239263296127317,0.24982865601778032,0.04041516706347466,0.9151739239692688,0.12798258662223816,-2.1791021324250464,79.11336316541332,47.27973254081421,2.553669703427237,0.4973896682262421,0.23951935768127441,0.5813446462154388,0.21581574082374572,0.9507528662681579,0.00928816180676222,0.005833127861842513,0.06216114982962608,0.023179437965154648,0.09595563411712646,0.12295639663934707,0.009166116220876574,0.006652738433331251,0.042623643018305304,0.049631287716329096,0.015007884241640568,0.6547458231449127,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6477.0,1705846.0,952018.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Benzydamine is a nonsteroidal anti-inflammatory drug that acts partly through an inhibitory effect on the phospholipase A2 by diminishing the liberation of arachidonic acid from phospholipids, and partly as a weak inhibitor of prostaglandin G/H synthase 1 and 2 by reducing the production of prostaglandins.",Weak inhibitotor of COX-1 and COX-2.,,,BENZYDAMINE HYDROCHLORIDE,CHEMBL1528134,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1965.0,-1.0,,0.0,,,Anti-Inflammatory; Antipyretic; Analgesic,0.0,0.0,0.0,"InChI=1S/C19H23N3O.ClH/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16;/h3-7,9-12H,8,13-15H2,1-2H3;1H",HNNIWKQLJSNAEQ-UHFFFAOYSA-N,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl,0.6094354627280297,4.0,345.87399999999997,3.836900000000003,4,0,0,30.29,-2.723790985106451,0.8377716779708863,-4.631244743926129,0.9947559356689453,-7.794171980132363,0.9113540172576904,0.7735278844833374,0.9767248153686523,89.5638933380167,-4.357940072072716,0.43239263296127317,0.24982865601778032,0.04041516706347466,0.9151739239692688,0.12798258662223816,-2.1791021324250464,79.11336316541332,47.27973254081421,2.553669703427237,0.4973896682262421,0.23951935768127441,0.5813446462154388,0.21581574082374572,0.9507528662681579,0.00928816180676222,0.005833127861842513,0.06216114982962608,0.023179437965154648,0.09595563411712646,0.12295639663934707,0.009166116220876574,0.006652738433331251,0.042623643018305304,0.049631287716329096,0.015007884241640568,0.6547458231449127,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6692.0,1702999.0,117758.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Ketoprofen is a non-steroidal anti-inï¬‚ammatory drug. It is a racemic mixture and its analgesic efï¬cacy is due to the (S)-enantiomer, dexketoprofen. The analgesic action of the (R)-enantiomer is considered to be less signiï¬cant, but causes the majority of adverse effects, that is gastric mucosa irritation. Its mechanism of action is the non-selective inhibition of cyclooxygenase-1 and cyclooxygenase-2.",Dexketoprofen was found to be a potent inhibitor of the prostaglandin F2 alpha (PGF2 alpha) production in rat brain (IC50 = 6.2 nM),,,DEXKETOPROFEN,CHEMBL75435,4.0,1.0,1.0,MOL,76128.0,Small molecule,1994.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,-1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/m0/s1",DKYWVDODHFEZIM-NSHDSACASA-N,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1,0.8528036890699656,4.0,254.285,3.1057000000000015,2,1,1,54.37,-3.4454709696597936,0.9531883358955383,-4.289279622229595,0.9922172784805298,-9.81587132758957,0.4592410624027252,0.01172845452092588,0.4028347015380859,95.0620551380181,1.7767986034868937,0.014666131464764476,0.042884964123368265,0.08097911924123764,0.0031077569583430886,0.0021913385717198253,5.584575084369978,15.644924077280148,1.8273571224742675,2.641191995524031,0.006869371794164181,0.4389857441186905,0.028888018801808357,0.9227887272834778,0.004760156711563468,0.05132804736495018,0.007074406230822205,0.27967669665813444,0.026851221919059753,0.013865559920668602,0.006300041684880853,0.18193161636590957,0.01690491819754243,0.00286904398817569,0.011835509166121482,0.0037967775017023085,0.2523058921098709,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,6692.0,1702999.0,117758.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Ketoprofen is a non-steroidal anti-inï¬‚ammatory drug. It is a racemic mixture and its analgesic efï¬cacy is due to the (S)-enantiomer, dexketoprofen. The analgesic action of the (R)-enantiomer is considered to be less signiï¬cant, but causes the majority of adverse effects, that is gastric mucosa irritation. Its mechanism of action is the non-selective inhibition of cyclooxygenase-1 and cyclooxygenase-2.",Dexketoprofen was found to be a potent inhibitor of the prostaglandin F2 alpha (PGF2 alpha) production in rat brain (IC50 = 6.2 nM),,,DEXKETOPROFEN,CHEMBL75435,4.0,1.0,1.0,MOL,76128.0,Small molecule,1994.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,-1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/m0/s1",DKYWVDODHFEZIM-NSHDSACASA-N,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1,0.8528036890699656,4.0,254.285,3.1057000000000015,2,1,1,54.37,-3.4454709696597936,0.9531883358955383,-4.289279622229595,0.9922172784805298,-9.81587132758957,0.4592410624027252,0.01172845452092588,0.4028347015380859,95.0620551380181,1.7767986034868937,0.014666131464764476,0.042884964123368265,0.08097911924123764,0.0031077569583430886,0.0021913385717198253,5.584575084369978,15.644924077280148,1.8273571224742675,2.641191995524031,0.006869371794164181,0.4389857441186905,0.028888018801808357,0.9227887272834778,0.004760156711563468,0.05132804736495018,0.007074406230822205,0.27967669665813444,0.026851221919059753,0.013865559920668602,0.006300041684880853,0.18193161636590957,0.01690491819754243,0.00286904398817569,0.011835509166121482,0.0037967775017023085,0.2523058921098709,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,7550.0,1702697.0,317541.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ESFLURBIPROFEN,CHEMBL435298,4.0,0.0,1.0,MOL,42446.0,Small molecule,2015.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,-1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m0/s1",SYTBZMRGLBWNTM-JTQLQIEISA-N,C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,0.8937504426107861,4.0,244.265,3.6808000000000023,1,1,1,37.3,-3.81271192584867,0.9849731087684631,-4.230441660482051,0.9992987513542175,-7.855916413499278,0.6678393602371215,0.009186200413387269,0.6970067977905273,98.74759247848428,-0.05161114636439077,0.07522680461406708,0.09099650532007217,0.1730879634618759,0.002472507127095014,0.005663575336802751,-7.6235332007756345,13.072488491329953,19.600708133759028,2.957805967176901,0.05628214441239834,0.6097138345241546,0.04347238019108772,0.9572884440422058,0.01868903459981084,0.058138445019721985,0.004784511914476752,0.2612370729446411,0.0377909891307354,0.05859179385006428,0.02516298145055771,0.3844157099723816,0.07758456561714411,0.003077285224571824,0.014775017276406288,0.012382539501413704,0.20364722609519958,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,7550.0,1702697.0,317541.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ESFLURBIPROFEN,CHEMBL435298,4.0,0.0,1.0,MOL,42446.0,Small molecule,2015.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,-1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m0/s1",SYTBZMRGLBWNTM-JTQLQIEISA-N,C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,0.8937504426107861,4.0,244.265,3.6808000000000023,1,1,1,37.3,-3.81271192584867,0.9849731087684631,-4.230441660482051,0.9992987513542175,-7.855916413499278,0.6678393602371215,0.009186200413387269,0.6970067977905273,98.74759247848428,-0.05161114636439077,0.07522680461406708,0.09099650532007217,0.1730879634618759,0.002472507127095014,0.005663575336802751,-7.6235332007756345,13.072488491329953,19.600708133759028,2.957805967176901,0.05628214441239834,0.6097138345241546,0.04347238019108772,0.9572884440422058,0.01868903459981084,0.058138445019721985,0.004784511914476752,0.2612370729446411,0.0377909891307354,0.05859179385006428,0.02516298145055771,0.3844157099723816,0.07758456561714411,0.003077285224571824,0.014775017276406288,0.012382539501413704,0.20364722609519958,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,7568.0,1700015.0,22873.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Activated in vivo.,Non-selective: active against COX-1 and COX-2.,,,LOXOPROFEN,CHEMBL19299,4.0,0.0,1.0,MOL,76172.0,Small molecule,1986.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,,-1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C15H18O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13H,2-4,9H2,1H3,(H,17,18)",YMBXTVYHTMGZDW-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,0.8883440640479293,4.0,246.30599999999993,2.7864000000000013,2,1,2,54.37,-2.35151861486465,0.9694253444671631,-4.3638987589108105,0.9994552493095398,-9.569583680524044,0.5405597448348999,0.005353294406086206,0.577200996875763,82.24363933472947,-0.8131865370777703,0.004336324380710721,0.06315702497959137,0.05315131489187479,0.008937655203044414,0.0031673834193497894,-8.05761193692373,24.53003161828854,-11.872014059555239,2.7400157184565037,0.014842284377664328,0.21341383829712868,0.0601420521736145,0.4202979505062103,0.001598555501550436,0.03207048997282982,0.0059861404122784736,0.1370001718401909,0.008356493944302202,0.015289705712348223,0.0014654713100753724,0.13652652725577355,0.00518546283710748,0.00782904140651226,0.008919775765389205,0.0030760525725781916,0.24423649311065673,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,7568.0,1700015.0,22873.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,Activated in vivo.,Non-selective: active against COX-1 and COX-2.,,,LOXOPROFEN,CHEMBL19299,4.0,0.0,1.0,MOL,76172.0,Small molecule,1986.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,,-1.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),,0.0,0.0,0.0,"InChI=1S/C15H18O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13H,2-4,9H2,1H3,(H,17,18)",YMBXTVYHTMGZDW-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,0.8883440640479293,4.0,246.30599999999993,2.7864000000000013,2,1,2,54.37,-2.35151861486465,0.9694253444671631,-4.3638987589108105,0.9994552493095398,-9.569583680524044,0.5405597448348999,0.005353294406086206,0.577200996875763,82.24363933472947,-0.8131865370777703,0.004336324380710721,0.06315702497959137,0.05315131489187479,0.008937655203044414,0.0031673834193497894,-8.05761193692373,24.53003161828854,-11.872014059555239,2.7400157184565037,0.014842284377664328,0.21341383829712868,0.0601420521736145,0.4202979505062103,0.001598555501550436,0.03207048997282982,0.0059861404122784736,0.1370001718401909,0.008356493944302202,0.015289705712348223,0.0014654713100753724,0.13652652725577355,0.00518546283710748,0.00782904140651226,0.008919775765389205,0.0030760525725781916,0.24423649311065673,False
PTGS2_COX2,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,9015.0,1705457.0,993371.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LORNOXICAM,CHEMBL1569487,4.0,1.0,1.0,MOL,31783.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1993.0,-1.0,-icam,0.0,-icam,anti-inflammatory agents (isoxicam type),Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)",WLHQHAUOOXYABV-UHFFFAOYSA-N,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O,0.8432700407675219,4.0,371.82700000000006,2.2958999999999996,6,2,0,99.6,-4.161932698307586,0.8282234907150269,-4.784776630836317,0.999748706817627,-15.789896196530382,0.8388318419456482,0.1275004878640175,0.300867423415184,93.086285582633,11.864628267689971,0.1684096187353134,0.2602475881576538,0.36970654875040054,0.03349870201200247,0.0972465917468071,56.965807993051214,64.82854869075949,18.412500657409275,4.177900643824777,0.02707428503781557,0.1386323720216751,0.03193948082625866,0.9849128246307373,0.07232816666364669,0.028106553480029106,0.01738871745765209,0.13212449178099633,0.004728298564441502,0.11527491137385368,0.042897016555070874,0.03512826450169086,0.012625111732631922,0.0279285853728652,0.5489620476961136,0.05172506161034107,0.33177803456783295,False
PTGS1_COX1,104725,PROTEIN FAMILY,Cyclooxygenase,9606,Homo sapiens,CHEMBL2094253,,0.0,9015.0,1705457.0,993371.0,Cyclooxygenase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LORNOXICAM,CHEMBL1569487,4.0,1.0,1.0,MOL,31783.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1993.0,-1.0,-icam,0.0,-icam,anti-inflammatory agents (isoxicam type),Anti-Inflammatory; Analgesic,0.0,0.0,0.0,"InChI=1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)",WLHQHAUOOXYABV-UHFFFAOYSA-N,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O,0.8432700407675219,4.0,371.82700000000006,2.2958999999999996,6,2,0,99.6,-4.161932698307586,0.8282234907150269,-4.784776630836317,0.999748706817627,-15.789896196530382,0.8388318419456482,0.1275004878640175,0.300867423415184,93.086285582633,11.864628267689971,0.1684096187353134,0.2602475881576538,0.36970654875040054,0.03349870201200247,0.0972465917468071,56.965807993051214,64.82854869075949,18.412500657409275,4.177900643824777,0.02707428503781557,0.1386323720216751,0.03193948082625866,0.9849128246307373,0.07232816666364669,0.028106553480029106,0.01738871745765209,0.13212449178099633,0.004728298564441502,0.11527491137385368,0.042897016555070874,0.03512826450169086,0.012625111732631922,0.0279285853728652,0.5489620476961136,0.05172506161034107,0.33177803456783295,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,1457.0,1344436.0,21697.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ROFECOXIB,CHEMBL122,4.0,1.0,1.0,MOL,8887.0,Small molecule,1999.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1998.0,-2.0,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,1.0,0.0,0.0,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",RZJQGNCSTQAWON-UHFFFAOYSA-N,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,0.8169951703125135,4.0,314.3620000000001,2.5577000000000005,4,0,0,60.44,-4.428675208880925,0.8414732456207276,-4.410412022618087,0.9961059331893921,-7.139328997048418,0.9365334749221802,0.3014404684305191,0.7611584067344666,91.19123233436444,0.7759891497438495,0.5230991423130036,0.6035429477691651,0.2682348906993866,0.01616791533306241,0.25148711502552035,21.54409909194602,45.44370343614368,21.054930631834957,2.1184780853802656,0.0389701658859849,0.41829376816749575,0.05018888115882873,0.9691069722175598,0.1365272343158722,0.019240185059607028,0.024525582417845727,0.10739997401833534,0.029535457026213408,0.017558763176202773,0.03377142213284969,0.04180395770817995,0.016830081958323716,0.022415289375931024,0.10329696275293827,0.01784958392381668,0.6114931702613831,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,1458.0,1344340.0,264453.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective,,,CARPROFEN,CHEMBL1316,4.0,1.0,1.0,MOL,364453.0,Small molecule,1987.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1976.0,0.0,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19)",PUXBGTOOZJQSKH-UHFFFAOYSA-N,CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12,0.7364039910992084,4.0,273.719,4.162600000000002,1,2,1,53.089999999999996,-4.740989738436373,0.9395682334899902,-4.851617840887815,0.9995588064193726,-11.924561902281491,0.5554270625114441,0.020652322471141814,0.6134514033794403,108.90527345034843,8.334929652223096,0.7438488185405732,0.13955505937337875,0.10862077921628951,0.04830001592636109,0.037276219204068185,38.02296113229823,-16.045312434159676,-17.8741559750877,3.0786372239345248,0.06095080114901066,0.1839875504374504,0.20269173085689546,0.9784144043922425,0.020290077570825814,0.026460571214556694,0.028081260435283185,0.09641890376806259,0.05368013456463814,0.6340444028377533,0.028446879237890244,0.42395134568214415,0.0944814845919609,0.09697536304593087,0.1347621873021126,0.23437024056911468,0.30938253104686736,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,1459.0,1344561.0,20496.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MELOXICAM,CHEMBL599,4.0,1.0,1.0,MOL,6741.0,Small molecule,2000.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1997.0,1.0,-icam,0.0,-icam,anti-inflammatory agents (isoxicam type),Anti-Inflammatory (nonsteroidal),0.0,0.0,0.0,"InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)",ZRVUJXDFFKFLMG-UHFFFAOYSA-N,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,0.8613672076779288,4.0,351.4090000000001,1.95092,6,2,0,99.59999999999998,-3.8003488680818185,0.8868134260177613,-4.6526299046454485,0.9998547911643982,-14.651097175204303,0.7536295652389526,0.1318199723958969,0.34810338616371156,93.64620023433764,-1.0896100032478961,0.10982980057597161,0.1936571031808853,0.32459993213415145,0.007669496536254883,0.14546265974640846,17.539682948109846,33.684116170548,24.92815532101058,2.893009289743985,0.024175024032592772,0.2332600995898247,0.013010123372077942,0.9818223714828491,0.07150354459881783,0.10003667846322059,0.02008609496988356,0.26272748559713366,0.0026266045751981437,0.25011162757873534,0.016634684149175884,0.014743225695565344,0.008423474431037904,0.018347070924937724,0.5257772088050843,0.017584550008177758,0.2986013352870941,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,1460.0,1343512.0,139210.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NABUMETONE,CHEMBL1070,4.0,1.0,1.0,MOL,7443.0,Small molecule,1991.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,1.0,0.0,1986.0,1.0,nab-,0.0,nab-,cannabinol derivatives,Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3",BLXXJMDCKKHMKV-UHFFFAOYSA-N,COc1ccc2cc(CCC(C)=O)ccc2c1,0.8015823313615688,4.0,228.29099999999997,3.370000000000002,2,0,0,26.3,-4.167463772096575,0.9345086097717286,-4.436564071039673,0.9999752044677734,-7.150412302948811,0.9916314244270324,0.28231542855501174,0.9464899659156799,96.88775517063002,-1.231838462777048,0.9932718276977539,0.6239055573940278,0.13468171209096907,0.2150191992521286,0.15549323558807374,-11.23285776179959,113.52334084757294,72.67089208365532,1.6726019892104749,0.41676204204559325,0.07875972539186478,0.03173566423356533,0.684943699836731,0.3650381088256836,0.052974351495504376,0.01701179859228432,0.38830742835998533,0.05265615060925484,0.6934477925300598,0.05585501864552498,0.0279436944052577,0.23063520193099976,0.04050482362508774,0.13209454715251923,0.0728399906307459,0.3125061303377151,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,1461.0,1343486.0,67010.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VALDECOXIB,CHEMBL865,4.0,1.0,1.0,MOL,63634.0,Small molecule,2001.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1998.0,-1.0,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,1.0,0.0,0.0,"InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)",LNPDTQAFDNKSHK-UHFFFAOYSA-N,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,0.8049353387121051,4.0,314.36600000000004,2.9644200000000005,4,1,0,86.19,-3.8118951641488876,0.9394709467887878,-4.791597719858963,0.9973307251930237,-8.74879099826825,0.9031007885932922,0.41390392780303953,0.7658601641654968,102.3244857918192,-2.303350277052894,0.6411259949207306,0.21662170737981795,0.23669849187135697,0.03385564144700766,0.1959689065814018,-25.984738076368945,34.908491367075165,31.568738156247623,2.1119709395985256,0.0982534248381853,0.5185213148593902,0.24682455956935884,0.9620666146278382,0.1885983407497406,0.10694919601082802,0.08368084952235222,0.11540543586015702,0.05212335102260113,0.10375002287328243,0.04757424592971802,0.01792795490473509,0.037405149545520544,0.015161500684916973,0.06636793352663517,0.02570539452135563,0.12663861662149428,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,1462.0,1344122.0,18694.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CELECOXIB,CHEMBL118,4.0,1.0,1.0,MOL,41423.0,Small molecule,1998.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1998.0,1.0,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",RZEKVGVHFLEQIL-UHFFFAOYSA-N,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,0.7541053298167572,4.0,381.3790000000001,3.5139200000000006,4,1,0,77.98,-4.484045150813927,0.9465335726737976,-4.889575055745313,0.9992149114608765,-5.507205298874522,0.8963689804077148,0.6596757292747497,0.8156947135925293,99.63877968177096,-2.708119279295701,0.7532875776290894,0.4758826196193695,0.3430666595697403,0.07704082168638707,0.5186875402927399,-45.27969406159527,24.21104478605306,26.691918295498215,2.3782557945715976,0.1245786152780056,0.8637241959571839,0.3340038269758224,0.9544352293014526,0.6055729687213898,0.1087129294872284,0.09349932745099068,0.11930352970957755,0.043255716748535636,0.04581616297364235,0.13988310247659683,0.052510813996195796,0.03730487897992134,0.009985715989023447,0.3153374493122101,0.05846566613763571,0.08249751105904579,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,1463.0,1344314.0,26431.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ETODOLAC,CHEMBL622,4.0,1.0,1.0,MOL,4909.0,Small molecule,1991.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1975.0,1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,0.0,0.0,0.0,"InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)",NNYBQONXHNTVIJ-UHFFFAOYSA-N,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,0.9057842881790305,4.0,287.35900000000004,3.383000000000002,2,2,1,62.32000000000001,-3.4526990999831804,0.8618934631347657,-5.124660694687931,0.9984842538833618,-10.361061479963809,0.4924891233444214,0.12544024735689163,0.8850530505180358,97.79506409820274,-4.582316294089201,0.06892725899815559,0.07629353031516076,0.03917257487773895,0.03565893229097128,0.018309009447693824,4.427183837803343,14.2040004809818,2.6496101803784873,2.8059764434690893,0.18523897603154182,0.07460838481783867,0.17371398359537124,0.6727807521820068,0.0681147187948227,0.01635674759745598,0.00372166158631444,0.07471444755792618,0.0244073498994112,0.23939652293920516,0.048210718855261805,0.15969736725091935,0.012340564094483853,0.09522148668766021,0.03945891670882702,0.08868293687701226,0.40907294750213624,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,5689.0,1703548.0,6706.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selectively inhibits COX-2 (IC(50) = 1.1 +/- 0.1microM) compared with COX-1 IC(50)=116 +/- 8 microM.,,,ETORICOXIB,CHEMBL416146,4.0,1.0,1.0,MOL,6339.0,Small molecule,2002.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2000.0,-1.0,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",MNJVRJDLRVPLFE-UHFFFAOYSA-N,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,0.7044044148957774,4.0,358.8500000000001,4.175920000000004,4,0,0,59.92,-4.741713392299818,0.9527098059654235,-4.831167681980806,0.9996583938598633,-8.53878751385242,0.9775277495384216,0.43075475096702576,0.8784817218780517,91.55532548893555,-0.31823622692779213,0.8051114916801453,0.699456250667572,0.2008505269885063,0.0654352769255638,0.7728928446769714,23.08766611079099,18.217120458016144,21.45432142797025,2.1383509559307017,0.12941983565688134,0.3974933922290802,0.27712099254131317,0.9359428405761718,0.31172530353069305,0.022218018304556608,0.025365152209997178,0.0676306925714016,0.03394508361816406,0.09487785995006562,0.12135336101055146,0.029177919309586287,0.01610144304577261,0.035522911325097085,0.06080180667340755,0.020002763578668238,0.15435285866260529,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,5713.0,1705229.0,1179259.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,APRICOXIB,CHEMBL1835207,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2008.0,,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C19H20N2O3S/c1-3-24-17-8-4-15(5-9-17)19-12-14(2)13-21(19)16-6-10-18(11-7-16)25(20,22)23/h4-13H,3H2,1-2H3,(H2,20,22,23)",JTMITOKKUMVWRT-UHFFFAOYSA-N,CCOc1ccc(-c2cc(C)cn2-c2ccc(S(N)(=O)=O)cc2)cc1,0.7601883265934699,4.0,356.44700000000006,3.498820000000001,4,1,0,74.32,-4.16380639731261,0.9478500008583068,-4.8875543130010515,0.9971591472625733,-8.958507711885487,0.9280592441558838,0.5064056366682053,0.7048963308334351,102.803183715634,-6.145385806700584,0.8296286106109619,0.47625129818916323,0.4785186231136322,0.12318389788269997,0.6004001796245575,-26.63947355806033,49.86885688984425,45.94637966628395,2.363081757530118,0.13027905374765397,0.5603180944919586,0.32223705053329466,0.9492021203041077,0.3639793246984482,0.13347110748291016,0.0902484580874443,0.12175935134291649,0.05867808870971203,0.14398414120078087,0.09263418838381768,0.06306409984827041,0.05694915577769279,0.0445200152695179,0.18963846415281296,0.07087670043110847,0.08485714048147201,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,5784.0,1976725.0,277493.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,POLMACOXIB,CHEMBL166863,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2013.0,,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H16FNO4S/c1-18(2)17(21)15(12-4-3-5-13(19)10-12)16(24-18)11-6-8-14(9-7-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23)",IJWPAFMIFNSIGD-UHFFFAOYSA-N,CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(F)c2)C1=O,0.9106234626144589,4.0,361.39400000000006,2.7193000000000014,4,1,0,86.46000000000001,-4.367289457931248,0.9402588129043579,-4.854783678669831,0.9983774304389954,-6.870632847000294,0.9202319145202636,0.3954044938087463,0.7192100048065185,96.64469129264745,2.8871157480378176,0.2941333517432213,0.29457971304655073,0.3429003983736038,0.15823878943920136,0.31457357108592987,10.575351126591851,52.737400844620254,25.550613547945876,2.707069247832517,0.07205019369721413,0.6510177791118622,0.13336258381605148,0.9188036441802978,0.23691117465496064,0.10549376904964447,0.10423795357346535,0.08087754361331463,0.02546191876754165,0.07029694579541683,0.05611698254942894,0.026576682925224304,0.02420414164662361,0.009195099957287312,0.18548679500818252,0.04014033600687981,0.06868449747562408,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,5884.0,1699203.0,67050.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Upon intravenous or intramuscular administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2.  This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever.",,,,PARECOXIB SODIUM,CHEMBL296913,4.0,1.0,1.0,MOL,,Small molecule,2002.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,1998.0,-1.0,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C19H18N2O4S.Na/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15;/h4-12H,3H2,1-2H3,(H,21,22);/q;+1/p-1",HQPVVKXJNZEAFW-UHFFFAOYSA-M,CCC(=O)[N-]S(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1.[Na+],0.6109827481756311,4.0,392.4120000000001,1.3200199999999997,5,0,0,91.34,-1.3577605141303797,0.8894063591957092,-4.808941666373835,0.9690143227577209,-9.762955178128477,0.8408867001533509,0.44118565022945405,0.5364378929138184,98.3888776345906,-1.5885548304820896,0.054506481438875196,0.24209156334400178,0.33812130689620973,0.00858155859168619,0.07824788875877857,40.30259743813903,30.447555042468025,27.026721347137947,2.9468758435712004,0.03135282956063747,0.5098128825426101,0.048365258052945136,0.9542619466781617,0.09476350620388985,0.05587676391005516,0.028939151763916017,0.06403426229953765,0.009141603857278824,0.006118359486572444,0.010133709548972547,0.0336895402520895,0.0051228726049885156,0.00857873372733593,0.023031917121261358,0.006012115092016756,0.10022094175219536,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,5912.0,1703479.0,680641.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever.  It does not inhibit COX-1 at therapeutic concentrations and, therefore, does not interfere with blood coagulation.",,,,PARECOXIB,CHEMBL1206690,4.0,1.0,0.0,MOL,73038.0,Small molecule,2002.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,1998.0,-1.0,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22)",TZRHLKRLEZJVIJ-UHFFFAOYSA-N,CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1,0.7419803073587753,4.0,370.43000000000006,3.531920000000002,5,1,0,89.27,-3.771018268338598,0.9167612314224243,-4.846602800396587,0.996677565574646,-9.942156194778557,0.9324936866760254,0.4024757966399193,0.5829320549964905,104.48699106730093,-0.8245521522327177,0.17627216279506683,0.3509297877550125,0.6449355125427246,0.01739211268723011,0.20235460475087166,38.01945100058272,25.82294808801467,36.33510906861868,2.414528283198478,0.0326542217284441,0.5351370006799698,0.09819409474730492,0.978640866279602,0.14575543999671936,0.06929914355278015,0.029588482901453973,0.0790625862777233,0.012568251322954893,0.01300333165563643,0.033066002652049065,0.03601957336068153,0.006191359157674015,0.014125744998455047,0.05760548114776611,0.011526809446513653,0.15761618912220002,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,6258.0,1705329.0,424824.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Cyclooxygenase 2 (COX2) is involved in the production of prostaglandins, in response to injury or certain diseases. These prostaglandins cause pain, swelling and inflammation. When COX2 is inhibited the production of these prostaglandins is blocked, and that relieves pain and inflammation.",It has the highest COX-2 selectivity of any NSAID.,It binds to a different site on the COX-2 enzyme than other COX-2 inhibitors.,,LUMIRACOXIB,CHEMBL404108,4.0,1.0,1.0,MOL,73044.0,Small molecule,2005.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2002.0,-2.0,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,1.0,0.0,0.0,"InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)",KHPKQFYUPIUARC-UHFFFAOYSA-N,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,0.8897457941317977,4.0,293.725,4.158220000000002,2,2,0,49.33,-4.299675937590433,0.9773751020431518,-4.45058699545139,0.9990545749664307,-8.02582353263088,0.6234730899333953,0.029051769571378828,0.6095144987106323,96.75066582539446,-1.2037139837623625,0.1632866993546486,0.45498259663581847,0.3271381616592407,0.041303133219480516,0.08124347552657127,-13.62226693703237,56.84127145037282,37.0615212167333,2.7923386933495826,0.07917418330907822,0.5132124572992325,0.06926891170442104,0.9490227818489074,0.051146465539932254,0.03947399239987135,0.008040407719090582,0.12855467051267624,0.03679690398275852,0.1818689674139023,0.07791313230991363,0.6113045454025269,0.04303586073219776,0.036023904010653494,0.1026687853038311,0.13800131306052207,0.26920561492443085,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,6760.0,1706328.0,150585.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Aceclofenac works by inhibiting the action of cyclooxygenase 2 (with minimal inhibition of COX1) involved in the production of prostaglandins which is accountable for pain, swelling, inflammation and fever. Aceclofenac has shown stimulatory effects on cartilage matrix synthesis that may be linked to the ability of the drug to inhibit the suppression by IL-1Î² of various growth factors.","Data from human whole blood assays show inhibition of COX-2 (with minimal effects on COX-1) by both the parent compound and 4â€²-hydroxyaceclofenac: IC50 values for COX-1 and COX-2, respectively, were >100 and 0.8 for aceclofenac and >100 and 36 for 4â€²- hydroxyaceclofenac.",,,ACECLOFENAC,CHEMBL93645,4.0,1.0,1.0,MOL,31159.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",MNIPYSSQXLZQLJ-UHFFFAOYSA-N,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,0.7696621138235622,4.0,354.1890000000001,3.907300000000002,4,2,0,75.63,-4.020355609024229,0.9235100746154785,-4.705531638954423,0.9917775154113769,-8.747444640929485,0.5527396559715271,0.03563324566930533,0.7774761080741882,93.87264849641585,-1.586445208770591,0.21842262893915176,0.35568017065525054,0.3347039699554443,0.06169356759637594,0.016800524573773144,0.12128602141201554,74.48553016083125,43.69612843745616,2.7965661936631223,0.01469912938773632,0.28658558130264283,0.10737350285053253,0.9589131355285645,0.06092991009354591,0.03009975515305996,0.017055756598711013,0.08192535936832428,0.01635156851261854,0.05395778641104698,0.025330142490565775,0.5591055929660798,0.033057248778641225,0.030987455695867538,0.027867748215794564,0.06896203942596912,0.28881546258926394,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,7757.0,1705211.0,1379725.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Also inhibits NFKB translocation. Mechanism not fully elucidated.,,,,IGURATIMOD,CHEMBL2107455,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-imod,0.0,-imod,immunomodulators,,0.0,0.0,0.0,"InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20)",ANMATWQYLIFGOK-UHFFFAOYSA-N,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1,0.6408758551254655,4.0,374.37400000000014,2.5251,6,2,0,114.71,-4.367511599026644,0.8751181364059448,-5.0715290458284175,0.9977137446403503,-12.217222956212535,0.8538405656814575,0.5183989614248276,0.8019655585289002,90.37963767057093,-10.086500530252561,0.7609375,0.28103737682104113,0.39903162121772767,0.09111570380628109,0.45552503168582914,39.164192390748745,55.36218838364933,16.805639645156145,2.3565665099997752,0.5294609546661377,0.3381775200366974,0.16643344461917878,0.9874253869056702,0.6209939956665039,0.0978939451277256,0.06280654408037663,0.09810884892940522,0.017029264569282533,0.21681069433689118,0.07201499417424202,0.04935317635536194,0.06624095365405083,0.029838490672409533,0.201369272172451,0.14717355817556382,0.27716404050588606,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,7938.0,1706030.0,191924.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CIMICOXIB,CHEMBL435381,2.0,0.0,0.0,MOL,76127.0,Small molecule,2011.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H13ClFN3O3S/c1-24-14-7-2-10(8-13(14)18)15-16(17)20-9-21(15)11-3-5-12(6-4-11)25(19,22)23/h2-9H,1H3,(H2,19,22,23)",KYXDNECMRLFQMZ-UHFFFAOYSA-N,COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F,0.7521440675222917,4.0,381.8160000000001,2.9878,5,1,0,87.21000000000001,-3.6942153311034382,0.96286039352417,-4.732391622527656,0.9991928815841675,-10.306875685056005,0.870096755027771,0.3807912051677704,0.7699830770492554,88.79495714776941,-6.3461629083427935,0.38826425969600675,0.4100911498069763,0.4896431744098663,0.09853997379541397,0.657813423871994,-11.230663911569371,33.30569657402511,19.790867009633754,2.3320009624720277,0.07270535565912724,0.403189617395401,0.20335363149642943,0.9732483148574829,0.359447118639946,0.05097212344408035,0.0439950168132782,0.05116988196969032,0.015174435544759035,0.10502884499728679,0.1285205602645874,0.01796879041939974,0.024460174329578876,0.01198280518874526,0.04802933223545551,0.018516626674681902,0.050068735331296924,False
PTGS2_COX2,126,SINGLE PROTEIN,Cyclooxygenase-2,9606,Homo sapiens,CHEMBL230,,0.0,8969.0,3132492.0,310199.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GW-406381,CHEMBL364804,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H19N3O3S/c1-3-27-17-10-6-16(7-11-17)21-20(19-5-4-14-22-24(19)23-21)15-8-12-18(13-9-15)28(2,25)26/h4-14H,3H2,1-2H3",NXMZBNYLCVTRGB-UHFFFAOYSA-N,CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1,0.5146434389372717,4.0,393.46800000000013,3.8655000000000026,6,0,0,73.56,-5.006099219927918,0.9018402576446534,-4.895014497752143,0.9962488055229187,-8.923451565595832,0.8483867406845093,0.719647490978241,0.6538230299949646,98.0725215721889,-6.163859063430754,0.6166302800178528,0.7259251594543457,0.6112911403179169,0.06661583371460437,0.7998351812362671,-4.386113889435029,11.674017657591433,26.130852164891945,2.0618164976640196,0.1390254020690918,0.5466718256473542,0.21060895919799805,0.9773590326309204,0.6307546615600585,0.029262810945510864,0.01627780208364129,0.06666194126009942,0.02421074118465185,0.12480268999934196,0.1113776408135891,0.06640839204192162,0.035673204623162744,0.045470830611884595,0.14968158453702926,0.06037147454917431,0.0878425508737564,False
PTGS2_COX2,11346,SINGLE PROTEIN,Cyclooxygenase-2,9615,Canis lupus familiaris,CHEMBL4033,,0.0,9657.0,1701416.0,39437.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Approved veterinary,Higher activity towards COX-2 vs COX-1,,,MAVACOXIB,CHEMBL28527,2.0,0.0,0.0,MOL,76207.0,Small molecule,2008.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H11F4N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25)",TTZNQDOUNXBMJV-UHFFFAOYSA-N,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(F)cc2)cc1,0.7026830395385886,4.0,385.34200000000004,3.3446000000000016,4,1,0,77.98,-4.533740566024595,0.9441779375076294,-4.9444270088460955,0.9978901028633118,-6.11792943586859,0.8417023301124573,0.592294043302536,0.8042135000228882,93.54333425516063,-1.5162547699803333,0.774957275390625,0.2983096018433571,0.25828691720962527,0.08909326568245887,0.41887801289558413,-20.08263287376483,18.539354401966488,1.211982664231185,2.557510540925071,0.11733947545289994,0.8045843243598938,0.44109938144683836,0.9648850083351135,0.616726177930832,0.10496851205825805,0.13346367031335832,0.09395576901733875,0.03710268978029489,0.041716170683503154,0.1226252943277359,0.04585303626954555,0.03480687867850065,0.009300261456519365,0.1963327184319496,0.06567741073668003,0.06825829893350602,False
PTGS1_COX1,11343,SINGLE PROTEIN,Cyclooxygenase-1,9615,Canis lupus familiaris,CHEMBL4133,,0.0,9656.0,1701416.0,39437.0,Cyclooxygenase-1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Approved veterinary,Higher activity towards COX-2 vs COX-1,,,MAVACOXIB,CHEMBL28527,2.0,0.0,0.0,MOL,76207.0,Small molecule,2008.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H11F4N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25)",TTZNQDOUNXBMJV-UHFFFAOYSA-N,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(F)cc2)cc1,0.7026830395385886,4.0,385.34200000000004,3.3446000000000016,4,1,0,77.98,-4.533740566024595,0.9441779375076294,-4.9444270088460955,0.9978901028633118,-6.11792943586859,0.8417023301124573,0.592294043302536,0.8042135000228882,93.54333425516063,-1.5162547699803333,0.774957275390625,0.2983096018433571,0.25828691720962527,0.08909326568245887,0.41887801289558413,-20.08263287376483,18.539354401966488,1.211982664231185,2.557510540925071,0.11733947545289994,0.8045843243598938,0.44109938144683836,0.9648850083351135,0.616726177930832,0.10496851205825805,0.13346367031335832,0.09395576901733875,0.03710268978029489,0.041716170683503154,0.1226252943277359,0.04585303626954555,0.03480687867850065,0.009300261456519365,0.1963327184319496,0.06567741073668003,0.06825829893350602,False
PTGS2_COX2,11346,SINGLE PROTEIN,Cyclooxygenase-2,9615,Canis lupus familiaris,CHEMBL4033,,0.0,9658.0,1705264.0,111117.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FIROCOXIB,CHEMBL69998,2.0,0.0,0.0,MOL,76136.0,Small molecule,2008.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,2003.0,,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3",FULAPETWGIGNMT-UHFFFAOYSA-N,CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1,0.7730356324611797,4.0,336.40900000000005,2.563200000000001,5,0,0,69.67,-4.557768287625594,0.8682561993598938,-4.349599031241818,0.9995562672615051,-5.558812668650491,0.9806918859481811,0.2480715334415436,0.8825599431991578,87.63595642925608,7.895533170423704,0.23317736834287645,0.484731388092041,0.15447314381599425,0.06527094058692455,0.6255031228065491,5.933961876950957,46.25179372332454,26.25058131838234,2.2590405941115193,0.049790809862315655,0.25949573814868926,0.0734263926744461,0.7862494587898254,0.13313445933163165,0.011005407781340182,0.0062443559058010575,0.038743669353425506,0.014848265144973994,0.010120333614759147,0.029233256168663502,0.0065919472835958,0.0037287722632754596,0.013735295971855521,0.07331880517303943,0.010775725543498992,0.4420567750930786,False
PTGS2_COX2,11346,SINGLE PROTEIN,Cyclooxygenase-2,9615,Canis lupus familiaris,CHEMBL4033,,0.0,9659.0,1706146.0,135680.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Approved veterinary,,,,TEPOXALIN,CHEMBL316040,2.0,0.0,0.0,MOL,76277.0,Small molecule,2001.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1987.0,,,0.0,,,Antipsoriatic,0.0,0.0,0.0,"InChI=1S/C20H20ClN3O3/c1-23(26)20(25)12-7-16-13-19(14-3-5-15(21)6-4-14)24(22-16)17-8-10-18(27-2)11-9-17/h3-6,8-11,13,26H,7,12H2,1-2H3",XYKWNRUXCOIMFZ-UHFFFAOYSA-N,COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1,0.5144417093532292,4.0,385.851,3.9815000000000023,5,1,0,67.59,-3.760374675435846,0.9409742236137391,-5.095342310486292,0.9998327493667603,-10.214447542601132,0.9702526211738587,0.708300256729126,0.6389460742473603,94.80545227996231,-4.52956719355269,0.5573672890663147,0.8809656858444214,0.7203429579734802,0.12839772775769234,0.8360647678375244,3.6907701419616084,18.231987616755838,49.03957745924331,2.387619878762801,0.6799027979373932,0.3662803336977959,0.36931188106536866,0.9050333976745606,0.5630047619342804,0.0126379719004035,0.00722955958917737,0.10193030089139939,0.036848684027791026,0.30492628514766695,0.3104212492704391,0.06128707230091095,0.06441612318158149,0.08018303290009499,0.12362976223230362,0.22977092862129211,0.1628537356853485,False
PTGS1_COX1,11343,SINGLE PROTEIN,Cyclooxygenase-1,9615,Canis lupus familiaris,CHEMBL4133,,0.0,9655.0,1706146.0,135680.0,Cyclooxygenase-1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Approved veterinary,,,,TEPOXALIN,CHEMBL316040,2.0,0.0,0.0,MOL,76277.0,Small molecule,2001.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1987.0,,,0.0,,,Antipsoriatic,0.0,0.0,0.0,"InChI=1S/C20H20ClN3O3/c1-23(26)20(25)12-7-16-13-19(14-3-5-15(21)6-4-14)24(22-16)17-8-10-18(27-2)11-9-17/h3-6,8-11,13,26H,7,12H2,1-2H3",XYKWNRUXCOIMFZ-UHFFFAOYSA-N,COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1,0.5144417093532292,4.0,385.851,3.9815000000000023,5,1,0,67.59,-3.760374675435846,0.9409742236137391,-5.095342310486292,0.9998327493667603,-10.214447542601132,0.9702526211738587,0.708300256729126,0.6389460742473603,94.80545227996231,-4.52956719355269,0.5573672890663147,0.8809656858444214,0.7203429579734802,0.12839772775769234,0.8360647678375244,3.6907701419616084,18.231987616755838,49.03957745924331,2.387619878762801,0.6799027979373932,0.3662803336977959,0.36931188106536866,0.9050333976745606,0.5630047619342804,0.0126379719004035,0.00722955958917737,0.10193030089139939,0.036848684027791026,0.30492628514766695,0.3104212492704391,0.06128707230091095,0.06441612318158149,0.08018303290009499,0.12362976223230362,0.22977092862129211,0.1628537356853485,False
PTGS2_COX2,11346,SINGLE PROTEIN,Cyclooxygenase-2,9615,Canis lupus familiaris,CHEMBL4033,,0.0,9660.0,1705980.0,1380044.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Approved veterinary,,,,ROBENACOXIB,CHEMBL2107774,2.0,0.0,0.0,MOL,76269.0,Small molecule,2008.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H13F4NO2/c1-2-8-3-4-12(9(5-8)6-13(22)23)21-16-14(19)10(17)7-11(18)15(16)20/h3-5,7,21H,2,6H2,1H3,(H,22,23)",ZEXGDYFACFXQPF-UHFFFAOYSA-N,CCc1ccc(Nc2c(F)c(F)cc(F)c2F)c(CC(=O)O)c1,0.6398084549855838,4.0,327.27700000000004,4.176100000000002,2,2,0,49.33,-4.363451711526315,0.9744587182998657,-4.687582883987489,0.9903939127922058,-6.722268286086985,0.40223613381385803,0.07424562647938729,0.5671277284622193,91.47959709747646,-1.6472249609975986,0.17550404369831085,0.21747719198465348,0.4014296054840088,0.03725166078656912,0.0349269974976778,-12.918497106083933,30.1901821290332,22.348863491868347,3.0063105798617524,0.05491452738642692,0.605926239490509,0.0681124608963728,0.9384487867355347,0.1497525654733181,0.051203318312764166,0.012082629278302193,0.1662220299243927,0.024217628221958876,0.07590767741203308,0.052315791323781016,0.4110434651374817,0.03895876556634903,0.01432310752570629,0.08244774788618088,0.04871264845132828,0.31140953302383423,False
PTGS2_COX2,11346,SINGLE PROTEIN,Cyclooxygenase-2,9615,Canis lupus familiaris,CHEMBL4033,,0.0,9661.0,3956719.0,2832711.0,Cyclooxygenase-2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Approved veterinary,,,,ENFLICOXIB,CHEMBL5315060,-1.0,0.0,0.0,MOL,,Small molecule,2021.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,-coxib,0.0,-coxib,cyclooxygenase-2 inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H12F5N3O2S/c17-9-1-6-12(13(18)7-9)14-8-15(16(19,20)21)23-24(14)10-2-4-11(5-3-10)27(22,25)26/h1-7,14H,8H2,(H2,22,25,26)",ZZMJXWXXMAAPLI-UHFFFAOYSA-N,NS(=O)(=O)c1ccc(N2N=C(C(F)(F)F)CC2c2ccc(F)cc2F)cc1,0.7948120428018629,4.0,405.348,3.481900000000002,4,1,1,75.76,-4.405739640889396,0.9152731418609619,-5.0899742528836045,0.9990214705467224,-5.747155106959136,0.889028012752533,0.3353850573301315,0.7811373353004456,85.07731985057134,3.2522589284427603,0.37668718695640563,0.5286921083927154,0.5743804812431336,0.09676403179764748,0.4551266372203827,7.016430092666759,31.992277580185508,6.317037504446887,3.060322165072198,0.12206917945295573,0.8708932638168335,0.21803350746631622,0.9245810151100159,0.7349898815155029,0.0981601282954216,0.03286195062100887,0.059059180319309235,0.01485885502770543,0.06713063716888427,0.07505786381661891,0.020915636233985423,0.01120138936676085,0.007521738950163126,0.5480644881725312,0.04374387785792351,0.13292398154735566,False
PTGS2_COX2,121122,SINGLE PROTEIN,Prostaglandin G/H synthase 2,9796,Equus caballus,CHEMBL5303566,,0.0,9721.0,1700889.0,1376734.0,Prostaglandin G/H synthase 2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Approved veterinary,,,,VEDAPROFEN,CHEMBL2104464,2.0,0.0,0.0,MOL,32292.0,Small molecule,1997.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1994.0,,-profen,0.0,-profen,anti-inflammatory/analgesic agents (ibuprofen type),Anti-Inflammatory (veterinary),0.0,0.0,0.0,"InChI=1S/C19H22O2/c1-13(19(20)21)15-11-12-16(14-7-3-2-4-8-14)18-10-6-5-9-17(15)18/h5-6,9-14H,2-4,7-8H2,1H3,(H,20,21)",VZUGVMQFWFVFBX-UHFFFAOYSA-N,CC(C(=O)O)c1ccc(C2CCCCC2)c2ccccc12,0.8524033315711854,3.0,282.3829999999999,5.075600000000004,1,1,1,37.3,-4.918842724674346,0.9316348195075989,-4.738615840055636,0.9995063543319702,-6.716671462891702,0.6903602123260498,0.061463598161935806,0.7692553043365479,102.56415789237994,-1.5958732097107422,0.08362684324383736,0.20872341096401215,0.09166336804628372,0.028730159997940062,0.015738660003989935,16.40877682362878,33.18273632230369,16.187962417013704,3.0264068623300653,0.04519970938563347,0.462296849489212,0.07282160520553589,0.8325051307678223,0.0684856627136469,0.01717795692384243,0.002172911138040945,0.14504736363887788,0.048017801344394685,0.07128405570983887,0.05257751811295748,0.6847114741802216,0.012823185045272112,0.07980506420135498,0.3439804702997208,0.026673730090260507,0.5316267788410187,False
PTGS1_COX1,96,SINGLE PROTEIN,Cyclooxygenase-1,9606,Homo sapiens,CHEMBL221,,0.0,6196.0,1699323.0,150722.0,Cyclooxygenase-1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"It acts by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions.",,PDBe: 1ht8 (The 2.7 angstrom resolution model of ovine COX-1 complexed with alclofenac),,ALCLOFENAC,CHEMBL94081,4.0,0.0,1.0,MOL,31183.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1971.0,-2.0,-ac,0.0,-ac,anti-inflammatory agents (acetic acid derivatives),Anti-Inflammatory,1.0,0.0,0.0,"InChI=1S/C11H11ClO3/c1-2-5-15-10-4-3-8(6-9(10)12)7-11(13)14/h2-4,6H,1,5,7H2,(H,13,14)",ARHWPKZXBHOEEE-UHFFFAOYSA-N,C=CCOc1ccc(CC(=O)O)cc1Cl,0.7852220850465939,4.0,226.659,2.5319000000000003,2,1,0,46.53,-2.817496750653433,0.9563074827194213,-4.250938540198492,0.9979465365409851,-8.249454331274718,0.5152830690145492,0.00791004861239344,0.6490317523479462,95.24754886295824,1.3190986144872565,0.1318312719464302,0.19256533309817314,0.1251617453992367,0.021922526136040687,0.01947817262262106,2.0649671405070356,35.56528483382403,27.111809989877138,2.615357946818452,0.11236057952046394,0.41118206083774567,0.15290442183613778,0.822438371181488,0.007406844897195697,0.02945872312411666,0.006648528948426246,0.07851456962525845,0.02053038515150547,0.025822843611240386,0.012043536361306905,0.4050962746143341,0.025200212933123113,0.029588042199611662,0.010804935451596975,0.03718712888658047,0.40730766355991366,False
PTGS1_COX1,96,SINGLE PROTEIN,Cyclooxygenase-1,9606,Homo sapiens,CHEMBL221,,0.0,6460.0,1702788.0,26820.0,Cyclooxygenase-1 inhibitor,,INHIBITOR,1.0,1.0,1.0,"Antipyrine inhibits a brain COX isoform, COX-3. COX-3 is a COX-1 variant that retains intron 1 in its mRNA.",IC50 uM values for Antipyrine inhibition of COX enzymes: COX-1 : >1000 COX-2 : > 1000 COX-3 : 863,"Antipyrine inhibits a brain COX isoform, COX-3. COX-3 is a COX-1 variant that retains intron 1 in its mRNA.",,ANTIPYRINE,CHEMBL277474,4.0,1.0,1.0,MOL,31225.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,,0.0,,,Analgesic,0.0,0.0,0.0,"InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3",VEQOALNAAJBPNY-UHFFFAOYSA-N,Cc1cc(=O)n(-c2ccccc2)n1C,0.6656235641878139,4.0,188.23000000000002,1.4844199999999999,3,0,0,26.93,-0.8793562851528509,0.9708851218223572,-3.890655191389912,0.9995622634887695,-8.398500699903128,0.963519287109375,0.02834006128832698,0.9774666666984558,48.90234298479377,-2.6426269909054096,0.13847398310899733,0.05190027914941311,0.013646902795881034,0.0016550406580790877,0.0018609350081533194,-17.59314169703821,25.69492205585714,44.93412649566613,2.2360389904529163,0.0700998429208994,0.1661601185798645,0.050591424107551575,0.6411499202251434,0.049019607901573184,0.055796831101179126,0.0072226602584123615,0.05301545485854149,0.004510666569694876,0.005744244274683297,0.003782975906506181,0.0016394021338783204,0.002938639256171882,0.0025158131029456854,0.0007173523103119805,0.0006294805149082095,0.4604968786239624,False
PTGS1_COX1,96,SINGLE PROTEIN,Cyclooxygenase-1,9606,Homo sapiens,CHEMBL221,,0.0,7576.0,1705882.0,429475.0,Cyclooxygenase-1 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Higher affinity for COX-1 over COX-2.,,,MOFEZOLAC,CHEMBL259972,4.0,0.0,1.0,MOL,,Small molecule,1994.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,-1.0,-ac,0.0,-ac (-zolac),anti-inflammatory agents (acetic acid derivatives): anti-inflammatory; pyrazole acetic acid derivatives,,0.0,0.0,0.0,"InChI=1S/C19H17NO5/c1-23-14-7-3-12(4-8-14)18-16(11-17(21)22)25-20-19(18)13-5-9-15(24-2)10-6-13/h3-10H,11H2,1-2H3,(H,21,22)",DJEIHHYCDCTAAH-UHFFFAOYSA-N,COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1,0.7380134904098221,4.0,339.34700000000004,3.6529000000000025,5,1,0,81.79,-4.074029863817696,0.9498913288116455,-4.895464718704346,0.9780032753944397,-10.054810900209256,0.6743104577064514,0.2011009007692337,0.4890707075595856,98.44207728218433,0.6979067671010222,0.2653757408261299,0.4168804407119751,0.31228098571300505,0.02544823931530118,0.1845869541168213,3.719349058311754,32.33379853422872,-3.778135552107522,2.674070467785328,0.08140669092535972,0.2011847823858261,0.16733788698911667,0.9753024101257324,0.12653083875775337,0.0672893013805151,0.01762564368546009,0.20036619007587433,0.06186919398605824,0.21768172979354858,0.11591769158840179,0.4713056802749634,0.13016245067119597,0.05336949303746223,0.05763881094753742,0.0787664320319891,0.18490285724401473,False
P2RY12_P2Y12,176,SINGLE PROTEIN,Purinergic receptor P2Y12,9606,Homo sapiens,CHEMBL2001,,0.0,1501.0,1344704.0,630396.0,Purinergic receptor P2Y12 antagonist,,ANTAGONIST,1.0,1.0,1.0,Irreversible inhibitor,,,,CLOPIDOGREL BISULFATE,CHEMBL1083385,4.0,1.0,1.0,MOL,3759.0,Small molecule,1997.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1997.0,1.0,-grel,0.0,-grel,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",Inhibitor (platelet),0.0,0.0,0.0,"InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1",FDEODCTUSIWGLK-RSAXXLAASA-N,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1.O=S(=O)(O)O,0.5815647707047376,4.0,419.9080000000001,3.0211000000000006,6,2,1,104.14,-1.8574536742047207,0.6306174397468567,-5.187009075990574,0.9071311116218567,-7.854839348136584,0.6119513571262359,0.385654491186142,0.8090428233146667,91.2241950314602,1.5417215970792626,0.20674257650971412,0.5775578200817109,0.22719753235578538,0.7277055382728577,0.20288496911525727,133.35449108039793,36.14923999398649,25.362030096626427,3.140823248960706,0.2126448556780815,0.4164907902479172,0.6100292026996612,0.7706599116325379,0.337564742565155,0.025866946764290334,0.03696888454724103,0.1650221452116966,0.10206231251358985,0.06289985347539187,0.03327886154875159,0.031135136308148504,0.030076617002487184,0.045196337066590785,0.25621112138032914,0.22624003738164902,0.38843584060668945,False
P2RY12_P2Y12,176,SINGLE PROTEIN,Purinergic receptor P2Y12,9606,Homo sapiens,CHEMBL2001,,0.0,1502.0,1343363.0,551003.0,Purinergic receptor P2Y12 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TICLOPIDINE HYDROCHLORIDE,CHEMBL1717,4.0,1.0,1.0,MOL,9589.0,Small molecule,1991.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,1.0,0.0,1978.0,1.0,,0.0,,,Inhibitor (platelet),0.0,0.0,0.0,"InChI=1S/C14H14ClNS.ClH/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14;/h1-4,6,8H,5,7,9-10H2;1H",MTKNGOHFNXIVOS-UHFFFAOYSA-N,Cl.Clc1ccccc1CN1CCc2sccc2C1,0.7952235100313724,4.0,300.254,4.381600000000003,2,0,0,3.24,-4.058971118595338,0.7275249600410462,-4.738987500098856,0.9999418258666992,-6.383988658628287,0.962921142578125,0.31608578860759734,0.9924529314041137,89.97026100941859,-6.856832464844244,0.8738292574882507,0.9452401280403138,0.12519008815288543,0.9891683697700501,0.1311556540429592,11.275587953606424,126.49293706283295,62.28968408397732,2.4833855827193707,0.4899239242076874,0.09333416000008583,0.28175551891326905,0.2948799178004265,0.8587669610977173,0.009271554835140704,0.0074007571674883366,0.34207187294960023,0.10023415088653564,0.1112844966351986,0.12121253982186317,0.010072912741452455,0.012747697159647941,0.10644264817237854,0.17686199843883516,0.055659735947847365,0.8808251142501831,False
P2RY12_P2Y12,176,SINGLE PROTEIN,Purinergic receptor P2Y12,9606,Homo sapiens,CHEMBL2001,,0.0,1503.0,1392859.0,416772.0,Purinergic receptor P2Y12 negative allosteric modulator,,NEGATIVE ALLOSTERIC MODULATOR,1.0,1.0,1.0,,,,,TICAGRELOR,CHEMBL398435,4.0,1.0,1.0,MOL,68558.0,Small molecule,2010.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,2007.0,1.0,-grel-,0.0,-grel-,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",,0.0,0.0,0.0,"InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1",OEKWJQXRCDYSHL-FNOIDJSQSA-N,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,0.23104078172688383,2.0,522.5780000000002,2.0136999999999996,11,4,6,138.44,-3.3643050445590794,0.7862393140792847,-5.476258902490864,0.9968358755111695,-11.56989091700498,0.6075040996074677,0.5736213624477386,0.7162259697914124,96.7368309098799,9.165044213643844,0.10138424783945084,0.20626230537891388,0.2897308349609375,0.11945283152163029,0.7213644623756409,91.83120332714707,36.4858448993131,18.452848634225095,2.7150810874809537,0.4486128807067871,0.08738428130745887,0.2185652732849121,0.8929123640060425,0.7418021440505982,0.026532832346856595,0.04902086481451988,0.09141592234373093,0.01909288875758648,0.18514128774404526,0.23214387893676758,0.13736746311187745,0.2812529981136322,0.06304096058011055,0.5458193719387054,0.4257703244686127,0.16029881238937377,False
P2RY12_P2Y12,176,SINGLE PROTEIN,Purinergic receptor P2Y12,9606,Homo sapiens,CHEMBL2001,,0.0,1504.0,1344889.0,675724.0,Purinergic receptor P2Y12 antagonist,,ANTAGONIST,1.0,1.0,1.0,Irreversible inhibitor,,,,PRASUGREL HYDROCHLORIDE,CHEMBL1201773,4.0,1.0,1.0,MOL,,Small molecule,2009.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2004.0,1.0,-grel,0.0,-grel,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",,0.0,0.0,0.0,"InChI=1S/C20H20FNO3S.ClH/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21;/h2-5,10,13,19H,6-9,11H2,1H3;1H",JALHGCPDPSNJNY-UHFFFAOYSA-N,CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2.Cl,0.6900727076015363,4.0,409.91,4.312800000000005,5,0,1,46.61,-4.440418425741177,0.8352222442626953,-4.282485894567721,0.9999752283096314,-6.0681804559732315,0.9706607103347779,0.7316024303436279,0.9937031507492066,94.34592887037716,-3.764687371442214,0.48050895929336546,0.8975857019424438,0.8432656407356263,0.6471620738506317,0.5184897899627685,13.966309218052135,117.69796870119265,78.68159953966979,3.4024857935405266,0.18786949217319487,0.06574247404932976,0.06900182329118251,0.3727051347494125,0.48082745671272276,0.12919495701789857,0.07990583181381225,0.2233259856700897,0.03397558117285371,0.11502027958631515,0.04602443650364876,0.012890254845842719,0.0558237798511982,0.0414603577926755,0.5388628602027893,0.0971122220158577,0.23867953419685364,False
P2RY12_P2Y12,176,SINGLE PROTEIN,Purinergic receptor P2Y12,9606,Homo sapiens,CHEMBL2001,,0.0,2342.0,1705052.0,626138.0,Purinergic receptor P2Y12 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CANGRELOR TETRASODIUM,CHEMBL1097279,4.0,1.0,1.0,MOL,,Small molecule,2015.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2005.0,1.0,-grel-,0.0,-grel-,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",,0.0,0.0,0.0,"InChI=1S/C17H25Cl2F3N5O12P3S2.4Na/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32;;;;/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32);;;;/q;4*+1/p-4/t8-,10-,11-,14-;;;;/m1..../s1",COWWROCHWNGJHQ-OPKBHZIBSA-J,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],0.03747639403646765,2.0,864.2940000000004,-11.661500000000013,19,3,6,267.23,-0.20014975355018483,0.4116631895303726,-6.183941059391388,0.5338843703269959,-12.54313097431095,0.42084120512008666,0.16468924954533576,0.5802802383899689,81.96949568881026,-5.958707726684005,0.0018183324955316493,0.03219884254503995,0.04718273899052292,0.08613751209340989,0.04746614301111549,34.74810893386355,30.500673923672245,22.6157616356386,2.9466718936518164,0.3947927862405777,0.07714082822203636,0.2080293208360672,0.7374906301498413,0.8102562665939331,0.0215298006311059,0.007796459016390145,0.10905465036630631,0.022554702311754226,0.00961290774284862,0.28002949655056,0.002405866311164573,0.006828442285768688,0.0033327057783026246,0.060046131093986335,0.06479582041502,0.18595373034477233,False
P2RY12_P2Y12,176,SINGLE PROTEIN,Purinergic receptor P2Y12,9606,Homo sapiens,CHEMBL2001,,0.0,4891.0,1699804.0,1376098.0,Purinergic receptor P2Y12 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ELINOGREL,CHEMBL2103828,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2008.0,,-grel,0.0,-grel,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",,0.0,0.0,0.0,"InChI=1S/C20H15ClFN5O5S2/c1-23-15-9-14-12(8-13(15)22)18(28)27(20(30)25-14)11-4-2-10(3-5-11)24-19(29)26-34(31,32)17-7-6-16(21)33-17/h2-9,23H,1H3,(H,25,30)(H2,24,26,29)",LGSDFTPAICUONK-UHFFFAOYSA-N,CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F,0.3164992103771708,3.0,523.9550000000003,3.0851000000000006,8,4,0,142.16,-4.168935352657891,0.7056780934333802,-5.381144766126734,0.7817530155181884,-14.628958875951898,0.2730862408876419,0.38466930389404297,0.39011465311050414,94.53533602118718,-6.402436560354353,0.32842670381069183,0.3526064157485962,0.602760624885559,0.12634387537837027,0.4085026390850544,183.79926709521135,15.81397602257159,-15.147839180623867,2.677459418379625,0.08246595114469528,0.5049907892942429,0.44022259712219236,0.9904563665390015,0.5590745866298675,0.061623509228229525,0.02714099008589983,0.057075819745659825,0.008305370970629156,0.038094541803002355,0.0243942859582603,0.03504258282482624,0.03302925042808056,0.022746009286493063,0.2315221384167671,0.11724182516336441,0.1964822605252266,False
P2RY12_P2Y12,176,SINGLE PROTEIN,Purinergic receptor P2Y12,9606,Homo sapiens,CHEMBL2001,,0.0,5049.0,1705108.0,433495.0,Purinergic receptor P2Y12 antagonist,,ANTAGONIST,1.0,1.0,1.0,"Phase 2 study terminated, possibly due to adverse effects.",,,,REGRELOR DISODIUM,CHEMBL261244,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-grel-,0.0,-grel-,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",,0.0,0.0,0.0,"InChI=1S/C22H25N6O8P.2Na/c1-2-23-22(29)27-19-16-20(25-11-24-19)28(12-26-16)21-18-17(14(34-21)10-33-37(30,31)32)35-15(36-18)9-8-13-6-4-3-5-7-13;;/h3-9,11-12,14-15,17-18,21H,2,10H2,1H3,(H2,30,31,32)(H2,23,24,25,27,29);;/q;2*+1/p-2/b9-8+;;/t14-,15+,17-,18-,21-;;/m1../s1",MKQKPLQMNCXTJE-VEZQGTPESA-L,CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21.[Na+].[Na+],0.19266328003806973,2.0,576.4140000000002,-5.458099999999996,12,2,5,184.83999999999997,-0.481291808139778,0.5999910175800324,-5.8769755296875745,0.5802822053432465,-14.241972034413305,0.31470327377319335,0.1681068293750286,0.6521100759506225,75.25261671229639,-11.608780359525195,0.004575668726465665,0.045275162905454636,0.06078885127790272,0.08364298921078443,0.031430582702159884,46.24431255446148,37.82432377321647,34.50671808279763,3.016013365285397,0.43074067384004594,0.04381690360605717,0.41582152247428894,0.8315233945846557,0.3756996601819992,0.03231843076646328,0.010425684368237853,0.26600421667099,0.033932833932340145,0.049369141086936,0.07203892320394516,0.007825387641787529,0.04115219679661095,0.007269047480076551,0.02066553889308125,0.12284216843545437,0.23746820390224457,False
P2RY12_P2Y12,176,SINGLE PROTEIN,Purinergic receptor P2Y12,9606,Homo sapiens,CHEMBL2001,,0.0,8181.0,3133182.0,2335560.0,Purinergic receptor P2Y12 antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SELATOGREL,CHEMBL4297589,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-grel,0.0,-grel,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",,0.0,0.0,0.0,"InChI=1S/C28H39N6O8P/c1-3-4-16-42-28(37)33-14-12-32(13-15-33)27(36)23(19-43(38,39)40)30-26(35)22-17-24(34-11-10-21(18-34)41-2)31-25(29-22)20-8-6-5-7-9-20/h5-9,17,21,23H,3-4,10-16,18-19H2,1-2H3,(H,30,35)(H2,38,39,40)/t21-,23-/m0/s1",FYXHWMQPCJOJCH-GMAHTHKFSA-N,CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1,0.2470967971671375,3.0,618.6280000000002,1.7257000000000005,9,3,2,174.73000000000002,-3.126422234886351,0.4144970715045929,-5.10997393934059,0.6916869103908538,-11.49170806777788,0.6745205640792846,0.6115307152271271,0.438390052318573,87.88191693585992,1.3835296228737985,0.024102244153618814,0.15683201625943183,0.25666317492723467,0.03863124968484044,0.40551752746105196,44.72977574543356,66.72649314691117,71.0236529978584,2.9196075379055375,0.5089887857437134,0.08558548837900162,0.6530027270317078,0.9131089091300965,0.7503334283828735,0.03886740058660507,0.022917372360825538,0.11740569695830345,0.06603039465844632,0.051767873018980025,0.07040829136967659,0.043667491897940634,0.08149292021989822,0.038915053755044934,0.14833712130784987,0.4374572277069092,0.27344982624053954,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,7352.0,2973316.0,2197829.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,Inhibits isocitrate dehydrogenase 1 resulting in decreased 2-hydroxyglutarate levels and induced myloid differentiation.,Active against Isocitrate dehydrogenase 1 and certain mutations that increase 2-hydroxyglutarate levels (most commonly R132 mutant forms). ,,2586.0,IVOSIDENIB,CHEMBL3989958,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,2017.0,1.0,-sidenib,0.0,-sidenib,mutated isocitrate dehydrogenase (IDH) inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25-/m0/s1",WIJZXSAJMHAVGX-DHLKQENFSA-N,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,0.4429869547987632,3.0,582.9700000000001,4.324580000000004,6,1,2,119.28999999999999,-5.8858958630274305,0.8265810489654541,-5.364123748337224,0.9995473265647888,-11.453874136544693,0.9033309102058411,0.524679571390152,0.7245028257369995,89.97504861718753,4.9625492901219435,0.009659008821472526,0.3617342248558998,0.47247070968151095,0.0366852093487978,0.958724069595337,31.049276162226516,60.29247211703341,45.42722460963163,3.829017322098655,0.2864481508731842,0.3762876808643341,0.4554286152124405,0.9468414068222046,0.7410958170890808,0.015432820748537779,0.009141774196177722,0.02873359490185976,0.012237268779426814,0.026129812747240067,0.34954480528831483,0.02258731359615922,0.015368450433015823,0.038119569420814514,0.658308482170105,0.20884879380464555,0.1590638156980276,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,7613.0,3133208.0,2335581.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OLUTASIDENIB,CHEMBL4297610,4.0,1.0,1.0,MOL,,Small molecule,2022.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2018.0,1.0,-sidenib,0.0,-sidenib,mutated isocitrate dehydrogenase (IDH) inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H15ClN4O2/c1-10(21-16-6-4-13(9-20)23(2)18(16)25)14-8-11-7-12(19)3-5-15(11)22-17(14)24/h3-8,10,21H,1-2H3,(H,22,24)/t10-/m0/s1",NEQYWYXGTJDAKR-JTQLQIEISA-N,C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O,0.7561838271258684,4.0,354.797,2.9249800000000006,5,2,1,90.68,-6.044829678734341,0.9528872966766357,-4.994017455879894,0.9994743943214417,-14.765169450477552,0.893938148021698,0.21925739273428918,0.6271530151367187,93.4856574714492,13.631153353456284,0.6748991966247558,0.32628646194934846,0.45746966600418093,0.07970571890473366,0.5911358535289765,96.21855127824824,60.6617253960334,-5.422098522932329,3.250158060100773,0.22096395045518874,0.3599843144416809,0.27012273818254473,0.9353867530822754,0.6573273301124573,0.07182857021689415,0.05500839278101921,0.06945409551262856,0.05651364140212536,0.696105670928955,0.32627097964286805,0.04551623612642288,0.23138877451419831,0.04635405167937279,0.6728554487228393,0.400430491566658,0.16531115472316743,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8534.0,3489918.0,2284184.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for IDH1 mutants vs. wild-type.,,1014.0,BAY1436032,CHEMBL4206033,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1",RNMAUIMMNAHKQR-QFBILLFUSA-N,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,0.3707659906777781,3.0,489.53800000000035,7.083000000000006,5,2,2,76.38,-5.299950986749818,0.929591429233551,-4.997687287908516,0.9948298573493958,-6.306248422158438,0.4445647358894348,0.6707353234291077,0.7573578953742981,98.69647611829869,3.483745857967314,0.11073800101876259,0.17510501369833947,0.23909353241324424,0.19193059671670198,0.19277415573596954,-4.8732191009668675,-0.980640460265296,17.44552433319857,3.653895647962048,0.5429764539003372,0.5820006191730499,0.31846938356757165,0.6856885731220246,0.5594728112220764,0.02472770158201456,0.01329677365720272,0.14676954746246337,0.052312488108873366,0.28025237619876864,0.35935627818107607,0.2817882925271988,0.13011794090270995,0.2720883011817932,0.4880799651145935,0.20616369396448136,0.21616544127464293,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8535.0,3489918.0,2284184.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for IDH1 mutants vs. wild-type.,,1527.0,BAY1436032,CHEMBL4206033,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1",RNMAUIMMNAHKQR-QFBILLFUSA-N,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,0.3707659906777781,3.0,489.53800000000035,7.083000000000006,5,2,2,76.38,-5.299950986749818,0.929591429233551,-4.997687287908516,0.9948298573493958,-6.306248422158438,0.4445647358894348,0.6707353234291077,0.7573578953742981,98.69647611829869,3.483745857967314,0.11073800101876259,0.17510501369833947,0.23909353241324424,0.19193059671670198,0.19277415573596954,-4.8732191009668675,-0.980640460265296,17.44552433319857,3.653895647962048,0.5429764539003372,0.5820006191730499,0.31846938356757165,0.6856885731220246,0.5594728112220764,0.02472770158201456,0.01329677365720272,0.14676954746246337,0.052312488108873366,0.28025237619876864,0.35935627818107607,0.2817882925271988,0.13011794090270995,0.2720883011817932,0.4880799651145935,0.20616369396448136,0.21616544127464293,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8536.0,3489918.0,2284184.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for IDH1 mutants vs. wild-type.,,1528.0,BAY1436032,CHEMBL4206033,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1",RNMAUIMMNAHKQR-QFBILLFUSA-N,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,0.3707659906777781,3.0,489.53800000000035,7.083000000000006,5,2,2,76.38,-5.299950986749818,0.929591429233551,-4.997687287908516,0.9948298573493958,-6.306248422158438,0.4445647358894348,0.6707353234291077,0.7573578953742981,98.69647611829869,3.483745857967314,0.11073800101876259,0.17510501369833947,0.23909353241324424,0.19193059671670198,0.19277415573596954,-4.8732191009668675,-0.980640460265296,17.44552433319857,3.653895647962048,0.5429764539003372,0.5820006191730499,0.31846938356757165,0.6856885731220246,0.5594728112220764,0.02472770158201456,0.01329677365720272,0.14676954746246337,0.052312488108873366,0.28025237619876864,0.35935627818107607,0.2817882925271988,0.13011794090270995,0.2720883011817932,0.4880799651145935,0.20616369396448136,0.21616544127464293,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8537.0,3489918.0,2284184.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for IDH1 mutants vs. wild-type.,,1529.0,BAY1436032,CHEMBL4206033,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1",RNMAUIMMNAHKQR-QFBILLFUSA-N,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,0.3707659906777781,3.0,489.53800000000035,7.083000000000006,5,2,2,76.38,-5.299950986749818,0.929591429233551,-4.997687287908516,0.9948298573493958,-6.306248422158438,0.4445647358894348,0.6707353234291077,0.7573578953742981,98.69647611829869,3.483745857967314,0.11073800101876259,0.17510501369833947,0.23909353241324424,0.19193059671670198,0.19277415573596954,-4.8732191009668675,-0.980640460265296,17.44552433319857,3.653895647962048,0.5429764539003372,0.5820006191730499,0.31846938356757165,0.6856885731220246,0.5594728112220764,0.02472770158201456,0.01329677365720272,0.14676954746246337,0.052312488108873366,0.28025237619876864,0.35935627818107607,0.2817882925271988,0.13011794090270995,0.2720883011817932,0.4880799651145935,0.20616369396448136,0.21616544127464293,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8585.0,3489918.0,2284184.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for IDH1 mutants vs. wild-type.,,534.0,BAY1436032,CHEMBL4206033,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1",RNMAUIMMNAHKQR-QFBILLFUSA-N,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,0.3707659906777781,3.0,489.53800000000035,7.083000000000006,5,2,2,76.38,-5.299950986749818,0.929591429233551,-4.997687287908516,0.9948298573493958,-6.306248422158438,0.4445647358894348,0.6707353234291077,0.7573578953742981,98.69647611829869,3.483745857967314,0.11073800101876259,0.17510501369833947,0.23909353241324424,0.19193059671670198,0.19277415573596954,-4.8732191009668675,-0.980640460265296,17.44552433319857,3.653895647962048,0.5429764539003372,0.5820006191730499,0.31846938356757165,0.6856885731220246,0.5594728112220764,0.02472770158201456,0.01329677365720272,0.14676954746246337,0.052312488108873366,0.28025237619876864,0.35935627818107607,0.2817882925271988,0.13011794090270995,0.2720883011817932,0.4880799651145935,0.20616369396448136,0.21616544127464293,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8548.0,3490059.0,2486542.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,Selective for R132X mutations,Selective for R132X mutations,,534.0,DS-1001B,CHEMBL4650282,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H18Cl3FN2O4.C4H11N/c1-12-11-31(17-6-4-5-13(19(12)17)7-8-18(32)33)24(34)21-22(30-35-23(21)25(2,3)29)20-15(27)9-14(26)10-16(20)28;1-4(2,3)5/h4-11H,1-3H3,(H,32,33);5H2,1-3H3/b8-7+;",UPPAAWQBZQBNIE-USRGLUTNSA-N,CC(C)(C)N.Cc1cn(C(=O)c2c(-c3c(Cl)cc(Cl)cc3Cl)noc2C(C)(C)F)c2cccc(/C=C/C(=O)O)c12,0.22050150631742146,2.0,608.9250000000003,8.299420000000007,6,2,0,111.35000000000001,-4.908503847209397,0.8920776724815369,-5.364979221860239,0.9612300157546997,-9.362493879467731,0.6346639037132263,0.7449368834495544,0.5782253265380859,93.75240290678389,-3.7219423196732806,0.038781432434916496,0.0380501133389771,0.08006069660186768,0.010827204212546349,0.036719975713640454,59.48533324094812,-24.070999314111415,-19.691520297843006,3.0892797650150348,0.32298992574214935,0.5711851835250854,0.20052060186862947,0.8313670992851258,0.4771704375743866,0.06650814861059189,0.05073336362838745,0.19340198934078218,0.15029735788702964,0.2017114654183388,0.6455442488193512,0.32143634557724,0.08121798411011696,0.19386114031076432,0.541897052526474,0.1263610415160656,0.26728916317224505,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8549.0,3490059.0,2486542.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,Selective for R132X mutations,Selective for R132X mutations,,1527.0,DS-1001B,CHEMBL4650282,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H18Cl3FN2O4.C4H11N/c1-12-11-31(17-6-4-5-13(19(12)17)7-8-18(32)33)24(34)21-22(30-35-23(21)25(2,3)29)20-15(27)9-14(26)10-16(20)28;1-4(2,3)5/h4-11H,1-3H3,(H,32,33);5H2,1-3H3/b8-7+;",UPPAAWQBZQBNIE-USRGLUTNSA-N,CC(C)(C)N.Cc1cn(C(=O)c2c(-c3c(Cl)cc(Cl)cc3Cl)noc2C(C)(C)F)c2cccc(/C=C/C(=O)O)c12,0.22050150631742146,2.0,608.9250000000003,8.299420000000007,6,2,0,111.35000000000001,-4.908503847209397,0.8920776724815369,-5.364979221860239,0.9612300157546997,-9.362493879467731,0.6346639037132263,0.7449368834495544,0.5782253265380859,93.75240290678389,-3.7219423196732806,0.038781432434916496,0.0380501133389771,0.08006069660186768,0.010827204212546349,0.036719975713640454,59.48533324094812,-24.070999314111415,-19.691520297843006,3.0892797650150348,0.32298992574214935,0.5711851835250854,0.20052060186862947,0.8313670992851258,0.4771704375743866,0.06650814861059189,0.05073336362838745,0.19340198934078218,0.15029735788702964,0.2017114654183388,0.6455442488193512,0.32143634557724,0.08121798411011696,0.19386114031076432,0.541897052526474,0.1263610415160656,0.26728916317224505,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8573.0,3489932.0,2270391.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for IDH1 mutants vs. wild-type,,1014.0,IDH305,CHEMBL4167360,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H22F4N6O2/c1-12-8-17(30-10-16(12)15-4-6-28-19(9-15)23(25,26)27)14(3)31-21-29-7-5-20(32-21)33-18(13(2)24)11-35-22(33)34/h4-10,13-14,18H,11H2,1-3H3,(H,29,31,32)/t13-,14+,18-/m1/s1",DCGDPJCUIKLTDU-QWQRMKEZSA-N,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,0.4797762430893212,3.0,490.4610000000001,5.117120000000004,7,1,3,93.13000000000001,-5.54485415902265,0.9312673449516297,-4.937783144357198,0.9987622261047363,-8.104209102729438,0.954387629032135,0.7159211039543152,0.5807946801185608,95.03361935898525,3.150873724255077,0.06675689350813627,0.23835514113307,0.20994928032159804,0.08313627894967794,0.9391375422477722,8.395397976589587,26.60163287747205,45.221141128742815,3.5422102582610018,0.558693277835846,0.33711135387420654,0.8256389975547791,0.936927604675293,0.785744571685791,0.036729745008051394,0.012373932264745235,0.120420391112566,0.029898128099739553,0.03985171299427748,0.2781123876571655,0.03833119086921215,0.04262708630412817,0.04156204424798489,0.35307099521160124,0.30859811007976534,0.16628904193639754,False
IDH1,104483,SINGLE PROTEIN,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,Homo sapiens,CHEMBL2007625,,0.0,8601.0,3489932.0,2270391.0,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,,INHIBITOR,1.0,1.0,1.0,,Selective for IDH1 mutants vs. wild-type,,534.0,IDH305,CHEMBL4167360,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H22F4N6O2/c1-12-8-17(30-10-16(12)15-4-6-28-19(9-15)23(25,26)27)14(3)31-21-29-7-5-20(32-21)33-18(13(2)24)11-35-22(33)34/h4-10,13-14,18H,11H2,1-3H3,(H,29,31,32)/t13-,14+,18-/m1/s1",DCGDPJCUIKLTDU-QWQRMKEZSA-N,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,0.4797762430893212,3.0,490.4610000000001,5.117120000000004,7,1,3,93.13000000000001,-5.54485415902265,0.9312673449516297,-4.937783144357198,0.9987622261047363,-8.104209102729438,0.954387629032135,0.7159211039543152,0.5807946801185608,95.03361935898525,3.150873724255077,0.06675689350813627,0.23835514113307,0.20994928032159804,0.08313627894967794,0.9391375422477722,8.395397976589587,26.60163287747205,45.221141128742815,3.5422102582610018,0.558693277835846,0.33711135387420654,0.8256389975547791,0.936927604675293,0.785744571685791,0.036729745008051394,0.012373932264745235,0.120420391112566,0.029898128099739553,0.03985171299427748,0.2781123876571655,0.03833119086921215,0.04262708630412817,0.04156204424798489,0.35307099521160124,0.30859811007976534,0.16628904193639754,False
IDH1,119376,PROTEIN FAMILY,IDH1/IDH2,9606,Homo sapiens,CHEMBL4523659,,0.0,8918.0,3460821.0,2318498.0,IDH1/IDH2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VORASIDENIB,CHEMBL4279047,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2020.0,,-sidenib,0.0,-sidenib,mutated isocitrate dehydrogenase (IDH) inhibitors,,0.0,0.0,0.0,"InChI=1S/C14H13ClF6N6/c1-6(13(16,17)18)22-11-25-10(8-4-3-5-9(15)24-8)26-12(27-11)23-7(2)14(19,20)21/h3-7H,1-2H3,(H2,22,23,25,26,27)/t6-,7-/m1/s1",QCZAWDGAVJMPTA-RNFRBKRXSA-N,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,0.5606168741905612,4.0,414.741,4.312400000000001,6,2,2,75.62,-5.292753592108281,0.8309806942939758,-4.962881215568446,0.9989131689071655,-7.259125764700089,0.9550968050956726,0.2319555152207613,0.6349869191646575,91.6623202040351,24.518875883299284,0.7330599904060364,0.451617693901062,0.4285018563270569,0.15204235166311264,0.25669345557689666,32.40382553505185,7.159550487295145,29.95795130594153,3.0910999551237652,0.08378705158829688,0.3571935534477234,0.2021394692361355,0.9141699790954589,0.6244374990463257,0.016124583035707473,0.03357301820069551,0.2796489208936691,0.16431540250778198,0.5303438067436218,0.542942363023758,0.0976252630352974,0.09009887203574181,0.17677632123231887,0.8510686993598938,0.4676187515258789,0.3431513249874115,False
TNF,11473,SINGLE PROTEIN,ADAM17,9606,Homo sapiens,CHEMBL3706,,0.0,9414.0,1701387.0,341940.0,ADAM17 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,APRATASTAT,CHEMBL206815,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2000.0,,-stat,0.0,-stat,enzyme inhibitors,,0.0,0.0,0.0,"InChI=1S/C17H22N2O6S2/c1-17(2)15(16(21)18-22)19(9-12-26-17)27(23,24)14-7-5-13(6-8-14)25-11-4-3-10-20/h5-8,15,20,22H,9-12H2,1-2H3,(H,18,21)/t15-/m0/s1",MAVDNGWEBZTACC-HNNXBMFYSA-N,CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO,0.3639067750713895,4.0,414.50500000000017,0.4512,7,3,1,116.17,-3.9128367671447535,0.7878251433372497,-5.610182547348044,0.9967634081840515,-12.493584002667244,0.811449122428894,0.11439215168356895,0.16027401201426983,84.64255200879624,2.70437537535098,0.05596525482833385,0.5232141971588135,0.253876855969429,0.10650576911866665,0.6582942128181457,-23.763436696303355,45.35707930903477,58.351825006533794,2.7934775871828226,0.48253859877586364,0.36656538099050523,0.3192533075809479,0.9166476368904114,0.3501956820487976,0.02723908657208085,0.012673936737701296,0.0911399282515049,0.025124396570026873,0.018416469730436803,0.10585872381925583,0.06800768859684467,0.005904288752935827,0.024373621866106986,0.09017823413014411,0.07531639486551285,0.31890077590942384,False
DHFR,70,SINGLE PROTEIN,Dihydrofolate reductase,5839,Plasmodium falciparum K1,CHEMBL1939,,0.0,453.0,1344839.0,2080.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PYRIMETHAMINE,CHEMBL36,4.0,1.0,1.0,MOL,8673.0,Small molecule,1953.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antimalarial,0.0,0.0,0.0,"InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)",WKSAUQYGYAYLPV-UHFFFAOYSA-N,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,0.8561371493463951,4.0,248.71700000000004,2.5238000000000005,4,2,0,77.82,-3.554177227435794,0.9798638820648193,-4.5932423916055205,0.9999340772628784,-10.856307904116967,0.9657874941825867,0.030265225935727356,0.8735102772712707,85.06231838204613,13.592690061832883,0.7539265990257263,0.1731674861162901,0.0364209963940084,0.040072163194417955,0.035039732325822116,54.269491707305974,43.36223544518634,39.41575954383567,2.786279594344587,0.1761882945895195,0.3824401706457138,0.04429604895412922,0.9186506509780884,0.12540742978453637,0.09564177617430687,0.02641832921653986,0.27761785984039306,0.04356113746762276,0.4444803178310394,0.12827311754226683,0.003461765591055155,0.05788854509592056,0.008510742289945483,0.12670952454209328,0.04536408968269825,0.3264068990945816,False
DHFR,70,SINGLE PROTEIN,Dihydrofolate reductase,5839,Plasmodium falciparum K1,CHEMBL1939,,0.0,454.0,1698346.0,2197696.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CYCLOGUANIL PAMOATE,CHEMBL3989825,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1964.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H16O6.2C11H14ClN5/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;2*1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2*3-6H,1-2H3,(H4,13,14,15,16)",LUNRMKZYOGNOTR-UHFFFAOYSA-N,CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,0.08102169567699426,0.0,891.8170000000001,7.442400000000007,14,8,0,275.05999999999995,-4.593637523080719,0.6988504290580749,-5.940434548548531,0.691751503944397,-10.363520511303367,0.16418561041355134,0.21090453267097473,0.10720614492893218,84.70110586657957,5.636487962865832,0.019245663611218333,0.03556454982608557,0.018846060801297426,0.17332934886217116,0.0012855686043621972,23.512638364809877,-5.1430514007513715,11.906843951253336,3.0411395478318406,0.12961017787456514,0.48349559903144834,0.19864791706204415,0.8405105471611023,0.600655484199524,0.014111726358532906,0.006716856942512095,0.21369913294911386,0.08321910705417394,0.037020296603441236,0.020809554448351263,0.034502827748656276,0.00868769153021276,0.017558902851305902,0.12738842368125916,0.052824389189481735,0.2045269176363945,False
DHFR,70,SINGLE PROTEIN,Dihydrofolate reductase,5839,Plasmodium falciparum K1,CHEMBL1939,,0.0,455.0,1343912.0,675010.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PROGUANIL HYDROCHLORIDE,CHEMBL1201059,4.0,1.0,1.0,MOL,,Small molecule,2000.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,2000.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C11H16ClN5.ClH/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9;/h3-7H,1-2H3,(H5,13,14,15,16,17);1H",SARMGXPVOFNNNG-UHFFFAOYSA-N,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1.Cl,0.4286685696155377,4.0,290.19800000000004,2.6308399999999996,2,5,0,83.79,-2.134711093825456,0.9064978003501892,-5.695636760329023,0.9649357080459595,-8.912029599855328,0.541623592376709,0.06102199219167233,0.657312536239624,68.66046662687755,16.937170304113316,0.569081974029541,0.26814945191144945,0.032776964083313945,0.6695052504539489,0.052369436918525025,55.104824113356756,-5.611848359345423,-1.678436797833296,2.1593992991694124,0.5753207921981811,0.35082747638225553,0.19094572961330414,0.44282692670822144,0.35013903230428695,0.0273020401597023,0.021769689954817296,0.14507369101047515,0.04525785762816668,0.12030361518263817,0.008938029408454895,0.005971921933814883,0.033994156681001184,0.052753175050020217,0.08313517980277538,0.09261540286242961,0.7668898701667786,False
DHFR,6,SINGLE PROTEIN,Dihydrofolate reductase,9606,Homo sapiens,CHEMBL202,,0.0,848.0,1344882.0,675697.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PRALATREXATE,CHEMBL1201746,4.0,1.0,1.0,MOL,71223.0,Small molecule,2009.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2004.0,1.0,-trexate,0.0,-trexate,antimetabolites (folic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1",OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,0.25993967726809375,4.0,477.4810000000002,0.9816000000000005,9,5,2,207.29999999999995,-3.177884692603513,0.7818640470504761,-6.242649584145214,0.3627778127789497,-13.717026394521639,0.09473765790462493,0.02160881571471691,0.6466298997402191,58.821206186367775,3.471724090052889,0.028147286921739578,0.019324615690857173,0.09133304357528686,0.12571618109941482,0.21621270775794982,22.144220399233717,-10.513182481680953,-25.182065482480866,2.4608723113715856,0.2937949329614639,0.2563906781375408,0.809809148311615,0.9524647831916809,0.4655895233154297,0.07002171576023102,0.035073718056082726,0.1368057280778885,0.042692124098539355,0.07481323927640915,0.03599861450493336,0.01901445505209267,0.06247643306851387,0.0038472820597235113,0.022852263972163202,0.20322176367044448,0.18855953812599183,False
DHFR,6,SINGLE PROTEIN,Dihydrofolate reductase,9606,Homo sapiens,CHEMBL202,,0.0,849.0,1344158.0,1737244.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,METHOTREXATE SODIUM,CHEMBL3244648,4.0,1.0,1.0,MOL,50679.0,Small molecule,1953.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,,1.0,-trexate,0.0,-trexate,antimetabolites (folic acid derivatives),,0.0,0.0,0.0,"InChI=1S/C20H22N8O5.2Na/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);;/q;2*+1/p-2/t13-;;/m0../s1",DASQOOZCTWOQPA-GXKRWWSZSA-L,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Na+].[Na+],0.23443149151334866,3.0,498.4110000000003,-8.39300000000001,12,3,1,216.2,-1.2131282153386107,0.7199805855751038,-6.497190002305632,0.18165336847305297,-16.02528591407035,0.05931272022426128,0.01087068598717451,0.6549195408821106,51.04343109230872,-0.7680794983606573,0.0058381136623211205,0.006268747919239104,0.018606666009873152,0.01871468492317945,0.01698451768606901,0.928726768968253,-12.75833523391017,13.09515198219827,2.470686407788352,0.21839878261089324,0.1654110312461853,0.4351941704750061,0.9424533486366272,0.35910325050354003,0.04416458830237389,0.022194473072886467,0.08859896510839463,0.011989074386656284,0.03515490405261516,0.018185006640851497,0.0050955084501765665,0.02132302653044462,0.005373088363558054,0.01547816339880228,0.11499764900654555,0.2770355030894279,False
DHFR,6,SINGLE PROTEIN,Dihydrofolate reductase,9606,Homo sapiens,CHEMBL202,,0.0,850.0,1343556.0,1537653.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEMETREXED DISODIUM,CHEMBL2360464,4.0,1.0,1.0,MOL,63722.0,Small molecule,2004.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1997.0,1.0,-trexed,0.0,-trexed,antineoplastic thymidylate synthetase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H21N5O6.2Na/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27;;/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29);;/q;2*+1/p-2/t13-;;/m0../s1",NYDXNILOWQXUOF-GXKRWWSZSA-L,Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+],0.22066971649227551,4.0,471.3810000000002,-7.99500000000001,8,4,1,196.92,-2.415324330664357,0.7262197494506836,-6.77131295568056,0.1787647619843483,-16.671084788241618,0.030361840315163136,0.041212859377264974,0.6499510765075683,60.815852138843034,1.4602397750069784,0.005640405486337841,0.017075752047821878,0.044830063451081516,0.011789942369796335,0.014893354242667555,41.052169803430296,-8.715661885540436,-6.7138592162234385,2.6151412528955307,0.25394620299339293,0.24574002474546433,0.4736467361450195,0.9071646571159363,0.34260096251964567,0.037135737016797066,0.015220438595861197,0.11179630383849144,0.015678734984248877,0.02169318459928036,0.01058494383469224,0.0034161505522206427,0.015801645070314407,0.004439781280234456,0.013395322463475167,0.08366933986544609,0.24872513264417648,False
DHFR,6,SINGLE PROTEIN,Dihydrofolate reductase,9606,Homo sapiens,CHEMBL202,,0.0,2256.0,1705350.0,49931.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,METHOTREXATE,CHEMBL34259,4.0,1.0,1.0,MOL,44185.0,Small molecule,1953.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1961.0,1.0,-trexate,0.0,-trexate,antimetabolites (folic acid derivatives),Antineoplastic,0.0,0.0,0.0,"InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1",FBOZXECLQNJBKD-ZDUSSCGKSA-N,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,0.29472034504927447,4.0,454.44700000000023,0.2684000000000012,10,5,1,210.53999999999996,-2.8060126266194025,0.6812435626983643,-6.518612243573782,0.21412307471036912,-16.13968748247088,0.052018367871642116,0.013571357913315296,0.601214462518692,54.212910698173474,2.3606439942616406,0.016461591795086862,0.009504155069589616,0.023134616669267416,0.05453265532851219,0.030500650592148303,15.445501436316349,-8.709012455633367,5.871292869740891,2.6048739210112757,0.2655566617846489,0.18145602345466613,0.6412833571434021,0.9467384576797485,0.43304547369480134,0.06228846982121468,0.030747804790735245,0.1285720206797123,0.027176716178655625,0.06425372511148453,0.0313143216073513,0.00830687778070569,0.03947542700916529,0.00671982645872049,0.030030897259712218,0.17922400683164597,0.24881063103675843,False
DHFR,6,SINGLE PROTEIN,Dihydrofolate reductase,9606,Homo sapiens,CHEMBL202,,0.0,9005.0,3129904.0,1915.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PIRITREXIM,CHEMBL7492,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1986.0,,,0.0,,,Antiproliferative Agent,0.0,0.0,0.0,"InChI=1S/C17H19N5O2/c1-9-11(6-10-7-12(23-2)4-5-13(10)24-3)8-20-16-14(9)15(18)21-17(19)22-16/h4-5,7-8H,6H2,1-3H3,(H4,18,19,20,21,22)",VJXSSYDSOJBUAV-UHFFFAOYSA-N,COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1,0.7556422641252262,4.0,325.37200000000007,2.10562,7,2,0,109.17,-3.6614367985487277,0.9831187963485718,-5.074611127837821,0.9999449133872986,-11.905345593005872,0.9727596998214721,0.05712785627692938,0.7810528159141541,87.79710754084016,0.6425785990842815,0.8209466218948365,0.49065172076225283,0.052503982186317445,0.17285272479057312,0.8911014556884765,10.261143552349395,58.93477995057115,35.5554017503472,2.67269066181989,0.49569223523139955,0.09191968161612749,0.09680253453552723,0.9272835731506348,0.5933223843574524,0.06051294431090355,0.01772247822955251,0.2456089586019516,0.04354662410914898,0.7825985312461853,0.18196487724781035,0.004453913355246186,0.22621365189552306,0.007733998424373567,0.18232088088989257,0.1353449396789074,0.16563243567943572,False
DHFR,6,SINGLE PROTEIN,Dihydrofolate reductase,9606,Homo sapiens,CHEMBL202,,0.0,9594.0,2973320.0,2197833.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEMETREXED TROMETHAMINE,CHEMBL3989962,4.0,1.0,1.0,MOL,,Small molecule,2022.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,1.0,-trexed,0.0,-trexed,antineoplastic thymidylate synthetase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H21N5O6.2C4H11NO3.2H2O/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27;2*5-4(1-6,2-7)3-8;;/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29);2*6-8H,1-3,5H2;2*1H2/t13-;;;;/m0..../s1",DUORKVZYABUEHW-AHJYMZSGSA-N,NC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1.O.O,0.07002077503523883,1.0,705.7190000000004,-5.661399999999995,14,14,1,427.68,-2.593629161063547,0.3354463756084442,-7.4419745685162555,0.04018677924759686,-17.261049273673937,0.013999131607124581,0.011407889425754547,0.25069003701210024,53.788615987556945,8.326538816197857,0.00984986606054008,0.012615092232590542,0.018602270691189915,0.035508697759360074,0.011040873127058148,64.20267886508427,-12.146847740630438,11.422536050414147,2.5512616762374822,0.14659013785421848,0.22096363231539726,0.33335737884044647,0.39980028867721557,0.6394070267677308,0.07472790591418743,0.03791346214711666,0.10914750844240188,0.025706058368086815,0.01617494908859953,0.004795734211802483,0.0008346767244802322,0.00884118293179199,0.0018167730915592984,0.01188380188541487,0.027287971414625644,0.10351186692714691,False
DHFR,6,SINGLE PROTEIN,Dihydrofolate reductase,9606,Homo sapiens,CHEMBL202,,0.0,9635.0,2795295.0,374008.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEMETREXED,CHEMBL225072,4.0,1.0,1.0,MOL,63616.0,Small molecule,2004.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1997.0,1.0,-trexed,0.0,-trexed,antineoplastic thymidylate synthetase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1",WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1,0.2867441070042202,3.0,427.41700000000014,0.6664000000000003,6,6,1,191.26,-3.9573483502295526,0.7053258895874024,-6.737103636017818,0.23647601157426834,-16.892006601220867,0.031189130060374735,0.036446789279580116,0.6461461305618286,65.25036545679428,3.846861401048936,0.02369398046284914,0.03042916804552078,0.06849902309477329,0.04834806323051453,0.024397856462746857,45.029207914853544,-6.4193488869958655,-9.407834837478475,2.7505200563753456,0.2923516795039177,0.301942041516304,0.7845643401145935,0.9211720824241638,0.44447472095489504,0.05164607316255569,0.022804591991007327,0.15691550821065903,0.03346959305927157,0.04577612429857254,0.016455018892884254,0.005797054967842996,0.036897290125489236,0.006267237931024283,0.02412051223218441,0.1676385685801506,0.20514140874147416,False
DHFR,6,SINGLE PROTEIN,Dihydrofolate reductase,9606,Homo sapiens,CHEMBL202,,0.0,9825.0,3956712.0,2832704.0,Dihydrofolate reductase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PEMETREXED MONOHYDRATE,CHEMBL5315053,4.0,1.0,1.0,MOL,,Small molecule,2016.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,-1.0,-trexed,0.0,-trexed,antineoplastic thymidylate synthetase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H21N5O6.H2O/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27;/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29);1H2/t13-;/m0./s1",NBNBOZLBWLNZHB-ZOWNYOTGSA-N,Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1.O,0.25879947189802655,3.0,445.4320000000002,-0.15829999999999939,6,6,1,222.76,-3.5714855406574606,0.6661956429481506,-6.867057955399856,0.18613108843564988,-17.12178249486407,0.02853840310126543,0.038671156764030455,0.6484985589981079,63.49742606218142,3.3623858000907774,0.023114584386348724,0.030664022639393808,0.06747618280351161,0.061368799582123754,0.024900804832577707,51.02615275370389,-7.420049650218613,-10.11223804348224,2.7329406300030934,0.3219702333211899,0.30349251329898835,0.8074639439582825,0.9031681537628173,0.49104365706443787,0.049680992215871814,0.022803070954978466,0.1543128788471222,0.03422689996659756,0.040322530269622806,0.017746131494641305,0.005977826844900847,0.03602219857275486,0.00627367765409872,0.025102663412690164,0.16173833459615708,0.21308566331863404,False
GLP1R,11758,SINGLE PROTEIN,Glucagon-like peptide 1 receptor,9606,Homo sapiens,CHEMBL1784,,0.0,7902.0,3460863.0,2389894.0,Glucagon-like peptide 1 receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DANUGLIPRON,CHEMBL4518483,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2020.0,,-glipron,0.0,-glipron,glucagon-like peptide receptor agonists,,0.0,0.0,0.0,"InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1",HYBAKUMPISVZQP-DEOSSOPVSA-N,N#Cc1ccc(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4C[C@@H]4CCO4)CC3)n2)c(F)c1,0.31072819789476197,3.0,555.6100000000004,4.887780000000004,8,1,1,113.5,-5.453761813914484,0.7677919745445252,-5.2689535515154,0.9673399090766907,-9.570823958991689,0.6302886843681336,0.7076834201812744,0.5474715828895569,86.87984030915939,4.61147787875589,0.013964613154530525,0.08735307827591896,0.3204744964838028,0.23895566463470458,0.4549532294273376,-17.72395596982103,47.704818797145506,31.62718736089363,3.380006162736217,0.5403351306915283,0.15171493366360664,0.7713140726089478,0.7501420140266418,0.8635400533676147,0.019736693892627954,0.019708194211125372,0.05816218182444573,0.04180152509361505,0.09321661815047264,0.16843535751104355,0.031177060678601265,0.039539970457553864,0.03235343806445599,0.1618472307920456,0.18499568849802017,0.2072374016046524,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1316.0,1344269.0,674536.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,OXYMETHOLONE,CHEMBL1200585,4.0,1.0,1.0,MOL,,Small molecule,1972.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1963.0,1.0,-olone,0.0,-olone,steroids (not prednisolone derivatives),Androgen,0.0,0.0,0.0,"InChI=1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-/t14-,15+,16-,17-,19-,20-,21-/m0/s1",ICMWWNHDUZJFDW-DHODBPELSA-N,C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,0.5104218936123291,4.0,332.4840000000001,4.401000000000005,3,2,7,57.53,-4.145801570031908,0.6585282862186432,-4.686142995280226,0.9992650628089905,-6.153723135464087,0.9638053417205811,0.2708769828081131,0.13394007161259652,86.03450594747335,-0.02457254845770871,0.0919969929382205,0.24003835022449493,0.1994781032204628,0.004160234075970948,0.03974154517054558,-14.790056758775233,72.1789157751662,14.064057021480513,2.91262540202048,0.03508080206811428,0.035971754376078025,0.010802506748586894,0.11372140198945999,0.1289321854710579,0.9363590240478515,0.9510329604148865,0.925091826915741,0.7634031057357789,0.007302428811090067,0.3578128397464752,0.03748178519308567,0.03488495945930481,0.13289282470941544,0.47268485724925996,0.20566583275794983,0.41629219651222227,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1317.0,1344083.0,52087.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,FLUTAMIDE,CHEMBL806,4.0,1.0,1.0,MOL,5132.0,Small molecule,1989.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,1.0,0.0,1975.0,1.0,-lutamide,0.0,-lutamide,non-steroid antiandrogens,,0.0,0.0,0.0,"InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)",MKXKFYHWDHIYRV-UHFFFAOYSA-N,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,0.6801783581027343,4.0,276.21399999999994,3.2081000000000017,3,1,0,72.24,-3.560299670323191,0.9550670027732849,-4.478423710215685,0.9999694585800171,-6.173289527096186,0.9826894879341126,0.04976937174797058,0.9766529321670532,91.41540458414208,6.12090485069678,0.9254056215286255,0.7025737404823303,0.17449558824300765,0.07458833232522011,0.23713573068380356,26.17356067961619,38.28481272627657,40.65292403456137,2.7105048059036374,0.44395912885665895,0.8122496366500854,0.05333905452862382,0.8002838730812073,0.373278820514679,0.03900463581085205,0.033753353729844095,0.19660430997610093,0.032463240809738635,0.11252954229712486,0.31319039314985275,0.007830823585391045,0.018324370495975018,0.04113064222037792,0.6951736390590668,0.08478386066854,0.7971839070320129,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1318.0,1343266.0,249414.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NILUTAMIDE,CHEMBL1274,4.0,1.0,1.0,MOL,7573.0,Small molecule,1996.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1995.0,1.0,-lutamide,0.0,-lutamide,non-steroid antiandrogens,Antineoplastic,0.0,0.0,0.0,"InChI=1S/C12H10F3N3O4/c1-11(2)9(19)17(10(20)16-11)6-3-4-8(18(21)22)7(5-6)12(13,14)15/h3-5H,1-2H3,(H,16,20)",XWXYUMMDTVBTOU-UHFFFAOYSA-N,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,0.5149371381813627,4.0,317.223,2.4484000000000004,4,1,0,92.55000000000001,-4.140002095830953,0.9467060208320618,-4.778480143615882,0.9998233914375305,-8.195547592283122,0.9148640275001526,0.0276177822612226,0.9524803996086121,93.46987340912132,6.377750490672488,0.24955386221408843,0.5445050537586212,0.12067394964396953,0.00818208339624107,0.08326201289892196,32.95243334085633,4.205691858388676,16.343790778062388,2.4734617368993876,0.4442471206188202,0.6938929200172425,0.10692409686744213,0.9212853193283081,0.14012217670679092,0.022640456072986127,0.006638921750709415,0.09702308550477028,0.009677608776837588,0.008917144779115916,0.14715875461697578,0.004367950605228543,0.0017387441243045033,0.019989681709557772,0.2815018527209759,0.02658070530742407,0.8086097240447998,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1319.0,1343457.0,674999.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DROMOSTANOLONE PROPIONATE,CHEMBL1201048,4.0,1.0,1.0,MOL,31523.0,Small molecule,1982.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1963.0,0.0,-olone,0.0,-olone,steroids (not prednisolone derivatives),Antineoplastic,0.0,0.0,0.0,"InChI=1S/C23H36O3/c1-5-21(25)26-20-9-8-17-16-7-6-15-12-19(24)14(2)13-23(15,4)18(16)10-11-22(17,20)3/h14-18,20H,5-13H2,1-4H3/t14-,15+,16+,17+,18+,20+,22+,23+/m1/s1",NOTIQUSPUUHHEH-UXOVVSIBSA-N,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C,0.6384037243072085,3.0,360.5380000000002,5.166000000000006,3,0,8,43.370000000000005,-5.164853091723111,0.8590039372444153,-4.560893609289826,0.9995117068290711,-2.2625102496600955,0.9939423322677612,0.647751373052597,0.6895670711994171,95.7784806614562,-4.3516678665522335,0.03641773294657469,0.1116289108991623,0.08204128965735435,0.015641293907538056,0.045043081417679785,-3.872955816701521,126.50464647996823,59.06394114069161,2.019059843916195,0.07083583362400532,0.0228496140538482,0.02369177700020373,0.09759083464741707,0.3724208980798721,0.8099003076553345,0.6725796937942505,0.7680930852890014,0.6085106253623962,0.0060742061003111305,0.05231763944029808,0.012757596652954816,0.009471230302006006,0.02334103542380035,0.14748114198446274,0.0640613880008459,0.34229773432016375,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1320.0,1344580.0,717.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,BICALUTAMIDE,CHEMBL409,4.0,1.0,1.0,MOL,,Small molecule,1995.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1994.0,1.0,-lutamide,0.0,-lutamide,non-steroid antiandrogens,Antineoplastic,0.0,0.0,0.0,"InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)",LKJPYSCBVHEWIU-UHFFFAOYSA-N,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,0.5604120760868545,4.0,430.3790000000001,2.8795800000000007,5,2,1,107.25999999999999,-4.4594005039046705,0.8353189349174499,-4.799112582835397,0.9964006781578064,-9.341222580639386,0.6956210970878601,0.5573866844177247,0.694910180568695,85.587470079392,0.9188641326860282,0.2679800495505333,0.7403153657913208,0.43897090554237367,0.13732959926128388,0.8350406765937806,69.09331505535087,26.496474538306728,10.454735981076762,3.1910617035927933,0.1452980123460293,0.8208104610443115,0.22799679189920424,0.8028152704238891,0.8773456692695618,0.05489197857677937,0.029755235835909843,0.03500291891396046,0.01102770995348692,0.015376060782000423,0.14990207105875014,0.07089582942426205,0.0034525601658970118,0.01825274182483554,0.6338260889053344,0.12302217409014701,0.13193524479866028,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1321.0,1343817.0,328400.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,METHYLTESTOSTERONE,CHEMBL1395,4.0,1.0,1.0,MOL,27436.0,Small molecule,1973.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-ster-; -terone,0.0,-ster-; -terone,"steroids (androgens, anabolics); antiandrogens",Androgen,0.0,0.0,0.0,"InChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h12,15-17,22H,4-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1",GCKMFJBGXUYNAG-HLXURNFRSA-N,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,0.7253305311285855,4.0,302.458,4.269300000000005,2,1,6,37.3,-4.1944131477826,0.7634237289428711,-4.344146166272145,0.9997124910354614,-4.739780793300829,0.9844433307647705,0.23771451264619828,0.2301267310976982,74.95194650846939,-1.5686890466514662,0.07761141322553158,0.304138770699501,0.1248932482674718,0.0025755669048521668,0.03928068373352289,-5.533124533809386,57.00886362715964,-1.9423719725629809,2.302329947802451,0.011586734559386969,0.02475957682581793,0.00858034766279161,0.07885719202458859,0.15042748898267747,0.9597110033035279,0.9198841571807861,0.938955557346344,0.8824995636940003,0.0026478480227524414,0.21754190325737,0.008782985247671604,0.005592301301658153,0.026363224443048238,0.137345652282238,0.03796883188188076,0.45542008280754087,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1322.0,1343319.0,674574.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,ETHYLESTRENOL,CHEMBL1200623,4.0,1.0,1.0,MOL,31578.0,Small molecule,1964.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1962.0,0.0,-estr-,0.0,-estr-,estrogens,Anabolic,0.0,0.0,0.0,"InChI=1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h6,15-18,21H,3-5,7-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1",AOXRBFRFYPMWLR-XGXHKTLJSA-N,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C,0.6662692979783309,3.0,288.475,5.090300000000005,1,1,6,20.23,-5.391117629127265,0.7455581068992615,-4.593775821891776,0.9998950004577637,-2.702405038320312,0.9878383040428161,0.1829410120844841,0.2018698588013649,89.8999784585433,7.165122374851846,0.3312334448099136,0.5647199988365174,0.2836423434317112,0.007640941115096211,0.14515080899000168,2.418058094030015,72.55322180114693,13.353708100083779,2.0894042342801904,0.011430967226624488,0.022948153462220944,0.005683584371581674,0.04481826340779662,0.23734790831804276,0.909609067440033,0.8165101051330567,0.9510488629341125,0.9376751780509949,0.0037074983949423766,0.2286396235227585,0.007233663415536285,0.003242216061335057,0.04915149789303541,0.37063795030117036,0.04845740869641304,0.5987686455249787,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1323.0,1343701.0,1363818.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,STANOZOLOL,CHEMBL2079587,4.0,1.0,1.0,MOL,9249.0,Small molecule,1962.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1962.0,0.0,-olol,0.0,-olol,beta-blockers (propranolol type),Androgen,0.0,0.0,0.0,"InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1",LKAJKIOFIWVMDJ-IYRCEVNGSA-N,C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,0.7524910781410399,4.0,328.5000000000001,4.1181000000000045,2,2,7,48.91,-4.6921018445314875,0.7986452102661132,-4.905736741177614,0.9998208403587341,-6.680967019946112,0.9442700147628784,0.1530780576169491,0.2345983475446701,83.68543546141089,0.7312321939200351,0.21495227217674256,0.437616366147995,0.33084715977311135,0.01104232743382454,0.33892728090286256,-18.250186782769127,36.802686513124414,-4.701537310993452,2.823843850791438,0.07299666218459606,0.042774620925047205,0.031022037006914617,0.16074785590171814,0.3542901188135147,0.6284629106521606,0.5572569489479064,0.8685092091560364,0.8579723477363587,0.04036428751423955,0.3564884215593338,0.022465359419584274,0.044941918924450874,0.1530212454497814,0.5154223591089249,0.2795619577169418,0.5039740085601807,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1324.0,1343322.0,190629.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TESTOSTERONE PROPIONATE,CHEMBL1170,4.0,1.0,1.0,MOL,9466.0,Small molecule,1974.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,,0.0,-ster-; -terone,0.0,-ster-; -terone,"steroids (androgens, anabolics); antiandrogens",Androgen,0.0,0.0,0.0,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",PDMMFKSKQVNJMI-BLQWBTBKSA-N,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,0.6732503232022307,4.0,344.4950000000001,4.840100000000005,3,0,6,43.370000000000005,-5.041361694320183,0.7551574826240539,-4.45355991660916,0.9996563792228699,-2.738178848947031,0.9910250544548035,0.5700360774993897,0.5957020163536072,91.89630360936435,-2.855028840727888,0.04432013323530555,0.19473568871617317,0.08462313003838062,0.016752184880897403,0.04865177161991596,0.48783023934273545,103.18547727852527,49.84087919495968,1.857795320444339,0.0290002160705626,0.02231430644460488,0.018384709302335978,0.08425621017813682,0.2095254436135292,0.9708522319793701,0.9320715665817261,0.9168170332908631,0.8123775839805603,0.0025786307291127742,0.09149129241704941,0.010184464720077812,0.009222063515335322,0.020313726365566255,0.07578070908784866,0.037161876633763316,0.4122828546911478,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1325.0,1343154.0,674286.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TESTOSTERONE ENANTHATE,CHEMBL1200335,4.0,1.0,1.0,MOL,9464.0,Small molecule,1953.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,,1.0,-ster-; -terone,0.0,-ster-; -terone,"steroids (androgens, anabolics); antiandrogens",Androgen,0.0,0.0,0.0,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",VOCBWIIFXDYGNZ-IXKNJLPQSA-N,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,0.3825496385561263,3.0,400.6030000000003,6.400500000000007,3,0,6,43.370000000000005,-5.540217960007621,0.6129957377910614,-4.843299873694969,0.9994425296783447,-1.6844088786955276,0.9848929524421692,0.9327094316482544,0.6674641847610474,100.02665182129692,-0.10261234540141517,0.03490311522036791,0.10577751845121383,0.09507494363933802,0.03587710214778781,0.14296601861715316,10.984222350311558,131.34285055215577,82.16434574172771,2.1415105598977107,0.05204342752695083,0.0380548671586439,0.021039959602057935,0.058115836977958676,0.5044667243957519,0.941211199760437,0.8927785873413085,0.8663880586624145,0.7155490100383759,0.003685911395587027,0.11021169871091843,0.014616475207731128,0.011541074328124522,0.04115863908082247,0.1467420846223831,0.04085972961038351,0.45993471071124076,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1326.0,1343721.0,674897.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,NANDROLONE DECANOATE,CHEMBL1200946,4.0,1.0,1.0,MOL,7467.0,Small molecule,1983.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1965.0,1.0,-andr-; -olone,0.0,-andr-; -olone,androgens; steroids (not prednisolone derivatives),Androgen,0.0,0.0,0.0,"InChI=1S/C28H44O3/c1-3-4-5-6-7-8-9-10-27(30)31-26-16-15-25-24-13-11-20-19-21(29)12-14-22(20)23(24)17-18-28(25,26)2/h19,22-26H,3-18H2,1-2H3/t22-,23+,24+,25-,26-,28-/m0/s1",JKWKMORAXJQQSR-MOPIKTETSA-N,CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,0.2884127521938969,3.0,428.6570000000003,7.180700000000009,3,0,6,43.370000000000005,-5.984390590702505,0.5502337098121644,-5.0034405691318256,0.9992695569992065,-1.2214394223916005,0.9773375868797303,0.967442536354065,0.648071926832199,103.9516669304185,0.34815541141076894,0.03581788521260023,0.07909778356552125,0.07897418215870858,0.03646913897246122,0.17110100761055946,21.20350529677615,140.2661709843494,96.91000455102355,2.242724907133704,0.03895482774823904,0.04466630992828868,0.017115958593785764,0.054365871101617814,0.5236891388893128,0.9198698163032532,0.8810320615768432,0.8498805046081543,0.6537827014923095,0.0029076773673295973,0.07962061017751694,0.01616529580205679,0.007479853834956885,0.046808363683521745,0.15211224257946016,0.03688127547502518,0.5077450536191463,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1327.0,1343248.0,674387.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,OXANDROLONE,CHEMBL1200436,4.0,1.0,1.0,MOL,7820.0,Small molecule,1964.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1962.0,1.0,-andr-; -olone,0.0,-andr-; -olone,androgens; steroids (not prednisolone derivatives),Androgen,0.0,0.0,0.0,"InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1",QSLJIVKCVHQPLV-PEMPUTJUSA-N,C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,0.6962908532154631,4.0,306.446,3.543100000000003,3,1,7,46.53,-4.340661743206732,0.8103801488876343,-4.517562323773159,0.9993843197822571,-4.571989454358432,0.9820581436157226,0.1715283516794443,0.2329878095537424,74.84443726121177,-8.18898106354997,0.0423005597665906,0.2935355484485626,0.1477544041350484,0.0023513501742854714,0.14191371947526932,-0.9876894410615151,69.65296618839685,0.08286173461160189,2.1391177679942786,0.08379059582948685,0.015383272620056232,0.021669186558574437,0.10925301313400268,0.3007243424654007,0.8026007890701294,0.6757312774658203,0.8757115125656127,0.7822733759880066,0.0030853576143272223,0.3608540028333664,0.04590920135378838,0.020989777334034444,0.03700934424996376,0.33585098162293436,0.28734950721263885,0.6352305948734284,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1328.0,1344069.0,675052.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TESTOSTERONE CYPIONATE,CHEMBL1201101,4.0,1.0,1.0,MOL,9463.0,Small molecule,1978.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,,1.0,-ster-; -terone,0.0,-ster-; -terone,"steroids (androgens, anabolics); antiandrogens",Androgen,0.0,0.0,0.0,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",HPFVBGJFAYZEBE-ZLQWOROUSA-N,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,0.5017591238230259,3.0,412.6140000000003,6.400500000000007,3,0,6,43.370000000000005,-5.833236845004816,0.5742363929748535,-4.895781834807987,0.9987057328224183,-1.67714495699223,0.9795734524726868,0.8866641640663147,0.37634416818618777,100.15686855900329,-0.18147044162639964,0.03717874763533473,0.09283592402935029,0.10010379310697318,0.024714390654116868,0.11315414234995842,22.970931825187805,112.22617796660754,81.70343565031067,2.2041946122048404,0.019055880792438983,0.03516110914060846,0.018426488060504197,0.06882194802165031,0.3978778749704361,0.9604584693908691,0.9464362859725952,0.9031465888023377,0.783848762512207,0.0016387973650125788,0.1457926794886589,0.02083404120057821,0.012151221744716167,0.037682789377868176,0.16802135556936265,0.05621377043426037,0.39545919969677923,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1329.0,1344918.0,364520.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TESTOSTERONE,CHEMBL386630,4.0,1.0,1.0,MOL,17347.0,Small molecule,1972.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,,1.0,-ster-; -terone,0.0,-ster-; -terone,"steroids (androgens, anabolics); antiandrogens",Androgen,0.0,0.0,0.0,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",MUMGGOZAMZWBJJ-DYKIIFRCSA-N,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,0.7342296115534325,4.0,288.431,3.879200000000003,2,1,6,37.3,-3.8359791380457233,0.648019140958786,-4.41719081185581,0.9995049476623535,-5.884179425412194,0.9795109391212463,0.20103854611515998,0.1346387930214405,76.84887308451611,1.3227086978268905,0.08449880499392748,0.24611270427703857,0.10254219733178616,0.002071939071174711,0.011595511436462402,7.499140984484799,64.28372763309497,-5.174512911545096,1.8437475171063404,0.00611076969653368,0.012437008081360546,0.006317421770654618,0.049638668075203896,0.12310348525643348,0.9851290583610535,0.9705010771751403,0.967095923423767,0.9099169850349427,0.0015476164298888762,0.1974226251244545,0.00425157779827714,0.004059136006981134,0.01156827099621296,0.07064807452261448,0.026096588373184203,0.39986745417118075,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1330.0,1344050.0,377718.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,FLUOXYMESTERONE,CHEMBL1445,4.0,1.0,1.0,MOL,5120.0,Small molecule,1956.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,1.0,-ster-; -terone,0.0,-ster-; -terone,"steroids (androgens, anabolics); antiandrogens",Androgen,0.0,0.0,0.0,"InChI=1S/C20H29FO3/c1-17-8-6-13(22)10-12(17)4-5-15-14-7-9-19(3,24)18(14,2)11-16(23)20(15,17)21/h10,14-16,23-24H,4-9,11H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/m0/s1",YLRFCQOZQXIBAB-RBZZARIASA-N,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,0.7132510411285401,4.0,336.44700000000006,3.332200000000002,3,2,7,57.53,-3.9744732607859694,0.905371630191803,-4.583367733787639,0.9999615550041199,-7.8937102155718595,0.9642844915390014,0.05991169139742851,0.8377252221107483,60.173095243105266,-0.7703927373395446,0.006884227448608726,0.04225438144057989,0.019662466004956514,0.0009914190944982693,0.0708292169496417,25.50277269965138,46.275718705830805,-9.966828960180592,2.9804976947027373,0.08099163882434368,0.019592777653815573,0.01436538454145193,0.0602796632796526,0.19200729727745056,0.9972324132919311,0.9663298964500427,0.8004320144653321,0.298487488925457,0.0044400998041965066,0.449847424030304,0.0016690169577486813,0.005944667616859078,0.0019278489518910647,0.06579505279660225,0.011685178149491549,0.11871436424553394,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1331.0,1679375.0,630886.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ENZALUTAMIDE,CHEMBL1082407,4.0,1.0,1.0,MOL,68534.0,Small molecule,2012.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,2012.0,1.0,-lutamide,0.0,-lutamide,deuterated compounds; non-steroid antiandrogens,,0.0,0.0,0.0,"InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)",WXCXUHSOUPDCQV-UHFFFAOYSA-N,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,0.5492417106050057,4.0,464.44400000000013,3.992480000000003,4,1,0,76.44,-6.002025022473925,0.7052933931350708,-4.647600431554487,0.992396104335785,-8.760278252076679,0.8997156262397766,0.6234809100627899,0.6553036093711853,87.72311529062966,1.169023511108525,0.06621377170085907,0.4989655137062073,0.5602032899856567,0.01921648597344756,0.5731609165668488,91.02746675411227,30.54997928238729,22.691817494488816,3.2047913986951904,0.3140289455652237,0.6873504638671875,0.15945610255002976,0.9347957611083985,0.8606573224067688,0.023221195861697196,0.015930990409106015,0.06517106667160988,0.02341174427419901,0.016266352403908967,0.37275649011135104,0.06349161341786384,0.012413930520415306,0.13086884915828706,0.7792401790618897,0.3885455667972565,0.4022527515888214,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1332.0,1343978.0,674363.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,NANDROLONE PHENPROPIONATE,CHEMBL1200412,4.0,1.0,1.0,MOL,7468.0,Small molecule,1959.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,,0.0,-andr-; -olone,0.0,-andr-; -olone,androgens; steroids (not prednisolone derivatives),Androgen,0.0,0.0,0.0,"InChI=1S/C27H34O3/c1-27-16-15-22-21-11-9-20(28)17-19(21)8-10-23(22)24(27)12-13-25(27)30-26(29)14-7-18-5-3-2-4-6-18/h2-6,17,21-25H,7-16H2,1H3/t21-,22+,23+,24-,25-,27-/m0/s1",UBWXUGDQUBIEIZ-QNTYDACNSA-N,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1,0.6049275845173735,3.0,406.56600000000014,5.672800000000006,3,0,6,43.370000000000005,-5.379797356737315,0.692070484161377,-4.811337416148173,0.9997079253196717,-3.33324513054727,0.9800439476966858,0.8869682312011719,0.38931575268507,101.69973025998401,-3.201570305750643,0.07059770189225674,0.262289796769619,0.1679719626903534,0.03635308109223843,0.18437885791063308,25.4803353701572,129.00099397620656,84.02319617496548,2.5693837660640804,0.02516674231737852,0.038824749035120475,0.017994213895872236,0.07951434925198556,0.3458840727806091,0.9835400938987732,0.9749821543693542,0.9581229329109192,0.8703320860862732,0.00226601047324948,0.10203481316566468,0.023132668528705835,0.0188870245590806,0.039189348742365834,0.21560726016759874,0.050915937311947344,0.3714574009180069,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,1333.0,1344474.0,405364.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,DANAZOL,CHEMBL1479,4.0,1.0,1.0,MOL,4315.0,Small molecule,1976.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1968.0,1.0,,0.0,,,Anterior Pituitary Suppressant,0.0,0.0,0.0,"InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1",POZRVZJJTULAOH-LHZXLZLDSA-N,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,0.7210430866196731,4.0,337.46300000000014,4.221000000000004,3,1,6,46.260000000000005,-5.841433984785757,0.8349114656448364,-4.773586866014772,0.9999854326248169,-5.446147816658298,0.9810160040855408,0.28923359811306,0.32358708679676057,97.81183623029487,-2.688330187071156,0.5610371410846711,0.6757713079452514,0.4464273452758789,0.05387816354632378,0.7156762957572937,-2.7696364358808347,26.216199328344146,-7.923140104127012,2.4507914815209473,0.1274684689939022,0.06132089079837897,0.04720261916518211,0.14213307350873947,0.1975732773542404,0.9215326070785522,0.9194074869155884,0.966461181640625,0.9530171871185302,0.06036379169672727,0.6234258890151978,0.04828832149505615,0.10137998387217521,0.2282087430357933,0.490061366558075,0.18943595439195632,0.4448801875114441,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,2270.0,1704784.0,1379337.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,TESTOSTERONE UNDECANOATE,CHEMBL2107067,4.0,1.0,1.0,MOL,,Small molecule,2014.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,2003.0,1.0,-ster-; -terone,0.0,-ster-; -terone,"steroids (androgens, anabolics); antiandrogens",,0.0,0.0,0.0,"InChI=1S/C30H48O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h21,24-27H,4-20H2,1-3H3/t24-,25-,26-,27-,29-,30-/m0/s1",UDSFVOAUHKGBEK-CNQKSJKFSA-N,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,0.24723781358374838,3.0,456.7110000000004,7.960900000000009,3,0,6,43.370000000000005,-6.14147818613853,0.5375420868396759,-5.013559065199529,0.9990594148635864,-0.9724774480835873,0.9715983271598816,0.977664852142334,0.6725975394248962,104.96987296973505,0.4380886704308883,0.02796054007485509,0.04567363020032644,0.06392809692770243,0.035701732896268365,0.157640041410923,26.712422884988722,136.13677831884416,100.89884187192851,2.301704850771745,0.05030916444957256,0.055198023677803576,0.018806722853332757,0.05757596641778946,0.6332246422767639,0.8549706816673279,0.8146955490112304,0.76959730386734,0.5490794599056243,0.0028175377403385935,0.09278256520628929,0.01923847645521164,0.007754639722406864,0.05559653267264366,0.14875769019126892,0.04402403254061937,0.5259853318333626,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,3883.0,2473329.0,1927086.0,Androgen Receptor modulator,,MODULATOR,1.0,1.0,1.0,,,,,HE3235,CHEMBL3545237,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H32O2/c1-4-21(23)12-9-18-16-6-5-14-13-15(22)7-10-19(14,2)17(16)8-11-20(18,21)3/h1,14-18,22-23H,5-13H2,2-3H3/t14?,15?,16?,17?,18?,19-,20-,21-/m0/s1",CKAXZOYFIHQCBN-UQOAMHMYSA-N,C#C[C@]1(O)CCC2C3CCC4CC(O)CC[C@]4(C)C3CC[C@@]21C,0.6681901280999849,4.0,316.48500000000007,3.7543000000000033,2,2,8,40.46,-5.3269999356942295,0.7468348383903504,-4.592933697896425,0.9978985905647277,-4.349842641239048,0.9373588681221008,0.27351156398653986,0.22789763808250427,88.68833600862546,0.07134253429568602,0.08352843150496483,0.24616271257400513,0.21673261225223542,0.01529302392154932,0.12052340358495713,16.547793433579663,31.37409962416759,-3.6315792599698424,1.9818453966086238,0.05880460180342197,0.1623037101526279,0.025187053252011538,0.053553028404712676,0.3991402924060822,0.4862358391284943,0.45043897032737734,0.8973529219627381,0.8997177839279175,0.010606906563043594,0.14418117254972457,0.03522154334932566,0.009710660157725214,0.08764601461589336,0.39414894878864287,0.15650738961994648,0.509915578365326,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4056.0,2473615.0,2741818.0,Androgen Receptor modulator,,MODULATOR,1.0,1.0,1.0,SARM,,,,VK5211,CHEMBL5170587,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C14H12F6N2O/c15-13(16,17)10-6-9(4-3-8(10)7-21)22-5-1-2-11(22)12(23)14(18,19)20/h3-4,6,11-12,23H,1-2,5H2/t11-,12-/m1/s1",OPSIVAKKLQRWKC-VXGBXAGGSA-N,N#Cc1ccc(N2CCC[C@@H]2[C@@H](O)C(F)(F)F)cc1C(F)(F)F,0.8402557624450276,4.0,338.251,3.4690800000000017,3,1,2,47.260000000000005,-3.87342570102006,0.864201545715332,-4.673345367401513,0.9999057531356812,-8.270267712030455,0.9593722581863403,0.528471827507019,0.9762245655059815,82.58187055380557,3.333540885977814,0.3931867003440857,0.6394403219223023,0.20256250053644181,0.03328222036361694,0.21137836277484895,9.231574286986458,25.13144468595427,6.4635981741926996,3.152241226990748,0.12435326278209687,0.2291070342063904,0.09355931729078293,0.3258544221520424,0.8632985591888428,0.18295108526945114,0.08806555271148682,0.07573705166578293,0.02350439690053463,0.035919713973999026,0.3992146164178848,0.03317730035632849,0.011107780784368516,0.01018939884379506,0.40444028079509736,0.12484017461538315,0.2579945921897888,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4057.0,2473482.0,52642.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Vitamin E derivate,,,,APC-100,CHEMBL37676,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C14H20O2/c1-8-9(2)13-11(10(3)12(8)15)6-7-14(4,5)16-13/h15H,6-7H2,1-5H3",SEBPXHSZHLFWRL-UHFFFAOYSA-N,Cc1c(C)c2c(c(C)c1O)CCC(C)(C)O2,0.7255781870655406,4.0,220.31199999999995,3.4210600000000024,2,1,0,29.46,-3.7957732938573705,0.819505226612091,-4.768744915757269,0.9999605298042298,-5.331844753193027,0.9860950946807862,0.03909694328904152,0.9537890076637268,87.50588166736532,4.408572598208556,0.8397432148456574,0.41280944347381593,0.2199986532330513,0.15860520545393228,0.04581617265939712,9.344046795652549,102.34638289690415,58.72441685463546,2.1772410184094086,0.035510368458926675,0.11046794205904006,0.0017473499523475767,0.3004098042845726,0.5169488549232483,0.009549085143953561,0.0001460664178011939,0.23186755776405335,0.08926246985793114,0.23076245188713074,0.027606961131095887,0.0056483900523744525,0.003466573543846607,0.047160596773028376,0.6455781817436218,0.03232184117659927,0.6412754356861115,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4058.0,2473752.0,1438891.0,Androgen Receptor modulator,,MODULATOR,1.0,1.0,1.0,selective androgen modulator (SARM),,,,GLPG0492,CHEMBL2178100,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H14F3N3O3/c1-24-17(28)25(14-8-7-12(10-23)15(9-14)19(20,21)22)16(27)18(24,11-26)13-5-3-2-4-6-13/h2-9,26H,11H2,1H3/t18-/m1/s1",VAJGULUVTFDTAS-GOSISDBHSA-N,CN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)[C@@]1(CO)c1ccccc1,0.8185019115256562,4.0,389.3330000000001,2.8632800000000005,4,1,1,84.64,-5.313171385661621,0.9451957225799561,-4.493460408700456,0.9995996117591858,-11.009826842246584,0.8967408180236817,0.2689420834183693,0.9392670631408692,92.52837120989463,0.18147418458936296,0.033096890710294244,0.19479680359363555,0.0806375777348876,0.001253682083915919,0.061629365757107736,21.43602086898929,29.657426779839163,23.43299606167384,2.665553008963033,0.093819884583354,0.5275531768798828,0.19056206643581391,0.9259066700935363,0.5581322371959686,0.05680099464952946,0.005677334405481816,0.010823936015367509,0.0009320865327026695,0.0063824431039392945,0.08325103558599949,0.01372330798767507,0.0014679893385618926,0.001267612649826333,0.2247220601886511,0.03472576998174191,0.12472931295633316,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4059.0,2473616.0,1528799.0,Androgen Receptor modulator,,MODULATOR,1.0,1.0,1.0,"Selective androgen receptor inhibitor and down-regulator (SARD). AZD3514 binds to AR, inhibits its nuclear translocation, ligand-dependent and independent transcriptional activity and is able to induce AR down-regulation in vitro and in vivo. .Discontinued, safety/efficacy reasons.",,,,AZD3514,CHEMBL2346976,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H32F3N7O2/c1-18(36)33-14-12-32(13-15-33)16-17-37-21-4-2-19(3-5-21)20-8-10-34(11-9-20)23-7-6-22-29-30-24(25(26,27)28)35(22)31-23/h2-5,20H,6-17H2,1H3",JMEYDSHPKCSIJC-UHFFFAOYSA-N,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1,0.6047873314845591,3.0,519.5720000000002,2.8272000000000013,8,0,0,79.09,-2.4579579298981047,0.7693965554237365,-5.189479091046219,0.9937263369560242,-7.8675774388453705,0.9148807168006897,0.9547383785247803,0.9158811688423156,82.0462820895698,-2.1386441988962948,0.008292819588677957,0.14468845576047898,0.1362188994884491,0.16554127559065818,0.3566087752580643,-10.508689738089794,-12.146959598028875,58.489065937467686,4.149334616388827,0.35352079570293427,0.19720567315816878,0.5008176088333129,0.5022230952978134,0.8877504944801331,0.04073534570634365,0.007860136590898037,0.12688925117254257,0.017030247766524554,0.0017101354140322655,0.015328713320195675,0.002401768276467919,0.011067915055900813,0.003746774746105075,0.021147394739091396,0.015790355391800404,0.17537033855915068,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4060.0,2472765.0,479591.0,Androgen Receptor modulator,,MODULATOR,1.0,1.0,1.0,Selective androgen modulator (SARM). No information about further clinical development (http://www.drugs.com/clinical_trials/ligand-research-published-journal-medicinal-chemistry-lgd-2941-shows-promise-treating-muscle-bone-2222.html),,,,LGD-2941,CHEMBL467888,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H16F6N2O2/c1-8-2-5-13(15(27)17(21,22)23)25(8)9-3-4-12-10(6-9)11(16(18,19)20)7-14(26)24-12/h3-4,6-8,13,15,27H,2,5H2,1H3,(H,24,26)/t8-,13-,15-/m1/s1",HWLLYFXDDGGHOE-BCSUUIJWSA-N,C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,0.7617453513269903,4.0,394.31500000000005,3.8274000000000026,3,2,3,56.33,-4.70162634190751,0.7813792705535889,-5.0937390255924,0.9993305683135987,-11.184298265195832,0.8148867130279541,0.513655811548233,0.9301687240600586,87.6350782197922,20.283455937656136,0.20868043899536132,0.35621482878923416,0.1778978956863284,0.10400645360350609,0.2878637135028839,35.95826602110806,23.500929734600184,-6.558251084658463,3.7265580229679194,0.08534595482051373,0.19963892549276352,0.3163844466209412,0.6598073363304138,0.8509823441505432,0.12920611798763276,0.09700129330158233,0.10874944925308228,0.01530526839196682,0.13829869031906128,0.3450653403997421,0.012935509998351335,0.02983614569529891,0.017279030149802567,0.6391577541828155,0.2765804767608643,0.10322989821434021,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4086.0,2473049.0,1925392.0,Androgen Receptor modulator,,MODULATOR,1.0,1.0,1.0,,,,,LY2452473,CHEMBL3542265,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H22N4O2/c1-14(2)28-22(27)25-17-10-19-18-9-15(12-23)6-7-20(18)26(21(19)11-17)13-16-5-3-4-8-24-16/h3-9,14,17H,10-11,13H2,1-2H3,(H,25,27)/t17-/m0/s1",IHIWYQYVBNODSV-KRWDZBQOSA-N,CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1,0.7571772910824709,4.0,374.44400000000013,3.558080000000002,5,1,1,79.94,-4.790846255788372,0.8430562138557434,-4.7914190628541125,0.9999334692955018,-10.531981071551415,0.9760701298713684,0.46566917300224303,0.9250994801521302,95.14129296131509,-5.522392732715398,0.8349519491195678,0.846119511127472,0.8790245890617371,0.22779914140701293,0.8677074909210205,10.86028846434363,35.22878263990491,56.97689134517027,2.920399832437229,0.5972233414649963,0.15497791022062302,0.5278351664543152,0.7544790863990783,0.8285837888717651,0.029086384922266006,0.02811623513698578,0.13249860405921937,0.07155361771583557,0.5507360100746155,0.36262778639793397,0.06701651811599732,0.14268901944160461,0.058729751780629155,0.6637717127799988,0.45244725346565245,0.21866147816181183,True
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4560.0,2473582.0,1927182.0,Androgen Receptor modulator,,MODULATOR,1.0,1.0,1.0,SARM,,,,MK-0773,CHEMBL3545333,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C27H34FN5O2/c1-26-11-10-17-15(6-9-21-27(17,2)13-19(28)25(35)33(21)3)16(26)7-8-18(26)24(34)30-14-22-31-20-5-4-12-29-23(20)32-22/h4-5,12-13,15-18,21H,6-11,14H2,1-3H3,(H,30,34)(H,29,31,32)/t15?,16?,17?,18-,21?,26+,27-/m1/s1",GBEUKTWTUSPHEE-PAWGCEJPSA-N,CN1C(=O)C(F)=C[C@]2(C)C3CC[C@@]4(C)C(CC[C@@H]4C(=O)NCc4nc5ncccc5[nH]4)C3CCC12,0.692720494939134,4.0,479.6000000000002,4.126900000000003,4,2,7,90.97999999999999,-4.1621600081561905,0.859676718711853,-5.124182845246631,0.9999412059783935,-10.772931136818386,0.9445582866668701,0.68668053150177,0.9062392950057984,87.75372203435506,5.588140590632284,0.025637506134808065,0.5154242992401123,0.4764679968357086,0.31752724647521974,0.9784078955650329,9.653984472978639,59.3423335934625,49.9946114904785,3.9973114793513043,0.3690524697303772,0.08066163137555123,0.5647024214267731,0.5330802857875824,0.8232433438301087,0.054146405309438705,0.011452151834964753,0.11980155408382416,0.010521976463496684,0.04222661666572094,0.13168337270617486,0.006379679194651544,0.027438444644212724,0.028293802216649056,0.2255055159330368,0.019401913322508336,0.16774905994534492,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4561.0,2472870.0,1951344.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CLASCOTERONE,CHEMBL3590187,4.0,1.0,1.0,MOL,,Small molecule,2020.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,2018.0,0.0,-terone,0.0,-terone,antiandrogens,,0.0,0.0,0.0,"InChI=1S/C24H34O5/c1-4-21(28)29-24(20(27)14-25)12-9-19-17-6-5-15-13-16(26)7-10-22(15,2)18(17)8-11-23(19,24)3/h13,17-19,25H,4-12,14H2,1-3H3/t17-,18+,19+,22+,23+,24+/m1/s1",GPNHMOZDMYNCPO-PDUMRIMRSA-N,CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,0.724146959959367,4.0,402.5310000000003,3.7717000000000027,5,1,6,80.67000000000002,-5.08315753251137,0.7136782646179199,-4.528515821808769,0.9998972415924072,-5.691526760031114,0.9822025537490845,0.5325415849685669,0.817504096031189,90.90004230650229,-2.8146522342049676,0.0070752157480455935,0.07877435106784106,0.07413629274815321,0.009767306130379438,0.1127884577959776,-23.431372743800516,115.23250906337375,72.62068598428887,2.484991574429,0.04057574048638344,0.016891007457161322,0.038409640081226826,0.13481875732541085,0.1885652706027031,0.9779287099838256,0.9486825346946717,0.6324518084526062,0.14364623427391052,0.0033694989047944545,0.14828887730836868,0.005970013723708689,0.012726125679910183,0.007643233658745885,0.09557598009705544,0.05240893326699734,0.1271067764610052,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,4562.0,1702648.0,1378008.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,GALETERONE,CHEMBL2105738,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2011.0,,-terone,0.0,-terone,antiandrogens,,0.0,0.0,0.0,"InChI=1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1",PAFKTGFSEFKSQG-PAASFTFBSA-N,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,0.6260224160831173,3.0,388.55500000000006,5.810800000000006,3,1,6,38.05,-5.23285005529485,0.6871626019477844,-5.0911160999857055,0.9998492360115051,-7.55234423171855,0.9543016791343689,0.8311608076095581,0.42264253199100493,99.79125755656221,3.565176639527472,0.14323684573173523,0.2805762641131878,0.22158648148179055,0.12630460411310196,0.23777859956026076,-8.169803423779396,50.14714165562104,37.52291555080696,3.284999584177659,0.18506987094879152,0.051332038955297324,0.18642250448465347,0.16110797002911567,0.8215780973434448,0.318526291847229,0.2798211365938187,0.6307939767837525,0.45502540469169617,0.08133953362703324,0.7371409654617309,0.03350083976984024,0.02981221191585064,0.38621343970298766,0.4404000222682953,0.1080250009894371,0.46244150698184966,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,5217.0,2473478.0,2335156.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,DAROLUTAMIDE,CHEMBL4297185,4.0,1.0,1.0,MOL,,Small molecule,2019.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2017.0,1.0,-lutamide,0.0,-lutamide,non-steroid antiandrogens,,0.0,0.0,0.0,"InChI=1S/C19H19ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11-12,27H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-,12?/m0/s1",BLIJXOOIHRSQRB-PXYINDEMSA-N,CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,0.5892234115643402,4.0,398.85400000000004,2.6700799999999996,6,3,2,119.62,-4.77831430350908,0.8659012317657471,-5.505292576730172,0.992504072189331,-15.598633118982217,0.6566950678825378,0.27176645696163176,0.10286682397127152,87.41902376926924,4.65503758888944,0.15588635206222534,0.3003651052713394,0.2507892608642578,0.06120224371552467,0.5269349694252015,46.04384236691108,3.8460345400380818,1.0998790548606308,2.810553874037361,0.2900711715221405,0.435086327791214,0.44874334931373594,0.8964447617530823,0.5622097074985504,0.01361633874475956,0.014411118254065514,0.044423733279109,0.025145900435745716,0.21052798330783845,0.18534040004014968,0.02932637818157673,0.016631878353655337,0.03145323432981968,0.34923998415470126,0.11103871911764145,0.2310404062271118,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,5218.0,1705256.0,1117936.0,Androgen Receptor modulator,,MODULATOR,1.0,1.0,1.0,SARM,,,,ENOBOSARM,CHEMBL1738889,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2011.0,,-sarm,0.0,-sarm,selective androgen receptor modulator (non-steroidal),,0.0,0.0,0.0,"InChI=1S/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m0/s1",JNGVJMBLXIUVRD-SFHVURJKSA-N,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,0.8167632554543229,4.0,389.3330000000001,3.2172600000000013,5,2,1,106.13999999999999,-4.85659538723184,0.903122067451477,-4.637292869121391,0.9964220404624939,-9.707739354638544,0.8130412817001342,0.5877409696578979,0.5462149560451508,84.87602766304585,-3.579365525954716,0.28976775854825976,0.43029847741127014,0.30013250559568405,0.04779047593474388,0.6556160807609558,24.81491020176743,41.819680536384226,22.625109946450042,2.8014731365176053,0.3607305407524109,0.6092282354831695,0.17508083954453468,0.6856139302253723,0.8179342985153198,0.10095626637339591,0.043813766539096834,0.11739505082368851,0.050048404932022096,0.07955289259552956,0.3638842970132828,0.10442851930856704,0.023194688186049462,0.042093683034181595,0.744335001707077,0.38709007799625395,0.1698773205280304,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,5219.0,2472755.0,1672700.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,APALUTAMIDE,CHEMBL3183409,4.0,1.0,1.0,MOL,,Small molecule,2018.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-lutamide,0.0,-lutamide,non-steroid antiandrogens,,0.0,0.0,0.0,"InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)",HJBWBFZLDZWPHF-UHFFFAOYSA-N,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,0.5376107076331194,4.0,477.4430000000002,3.5315800000000026,5,1,0,89.33000000000001,-6.114115112279227,0.8271389842033386,-4.72983755668411,0.9982362270355225,-9.972722996639362,0.934533441066742,0.449939227104187,0.8015586137771606,83.95214789879034,4.61785548008004,0.030624081287533043,0.2838129013776779,0.5613609611988067,0.009954282687976957,0.4377366840839386,79.92778193312529,27.82022630799721,16.923285326475593,3.2589565264429927,0.49267971217632295,0.3860147923231125,0.3006837904453278,0.9593112707138062,0.6915911436080933,0.04286880679428577,0.025816477835178375,0.06277266070246697,0.017950521409511568,0.02169505339115858,0.4169426798820496,0.05248240977525711,0.0849107027053833,0.1327224239706993,0.7773417711257935,0.4701064318418503,0.27538453191518786,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,6262.0,1703573.0,842060.0,Androgen Receptor agonist,,AGONIST,1.0,1.0,1.0,"Methandrostenolone binds to and activates the androgen receptor (AR) causing dramatic increases in protein synthesis, glycogenolysis, and muscle strength over a short space of time.",,,,METHANDROSTENOLONE,CHEMBL1418176,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,-2.0,-andr-; -olone,0.0,-andr-; -olone,androgens; steroids (not prednisolone derivatives),,1.0,0.0,0.0,"InChI=1S/C20H28O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h6,9,12,15-17,22H,4-5,7-8,10-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1",XWALNWXLMVGSFR-HLXURNFRSA-N,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,0.7326817037049284,4.0,300.442,4.045300000000004,2,1,6,37.3,-4.372293876673628,0.7670869708061219,-4.38984141884113,0.9998216509819031,-5.275727633932536,0.9827598571777344,0.23637655451893808,0.32965558767318726,78.9002062808133,-1.4700088990546865,0.07487401440739631,0.47408549189567567,0.1320225177332759,0.005500236712396145,0.07174514047801495,-12.63586666615213,58.4783605636675,1.323504360981444,2.5191628362815206,0.01892737913876772,0.03280223350793676,0.01623583072796464,0.10784501060843468,0.12331505268812179,0.9587363362312317,0.9163114786148071,0.9207697987556458,0.8349910974502563,0.0050954892300069336,0.29919970631599424,0.011641297675669193,0.01140732429921627,0.04634431190788746,0.19466252028942108,0.04165431335568428,0.5034313917160034,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,6884.0,1706236.0,422175.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Abiraterone is converted by an enzyme to the more active Î”4-abiraterone (D4A). D4A inhibits 17Î±-hydroxylase/17,20-lyase (CYP17A1), 3Î²-hydroxysteroid dehydrogenase (3Î²HSD) and steroid-5Î±-reductase (SRD5A), which are required for 5Î±-dihydrotestosterone (DHT) synthesis. DHT promotes signaling by the androgen receptor and the development of castration-resistant prostate cancer. D4A also antagonizes the androgen receptor.",,,,ABIRATERONE,CHEMBL254328,4.0,1.0,1.0,MOL,68642.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,,-1.0,-terone,0.0,-terone,antiandrogens,,0.0,0.0,0.0,"InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1",GZOSMCIZMLWJML-VJLLXTKPSA-N,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12,0.6887813871003827,3.0,349.51800000000003,5.398600000000005,2,1,6,33.120000000000005,-4.937126602076702,0.785356342792511,-4.962633589065264,0.9999686241149902,-6.69429756026002,0.9838630080223083,0.4931096076965332,0.4385202556848526,94.25218947004753,2.364988300606872,0.2514320179820061,0.49306961297988894,0.3634022086858749,0.058144188672304156,0.6281298100948334,-4.4620105223320765,56.3516309021547,18.913291440306402,3.0247189144141373,0.04416477084159851,0.026891203416744246,0.13825133740901946,0.1041194811463356,0.5446709811687469,0.5176381886005401,0.41600911021232606,0.8164334654808044,0.7105469107627869,0.04418801888823509,0.603574800491333,0.010780655918642879,0.013572070002555846,0.21097038090229034,0.405409836769104,0.06537662819027901,0.453132301568985,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,8518.0,3490053.0,2486536.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SHR3680,CHEMBL4650276,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H20F3N3O4S/c1-21(2)19(31)27(15-4-3-13(10-26)18(9-15)22(23,24)25)20(33)28(21)14-5-7-17(8-6-14)32-12-16(30)11-29/h3-9,16,29-30H,11-12H2,1-2H3/t16-/m0/s1",KRBMOYIWQCZVHA-INIZCTEOSA-N,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(OC[C@@H](O)CO)cc1,0.6143686608944383,4.0,479.4800000000002,3.225780000000002,6,2,1,97.03000000000002,-5.1175942070702565,0.7303452730178833,-4.949053548909189,0.9901858687400817,-10.391143598917413,0.8282113313674927,0.6762861907482147,0.4521371558308601,86.00110400136637,0.06728380355680912,0.031485518999397756,0.3588591694831848,0.48111305832862855,0.017226978205144405,0.5269968271255493,67.5092681309875,35.70708442065525,24.044498163739696,3.074113165293316,0.2706589728593826,0.5277513265609741,0.0979237798601389,0.8450613617897034,0.8526833057403564,0.024999594874680044,0.015167283639311791,0.053467239066958425,0.013315532123669982,0.015941731072962283,0.40378988087177276,0.07034744992852211,0.008080024365335703,0.06181639842689037,0.7917389273643494,0.3156781792640686,0.15323150977492334,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,8782.0,3461087.0,2464848.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PRUXELUTAMIDE,CHEMBL4594417,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-lutamide,0.0,-lutamide,non-steroid antiandrogens,,0.0,0.0,0.0,"InChI=1S/C24H19F4N5O2S/c1-23(2)21(34)32(17-9-6-14(12-29)19(20(17)25)24(26,27)28)22(36)33(23)16-8-7-15(31-13-16)4-3-5-18-30-10-11-35-18/h6-11,13H,3-5H2,1-2H3",KCBJGVDOSBKVKP-UHFFFAOYSA-N,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2F)C(=S)N1c1ccc(CCCc2ncco2)nc1,0.3285522518056564,2.0,517.5080000000003,5.191180000000005,6,0,0,86.26,-7.126782879255714,0.8369576692581177,-4.851921801187591,0.999673855304718,-7.313002987208835,0.97946218252182,0.8072898268699646,0.7900216579437256,93.27033339346147,3.432597951309977,0.014842033572494983,0.6216175377368927,0.7381910920143128,0.02657577246427536,0.8627578377723694,33.10106650458247,54.86976052393743,61.19485162733589,2.6308021974767195,0.18900964558124542,0.4289857089519501,0.20183984488248824,0.9140906453132629,0.6833401441574096,0.07669960483908653,0.013512406591325998,0.08165871426463127,0.036143766902387145,0.017172268033027648,0.6077134132385253,0.0742313351482153,0.014970616903156042,0.09214191939681768,0.8115995049476623,0.2094208002090454,0.14602501094341278,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,9378.0,3132641.0,1749601.0,Androgen Receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SEVITERONEL,CHEMBL3264610,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C18H17F4N3O3/c1-9(2)18(26,15-8-23-25-24-15)12-4-3-10-6-13(27-16(19)20)14(28-17(21)22)7-11(10)5-12/h3-9,16-17,26H,1-2H3,(H,23,24,25)/t18-/m0/s1",ZBRAJOQFSNYJMF-SFHVURJKSA-N,CC(C)[C@](O)(c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1)c1c[nH]nn1,0.5861475090657895,4.0,399.344,4.052600000000003,5,2,1,80.26,-6.203678583785587,0.9688417434692382,-4.917789842214017,0.999115252494812,-6.892167523430269,0.7813950061798096,0.5147930085659027,0.8014980316162109,99.07376961424137,1.311929135188277,0.665316927433014,0.4846474289894104,0.5906733930110931,0.07207228690385818,0.7224991679191589,12.255075392790328,1.0273318143702526,7.024982958088498,3.2236733147785683,0.4780032753944397,0.6755046725273133,0.4033737391233444,0.8076524257659912,0.783147656917572,0.016403876058757306,0.008755472279153765,0.047018864378333095,0.02086203349754214,0.5075860977172851,0.24398913681507112,0.03133840784430504,0.07315987423062324,0.023442702367901802,0.7288679718971253,0.16284486651420593,0.158527010679245,False
AR_NR3C4,56,SINGLE PROTEIN,Androgen Receptor,9606,Homo sapiens,CHEMBL1871,,0.0,9428.0,3132010.0,212538.0,Androgen Receptor degrader,,DEGRADER,1.0,1.0,1.0,Mode of action: degradation enhancer,,,,DIMETHYLCURCUMIN,CHEMBL128748,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C23H24O6/c1-26-20-11-7-16(13-22(20)28-3)5-9-18(24)15-19(25)10-6-17-8-12-21(27-2)23(14-17)29-4/h5-15,24H,1-4H3/b9-5+,10-6+,18-15-",ZMGUKFHHNQMKJI-CIOHCNBKSA-N,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,0.38325374410825463,4.0,396.4390000000002,4.458600000000003,6,1,0,74.22000000000001,-5.372910842788029,0.7655720353126526,-4.78558716903612,0.9634410977363587,-9.299978095180041,0.8685229897499085,0.9592520117759704,0.3068809360265732,94.10083140749066,-4.573445647428537,0.06158392913639545,0.3293230041861534,0.2824535369873047,0.013867007405497133,0.44578845500946046,-21.640697518955214,43.521038034946166,74.29437362560246,1.7817970509837036,0.3214109390974045,0.2887988701462746,0.0712812103331089,0.9302739977836609,0.6636747181415558,0.06786133348941803,0.04407623847946525,0.09348352029919624,0.04291414432227612,0.45258584022521975,0.17128222733736037,0.08899671286344528,0.19197771400213243,0.3259992688894272,0.4643515169620514,0.2026625692844391,0.4178331971168518,False
AR_NR3C4,10472,SINGLE PROTEIN,Cholecystokinin A receptor,9606,Homo sapiens,CHEMBL1901,,0.0,7800.0,3132473.0,708488.0,Cholecystokinin A receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,CE-326597,CHEMBL1269258,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C37H34N6O2/c1-25(2)41(23-26-13-5-3-6-14-26)34(44)24-42-32-19-11-12-20-33(32)43-35(27-15-7-4-8-16-27)39-40-36(43)30(37(42)45)21-28-22-38-31-18-10-9-17-29(28)31/h3-20,22,25,30,38H,21,23-24H2,1-2H3/t30-/m0/s1",UBNMGTSDHSQBEL-PMERELPUSA-N,CC(C)N(Cc1ccccc1)C(=O)CN1C(=O)[C@@H](Cc2c[nH]c3ccccc23)c2nnc(-c3ccccc3)n2-c2ccccc21,0.21725439663770651,2.0,594.7190000000002,6.525700000000007,5,1,1,87.12,-5.668087694702456,0.681772768497467,-5.2878811475704754,0.9987383723258972,-9.984640178108105,0.858518660068512,0.9833655953407288,0.649207079410553,100.14960405282211,0.6702791852510032,0.13392874449491501,0.9582468152046204,0.9506671667098999,0.302672079205513,0.9758315086364746,92.69902376576108,66.7869087345751,81.54611359635527,3.165285086401147,0.11472144275903702,0.2689242511987686,0.15727110356092452,0.9184365510940552,0.9277382969856263,0.009618549421429635,0.005798038537614047,0.051927196234464644,0.01154871890321374,0.20801791846752166,0.08034436032176018,0.05050334706902504,0.027399298362433912,0.08808533512055874,0.4838575541973114,0.08055542856454849,0.14578638076782227,False
AR_NR3C4,10472,SINGLE PROTEIN,Cholecystokinin A receptor,9606,Homo sapiens,CHEMBL1901,,0.0,8253.0,1705857.0,560084.0,Cholecystokinin A receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,DEXLOXIGLUMIDE,CHEMBL550781,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-glumide,0.0,-glumide,"cholecystokinin (CCK) antagonists, antiulcer, anxiolytic agent",,0.0,0.0,0.0,"InChI=1S/C21H30Cl2N2O5/c1-3-4-5-11-25(12-6-13-30-2)21(29)18(9-10-19(26)27)24-20(28)15-7-8-16(22)17(23)14-15/h7-8,14,18H,3-6,9-13H2,1-2H3,(H,24,28)(H,26,27)/t18-/m1/s1",QNQZBKQEIFTHFZ-GOSISDBHSA-N,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1,0.4084054154434649,4.0,461.3860000000001,4.0119000000000025,4,2,1,95.94,-3.299995636564739,0.7469790816307068,-5.359959152673916,0.8415203332901001,-9.548081080897262,0.605722290277481,0.5012647867202759,0.672574645280838,85.86986024028914,-0.6379467254838624,0.11362915262579917,0.2819507703185081,0.29665452241897583,0.24588971585035324,0.7207319855690002,10.61105929036572,58.17692913374685,32.61348750611676,2.457442292635532,0.30013764798641207,0.2287846103310585,0.3522997826337814,0.41675732135772703,0.4104093074798584,0.02399850804358721,0.0211713258177042,0.10561671406030655,0.0844906136393547,0.04501169286668301,0.07265343964099884,0.14011193662881852,0.01814176756888628,0.08388100266456604,0.031923805549740794,0.07968198917806149,0.49003828763961793,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5004.0,2472964.0,298316.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SPARSENTAN,CHEMBL539423,4.0,1.0,1.0,MOL,,Small molecule,2023.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2014.0,1.0,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35)",WRFHGDPIDHPWIQ-UHFFFAOYSA-N,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1,0.2554754512604677,2.0,592.7620000000001,6.539440000000007,7,1,0,114.10000000000001,-4.35748291955249,0.9113606214523315,-5.360040773736932,0.9999411702156067,-8.201303927444624,0.9504558205604553,0.9904717326164245,0.8542673826217652,100.62097778747366,4.308588940829222,0.08351365439593791,0.8828395962715149,0.9584898471832275,0.1850638210773468,0.9873576164245605,101.78080278711997,21.46013189496375,55.837315503698264,3.275139324177058,0.15931472778320313,0.3953406274318695,0.20129778385162353,0.8945117115974426,0.8595880627632141,0.02375337891280651,0.00599043999100104,0.05312820002436638,0.00671259704977274,0.011116054374724627,0.06805233731865883,0.08369044438004494,0.022971584647893905,0.058062129840254786,0.6237246274948121,0.03780841715633869,0.11223846301436424,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5059.0,1705959.0,1380030.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NEBENTAN,CHEMBL2107760,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C24H21N5O5S/c1-32-18-11-6-7-12-19(18)34-20-21(29-35(30,31)16-13-17-9-4-3-5-10-17)27-23(28-24(20)33-2)22-25-14-8-15-26-22/h3-16H,1-2H3,(H,27,28,29)/b16-13+",LONWRQOYFPYMQD-DTQAZKPQSA-N,COc1ccccc1Oc1c(NS(=O)(=O)/C=C/c2ccccc2)nc(-c2ncccn2)nc1OC,0.3672767783081491,4.0,491.52900000000017,4.155700000000002,9,1,0,125.42,-5.644615636081776,0.8650074362754822,-5.087180088504175,0.9991584658622742,-8.802585734731393,0.9372002363204956,0.842982828617096,0.6303913414478302,102.72586770817966,-5.185904138369613,0.5131492435932159,0.8200171113014221,0.9323805928230285,0.0873697880655527,0.9307583689689636,-21.953662639164634,49.13437953598846,47.05521987969246,2.068719826132022,0.09124976098537445,0.20625298619270324,0.12809486016631128,0.9935168504714966,0.8993717432022095,0.029143275879323482,0.006060800515115261,0.04592772871255875,0.011017584661021828,0.30009702444076536,0.13718218952417374,0.15203865244984627,0.08201620616018772,0.09390625804662704,0.5924499988555908,0.11732141971588135,0.19560586810112,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5073.0,1702466.0,179627.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ENRASENTAN,CHEMBL431651,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C29H30O8/c1-3-11-34-19-6-7-20-22(14-19)27(21-8-5-18(33-2)15-24(21)35-12-10-30)28(29(31)32)26(20)17-4-9-23-25(13-17)37-16-36-23/h4-9,13-15,26-28,30H,3,10-12,16H2,1-2H3,(H,31,32)/t26-,27+,28+/m0/s1",GLCKXJLCYIJMRB-UPRLRBBYSA-N,CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCCO)[C@H](C(=O)O)[C@H]2c1ccc2c(c1)OCO2,0.412513175538999,3.0,506.55100000000033,4.562000000000003,7,2,3,103.68000000000002,-5.048006155743859,0.9161875605583191,-5.54350495794921,0.99563649892807,-8.311948049677957,0.5694417953491211,0.7488335490226745,0.31806255877017975,84.7609202803826,3.5439927152661914,0.17215976640582084,0.43300036787986756,0.7527400255203247,0.04205656554549932,0.7663018584251404,19.77277912315906,19.054621041961774,28.452407774062248,3.4729205504654046,0.036917215958237645,0.11977322399616241,0.09589432924985886,0.9144480586051941,0.6176494121551513,0.04938338790088892,0.010526971239596606,0.056937634199857715,0.016147357411682606,0.3900717914104462,0.13102814555168152,0.1734500229358673,0.023380444198846818,0.054637427628040316,0.45995512008666994,0.10647902116179467,0.07687716111540795,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5344.0,1699819.0,1051539.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ZIBOTENTAN,CHEMBL1628688,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2008.0,,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C19H16N6O4S/c1-12-10-21-17(19(23-12)28-2)25-30(26,27)15-4-3-9-20-16(15)13-5-7-14(8-6-13)18-24-22-11-29-18/h3-11H,1-2H3,(H,21,25)",FJHHZXWJVIEFGJ-UHFFFAOYSA-N,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1,0.49569447714738857,4.0,424.4420000000002,2.7064200000000014,9,1,0,132.99,-3.883916914120854,0.9498200654983521,-5.0946962995822975,0.994007921218872,-10.552328248003317,0.8774271368980407,0.32376893907785415,0.39891497492790223,98.39496429297354,-4.131618247165135,0.08558571711182594,0.17572211027145385,0.5104618489742279,0.021819372102618216,0.620311838388443,-0.12653589352362396,27.953619825946458,17.793706872167018,2.2844283024170804,0.09430608078837395,0.39597546607255935,0.28606935739517214,0.9912227392196655,0.405989933013916,0.033513162098824975,0.011294499970972538,0.042033172026276586,0.0065335278864949945,0.044823264703154564,0.01969888242892921,0.028330664662644268,0.011183846183121205,0.01049115564674139,0.04639781638979912,0.04246517531573772,0.12243658527731896,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5385.0,1703726.0,1378338.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,ATRASENTAN HYDROCHLORIDE,CHEMBL2106068,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2000.0,,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C29H38N2O6.ClH/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20;/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34);1H/t23-,27-,28+;/m1./s1",IJFUJIFSUKPWCZ-SQMFDTLJSA-N,CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1.Cl,0.39523921923713323,2.0,547.0920000000003,5.1158000000000055,6,1,3,88.54,-3.749332500774524,0.8621459126472473,-5.398565396816561,0.9834742903709411,-7.606097335953885,0.6315667688846588,0.7812073349952697,0.6220861315727234,94.90592351943471,-1.8599781582433377,0.23895969986915588,0.5740946054458618,0.6868589162826538,0.5252394556999207,0.9769057154655456,27.228965520578782,19.304396642132122,56.08297072259309,3.070960737520513,0.1267589509487152,0.08712681904435157,0.331532871723175,0.7351223707199097,0.5720371782779694,0.027787281759083272,0.010092097520828246,0.07774863392114639,0.022352743707597256,0.14690597504377365,0.03253604844212532,0.10262949764728546,0.023069221712648868,0.05390699654817581,0.06880059465765953,0.05966238044202328,0.21161196529865264,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5392.0,1699537.0,94071.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,Discontinueddue to lack of clinical benefit.,,,,TEZOSENTAN,CHEMBL61780,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C27H27N9O6S/c1-16(2)18-8-9-22(29-15-18)43(38,39)34-26-23(42-21-7-5-4-6-20(21)40-3)27(41-13-12-37)31-24(30-26)17-10-11-28-19(14-17)25-32-35-36-33-25/h4-11,14-16,37H,12-13H2,1-3H3,(H,30,31,34)(H,32,33,35,36)",TUYWTLTWNJOZNY-UHFFFAOYSA-N,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nnn[nH]3)c2)nc1OCCO,0.18733130978175302,2.0,605.6370000000001,3.2099000000000015,13,3,0,200.10999999999996,-4.233002746632873,0.823559308052063,-5.716303963516487,0.9994872689247132,-12.141718722932243,0.8558299541473389,0.7288193106651306,0.19779613614082336,100.98591644990681,2.4496261501215066,0.31012142039835455,0.893655800819397,0.9571060061454773,0.09425030145794153,0.9304099202156066,-3.662146039117238,24.19152608545551,50.2107449113852,2.1038925998314153,0.04363646656274796,0.30859633907675743,0.15300665348768233,0.9860774397850036,0.8250132322311401,0.009052239079028367,0.0033790151996072383,0.014669175632297993,0.002470272872596979,0.0772156722843647,0.048554133623838425,0.08332521095871925,0.005818011960946024,0.015453530615195632,0.38691371083259585,0.05502710565924644,0.08215263225138188,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5396.0,1706096.0,2197705.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,Ph 3 trial Discontinueddue to adverse effects.,,,,AVOSENTAN,CHEMBL3989834,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C23H21N5O5S/c1-15-8-9-19(25-14-15)34(29,30)28-22-20(33-18-7-5-4-6-17(18)31-2)23(32-3)27-21(26-22)16-10-12-24-13-11-16/h4-14H,1-3H3,(H,26,27,28)",YBWLTKFZAOSWSM-UHFFFAOYSA-N,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccncc2)nc1OC,0.4008984378028223,4.0,479.5180000000002,3.8523200000000015,9,1,0,125.42,-4.82532569020378,0.9238285422325134,-5.081649469422418,0.999874722957611,-8.957711182505443,0.9758480668067933,0.678066611289978,0.5598837256431579,98.61516410229356,-2.8134149429970963,0.5722472369670868,0.8932868480682373,0.9531097173690796,0.15063108652830123,0.992145836353302,12.042479459056816,53.73010248520789,52.97295264775079,1.9693836561290645,0.0466638658195734,0.22454360723495484,0.18725601434707642,0.9890847563743591,0.9015310883522034,0.014668941963464022,0.004243103205226362,0.01771899573504925,0.0034608159388881178,0.20846906304359436,0.09246639758348466,0.059341130405664445,0.007076604315079749,0.02121911309659481,0.330989146232605,0.022881514206528664,0.10830641239881515,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5399.0,1706026.0,182389.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,Phase 3 study terminated due to lack of efficacy,,,,CLAZOSENTAN,CHEMBL109648,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C25H23N9O6S/c1-15-7-8-20(27-14-15)41(36,37)32-24-21(40-19-6-4-3-5-18(19)38-2)25(39-12-11-35)29-22(28-24)16-9-10-26-17(13-16)23-30-33-34-31-23/h3-10,13-14,35H,11-12H2,1-2H3,(H,28,29,32)(H,30,31,33,34)",LFWCJABOXHSRGC-UHFFFAOYSA-N,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccnc(-c3nnn[nH]3)c2)nc1OCCO,0.2067680705746985,2.0,577.5830000000001,2.3949200000000004,13,3,0,200.10999999999996,-3.8232296327070094,0.8465425968170166,-5.847401908271986,0.9993992686271668,-12.114634170653398,0.8136266231536865,0.7143685698509217,0.2241465926170349,97.11520068564877,0.054848466094975734,0.2765739895403385,0.7785571098327637,0.9077428460121155,0.0815998962149024,0.9373103380203247,-2.0723429862196383,23.84438844954584,39.728945259997055,1.9084393092965737,0.04138360433280468,0.32792493999004363,0.20430499613285064,0.9889879941940307,0.864574420452118,0.0077217014506459234,0.003173206280916929,0.013100891187787057,0.0017018693615682423,0.07167475931346416,0.024499014485627413,0.07042562048882246,0.004902509716339409,0.009831453277729451,0.2685271978378296,0.03944531194865704,0.07777289561927318,False
AR_NR3C4,249,SINGLE PROTEIN,Endothelin receptor ET-A,9606,Homo sapiens,CHEMBL252,,0.0,5403.0,1700631.0,30255.0,Endothelin receptor ET-A antagonist,,ANTAGONIST,1.0,1.0,1.0,Discontinued failed to meet primary endpoints in phase 3 study,,,,DARUSENTAN,CHEMBL23261,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-entan,0.0,-entan,endothelin receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",FEJVSJIALLTFRP-LJQANCHMSA-N,COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1,0.5747972752011099,4.0,410.42600000000004,2.9160000000000013,7,1,1,100.0,-3.704355175134477,0.9475160598754883,-5.141812264505801,0.9800787925720215,-8.522362794201806,0.615948212146759,0.09160519065335393,0.6264661371707916,95.27661849230716,5.307466974991805,0.012217700574547052,0.1716788411140442,0.31915411353111267,0.006889667247014586,0.11003287676721811,-41.19661824793284,28.330814181623975,22.911642600919926,2.4275712832557232,0.017885890509933233,0.1372857630252838,0.05639717467129231,0.9551129937171936,0.08607297092676162,0.010830515716224908,0.0017568985233083368,0.02863150555640459,0.007838041661307216,0.09302629083395005,0.04321887828409672,0.051783645153045656,0.003268272988498211,0.00397812775336206,0.01080728368833661,0.006786308949813247,0.07174893245100974,False
AR_NR3C4,121113,SINGLE PROTEIN,Androgen receptor,9615,Canis lupus familiaris,CHEMBL5303557,,0.0,9712.0,3956718.0,2832710.0,Androgen receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Approved veterinary,,,,OSATERONE ACETATE,CHEMBL5315059,-1.0,0.0,0.0,MOL,,Small molecule,2007.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,-terone,0.0,-terone,antiandrogens,,0.0,0.0,0.0,"InChI=1S/C22H27ClO5/c1-12(24)22(28-13(2)25)8-6-16-14-9-18(23)17-10-19(26)27-11-20(17,3)15(14)5-7-21(16,22)4/h9-10,14-16H,5-8,11H2,1-4H3/t14-,15+,16+,20-,21+,22+/m1/s1",KKTIOMQDFOYCEN-OFUYBIASSA-N,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)OC[C@]4(C)[C@H]3CC[C@@]21C,0.6492840414760506,4.0,406.9060000000003,3.9456000000000033,5,0,6,69.67,-5.031313228056259,0.7873267412185669,-4.533910398461147,0.999869990348816,-4.488652430258357,0.9654912233352662,0.5851910829544067,0.8931371808052063,89.12297909674062,0.7290471550870046,0.011720815917942672,0.22875430881977082,0.18149521797895432,0.04611673280596733,0.5723049700260162,7.279378483338993,87.30500044876592,31.86666874298428,2.948353787144805,0.19431352913379668,0.07877239952795208,0.06974522024393082,0.39611140787601473,0.15544930547475816,0.7675102472305297,0.6967646718025208,0.4142919361591339,0.16227558255195618,0.005363765242509544,0.471511697769165,0.050982480868697166,0.04433980099856853,0.09400283321738243,0.5650561511516571,0.2779402121901512,0.568198898434639,False
CHK2,10531,SINGLE PROTEIN,Serine/threonine-protein kinase Chk2,9606,Homo sapiens,CHEMBL2527,,0.0,5855.0,2472675.0,1926760.0,Serine/threonine-protein kinase Chk2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Selective ATP competitor inhibitor of Chk1 and Chk2 proteins,,,,PREXASERTIB,CHEMBL3544911,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2015.0,,-sertib,0.0,-sertib,serine/threonine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)",DOTGPNHGTYJDEP-UHFFFAOYSA-N,COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1,0.5171794586160352,4.0,365.397,2.2181799999999994,8,3,0,134.76,-3.566988007772166,0.9053386092185974,-5.622889191518443,0.9993759512901306,-12.361750045585994,0.827171242237091,0.5235628426074982,0.518878161907196,83.592507367026,2.2907008024901967,0.820256507396698,0.4463799148797989,0.35874013900756835,0.2495751529932022,0.8999957203865051,-5.0350067883244325,34.813570772846745,6.103290232504206,2.404877226284716,0.6683929920196533,0.19866840094327926,0.4785038113594055,0.8695914030075074,0.9478855729103088,0.02969808131456375,0.014761605486273765,0.049699464812874794,0.05463121794164181,0.8824618935585022,0.37101773023605344,0.034023897536098954,0.46925129294395446,0.06282184720039367,0.4363303929567337,0.4811883807182312,0.2670251548290253,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,936.0,1435100.0,1158402.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RUXOLITINIB PHOSPHATE,CHEMBL1795071,4.0,1.0,1.0,MOL,66917.0,Small molecule,2011.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,2010.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C17H18N6.H3O4P/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16;1-5(2,3)4/h6,8-12,15H,1-5H2,(H,19,20,21);(H3,1,2,3,4)/t15-;/m1./s1",JFMWPOCYMYGEDM-XFULWGLBSA-N,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O,0.4823742806551247,4.0,404.3670000000001,2.537780000000001,6,4,1,160.94,-2.5976105668198017,0.6882855296134949,-5.762469962362641,0.7271401047706604,-12.573043572086327,0.1068066868931055,0.05748382247984409,0.5719574630260468,85.8088696740627,-1.5367519847829079,0.09314085766673089,0.11586808990687132,0.10325677394866943,0.2681293934583664,0.16279172897338867,38.97833886564722,-0.1936859210042563,-13.293169573301153,2.8695374978368426,0.05871775858104229,0.08494552597403526,0.8240230083465576,0.7254113674163818,0.32970926761627195,0.011940088402479888,0.006217639148235321,0.12955704629421233,0.07024600580334664,0.1375362418591976,0.02609342816285789,0.0026038557567517272,0.025857408181764185,0.008771091781090945,0.05698447139002383,0.1114647202193737,0.078392668440938,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4099.0,2473335.0,1927090.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AC-430,CHEMBL3545241,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H16FN5O/c1-11-10-16(25-24-11)22-18-14-4-2-3-5-15(14)21-19(23-18)17(26)12-6-8-13(20)9-7-12/h2-10,17,26H,1H3,(H2,21,22,23,24,25)",DCRWIATZWHLIPN-UHFFFAOYSA-N,Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1,0.5237094076283522,4.0,349.3690000000001,3.625720000000001,5,3,1,86.72,-4.141734499024291,0.953804075717926,-5.6118977834881605,0.9999462246894837,-12.691236560162583,0.9001214027404785,0.714369386434555,0.7112130045890808,99.61429292598183,18.061904062389903,0.8343853116035461,0.904331374168396,0.7267937421798706,0.2350062310695648,0.8770131826400757,75.56707166327003,19.49374785248266,29.968123818044454,2.9885010813692574,0.1633628100156784,0.25103671103715897,0.28284873962402346,0.948141348361969,0.8729519367218017,0.036357158049941066,0.012833119952119887,0.11204971000552177,0.016056756768375636,0.7199156880378723,0.41782158613204956,0.04770773351192474,0.11009435430169105,0.027873897366225718,0.7255038380622864,0.14846357107162475,0.1331106424331665,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4262.0,2472847.0,2739454.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LS-104,CHEMBL5095023,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C19H16N2O3/c20-12-16(19(24)21-13-15-5-2-1-3-6-15)8-4-7-14-9-10-17(22)18(23)11-14/h1-11,22-23H,13H2,(H,21,24)/b7-4+,16-8+",DTCCYSMPUUYHOF-LHQXNBGVSA-N,N#C/C(=C\C=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,0.34165816135300386,4.0,320.34799999999996,2.8773800000000014,4,3,0,93.35,-4.369728035113779,0.5915473937988281,-5.165874113234116,0.9991905808448791,-11.845071917255098,0.8748955368995667,0.236573988199234,0.23974283039569855,93.63175744169025,-8.498586700283628,0.7967180609703064,0.5224586725234985,0.4988552391529083,0.17455363273620605,0.9216626167297364,-23.77460123803113,102.91434252669838,59.93509347201793,2.693384867476984,0.5380592674016953,0.30706228613853453,0.029139801487326623,0.8266859292984009,0.5840425968170166,0.02232624888420105,0.030135722272098063,0.3653842628002167,0.3191677153110504,0.2908046007156372,0.2975122511386871,0.17757384479045868,0.2312566675245762,0.5487036526203155,0.9010097026824951,0.3055606335401535,0.9226813793182373,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4416.0,2473574.0,1927177.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,XL-019,CHEMBL3545328,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C25H28N6O2/c32-24(23-2-1-12-26-23)28-19-5-3-18(4-6-19)22-11-13-27-25(30-22)29-20-7-9-21(10-8-20)31-14-16-33-17-15-31/h3-11,13,23,26H,1-2,12,14-17H2,(H,28,32)(H,27,29,30)",ISOCDPQFIXDIMS-UHFFFAOYSA-N,O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1,0.5366372298871934,4.0,444.53900000000027,3.4143000000000017,7,3,1,91.41000000000001,-3.54166813187976,0.7505491971969604,-4.971228432745339,0.9474029183387757,-12.426769928429316,0.6868497729301453,0.4204615533351898,0.3687128484249115,91.55057185207673,1.254980069365999,0.15695313438773156,0.2500904887914658,0.18171122074127197,0.07414687611162663,0.42932175993919375,18.60039483970816,14.41234267429922,25.300046887343008,2.6390038633139703,0.3197472274303436,0.20735033005475997,0.3867552191019058,0.9625831723213196,0.7793409109115601,0.042237546667456626,0.03909617401659489,0.1650483101606369,0.08776429146528245,0.5197998821735382,0.29166660010814666,0.0744551133364439,0.2589322865009308,0.2769348084926605,0.61188103556633,0.7158312201499939,0.29779766499996185,True
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4641.0,2473709.0,693474.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,Also potent inhibitor of JAK1,,,,AZD-1480,CHEMBL1231124,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C14H14ClFN8/c1-7-3-11(24-23-7)21-13-10(15)6-19-14(22-13)20-8(2)12-17-4-9(16)5-18-12/h3-6,8H,1-2H3,(H3,19,20,21,22,23,24)/t8-/m0/s1",PDOQBOJDRPLBQU-QMMMGPOBSA-N,Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1,0.6505657114536998,4.0,348.7730000000001,3.00732,7,3,1,104.3,-3.7975050440111415,0.9782253980636597,-5.50187818900249,0.999541974067688,-11.92525742942478,0.8547272920608521,0.03671710900962353,0.47782731652259824,82.44339689941057,23.62997467403445,0.2745424747467041,0.29102866649627684,0.1288633868098259,0.0199622574262321,0.7970150709152222,55.11458451017171,24.073770730428443,32.86289558675545,2.6390753581068926,0.09449260756373405,0.12843840271234513,0.19255068935453892,0.9812989473342896,0.21835468709468842,0.012483556615188717,0.0038995979353785514,0.046713436022400856,0.024072452541440727,0.5300796508789063,0.13358604311943054,0.0065132963703945276,0.05305692497640848,0.016637623612768947,0.0748767264187336,0.07804453186690807,0.2390010565519333,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4678.0,2473291.0,1927064.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BMS-911543,CHEMBL3545215,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,1.0,0.0,"InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)",JCINBYQJBYJGDM-UHFFFAOYSA-N,CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21,0.5040438668001951,4.0,432.53200000000015,3.495420000000002,8,1,0,85.8,-4.276325153907999,0.8512105703353882,-5.037041876908914,0.9995976090431213,-9.508273135553832,0.9711363911628723,0.7785762429237366,0.8645448207855224,80.05420690367187,9.943644734561506,0.1540850203484297,0.18003393858671188,0.37355670630931853,0.06255868896842003,0.6381904006004333,99.22739324259001,16.378792314809083,46.61861799108991,3.2789947625331606,0.5883338749408722,0.1870581865310669,0.4320610582828522,0.8870908737182617,0.8924750447273254,0.050087086483836175,0.05023017302155495,0.09394466280937194,0.026414339430630207,0.21193170994520188,0.33748741149902345,0.02400614470243454,0.3319419264793396,0.0883511759340763,0.36518078446388247,0.27746746242046355,0.22978911846876143,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4757.0,1706449.0,1380093.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GANDOTINIB,CHEMBL2107823,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2012.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,1.0,0.0,"InChI=1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,11-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30)",SQSZANZGUXWJEA-UHFFFAOYSA-N,Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1,0.44338437692174615,4.0,469.95200000000006,4.028340000000003,7,2,0,83.37,-4.011373400922535,0.8605239868164063,-5.240145696663083,0.9995553851127624,-10.757183164240496,0.8839119076728821,0.9396944165229797,0.7608947157859802,92.06550235870404,12.657324756256816,0.20560289472341536,0.9115553259849548,0.8686758279800415,0.5288898110389709,0.980930757522583,30.57603187516912,21.257269131486634,36.77377412582576,2.836871710159619,0.17972896695137025,0.20782980769872667,0.6191828727722168,0.8344316482543945,0.9515151143074035,0.010183296538889408,0.0037258654367178677,0.07991061359643936,0.023376244679093362,0.4852535128593445,0.20789741575717927,0.023897786065936087,0.045683739334344865,0.10498058944940566,0.4111178904771805,0.14249175637960435,0.23090880811214448,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,4775.0,2473295.0,2341260.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NS-018,CHEMBL4303389,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1",UQTPDWDAYHAZNT-AWEZNQCLSA-N,C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1,0.5109555440748396,4.0,389.43800000000005,4.327900000000002,7,2,1,80.55,-4.736277916091389,0.9700181603431701,-5.365192908575983,0.9985170364379883,-9.804734610362143,0.8899269700050354,0.525335031747818,0.4602066814899445,95.50547137912261,2.07790957663031,0.5345860719680786,0.4224392235279083,0.2390281930565834,0.20842258334159852,0.8973433136940002,68.99872126780421,24.50820764977177,33.18042245062831,2.472921404367024,0.31197903156280515,0.5075849652290344,0.598551344871521,0.9012226700782776,0.8885441064834595,0.06458352245390415,0.026250273268669844,0.098125521838665,0.034192873537540434,0.44390398263931274,0.34297928512096404,0.041608734522014856,0.1606813956052065,0.048377945087850094,0.35600249469280243,0.14356580786406994,0.14068089053034782,False
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,5281.0,1699900.0,617563.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MOMELOTINIB,CHEMBL1078178,4.0,1.0,0.0,MOL,,Small molecule,2023.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2011.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28)",ZVHNDZWQTBEVRY-UHFFFAOYSA-N,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,0.597823059764905,4.0,414.4690000000002,2.9771800000000015,7,2,0,103.17,-4.870475134679362,0.8897497892379761,-5.086967806580899,0.9801514744758606,-13.386231243988746,0.8266780853271485,0.2923664957284927,0.3849947154521942,92.50377508803567,0.729431607280406,0.1912688747048378,0.08616815954446792,0.13020028546452522,0.034763241186738014,0.4187107980251312,16.19043690337475,52.76470499552547,43.17037182906788,2.3006056632491485,0.4946321308612823,0.28126309663057325,0.45961983501911163,0.9797461867332459,0.8967548847198487,0.044534496031701565,0.05904775187373161,0.1105068489909172,0.048468951135873795,0.4584068417549133,0.3263876140117645,0.03376528359949589,0.1920153468847275,0.06239367760717869,0.7222972750663758,0.6821090459823609,0.22301090881228447,True
JAK2,10938,SINGLE PROTEIN,Tyrosine-protein kinase JAK2,9606,Homo sapiens,CHEMBL2971,,0.0,5294.0,1702681.0,1378029.0,Tyrosine-protein kinase JAK2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BARICITINIB,CHEMBL2105759,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2011.0,1.0,-tinib,0.0,-tinib (-citinib),tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)",XUZMWHLSFXCVMG-UHFFFAOYSA-N,CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,0.7167032115900049,4.0,371.4260000000001,1.09568,7,1,0,120.55999999999999,-4.076799473533431,0.7604209542274475,-5.432460781295346,0.9985719799995423,-14.189820760601009,0.7801384687423706,0.01713214097544551,0.5382316052913666,85.7331581840647,-5.8912202742822775,0.14032925367355348,0.053991655632853505,0.056571411713957784,0.012674746848642827,0.4430229961872101,-50.875564325428726,49.773907709585174,39.975594719618435,3.002183837583837,0.27072243243455885,0.067228739336133,0.4945594370365143,0.8939917325973511,0.6371939301490783,0.01329412218183279,0.02378880362957716,0.048569381982088086,0.04689081758260727,0.06780587173998356,0.17357639074325562,0.006589429080486297,0.011600924981757998,0.011457821493968368,0.018537225387990474,0.09115357920527459,0.3897071212530136,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,446.0,1344476.0,361469.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DASATINIB,CHEMBL1421,4.0,1.0,1.0,MOL,49375.0,Small molecule,2006.0,1.0,0.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,2005.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)",ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,0.4657173060978848,4.0,488.01700000000034,3.3135400000000015,9,3,0,106.50999999999999,-3.2560128542207245,0.7098861634731293,-5.458676746167045,0.9958778858184815,-11.50278261887888,0.8266928195953369,0.9337372660636902,0.4926722526550293,98.96702282987965,15.555400196682566,0.1214497596025467,0.4614856481552124,0.2785066783428192,0.19786253869533538,0.5118308424949646,73.25830890436546,14.26783304753556,48.68828630393347,2.5962232191222014,0.37584269642829893,0.30062703788280487,0.7534064173698425,0.894129478931427,0.9331321597099305,0.019206582568585873,0.01194582637399435,0.05718080028891563,0.01027284674346447,0.43127709031105044,0.0943487673997879,0.020524937473237515,0.01778378151357174,0.06621035411953927,0.45765483379364014,0.10287871062755585,0.34895710945129393,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,447.0,1344456.0,675684.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PAZOPANIB HYDROCHLORIDE,CHEMBL1201733,4.0,1.0,1.0,MOL,71217.0,Small molecule,2009.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2005.0,1.0,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H",MQHIQUBXFFAOMK-UHFFFAOYSA-N,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl,0.454380229952716,4.0,473.9900000000002,3.560840000000001,8,2,0,119.03,-1.9021037866294435,0.9389209508895874,-5.694571298953576,0.996160340309143,-10.87309295979654,0.8343236804008484,0.4334856182336807,0.6470058560371399,95.27603829337252,-8.884982449405197,0.6355791509151458,0.30345010459423066,0.19791695922613145,0.4330443739891052,0.8642626762390136,62.01019758068035,29.31106169934453,51.41611429047917,2.3018489145746774,0.2372928589582443,0.6170671880245209,0.4964186489582062,0.9530220746994018,0.8424562215805054,0.07662767916917801,0.07997342422604561,0.09379372149705886,0.021601230651140214,0.2672311544418335,0.08950959369540215,0.013133990950882435,0.042294909432530406,0.01194777451455593,0.18385165929794312,0.1127654567360878,0.06032003909349441,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,451.0,1343743.0,485100.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IMATINIB MESYLATE,CHEMBL1642,4.0,1.0,1.0,MOL,31690.0,Small molecule,2001.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)",YLMAHDNUQAMNNX-UHFFFAOYSA-N,CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,0.2699949784744892,3.0,589.7220000000003,4.094320000000002,9,3,0,140.64999999999998,-2.7055692369789575,0.7916144728660583,-5.296987609282586,0.9489835143089295,-12.142460669189507,0.7414408922195435,0.5961130410432816,0.5392262935638428,84.92942318040654,2.921220501263894,0.09733658656477928,0.19235373735427858,0.19952369928359986,0.30618946850299833,0.6587069928646088,115.8103542202211,-7.624489703303932,11.038611875161624,2.5102466359212396,0.2691380500793457,0.5901945948600769,0.9135952353477478,0.9250534892082214,0.9393022537231446,0.01591054638847709,0.007211437821388245,0.03813269585371017,0.012077710777521133,0.14104679375886917,0.035139020532369614,0.009255564608611166,0.012330597126856446,0.026208662427961826,0.22861369401216508,0.13026877790689467,0.16875803023576735,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4299.0,2473688.0,1037721.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,OSI-930,CHEMBL1614710,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C22H16F3N3O2S/c23-22(24,25)30-16-7-5-15(6-8-16)28-21(29)20-19(10-12-31-20)27-13-14-9-11-26-18-4-2-1-3-17(14)18/h1-12,27H,13H2,(H,28,29)",FGTCROZDHDSNIO-UHFFFAOYSA-N,O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12,0.38031167208159433,3.0,443.4500000000001,6.059300000000004,5,2,0,63.25,-6.230399345807781,0.8619761109352112,-5.194944077010198,0.9994755268096924,-9.359950278998515,0.8159533500671386,0.8666692972183228,0.8112393021583557,107.2063167272058,-6.011266970284945,0.8162561178207397,0.9573269724845886,0.8385048031806945,0.39150039553642274,0.7792103052139282,79.70701813582318,68.14437392609874,56.337535423094074,3.444775603526164,0.6641990780830384,0.5101168155670166,0.23299654126167296,0.9243667006492615,0.842025876045227,0.014663121476769448,0.010482267756015063,0.22114437222480773,0.02684747576713562,0.7049351096153259,0.3060418576002121,0.1850801080465317,0.08096707239747047,0.3868969976902008,0.90401531457901,0.5060558021068573,0.3413249969482422,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4619.0,2472876.0,2341072.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,Multi-targeted receptor tyrosine kinase inhibitor,,,,CATEQUENTINIB,CHEMBL4303201,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2022.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3",KSMZEXLVHXZPEF-UHFFFAOYSA-N,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,0.47816600016000094,4.0,407.4450000000002,4.834620000000004,5,2,0,82.39,-4.777130990137668,0.9815168142318725,-4.867756701863476,0.9998850584030151,-11.056405127395534,0.9051691174507142,0.8086488962173461,0.8827885150909424,91.96792499041669,3.0701712419117473,0.8326576828956604,0.2592393755912781,0.18123842924833297,0.3138849064707756,0.9449241399765015,19.118810801012735,22.284136383746052,8.161164058131783,3.5968793271699737,0.7446903467178345,0.2043782189488411,0.6772618055343628,0.7337378978729248,0.9375517725944519,0.046879729628562926,0.07375508099794388,0.10716975182294845,0.05627622492611408,0.7748364329338073,0.27240829169750214,0.03736701421439648,0.49536659717559817,0.06773628294467926,0.5516412138938904,0.38190885484218595,0.12050388157367706,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,4655.0,2473710.0,1363819.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TELATINIB,CHEMBL2079588,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)",QFCXANHHBCGMAS-UHFFFAOYSA-N,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,0.49660282011600054,4.0,409.83300000000014,3.953400000000002,7,2,0,102.17,-5.479043148938203,0.9327312231063842,-5.179995645906142,0.9995655059814453,-12.111416210555785,0.9301985383033753,0.653198528289795,0.5553459227085114,100.69362871498144,7.911182588521579,0.6869791388511658,0.6569333076477051,0.5790437817573547,0.3479802429676056,0.7780659675598145,133.08731744574575,57.58331923018672,35.26765714237378,2.45024715665501,0.4074749857187271,0.2849829882383347,0.2940918207168579,0.9758264541625976,0.6902809739112854,0.01675761677324772,0.008212226745672523,0.1082769513130188,0.01188718741759658,0.7026602506637574,0.1390934482216835,0.059798643738031385,0.09175880402326583,0.11608605310320855,0.41299371123313905,0.20054867565631868,0.26667929738759993,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,5242.0,2472757.0,1248752.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,"Approved veterinary - 2012. Not recommended for approval (Negative opinion) in EU, phase 3 trials in US.",,,,MASITINIB,CHEMBL1908391,4.0,1.0,0.0,MOL,63450.0,Small molecule,2008.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,,-1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)",WJEOLQLKVOPQFV-UHFFFAOYSA-N,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,0.3622966712802839,3.0,498.6560000000002,5.256820000000005,7,2,0,73.39000000000001,-3.5317605047205283,0.7822469711303711,-5.299111458519047,0.9933438181877137,-11.378876808665153,0.7649243116378784,0.9191733241081238,0.596434223651886,94.6659607648893,10.979317743143294,0.25903968811035155,0.5143114864826203,0.3831844747066498,0.5036621630191803,0.9140794038772583,83.28721587069822,6.3351616941751505,14.697053779488034,1.818408540676327,0.3100746989250183,0.5693534433841705,0.8507622241973877,0.907576858997345,0.9502742767333985,0.012379834428429604,0.015127675235271454,0.05720562860369682,0.01452841330319643,0.3786603271961212,0.12665827423334122,0.039097191952168944,0.022928128391504286,0.12015553936362267,0.38642155230045316,0.09145976454019547,0.37001532316207886,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,5257.0,1705219.0,456867.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,CEDIRANIB,CHEMBL491473,3.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2007.0,,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3",XXJWYDDUDKYVKI-UHFFFAOYSA-N,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,0.37102530780077236,3.0,450.51400000000035,5.224220000000004,6,1,0,72.5,-4.734554297990736,0.9193935036659241,-4.9644432012113135,0.9990997791290284,-9.523493019055518,0.918368661403656,0.8617622375488281,0.8857370734214782,92.94243813260358,8.615455491667145,0.37354888021945953,0.09350196868181229,0.041644617542624475,0.37696977853775027,0.8959109663963318,-19.588054398426188,57.00431999830054,51.997404405599454,3.472400200409962,0.5641542673110962,0.17070166766643524,0.7938210725784302,0.7518107771873475,0.9712849974632263,0.06010580733418465,0.027433827891945838,0.06916026547551155,0.04074871223419905,0.6574104070663452,0.17461022287607192,0.009343812568113207,0.18536343574523925,0.03444435335695743,0.24610597789287567,0.22045868039131164,0.14522862285375596,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,5319.0,1706190.0,165012.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VATALANIB,CHEMBL101253,3.0,0.0,0.0,MOL,90620.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2004.0,,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)",YCOYDOIWSSHVCK-UHFFFAOYSA-N,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,0.5638252652189537,3.0,346.8210000000001,5.012600000000003,4,1,0,50.7,-5.282348854893153,0.9150380730628968,-5.067562778231816,0.9999826192855835,-9.491584943498065,0.9164356827735901,0.6603512406349182,0.8738016366958619,100.96410167767894,13.089226408916867,0.973594319820404,0.9846119046211242,0.9360373139381408,0.8732889056205749,0.9778534889221191,94.30859117203946,54.397293965474304,38.15460977017576,2.2880785063686604,0.24118694067001342,0.21016161888837814,0.3056984931230545,0.9345851898193359,0.8015251994132996,0.013258081581443548,0.008378042746335268,0.1551041290163994,0.030919484980404376,0.7897983312606811,0.6777358651161194,0.1040649339556694,0.07622149288654327,0.20308240950107576,0.6998191475868225,0.1931983545422554,0.4023450016975403,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,5331.0,1703657.0,12911.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SEMAXANIB,CHEMBL276711,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2000.0,,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-",WUWDLXZGHZSWQZ-WQLSENKSSA-N,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,0.7365043879614916,4.0,238.29000000000002,3.1242400000000004,1,2,0,44.89,-4.730889317493429,0.9363541722297668,-4.64511909500723,0.9999866008758544,-11.689024631860953,0.9689374566078186,0.2231750100851059,0.9786919474601745,89.97389624535914,-3.2000049646006063,0.9846997261047363,0.5707458257675171,0.367003071308136,0.1362494483590126,0.665107935667038,32.932565494288085,49.92036679663387,47.90435268881969,2.5824367593439126,0.7084072589874267,0.10085076242685317,0.051176942512393,0.9477460026741028,0.6393082737922668,0.0354954719543457,0.0410367576405406,0.2679579764604568,0.041032823547720906,0.9346883416175842,0.19662915915250778,0.05789258889853954,0.34972259402275085,0.24709555357694626,0.8449259400367737,0.5469823867082596,0.8131821513175964,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,7482.0,3132601.0,2282945.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,"Receptor tyrosine kinases have a role in cell proliferation and are targeted by cancer chemotherapy. Avapritinib inhibits autophosphorylation in KIT D816V and PDGFRA D842V mutants (IC50 of 4 nM and 30 nM, respectively) in vitro and was active in a mouse xenograft model.","Active against PDGFRA and PDGFRA D842 and multiple KIT exon 11, 11/17 and 17 mutants (IC50s < 25 nM). Other potential targets: wild-type KIT, PDGFRB, CSFR1.",,,AVAPRITINIB,CHEMBL4204794,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2017.0,1.0,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C26H27FN10/c1-26(28,20-3-5-22(27)6-4-20)21-13-29-25(30-14-21)36-9-7-35(8-10-36)24-23-11-18(16-37(23)33-17-31-24)19-12-32-34(2)15-19/h3-6,11-17H,7-10,28H2,1-2H3/t26-/m0/s1",DWYRIWUZIJHQKQ-SANMLTNESA-N,Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1,0.3942447654838286,4.0,498.57000000000016,2.6077000000000004,10,1,1,106.28999999999999,-3.1212810892821454,0.9223074316978455,-5.577593729189099,0.9968207478523254,-10.271488394463082,0.888834810256958,0.7811868548393249,0.6088700652122497,91.06233390481643,2.852301371499111,0.06067560911178589,0.24406839087605475,0.22956098839640618,0.06261883825063705,0.7716493368148803,-32.131910602125124,31.347925400817143,72.03819216115248,3.2100692060249,0.17342402637004853,0.40372019112110136,0.6055672347545624,0.9581900358200073,0.934271228313446,0.035512175783514975,0.014979064743965865,0.04308551177382469,0.02433894146233797,0.08109950944781304,0.1696351170539856,0.016521662939339876,0.027548512257635594,0.00922117978334427,0.1124574974179268,0.0645486630499363,0.07992328703403473,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,7607.0,3132686.0,2294618.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Active against wild type, primary, and secondary mutations. Also inhibits PDGFRB, TIE2, VEGFR2, and BRAF in vitro. ",,,RIPRETINIB,CHEMBL4216467,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2017.0,1.0,-retin-; -tinib,0.0,-retin-; -tinib,retinol derivatives; tyrosine kinase inhibitors,,0.0,0.0,1.0,"InChI=1S/C24H21BrFN5O2/c1-3-31-21-12-22(27-2)28-13-14(21)9-17(23(31)32)16-10-20(19(26)11-18(16)25)30-24(33)29-15-7-5-4-6-8-15/h4-13H,3H2,1-2H3,(H,27,28)(H2,29,30,33)",CEFJVGZHQAGLHS-UHFFFAOYSA-N,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,0.32297501845407367,2.0,510.36700000000013,5.670700000000004,5,3,0,88.05000000000001,-6.066170219879954,0.8872613430023193,-4.97766170733753,0.9946355223655701,-11.87613304009027,0.8437626004219055,0.8757317304611206,0.7410460114479065,99.80756362717307,1.7660389484713364,0.3175471037626266,0.5470660209655762,0.4007516920566559,0.19045432657003403,0.5598835110664367,186.96084226019508,49.27594871503117,76.36804054374224,3.0173546420283226,0.43254430294036866,0.5847761034965515,0.5197299659252167,0.9625112771987915,0.8836719751358032,0.03264506869018078,0.025286014564335345,0.058620058745145795,0.00753861078992486,0.5407359063625335,0.13402846604585647,0.05999656915664673,0.04733313247561455,0.07702251747250558,0.6481699228286744,0.24293121099472045,0.22096727788448334,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,8711.0,1702678.0,1378026.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,More potent against VEGFR vs. c-KIT/PDGFR-beta,,,TIVOZANIB HYDROCHLORIDE,CHEMBL2105756,4.0,1.0,1.0,MOL,,Small molecule,2017.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2011.0,1.0,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H19ClN4O5.ClH.H2O/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18;;/h4-11H,1-3H3,(H2,25,26,27,28);1H;1H2",RQXMKRRBJITKRN-UHFFFAOYSA-N,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC.Cl.O,0.36257775679707344,2.0,509.34600000000034,5.2352200000000035,7,2,0,139.24,-5.420386555876893,0.9653760910034179,-5.021597808031758,0.994165015220642,-12.159518332128153,0.8116440653800965,0.8672199010848999,0.49190965890884397,95.6997955043586,4.661929216763758,0.2086436502635479,0.3712155282497406,0.4517023921012878,0.0886812947690487,0.7194483995437622,150.17274348421952,35.79886853343362,60.68331162910893,2.836189740314935,0.5106909930706024,0.38122340738773347,0.4765462338924408,0.9793912291526794,0.7876075506210327,0.017391146905720235,0.007048564311116934,0.061168058216571806,0.01250140443444252,0.677141535282135,0.10565317571163177,0.07783936262130738,0.1260234907269478,0.09471784457564354,0.6447908759117127,0.4854017853736877,0.1433701515197754,False
KIT,238,SINGLE PROTEIN,Stem cell growth factor receptor,9606,Homo sapiens,CHEMBL1936,,0.0,9311.0,3490117.0,2486593.0,Stem cell growth factor receptor inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SERALUTINIB,CHEMBL4650333,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2020.0,,-tinib,0.0,-tinib,tyrosine kinase inhibitors,,0.0,0.0,0.0,"InChI=1S/C27H27N5O3/c1-17-10-21(14-28-13-17)27(33)31-22-7-5-6-19(11-22)18(2)30-26-16-29-15-23(32-26)20-8-9-24(34-3)25(12-20)35-4/h5-16,18H,1-4H3,(H,30,32)(H,31,33)/t18-/m0/s1",JHJNPOSPVGRIAN-SFHVURJKSA-N,COc1ccc(-c2cncc(N[C@@H](C)c3cccc(NC(=O)c4cncc(C)c4)c3)n2)cc1OC,0.36175756217639904,3.0,469.54500000000024,5.289620000000004,7,2,1,98.26,-5.055395366710753,0.9400670170783997,-5.349880428606917,0.9992170095443725,-10.41465786850122,0.9221933960914612,0.9099053025245667,0.2397208333015442,95.77566591455866,2.0524116975347413,0.1378743454813957,0.6562777876853942,0.7531848073005676,0.09281652346253395,0.972432279586792,81.8169462014738,36.90883527830948,58.705388908857024,2.299818995060949,0.2226226106286049,0.30941690802574157,0.2976038187742233,0.9628960371017456,0.9175341606140137,0.01926790354773402,0.005210320395417511,0.04955539405345917,0.00868182796984911,0.5222573935985565,0.18463871777057647,0.05196532849222422,0.04614588804543018,0.11078320741653443,0.5967086613178253,0.16015538275241853,0.1115995354950428,False
KIT,121119,SINGLE PROTEIN,Mast/stem cell growth factor receptor Kit,9615,Canis lupus familiaris,CHEMBL5303563,,0.0,9718.0,1699816.0,1376103.0,Mast/stem cell growth factor receptor Kit inhibitor,,INHIBITOR,1.0,1.0,1.0,Approved veterinary,,,,TOCERANIB PHOSPHATE,CHEMBL2103833,-1.0,0.0,0.0,MOL,,Small molecule,2009.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2008.0,,-anib,0.0,-anib,angiogenesis inhibitors,,0.0,0.0,0.0,"InChI=1S/C22H25FN4O2.H3O4P/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27;1-5(2,3)4/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28);(H3,1,2,3,4)/b17-12-;",AOORBROPMMRREB-HBPAQXCTSA-N,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1.O=P(O)(O)O,0.27490886351083904,3.0,494.46000000000026,2.160340000000002,4,6,0,154.98999999999998,-1.8244352741802015,0.4701723873615265,-5.611895096492893,0.21541528701782225,-13.32400008918366,0.11149280965328216,0.10334152616560459,0.5432903468608856,77.82864793964436,0.23775926006986,0.1143243931233883,0.0674856398254633,0.040712372260168196,0.5262524604797363,0.02899240469560027,127.14175474231592,-22.906235853782647,-11.887712632357076,2.8803051168765172,0.453569632768631,0.22810752987861632,0.7982414722442627,0.5326725870370865,0.677982622385025,0.036408457159996035,0.017762075737118722,0.22310261204838752,0.07023917585611343,0.08241618052124977,0.006101110158488155,0.0008773004767135717,0.019129513204097746,0.005097274552099407,0.039896713383495805,0.10925647988915443,0.24621245861053467,False
ACHE,104805,SELECTIVITY GROUP,Cholinesterases; ACHE & BCHE,9606,Homo sapiens,CHEMBL2095233,,0.0,1285.0,1343424.0,355897.0,Cholinesterases; ACHE & BCHE inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RIVASTIGMINE TARTRATE,CHEMBL215645,4.0,1.0,1.0,MOL,,Small molecule,1998.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-stigmine,0.0,-stigmine,cholinesterase inhibitors (physostigmine type),,0.0,0.0,0.0,"InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;/m0./s1",GWHQHAUAXRMMOT-MERQFXBCSA-N,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)C(O)C(O)C(=O)O,0.5171714738662352,4.0,400.4280000000001,0.6371000000000009,7,4,3,147.84,-0.1488904118430904,0.47508895993232725,-6.022309879154471,0.18278998732566834,-15.230898861397833,0.150467087328434,0.061431844532489774,0.5573575079441071,50.25125042290964,1.6946742284867795,0.02430957295000553,0.017376549541950226,0.006753970263525843,0.23426038026809692,0.0025725897983647885,-30.25308550570393,-37.27526625201473,-5.381840226562424,2.5489389267863656,0.04330757800489664,0.09201328828930855,0.2941868245601654,0.20831471532583237,0.17218781709671022,0.091642115265131,0.01506091384217143,0.1351039230823517,0.02893812246620655,0.00874766893684864,0.004873742931522429,0.0023015000217128543,0.0011593327886657788,0.004176006780471653,0.001955123385414481,0.002487838943488896,0.12779078185558318,False
BCHE,104805,SELECTIVITY GROUP,Cholinesterases; ACHE & BCHE,9606,Homo sapiens,CHEMBL2095233,,0.0,1285.0,1343424.0,355897.0,Cholinesterases; ACHE & BCHE inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RIVASTIGMINE TARTRATE,CHEMBL215645,4.0,1.0,1.0,MOL,,Small molecule,1998.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,-stigmine,0.0,-stigmine,cholinesterase inhibitors (physostigmine type),,0.0,0.0,0.0,"InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;/m0./s1",GWHQHAUAXRMMOT-MERQFXBCSA-N,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)C(O)C(O)C(=O)O,0.5171714738662352,4.0,400.4280000000001,0.6371000000000009,7,4,3,147.84,-0.1488904118430904,0.47508895993232725,-6.022309879154471,0.18278998732566834,-15.230898861397833,0.150467087328434,0.061431844532489774,0.5573575079441071,50.25125042290964,1.6946742284867795,0.02430957295000553,0.017376549541950226,0.006753970263525843,0.23426038026809692,0.0025725897983647885,-30.25308550570393,-37.27526625201473,-5.381840226562424,2.5489389267863656,0.04330757800489664,0.09201328828930855,0.2941868245601654,0.20831471532583237,0.17218781709671022,0.091642115265131,0.01506091384217143,0.1351039230823517,0.02893812246620655,0.00874766893684864,0.004873742931522429,0.0023015000217128543,0.0011593327886657788,0.004176006780471653,0.001955123385414481,0.002487838943488896,0.12779078185558318,False
ACHE,104805,SELECTIVITY GROUP,Cholinesterases; ACHE & BCHE,9606,Homo sapiens,CHEMBL2095233,,0.0,1286.0,1343992.0,27251.0,Cholinesterases; ACHE & BCHE inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RIVASTIGMINE,CHEMBL636,4.0,1.0,1.0,MOL,8874.0,Small molecule,1998.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1997.0,1.0,-stigmine,0.0,-stigmine,cholinesterase inhibitors (physostigmine type),,0.0,0.0,0.0,"InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1",XSVMFMHYUFZWBK-NSHDSACASA-N,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,0.8234224757170807,4.0,250.34199999999998,2.7597000000000014,3,0,1,32.78,-1.1215638303991367,0.7567932724952697,-3.9794791994330723,0.9850593090057373,-9.45699942594177,0.985735821723938,0.0164106423035264,0.9810377955436707,51.85987301171228,-1.401192111823589,0.08289987202733755,0.029821924306452273,0.002512170094996691,0.17788666039705275,0.005592912039719522,-5.9313652429730634,41.85688683508647,24.639212986906813,3.6352537439725694,0.07102709747850895,0.13876536190509797,0.23169635534286498,0.05467761345207691,0.5978179216384888,0.03503120299428701,0.0019429042818956076,0.11864299327135086,0.010231125075370074,0.005887932679615915,0.0059675635304301975,0.00015392548175441334,0.0005844940904353279,0.0008596688538091257,0.0019142556178849191,0.00047649381813243965,0.43927342891693116,False
BCHE,104805,SELECTIVITY GROUP,Cholinesterases; ACHE & BCHE,9606,Homo sapiens,CHEMBL2095233,,0.0,1286.0,1343992.0,27251.0,Cholinesterases; ACHE & BCHE inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,RIVASTIGMINE,CHEMBL636,4.0,1.0,1.0,MOL,8874.0,Small molecule,1998.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1997.0,1.0,-stigmine,0.0,-stigmine,cholinesterase inhibitors (physostigmine type),,0.0,0.0,0.0,"InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1",XSVMFMHYUFZWBK-NSHDSACASA-N,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,0.8234224757170807,4.0,250.34199999999998,2.7597000000000014,3,0,1,32.78,-1.1215638303991367,0.7567932724952697,-3.9794791994330723,0.9850593090057373,-9.45699942594177,0.985735821723938,0.0164106423035264,0.9810377955436707,51.85987301171228,-1.401192111823589,0.08289987202733755,0.029821924306452273,0.002512170094996691,0.17788666039705275,0.005592912039719522,-5.9313652429730634,41.85688683508647,24.639212986906813,3.6352537439725694,0.07102709747850895,0.13876536190509797,0.23169635534286498,0.05467761345207691,0.5978179216384888,0.03503120299428701,0.0019429042818956076,0.11864299327135086,0.010231125075370074,0.005887932679615915,0.0059675635304301975,0.00015392548175441334,0.0005844940904353279,0.0008596688538091257,0.0019142556178849191,0.00047649381813243965,0.43927342891693116,False
ACHE,104805,SELECTIVITY GROUP,Cholinesterases; ACHE & BCHE,9606,Homo sapiens,CHEMBL2095233,,0.0,1287.0,1344499.0,508604.0,Cholinesterases; ACHE & BCHE inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TACRINE HYDROCHLORIDE,CHEMBL1677,4.0,1.0,1.0,MOL,,Small molecule,1993.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1988.0,0.0,-crine,0.0,-crine,acridine derivatives,Cognition Adjuvant; Dementia Symptoms Treatment Adjunct,0.0,0.0,0.0,"InChI=1S/C13H14N2.ClH/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13;/h1,3,5,7H,2,4,6,8H2,(H2,14,15);1H",ZUFVXZVXEJHHBN-UHFFFAOYSA-N,Cl.Nc1c2c(nc3ccccc13)CCCC2,0.7608532205240113,4.0,234.72999999999996,3.1176000000000013,2,1,0,38.91,-1.9306526971323223,0.9442432761192322,-4.8590811540216725,0.9999903202056885,-10.069603334531212,0.9262025833129883,0.2000987485051155,0.990184772014618,73.92996907415147,3.4579122502192945,0.947864043712616,0.4158166229724884,0.05077774608507753,0.5489528059959412,0.11664430871605873,24.560342395574686,43.987448647533846,13.89947605331571,2.7035644669071237,0.8972407937049866,0.23442032784223557,0.11729413010179997,0.5491438448429108,0.4993245542049408,0.020168432034552097,0.018664647359400988,0.24525408148765565,0.04767202660441398,0.8052863955497742,0.14020139276981353,0.017065499490126968,0.05820246115326881,0.08697392344474793,0.2473499670624733,0.13660022020339965,0.5629415392875672,False
BCHE,104805,SELECTIVITY GROUP,Cholinesterases; ACHE & BCHE,9606,Homo sapiens,CHEMBL2095233,,0.0,1287.0,1344499.0,508604.0,Cholinesterases; ACHE & BCHE inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TACRINE HYDROCHLORIDE,CHEMBL1677,4.0,1.0,1.0,MOL,,Small molecule,1993.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1988.0,0.0,-crine,0.0,-crine,acridine derivatives,Cognition Adjuvant; Dementia Symptoms Treatment Adjunct,0.0,0.0,0.0,"InChI=1S/C13H14N2.ClH/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13;/h1,3,5,7H,2,4,6,8H2,(H2,14,15);1H",ZUFVXZVXEJHHBN-UHFFFAOYSA-N,Cl.Nc1c2c(nc3ccccc13)CCCC2,0.7608532205240113,4.0,234.72999999999996,3.1176000000000013,2,1,0,38.91,-1.9306526971323223,0.9442432761192322,-4.8590811540216725,0.9999903202056885,-10.069603334531212,0.9262025833129883,0.2000987485051155,0.990184772014618,73.92996907415147,3.4579122502192945,0.947864043712616,0.4158166229724884,0.05077774608507753,0.5489528059959412,0.11664430871605873,24.560342395574686,43.987448647533846,13.89947605331571,2.7035644669071237,0.8972407937049866,0.23442032784223557,0.11729413010179997,0.5491438448429108,0.4993245542049408,0.020168432034552097,0.018664647359400988,0.24525408148765565,0.04767202660441398,0.8052863955497742,0.14020139276981353,0.017065499490126968,0.05820246115326881,0.08697392344474793,0.2473499670624733,0.13660022020339965,0.5629415392875672,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,737.0,1703356.0,353902.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NEOSTIGMINE METHYLSULFATE,CHEMBL211471,4.0,1.0,1.0,MOL,7516.0,Small molecule,2013.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-stigmine,0.0,-stigmine,cholinesterase inhibitors (physostigmine type),Cholinergic,0.0,0.0,0.0,"InChI=1S/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1",OSZNNLWOYWAHSS-UHFFFAOYSA-M,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-],0.4653768532502722,4.0,334.394,1.0367000000000002,6,0,0,95.97,0.5770814127257181,0.2980314701795578,-4.783889799659013,0.034004475781694056,-11.37693008007177,0.7272611677646637,0.016588838957250118,0.6894856929779053,51.47839115813078,-4.732495883976396,0.03734249621629715,0.012425786070525646,0.0011637247691396624,0.015938910376280545,0.0008038165760808624,-43.50272945214927,6.263628448031055,17.534967149107096,3.62284687335075,0.34344127774238586,0.190587355196476,0.0033305667457170784,0.2926225498318672,0.2504512816667557,0.03976138634607196,0.007971452502533793,0.1869514912366867,0.01994721107184887,0.005562624335289002,0.00635239202529192,0.0003216637371224351,0.0015979289775714279,0.0017925757681950926,0.0036331715527921915,0.004305854206904769,0.5569947123527527,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,738.0,1344374.0,508667.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DONEPEZIL HYDROCHLORIDE,CHEMBL1678,4.0,1.0,1.0,MOL,4696.0,Small molecule,1996.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1997.0,1.0,-pezil,0.0,-pezil,acetylcholinesterase inhibitors used in the treatment of Alzheimer's disease,Dementia Symptoms Treatment Adjunct; Inhibitor (acetylcholinesterase); Cognition Adjuvant; Alzheimer's Disease Treatment (adjunct),0.0,0.0,0.0,"InChI=1S/C24H29NO3.ClH/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18;/h3-7,14-15,17,20H,8-13,16H2,1-2H3;1H",XWAIAVWHZJNZQQ-UHFFFAOYSA-N,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl,0.679924189657892,4.0,415.9610000000002,4.782900000000006,4,0,1,38.77,-3.6008638951713836,0.9060510993003845,-4.832032239656698,0.9997416257858276,-5.917493359907811,0.8888908982276916,0.940670120716095,0.9831061482429504,95.69259164222244,2.725193150367574,0.1636145256459713,0.23622543215751649,0.13734674006700515,0.9396517872810364,0.3759684026241302,-0.4486978108950737,50.29044726872496,49.44768633303567,2.6772386035527473,0.2906073719263077,0.1184359461069107,0.5094848871231079,0.1701052278280258,0.9450332641601562,0.009163184557110071,0.00819978741928935,0.08210134878754616,0.008301313687115907,0.2805014193058014,0.021935965679585934,0.004387599579058587,0.033110592234879735,0.06337188668549061,0.10868680104613304,0.027292975783348085,0.4031947374343872,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,739.0,1343722.0,674884.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,HEXAFLUORENIUM BROMIDE,CHEMBL1200933,4.0,1.0,1.0,MOL,,Small molecule,1982.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1961.0,0.0,-ium,0.0,-ium,quaternary ammonium derivatives,Relaxant (skeletal muscle); Synergist (succinylcholine),0.0,0.0,0.0,"InChI=1S/C36H42N2.2BrH/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-24-34(30)36;;/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3;2*1H/q+2;;/p-2",WDEFPRUEZRUYNW-UHFFFAOYSA-L,C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21.[Br-].[Br-],0.19086092423282666,3.0,662.5540000000003,2.247600000000002,0,0,0,0.0,0.5943249912872101,0.2743875779211521,-5.723222148162472,0.09466150589287281,-7.796193747598069,0.6708994925022125,0.8155426383018494,0.7331318855285645,80.50183967508454,11.552481678909963,0.19591582268476487,0.026684703398495914,0.004496041685342789,0.9232714772224426,0.019031088892370464,41.462732042817024,27.1913265003542,23.26094434851181,3.5168378806015594,0.12569527849555015,0.18462468199431897,0.0036487117264186963,0.05452429312281311,0.9888665080070496,0.0024411347694694996,0.0034801752073690293,0.04887656476348638,0.015267080254852771,0.02236426156014204,0.16081195920705796,0.002908743682564818,0.0008092713716905565,0.025062283780425788,0.1951429147273302,0.005810154578648507,0.8394147992134094,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,740.0,1344331.0,54149.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PYRIDOSTIGMINE BROMIDE,CHEMBL812,4.0,1.0,1.0,MOL,,Small molecule,1955.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-stigmine,0.0,-stigmine,cholinesterase inhibitors (physostigmine type),Cholinergic,0.0,0.0,0.0,"InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1",VNYBTNPBYXSMOO-UHFFFAOYSA-M,CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-],0.5269729547998269,4.0,261.11899999999997,-2.4244999999999974,2,0,0,33.42,1.1900228496130179,0.5010925114154816,-3.9982993997292064,0.3185099199414253,-11.804204391557104,0.42216248959302904,0.008523258316563443,0.7811968803405762,52.06032501904684,5.57929834318025,0.00305063552223146,0.0027688960981322452,0.00017292985749008948,0.041222250740975144,8.960195777945046e-05,-0.3854729363996185,61.9669820702119,16.62371327992627,3.7858329726838647,0.3457583039999008,0.09925536997616291,0.03342957914574072,0.07224663123488426,0.045519846677780154,0.14422526024281979,0.06663044253364206,0.18614469710737466,0.011689233034849167,0.0036647369008278472,0.002750818108324893,0.00023320303939726726,0.0034598836660734377,0.0012495751951064448,0.0006466094080678885,0.0019920963270124046,0.5838443756103515,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,741.0,1344805.0,443255.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GALANTAMINE HYDROBROMIDE,CHEMBL1555,4.0,1.0,1.0,MOL,,Small molecule,2001.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2000.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H21NO3.BrH/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17;/h3-6,12,14,19H,7-10H2,1-2H3;1H/t12-,14-,17-;/m0./s1",QORVDGQLPPAFRS-XPSHAMGMSA-N,Br.COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,0.7736183032099592,4.0,368.2710000000002,2.4282000000000004,4,1,3,41.93,-1.6324597837275505,0.8165287137031555,-4.882235785096405,0.9968657851219177,-10.128634399117875,0.8161766648292541,0.5138067603111267,0.9451974391937256,59.163387912420966,5.927921529619651,0.1726655401289463,0.2775650888681412,0.015990547277033328,0.8237033009529113,0.05403271783143282,16.103812402526486,16.37753363449023,7.490771175480077,3.18206204627636,0.7535438179969788,0.08455270826816559,0.44543300569057465,0.086458982527256,0.7413892030715943,0.04279800429940224,0.015002786740660667,0.16030725538730622,0.01971761919558048,0.16767668426036836,0.09227302223443985,0.009192828601226211,0.015071731340140105,0.045350174978375436,0.16750519946217537,0.04581025559455156,0.601159256696701,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,742.0,1343459.0,119717.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ISOFLUROPHATE,CHEMBL1025,4.0,1.0,1.0,MOL,17941.0,Small molecule,1957.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,,0.0,,,Cholinergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3",MUCZHBLJLSDCSD-UHFFFAOYSA-N,CC(C)OP(=O)(F)OC(C)C,0.6298693189390489,4.0,184.147,2.9140000000000015,3,0,0,35.53,-0.40984032462519,0.9857797861099243,-3.799638929037994,0.9999800205230713,-5.4560422352259526,0.995248532295227,0.0019504646395034797,0.9948611378669738,51.226291420695155,-2.5384345655549994,0.015699149947613476,0.5011290818452835,0.08144570291042327,0.00010734911975305295,0.001388640843651956,-4.448558708158087,0.2847995307465695,19.536723236052676,4.246947693585768,0.4335900187492371,0.7934062421321869,0.0009733517532367842,0.4435401618480682,0.04944455462973565,0.0013148538186214865,5.118714854290829e-05,0.11294146627187729,0.004686736036092043,0.059390679281204936,0.002996572689153254,0.0005326907651806323,0.0005492823926033452,0.0012688060523942113,0.007576840533874929,0.0002652858706369443,0.3101831927895546,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,743.0,1343918.0,167875.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,EDROPHONIUM CHLORIDE,CHEMBL1128,4.0,1.0,1.0,MOL,4759.0,Small molecule,1951.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-ium; -onium,0.0,-ium; -onium,quaternary ammonium derivatives; quaternary ammonium derivatives,Antidote (to curare principles); Diagnostic Aid (myasthenia gravis),0.0,0.0,0.0,"InChI=1S/C10H15NO.ClH/c1-4-11(2,3)9-6-5-7-10(12)8-9;/h5-8H,4H2,1-3H3;1H",BXKDSDJJOVIHMX-UHFFFAOYSA-N,CC[N+](C)(C)c1cccc(O)c1.[Cl-],0.6081123273217008,4.0,201.69699999999997,-1.0169999999999997,1,1,0,20.23,-0.2951043406214496,0.11038090363144874,-5.046027020667486,0.061842840537428855,-9.607139140580014,0.36336698308587073,0.00517321788938716,0.30807197988033297,29.1577427837125,2.3035476237334493,0.05733767934143543,0.0024867369094863532,0.0007939454273582669,0.10664528850466012,0.0006415652358555235,0.6649456382686907,83.0538081638714,19.34156995589617,2.9071992591703504,0.02480100905522704,0.16182552045211196,0.00014955228285202794,0.00719345947727561,0.3015774995088577,0.010117997764609754,0.0016009078361093998,0.0806607517413795,0.017545450991019607,0.005737266642972827,0.010904006659984589,0.0001252642122835823,0.0009689320286270231,0.0015355604991782457,0.04171158596873283,0.004922009783331305,0.8889076709747314,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,744.0,1343466.0,674318.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ECHOTHIOPHATE IODIDE,CHEMBL1200367,4.0,1.0,1.0,MOL,59849.0,Small molecule,1960.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Cholinergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C9H23NO3PS.HI/c1-6-12-14(11,13-7-2)15-9-8-10(3,4)5;/h6-9H2,1-5H3;1H/q+1;/p-1",OVXQHPWHMXOFRD-UHFFFAOYSA-M,CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-],0.3251591398097626,4.0,383.23199999999997,-0.38909999999999867,4,0,0,35.53,1.200235484619734,0.6176728755235672,-5.033631383999191,0.027102642226964235,-7.782890567539941,0.7930922865867615,0.0033017139197909274,0.7708832025527954,25.024220043428507,-0.6075879916253266,0.00011035726947739022,0.0010685497167287395,5.010923568988801e-05,0.005258798412978649,2.0113833579671335e-05,-28.553781236924806,11.144541361850024,6.5173920117346285,4.723442151274139,0.06371501423418521,0.10540547841228545,0.00044621330307563766,0.004697785450844094,0.5493014857172966,0.0011865244508953766,0.00019051946019317257,0.14792868569493295,0.007725777057930827,0.0003372894134372473,0.0013167191995307804,4.645706932819849e-05,2.3758239558446802e-05,9.950464491339516e-05,0.004619983308657538,5.31572624851151e-05,0.9511396169662476,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,745.0,1343199.0,674465.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DEMECARIUM BROMIDE,CHEMBL1200514,4.0,1.0,1.0,MOL,4391.0,Small molecule,1959.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,,0.0,-ium,0.0,-ium,quaternary ammonium derivatives,Cholinergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C32H52N4O4.2BrH/c1-33(31(37)39-29-21-17-19-27(25-29)35(3,4)5)23-15-13-11-9-10-12-14-16-24-34(2)32(38)40-30-22-18-20-28(26-30)36(6,7)8;;/h17-22,25-26H,9-16,23-24H2,1-8H3;2*1H/q+2;;/p-2",YHKBUDZECQDYBR-UHFFFAOYSA-L,CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-].[Br-],0.20224196782935647,3.0,716.6000000000001,0.7702000000000064,4,0,0,59.08,0.24074318568443945,0.1264980010688305,-5.124561178534361,0.015379955247044563,-8.497519743225153,0.8322539806365967,0.8783928871154785,0.2769792973995209,81.0372396742817,-3.683052322535257,0.01590325739234686,0.021890535578131677,0.004892991902306676,0.3300382226705551,0.1191933050751686,-9.528908851349161,50.3897953020952,91.36442176842574,3.556540013745093,0.17707395702600479,0.24919052571058273,0.0038927154906559735,0.08253658711910247,0.9666039705276489,0.01826079348102212,0.006471821549348533,0.08840309008955956,0.03527145031839609,0.007510060258209705,0.07056062668561935,0.0026198204344836996,0.0031735716736875476,0.020816031098365783,0.09291468411684037,0.013841629726812243,0.6154950261116028,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,746.0,1343859.0,674492.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AMBENONIUM CHLORIDE,CHEMBL1200541,4.0,1.0,1.0,MOL,2628.0,Small molecule,1956.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,-ium; -onium,0.0,-ium; -onium,quaternary ammonium derivatives; quaternary ammonium derivatives,,0.0,0.0,0.0,"InChI=1S/C28H40Cl2N4O2.2ClH/c1-5-33(6-2,21-23-13-9-11-15-25(23)29)19-17-31-27(35)28(36)32-18-20-34(7-3,8-4)22-24-14-10-12-16-26(24)30;;/h9-16H,5-8,17-22H2,1-4H3;2*1H",DXUUXWKFVDVHIK-UHFFFAOYSA-N,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl.[Cl-].[Cl-],0.2061136073725602,3.0,608.4820000000002,-1.3527999999999927,2,2,0,58.2,0.5676668403788112,0.19188382178545,-6.059699357849785,0.0024107465287670493,-11.42802735594062,0.281722666323185,0.05803544847294688,0.05499378442764282,58.07556143557548,23.09270188155299,0.05735815651714802,0.09466178859584033,0.004025820738752373,0.7998920261859894,0.019023499358445405,156.80859143768095,8.347722321855638,54.181028808296865,2.846147375893709,0.2506903849542141,0.26430526077747346,0.006758353498298675,0.020442268426995723,0.8897286653518677,0.006154680252075195,0.013843207561876625,0.11914777681231499,0.024618237838149072,0.001663811836624518,0.007323074340820313,0.0007284769330908603,0.010918532032519579,0.0028720734204398467,0.014386197552084923,0.0019947590306401254,0.9426442980766296,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,747.0,1344139.0,39624.0,Acetylcholinesterase activator,,ACTIVATOR,1.0,1.0,1.0,reactivates acetylcholinesterase deactivated by organophosphates,,,,PRALIDOXIME CHLORIDE,CHEMBL748,4.0,1.0,1.0,MOL,8355.0,Small molecule,1964.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,1.0,,0.0,,,Cholinesterase Reactivator,0.0,0.0,0.0,"InChI=1S/C7H8N2O.ClH/c1-9-5-3-2-4-7(9)6-8-10;/h2-6H,1H3;1H",HIGSLXSBYYMVKI-UHFFFAOYSA-N,C[n+]1ccccc1/C=N/O.[Cl-],0.21331255223089682,4.0,172.615,-2.6767999999999983,2,1,0,36.47,0.8259160118337465,0.39635627865791323,-4.878992828468465,0.5240754887461663,-8.70950541460498,0.10162837132811546,0.01871220419416204,0.5191036850214005,48.28750869024075,13.379469363214465,0.0050362339126877485,0.0072089644134393895,0.0007115960093869944,0.08082110043615102,0.0005110484687520511,13.284704450763027,50.915601243468394,3.035887440525106,2.487319107517101,0.5725494205951691,0.13552967235445976,0.033485264364571776,0.08272516950964928,0.039353920985013245,0.07699893862009048,0.13911227099597454,0.10986862829886376,0.0237894928897731,0.025735135865397753,0.005460741592105478,0.0006259385034354636,0.006154375488404184,0.007716123922728002,0.004177443578373641,0.01169156765099615,0.7695950627326965,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,5522.0,2792167.0,675292.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,Irreversible,,,,ECHOTHIOPHATE,CHEMBL1201341,4.0,1.0,0.0,MOL,4753.0,Small molecule,1960.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Cholinergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C9H23NO3PS/c1-6-12-14(11,13-7-2)15-9-8-10(3,4)5/h6-9H2,1-5H3/q+1",BJOLKYGKSZKIGU-UHFFFAOYSA-N,CCOP(=O)(OCC)SCC[N+](C)(C)C,0.49378909950033995,4.0,256.328,2.6069000000000004,4,0,0,35.53,0.045468963840165785,0.6711685359477997,-4.485715167943854,0.1528028417378664,-7.276230333140215,0.9324106693267822,0.0015627186818164772,0.9364306926727295,16.74823338190529,-6.568328142278853,0.0001290788481128402,0.001078488644270692,4.399869494591258e-05,0.0006574378494406119,2.7821104140457464e-05,-49.54255145825647,16.270996184665215,2.7491362564672115,4.70369591254357,0.04543127194046974,0.13595920633524655,0.0006808695281506516,0.005193874874385074,0.4725277990102768,0.0011868607514770701,0.00015551577096175606,0.11090776324272156,0.009139868663623929,0.000420214343466796,0.0010412920848466456,4.063628663004692e-05,9.6692431725387e-06,0.00011664754506455211,0.002673725737258792,5.708809999305231e-05,0.9793731212615967,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,6859.0,1701840.0,1377615.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Propanidid is a competitive inhibitor of serum cholinesterase, and neuromuscular plaque and brain acetylcholinesterase.  It is an intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration.",,,,PROPANIDID,CHEMBL2105345,4.0,0.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1963.0,-2.0,,0.0,,,Anesthetic (intravenous),1.0,0.0,0.0,"InChI=1S/C18H27NO5/c1-5-10-23-18(21)12-14-8-9-15(16(11-14)22-4)24-13-17(20)19(6-2)7-3/h8-9,11H,5-7,10,12-13H2,1-4H3",KEJXLQUPYHWCNM-UHFFFAOYSA-N,CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1,0.613650624467494,4.0,337.41600000000005,2.4381000000000004,5,0,0,65.07000000000001,-2.2825112713341063,0.8478493690490723,-4.106987630191697,0.9990542531013489,-8.465835672204122,0.9926782011985779,0.152892829477787,0.9344503045082092,57.063085388832704,-3.963348839413056,0.40983020663261416,0.6547452569007873,0.17675622105598449,0.016352326981723307,0.45839216113090514,-30.030303298622403,127.85291362741114,90.53831457200693,2.322452488744899,0.17037811130285263,0.11036806479096413,0.02510725986212492,0.4534574091434479,0.3365038424730301,0.01420253748074174,0.0034132067405153064,0.05634426828473806,0.008975995797663927,0.037350453343242405,0.01039916779845953,0.004648114182054996,0.006448357150657102,0.0052912583574652675,0.0025335395941510795,0.002505685307551175,0.39167205691337587,False
BCHE,10532,SINGLE PROTEIN,Butyrylcholinesterase,9606,Homo sapiens,CHEMBL1914,,0.0,6291.0,1701840.0,1377615.0,Butyrylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,"Propanidid is a competitive inhibitor of serum cholinesterase, and neuromuscular plaque and brain acetylcholinesterase.  It is an intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration.",,,,PROPANIDID,CHEMBL2105345,4.0,0.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1963.0,-2.0,,0.0,,,Anesthetic (intravenous),1.0,0.0,0.0,"InChI=1S/C18H27NO5/c1-5-10-23-18(21)12-14-8-9-15(16(11-14)22-4)24-13-17(20)19(6-2)7-3/h8-9,11H,5-7,10,12-13H2,1-4H3",KEJXLQUPYHWCNM-UHFFFAOYSA-N,CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1,0.613650624467494,4.0,337.41600000000005,2.4381000000000004,5,0,0,65.07000000000001,-2.2825112713341063,0.8478493690490723,-4.106987630191697,0.9990542531013489,-8.465835672204122,0.9926782011985779,0.152892829477787,0.9344503045082092,57.063085388832704,-3.963348839413056,0.40983020663261416,0.6547452569007873,0.17675622105598449,0.016352326981723307,0.45839216113090514,-30.030303298622403,127.85291362741114,90.53831457200693,2.322452488744899,0.17037811130285263,0.11036806479096413,0.02510725986212492,0.4534574091434479,0.3365038424730301,0.01420253748074174,0.0034132067405153064,0.05634426828473806,0.008975995797663927,0.037350453343242405,0.01039916779845953,0.004648114182054996,0.006448357150657102,0.0052912583574652675,0.0025335395941510795,0.002505685307551175,0.39167205691337587,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,7527.0,1705034.0,1379578.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,Reversible inhibitor.,Selective for AChE over BuChE.,,,ACOTIAMIDE HYDROCHLORIDE,CHEMBL2107308,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C21H30N4O5S.ClH.3H2O/c1-12(2)25(13(3)4)8-7-22-20(28)15-11-31-21(23-15)24-19(27)14-9-17(29-5)18(30-6)10-16(14)26;;;;/h9-13,26H,7-8H2,1-6H3,(H,22,28)(H,23,24,27);1H;3*1H2",NPTDXIXCQCFGKC-UHFFFAOYSA-N,COc1cc(O)c(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)cc1OC.Cl.O.O.O,0.3959124476392093,3.0,541.0670000000001,0.9145000000000008,8,3,0,207.52,-1.2590391686190707,0.7025422334671021,-6.102921759764692,0.6956434130668641,-11.840837887927467,0.396109539270401,0.31727158427238467,0.5861962616443634,68.67270858910905,3.470779688087532,0.16713670641183853,0.13528954088687897,0.10500092431902885,0.3137762188911438,0.10396828912198544,72.32486707699614,23.166385764181207,16.76406382111959,1.964876085900956,0.787366247177124,0.3401183545589447,0.586940324306488,0.42796162366867063,0.8150598168373108,0.013941611722111702,0.021261492930352687,0.10768453851342201,0.05394927561283112,0.1725127398967743,0.019840195775032043,0.004705029900651425,0.09633729755878448,0.04843427278101444,0.10930770300328732,0.13244830220937728,0.4131969302892685,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,7605.0,1703438.0,200958.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PHYSOSTIGMINE SALICYLATE,CHEMBL338975,4.0,1.0,1.0,MOL,48883.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,-1.0,sal-; -stigmine,0.0,sal-; -stigmine,anti-inflammatory agents (salicylic acid derivatives); cholinesterase inhibitors (physostigmine type),Cholinergic (ophthalmic),0.0,0.0,0.0,"InChI=1S/C15H21N3O2.C7H6O3/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2;8-6-4-2-1-3-5(6)7(9)10/h5-6,9,13H,7-8H2,1-4H3,(H,16,19);1-4,8H,(H,9,10)/t13-,15+;/m1./s1",HZOTZTANVBDFOF-PBCQUBLHSA-N,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=C(O)c1ccccc1O,0.6956933095843276,4.0,413.4740000000001,2.8643000000000014,6,3,2,102.34,-2.983669652652373,0.5845486879348755,-5.611197034912658,0.6394244790077209,-12.071155035192302,0.161455899477005,0.050044314563274385,0.5020595133304596,73.8767917035504,-0.35568606099961764,0.007239993987604975,0.02433566953986883,0.009569471888244151,0.24179314970970153,0.01824472416192293,9.552251626175607,12.283596106796281,1.9866190918355486,3.197361339823201,0.3034605383872986,0.07881265878677368,0.5302454650402069,0.39526419043540956,0.35891360938549044,0.046158217638731,0.00746057708747685,0.10221834853291512,0.01656854199245572,0.04543437957763672,0.0038843343034386637,0.0044385908171534535,0.011121696326881647,0.008985496312379836,0.01033250279724598,0.023028952814638615,0.1801463320851326,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,8246.0,2791439.0,673257.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DISTIGMINE,CHEMBL1199307,4.0,1.0,0.0,MOL,80756.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,-1.0,-stigmine,0.0,-stigmine,cholinesterase inhibitors (physostigmine type),,0.0,0.0,0.0,"InChI=1S/C22H32N4O4/c1-23-13-9-11-19(17-23)29-21(27)25(3)15-7-5-6-8-16-26(4)22(28)30-20-12-10-14-24(2)18-20/h9-14,17-18H,5-8,15-16H2,1-4H3/q+2",AHZBEVXBKNYXPU-UHFFFAOYSA-N,CN(CCCCCCN(C)C(=O)Oc1ccc[n+](C)c1)C(=O)Oc1ccc[n+](C)c1,0.46526210388499506,4.0,416.52200000000016,2.4574000000000007,4,0,0,66.84,-1.9165552711997798,0.2576560229063034,-4.609414997672962,0.053473755810409786,-8.62088541555699,0.6943848311901093,0.5080306112766266,0.5564730703830719,79.1666599457503,6.48155986852363,0.005711066629737615,0.02054472463205457,0.00977594922296703,0.15160739421844482,0.018077766755595803,-13.779264167567707,101.49768979334124,80.01708450778573,3.1046937673975052,0.25632990412414075,0.18231411203742026,0.21988677710760385,0.09422247409820557,0.7884490251541137,0.1768797069787979,0.1897283636033535,0.1967269077897072,0.07442887388169765,0.00826285663060844,0.03917616438120604,0.002542394674674142,0.02183587085455656,0.01006289953365922,0.02014685943722725,0.02063471688888967,0.4372857570648193,False
ACHE,93,SINGLE PROTEIN,Acetylcholinesterase,9606,Homo sapiens,CHEMBL220,,0.0,9408.0,3132181.0,704882.0,Acetylcholinesterase inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,HUPERZINE A,CHEMBL1255901,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3+/t10-,15-/m0/s1",ZRJBHWIHUMBLCN-HZRLMBICSA-N,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,0.6835351502151038,4.0,242.32199999999997,1.9975,2,2,2,58.88,-2.492078857930831,0.8909043312072754,-4.6334659001883605,0.9997677087783814,-11.537720130869197,0.7089628219604492,0.037312065809965135,0.8701445102691651,54.30374345726805,2.2179680289325296,0.05570491421967745,0.04493398107588291,0.01735955560579896,0.1994285523891449,0.30005876421928407,-30.088720440292583,6.016603819076077,-14.766657592966999,3.7004130112492426,0.21686394214630128,0.0941857935860753,0.3075932145118713,0.19075097143650055,0.17485453188419342,0.033533205091953275,0.013098522368818522,0.07687999978661537,0.029567806981503963,0.22257665693759918,0.05897362567484379,0.0014830600935965776,0.006933608883991837,0.054642312973737714,0.09687608033418656,0.04808114785701036,0.41644605696201326,False
ACHE,109497,SINGLE PROTEIN,Acetylcholinesterase 1,6239,Caenorhabditis elegans,CHEMBL3341583,,0.0,9064.0,1706257.0,277372.0,Acetylcholinesterase 1 inhibitor,,INHIBITOR,1.0,1.0,1.0,Anthelmintic,Also active against mammalian enzymes.,,,TRICHLORFON,CHEMBL167150,4.0,1.0,1.0,MOL,6908.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1995.0,-1.0,,0.0,,,Anthelmintic (veterinary),0.0,0.0,0.0,"InChI=1S/C4H8Cl3O4P/c1-10-12(9,11-2)3(8)4(5,6)7/h3,8H,1-2H3",NFACJZMKEDPNKN-UHFFFAOYSA-N,COP(=O)(OC)C(O)C(Cl)(Cl)Cl,0.6216381470286191,4.0,257.437,2.1609000000000003,4,1,1,55.760000000000005,-0.36341944985362173,0.9201646566390991,-4.954124162685595,0.9892504572868347,-10.6513392087446,0.9016379237174987,0.006958382716402411,0.9842641115188598,56.63576380922564,6.455875009139907,0.00159169458784163,0.07535263439640402,0.004859862950979732,0.00035600527956631823,0.00034812189269359803,3.3244586100220808,15.241271512583321,1.5592526687872508,2.6741582069425025,0.8515555381774902,0.6662801325321197,0.01463728044182062,0.25435738936066626,0.09688369007781147,0.00534420795738697,0.049594669148791584,0.028290653508156537,0.041380465985275804,0.002108626202971209,0.007391164777800441,0.00981174644548446,0.005249251349596307,0.007533159060403705,0.011685583395592402,0.008623624523170292,0.7846839427947998,False
SLC6A2,104870,SELECTIVITY GROUP,Monoamine transporters; Norepinephrine & dopamine,9606,Homo sapiens,CHEMBL2096990,,0.0,6293.0,1701224.0,1377063.0,Monoamine transporters; Norepinephrine & dopamine inhibitor,,INHIBITOR,1.0,1.0,1.0,"It is an inhibitor of the transporters for certain monoamine neurotransmitters, including dopamine and norepinephrine, preventing their uptake.",,,,PYROVALERONE HYDROCHLORIDE,CHEMBL2104793,4.0,0.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1964.0,-2.0,,0.0,,,Stimulant (central),1.0,0.0,0.0,"InChI=1S/C16H23NO.ClH/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14;/h7-10,15H,3-6,11-12H2,1-2H3;1H",MWRACNBZNVAJHE-UHFFFAOYSA-N,CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl,0.763961387212248,4.0,281.82699999999994,3.864020000000004,2,0,1,20.310000000000002,-2.8810384835043896,0.9164275169372559,-4.599075208254672,0.9999589681625366,-6.1430336927801665,0.9808926701545715,0.6154983878135681,0.9847745060920715,72.05353408814582,1.9842457909251212,0.48767161667346953,0.891051983833313,0.17418652027845383,0.9020166039466858,0.28131699860095977,7.43870931825702,87.16074278836825,43.62146804552541,2.6398384316061487,0.28723244965076444,0.14821628034114837,0.3997763514518738,0.07660811319947243,0.8151970028877258,0.006506942864507437,0.004820361908059567,0.1634809374809265,0.005978032760322094,0.04554534703493118,0.018381598591804504,0.005121558695100248,0.011816888372413814,0.041316309943795204,0.01890801452100277,0.005719984881579876,0.8684465050697326,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,875.0,1343341.0,1382808.0,Norepinephrine transporter substrate,,SUBSTRATE,1.0,1.0,1.0,accumulates and displaces NE,,,,BETHANIDINE SULFATE,CHEMBL2110368,4.0,1.0,1.0,MOL,31279.0,Small molecule,1982.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1962.0,0.0,,0.0,,,Antihypertensive,0.0,0.0,0.0,"InChI=1S/2C10H15N3.H2O4S/c2*1-11-10(12-2)13-8-9-6-4-3-5-7-9;1-5(2,3)4/h2*3-7H,8H2,1-2H3,(H2,11,12,13);(H2,1,2,3,4)",YTIJUXVIZLYQTB-UHFFFAOYSA-N,C/N=C(\NC)NCc1ccccc1.C/N=C(\NC)NCc1ccccc1.O=S(=O)(O)O,0.2311381527375003,3.0,452.58100000000013,1.3100000000000016,4,6,0,147.44,-0.8081082369144337,0.48973366618156433,-6.591224737570879,0.08826358320657164,-10.407085768382114,0.19590508565306664,0.08244375586509704,0.38851883411407473,55.736021691458646,-4.82819787744377,0.015181672014296054,0.030776590527966618,0.0015312723466195167,0.7226112127304077,0.0030493951693642885,85.93954730841156,-19.458154790270036,-8.92118675774699,1.4860162180498828,0.05382644012570381,0.05836397968232632,0.10902482122182847,0.07592300176620484,0.49666172862052915,0.03162613734602928,0.003473549382761121,0.2113344445824623,0.02824067501351237,0.005623907316476107,0.0007172216282924637,0.0001369522324694117,0.0006480355001258431,0.0009872248789179138,0.005752163444412872,0.000723328381718602,0.5288238883018493,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,876.0,1879208.0,161281.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DESVENLAFAXINE,CHEMBL1118,4.0,1.0,1.0,MOL,83527.0,Small molecule,2008.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2003.0,1.0,-faxine,0.0,-faxine,"antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake",,0.0,0.0,0.0,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3",KYYIDSXMWOZKMP-UHFFFAOYSA-N,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,0.8775816874821688,4.0,263.381,2.7326000000000006,3,2,1,43.7,-1.8757350968491227,0.6888442099094391,-4.8415090273061425,0.9933962821960449,-11.357315435411149,0.6653288245201111,0.029305598326027395,0.8285399794578552,25.23131111698148,2.8546756026502416,0.02381820948794484,0.02934229951351881,0.005817949259653688,0.22547280341386794,0.009662541979923844,3.9700014444129215,66.2821028387818,0.9518563591171294,2.569682168127213,0.046565674059092996,0.0797324689105153,0.21892884522676467,0.009160671476274728,0.5476935744285584,0.006298944540321827,0.0006744272111973259,0.10506711825728417,0.03717372268438339,0.005705678032245487,0.00973793021403253,0.001103599529596977,0.0007247978195664473,0.008038938255049288,0.1494424059987068,0.004505691528902389,0.6852314352989197,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,878.0,1343434.0,699486.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,reuptake inhibitor,,,,MAPROTILINE HYDROCHLORIDE,CHEMBL1237135,4.0,1.0,1.0,MOL,,Small molecule,1980.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Antidepressant,0.0,0.0,0.0,"InChI=1S/C20H23N.ClH/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20;/h2-5,7-10,15,21H,6,11-14H2,1H3;1H",NZDMFGKECODQRY-UHFFFAOYSA-N,CNCCCC12CCC(c3ccccc31)c1ccccc12.Cl,0.8112682972634434,4.0,313.872,4.633200000000005,1,1,0,12.03,-3.75099930213486,0.9128760457038879,-4.91734818099243,0.9991547226905823,-5.413660913429303,0.8344751954078674,0.5797362744808197,0.9795632123947143,88.39677675940796,9.971103371187947,0.2251194879412651,0.3599658995866776,0.04150337763130665,0.9674019455909729,0.23342017233371734,20.886465903801714,51.64828491368053,1.1615834716818405,2.719742194510922,0.5726975262165069,0.31368426978588104,0.37526403963565824,0.11059434488415718,0.9653734564781189,0.00865704263560474,0.004779404518194497,0.1189612790942192,0.04077632687985897,0.12613382190465927,0.1103635624051094,0.006634660414420068,0.007423040177673102,0.07353695072233676,0.59799884557724,0.04751999117434025,0.7968073725700379,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,879.0,1344338.0,1673434.0,Norepinephrine transporter substrate,,SUBSTRATE,1.0,1.0,1.0,Taken up by transporter and displaces NE from vesicles,,,,GUANADREL SULFATE,CHEMBL3184143,4.0,1.0,1.0,MOL,5556.0,Small molecule,1982.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1968.0,0.0,guan-,0.0,guan-,antihypertensives (guanidine derivatives),,0.0,0.0,0.0,"InChI=1S/2C10H19N3O2.H2O4S/c2*11-9(12)13-6-8-7-14-10(15-8)4-2-1-3-5-10;1-5(2,3)4/h2*8H,1-7H2,(H4,11,12,13);(H2,1,2,3,4)",RTEVGQJRTFFMLL-UHFFFAOYSA-N,N=C(N)NCC1COC2(CCCCC2)O1.N=C(N)NCC1COC2(CCCCC2)O1.O=S(=O)(O)O,0.1419875662076594,2.0,524.6410000000004,0.43774000000000435,8,8,2,235.31999999999996,-1.1406713664059491,0.3855526313185692,-7.431956737054333,0.07929282693658024,-12.225077319003754,0.11775514502078295,0.05153602808713913,0.30936144292354584,34.40689706846895,-2.980154542615723,0.0011743550472601782,0.02463034987449646,0.0017172124003991484,0.15924936812371016,0.010782412040862254,103.56911154565452,-10.190005216621532,-1.5610416054325278,2.2979972037651946,0.4766647607088089,0.03840691316872835,0.12936516776680945,0.06604309193789959,0.3086540177464485,0.016643517790362237,0.004402022628346458,0.3835160434246063,0.16012524664402009,0.0033711489057168366,0.00799373621121049,0.001642271452874411,0.013660242481273599,0.023700221814215182,0.09712494350969791,0.05407910607755184,0.5162663638591767,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,880.0,1343456.0,453532.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,PHENTERMINE,CHEMBL1574,4.0,1.0,1.0,MOL,8080.0,Small molecule,1959.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1962.0,1.0,,0.0,,,"Anorexic,Appetite Suppressant (systemic)",0.0,0.0,0.0,"InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3",DHHVAGZRUROJKS-UHFFFAOYSA-N,CC(C)(N)Cc1ccccc1,0.6831676333388244,4.0,149.237,1.9664,1,1,0,26.02,-0.8753047015732658,0.8772936940193177,-4.274232968050916,0.999473261833191,-5.608423378610169,0.9053446531295777,0.0024149575969204307,0.9813791394233704,24.20675855801098,1.5695884610949704,0.006540709780529142,0.022396062908228487,0.0008074690122157335,0.13093922808766364,0.0008912317323847673,3.5662534580610106,41.434692726836616,-16.221299291881586,2.899166952049559,0.006768414471298456,0.25051690116524694,0.012916618495364674,0.0020829216344282033,0.2878717303276062,0.0014288708567619323,7.02281526173465e-05,0.09264309015125036,0.0038521283539012076,0.0005531786911888048,0.0003963066061260179,3.565860374976637e-05,9.615872301083073e-06,0.0010083971421408933,0.0015176911314483733,2.0104907230233947e-05,0.8772443890571594,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,881.0,1344351.0,1051125.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,reuptake inhibitor,,,,DOXEPIN HYDROCHLORIDE,CHEMBL1628234,4.0,1.0,1.0,MOL,,Small molecule,1969.0,1.0,0.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,1964.0,1.0,-pin,0.0,-pin,tricyclic compounds,Antidepressant,0.0,0.0,0.0,"InChI=1S/C19H21NO.ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19;/h3-6,8-12H,7,13-14H2,1-2H3;1H",MHNSPTUQQIYJOT-UHFFFAOYSA-N,CN(C)CCC=C1c2ccccc2COc2ccccc21.Cl,0.8329114462461583,4.0,315.844,4.384200000000005,2,0,0,12.47,-3.67775599931552,0.8938295602798462,-4.676957712171644,0.9977542400360108,-6.4489423652863636,0.9380078077316284,0.8156084775924682,0.9925329566001893,87.99553620052254,-3.862413701024289,0.818712306022644,0.21571765691041947,0.018202824145555498,0.9638086557388306,0.07002247646450996,19.306006988372367,64.23009823712108,30.74053578410667,2.5946201021899333,0.6611257553100586,0.26952719390392305,0.5302481591701508,0.37955157458782196,0.974576187133789,0.012297211028635503,0.005703617725521326,0.07256774231791496,0.023914028704166413,0.13074254170060157,0.10573990195989609,0.01439753663726151,0.0073508195579051975,0.03927025734446943,0.10762070901691914,0.037643874622881414,0.7340468764305115,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,882.0,1344689.0,545075.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,reuptake inhibitor,,,,DESIPRAMINE HYDROCHLORIDE,CHEMBL1696,4.0,1.0,1.0,MOL,4449.0,Small molecule,1964.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1962.0,1.0,-pramine,0.0,-pramine,antidepressants (imipramine type),Antidepressant,0.0,0.0,0.0,"InChI=1S/C18H22N2.ClH/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20;/h2-5,7-10,19H,6,11-14H2,1H3;1H",XAEWZDYWZHIUCT-UHFFFAOYSA-N,CNCCCN1c2ccccc2CCc2ccccc21.Cl,0.8602597856715056,4.0,302.849,3.954600000000004,2,1,0,15.27,-3.4381604201349405,0.9044328808784485,-4.678156274461689,0.9988908171653748,-6.905478697583382,0.8284400224685669,0.6721266627311706,0.9928123116493225,91.34904374188172,6.653498584515058,0.6412329792976379,0.4791829526424408,0.024329500645399092,0.9690608501434326,0.08124169036746025,32.869303598866885,105.20266989593343,21.98278117234123,2.515216110462589,0.5981907963752746,0.33430503904819486,0.42919139564037323,0.23768590688705443,0.981508195400238,0.008817382808774709,0.008614868484437465,0.07809830084443092,0.018722356855869295,0.16023386120796204,0.0949367567896843,0.008600293891504407,0.010658599343150854,0.057769542559981346,0.15141860842704774,0.08409105464816094,0.823406434059143,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,883.0,1344347.0,624251.0,Norepinephrine transporter substrate,,SUBSTRATE,1.0,1.0,1.0,Taken up by transporter and displaces NE from vesicles,,,,BRETYLIUM TOSYLATE,CHEMBL1095292,4.0,1.0,1.0,MOL,3173.0,Small molecule,1986.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1976.0,1.0,-ium,0.0,-ium,quaternary ammonium derivatives,Cardiac Depressant (anti-arrhythmic); Anti-Adrenergic,0.0,0.0,0.0,"InChI=1S/C11H17BrN.C7H8O3S/c1-4-13(2,3)9-10-7-5-6-8-11(10)12;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1",KVWNWTZZBKCOPM-UHFFFAOYSA-M,CC[N+](C)(C)Cc1ccccc1Br.Cc1ccc(S(=O)(=O)[O-])cc1,0.5625609495499733,4.0,414.3650000000001,3.9445200000000034,3,0,0,57.2,-0.20292865336417884,0.5172857701778412,-5.456102576571245,0.06445962693542243,-6.464534000410488,0.7099243700504303,0.41768958866596223,0.26318890452384947,85.28301417243092,-5.221146991200466,0.04574220702052116,0.07413548240438103,0.0020727363633341158,0.6770408451557159,0.006759070383850485,69.48482372718047,43.19957533751956,36.93555219651103,2.6833778038699516,0.030413280054926873,0.495985221862793,0.0027864352508913726,0.13347959741950036,0.844159746170044,0.004743737354874611,0.0013246878370409831,0.14561015516519546,0.007659980375319719,0.000621641987527255,0.010829085542354733,0.0002767276807389862,5.5721975149936044e-05,0.0030845178000163285,0.03908349657431245,0.00024221884268627036,0.7838692188262939,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,884.0,1343598.0,289505.0,Norepinephrine transporter substrate,,SUBSTRATE,1.0,1.0,1.0,Taken up by transporter and displaces NE from vesicles,,,,GUANETHIDINE MONOSULFATE,CHEMBL1345,4.0,1.0,1.0,MOL,51016.0,Small molecule,1960.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1966.0,0.0,guan-,0.0,guan-,antihypertensives (guanidine derivatives),Antihypertensive,0.0,0.0,0.0,"InChI=1S/C10H22N4.H2O4S/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14;1-5(2,3)4/h1-9H2,(H4,11,12,13);(H2,1,2,3,4)",YUFWAVFNITUSHI-UHFFFAOYSA-N,N=C(N)NCCN1CCCCCCC1.O=S(=O)(O)O,0.28212484379298514,4.0,296.393,0.08277000000000057,4,5,0,139.74,-0.7459313041701592,0.16021928563714027,-6.8536080585872785,0.02872871177532943,-13.964776609210535,0.01711499947414268,0.003860790515318513,0.2829248756170273,-0.9359249438936927,-9.689764776611337,0.00039421471556124745,0.010065760533325373,0.000578951517763926,0.1507801154628396,1.3000896467474377e-05,74.17050410187554,-16.839382511611966,-42.150170999781174,1.4956458969090238,0.12754953037947417,0.04428052110597491,0.056020021066069604,0.014388947933912277,0.14923986755311489,0.010279697459191084,0.0007511332165449858,0.2930698230862617,0.01966296285390854,0.0009644291800213978,8.89656538674899e-05,8.078662579791285e-06,0.00033423099969240864,0.00039458548508264357,0.00174663093930576,0.0010297598782926798,0.7274285316467285,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,885.0,1343140.0,547576.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,reuptake inhibitor,,,,ATOMOXETINE HYDROCHLORIDE,CHEMBL1702,4.0,1.0,1.0,MOL,331697.0,Small molecule,2002.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2001.0,1.0,-oxetine,0.0,-oxetine,antidepressants (fluoxetine type),,0.0,0.0,0.0,"InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m1./s1",LUCXVPAZUDVVBT-UNTBIKODSA-N,CNCC[C@@H](Oc1ccccc1C)c1ccccc1.Cl,0.8632623386728676,4.0,291.82199999999995,4.146420000000004,2,1,1,21.259999999999998,-2.5279876725413244,0.9685359001159668,-4.702807690038643,0.9997267484664917,-5.828470770163956,0.8996227145195007,0.27214913070201874,0.8578198552131653,77.74795779120497,-0.570989860250105,0.8441362857818604,0.46012516915798185,0.038046888262033465,0.9531290411949158,0.1953894764184952,15.437465942392038,91.46127172176453,24.751523128712,2.500003480234552,0.4791643381118774,0.43657523989677427,0.24306443482637405,0.11024106591939926,0.9360083818435669,0.006530896062031388,0.001718908129259944,0.1467976450920105,0.022885439172387122,0.06122172251343727,0.055235911160707474,0.006751247309148311,0.0037510868860408664,0.04001523014158011,0.12219532281160354,0.007858416019007563,0.736076021194458,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,886.0,1343181.0,674863.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,PHENTERMINE HYDROCHLORIDE,CHEMBL1200912,4.0,1.0,1.0,MOL,50506.0,Small molecule,1973.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,1.0,,0.0,,,Appetite Suppressant (systemic),0.0,0.0,0.0,"InChI=1S/C10H15N.ClH/c1-10(2,11)8-9-6-4-3-5-7-9;/h3-7H,8,11H2,1-2H3;1H",NCAIGTHBQTXTLR-UHFFFAOYSA-N,CC(C)(N)Cc1ccccc1.Cl,0.7526332438710864,4.0,185.698,2.3882000000000008,1,1,0,26.02,-1.1836636812339807,0.9097660183906555,-4.5835232668895225,0.9990628004074097,-4.848241508391849,0.8353139758110046,0.006869893986731768,0.967346727848053,36.55460789771759,4.540547983596355,0.014710255386307835,0.050889135291799906,0.0010904240072704852,0.4910652279853821,0.0014343098242534324,14.21222963795933,34.35667846898862,-12.784559734713564,3.0137583878698186,0.046207637153565885,0.47926534712314606,0.04214361801277846,0.003911600355058909,0.49500337839126585,0.0012393776210956275,0.00020512915798462928,0.11428428813815117,0.006967038800939918,0.001058369904058054,0.0011942805227590724,0.0001385609614999339,5.296029899000132e-05,0.002907923035672866,0.0032751023070886733,9.973444039133029e-05,0.8769270896911621,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,887.0,1344333.0,1926755.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,BENZPHETAMINE HYDROCHLORIDE,CHEMBL3544906,4.0,1.0,1.0,MOL,59169.0,Small molecule,1960.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C17H21N.ClH/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17;/h3-12,15H,13-14H2,1-2H3;1H/t15-;/m0./s1",ANFSNXAXVLRZCG-RSAXXLAASA-N,C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1.Cl,0.791555478759392,4.0,275.8229999999999,4.171400000000005,1,0,1,3.24,-3.6716579868629537,0.8946982979774475,-4.480189420736966,0.9990740656852722,-5.571374766254772,0.9461466550827027,0.09974423721432686,0.9698240518569946,79.44681839250242,5.182971302735235,0.536955964565277,0.5867862522602081,0.03356535211205482,0.9884249567985535,0.024154584389179945,28.960877362949454,88.21938839755887,15.604753896803109,2.6593987894414357,0.18549562990665436,0.23402039408683778,0.2532635033130646,0.04009242206811905,0.9509467601776123,0.0028452664613723756,0.001048951206030324,0.13539867997169494,0.011570875439792872,0.00905127900186926,0.01758754104375839,0.0027022381633287295,0.0027262813528068364,0.011806917143985629,0.07668543979525566,0.0013743710005655885,0.9681732535362244,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,888.0,1344610.0,675686.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BUPROPION HYDROBROMIDE,CHEMBL1201735,4.0,1.0,1.0,MOL,,Small molecule,2008.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2008.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C13H18ClNO.BrH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H",WSTCENNATOVXKQ-UHFFFAOYSA-N,Br.CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,0.8564504380653267,4.0,320.658,3.877200000000003,2,1,1,29.1,-3.270105412236365,0.9286132693290711,-4.562498443939804,0.9999138832092285,-6.091415949615794,0.9815088510513306,0.04447285681962967,0.9070565342903137,62.740986044385934,11.631483673244125,0.3830274619162083,0.5692054033279419,0.040381739381700754,0.7158936262130737,0.1143284622579813,49.0636570473867,52.10563313721415,12.327864177998137,2.7560523960403507,0.11727009490132331,0.5255186855792999,0.11071299910545349,0.09784698486328125,0.27894820719957353,0.002518965513445437,0.001593808375764638,0.18287684321403502,0.03408431764692068,0.07688837535679341,0.026251574978232384,0.003963637363631279,0.002671775023918599,0.02315285289660096,0.16767454706132412,0.004218743473757058,0.7446763992309571,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,889.0,1344146.0,675679.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DESVENLAFAXINE SUCCINATE,CHEMBL1201728,4.0,1.0,1.0,MOL,,Small molecule,2008.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2003.0,1.0,-faxine,0.0,-faxine,"antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake",,0.0,0.0,0.0,"InChI=1S/C16H25NO2.C4H6O4/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16;5-3(6)1-2-4(7)8/h6-9,15,18-19H,3-5,10-12H2,1-2H3;1-2H2,(H,5,6)(H,7,8)",ORUUBRMVQCKYHB-UHFFFAOYSA-N,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O=C(O)CCC(=O)O,0.5732510481194091,4.0,381.46900000000016,2.6684,5,4,1,118.3,-1.5445806059736236,0.5220111727714538,-6.142085684496809,0.4583081632852554,-12.920497851754643,0.0850430740043521,0.036704822815954684,0.4477290749549866,41.80568873401402,0.340009428278447,0.006511037354357541,0.020569036714732647,0.005200846120715141,0.11881285160779953,0.002122901479015127,-20.669148600510905,7.378654671867372,-12.689845113300192,2.393389770986205,0.04443550482392311,0.054045873880386355,0.28387869596481324,0.053687960095703605,0.11795014590024948,0.015457141399383544,0.0026400633854791523,0.2182557612657547,0.044350764527916905,0.004420119640417397,0.0032571423216722906,0.005949417033116333,0.0010476839262992144,0.012862230464816094,0.013924211729317904,0.003319423971697688,0.26428271979093554,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,890.0,1344109.0,78902.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DEXMETHYLPHENIDATE HYDROCHLORIDE,CHEMBL904,4.0,1.0,1.0,MOL,,Small molecule,2001.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2002.0,1.0,-,0.0,-,-,,0.0,0.0,0.0,"InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H/t12-,13-;/m1./s1",JUMYIBMBTDDLNG-OJERSXHUSA-N,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1.Cl,0.8572108764494875,4.0,269.77199999999993,2.5071000000000008,3,1,2,38.33,-2.014933142696172,0.8472111940383911,-4.744667187771343,0.9998027801513671,-7.808634326991881,0.9091750383377075,0.02482392769306898,0.9297121167182922,55.99476020738941,2.11769338023694,0.07807024791836739,0.3017762690782547,0.012451752368360759,0.7467628359794617,0.15172159001231195,3.504940762830851,56.94333943113819,-2.4980033316066375,2.904664226044312,0.40660532414913175,0.0459833774715662,0.42475815415382384,0.06337157636880875,0.5011050164699554,0.007046967186033726,0.004431086918339133,0.09604182466864586,0.00732570057734847,0.016001879703253508,0.009586534276604653,0.002265593392075971,0.006054721493273974,0.01277493597008288,0.0012954240606632083,0.003969670133665204,0.8227343916893005,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,891.0,1343125.0,23199.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,DEXTROAMPHETAMINE,CHEMBL612,4.0,1.0,1.0,MOL,4469.0,Small molecule,1955.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1964.0,1.0,,0.0,,,Stimulant (central),0.0,0.0,0.0,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1",KWTSXDURSIMDCE-QMMMGPOBSA-N,C[C@H](N)Cc1ccccc1,0.6542162175383444,4.0,135.20999999999998,1.5763,1,1,1,26.02,-0.8247277292779132,0.9248070240020752,-4.307363750318241,0.9998330116271973,-5.602788225081587,0.811141312122345,0.0026007105712778865,0.957048761844635,26.48971717807286,3.2255748880301867,0.04565852005034685,0.023631280940026044,0.0012554945482406766,0.25736178308725355,0.003172909375280142,4.670800318973111,55.19894293060486,-20.55608185939513,2.9398564987930773,0.02587075252085924,0.23089684247970582,0.01363398318644613,0.0035327489487826822,0.15405243784189224,0.008632420422509312,0.0007263831794261932,0.0478581141680479,0.0016340410336852073,0.002688472787849605,0.0006220215334906242,5.09162113758066e-05,4.02577777094848e-05,0.0012937827166751958,0.0005244973610388115,4.208171189929999e-05,0.7785794377326966,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,892.0,1344859.0,674733.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,DEXTROAMPHETAMINE ADIPATE,CHEMBL1200782,4.0,1.0,1.0,MOL,,Small molecule,1975.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C9H13N.C6H10O4/c1-8(10)7-9-5-3-2-4-6-9;7-5(8)3-1-2-4-6(9)10/h2-6,8H,7,10H2,1H3;1-4H2,(H,7,8)(H,9,10)/t8-;/m0./s1",OFCJKOOVFDGTLY-QRPNPIFTSA-N,C[C@H](N)Cc1ccccc1.O=C(O)CCCCC(=O)O,0.6656404299220928,4.0,281.3519999999999,2.2923,3,3,1,100.62000000000002,-1.5895182783390844,0.6982911705970765,-5.370341461646975,0.681342077255249,-9.997450258447193,0.09224871471524239,0.02711195209994912,0.654277789592743,64.4310169323847,3.824388318095282,0.006728773034410551,0.023649827763438224,0.0075515186414122585,0.22214358896017075,0.001553678174968809,10.241909794530528,39.71137701912352,-27.588338733563454,2.1647865489304503,0.04840202778577805,0.16540559530258178,0.15939089506864548,0.06752537470310926,0.1286362960934639,0.026144454814493658,0.0038991127163171767,0.24560689628124238,0.033956756070256236,0.006278223218396306,0.0012111591873690485,0.005349891059449874,0.0011215744831133633,0.008586571901105344,0.003088720893720165,0.001860899548046291,0.3680096104741096,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,893.0,1343296.0,1926820.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,DEXTROAMPHETAMINE SULFATE,CHEMBL3544971,4.0,1.0,1.0,MOL,51064.0,Small molecule,1960.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,Stimulant (central),0.0,0.0,0.0,"InChI=1S/2C9H13N.H2O4S/c2*1-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h2*2-6,8H,7,10H2,1H3;(H2,1,2,3,4)/t2*8-;/m00./s1",PYHRZPFZZDCOPH-QXGOIDDHSA-N,C[C@H](N)Cc1ccccc1.C[C@H](N)Cc1ccccc1.O=S(=O)(O)O,0.6141928866476464,4.0,368.499,2.4998,4,4,2,126.64000000000001,-0.6091929500571556,0.6808286786079407,-5.751627172074963,0.6683352768421174,-8.204697169451094,0.3347656086087227,0.17100484520196915,0.6459482073783874,69.5855366130397,1.5353960342744508,0.033637421764433385,0.05083912694826722,0.01018219570396468,0.6546050310134888,0.019088525790721178,130.3792170847342,16.17001245580555,-12.462453253367823,2.341239480148986,0.07629267815500498,0.5162569165229798,0.28945929408073423,0.082684026658535,0.5811769872903824,0.0210968516767025,0.007629748154431582,0.1808180958032608,0.03469808809459209,0.014167542289942502,0.005861141800414771,0.0012449050094801351,0.0010200745426118373,0.00963520492077805,0.09746090471744537,0.0038390987872844564,0.4283844754099846,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,894.0,1343558.0,2197715.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,DEXTROAMPHETAMINE SACCHARATE,CHEMBL3989844,4.0,1.0,1.0,MOL,,Small molecule,1996.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C9H13N.C6H10O8/c1-8(10)7-9-5-3-2-4-6-9;7-1(3(9)5(11)12)2(8)4(10)6(13)14/h2-6,8H,7,10H2,1H3;1-4,7-10H,(H,11,12)(H,13,14)/t8-;1-,2-,3-,4+/m00/s1",VHKVKWTWHZUFIA-DGOKBZBKSA-N,C[C@H](N)Cc1ccccc1.O=C(O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O,0.2989053002700252,3.0,345.34800000000007,-1.8244999999999982,7,7,5,181.54,-0.8370461633510164,0.34345616698265075,-6.804263456159246,0.21970801651477814,-17.24628219506571,0.03633559970185161,0.04490963462740183,0.3936010003089905,45.21426117441017,6.8739956787883445,0.09516576938331127,0.12047938406467437,0.012924438621848822,0.4956028461456299,0.0015456694876775146,6.921032216367618,-1.371460356989718,-20.040350616578046,1.63175837240267,0.018254402000457047,0.05769712217152119,0.23184707015752792,0.08098908886313438,0.13570516034960747,0.09144341312348843,0.01799986306577921,0.15087483674287797,0.04830547124147415,0.010966064408421516,0.0018876510031986982,0.002520512361661531,0.0014398242601600941,0.0034842614259105176,0.0035515450756065546,0.002570348687004298,0.15025195777416228,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,895.0,1343740.0,543703.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DIETHYLPROPION HYDROCHLORIDE,CHEMBL1693,4.0,1.0,1.0,MOL,643703.0,Small molecule,1959.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Anorexic,0.0,0.0,0.0,"InChI=1S/C13H19NO.ClH/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12;/h6-11H,4-5H2,1-3H3;1H",ICFXZZFWRWNZMA-UHFFFAOYSA-N,CCN(CC)C(C)C(=O)c1ccccc1.Cl,0.7390237733304519,4.0,241.76200000000003,3.021400000000002,2,0,1,20.310000000000002,-1.6591955531401061,0.904048752784729,-4.34602067561164,0.9989917874336243,-5.894533936282639,0.956946587562561,0.05185201596468687,0.9662218451499939,42.64150886341453,11.875745816782048,0.5189070910215378,0.36055023074150083,0.024555709585547446,0.735551631450653,0.004784883465617895,62.001003068799534,71.36272816215012,28.498831054534797,2.8821592360259793,0.38761005699634554,0.431837660074234,0.37421857863664626,0.06387050859630108,0.5183368861675263,0.003740596678107977,0.005499198101460934,0.22992732524871826,0.006682736519724131,0.013939536083489657,0.003216506773605943,0.004553698486415669,0.02054523313418031,0.007760813180357218,0.005530751054175198,0.003213511686772108,0.9493849635124206,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,896.0,1343413.0,674434.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PHENMETRAZINE HYDROCHLORIDE,CHEMBL1200483,4.0,1.0,1.0,MOL,8068.0,Small molecule,1982.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,Anorexic,0.0,0.0,0.0,"InChI=1S/C11H15NO.ClH/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10;/h2-6,9,11-12H,7-8H2,1H3;1H",VJNXVAVKCZJOFQ-UHFFFAOYSA-N,CC1NCCOC1c1ccccc1.Cl,0.7722252019917194,4.0,213.70800000000003,2.1578000000000004,2,1,2,21.259999999999998,-1.4837061372738145,0.9721078753471375,-4.566652477806483,0.9999360680580139,-6.638097989185809,0.864057433605194,0.008258472546003759,0.9803838133811951,41.927802421558624,0.5372359825811418,0.051853903010487555,0.6601281821727752,0.008311443449929356,0.3854674190282822,0.01676063798367977,2.0226329396184157,39.7872170426482,-28.08754794771948,2.70090369798531,0.7606792569160461,0.1956336997449398,0.15274839624762535,0.06719269156455994,0.2028198778629303,0.00372105804271996,0.0010166089967242442,0.08231448382139206,0.003411706746555865,0.013336409768089651,0.003987334738485515,0.0010111407551448791,0.0015675933856982738,0.010135619272477924,0.0017743606731528416,0.0014433870928769466,0.827048909664154,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,897.0,1344287.0,674328.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,AMPHETAMINE ASPARTATE,CHEMBL1200377,4.0,1.0,1.0,MOL,,Small molecule,1996.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C9H13N.C4H7NO4/c1-8(10)7-9-5-3-2-4-6-9;5-2(4(8)9)1-3(6)7/h2-6,8H,7,10H2,1H3;2H,1,5H2,(H,6,7)(H,8,9)",DYOBNLAYPQSBLB-UHFFFAOYSA-N,CC(N)Cc1ccccc1.NC(CC(=O)O)C(=O)O,0.6137456922602698,4.0,268.31299999999993,0.44930000000000037,4,4,2,126.64,-1.1439142734052454,0.8382505774497986,-5.891021687104558,0.8790804505348205,-12.689703186355962,0.059314321260899305,0.006005261605605483,0.599317979812622,45.58086848573804,5.881021520634237,0.005748827871866524,0.05526438131928444,0.011422447208315135,0.1968353271484375,0.002458689594641328,-0.27614264391684884,9.823386894287578,-32.21448833295089,2.116213282648152,0.06401470750570297,0.22286041229963302,0.17371430844068528,0.072785734385252,0.02904830239713192,0.03599645420908928,0.00440611788071692,0.1204824060201645,0.013369634095579386,0.018958995677530767,0.000685867021093145,0.0043366396042983976,0.001339064963394776,0.006267219688743353,0.0013699183822609485,0.0011390100844437256,0.3688080534338951,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,898.0,1344680.0,2197716.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IMIPRAMINE PAMOATE,CHEMBL3989845,4.0,1.0,1.0,MOL,,Small molecule,1973.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-pramine,0.0,-pramine,antidepressants (imipramine type),,0.0,0.0,0.0,"InChI=1S/C23H16O6.2C19H24N2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;2*1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2*3-6,8-11H,7,12-15H2,1-2H3",BPQZYOJIXDMZSX-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2CCc2ccccc21.CN(C)CCCN1c2ccccc2CCc2ccccc21.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,0.09397480895963967,2.0,949.2050000000003,12.141399999999985,8,4,0,128.02,-4.8573465647394825,0.6867950439453125,-5.688282322737377,0.8422906994819641,-9.96256592723638,0.35573360323905945,0.8018692851066589,0.4912393420934677,89.33600228548792,-1.8252439440119943,0.12567230463027954,0.2583458602428436,0.12138337008655072,0.3945657223463058,0.014532338734716177,53.5299453290509,37.10579578011051,34.629933139375,2.786001154185987,0.3503122955560684,0.3217746436595917,0.25130014792084693,0.7981622338294982,0.8794772863388062,0.00894914916716516,0.005250508361496031,0.06558241453021765,0.02879303190857172,0.14585687071084977,0.06776039376854896,0.11453655138611793,0.011537761893123388,0.1306905746459961,0.31216539442539215,0.08916784711182117,0.4532512366771698,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,900.0,1344804.0,8838.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,AMPHETAMINE SULFATE,CHEMBL501,4.0,1.0,1.0,MOL,,Small molecule,1960.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Stimulant (central),0.0,0.0,0.0,"InChI=1S/C9H13N.H2O4S/c1-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h2-6,8H,7,10H2,1H3;(H2,1,2,3,4)",SOFQDLYSFOWTJX-UHFFFAOYSA-N,CC(N)Cc1ccccc1.O=S(=O)(O)O,0.6594121748055052,4.0,233.289,0.9235000000000004,3,3,1,100.62,-0.5902416407833257,0.527573436498642,-5.346252401459189,0.5316229999065399,-9.083417907455134,0.16869634962640703,0.028268561139702796,0.7648646235466003,52.941976003107605,-0.9460939700235279,0.004557102377293632,0.031200415408238768,0.0027276584762148557,0.11519527286291123,0.00023428962740581482,114.45174723027901,-9.397939210217483,-19.349444778102363,2.0738714092922264,0.04845455060712993,0.5139759838581085,0.07967217676341534,0.17349853813648225,0.058499799994751814,0.010488283634185792,0.002461749198846519,0.09227442443370819,0.006945943925529718,0.012361197057180107,0.0004871035227552056,0.00015077730335519846,0.0004792634804289264,0.0059926653178990815,0.05230997074395418,0.0030979378148913383,0.3526746317744255,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,901.0,1343212.0,674279.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DULOXETINE HYDROCHLORIDE,CHEMBL1200328,4.0,1.0,1.0,MOL,31526.0,Small molecule,2004.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1992.0,1.0,-oxetine,0.0,-oxetine,antidepressants (fluoxetine type),Antidepressant,0.0,0.0,0.0,"InChI=1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1",BFFSMCNJSOPUAY-LMOVPXPDSA-N,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1.Cl,0.6809814729769105,3.0,333.88399999999996,5.052700000000004,3,1,1,21.259999999999998,-3.4942339186550084,0.8664428353309631,-5.059560321543573,0.9994845032691956,-8.521792992785176,0.8582085013389588,0.7577490925788879,0.9621421694755554,93.26207011306671,-2.264367322117142,0.978204882144928,0.6786476612091065,0.1869940847158432,0.9708940029144287,0.4514618694782257,62.32009350321762,97.04509311484333,36.61805595117268,2.9467156342521794,0.8010842323303222,0.2963264942169189,0.5638457417488099,0.616422027349472,0.9338569521903992,0.016124051250517368,0.017891865596175192,0.198193496465683,0.049949420243501665,0.5289232492446899,0.2830473333597183,0.05632146000862122,0.06600979678332805,0.17451701164245606,0.28750030398368837,0.15182631611824035,0.5573670983314514,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,902.0,1344593.0,543.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,AMPHETAMINE,CHEMBL405,4.0,1.0,1.0,MOL,2679.0,Small molecule,1955.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Stimulant (central),0.0,0.0,0.0,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3",KWTSXDURSIMDCE-UHFFFAOYSA-N,CC(N)Cc1ccccc1,0.6542162175383444,4.0,135.20999999999998,1.5763,1,1,1,26.02,-0.7221082117859007,0.9201722383499146,-4.301886686461397,0.9999283432960511,-5.586457785380545,0.8416708588600159,0.0028655495261773467,0.9706936120986939,23.542596761647555,3.540412723244381,0.07169664949178696,0.08182436442002654,0.0034562395652756096,0.32913356423377993,0.0028165165334939958,2.486405618399318,52.789338040078675,-21.410771588623636,3.0178387153475703,0.030397314764559268,0.26893479749560356,0.01566268651804421,0.004958259733393788,0.2067801147699356,0.007039053924381733,0.0005639401555527001,0.057165412977337834,0.0018218341167084873,0.00398509930819273,0.0004565285562421195,8.150392138759344e-05,4.718980353572988e-05,0.0017086507519707083,0.0007673084503039718,4.75861235827324e-05,0.8374063968658447,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,903.0,1343844.0,2197726.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,PSEUDOEPHEDRINE SULFATE,CHEMBL3989855,4.0,1.0,1.0,MOL,,Small molecule,1963.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1978.0,2.0,-drine,0.0,-drine,sympathomimetics,,0.0,0.0,0.0,"InChI=1S/2C10H15NO.H2O4S/c2*1-8(11-2)10(12)9-6-4-3-5-7-9;1-5(2,3)4/h2*3-8,10-12H,1-2H3;(H2,1,2,3,4)/t2*8-,10+;/m00./s1",CAVQBDOACNULDN-NRCOEFLKSA-N,CN[C@@H](C)[C@@H](O)c1ccccc1.CN[C@@H](C)[C@@H](O)c1ccccc1.O=S(=O)(O)O,0.38415562637133444,3.0,428.5510000000001,2.003,6,6,4,139.12,-0.09279204079394035,0.4514477729797363,-6.569756280838634,0.18321618288755417,-13.683542882243591,0.18992950394749641,0.10289202108979226,0.0852576095610857,51.53964550537794,0.3371055059488744,0.04426424764096737,0.029810905735939742,0.004051486263051629,0.5168928325176239,0.007627061754465103,123.0415555261844,-10.581086028652907,-14.778259467845297,1.712477245792145,0.021297626267187297,0.25927311182022095,0.26069667041301725,0.08021707832813263,0.44907506108283995,0.05878010205924511,0.013902779622003435,0.1648051157593727,0.012288288306444883,0.0072811808437109,0.0016011691419407724,0.00043437977765279354,0.000476437453107792,0.003078163653117372,0.03652321891859174,0.0020296303009672556,0.2536011546850204,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,904.0,1343143.0,674915.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AMITRIPTYLINE HYDROCHLORIDE,CHEMBL1200964,4.0,1.0,1.0,MOL,,Small molecule,1961.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-triptyline,0.0,-triptyline,"antidepressants (dibenzol[a,d]cycloheptane derivatives)",Antidepressant,0.0,0.0,0.0,"InChI=1S/C20H23N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-12H,7,13-15H2,1-2H3;1H",KFYRPLNVJVHZGT-UHFFFAOYSA-N,CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl,0.8007811645803259,4.0,313.872,4.590400000000005,1,0,0,3.24,-3.717028945510063,0.9248571157455444,-4.62116286171429,0.9974303483963013,-6.280061521056382,0.8661195635795593,0.7863188266754151,0.9918947577476501,90.0697989115679,2.176070823916296,0.7609673500061035,0.2672695487737656,0.01933695040643215,0.837408983707428,0.033141975104808805,41.890813493462424,63.512426314298764,10.636300209005842,2.458571066463846,0.7151204466819763,0.4020951747894287,0.40520374178886415,0.3376240074634552,0.9647270321846009,0.008294837735593318,0.007386540342122316,0.05945836268365383,0.024903662130236627,0.09691578000783921,0.1219160184264183,0.018853831477463244,0.012005101982504129,0.05228508841246367,0.22195062786340714,0.04794083572924137,0.870793092250824,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,905.0,1344632.0,674283.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PROTRIPTYLINE HYDROCHLORIDE,CHEMBL1200332,4.0,1.0,1.0,MOL,8598.0,Small molecule,1967.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1963.0,1.0,-triptyline,0.0,-triptyline,"antidepressants (dibenzol[a,d]cycloheptane derivatives)",Antidepressant,0.0,0.0,0.0,"InChI=1S/C19H21N.ClH/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19;/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3;1H",OGQDIIKRQRZXJH-UHFFFAOYSA-N,CNCCCC1c2ccccc2C=Cc2ccccc21.Cl,0.8052987995852723,4.0,299.84499999999997,4.7237000000000045,1,1,0,12.03,-3.3021547196506567,0.9198317050933837,-4.87397578798677,0.999354362487793,-6.29483319324099,0.8378912210464478,0.5413637638092041,0.9881995677947998,90.23076726638996,13.345906372161616,0.8287551999092102,0.3360354244709015,0.04179332908242941,0.9472295999526977,0.08107832111418248,31.04826245857268,52.354633288176366,-5.461057888631875,2.7944733615775297,0.7984325051307678,0.4601561963558197,0.46734212040901185,0.33436214327812197,0.9609168410301209,0.010831140540540218,0.009615551680326462,0.15310467779636383,0.029131488129496574,0.3576705574989319,0.08777239993214607,0.015004462841898204,0.022301949560642242,0.07365832030773163,0.3482886701822281,0.07516974359750747,0.8362845301628112,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,906.0,1344586.0,674338.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,AMPHETAMINE ADIPATE,CHEMBL1200387,4.0,1.0,1.0,MOL,,Small molecule,1975.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C9H13N.C6H10O4/c1-8(10)7-9-5-3-2-4-6-9;7-5(8)3-1-2-4-6(9)10/h2-6,8H,7,10H2,1H3;1-4H2,(H,7,8)(H,9,10)",OFCJKOOVFDGTLY-UHFFFAOYSA-N,CC(N)Cc1ccccc1.O=C(O)CCCCC(=O)O,0.6656404299220928,4.0,281.3519999999999,2.2923,3,3,1,100.62000000000002,-1.5096587679527753,0.7089275479316711,-5.372219671037277,0.7364632546901703,-10.027233478909821,0.09437476880848408,0.0238655642606318,0.6682131469249726,62.951248058746614,4.037286486763175,0.0076891996257472785,0.032128147315233946,0.009732634481042623,0.22140561938285827,0.001473563036415726,9.507090159937126,38.42274558000214,-28.45812355559143,2.1812675376608346,0.05070431791245937,0.1861524000763893,0.16526559889316558,0.08204758614301681,0.13177209496498107,0.024912566225975753,0.003736922470852733,0.2488318234682083,0.035265103727579114,0.007155605917796492,0.0011748096148949116,0.007388667174382135,0.001346217916579917,0.01006582488771528,0.0034750205231830478,0.0020248685381375254,0.38458492159843444,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,907.0,1343619.0,545956.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,BUPROPION HYDROCHLORIDE,CHEMBL1698,4.0,1.0,1.0,MOL,,Small molecule,1985.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1974.0,1.0,,0.0,,,Antidepressant,0.0,0.0,0.0,"InChI=1S/C13H18ClNO.ClH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H",HEYVINCGKDONRU-UHFFFAOYSA-N,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl,0.8523538514649887,4.0,276.207,3.721100000000003,2,1,1,29.1,-3.0834840318245105,0.9293444037437439,-4.50511717286943,0.9999186396598816,-6.084861499899931,0.9817874431610107,0.03347514010965824,0.9117377400398254,59.72546238531635,10.785031652680289,0.3543334506452084,0.5298106729984283,0.03007307918742299,0.6738880157470704,0.10114082079380751,44.746461094705786,53.306394473877766,13.20115248962241,2.718182215983202,0.10838802717626095,0.5047707796096802,0.09671306051313877,0.08450250774621963,0.2421892285346985,0.002460174961015582,0.0015252573706675322,0.19661520272493363,0.036770187132060525,0.06542571559548378,0.02504813838750124,0.0031545242934953423,0.0025062847009394316,0.020160710252821446,0.12519921995699407,0.0031999851285945623,0.7507711887359619,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,908.0,1343253.0,2335035.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MILNACIPRAN HYDROCHLORIDE,CHEMBL4297064,4.0,1.0,1.0,MOL,,Small molecule,2009.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2007.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H",XNCDYJFPRPDERF-UHFFFAOYSA-N,CCN(CC)C(=O)C1(c2ccccc2)CC1CN.Cl,0.8998494806260565,4.0,282.815,2.1931999999999996,2,1,2,46.33,-1.2194842267809352,0.9357480525970459,-4.446883214986661,0.9998738527297973,-8.64684290649556,0.9282721281051636,0.0058677927125245334,0.9774015069007873,35.99992691668943,4.020619694549086,0.04514851868152618,0.3175425171852112,0.013670997694134712,0.4561747074127197,0.3910734072327614,16.83064364549433,53.93336139980333,5.748112361411631,2.889553634725703,0.6388581156730652,0.34769933223724364,0.31924513876438143,0.02015221808105707,0.3195833623409271,0.003852898441255093,0.0026679453381802886,0.05325196646153927,0.010991953546181321,0.035122723784297705,0.017368228267878295,0.0005915126675972715,0.002798534696921706,0.01051623821258545,0.0063306157477200035,0.0021644638385623694,0.7201385021209716,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,909.0,1344047.0,49842.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,METHYLPHENIDATE,CHEMBL796,4.0,1.0,1.0,MOL,84276.0,Small molecule,1955.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,2003.0,1.0,,0.0,,,Stimulant (central),0.0,0.0,0.0,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3",DUGOZIWVEXMGBE-UHFFFAOYSA-N,COC(=O)C(c1ccccc1)C1CCCCN1,0.8123400616112664,4.0,233.31099999999995,2.0852999999999997,3,1,2,38.33,-1.4342615611128902,0.7546398997306824,-4.436762740162753,0.9999557256698608,-7.557833457053294,0.9534605979919434,0.005678430409170687,0.970595908164978,39.59517257524923,-0.9230447233314727,0.019439585600048305,0.4372869312763214,0.01988354790955782,0.289931720495224,0.04859275557100773,-10.757282857235769,60.81680630771213,-5.794224351028776,2.6278603232641897,0.08293904066085815,0.016782031045295298,0.0760173812508583,0.03974951934069395,0.1758678823709488,0.005489223310723901,0.0007564660219941289,0.05077860206365585,0.0020485171698965132,0.0051992821739986535,0.0018845862708985806,0.0006198952341947006,0.0006547150274855085,0.0043585424835328014,0.00043065976642537863,0.0004338641971116886,0.83335862159729,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,910.0,1344279.0,552883.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,METHYLPHENIDATE HYDROCHLORIDE,CHEMBL1722,4.0,1.0,1.0,MOL,31836.0,Small molecule,1955.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,1.0,,0.0,,,Stimulant (central),0.0,0.0,0.0,"InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H",JUMYIBMBTDDLNG-UHFFFAOYSA-N,COC(=O)C(c1ccccc1)C1CCCCN1.Cl,0.8572108764494875,4.0,269.77199999999993,2.5071000000000008,3,1,2,38.33,-2.0294507821526158,0.7860412120819091,-4.731685786116212,0.9998662233352661,-7.594633438891941,0.9173569798469543,0.016215654090046883,0.9322659254074097,54.6669836158055,1.9686356331515775,0.036181410774588585,0.6009801924228668,0.02448377637192607,0.7220943331718445,0.07112510893493891,3.526070001055378,55.135870493560844,-2.2569278027818553,2.9300655836107627,0.28265341818332673,0.05487668979912996,0.25576481521129607,0.052801552787423135,0.4380472004413605,0.0041954511310905215,0.0023002262925729154,0.10664979070425033,0.0058674364350736145,0.01144477678462863,0.005049645761027932,0.002186724862258416,0.0036414272733964028,0.012174255307763815,0.0011428290221374483,0.0019502497976645826,0.8656389713287354,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,911.0,1344096.0,674443.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NEFAZODONE HYDROCHLORIDE,CHEMBL1200492,4.0,1.0,1.0,MOL,7495.0,Small molecule,1994.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1984.0,1.0,,0.0,,,Antidepressant,1.0,0.0,0.0,"InChI=1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H",DYCKFEBIOUQECE-UHFFFAOYSA-N,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl,0.4167060854057817,3.0,506.47800000000035,3.973700000000003,7,0,0,55.53,-4.111038408799574,0.7055022120475769,-5.197354869510391,0.9987738490104675,-8.04651586715688,0.9508721828460693,0.9753796100616455,0.7955697178840637,97.29441161811194,-2.6150013035120123,0.1325439989566803,0.7827199935913086,0.4636274755001068,0.5982698500156403,0.9401918172836303,4.563724042947096,59.446906860385035,57.058081598458514,2.8659757458426887,0.3339324712753296,0.422669780254364,0.5484588861465454,0.6348129749298096,0.9598268151283265,0.013929997477680445,0.009046681737527252,0.057349677011370656,0.03675952386111021,0.04313311465084553,0.14363451451063156,0.05461949408054352,0.004847086081281304,0.07122595012187957,0.21692579984664917,0.06344565227627755,0.4169317245483398,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,593.0,1344096.0,674443.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,NEFAZODONE HYDROCHLORIDE,CHEMBL1200492,4.0,1.0,1.0,MOL,7495.0,Small molecule,1994.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1984.0,1.0,,0.0,,,Antidepressant,1.0,0.0,0.0,"InChI=1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H",DYCKFEBIOUQECE-UHFFFAOYSA-N,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl,0.4167060854057817,3.0,506.47800000000035,3.973700000000003,7,0,0,55.53,-4.111038408799574,0.7055022120475769,-5.197354869510391,0.9987738490104675,-8.04651586715688,0.9508721828460693,0.9753796100616455,0.7955697178840637,97.29441161811194,-2.6150013035120123,0.1325439989566803,0.7827199935913086,0.4636274755001068,0.5982698500156403,0.9401918172836303,4.563724042947096,59.446906860385035,57.058081598458514,2.8659757458426887,0.3339324712753296,0.422669780254364,0.5484588861465454,0.6348129749298096,0.9598268151283265,0.013929997477680445,0.009046681737527252,0.057349677011370656,0.03675952386111021,0.04313311465084553,0.14363451451063156,0.05461949408054352,0.004847086081281304,0.07122595012187957,0.21692579984664917,0.06344565227627755,0.4169317245483398,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,912.0,1344972.0,675107.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NORTRIPTYLINE HYDROCHLORIDE,CHEMBL1201156,4.0,1.0,1.0,MOL,,Small molecule,1964.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1963.0,1.0,-triptyline,0.0,-triptyline,"antidepressants (dibenzol[a,d]cycloheptane derivatives)",Antidepressant,0.0,0.0,0.0,"InChI=1S/C19H21N.ClH/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19;/h2-5,7-11,20H,6,12-14H2,1H3;1H",SHAYBENGXDALFF-UHFFFAOYSA-N,CNCCC=C1c2ccccc2CCc2ccccc21.Cl,0.8356463283652654,4.0,299.84499999999997,4.248200000000004,1,1,0,12.03,-2.9937453543989223,0.9187914609909058,-4.8520287622971,0.9994438290596008,-6.6109575346842675,0.8125720858573914,0.6681843161582947,0.9848695397377014,90.89258873418876,11.987514103664346,0.9270091772079467,0.5315695464611053,0.04934854917228222,0.9247971653938294,0.12958835065364838,38.78831557612694,77.89242304381713,3.952686357000996,2.4913520450106406,0.8259897112846375,0.5209405362606049,0.4565032243728638,0.389036038517952,0.9553876042366027,0.009574787179008126,0.012278653588145972,0.1098294846713543,0.0354642603546381,0.2390060693025589,0.13980353474617005,0.025120125152170658,0.024197411723434925,0.1053256407380104,0.31632464826107026,0.10373755097389221,0.8661362290382385,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,915.0,1343843.0,674675.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,PSEUDOEPHEDRINE HYDROCHLORIDE,CHEMBL1200724,4.0,1.0,1.0,MOL,8604.0,Small molecule,1975.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1963.0,2.0,-drine,0.0,-drine,sympathomimetics,Adrenergic (vasoconstrictor),0.0,0.0,0.0,"InChI=1S/C10H15NO.ClH/c1-8(11-2)10(12)9-6-4-3-5-7-9;/h3-8,10-12H,1-2H3;1H/t8-,10+;/m0./s1",BALXUFOVQVENIU-KXNXZCPBSA-N,CN[C@@H](C)[C@@H](O)c1ccccc1.Cl,0.7813001545014681,4.0,201.697,1.7496999999999998,2,2,2,32.26,-0.8268747934380343,0.93086017370224,-5.114928600089837,0.9976859450340271,-11.1908352324406,0.5133415281772613,0.013216839637607336,0.4427116274833679,23.314114700065744,17.84986037376758,0.04402152635157108,0.01161237310152501,0.0003554121994966408,0.3256103843450546,0.0004989378474419936,22.111847718716014,3.9544259918018674,-41.22630836934573,2.4849890603143736,0.10913260318338872,0.27962917387485503,0.10441509895026684,0.012997738271951675,0.13012441471219063,0.03127634599804878,0.003910656459629536,0.07890064120292664,0.0013202967937104404,0.0026421392103657126,0.0003210897790268064,0.00020175420359009878,0.00013789999138680287,0.0006640304498432669,0.0005003551537811291,0.0001434275184692524,0.6160671472549438,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,916.0,1343847.0,1355754.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,PHENDIMETRAZINE TARTRATE,CHEMBL2062163,4.0,1.0,1.0,MOL,,Small molecule,1976.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C12H17NO.C4H6O6/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11;5-1(3(7)8)2(6)4(9)10/h3-7,10,12H,8-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t10-,12+;/m0./s1",VEPOHXYIFQMVHW-XOZOLZJESA-N,C[C@H]1[C@H](c2ccccc2)OCCN1C.O=C(O)C(O)C(O)C(=O)O,0.6004203687413272,4.0,341.36,-0.04439999999999955,6,4,4,127.53000000000002,-0.3079074732693094,0.6437162637710572,-6.271976107496273,0.48308650255203245,-16.07815946453111,0.06562130991369486,0.017052603606134652,0.4492290556430817,36.7282263896421,4.405190925680116,0.012724431825336068,0.049343974143266675,0.003285289346240461,0.16110471170395613,0.0019865548689267597,-12.168213627470939,-19.67106457312768,-26.238038026349436,1.8098942749160383,0.047921994142234324,0.04552461616694927,0.4603786036372185,0.2625144302845001,0.04308892264962196,0.08176621049642563,0.006529111135751009,0.10501721650362014,0.01403070306405425,0.01120297908782959,0.0023038621176965533,0.004782896069809794,0.0042454900860320775,0.004209209617692977,0.0020465458190301435,0.005390435631852597,0.29161425679922104,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,917.0,1344552.0,674646.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,PHENYLPROPANOLAMINE HYDROCHLORIDE,CHEMBL1200695,4.0,1.0,1.0,MOL,,Small molecule,1958.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,-2.0,,0.0,,,Adrenergic (vasoconstrictor),1.0,0.0,0.0,"InChI=1S/C9H13NO.ClH/c1-7(10)9(11)8-5-3-2-4-6-8;/h2-7,9,11H,10H2,1H3;1H",DYWNLSQWJMTVGJ-UHFFFAOYSA-N,CC(N)C(O)c1ccccc1.Cl,0.7372159290846667,4.0,187.67,1.489,2,2,2,46.25,-0.8214149464692037,0.9129527688026429,-4.942428880030013,0.9997373342514038,-9.991493105286688,0.49156837463378905,0.01019065927248448,0.6890249252319336,29.35006456252284,4.988426548040925,0.037882059812545776,0.04100288627669215,0.003130233864067122,0.39917334318161013,0.001579615194350481,8.363184058175879,19.470466456736563,-26.86790629456728,2.407355594517358,0.10331164188683033,0.48969066739082334,0.03027356043457985,0.004955334705300629,0.12597489804029466,0.009494305308908223,0.004998558107763529,0.03427017256617546,0.0019086081709247082,0.0032189181074500084,0.0007163991089328192,0.00033860221483337225,0.00010884174744205666,0.001938193361274898,0.0013896288604883012,0.00019607518820521363,0.4927477687597275,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,918.0,1344995.0,675728.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TAPENTADOL HYDROCHLORIDE,CHEMBL1201777,4.0,1.0,1.0,MOL,,Small molecule,2008.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,,1.0,-adol,0.0,-adol,analgesics (mixed opiate receptor agonists/antagonists),,0.0,0.0,0.0,"InChI=1S/C14H23NO.ClH/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12;/h6-9,11,14,16H,5,10H2,1-4H3;1H/t11-,14+;/m0./s1",ZELFLGGRLLOERW-YECZQDJWSA-N,CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl,0.8727739474641211,4.0,257.80499999999995,3.505300000000003,2,1,2,23.47,-2.140813858361965,0.8762996554374695,-4.753621468195475,0.9953371763229371,-7.006298145740791,0.8448994159698486,0.10227086842060089,0.8749452471733093,62.03063855727921,0.7657737624630813,0.19189309142529964,0.014047687686979771,0.005819839041214437,0.6528905808925629,0.02957638730877079,32.910583433881975,78.08970758379735,24.164791434215736,2.870347779894736,0.07292537000030279,0.27523122280836104,0.13171837851405144,0.015476924180984498,0.9016192555427551,0.004193678125739097,0.0005409146629972384,0.10331300646066666,0.022933147568255662,0.006537529733031988,0.013615871593356133,0.0006828698853496463,0.0007385167846223339,0.009542033029720186,0.1285384450107813,0.00408055484876968,0.7748025178909301,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,919.0,1344311.0,543658.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,IMIPRAMINE HYDROCHLORIDE,CHEMBL1692,4.0,1.0,1.0,MOL,5882.0,Small molecule,1959.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,,1.0,-pramine,0.0,-pramine,antidepressants (imipramine type),Antidepressant,0.0,0.0,0.0,"InChI=1S/C19H24N2.ClH/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21;/h3-6,8-11H,7,12-15H2,1-2H3;1H",XZZXIYZZBJDEEP-UHFFFAOYSA-N,CN(C)CCCN1c2ccccc2CCc2ccccc21.Cl,0.8296313675542119,4.0,316.87600000000003,4.296800000000005,2,0,0,6.48,-3.8636156539114572,0.9130439281463623,-4.452117527206658,0.9950546264648438,-6.377513928268903,0.8856257319450378,0.7675469160079956,0.9965688824653626,92.08941526690155,-0.9888822930257888,0.3339943617582321,0.20357983112335204,0.008587157493457198,0.9322310805320739,0.02037281347438693,29.005191751556147,97.29945232388204,29.99489187800044,2.3865004521241,0.5072202444076538,0.2866217136383057,0.41161113083362577,0.2240836054086685,0.9830087065696717,0.0072257696650922295,0.004280927032232285,0.040146031975746156,0.01350149791687727,0.0484927274286747,0.0872980773448944,0.006002758629620075,0.003896379005163908,0.025943075958639383,0.12033869810402394,0.038044564053416254,0.8519124269485474,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,920.0,1344227.0,675129.0,Norepinephrine transporter releasing agent,,RELEASING AGENT,1.0,1.0,1.0,,,,,LISDEXAMFETAMINE DIMESYLATE,CHEMBL1201178,4.0,1.0,1.0,MOL,,Small molecule,2007.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,2005.0,1.0,-fetamine,0.0,-fetamine,amfetamine derivatives,,0.0,0.0,0.0,"InChI=1S/C15H25N3O.2CH4O3S/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16;2*1-5(2,3)4/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19);2*1H3,(H,2,3,4)/t12-,14-;;/m0../s1",CETWSOHVEGTIBR-FORAGAHYSA-N,CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,0.2689935142797803,4.0,455.5990000000003,0.19810000000000338,7,5,2,189.88000000000002,-0.07503226383531576,0.4405499458312988,-6.666725753476738,0.2864170536398888,-10.2897744651246,0.24012642502784728,0.13480687588453294,0.5274002552032471,47.74732589384804,-6.919810977971254,0.05134740248322487,0.07087778970599175,0.022234278731048107,0.47893501818180084,0.13184075504541398,114.4127538386555,14.91595067113401,-17.303071856586424,2.129261392065864,0.36264716684818266,0.6341368973255157,0.3407381594181061,0.22218449115753175,0.5266960561275482,0.05013637878000736,0.02349112369120121,0.17460560500621797,0.049341863766312596,0.019639558251947166,0.014485881570726633,0.002068965692888014,0.00535972032812424,0.01970509560778737,0.10741109643131494,0.02306332834996283,0.4596843421459198,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,922.0,1343312.0,675017.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VENLAFAXINE HYDROCHLORIDE,CHEMBL1201066,4.0,1.0,1.0,MOL,9944.0,Small molecule,1993.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1989.0,1.0,-faxine,0.0,-faxine,"antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake",Antidepressant,0.0,0.0,0.0,"InChI=1S/C17H27NO2.ClH/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14;/h7-10,16,19H,4-6,11-13H2,1-3H3;1H",QYRYFNHXARDNFZ-UHFFFAOYSA-N,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1.Cl,0.903372552226282,4.0,313.86899999999986,3.457400000000003,3,1,1,32.7,-1.9971138668029405,0.9366032361984253,-4.418400803242613,0.9987378358840943,-8.674320184993293,0.9042585730552674,0.30755414962768557,0.9420625567436218,45.68470514731621,3.470440669193601,0.07802176419645548,0.1499924972653389,0.006774347275495529,0.9333639860153198,0.15197286233305932,-8.484139406050414,45.66541024231379,19.03628946553969,2.928965710989953,0.319498273730278,0.10961514636874199,0.6067351996898651,0.023736861161887647,0.8670535922050476,0.0031031386461108923,0.0006294166538282298,0.04779312163591385,0.013486930169165134,0.01814623037353158,0.029272234439849852,0.002650098758749664,0.0019386678468436003,0.022428538557142018,0.11276596412062645,0.003735419118311256,0.574070954322815,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,2250.0,1938076.0,2197732.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,DESVENLAFAXINE FUMARATE,CHEMBL3989861,4.0,1.0,1.0,MOL,,Small molecule,2013.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,1.0,-faxine,0.0,-faxine,"antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake",,0.0,0.0,0.0,"InChI=1S/C16H25NO2.C4H4O4.H2O/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16;5-3(6)1-2-4(7)8;/h6-9,15,18-19H,3-5,10-12H2,1-2H3;1-2H,(H,5,6)(H,7,8);1H2/b;2-1+;",YETWCSLOYUZBLK-JITBQSAISA-N,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O.O=C(O)/C=C/C(=O)O,0.5326311881601543,4.0,397.46800000000013,1.6197,5,4,1,149.8,-1.2272553352494544,0.5164535343647003,-6.362935495371703,0.5837973654270172,-14.303077083139533,0.13137086480855942,0.05347797702997923,0.5367744088172912,45.62309318114641,0.24872255104285487,0.02105007115751505,0.09229247942566872,0.03211006559431553,0.23043036609888076,0.004154610179830343,-27.414819176725427,-1.7743429107105697,-16.129918648975366,2.264510177369421,0.06978688165545463,0.08173104971647263,0.3961977601051331,0.13879208452999592,0.17965734750032425,0.024906738847494125,0.006448308005928993,0.18730086386203765,0.06438456308096648,0.0052472831215709444,0.005692607397213579,0.024697853717952967,0.008389882231131195,0.028311741724610328,0.01544088264927268,0.00842097527347505,0.3091591238975525,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,2253.0,1702639.0,1378002.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,LEVOMILNACIPRAN HYDROCHLORIDE,CHEMBL2105732,4.0,1.0,1.0,MOL,,Small molecule,2013.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2011.0,1.0,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H/t13-,15+;/m0./s1",XNCDYJFPRPDERF-NQQJLSKUSA-N,CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl,0.8998494806260565,4.0,282.815,2.1931999999999996,2,1,2,46.33,-1.232900006667333,0.9539237737655639,-4.451635784131591,0.9998181462287903,-8.726287801799192,0.9293354034423829,0.011597383953630924,0.9748362183570862,35.24202360650558,4.104117346475167,0.12661418244242667,0.1907469689846039,0.009437648835591972,0.47424951791763303,0.48462126553058626,17.43487590679446,55.96467296134532,3.3104186535944757,2.8986543898939106,0.6760993838310242,0.26383850872516634,0.46250874996185304,0.025484780967235564,0.3836532086133957,0.004985000612214208,0.004137739737052471,0.04852163251489401,0.009338727197609841,0.047949094837531445,0.017599545046687128,0.0007309190783416853,0.0055807298514992,0.011022745538502932,0.00553920075763017,0.0029413796379230916,0.6378185272216796,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,4896.0,1701432.0,1377256.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TEDATIOXETINE,CHEMBL2104986,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2011.0,,-oxetine,0.0,-oxetine (-tioxetine),antidepressants (fluoxetine type): thioether derivatives,,0.0,0.0,0.0,"InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3",CVASBKDYSQKLSO-UHFFFAOYSA-N,Cc1ccc(Sc2ccccc2C2CCNCC2)cc1,0.8822964051269638,4.0,283.44,4.613220000000004,2,1,0,12.03,-3.5433294914019333,0.9443045616149902,-4.877432535917303,0.9999153017997742,-5.156103158112506,0.9602059960365296,0.31964088678359986,0.9737089157104493,79.45198011252053,1.602583859100293,0.17968648225069045,0.5948261737823486,0.06399861723184586,0.6639077961444855,0.17080398947000502,-2.4590903417749503,51.9681274535872,-10.355374386619594,2.9487943301424386,0.213599993288517,0.10020808801054955,0.15375463888049126,0.20698084235191344,0.8336639046669007,0.013258107751607896,0.002205487131141126,0.18237887620925902,0.024300398770719767,0.031386403180658815,0.02530257645994425,0.005086136469617486,0.002551123313605785,0.07493880428373814,0.07709601260721684,0.007382448483258486,0.832524299621582,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,4898.0,1701432.0,1377256.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TEDATIOXETINE,CHEMBL2104986,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2011.0,,-oxetine,0.0,-oxetine (-tioxetine),antidepressants (fluoxetine type): thioether derivatives,,0.0,0.0,0.0,"InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3",CVASBKDYSQKLSO-UHFFFAOYSA-N,Cc1ccc(Sc2ccccc2C2CCNCC2)cc1,0.8822964051269638,4.0,283.44,4.613220000000004,2,1,0,12.03,-3.5433294914019333,0.9443045616149902,-4.877432535917303,0.9999153017997742,-5.156103158112506,0.9602059960365296,0.31964088678359986,0.9737089157104493,79.45198011252053,1.602583859100293,0.17968648225069045,0.5948261737823486,0.06399861723184586,0.6639077961444855,0.17080398947000502,-2.4590903417749503,51.9681274535872,-10.355374386619594,2.9487943301424386,0.213599993288517,0.10020808801054955,0.15375463888049126,0.20698084235191344,0.8336639046669007,0.013258107751607896,0.002205487131141126,0.18237887620925902,0.024300398770719767,0.031386403180658815,0.02530257645994425,0.005086136469617486,0.002551123313605785,0.07493880428373814,0.07709601260721684,0.007382448483258486,0.832524299621582,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,4999.0,1699805.0,1376099.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,FAXELADOL,CHEMBL2103829,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2008.0,,-adol,0.0,-adol,analgesics (mixed opiate receptor agonists/antagonists),,0.0,0.0,0.0,"InChI=1S/C15H23NO/c1-16(2)11-13-6-3-4-9-15(13)12-7-5-8-14(17)10-12/h5,7-8,10,13,15,17H,3-4,6,9,11H2,1-2H3/t13-,15-/m0/s1",JIRYWFYYBBRJAN-ZFWWWQNUSA-N,CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1,0.8661273969807777,4.0,233.35500000000002,3.2276000000000016,2,1,2,23.47,-2.4497497689904573,0.7837392807006835,-4.579511038451569,0.999123215675354,-7.968825438875234,0.9066145181655884,0.07773681841790676,0.9396692752838135,54.68536504035736,4.7791448641751275,0.20257733166217803,0.02694791220128536,0.00510414870805107,0.37139217406511305,0.030635311920195817,14.547725771703615,97.30822023867874,29.465850374085978,2.6633753404633325,0.047830221429467204,0.052244579792022704,0.09630179926753044,0.0170132446102798,0.6629515528678894,0.013547372817993165,0.001013372591114603,0.12374222204089165,0.04865914732217789,0.021476354589685796,0.013642217731103301,0.0006121080266893841,0.0011093972600065172,0.013091426121536642,0.13496006103232502,0.006161831377539784,0.6533530175685882,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,5616.0,1699854.0,1376127.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,EDIVOXETINE,CHEMBL2103857,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2010.0,,-oxetine,0.0,-oxetine,antidepressants (fluoxetine type),,0.0,0.0,0.0,"InChI=1S/C18H26FNO4/c1-22-16-3-2-15(19)10-13(16)11-18(21,14-4-7-23-8-5-14)17-12-20-6-9-24-17/h2-3,10,14,17,20-21H,4-9,11-12H2,1H3/t17-,18+/m0/s1",CPBHSHYQQLFAPW-ZWKOTPCHSA-N,COc1ccc(F)cc1C[C@@](O)(C1CCOCC1)[C@@H]1CNCCO1,0.851830427392598,4.0,339.40700000000004,1.5229,5,2,2,59.95,-1.2171699943118532,0.978759253025055,-4.457802218392078,0.9998366236686707,-10.39717342441285,0.9088386774063111,0.10652398131787777,0.925205409526825,39.16193551618217,4.361839527166254,0.007803905615583062,0.2152225688099861,0.027249536104500295,0.05740648433566094,0.4617349684238434,5.448182731385037,9.544360327740193,-13.725600403824206,2.884841095446877,0.576399165391922,0.08205857500433922,0.4562683939933777,0.10898640528321266,0.6951270699501038,0.026768168807029723,0.0034276611695531756,0.05228817909955978,0.008785374276340008,0.0378776453435421,0.029517112672328948,0.0013697626302018762,0.0025048746494576333,0.0028126049903221427,0.004034297366160899,0.008563585171941668,0.11329007521271706,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,5711.0,1705222.0,302799.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,ESREBOXETINE,CHEMBL180101,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2007.0,,-oxetine,0.0,-oxetine,antidepressants (fluoxetine type),,0.0,0.0,0.0,"InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1",CBQGYUDMJHNJBX-OALUTQOASA-N,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1,0.8888730494256725,4.0,313.39700000000005,3.1938000000000004,4,1,2,39.72,-2.6086664799668973,0.9436935663223267,-4.483249233002317,0.9999116063117981,-7.6703543730925645,0.9605578422546387,0.2866403117775917,0.9120701670646667,75.12463636345115,0.9007098664062685,0.463596385717392,0.718781840801239,0.1397741124033928,0.2909760385751724,0.5276034653186799,6.88978915554687,67.55846814097747,-0.14692357098115494,2.381787766374076,0.376320818066597,0.10788303315639496,0.14630227237939836,0.39082746505737304,0.7369250535964966,0.014495404716581107,0.0025570721831172706,0.16774577423930168,0.015180522482842207,0.14145423471927643,0.11753001809120178,0.019594166427850723,0.013194762356579303,0.03049725480377674,0.06869221180677414,0.008717124443501234,0.5323973417282104,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,5901.0,1700714.0,14263.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,"It acts by binding to the norepinephrine transporter and blocking reuptake of extracellular norepinephrine (noradrenaline) back into the terminals. A meta-analysis showed that reboxetine (marketed by Pfizer in Europe, but not in the U.S. ) lacks efficacy.",High selectivity for NET over SERT/DAT. Low affinity for monoamine/histamine/ACh receptors,,,REBOXETINE,CHEMBL14370,4.0,1.0,1.0,MOL,,Small molecule,1997.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1997.0,-1.0,-oxetine,0.0,-oxetine,antidepressants (fluoxetine type),,0.0,0.0,0.0,"InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3",CBQGYUDMJHNJBX-UHFFFAOYSA-N,CCOc1ccccc1OC(c1ccccc1)C1CNCCO1,0.8888730494256725,4.0,313.39700000000005,3.1938000000000004,4,1,2,39.72,-2.5017450817432505,0.9273381233215332,-4.485910271864342,0.9999547243118286,-7.532171027097126,0.9658867716789246,0.2638953045010567,0.9199108719825745,73.82780881216374,1.2477123148886782,0.48297980427742004,0.8661590576171875,0.25430398881435395,0.3061883747577667,0.47249366641044616,4.857824086385319,65.08123626023404,-1.878555161923223,2.3850698123338256,0.2443651258945465,0.10335215479135514,0.08092079646885394,0.3870709240436554,0.6730897545814514,0.008178207138553262,0.0012743892904836685,0.1471619948744774,0.011060346756130457,0.12104531228542328,0.08890829011797904,0.024400374665856362,0.007655954034999013,0.03270300030708313,0.05935692489147186,0.005258303601294756,0.5013478517532348,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,6690.0,2791057.0,282577.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,"Debrisoquin is an adrenergic neuron-blocking drug. It acts at the sympathetic neuroeffector junction by inhibiting or interfering with the release and/or distribution of norepinephrine (NE), rather than acting at the effector cell by inhibiting the association of norepinephrine with its receptors. It is taken up by norepinephrine transporters. It becomes concentrated in NE transmitter vesicles, replacing NE in these vesicles. This leads to a gradual depletion of NE stores in the nerve endings. Once inside the terminal it blocks the release of noradrenaline in response to arrival of an action potential. In contrast to ganglionic blocking agents, debrisoquin suppresses equally the responses mediated by alpha-and beta-adrenergic receptors but does not produce parasympathetic blockade. Since sympathetic blockade results in modest decreases in peripheral resistance and cardiac output, debrisoquin lowers blood pressure in the supine position. It further reduces blood pressure by decreasing the degree of vasoconstriction that normally results from reflex sympathetic nervous activity upon assumption of the upright posture, thus reducing venous return and cardiac output more.",,,,DEBRISOQUIN,CHEMBL169901,4.0,1.0,0.0,MOL,34665.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1965.0,-1.0,,0.0,,,Antihypertensive,0.0,0.0,0.0,"InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12)",JWPGJSVJDAJRLW-UHFFFAOYSA-N,N=C(N)N1CCc2ccccc2C1,0.4551591876631269,4.0,175.23499999999999,0.9381699999999995,1,2,0,53.11000000000001,-0.68256767214168,0.7830541253089904,-5.2687417363468825,0.993713891506195,-10.332888522032613,0.5790298074483872,0.010209624096751213,0.9108909964561462,20.22912387204348,-5.968849934081641,0.02818085364997387,0.01826385795138776,0.0006130072491941973,0.30630770325660706,0.0009991736729716648,-19.552998527283226,-0.019493362160764603,-9.779533913446429,2.517496864017562,0.26677085310220716,0.04588514044880867,0.02255462625762448,0.03075636364519596,0.07990932017564774,0.02431394122540951,0.0027279087342321874,0.12816713750362396,0.008676173444837332,0.027303762547671796,0.0003034776440472342,0.00018832350469892843,0.0006262352602789178,0.0026962814503349365,0.0007626349804922938,0.0007764125941321254,0.7449020385742188,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,6877.0,2792081.0,866306.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dibenzepin is a tricyclic antidepressant (TCA). It acts as a selective norepinephrine reuptake inhibitor (NRI). It is also a potent antihistamine (H1 receptor). The drug has weak or negligible effects on serotonin and dopamine reuptake. Unlike many other TCAs, dibenzepin has no antiadrenergic (Î±1, Î±2), antiserotonergic (5-HT1A, 5-HT2A), or antidopaminergic effects and has few or no anticholinergic (mACh) effects.",Inhibitory effect on the uptake of noradrenaline (59 nM) by the perfused rabbit heart: 44.8 mM (ID50) Ki = 23 nM for H1 receptors.,,,DIBENZEPIN,CHEMBL1442422,4.0,1.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1964.0,-1.0,-pin,0.0,-pin,tricyclic compounds,Antidepressant,0.0,0.0,0.0,"InChI=1S/C18H21N3O/c1-19(2)12-13-21-17-11-7-6-10-16(17)20(3)15-9-5-4-8-14(15)18(21)22/h4-11H,12-13H2,1-3H3",QPGGEKPRGVJKQB-UHFFFAOYSA-N,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,0.870763155680302,4.0,295.386,2.976300000000001,3,0,0,26.79,-3.096505700984452,0.8760736346244812,-4.083033809200704,0.9935282588005065,-9.786559269331885,0.9567694544792176,0.25521933734416963,0.997599971294403,55.04920908144622,-8.016669128576002,0.5585909843444824,0.0930756874382496,0.011831405200064182,0.33652459383010863,0.06665835455060005,33.42774565368491,71.6630077460618,19.33679306689657,2.790316628951394,0.6131136655807495,0.2587573528289795,0.6020727396011353,0.5772313296794891,0.9405994772911072,0.05163739621639252,0.022863806784152986,0.04663011077791453,0.004721266496926546,0.11644834876060486,0.019487210735678672,0.0037160754669457673,0.0079047208186239,0.0033736893674358726,0.027954156696796417,0.026640506647527217,0.722951865196228,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,7593.0,1706401.0,1038730.0,Norepinephrine transporter substrate,,SUBSTRATE,1.0,1.0,1.0,"Is similar in structure to the neurotransmitter norepinephrine (NE) and is taken up by the NE transporter and accumulates in adrenergically innervated tissues, including tumors of neural crest origin that express high levels of surface NE transporter. Radiation causes cell death.",,,,IOBENGUANE I 131,CHEMBL1615779,4.0,0.0,1.0,MOL,,Small molecule,2018.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1997.0,1.0,io-,0.0,io-,iodine-containing contrast media,Radioactive Agent; Diagnostic Aid,0.0,0.0,0.0,"InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)/i9+4",PDWUPXJEEYOOTR-JRGAVVOBSA-N,N=C(N)NCc1cccc([131I])c1,0.433567726429014,4.0,279.09512459999996,1.27427,1,3,0,61.900000000000006,-1.125768318559112,0.8634976267814636,-5.850591530224664,0.9811595797538757,-10.322594124475554,0.3710015043616295,0.008109160466119647,0.6519293248653412,26.360129821263865,8.106305182262746,0.05102696251124143,0.039009046740829945,0.000632837403099984,0.52486292719841,0.007284138503018766,11.602747353618815,-0.4086009130204339,-23.181885327675822,2.5619053217655554,0.3089159958064556,0.10637669079005718,0.022408560779877008,0.03553273975849151,0.07744012549519538,0.03548640329390764,0.00555208595469594,0.09191196784377098,0.01193097522482276,0.014863067772239447,0.0007426438402035274,0.00016549751671846025,0.0003657844146800926,0.0038593288394622506,0.0014736692639417015,0.0006635449361056089,0.7838620781898499,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,8415.0,3133253.0,2335617.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,Also displays activity against the serotonin transporter (but is selective for the norepinephrine transporter).,,,AMPRELOXETINE,CHEMBL4297646,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2019.0,,-oxetine,0.0,-oxetine,antidepressants (fluoxetine type),,0.0,0.0,0.0,"InChI=1S/C18H18F3NO/c19-14-9-16(20)18(17(21)10-14)23-11-13-3-1-2-4-15(13)12-5-7-22-8-6-12/h1-4,9-10,12,22H,5-8,11H2",TZIALEBTHQWNAO-UHFFFAOYSA-N,Fc1cc(F)c(OCc2ccccc2C2CCNCC2)c(F)c1,0.9132579094390005,4.0,321.3420000000001,4.149900000000002,2,1,0,21.259999999999998,-2.9532184295421477,0.9745151281356812,-4.5735943909907375,0.9999371886253356,-5.400715054528947,0.9616854429244995,0.5406009376049041,0.9809440016746521,66.61646094540478,0.31178669731516645,0.7141946196556092,0.7225551247596741,0.3843177020549774,0.5604749143123626,0.15034161284565925,13.993172978282127,25.791968021139486,-6.670250184765538,3.0194632409909246,0.4001699239015579,0.2689986079931259,0.22593480199575425,0.40879149436950685,0.9175978899002075,0.03590611200779677,0.01273011420853436,0.21897795498371125,0.019366178009659053,0.08421071507036686,0.09477611780166625,0.011653794441372156,0.011403827089816332,0.008954615984112024,0.09482575133442879,0.013137525133788585,0.48154927492141725,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,8574.0,1704182.0,1378753.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,VILOXAZINE HYDROCHLORIDE,CHEMBL2106483,4.0,1.0,1.0,MOL,,Small molecule,2021.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1976.0,1.0,-,0.0,-,-,Antidepressant,0.0,0.0,0.0,"InChI=1S/C13H19NO3.ClH/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11;/h3-6,11,14H,2,7-10H2,1H3;1H",HJOCKFVCMLCPTP-UHFFFAOYSA-N,CCOc1ccccc1OCC1CNCCO1.Cl,0.8891836962055838,4.0,273.75999999999993,1.8742999999999994,4,1,1,39.72,-1.2557513737922288,0.9782480120658874,-4.554673134130399,0.9997441649436951,-8.229575093329805,0.9167468428611756,0.036894652200862764,0.9518332839012146,52.19738337179619,4.1586162630808925,0.3338010162115097,0.27035098522901535,0.006295611523091793,0.08547001406550407,0.03350435998290777,6.006082470818722,43.22408497279323,-14.66100726778276,2.0704286146115036,0.8556041359901428,0.3090077072381973,0.18856888264417648,0.2754674702882767,0.3339942306280136,0.0034372783382423224,0.0032310105510987342,0.07566919587552548,0.004099892172962427,0.020420793257653714,0.017714927159249782,0.013518980517983437,0.011560867493972182,0.013988186977803707,0.0020016295253299176,0.006065558595582843,0.7569525718688965,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,8582.0,3133837.0,2336110.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SERDEXMETHYLPHENIDATE CHLORIDE,CHEMBL4298139,4.0,1.0,1.0,MOL,,Small molecule,2021.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,2018.0,1.0,-,0.0,-,-,,0.0,0.0,0.0,"InChI=1S/C25H29N3O8.ClH/c1-35-24(33)21(17-8-3-2-4-9-17)20-11-5-6-13-28(20)25(34)36-16-27-12-7-10-18(14-27)22(30)26-19(15-29)23(31)32;/h2-4,7-10,12,14,19-21,29H,5-6,11,13,15-16H2,1H3,(H-,26,30,31,32);1H/t19-,20+,21+;/m0./s1",GONQEUJYYMYNMN-HWAJWLCKSA-N,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1C(=O)OC[n+]1cccc(C(=O)N[C@@H](CO)C(=O)O)c1.[Cl-],0.24819489562285657,3.0,535.9810000000002,-1.9411999999999947,7,3,3,146.35,-1.9038248241592082,0.324187821149826,-6.22215275719451,0.21545338183641433,-14.277896707182384,0.09823281019926071,0.13317037895321845,0.2799061000347137,70.89676042908127,8.271024597635693,0.002006842789705843,0.032340992521494624,0.02587765082716942,0.18719050288200378,0.03387956041842699,10.083294951992254,14.54392044795299,-8.560952793322418,2.4766985063153415,0.10993066430091858,0.09932958260178566,0.1821622759103775,0.4253998786211014,0.23812118470668792,0.054162461310625076,0.0389927577227354,0.11690081655979156,0.007224310515448451,0.006918652495369315,0.014407474920153618,0.0037867385428398846,0.00419999894220382,0.008255271078087389,0.003790962864877656,0.007483975705690682,0.15012188404798507,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,8604.0,3955727.0,2339113.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SERDEXMETHYLPHENIDATE,CHEMBL4301162,4.0,1.0,0.0,MOL,,Small molecule,2021.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,2018.0,1.0,-,0.0,-,-,,0.0,0.0,0.0,"InChI=1S/C25H29N3O8/c1-35-24(33)21(17-8-3-2-4-9-17)20-11-5-6-13-28(20)25(34)36-16-27-12-7-10-18(14-27)22(30)26-19(15-29)23(31)32/h2-4,7-10,12,14,19-21,29H,5-6,11,13,15-16H2,1H3,(H-,26,30,31,32)/p+1/t19-,20+,21+/m0/s1",UBZPNQRBUOBBLN-PWRODBHTSA-O,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1C(=O)OC[n+]1cccc(C(=O)N[C@@H](CO)C(=O)O)c1,0.34215621262174156,3.0,500.5280000000002,1.0548,7,3,3,146.35,-2.5075312964502725,0.3092952847480774,-6.1257187426678765,0.2964014202356339,-14.142456311806143,0.17164523899555206,0.16886329054832458,0.2919352948665619,67.51003964021196,8.486695510846129,0.0021175153204239907,0.0381856594234705,0.033227114751935,0.09363345876336097,0.04351117201149464,9.796402337263999,17.455511936698812,-1.6351129649249074,2.41266414341979,0.0631800239905715,0.07478593140840531,0.1723252072930336,0.5188581287860871,0.19641372859477996,0.057501327246427536,0.03502816259860993,0.11222711056470872,0.007483694283291697,0.014021796733140945,0.01548741851001978,0.0037186892703175546,0.003516896045766771,0.009591459087096155,0.003949056309647858,0.008732571080327035,0.13669673949480057,False
SLC6A2,100,SINGLE PROTEIN,Norepinephrine transporter,9606,Homo sapiens,CHEMBL222,,0.0,9077.0,2795253.0,916384.0,Norepinephrine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Also inhibits the neuronal uptake of dopamine and has other effects (e.g. anticholinergic, antihistaminic and anti-Î±1 adrenergic effects)",,,DOTHIEPIN,CHEMBL1492500,4.0,1.0,0.0,MOL,36803.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1975.0,-1.0,-pin,0.0,-pin,tricyclic compounds,Antidepressant,0.0,0.0,0.0,"InChI=1S/C19H21NS/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11+",PHTUQLWOUWZIMZ-GZTJUZNOSA-N,CN(C)CC/C=C1\c2ccccc2CSc2ccccc21,0.8088707188299813,4.0,295.451,4.675700000000004,2,0,0,3.24,-4.586977125554347,0.8614404559135437,-4.703300116707295,0.9983787775039673,-5.968792227225327,0.9578037619590759,0.6827516674995422,0.9950757265090943,78.1650276041991,-0.2653244884576919,0.7178327322006226,0.21373177617788314,0.024720227532088756,0.8365910172462463,0.15619930624961853,5.385034674349756,73.35983000378029,31.229232030758233,2.8410503013699167,0.3208915501832962,0.15690173357725143,0.4168929785490036,0.5075957000255584,0.9465293884277344,0.01508268378674984,0.009311769716441631,0.07724659852683544,0.020585492812097074,0.07298612296581268,0.046980961412191394,0.01830392945557833,0.004453814448788762,0.04290073625743389,0.10365257039666176,0.046165048703551294,0.8683637738227844,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,1567.0,1344277.0,674903.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,METHAMPHETAMINE HYDROCHLORIDE,CHEMBL1200952,4.0,1.0,1.0,MOL,35340.0,Small molecule,1943.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,,1.0,,0.0,,,Stimulant (central),0.0,0.0,0.0,"InChI=1S/C10H15N.ClH/c1-9(11-2)8-10-6-4-3-5-7-10;/h3-7,9,11H,8H2,1-2H3;1H/t9-;/m0./s1",TWXDDNPPQUTEOV-FVGYRXGTSA-N,CN[C@@H](C)Cc1ccccc1.Cl,0.7621097322978312,4.0,185.698,2.2588000000000004,1,1,1,12.03,-1.1535487402846258,0.9551570534706115,-4.672119176803309,0.9994208693504334,-5.016398483768755,0.8556624531745911,0.0073116292711347345,0.9131582260131836,29.28795148354127,15.099864479316148,0.1423589214682579,0.07984047401696444,0.00044918166822753846,0.7842886090278626,0.0032349145621992648,27.979394226223825,35.90067239604022,-28.766369627626055,3.2128587553367267,0.22312734723091127,0.3434265375137329,0.16663396283984183,0.01952400915324688,0.4818495690822601,0.007167868874967098,0.0007082518248353153,0.10758134201169015,0.0020091204904019834,0.006648197723552585,0.0008910194155760109,0.0001448628852813272,0.0003259823999542277,0.0014075057086301967,0.001205294532701373,0.00012295842716412154,0.9307832837104797,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,1568.0,1344126.0,46385.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,MAZINDOL,CHEMBL781,4.0,1.0,1.0,MOL,,Small molecule,1973.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1970.0,0.0,,0.0,,,Anorexic,0.0,0.0,0.0,"InChI=1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2",ZPXSCAKFGYXMGA-UHFFFAOYSA-N,OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21,0.8737077174467992,4.0,284.74600000000004,2.6092000000000004,3,1,1,35.830000000000005,-3.473572020445902,0.9132780432701111,-4.8492102747800585,0.9999061822891235,-9.69893771319521,0.8901417136192322,0.5316981047391891,0.9273271083831787,76.39046511403096,0.37556982876742306,0.1410508669912815,0.3256643071770668,0.13082366362214087,0.3183224380016327,0.10785902366042137,15.326955674954288,20.071493981130413,11.503132992249949,3.0078866939642266,0.030668016895651816,0.08269043862819672,0.06944250538945199,0.25727925896644593,0.5535334348678589,0.025632187724113464,0.010783511772751808,0.23914338946342467,0.027904132008552553,0.03165844306349754,0.07055016010999679,0.00597712080925703,0.009947373205795884,0.009593109041452408,0.25428551733493804,0.02918872982263565,0.481084144115448,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,1569.0,1343542.0,2197701.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,SIBUTRAMINE HYDROCHLORIDE,CHEMBL3989830,4.0,1.0,1.0,MOL,,Small molecule,1997.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1990.0,-2.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/C17H26ClN.ClH.H2O/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14;;/h6-9,13,16H,5,10-12H2,1-4H3;1H;1H2",KFNNPQDSPLWLCX-UHFFFAOYSA-N,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1.Cl.O,0.7888949705692078,4.0,334.33100000000013,4.335100000000007,1,0,1,34.74,-3.757365293431159,0.9224629282951355,-4.6368768056443965,0.9998946905136108,-4.73702757203384,0.9731810092926025,0.28919127583503723,0.9831710457801819,83.09835651803137,11.750161446910631,0.07028810940682888,0.36456437706947326,0.016639705933630466,0.9694134712219238,0.28492108881473543,51.04020890910279,45.860419169784045,7.295995155866049,2.6382211521064507,0.0835678331553936,0.24117887914180755,0.3487350732088089,0.02418900690972805,0.8514814496040344,0.0016719675506465137,0.00018869585037464275,0.03453548140823841,0.01564404312521219,0.019751986488699913,0.05372417084872723,0.0011856231052661315,0.00039865580620244143,0.04268115926533937,0.3320285379886627,0.002465346356621012,0.8043658614158631,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,5760.0,1879136.0,1540486.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,"Selectively inhibits the reuptake of serotonin, norepinephrine, and dopamine",,,,LIAFENSINE,CHEMBL2364614,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2012.0,,-fensine,0.0,-fensine,"norepinephrine, serotonin, dopamine, reuptake inhibitor",,0.0,0.0,0.0,"InChI=1S/C24H22N4/c1-28-14-20-13-19(23-10-11-24(25)27-26-23)8-9-21(20)22(15-28)18-7-6-16-4-2-3-5-17(16)12-18/h2-13,22H,14-15H2,1H3,(H2,25,27)/t22-/m0/s1",VCIBGDSRPUOBOG-QFIPXVFZSA-N,CN1Cc2cc(-c3ccc(N)nn3)ccc2[C@H](c2ccc3ccccc3c2)C1,0.5691491961978324,4.0,366.4680000000001,4.456300000000003,4,1,1,55.04,-4.766870936399179,0.9079018592834472,-5.019195952722922,0.9938565850257873,-10.273835873155075,0.8113154411315918,0.8584496974945068,0.9262856841087341,97.95650535300864,7.222420033734537,0.3039052695035934,0.2345348507165909,0.050401640310883525,0.422010549902916,0.4291648089885712,3.4667647532200276,16.354888789595815,1.2800620458744199,3.113560056676911,0.8091935276985168,0.3788429230451584,0.5488935530185699,0.826264226436615,0.9130761861801148,0.057831376791000366,0.031300020217895505,0.15353596955537796,0.07309234105050563,0.6642518401145935,0.32755617797374725,0.03688824735581875,0.17412132769823074,0.08662266358733177,0.27511527836322786,0.21819525361061096,0.341293939948082,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,5802.0,2139003.0,1763557.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,"Dopamine and norepinephrine reuptake inhibitor 
Dasotraline acts as a potent inhibitor of human DA transporters (DAT; dopamine uptake IC50 3Â¿nM) and NE transporters (NET; norepinephrine uptake IC50 4Â¿nM), and a weaker inhibitor of human serotonin transporters (SERT; serotonin uptake IC50 15Â¿nM)",,,,DASOTRALINE,CHEMBL3301595,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2014.0,,-traline,0.0,-traline,selective serotonin reuptake inhibitors (SSRI),,0.0,0.0,0.0,"InChI=1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1",SRPXSILJHWNFMK-MEDUHNTESA-N,N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,0.7929320007860753,4.0,292.209,4.918900000000003,1,1,2,26.02,-4.910572356825016,0.9554846048355102,-4.59091039369281,0.9999806880950928,-5.842711099799433,0.9274492859840393,0.09697540253400802,0.9576883316040039,88.3943722049434,16.098530857412783,0.9038638830184936,0.5941657960414887,0.17331120148301124,0.6584822237491608,0.7026158392429351,39.730931325684104,54.519098055230714,-4.760858368560886,3.108616553477603,0.2503316819667816,0.2399287313222885,0.05994322896003723,0.18599006831645964,0.7574897885322571,0.021654889360070227,0.0063422799576073885,0.23250173926353454,0.1571073368191719,0.27779523134231565,0.19533590152859687,0.008264750451780855,0.014837150182574987,0.06291628265753388,0.7120288610458374,0.07444989588111639,0.6561057209968567,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,6276.0,1703586.0,705835.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,It strongly inhibits the re-uptake of dopamine as well as noradrenaline and it is a relatively weak inhibitor of serotonin uptake.,Nomifensine inhibition of norepinephrine (NA) uptake by synaptosomal fractions from rat hypothalamus (IC50 = 7.0 Ã— 10âˆ’7 M) was similar to that of nortriptyline and protriptyline. It was found to be a powerful inhibitor of NA uptake in synaptosomes obtained from whole brain (IC50 = 9.0 Ã— 10âˆ’8 M). Nomifensine had only a moderate effect on serotonin accumulation (IC50 = 2.8 Ã— 10âˆ’5 M).,,,NOMIFENSINE MALEATE,CHEMBL1256842,4.0,0.0,1.0,MOL,,Small molecule,1984.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1975.0,-2.0,-fensine,0.0,-fensine,"norepinephrine, serotonin, dopamine, reuptake inhibitor",Antidepressant,1.0,0.0,0.0,"InChI=1S/C16H18N2.C4H4O4/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18;5-3(6)1-2-4(7)8/h2-9,14H,10-11,17H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-",GEOCVSMCLVIOEV-BTJKTKAUSA-N,CN1Cc2c(N)cccc2C(c2ccccc2)C1.O=C(O)/C=C\C(=O)O,0.5780132678451209,4.0,354.40600000000006,2.5579,4,3,1,103.86,-2.389655499399489,0.7569993495941162,-5.646061706369176,0.7373525738716126,-10.945436283532098,0.16544924974441527,0.07623349949717521,0.9479261875152588,71.39207903934,3.9404573180646034,0.02190119568258524,0.1406717300415039,0.04210070390254259,0.6717199683189392,0.008781903190538287,-20.334880688683295,5.749981865458463,-9.062368108118076,2.940926248091954,0.18145723193883895,0.14169033020734786,0.5193580567836762,0.5476387083530426,0.42713429033756256,0.05157334916293621,0.005097231129184365,0.09667817577719688,0.01367991380393505,0.05153822042047977,0.007569225504994392,0.011536696925759315,0.013737637735903262,0.013041718024760484,0.011456591170281171,0.012015135399997235,0.4262002021074295,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,8189.0,3130158.0,449425.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,Norepinephrine > serotonin > dopamine (approximately 1:2:17),,,BICIFADINE,CHEMBL511099,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1979.0,,-fadine,0.0,-fadine,monoamine transport inhibitors,Analgesic,0.0,0.0,0.0,"InChI=1S/C12H15N/c1-9-2-4-10(5-3-9)12-6-11(12)7-13-8-12/h2-5,11,13H,6-8H2,1H3",OFYVIGTWSQPCLF-UHFFFAOYSA-N,Cc1ccc(C23CNCC2C3)cc1,0.6831757539262934,4.0,173.25900000000001,1.8559199999999998,1,1,2,12.03,-1.1184414414783892,0.9642549633979798,-4.500751905527715,0.9999934434890747,-5.756526072922678,0.9482378840446473,0.009836941258981824,0.9968463778495789,39.57534926930219,0.27565970203154766,0.048918872326612475,0.41764441430568694,0.005999794416129589,0.6428575873374939,0.0950317669659853,-22.649075628617997,32.03140653451446,-15.972954384951212,3.029980633624077,0.31684123277664183,0.016840786207467318,0.07998581267893315,0.026879314333200455,0.3637566417455673,0.004571076855063439,0.00016472780698677524,0.02054514326155186,0.0010527745791478083,0.018436405062675475,0.002873917791293934,7.198132898338372e-05,0.0003667194803711027,0.003523141413461417,0.0018629384809173643,0.0002866823233489413,0.6816199243068695,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,8236.0,1705252.0,596408.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,AMITIFADINE,CHEMBL592374,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2011.0,,-fadine,0.0,-fadine,monoamine transport inhibitors,,0.0,0.0,0.0,"InChI=1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2/t8-,11+/m1/s1",BSMNRYCSBFHEMQ-KCJUWKMLSA-N,Clc1ccc([C@]23CNC[C@H]2C3)cc1Cl,0.7787806701236775,4.0,228.12199999999999,2.854300000000001,1,1,2,12.03,-2.830898914238601,0.9608417987823487,-4.394742323097857,0.9999974966049194,-5.88209902168718,0.9746949195861816,0.00955878160893917,0.9950430393218994,65.32256552815716,7.420131016385208,0.563757449388504,0.40618434846401213,0.03123618718236685,0.7064644277095795,0.42584473341703416,-6.89473860697052,34.58422025404168,-11.312633519814181,2.8982318746189675,0.19537655785679817,0.00887861093506217,0.09503202997148037,0.11375957801938057,0.3647754848003387,0.022657548263669013,0.003907262580469251,0.04578053876757622,0.0064536741003394125,0.09938369914889336,0.0257557456381619,0.0003227800720196683,0.0016187004977837205,0.011552140954881907,0.015866439789533615,0.004495527816470712,0.6779535174369812,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,8238.0,1705999.0,2197561.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,TESOFENSINE,CHEMBL3989690,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-fensine,0.0,-fensine,"norepinephrine, serotonin, dopamine, reuptake inhibitor",,0.0,0.0,0.0,"InChI=1S/C17H23Cl2NO/c1-3-21-10-14-13(9-12-5-7-17(14)20(12)2)11-4-6-15(18)16(19)8-11/h4,6,8,12-14,17H,3,5,7,9-10H2,1-2H3/t12-,13+,14+,17+/m0/s1",VCVWXKKWDOJNIT-ZOMKSWQUSA-N,CCOC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C,0.8010495161265205,4.0,328.2830000000001,4.596200000000005,2,0,4,12.47,-4.251081815594899,0.9559450745582581,-4.612485862703657,0.9999547719955444,-4.78907258439577,0.9870200395584107,0.4108909606933594,0.9971018671989441,82.42191025375709,12.800486259920111,0.17104952931404113,0.20838383138179778,0.023618015833199023,0.8186227560043335,0.0809529721736908,38.82325978013953,60.08767242158458,-0.05482308652511847,2.7701905287594033,0.3056617259979248,0.01683790171518922,0.28626379668712615,0.12547000721096993,0.9072778344154357,0.06315630972385407,0.00285715670324862,0.07775808796286583,0.011517071537673474,0.12130031287670136,0.04550616145133972,0.0007953229622216895,0.0010053893551230431,0.009831664059311152,0.021224376186728476,0.005319333402439952,0.6789766788482666,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,8437.0,2139036.0,1763583.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,"Inhibition ratio for norepinephrine, dopamine, serotonin; 1:6:14.",,,CENTANAFADINE,CHEMBL3301621,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2014.0,,-fadine,0.0,-fadine,monoamine transport inhibitors,,0.0,0.0,0.0,"InChI=1S/C15H15N/c1-2-4-12-7-13(6-5-11(12)3-1)15-8-14(15)9-16-10-15/h1-7,14,16H,8-10H2/t14-,15+/m1/s1",HKHCSWPSUSWGLI-CABCVRRESA-N,c1ccc2cc([C@]34CNC[C@H]3C4)ccc2c1,0.7611287420213179,4.0,209.29199999999997,2.700700000000001,1,1,2,12.03,-2.7638529983959144,0.9536219120025635,-4.66491922264711,0.9999911308288574,-6.616947712854797,0.9453484416007996,0.02834454011172056,0.9945268034934998,69.84763030648122,3.841903907095132,0.8343444466590881,0.18922867774963378,0.010192986018955708,0.6223313450813294,0.17158283665776253,-18.739773189807885,42.74596551461417,-16.908578967491774,3.2767538735593016,0.7478951454162598,0.011301117949187756,0.18368182927370072,0.29332311898469926,0.6780993580818176,0.02701114546507597,0.009316773526370526,0.1038401409983635,0.015405154973268508,0.3641769468784332,0.043035269156098364,0.001531169400550425,0.011822868324816226,0.01705090533941984,0.02740585021674633,0.01477650310844183,0.6763091564178467,False
SLC6A2,105759,PROTEIN FAMILY,Monoamine transporter,9606,Homo sapiens,CHEMBL2363064,,0.0,9020.0,3132953.0,2335356.0,Monoamine transporter inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,NS-2359,CHEMBL4297385,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C16H21Cl2NO/c1-19-11-4-6-16(19)13(9-20-2)12(8-11)10-3-5-14(17)15(18)7-10/h3,5,7,11-13,16H,4,6,8-9H2,1-2H3/t11-,12+,13+,16+/m0/s1",PGYDXVBZYKQYCS-VPWBDBDCSA-N,COC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C,0.8286470799302998,4.0,314.2560000000001,4.206100000000004,2,0,4,12.47,-3.766696051751782,0.9669619917869567,-4.502219356783714,0.9999629259109497,-5.59033265337359,0.9915666222572327,0.2304116189479828,0.9975937962532043,73.13604428793253,8.6620874752923,0.09786793999373913,0.1746067926287651,0.012583114113658667,0.7328976392745972,0.06981736943125724,16.553977461733712,62.21272986473978,3.8485010049936696,2.767454107329685,0.3713694393634796,0.009961847355589271,0.3380471169948578,0.13936877250671387,0.8804041266441345,0.057445328682661057,0.0024748942349106075,0.05496433563530445,0.008274821471422911,0.1087745599448681,0.03782644085586071,0.0004960078309522942,0.0011170152807608246,0.005053457594476641,0.010791311226785182,0.004324054531753063,0.6388004958629608,False
HTR2A,104784,PROTEIN FAMILY,Serotonin 2 (5-HT2) receptor,9606,Homo sapiens,CHEMBL2095200,,0.0,6681.0,1699681.0,103542.0,Serotonin 2 (5-HT2) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Clotiapine affects multiple receptors. It blocks 5HT3-receptors and downregulates cortical 5HT2- receptors. It has high affinity for the 5HT-6 and 5HT-7 receptors and acts as an antagonist of the D-4 receptors.,,,,CLOTHIAPINE,CHEMBL304902,4.0,1.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1966.0,-1.0,-pine,0.0,-pine,tricyclic compounds,Antipsychotic,0.0,0.0,0.0,"InChI=1S/C18H18ClN3S/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3",KAAZGXDPUNNEFN-UHFFFAOYSA-N,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,0.7163896237621907,4.0,343.8830000000001,4.1303000000000045,4,0,0,18.84,-4.664094235950126,0.8790180206298828,-4.559850385733109,0.9997609376907348,-6.98632535019799,0.9847142577171326,0.9035589814186096,0.9985604166984559,102.5423666664647,-0.9506477195999607,0.45390779376029966,0.2271086558699608,0.027448490634560584,0.9128273367881775,0.10713671296834945,-40.367179289653855,40.2109509901923,14.614268895654439,2.816510919962566,0.21125410497188568,0.0732917070388794,0.5256937205791473,0.5387584686279296,0.9772590875625611,0.012602175213396549,0.0018361711991019547,0.031445368006825444,0.004374310979619623,0.05621364302933216,0.057398493587970736,0.00279545858502388,0.0010151541384402663,0.006975472741760314,0.035976553335785866,0.006657016184180975,0.632542759180069,False
HTR2A,104841,PROTEIN FAMILY,Serotonin (5-HT) receptor,9606,Homo sapiens,CHEMBL2096904,,0.0,6232.0,1702985.0,1228462.0,Serotonin (5-HT) receptor agonist,,AGONIST,1.0,1.0,1.0,"It reduces appetite by increasing the amount of extracellular serotonin in the brain. Dexfenfluramine is an anorectic agent that acts by enhancing serotonergic transmission through inhibition of 5-HT reuptake by the parent compound, and through its major circulating des-ethylated metabolite, dexnorfenfluramine, which is a 5-HT reuptake inhibitor, a 5-HT and noradrenaline releasing agent, and a potent agonist at postsynaptic 5-HT2 receptors.",,,,DEXFENFLURAMINE HYDROCHLORIDE,CHEMBL1887891,4.0,1.0,1.0,MOL,59730.0,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1991.0,-2.0,,0.0,,,Appetite Suppressant (systemic),1.0,0.0,0.0,"InChI=1S/C12H16F3N.ClH/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15;/h4-6,8-9,16H,3,7H2,1-2H3;1H/t9-;/m0./s1",ZXKXJHAOUFHNAS-FVGYRXGTSA-N,CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1.Cl,0.8777404716697845,4.0,267.7219999999999,3.667700000000003,1,1,1,12.03,-2.0720488593393123,0.9790523290634155,-4.751966661428751,0.9999714374542237,-5.134850133455378,0.9645352363586426,0.11618515327572823,0.9850017666816712,65.50890270832097,7.157991041370148,0.671014404296875,0.13913693875074387,0.0011463723494671285,0.9164860129356385,0.10402810536324977,15.06196526135036,20.90552736490661,-1.3219923926177017,3.271425737912159,0.10575692243874073,0.6826092720031738,0.29560078382492067,0.049266813695430754,0.8317965865135193,0.006928894901648164,0.0021125487226527186,0.05952040776610375,0.0029891130514442922,0.008739112294279039,0.003259289893321693,0.00017214027757290752,0.00039727331313770263,0.0008632232536911033,0.012090922798961401,0.000793187321323785,0.5974473983049393,False
HTR2A,104841,PROTEIN FAMILY,Serotonin (5-HT) receptor,9606,Homo sapiens,CHEMBL2096904,,0.0,6324.0,1702154.0,1532522.0,Serotonin (5-HT) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Zimelidine (ZIM) and its main active metabolite norzimelidine (NZIM) have been shown to preferentially inhibit 5-hydroxytryptamine (5-HT, serotonin) neuronal uptake both in vitro and in vivo while having much less effect on noradrenaline (NA) uptake. ZIM in vivo blocked the 5-HT uptake mechanism in the cerebral cortex, hippocampus, striatum, hypothalamus and spinal cord, thus indicating effects on both the ascending and descending 5-HT pathways. ZIM is devoid of a 5-HT releasing action, MAO-inhibitory properties and effects on dopamine (DA) uptake",,,,ZIMELDINE HYDROCHLORIDE,CHEMBL2355333,4.0,0.0,1.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1977.0,-2.0,,0.0,,,,1.0,0.0,0.0,"InChI=1S/C16H17BrN2.2ClH.H2O/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13;;;/h3-10,12H,11H2,1-2H3;2*1H;1H2/b16-9-;;;",WFUAVXYXJOQWAZ-GVKRCPFFSA-N,CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1.Cl.Cl.O,0.7719056218440901,4.0,408.16700000000003,3.856300000000004,2,0,0,47.63,-2.9520908661558627,0.91440269947052,-4.912549210858629,0.9937886595726013,-9.438533440268682,0.8965795159339904,0.45099068284034727,0.9386960506439209,85.02958630585402,16.70290585048502,0.3929125934839249,0.23247260898351668,0.046737489849328996,0.7954946279525756,0.25297155380249026,92.68181770601814,32.941037324093124,2.8912056072136756,2.2260779328880593,0.41160731911659243,0.31718058288097384,0.7970211267471313,0.2120026931166649,0.8624736547470093,0.00882941959425807,0.006964939110912382,0.04956363588571548,0.01943458467721939,0.06544633023440838,0.11215804368257523,0.00398847734904848,0.0075992291094735265,0.054166528023779394,0.09059299435466528,0.015881838416680692,0.7233986616134643,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,580.0,1344662.0,674587.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,CYCLOBENZAPRINE HYDROCHLORIDE,CHEMBL1200636,4.0,1.0,1.0,MOL,3997.0,Small molecule,1977.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1977.0,1.0,,0.0,,,Relaxant (muscle),0.0,0.0,0.0,"InChI=1S/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H",VXEAYBOGHINOKW-UHFFFAOYSA-N,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl,0.6594351472117174,4.0,311.85600000000005,4.9756000000000045,1,0,0,3.24,-4.142243935281117,0.902516531944275,-4.6590995973778835,0.9958935260772706,-6.3516329395354605,0.8574418425559998,0.7028593182563782,0.9927532911300659,91.19744089004307,4.709061903900458,0.9240902662277222,0.13122764080762864,0.021064717788249254,0.8383443593978882,0.03300201576203108,39.52997611915562,45.7083207421799,0.05317883363947971,2.4410749162591836,0.8508584856986999,0.42197696566581727,0.48777636885643005,0.613635516166687,0.9460384964942932,0.011587296798825263,0.023304300289601086,0.07263920269906521,0.032842967659235,0.30765293836593627,0.13952130675315857,0.03345269672572613,0.022599345073103905,0.0644062377512455,0.2639770478010178,0.1177314691245556,0.835746419429779,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,582.0,1343377.0,674749.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRAZODONE HYDROCHLORIDE,CHEMBL1200798,4.0,1.0,1.0,MOL,9655.0,Small molecule,1981.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1970.0,1.0,,0.0,,,Antidepressant,0.0,0.0,0.0,"InChI=1S/C19H22ClN5O.ClH/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25;/h1-3,5-7,9,15H,4,8,10-14H2;1H",OHHDIOKRWWOXMT-UHFFFAOYSA-N,Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,0.6516049396209824,4.0,408.33300000000014,2.783500000000001,6,0,0,45.78,-2.8987420121950698,0.7582329392433167,-4.864549791138497,0.998312258720398,-10.318620579152952,0.9344904899597168,0.7267840504646301,0.9699784994125367,87.46768648722272,2.5874421569852415,0.3374193996191025,0.5087939918041229,0.16735710352659225,0.6942179799079895,0.5096588671207428,-1.4745504629279125,64.79989888354154,36.895156882626836,2.4306272475749586,0.4472335368394852,0.242032590508461,0.8288350224494934,0.6835495233535767,0.9122923016548157,0.05031701438128948,0.04115522503852844,0.1288254514336586,0.027314639836549758,0.11387092769145965,0.05089543014764786,0.01959500168450177,0.013422486372292042,0.01922365641221404,0.047000202164053914,0.03961134441196919,0.4789940416812897,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,591.0,1343548.0,27610.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,MIRTAZAPINE,CHEMBL654,4.0,1.0,1.0,MOL,6950.0,Small molecule,1996.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1989.0,1.0,-pine,0.0,-pine,tricyclic compounds,Antidepressant,0.0,0.0,0.0,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",RONZAEMNMFQXRA-UHFFFAOYSA-N,CN1CCN2c3ncccc3Cc3ccccc3C2C1,0.7292796247091089,4.0,265.36,2.4789000000000003,3,0,1,19.37,-2.2287038908124432,0.8335858583450317,-4.3736601957848595,0.9998083591461182,-10.155695495748427,0.9697137475013733,0.19152219146490096,0.9944703698158264,67.62569382555822,5.324408250478199,0.16943909972906113,0.2693541944026947,0.02344189826399088,0.6054737865924835,0.09553963169455529,-15.534520372699205,83.22429344248809,33.85161965663552,2.8981749665686287,0.34599233567714693,0.02401882139965892,0.44577221274375917,0.3210626542568207,0.8916945099830628,0.03447464518249035,0.002297626808285713,0.060588163509964946,0.00408918964676559,0.11698381304740905,0.01199978543445468,0.0003556267503881827,0.0010157137643545867,0.0025695200194604693,0.00703581739217043,0.003065225016325712,0.6261929631233215,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,4430.0,1699850.0,631950.0,Serotonin 2a (5-HT2a) receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,,,,,TEMANOGREL,CHEMBL1084617,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2010.0,,-grel,0.0,-grel,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",,0.0,0.0,0.0,"InChI=1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29)",ZEOQUKRCASTCFR-UHFFFAOYSA-N,COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1,0.5848898326557894,4.0,436.5120000000002,3.059000000000002,7,1,0,77.85,-3.3526479126660873,0.9467809438705445,-4.897109702976323,0.9987821459770203,-11.539752203748572,0.8735252976417541,0.7879600882530212,0.6894927978515625,80.54444246317873,1.3372015986271157,0.08116249218583108,0.20449493825435638,0.17733422964811324,0.053830916061997414,0.8614094495773316,40.88189569515864,26.743962157427358,15.52999192617311,2.6569245490815443,0.4608044564723969,0.3128267049789429,0.8108606219291687,0.9124786496162415,0.9086140394210815,0.02538425214588642,0.010314550250768661,0.050569327920675276,0.016395823564380407,0.30544289350509646,0.08101364523172379,0.018560904636979104,0.06795889921486378,0.03471589870750904,0.1740407168865204,0.203981202095747,0.12180287763476372,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,4873.0,1706411.0,687528.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,PRUVANSERIN,CHEMBL1215661,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2005.0,,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C22H21FN4O/c23-18-6-4-16(5-7-18)8-9-26-10-12-27(13-11-26)22(28)20-3-1-2-19-17(14-24)15-25-21(19)20/h1-7,15,25H,8-13H2",AQRLDDAFYYAIJP-UHFFFAOYSA-N,N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)cccc12,0.760704476818076,4.0,376.43500000000006,3.1791800000000014,3,1,0,63.13,-4.167094595015603,0.7918322563171387,-5.050473577738795,0.9983645081520081,-13.015320269000597,0.883639907836914,0.7525372385978699,0.9478697419166565,90.62110475261372,-8.250195028626282,0.42155619263648986,0.5058484435081482,0.42524908781051635,0.4617124140262604,0.6354162454605102,-8.284816323096639,51.350412372335974,36.43825186906053,3.0152615539935383,0.4900762319564819,0.3425978422164917,0.832951831817627,0.6870544672012329,0.9919812083244324,0.029655137658119203,0.02465106323361397,0.03487044461071491,0.021166184823960064,0.13129024878144263,0.1160591721534729,0.009360264614224434,0.013294667471200228,0.008654859801754355,0.18734351098537444,0.08658947125077247,0.4619332909584045,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,4904.0,1701438.0,1377261.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,VABICASERIN HYDROCHLORIDE,CHEMBL2104991,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-caserin,0.0,-caserin,"serotonin receptor agonists, primarily 5-HT2",,0.0,0.0,0.0,"InChI=1S/C15H20N2.ClH/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17;/h1,3,6,12-13,16H,2,4-5,7-10H2;1H/t12-,13-;/m0./s1",PYPPENBDXAWXJC-QNTKWALQSA-N,Cl.c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2,0.7752094174287202,4.0,264.79999999999995,2.915300000000001,2,1,2,15.27,-2.523921265501671,0.9096968770027161,-4.509881162292062,0.9999375343322754,-6.679840483427934,0.7749497413635253,0.12633585333824157,0.9935275793075562,68.71487600178249,7.873845797364557,0.33306881189346316,0.20685392245650291,0.0057377199060283605,0.9196096181869506,0.26332828104496003,28.86660161159535,62.41541254335582,26.766461277327856,2.7832181891042174,0.6920779407024383,0.06029124744236469,0.21189025342464446,0.204685215651989,0.8481060147285462,0.0202933918684721,0.006762812100350857,0.12656416669487952,0.02521240636706352,0.34195876121520996,0.04007938466966152,0.0009690687176771462,0.011232779361307621,0.02301404750905931,0.06292390301823617,0.036326659843325615,0.5251170337200165,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,5031.0,1702534.0,603815.0,Serotonin 2a (5-HT2a) receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,Discontinued did not meet trial endpoints.,,,,NELOTANSERIN,CHEMBL598172,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2009.0,,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26)",COSPVUFTLGQDQL-UHFFFAOYSA-N,COc1ccc(NC(=O)Nc2ccc(F)cc2F)cc1-c1c(Br)cnn1C,0.6176088415907739,4.0,437.2440000000001,4.780400000000002,4,2,0,68.18,-5.459524690501762,0.9866726160049438,-4.647704079298032,0.9997657179832459,-11.50489986210495,0.8807407736778259,0.5518167376518249,0.7568499445915222,93.63425360144865,-5.119527770451501,0.6774421811103821,0.6848903298377991,0.6482128322124481,0.09218605719506741,0.7484072089195252,118.92357337883735,47.39253931611954,64.88040163999115,3.067960199409036,0.3503401786088943,0.4608413606882095,0.26473257690668106,0.9863833427429199,0.6728720843791962,0.03384552113711834,0.0077905650716274975,0.06071730703115463,0.006669549224898219,0.711553955078125,0.12697094827890396,0.07373462617397308,0.20775992274284363,0.05308424942195415,0.7039311647415161,0.4314229488372803,0.058554394915699956,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,5043.0,2473166.0,1673031.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,TRELANSERIN,CHEMBL3183740,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,,,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C24H24FN5O2S/c25-17-1-2-18-16(13-23(32)30(15-22(26)31)20(18)14-17)4-7-28-8-10-29(11-9-28)24-19-5-12-33-21(19)3-6-27-24/h1-3,5-6,12-14H,4,7-11,15H2,(H2,26,31)",JDLYOFUDIKMYBL-UHFFFAOYSA-N,NC(=O)Cn1c(=O)cc(CCN2CCN(c3nccc4sccc34)CC2)c2ccc(F)cc21,0.47328469647170246,4.0,465.55400000000014,2.6003,7,1,0,84.46,-3.1466374853024033,0.7415764451026916,-5.344840777647766,0.9923713445663452,-12.829501969307506,0.8446870088577271,0.6633073627948761,0.9264919877052307,86.97621470137031,0.9659417095860967,0.23505939841270446,0.5760404706001282,0.3798412084579468,0.6503450870513916,0.8014087319374085,-14.233665522469389,52.28065476681733,50.02094721724982,3.1603883772506713,0.6484001159667969,0.3493553876876831,0.8888398766517639,0.8789836883544921,0.9346822261810303,0.03552711196243763,0.0673193708062172,0.08227939009666443,0.05013208240270615,0.1126467913389206,0.07107112929224968,0.02719099968671799,0.04497578758746386,0.02439810410141945,0.07183929812163115,0.17971403896808624,0.26828680336475375,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,5358.0,1705074.0,1379609.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,Discontinued(strategic reasons),,,,ESMIRTAZAPINE MALEATE,CHEMBL2107339,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2005.0,,-pine,0.0,-pine,tricyclic compounds,,0.0,0.0,0.0,"InChI=1S/C17H19N3.C4H4O4/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20;5-3(6)1-2-4(7)8/h2-8,16H,9-12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-;/m1./s1",RPUBHMMISKEXSR-MLCLTIQSSA-N,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O,0.77029534660043,4.0,381.43200000000013,2.1907,5,2,1,93.97000000000001,-2.5562875886203993,0.672150456905365,-5.284971999779598,0.6498773276805878,-11.335688298150522,0.212741219997406,0.05130773857235908,0.8583219170570373,76.23680294303298,0.32968236247609256,0.01179179297760129,0.10334173291921615,0.04055877421051264,0.2072618067264557,0.007947223307564855,-17.81537576501765,6.859200864059231,-4.774139404724058,2.7992580790768686,0.11200354136526584,0.06277581974864006,0.5842316150665283,0.6959006547927856,0.17805449962615966,0.04971301052719355,0.009422612329944968,0.15014246106147766,0.021840042248368264,0.037520718201994895,0.005073449900373816,0.009460462955757976,0.010756984166800976,0.018468680046498775,0.008358011161908508,0.02280998444184661,0.3414964944124222,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,5389.0,1705104.0,1590761.0,Serotonin 2a (5-HT2a) receptor inverse agonist,,INVERSE AGONIST,1.0,1.0,1.0,,,,,PIMAVANSERIN TARTRATE,CHEMBL2448613,4.0,1.0,1.0,MOL,,Small molecule,2016.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2005.0,1.0,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/2C25H34FN3O2.C4H6O6/c2*1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21;5-1(3(7)8)2(6)4(9)10/h2*4-11,19,23H,12-18H2,1-3H3,(H,27,30);1-2,5-6H,(H,7,8)(H,9,10)",RGSULKHNAKTFIZ-UHFFFAOYSA-N,CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.O=C(O)C(O)C(O)C(=O)O,0.05518656817222764,1.0,1005.2139999999999,7.21040000000001,10,6,2,204.67999999999998,-3.162445142243599,0.6379301309585571,-5.801967028529296,0.6542375087738037,-10.610071090709422,0.20657237470149994,0.7636311411857605,0.20667978078126908,86.93533523056816,-8.885552795963251,0.034602722991257905,0.2128517210483551,0.14547450095415115,0.4294301599264145,0.17227690368890763,38.95461671227596,-30.631393031495115,23.31574779135968,3.1761234997363403,0.04930257312953472,0.15127186179161073,0.2773279145359993,0.5255466580390931,0.756990647315979,0.016153201833367346,0.004258202272467315,0.06443752571940423,0.00795459607616067,0.040220347605645655,0.020716306753456593,0.024530405178666115,0.006043101847171784,0.02963806502521038,0.08390293940901757,0.009410129394382238,0.1603885844349861,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,5391.0,2472913.0,120674.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,VOLINANSERIN,CHEMBL74355,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,,,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1",HXTGXYRHXAGCFP-OAQYLSRUSA-N,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,0.8009360645240826,4.0,373.46800000000013,3.831000000000003,4,1,1,41.93000000000001,-2.486725890249154,0.8770507216453552,-4.696785976705739,0.9995583415031433,-8.13939268843448,0.9499078512191772,0.9144040822982789,0.9711191058158875,60.07822967709253,3.601361909279889,0.050781185179948805,0.06135921627283096,0.0174572117626667,0.9303823351860047,0.14588962197303773,-0.39852104791250087,26.922598517050176,12.811279219397829,2.8155240031122752,0.12405490130186081,0.06002888530492782,0.5209420770406723,0.02559065129607916,0.9841587781906128,0.03615720719099045,0.0042147517669945955,0.06180728375911713,0.003534825728274882,0.037292739003896715,0.019968324899673463,0.0006099488819018006,0.000861654378240928,0.004761200398206711,0.010280140535905957,0.0012496514711529017,0.25907471477985383,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,5398.0,1705950.0,2197557.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,"Phase 3 study terminated, primary endpoint was not met on the double blind data (NCT01355874)",,,,IFERANSERIN,CHEMBL3989686,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C23H28N2O/c1-25-18-8-7-12-21(25)16-15-20-11-5-6-13-22(20)24-23(26)17-14-19-9-3-2-4-10-19/h2-6,9-11,13-14,17,21H,7-8,12,15-16,18H2,1H3,(H,24,26)/b17-14+/t21-/m0/s1",UXIPFQUBOVWAQW-UEBLJOKOSA-N,CN1CCCC[C@H]1CCc1ccccc1NC(=O)/C=C/c1ccccc1,0.7637790745627497,4.0,348.49000000000007,4.755400000000004,2,1,1,32.34,-3.621152700327513,0.7356648325920105,-4.972768761181895,0.9939873218536377,-8.111081426025844,0.9087871432304382,0.7617550015449523,0.9921060562133789,85.40017263090861,0.8479653325058372,0.20269744992256164,0.14021450504660607,0.016818247456103563,0.8607165575027466,0.06531560663133859,13.207305281688908,52.65915092427591,10.780457879663663,2.87016475800612,0.21178197115659714,0.14998882859945298,0.5862410247325898,0.25724211037158967,0.9718484520912171,0.037878749519586564,0.0230826361104846,0.08742256313562394,0.00958643089979887,0.12243022918701171,0.07971753068268299,0.004292134544812143,0.016579524055123328,0.03624859191477299,0.07024060785770417,0.03426242470741272,0.6992694020271302,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,5719.0,1705240.0,434796.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,EPLIVANSERIN,CHEMBL257704,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2009.0,,-anserin,0.0,-anserin,serotonin 5-HT2 receptor antagonists,,0.0,0.0,0.0,"InChI=1S/C19H21FN2O2/c1-22(2)13-14-24-21-19(17-5-3-4-6-18(17)20)12-9-15-7-10-16(23)11-8-15/h3-12,23H,13-14H2,1-2H3/b12-9+,21-19-",VAIOZOCLKVMIMN-PRJWTAEASA-N,CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F,0.4803680152352067,4.0,328.38700000000006,3.527000000000003,4,1,0,45.06,-3.0958654998731268,0.6623467803001404,-4.783426526058561,0.9859028935432435,-7.355135705849948,0.8300531387329102,0.6829884767532348,0.7880340456962586,83.8072252464665,-0.14810945442381424,0.46731585562229155,0.2767630875110626,0.13598732128739358,0.331240551173687,0.29716451168060304,3.5515208369745026,77.90566009890605,30.556764192608806,2.3465101591086444,0.6177122473716736,0.4508898854255676,0.35037173628807067,0.2973613262176514,0.8983006119728089,0.07947741858661175,0.02008879352360964,0.23280715048313141,0.15594188272953033,0.3374405950307846,0.19884457290172577,0.02323665823787451,0.1418358888477087,0.07046974897384643,0.20180842280387878,0.04595841467380524,0.5513637721538543,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,8813.0,1703680.0,80532.0,Serotonin 2a (5-HT2a) receptor antagonist,,ANTAGONIST,1.0,1.0,1.0,,,,,SARPOGRELATE,CHEMBL52939,3.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,-grel-,0.0,-grel-,"platelet aggregation inhibitors, primarily platelet P2Y12 receptor antagonists",,0.0,0.0,0.0,"InChI=1S/C24H31NO6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27)",FFYNAVGJSYHHFO-UHFFFAOYSA-N,COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1,0.48954068514813565,4.0,429.51300000000026,3.197400000000002,6,1,1,85.3,-2.9779377703164918,0.8495971441268921,-5.193570968283061,0.918730866909027,-7.905084395959902,0.7525681257247925,0.5336007565259934,0.5019082009792328,73.88425534957328,0.07332889497525015,0.08062513321638107,0.23625788390636443,0.05512007102370262,0.43116039633750913,0.5200629591941833,-20.51571401043798,75.40836420947058,33.16633061658116,2.2299423419296094,0.07192864790558814,0.10081034675240516,0.21266234368085862,0.3116435334086418,0.48745599389076233,0.021212439239025115,0.006659566238522529,0.09221862107515336,0.03908088617026806,0.013152614980936051,0.021295621898025273,0.07673412077128887,0.0026898681651800873,0.019696229323744773,0.007770255906507373,0.004354895232245326,0.3428517460823059,False
HTR2A,107,SINGLE PROTEIN,Serotonin 2a (5-HT2a) receptor,9606,Homo sapiens,CHEMBL224,,0.0,9255.0,1705886.0,331146.0,Serotonin 2a (5-HT2a) receptor agonist,,AGONIST,1.0,1.0,1.0,,,,,PSILOCYBINE,CHEMBL194378,3.0,0.0,0.0,MOL,8614.0,Small molecule,,0.0,0.0,0.0,0.0,1.0,0.0,2.0,1.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C12H17N2O4P/c1-14(2)7-6-9-8-13-10-4-3-5-11(12(9)10)18-19(15,16)17/h3-5,8,13H,6-7H2,1-2H3,(H2,15,16,17)",QVDSEJDULKLHCG-UHFFFAOYSA-N,CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12,0.728144977803554,4.0,284.252,1.7435,3,3,0,85.79,-1.3321075682609276,0.7429512679576874,-5.194892753604338,0.7814719915390015,-14.717348493230626,0.17543109580874444,0.009880700521171093,0.8924902677536011,63.59239685732079,10.046638240313664,0.06539824260398745,0.005851078708656132,0.0011364981066435576,0.2559504836797714,0.0009149560428340919,11.125110102539685,-11.053630958786592,-11.755572571585747,2.762716908916372,0.06854492798447609,0.04404625315219164,0.45309487283229827,0.4101769313216209,0.19935980215668678,0.045284361392259595,0.005042302515357732,0.10047804191708565,0.012671031802892686,0.05079875513911247,0.001147264486644417,6.266070577112259e-05,0.0007477126229787246,0.00026184989837929606,0.0015981393109541387,0.0037581084528937937,0.21453459411859513,False
SHP2_PTPN11,11523,SINGLE PROTEIN,Protein-tyrosine phosphatase 2C,9606,Homo sapiens,CHEMBL3864,,0.0,8244.0,3490332.0,2486781.0,Protein-tyrosine phosphatase 2C inhibitor,,INHIBITOR,1.0,1.0,1.0,Allosteric inhibitor,,,,BATOPROTAFIB,CHEMBL4650521,2.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,,,-protafib,0.0,-protafib,protein tyrosine phosphatase 1B inhibitors,,0.0,1.0,0.0,"InChI=1S/C18H24ClN7OS/c1-10-14(20)18(9-27-10)3-6-26(7-4-18)12-8-24-17(16(22)25-12)28-11-2-5-23-15(21)13(11)19/h2,5,8,10,14H,3-4,6-7,9,20H2,1H3,(H2,21,23)(H2,22,25)/t10-,14+/m0/s1",UCJZOKGUEJUNIO-IINYFYTJSA-N,C[C@@H]1OCC2(CCN(c3cnc(Sc4ccnc(N)c4Cl)c(N)n3)CC2)[C@@H]1N,0.6819096822823504,4.0,421.9580000000003,2.1732000000000005,9,3,2,129.2,-2.798278452698227,0.7989716291427612,-5.481025992590195,0.9980774521827698,-10.019095695789431,0.8675072073936463,0.1688467815518379,0.7393074750900268,82.1157138281583,11.012378173594463,0.06946169361472129,0.2514087721705437,0.3564359486103058,0.15737830400466918,0.4559948444366455,10.960428396291867,35.89097883575474,10.115034359758392,2.386079691499456,0.5469952404499054,0.05267409458756447,0.6309473752975464,0.659008264541626,0.8086689710617065,0.062469900399446485,0.061950328201055525,0.26140905916690826,0.1488535925745964,0.42968372702598573,0.62280433177948,0.0711497064679861,0.27528811544179915,0.1477984219789505,0.2855472952127457,0.3872411072254181,0.46696783900260924,False
EZH2,105440,SINGLE PROTEIN,Histone-lysine N-methyltransferase EZH2,9606,Homo sapiens,CHEMBL2189110,,0.0,7484.0,3133876.0,2464691.0,Histone-lysine N-methyltransferase EZH2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,Inhibits some EZH2 mutants including Y646X and A687V and inhibits EZH1 at an IC50 of 392 nM (36 x higher than for EZH2). ,,,TAZEMETOSTAT HYDROBROMIDE,CHEMBL4594260,4.0,1.0,1.0,MOL,,Small molecule,2020.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,2018.0,1.0,-stat,0.0,-stat (-metostat),enzyme inhibitors: histone N-methyl transferase inhibitors,,0.0,0.0,0.0,"InChI=1S/C34H44N4O4.BrH/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40;/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40);1H",UQRICAQPWZSJNF-UHFFFAOYSA-N,Br.CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,0.3257827815659002,2.0,653.662,5.312560000000005,6,2,0,86.9,-4.114055036590409,0.7452422142028808,-5.065810129907272,0.9758163928985596,-10.755526243207942,0.5881826341152191,0.9126735806465149,0.464214825630188,94.97635565065323,7.573133385583697,0.059189919754862784,0.5793213725090027,0.3972609132528305,0.15250068083405494,0.8419296383857727,99.1003915896191,32.42009712812495,37.98790409236068,2.434864357303319,0.27467742264270784,0.42451404333114623,0.5723246991634369,0.7830175399780274,0.8880812525749207,0.008653721027076244,0.010353937372565269,0.07454518452286721,0.04566748179495335,0.14748285263776778,0.08953645676374436,0.030847769230604172,0.08140752650797367,0.22566330432891846,0.4876768887042999,0.22308595478534698,0.3326383143663406,False
EZH2,105440,SINGLE PROTEIN,Histone-lysine N-methyltransferase EZH2,9606,Homo sapiens,CHEMBL2189110,,0.0,8597.0,3489928.0,1758265.0,Histone-lysine N-methyltransferase EZH2 inhibitor,,INHIBITOR,1.0,1.0,1.0,,,,,GSK2816126,CHEMBL3287735,1.0,0.0,0.0,MOL,,Small molecule,,0.0,0.0,0.0,0.0,0.0,0.0,-1.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0,"InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39)/t22-/m0/s1",FKSFKBQGSFSOSM-QFIPXVFZSA-N,CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3ccc(N4CCNCC4)nc3)cc21,0.32651181139960866,3.0,526.6850000000003,4.627460000000004,6,3,1,95.05,-4.077014071920207,0.6749528408050537,-5.267205163950357,0.9956904649734497,-11.06585473512481,0.8488448739051819,0.8767356276512146,0.4087876081466675,90.01986550588657,12.866442383713842,0.19896710366010667,0.6338915348052978,0.7062963604927063,0.10060159713029862,0.8899057507514954,108.23315817789758,10.873455439376304,37.672439308872484,3.069177811526912,0.17692867219448088,0.3468243658542633,0.616707706451416,0.9232432961463928,0.9389485836029052,0.01877344762906432,0.017357847839593887,0.06849748715758323,0.02631670590490103,0.27300684750080106,0.10777269676327705,0.044523341953754424,0.06137329563498497,0.10005065947771072,0.3760219275951385,0.24957314431667327,0.19978486895561218,False
